0001877322-23-000007.txt : 20230307 0001877322-23-000007.hdr.sgml : 20230307 20230307064304 ACCESSION NUMBER: 0001877322-23-000007 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 129 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230307 DATE AS OF CHANGE: 20230307 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ESAB Corp CENTRAL INDEX KEY: 0001877322 STANDARD INDUSTRIAL CLASSIFICATION: GENERAL INDUSTRIAL MACHINERY & EQUIPMENT, NEC [3569] IRS NUMBER: 870923837 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41297 FILM NUMBER: 23710985 BUSINESS ADDRESS: STREET 1: 909 ROSE AVENUE STREET 2: 8TH FLOOR CITY: NORTH BETHESDA STATE: MD ZIP: 20852 BUSINESS PHONE: (302) 252-9160 MAIL ADDRESS: STREET 1: 909 ROSE AVENUE STREET 2: 8TH FLOOR CITY: NORTH BETHESDA STATE: MD ZIP: 20852 10-K 1 cfx-20221231.htm 10-K cfx-20221231
0001877322falseFY20220.333P10Yhttp://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent00018773222022-01-012022-12-3100018773222022-07-01iso4217:USD00018773222023-02-28xbrli:shares00018773222021-01-012021-12-3100018773222020-01-012020-12-31iso4217:USDxbrli:shares00018773222022-12-3100018773222021-12-310001877322us-gaap:CommonStockMember2019-12-310001877322us-gaap:AdditionalPaidInCapitalMember2019-12-310001877322us-gaap:RetainedEarningsMember2019-12-310001877322cfx:FormerParentInvestmentMember2019-12-310001877322us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001877322us-gaap:NoncontrollingInterestMember2019-12-3100018773222019-12-310001877322cfx:FormerParentInvestmentMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310001877322us-gaap:NoncontrollingInterestMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310001877322srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310001877322cfx:FormerParentInvestmentMember2020-01-012020-12-310001877322us-gaap:NoncontrollingInterestMember2020-01-012020-12-310001877322us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310001877322us-gaap:CommonStockMember2020-12-310001877322us-gaap:AdditionalPaidInCapitalMember2020-12-310001877322us-gaap:RetainedEarningsMember2020-12-310001877322cfx:FormerParentInvestmentMember2020-12-310001877322us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001877322us-gaap:NoncontrollingInterestMember2020-12-3100018773222020-12-310001877322cfx:FormerParentInvestmentMember2021-01-012021-12-310001877322us-gaap:NoncontrollingInterestMember2021-01-012021-12-310001877322us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310001877322us-gaap:CommonStockMember2021-12-310001877322us-gaap:AdditionalPaidInCapitalMember2021-12-310001877322us-gaap:RetainedEarningsMember2021-12-310001877322cfx:FormerParentInvestmentMember2021-12-310001877322us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001877322us-gaap:NoncontrollingInterestMember2021-12-310001877322us-gaap:RetainedEarningsMember2022-01-012022-12-310001877322cfx:FormerParentInvestmentMember2022-01-012022-12-310001877322us-gaap:NoncontrollingInterestMember2022-01-012022-12-310001877322us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001877322us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-12-310001877322us-gaap:CommonStockMember2022-01-012022-12-310001877322us-gaap:CommonStockMember2022-12-310001877322us-gaap:AdditionalPaidInCapitalMember2022-12-310001877322us-gaap:RetainedEarningsMember2022-12-310001877322cfx:FormerParentInvestmentMember2022-12-310001877322us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001877322us-gaap:NoncontrollingInterestMember2022-12-31cfx:segment0001877322us-gaap:UnfundedPlanMember2022-03-212022-03-21cfx:plan0001877322us-gaap:CommonStockMember2022-04-042022-04-04xbrli:pure0001877322cfx:EnovisCorporationMembercfx:ESABCorporationMember2022-04-040001877322cfx:EnovisCorporationMember2022-04-040001877322cfx:TheCreditAgreementMember2022-04-042022-04-040001877322cfx:EnovisCorporationMember2022-04-042022-04-040001877322us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMembercountry:RU2022-01-012022-12-310001877322country:RU2022-01-012022-12-310001877322us-gaap:GeographicConcentrationRiskMembercountry:RUus-gaap:AssetsTotalMember2022-01-012022-12-310001877322us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001877322cfx:EnovisCorporationMemberus-gaap:CommonStockMember2022-04-042022-04-04cfx:reporting_unit0001877322cfx:AcquiredTradeNamesCustomerRelationshipsAcquiredTechnologyAndSoftwareLicenseAgreementsMembersrt:MinimumMember2022-01-012022-12-310001877322cfx:AcquiredTradeNamesCustomerRelationshipsAcquiredTechnologyAndSoftwareLicenseAgreementsMembersrt:MaximumMember2022-01-012022-12-310001877322us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-12-310001877322us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-12-310001877322us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-12-310001877322us-gaap:OtherNonoperatingIncomeExpenseMember2022-01-012022-12-310001877322us-gaap:OtherNonoperatingIncomeExpenseMember2021-01-012021-12-310001877322us-gaap:OtherNonoperatingIncomeExpenseMember2020-01-012020-12-310001877322us-gaap:SellingGeneralAndAdministrativeExpensesMembercurrency:ARS2022-01-012022-12-310001877322us-gaap:OtherNonoperatingIncomeExpenseMembercurrency:ARS2022-01-012022-12-310001877322currency:ARS2022-01-012022-12-310001877322cfx:AsbestosRelatedActivityMember2022-01-012022-12-310001877322cfx:OhioMedicalLLCMember2022-10-172022-10-170001877322cfx:OhioMedicalLLCMember2022-10-142022-10-140001877322cfx:SwiftCutAutomationLimitedMember2022-10-312022-10-310001877322cfx:ConsumableProductsMember2022-01-012022-12-310001877322cfx:EquipmentProductsMember2021-01-012021-12-310001877322cfx:EquipmentProductsMember2020-01-012020-12-310001877322cfx:EquipmentProductsMember2022-01-012022-12-310001877322cfx:ConsumableProductsMember2021-01-012021-12-310001877322cfx:ConsumableProductsMember2020-01-012020-12-3100018773222022-04-042022-04-040001877322us-gaap:OtherAssetsMember2022-12-310001877322us-gaap:OtherAssetsMember2021-12-310001877322us-gaap:OtherLiabilitiesMember2022-12-310001877322us-gaap:OtherLiabilitiesMember2021-12-310001877322us-gaap:ForeignCountryMember2022-12-310001877322srt:ScenarioForecastMember2023-01-012023-04-010001877322cfx:AmericasBusinessSegmentMember2020-12-310001877322cfx:EMEAAPACBusinessSegmentMember2020-12-310001877322cfx:AmericasBusinessSegmentMember2021-01-012021-12-310001877322cfx:EMEAAPACBusinessSegmentMember2021-01-012021-12-310001877322cfx:AmericasBusinessSegmentMember2021-12-310001877322cfx:EMEAAPACBusinessSegmentMember2021-12-310001877322cfx:AmericasBusinessSegmentMember2022-01-012022-12-310001877322cfx:EMEAAPACBusinessSegmentMember2022-01-012022-12-310001877322cfx:AmericasBusinessSegmentMember2022-12-310001877322cfx:EMEAAPACBusinessSegmentMember2022-12-310001877322us-gaap:TradeNamesMember2022-01-012022-12-310001877322us-gaap:TradeNamesMember2021-01-012021-12-310001877322us-gaap:CustomerRelationshipsMember2022-12-310001877322us-gaap:CustomerRelationshipsMember2021-12-310001877322us-gaap:TechnologyBasedIntangibleAssetsMember2022-12-310001877322us-gaap:TechnologyBasedIntangibleAssetsMember2021-12-310001877322us-gaap:TradeNamesMember2022-12-310001877322us-gaap:TradeNamesMember2021-12-310001877322us-gaap:ComputerSoftwareIntangibleAssetMember2022-12-310001877322us-gaap:ComputerSoftwareIntangibleAssetMember2021-12-310001877322us-gaap:OtherIntangibleAssetsMember2022-12-310001877322us-gaap:OtherIntangibleAssetsMember2021-12-310001877322us-gaap:LandMember2022-12-310001877322us-gaap:LandMember2021-12-310001877322srt:MinimumMemberus-gaap:BuildingAndBuildingImprovementsMember2022-01-012022-12-310001877322srt:MaximumMemberus-gaap:BuildingAndBuildingImprovementsMember2022-01-012022-12-310001877322us-gaap:BuildingAndBuildingImprovementsMember2022-12-310001877322us-gaap:BuildingAndBuildingImprovementsMember2021-12-310001877322us-gaap:MachineryAndEquipmentMembersrt:MinimumMember2022-01-012022-12-310001877322us-gaap:MachineryAndEquipmentMembersrt:MaximumMember2022-01-012022-12-310001877322us-gaap:MachineryAndEquipmentMember2022-12-310001877322us-gaap:MachineryAndEquipmentMember2021-12-310001877322us-gaap:PropertyPlantAndEquipmentMember2022-01-012022-12-310001877322us-gaap:PropertyPlantAndEquipmentMember2021-01-012021-12-310001877322us-gaap:PropertyPlantAndEquipmentMember2020-01-012020-12-310001877322us-gaap:EmployeeSeveranceMembercfx:AmericasBusinessSegmentMember2021-12-310001877322us-gaap:EmployeeSeveranceMembercfx:AmericasBusinessSegmentMember2022-01-012022-12-310001877322us-gaap:EmployeeSeveranceMembercfx:AmericasBusinessSegmentMember2022-12-310001877322us-gaap:FacilityClosingMembercfx:AmericasBusinessSegmentMember2021-12-310001877322us-gaap:FacilityClosingMembercfx:AmericasBusinessSegmentMember2022-01-012022-12-310001877322us-gaap:FacilityClosingMembercfx:AmericasBusinessSegmentMember2022-12-310001877322us-gaap:EmployeeSeveranceMembercfx:EMEAAndAPACSegmentMember2021-12-310001877322us-gaap:EmployeeSeveranceMembercfx:EMEAAndAPACSegmentMember2022-01-012022-12-310001877322us-gaap:EmployeeSeveranceMembercfx:EMEAAndAPACSegmentMember2022-12-310001877322cfx:EMEAAndAPACSegmentMemberus-gaap:FacilityClosingMember2021-12-310001877322cfx:EMEAAndAPACSegmentMemberus-gaap:FacilityClosingMember2022-01-012022-12-310001877322cfx:EMEAAndAPACSegmentMemberus-gaap:FacilityClosingMember2022-12-310001877322cfx:EMEAAndAPACSegmentMember2021-12-310001877322cfx:EMEAAndAPACSegmentMember2022-01-012022-12-310001877322cfx:EMEAAndAPACSegmentMember2022-12-310001877322us-gaap:EmployeeSeveranceMembercfx:AmericasBusinessSegmentMember2020-12-310001877322us-gaap:EmployeeSeveranceMembercfx:AmericasBusinessSegmentMember2021-01-012021-12-310001877322us-gaap:FacilityClosingMembercfx:AmericasBusinessSegmentMember2020-12-310001877322us-gaap:FacilityClosingMembercfx:AmericasBusinessSegmentMember2021-01-012021-12-310001877322us-gaap:EmployeeSeveranceMembercfx:EMEAAndAPACSegmentMember2020-12-310001877322us-gaap:EmployeeSeveranceMembercfx:EMEAAndAPACSegmentMember2021-01-012021-12-310001877322cfx:EMEAAndAPACSegmentMemberus-gaap:FacilityClosingMember2020-12-310001877322cfx:EMEAAndAPACSegmentMemberus-gaap:FacilityClosingMember2021-01-012021-12-310001877322cfx:EMEAAndAPACSegmentMember2020-12-310001877322cfx:EMEAAndAPACSegmentMember2021-01-012021-12-310001877322us-gaap:PensionPlansDefinedBenefitMembercfx:FormerParentMember2021-12-310001877322us-gaap:PensionPlansDefinedBenefitMemberus-gaap:UnfundedPlanMembercfx:FormerParentMember2021-01-012021-12-310001877322us-gaap:PensionPlansDefinedBenefitMemberus-gaap:UnfundedPlanMembercfx:FormerParentMember2021-12-310001877322us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMembercfx:FormerParentMember2021-01-012021-12-310001877322us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMembercfx:FormerParentMember2021-12-310001877322us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-12-310001877322us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001877322us-gaap:PensionPlansDefinedBenefitMember2021-12-310001877322us-gaap:PensionPlansDefinedBenefitMember2020-12-310001877322us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-12-310001877322us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-12-310001877322us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-12-310001877322us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-12-310001877322us-gaap:PensionPlansDefinedBenefitMember2022-12-310001877322us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-012022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001877322us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001877322cfx:U.S.EquitySecuritiesMembercountry:US2022-12-310001877322cfx:U.S.EquitySecuritiesMembercountry:US2021-12-310001877322cfx:InternationalEquitySecuritiesMembercountry:US2022-12-310001877322cfx:InternationalEquitySecuritiesMembercountry:US2021-12-310001877322us-gaap:FixedIncomeSecuritiesMembercountry:US2022-12-310001877322us-gaap:FixedIncomeSecuritiesMembercountry:US2021-12-310001877322us-gaap:CashAndCashEquivalentsMembercountry:US2022-12-310001877322us-gaap:CashAndCashEquivalentsMembercountry:US2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:EquitySecuritiesMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:EquitySecuritiesMember2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FixedIncomeSecuritiesMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FixedIncomeSecuritiesMember2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:CashAndCashEquivalentsMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:CashAndCashEquivalentsMember2021-12-310001877322us-gaap:ForeignPlanMembercfx:DefinedBenefitPlanInsuranceContractsMember2022-12-310001877322us-gaap:ForeignPlanMembercfx:DefinedBenefitPlanInsuranceContractsMember2021-12-310001877322us-gaap:ForeignPlanMembercfx:DefinedBenefitPlanInvestmentFundsMember2022-12-310001877322us-gaap:ForeignPlanMembercfx:DefinedBenefitPlanInvestmentFundsMember2021-12-310001877322us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:CashAndCashEquivalentsMembercountry:US2022-12-310001877322us-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Membercountry:US2022-12-310001877322us-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel2Membercountry:US2022-12-310001877322us-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel3Membercountry:US2022-12-310001877322us-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercountry:USus-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember2022-12-310001877322us-gaap:FairValueInputsLevel1Membercountry:USus-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember2022-12-310001877322us-gaap:FairValueInputsLevel2Membercountry:USus-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember2022-12-310001877322us-gaap:FairValueInputsLevel3Membercountry:USus-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember2022-12-310001877322country:USus-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember2022-12-310001877322us-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercfx:DefinedBenefitPlanEquitySecuritiesUSMidSmallCapMembercountry:US2022-12-310001877322cfx:DefinedBenefitPlanEquitySecuritiesUSMidSmallCapMemberus-gaap:FairValueInputsLevel1Membercountry:US2022-12-310001877322cfx:DefinedBenefitPlanEquitySecuritiesUSMidSmallCapMemberus-gaap:FairValueInputsLevel2Membercountry:US2022-12-310001877322cfx:DefinedBenefitPlanEquitySecuritiesUSMidSmallCapMemberus-gaap:FairValueInputsLevel3Membercountry:US2022-12-310001877322cfx:DefinedBenefitPlanEquitySecuritiesUSMidSmallCapMembercountry:US2022-12-310001877322us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercountry:US2022-12-310001877322us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel1Membercountry:US2022-12-310001877322us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel2Membercountry:US2022-12-310001877322us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel3Membercountry:US2022-12-310001877322us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMembercountry:US2022-12-310001877322cfx:USGovernmentAgenciesDebtSecuritiesAndCorporateDebtSecuritiesMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercountry:US2022-12-310001877322cfx:USGovernmentAgenciesDebtSecuritiesAndCorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Membercountry:US2022-12-310001877322cfx:USGovernmentAgenciesDebtSecuritiesAndCorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Membercountry:US2022-12-310001877322cfx:USGovernmentAgenciesDebtSecuritiesAndCorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Membercountry:US2022-12-310001877322cfx:USGovernmentAgenciesDebtSecuritiesAndCorporateDebtSecuritiesMembercountry:US2022-12-310001877322us-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercfx:DefinedBenefitPlanOtherFixedIncomeMutualFundsMembercountry:US2022-12-310001877322cfx:DefinedBenefitPlanOtherFixedIncomeMutualFundsMemberus-gaap:FairValueInputsLevel1Membercountry:US2022-12-310001877322cfx:DefinedBenefitPlanOtherFixedIncomeMutualFundsMemberus-gaap:FairValueInputsLevel2Membercountry:US2022-12-310001877322cfx:DefinedBenefitPlanOtherFixedIncomeMutualFundsMemberus-gaap:FairValueInputsLevel3Membercountry:US2022-12-310001877322cfx:DefinedBenefitPlanOtherFixedIncomeMutualFundsMembercountry:US2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:CashAndCashEquivalentsMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Member2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel2Member2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel3Member2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:EquitySecuritiesMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EquitySecuritiesMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EquitySecuritiesMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMember2022-12-310001877322us-gaap:ForeignPlanMembercfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMemberus-gaap:FairValueInputsLevel1Member2022-12-310001877322us-gaap:ForeignPlanMembercfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMemberus-gaap:FairValueInputsLevel2Member2022-12-310001877322us-gaap:ForeignPlanMembercfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMemberus-gaap:FairValueInputsLevel3Member2022-12-310001877322us-gaap:ForeignPlanMembercfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMember2022-12-310001877322us-gaap:ForeignPlanMembercfx:DefinedBenefitPlanInsuranceContractsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-12-310001877322us-gaap:ForeignPlanMembercfx:DefinedBenefitPlanInsuranceContractsMemberus-gaap:FairValueInputsLevel1Member2022-12-310001877322us-gaap:ForeignPlanMembercfx:DefinedBenefitPlanInsuranceContractsMemberus-gaap:FairValueInputsLevel2Member2022-12-310001877322us-gaap:ForeignPlanMembercfx:DefinedBenefitPlanInsuranceContractsMemberus-gaap:FairValueInputsLevel3Member2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercfx:DefinedBenefitPlanInvestmentFundsMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel1Membercfx:DefinedBenefitPlanInvestmentFundsMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel2Membercfx:DefinedBenefitPlanInvestmentFundsMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel3Membercfx:DefinedBenefitPlanInvestmentFundsMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercfx:DefinedBenefitPlanOtherAssetsMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel1Membercfx:DefinedBenefitPlanOtherAssetsMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel2Membercfx:DefinedBenefitPlanOtherAssetsMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel3Membercfx:DefinedBenefitPlanOtherAssetsMember2022-12-310001877322us-gaap:ForeignPlanMembercfx:DefinedBenefitPlanOtherAssetsMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel1Member2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel2Member2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel3Member2022-12-310001877322us-gaap:ForeignPlanMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:CashAndCashEquivalentsMember2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel2Member2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:EquitySecuritiesMember2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EquitySecuritiesMember2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EquitySecuritiesMember2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMember2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMember2021-12-310001877322us-gaap:ForeignPlanMembercfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMemberus-gaap:FairValueInputsLevel1Member2021-12-310001877322us-gaap:ForeignPlanMembercfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMemberus-gaap:FairValueInputsLevel2Member2021-12-310001877322us-gaap:ForeignPlanMembercfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMemberus-gaap:FairValueInputsLevel3Member2021-12-310001877322us-gaap:ForeignPlanMembercfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMember2021-12-310001877322us-gaap:ForeignPlanMembercfx:DefinedBenefitPlanInsuranceContractsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2021-12-310001877322us-gaap:ForeignPlanMembercfx:DefinedBenefitPlanInsuranceContractsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001877322us-gaap:ForeignPlanMembercfx:DefinedBenefitPlanInsuranceContractsMemberus-gaap:FairValueInputsLevel2Member2021-12-310001877322us-gaap:ForeignPlanMembercfx:DefinedBenefitPlanInsuranceContractsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercfx:DefinedBenefitPlanInvestmentFundsMember2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel1Membercfx:DefinedBenefitPlanInvestmentFundsMember2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel2Membercfx:DefinedBenefitPlanInvestmentFundsMember2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel3Membercfx:DefinedBenefitPlanInvestmentFundsMember2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercfx:DefinedBenefitPlanOtherAssetsMember2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel1Membercfx:DefinedBenefitPlanOtherAssetsMember2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel2Membercfx:DefinedBenefitPlanOtherAssetsMember2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel3Membercfx:DefinedBenefitPlanOtherAssetsMember2021-12-310001877322us-gaap:ForeignPlanMembercfx:DefinedBenefitPlanOtherAssetsMember2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel1Member2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel2Member2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel3Member2021-12-310001877322us-gaap:ForeignPlanMember2021-12-310001877322us-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001877322us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-12-310001877322us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001877322us-gaap:ForeignPlanMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-12-310001877322us-gaap:ForeignPlanMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-12-310001877322us-gaap:ForeignPlanMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-12-310001877322us-gaap:LineOfCreditMembercfx:TheCreditAgreementMemberus-gaap:SecuredDebtMember2022-12-310001877322us-gaap:LineOfCreditMembercfx:TheCreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2022-12-310001877322us-gaap:LineOfCreditMembercfx:TheCreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2022-04-040001877322us-gaap:LineOfCreditMembercfx:TheCreditAgreementMemberus-gaap:SecuredDebtMember2022-04-040001877322cfx:TheCreditAgreementMemberus-gaap:SecuredDebtMemberus-gaap:SeniorNotesMember2022-04-040001877322cfx:TheCreditAgreementMemberus-gaap:SecuredDebtMemberus-gaap:SeniorNotesMember2022-04-042022-04-040001877322us-gaap:LetterOfCreditMemberus-gaap:LineOfCreditMembercfx:TheCreditAgreementMember2022-04-040001877322us-gaap:LineOfCreditMembercfx:TheCreditAgreementMemberus-gaap:BridgeLoanMember2022-04-040001877322us-gaap:LineOfCreditMembercfx:TheCreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2022-04-042022-04-040001877322us-gaap:LineOfCreditMembercfx:TheCreditAgreementMemberus-gaap:SecuredDebtMember2022-04-042022-04-040001877322cfx:TheCreditAgreementMemberus-gaap:SecuredDebtMemberus-gaap:SeniorNotesMember2022-06-280001877322us-gaap:LineOfCreditMembercfx:TheCreditAgreementMember2022-12-310001877322us-gaap:LineOfCreditMembercfx:TheCreditAgreementMembersrt:ScenarioForecastMember2023-06-300001877322us-gaap:LineOfCreditMembercfx:TheCreditAgreementMembersrt:ScenarioForecastMember2024-06-300001877322cfx:TheCreditAgreementMembersrt:MinimumMember2022-04-042022-04-040001877322cfx:TheCreditAgreementMembersrt:MaximumMember2022-04-042022-04-040001877322us-gaap:BaseRateMembercfx:TheCreditAgreementMembersrt:MinimumMember2022-04-042022-04-040001877322us-gaap:BaseRateMembercfx:TheCreditAgreementMembersrt:MaximumMember2022-04-042022-04-040001877322cfx:TheCreditAgreementMember2022-12-310001877322us-gaap:LetterOfCreditMembercfx:UncommittedCreditLineMember2022-12-310001877322us-gaap:LetterOfCreditMember2022-12-310001877322us-gaap:LongTermDebtMember2022-12-310001877322us-gaap:InterestRateSwapMember2022-07-14cfx:agreement0001877322srt:MinimumMemberus-gaap:InterestRateSwapMember2022-07-140001877322srt:MaximumMemberus-gaap:InterestRateSwapMember2022-07-140001877322us-gaap:InterestRateSwapMember2022-12-310001877322us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2022-01-012022-12-310001877322cfx:InterestExpenseIncomeAndOtherNetMemberus-gaap:InterestRateSwapMember2022-01-012022-12-310001877322us-gaap:ForeignExchangeContractMember2022-07-220001877322us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-31iso4217:EUR0001877322us-gaap:InterestRateSwapMember2022-01-012022-12-310001877322us-gaap:ForeignExchangeContractMember2022-12-310001877322us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2022-12-310001877322us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2021-12-310001877322us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2022-01-012022-12-310001877322us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2021-01-012021-12-310001877322us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2020-01-012020-12-310001877322us-gaap:FairValueInputsLevel1Member2022-12-310001877322us-gaap:FairValueInputsLevel2Member2022-12-310001877322us-gaap:FairValueInputsLevel3Member2022-12-310001877322us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel1Member2022-12-310001877322us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Member2022-12-310001877322us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel3Member2022-12-310001877322us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel1Member2022-12-310001877322us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Member2022-12-310001877322us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel3Member2022-12-310001877322us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001877322us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001877322us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001877322us-gaap:FairValueInputsLevel1Member2021-12-310001877322us-gaap:FairValueInputsLevel2Member2021-12-310001877322us-gaap:FairValueInputsLevel3Member2021-12-310001877322us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel1Member2021-12-310001877322us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Member2021-12-310001877322us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel3Member2021-12-310001877322us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-310001877322us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310001877322cfx:AccumulatedGainLossNetInvestmentHedgesParentMember2019-12-310001877322us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-12-310001877322us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-12-310001877322cfx:AccumulatedGainLossNetInvestmentHedgesParentMember2020-01-012020-12-310001877322us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-01-012020-12-310001877322us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-12-310001877322us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310001877322us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310001877322cfx:AccumulatedGainLossNetInvestmentHedgesParentMember2020-12-310001877322us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-12-310001877322us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-12-310001877322cfx:AccumulatedGainLossNetInvestmentHedgesParentMember2021-01-012021-12-310001877322us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-12-310001877322us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-12-310001877322us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310001877322us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001877322cfx:AccumulatedGainLossNetInvestmentHedgesParentMember2021-12-310001877322us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310001877322us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-12-310001877322us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-12-310001877322cfx:AccumulatedGainLossNetInvestmentHedgesParentMember2022-01-012022-12-310001877322us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-12-310001877322us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310001877322cfx:AccumulatedGainLossNetInvestmentHedgesParentMember2022-12-310001877322us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-3100018773222022-01-012022-04-010001877322us-gaap:EmployeeStockOptionMembersrt:MaximumMember2022-01-012022-12-310001877322us-gaap:EmployeeStockOptionMember2022-01-012022-12-310001877322us-gaap:PerformanceSharesMember2022-01-012022-12-310001877322us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001877322us-gaap:PerformanceSharesMember2021-12-310001877322us-gaap:RestrictedStockUnitsRSUMember2021-12-310001877322us-gaap:PerformanceSharesMember2022-12-310001877322us-gaap:RestrictedStockUnitsRSUMember2022-12-31cfx:claim0001877322cfx:AmericasSegmentMember2022-01-012022-12-310001877322cfx:AmericasSegmentMember2021-01-012021-12-310001877322cfx:AmericasSegmentMember2020-01-012020-12-310001877322cfx:EMEAAndAPACSegmentMember2020-01-012020-12-310001877322country:US2022-01-012022-12-310001877322country:US2021-01-012021-12-310001877322country:US2020-01-012020-12-310001877322cfx:AmericasSegmentMember2022-12-310001877322cfx:AmericasSegmentMember2021-12-310001877322country:US2022-12-310001877322country:US2021-12-310001877322country:CZ2022-12-310001877322country:CZ2021-12-310001877322country:IN2022-12-310001877322country:IN2021-12-310001877322country:RU2022-12-310001877322country:RU2021-12-310001877322country:MX2022-12-310001877322country:MX2021-12-310001877322cfx:OtherForeignCountriesMember2022-12-310001877322cfx:OtherForeignCountriesMember2021-12-310001877322srt:AffiliatedEntityMember2022-01-012022-04-010001877322srt:AffiliatedEntityMember2021-01-012021-12-310001877322srt:AffiliatedEntityMember2020-01-012020-12-310001877322us-gaap:SubsequentEventMember2023-01-132023-01-130001877322us-gaap:SubsequentEventMember2023-03-022023-03-020001877322cfx:TherapyEquipmentLimitedMemberus-gaap:SubsequentEventMember2023-01-112023-01-110001877322us-gaap:AllowanceForCreditLossMember2021-12-310001877322us-gaap:AllowanceForCreditLossMember2022-01-012022-12-310001877322us-gaap:AllowanceForCreditLossMember2022-12-310001877322us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2021-12-310001877322us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2022-01-012022-12-310001877322us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2022-12-310001877322us-gaap:AllowanceForCreditLossMember2020-12-310001877322us-gaap:AllowanceForCreditLossMember2021-01-012021-12-310001877322us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2020-12-310001877322us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2021-01-012021-12-310001877322us-gaap:AllowanceForCreditLossMember2019-12-310001877322us-gaap:AllowanceForCreditLossMember2020-01-012020-12-310001877322us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2019-12-310001877322us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2020-01-012020-12-310001877322cfx:TransferredFromFormerParentMember2022-01-012022-12-31

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________
Form 10-K
☑      ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2022
OR
☐     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _______to_______

Commission File No. 001-41297
_________________________
ESAB CORPORATION
(Exact name of registrant as specified in its charter)
Delaware87-0923837
(State or other jurisdiction of(I.R.S. Employer
incorporation or organization)Identification Number)
909 Rose Avenue 8th Floor
North Bethesda Maryland
20852
(Address of principal executive offices)(Zip Code)

301-323-9099
(Registrant’s telephone number, including area code)
_________________________

SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:
TITLE OF EACH CLASSTrading Symbol(s)NAME OF EACH EXCHANGE ON WHICH REGISTERED
Common Stock, par value $0.001 per share
ESAB
New York Stock Exchange

SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT:
None
_________________________
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐  No ☑

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☑

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐     Accelerated filer ☐    Non-accelerated filer ☑ Smaller reporting company ☐    Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

The aggregate market value of common shares held by non-affiliates of the Registrant on July 1, 2022 was $2.625 billion based upon the aggregate price of the registrant’s common shares as quoted on the New York Stock Exchange composite tape on such date.

As of February 28, 2023, the number of shares of the Registrant’s common stock outstanding was 60,194,601.

EXHIBIT INDEX APPEARS ON PAGE
DOCUMENTS INCORPORATED BY REFERENCE

Part III incorporates certain information by reference from the Registrant’s definitive proxy statement for its 2023 annual meeting of stockholders (the “2023 Proxy Statement”) to be filed pursuant to Regulation 14A within 120 days after the end of the Registrant’s fiscal year covered by this report. With the exception of the sections of the 2023 Proxy Statement specifically incorporated herein by reference, the 2023 Proxy Statement is not deemed to be filed as part of this Form 10-K.


TABLE OF CONTENTS
ItemDescriptionPage
Special Note Regarding Forward-Looking Statements
Part I
1Business
1ARisk Factors
1BUnresolved Staff Comments
2Properties
3Legal Proceedings
4Mine Safety Disclosures
Information about our Executive Officers
Part II
5Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
6Selected Financial Data
7Management’s Discussion and Analysis of Financial Condition and Results of Operations
7AQuantitative and Qualitative Disclosures About Market Risk
8Financial Statements and Supplementary Data
9Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
9AControls and Procedures
9BOther Information
Part III
10Directors, Executive Officers and Corporate Governance
11Executive Compensation
12Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
13Certain Relationships and Related Transactions, and Director Independence
14Principal Accountant Fees and Services
Part IV
15Exhibits and Financial Statement Schedules
16Form 10-K Summary
Signatures
1

Unless otherwise indicated, references in this Annual Report on Form 10-K (this “Form 10-K”) to “ESAB,” “the Company,” “we,” “our,” and “us” refer to ESAB Corporation and its subsidiaries.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

Some of the statements contained in this Form 10-K that are not historical facts are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Exchange Act. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this Form 10-K is filed with the Securities and Exchange Commission (the “SEC”). All statements other than statements of historical fact are statements that could be deemed to be forward-looking statements, including statements regarding: anticipated benefits of ESAB’s separation (“the Separation”) from Enovis Corporation, formerly known as Colfax Corporation (“Enovis,” “Colfax” or “The Former Parent”); the expected financial and operating performance of, and future opportunities for, the Company following the Separation; the tax treatment of the Separation; the impact of COVID-19, including the actions by governments, businesses, and individuals in response to the situation, on the global and regional economies, financial markets, and overall demand for our products; projections of revenue, profit margins, expenses, tax provisions and tax rates, earnings or losses from operations, impact of foreign exchange rates, cash flows, pension and benefit obligations and funding requirements, synergies or other financial items; plans, strategies and objectives of our management for future operations including statements relating to potential acquisitions, compensation plans or purchase commitments; developments, performance or industry or market rankings relating to products or services; future economic conditions or performance; the outcome of outstanding claims or legal proceedings including asbestos-related liabilities and insurance coverage litigation; potential gains and recoveries of costs; assumptions underlying any of the foregoing; and any other statements that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. Forward-looking statements may be, but not always characterized by terminology such as “believe,” “anticipate,” “should,” “would,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy,” “targets,” “aims,” “seeks,” “sees,” and similar expressions. These statements are based on assumptions and assessments made by our management as of the filing of this Form 10-K in light of their experience and perception of historical trends, current conditions, expected future developments and other factors we believe to be appropriate. These forward-looking statements are subject to a number of risks and uncertainties and actual results or outcomes could differ materially due to numerous factors, including but not limited to the following:

•our ability to operate as a stand-alone public company;

•our ability to achieve the intended benefits from the Separation;

•the war in Ukraine and escalating geopolitical tensions as a result of Russia’s invasion of Ukraine and the related impact on energy supplies and prices;

•changes in the general economy, as well as the cyclical nature of the markets we serve;

•supply chain constraints and backlogs, including risks affecting raw material, part and component availability, labor shortages and inefficiencies, freight and logistical challenges, and inflation in raw material, part, component, freight and delivery costs and our ability to increase our prices to account for increased costs;

•the impact of the COVID-19 global pandemic, including actions taken in response, including supply chain disruptions, the impact on creditworthiness and financial viability of customers, and other impacts on our business and ability to execute business continuity plans;

•volatility in the commodity markets and certain commodity prices, including oil and steel;

•our ability to identify, finance, acquire and successfully integrate attractive acquisition targets;

•our exposure to unanticipated liabilities resulting from acquisitions;

•significant movements in foreign currency exchange rates or inflation rates;

•our ability and the ability of our customers to access required capital at a reasonable cost;
2


•our ability to accurately estimate the cost of or realize savings from our restructuring programs;

•the amount of, and our ability to estimate our asbestos-related liabilities;

•the solvency of our insurers and the likelihood of their payment for asbestos-related costs;

•material disruptions at any of our manufacturing facilities;

•noncompliance with various laws and regulations associated with our international operations, including anti-bribery laws, export control regulations and sanctions and embargoes;

•risks associated with our international operations, including risks from trade protection measures and other changes in trade relations;

•risks associated with the representation of our employees by trade unions and work councils;

•our exposure to product liability claims;

•potential costs and liabilities associated with environmental, health and safety laws and regulations;

•failure to maintain, protect and defend our intellectual property rights;

•our ability to attract and retain employees including the loss of key members of our leadership team;

•restrictions in our financing arrangements that may limit our flexibility in operating our business;

•impairment in the value of intangible assets;

•the funding requirements or obligations of our defined benefit pension plans and other postretirement benefit plans;

•new regulations and customer preferences reflecting an increased focus on environmental, social and governance issues, including new regulations related to the use of conflict minerals;

•service interruptions, data corruption, cyber-based attacks or network security breaches affecting our information technology infrastructure;

•risks arising from changes in technology;

•the competitive environment in our industries;

•changes in our tax rates, realizability of deferred tax assets, or exposure to additional income tax liabilities, including the effects of the COVID-19 pandemic and the Coronavirus Aid, Relief, and Economic Security Act;

•our ability to manage and grow our business and execution of our business and growth strategies;

•the level of capital investment and expenditures by our customers in our strategic markets;

•our financial performance;

•difficulties and delays in integrating or fully realizing projected cost savings and benefits of our acquisitions; and

•other risks and factors set forth under Item 1.A. “Risk Factors” in Part 1 of this Form 10-K.


3

Actual results and outcomes may differ materially from the results, developments and business decisions contemplated by our forward-looking statements. Forward-looking statements speak only as of the date of this Form 10-K. We do not assume any obligation and do not intend to update or revise any forward-looking statement except as required by law. See Item 1A. “Risk Factors” in Part I of this Form 10-K for a further discussion regarding some of the factors that may cause actual results to differ materially from those that we anticipate.

Risk Factor Summary

The following summarizes the principal factors that make an investment in ESAB speculative or risky, all of which are more fully described in the “Risk Factors” section below. This summary should be read in connection with the “Risk Factors” section and should not be relied upon as an exhaustive summary of the material risks facing our business.

Our business is subject to a number of risks, including risks that may prevent us from achieving our business objectives or may adversely affect our business, financial condition, results of operations, cash flows, and prospects. These risks are discussed more fully below and include, but are not limited to, risks related to:

Risks Related to Our Business

•The cyclical nature and maturity of the welding and cutting industry in developed markets.
•A significant or sustained decline in the levels of new capital investment and maintenance expenditures by certain of our customers could reduce the demand for our products.
•Specific risks associated with international operations.
•The Russian invasion of Ukraine and the international response to the invasion.
•The effects of the COVID-19 pandemic.
•Our restructuring activities, which may subject us to additional uncertainty in our operating results.
•Any impairment in the value of our intangible assets, including Goodwill.
•The possibility of product liability lawsuits.
•Service interruptions, data corruption, cyber-based attacks or network security breaches to our information technology infrastructure.
•A material disruption at any of our manufacturing facilities.
•Strikes, work stoppages or other slowdowns by our associates represented by trade unions or work counsels or the failure to negotiate new and acceptable agreements with our associates represented by trade unions or work counsels.
•Any failure to maintain and protect our intellectual property rights or challenges to these rights by third parties.
•The loss of key leadership.

Risks Related to Litigation and Regulatory Compliance

•Available insurance coverage, the number of future asbestos-related claims and the average settlement value of current and future asbestos-related claims of certain subsidiaries could be different than current estimates.
•Failure to comply with various sanction and embargo laws may result in enforcement or other regulatory actions.
•Failure to comply with export control regulations could result in substantial fines or other sanctions.
•Evolving risks related to privacy, data protection and data security.
•Environmental and health and safety laws for which compliance, or related liabilities, could be costly.
•Certain regulatory and financial risks related to climate change.
•Certain regulatory and financial risks related to anti-corruption, export control, medical device and other regulations.

Risks Related to the Separation and Our Relationship with Enovis

•Our limited history of operating as a separate, publicly traded company.
•As a separate, publicly traded company, we may not enjoy the same benefits that we did as a part of Colfax.
•Significant fluctuations in our stock price.
•Our inability to achieve some or all of the expected benefits of the Separation.
•Failure of Enovis to indemnify us from certain agreed-upon liabilities in connection with the Separation.


4

Risks Related to Our Common Stock

•If we are unable to implement and maintain effective internal control over financial reporting in the future, investors may lose confidence in the accuracy and completeness of our financial reports and the market price of our common stock may be negatively affected.
•The obligations associated with being a public company require significant resources and management attention.
•We cannot guarantee the payment of dividends on our common stock, or the timing or amount of any such dividends.
•Your percentage ownership in us may be diluted in the future.
















































5

PART I

Item 1. Business

General

Founded in 1904, ESAB Corporation is a world leader in connected fabrication technology and gas control solutions. We provide our partners with advanced equipment, consumables, gas control equipment, robotics and digital solutions. Our rich history of innovative products and workflow solutions and our business system, ESAB Business Excellence (“EBX”), allows us to realize our purpose of Shaping the world we imagine. Our products are utilized to solve challenges in a wide range of industries, including cutting, joining and automated welding. Products are marketed under several brand names, most notably ESAB, which we believe is well known in the international welding industry. ESAB’s comprehensive range of welding consumables includes electrodes, cored and solid wires, and fluxes using a wide range of specialty and other materials, and cutting consumables includes electrodes, nozzles, shields and tips. ESAB’s equipment ranges from portable welding machines to large customized automated cutting and welding systems. ESAB also offers a range of software and digital solutions to help its customers increase their productivity, remotely monitor their welding operations and digitize their documentation. Products are sold into a wide range of global end markets, including general industry, infrastructure, renewable energy, medical and life sciences, transportation, construction and energy. Our sales channels include both independent distributors and direct salespeople who, depending on geography and end market, sell our products to our end users. ESAB Corporation is based in North Bethesda, Maryland and employs approximately 9,000 associates and serves customers in approximately 150 countries.

ESAB Corporation is a Delaware corporation and was incorporated in 2021 for the purpose of holding the fabrication technology business of Colfax in connection with the separation of ESAB from Colfax. On December 29, 2021, in anticipation of the Distribution (as defined below), certain subsidiaries of Colfax were transferred into the ownership of ESAB in a common-control transaction. We completed the Separation on April 4, 2022 and became an independent, publicly-traded company, listed on the New York Stock Exchange. The Separation was effected through a pro-rata distribution of 90% of the then outstanding shares of common stock of ESAB Corporation to the holders of common stock of the Former Parent (the “Distribution”). Upon completion of the Distribution, Colfax changed its name to Enovis and continued to hold 10% of the outstanding common stock of ESAB. In November 2022, Enovis sold a total of 6.0 million shares of the Company’s common stock as part of a secondary offering. After the secondary offering, Enovis no longer owned any of the Company’s outstanding common stock.

We believe our company, which competes in an estimated $30 billion market, is one of the prominent industry players with a substantial position in every major market in the world, combining global scale with regional agility to maximize growth and profits. We define our addressable market as established equipment products and new products in automation, software and services, and estimate its size based on public data from peer companies, customer surveys, and market analysis conducted by our sales function. Approximately 50% of our 2022 revenues were derived from developing markets, which we define as South America, Eastern Europe, India, Asia, Australia and the Middle East, and which are expected to grow at greater than twice the rate of more mature markets in North America and Europe based on publicly available economic data from sources such as IHS Markit and the International Monetary Fund. Our gas control business is also well-positioned in attractive markets like healthcare and life sciences.

Acquisitions are a core part of our strategy and are used to strengthen our company and accelerate growth. Acquisitions follow our disciplined process to ensure strategic alignment, rapid integration and attractive long-term financial returns. During the year ended December 31, 2022, we completed two acquisitions and we expect to complete more acquisitions in the following years. See Note 5, “Acquisitions” in Item 8 of this Form 10-K for further information.

The Company

The Company has been built through a series of acquisitions, as well as organic growth. We seek to build an enduring premier global enterprise by applying EBX, our business management system to continuously improve our Company and pursue growth in revenues and improvements in profit and cash flow.

EBX is integral to our operations. EBX is our culture and includes our values, a comprehensive set of tools, and repeatable, teachable processes that we use to drive continuous improvement and create superior value for our customers, stockholders and associates. We believe that our management team’s access to, and experience in, the application of the EBX methodology is one of our primary competitive strengths. We have used EBX to accelerate our growth and improve business performance.
6

Industry Overview

Our products and services are marketed worldwide, and the markets we serve are fragmented and competitive. Because we compete in selected niches of these markets and due to the diversity of our products and services, no single company competes directly with us across all our markets. We encounter a wide variety of competitors that differ by product line, including well-established regional competitors, competitors with greater specialization in particular markets, as well as larger competitors. The markets that we compete in are also served by Lincoln Electric and the welding business within Illinois Tool Works, Inc. Our customer base is broadly diversified across many sectors of the economy, and we believe customers place a premium on quality, reliability, availability, design and application engineering support. We believe the principal elements of competition in
our served markets are the technical ability to meet customer specifications, product quality and reliability, brand names, price, application expertise and engineering capabilities, timely delivery and strong aftermarket support. We believe that we are a leading competitor in each of our markets.

We continue to actively monitor the effects of COVID-19, including the rise, prevalence and severity of variants of the virus, the related government regulations, and the impacts on our results and operations. The pandemic and actions taken in response to it have had a variety of impacts on our results of operations including sales levels, and together with other market dynamics has contributed to inflation and widespread supply chain challenges; including labor, raw materials, and component shortages. For additional information on the risks of COVID-19 to our operations refer to Item 1A. “Risk Factors—Risks Related to Our Business—The effects of the COVID-19 pandemic have adversely impacted, and may in the future adversely impact, our results of operations, financial condition, and overall financial performance.”

Reportable Segments

We conduct our operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America, and “EMEA & APAC,” which includes Europe, Middle East, India, Africa and Asia Pacific. We serve a global customer base across multiple markets through a combination of direct sales and third-party distribution channels. Our customer base is highly diversified in the industrial end markets.

The following discussions of International Operations, Research and Development, Intellectual Property, Raw Materials, Seasonality, Working Capital, Regulatory Environment, Human Capital Management, and Company Information and Access to SEC Reports include information that is common to both of our reportable segments, unless indicated otherwise.

International Operations

Our products and services are available worldwide. We believe this geographic diversity allows us to draw on the skills of a global workforce, provides stability to our operations, allows us to drive economies of scale, provides revenue streams that may offset economic trends in individual economies, and offers an opportunity to access new markets for products. In addition, we believe that our exposure to developing economies will provide additional opportunities for growth in the future.

Our principal markets as a whole outside the United States are Europe, Asia, South America, and the Middle East. Our international operations subject us to certain risks. See Item 1A. “Risk Factors—Risks Related to Our Business”. The majority of our sales are derived from international operations. We are subject to specific risks associated with international operations.

Research and Development

Our research and development focus on innovation; developing new products, software and services, as well as the enhancement of existing products with the latest technology and updated designs; creating new applications for existing products; lowering the cost of manufacturing our existing products; and, redesigning existing product lines to increase efficiency, improve durability, enhance performance and usability.

Research and development expense was $36.0 million, $39.7 million and $34.8 million for the years ended December 31, 2022, 2021 and 2020, respectively. These amounts do not include development and application engineering costs incurred in conjunction with fulfilling customer orders and executing customer projects, nor do they include costs related to securing third party product rights. We expect to continue making significant expenditures for research and development to maintain and improve our competitive positions.


7

Intellectual Property

We rely on a combination of intellectual property rights, including patents, trademarks, copyrights, trade secrets and contractual provisions to protect our intellectual property both in the United States and around the world for our business. Although we highlight recent additions to our patent portfolio as part of our marketing efforts, we do not consider any one patent or trademark or any group thereof essential to our business as a whole or to any of our business operations. We also rely on proprietary product knowledge and manufacturing processes in our operations. We do not rely solely on our patents and other intellectual property rights to maintain our competitive position. We believe that the development and marketing of new products and improvement of existing ones is, and will continue to be, more important to our competitive position than relying solely on existing products and intellectual property.

Raw Materials

We obtain raw materials, component parts and supplies from a variety of global sources, generally each from more than one supplier. Our principal raw materials and components for our business are steel, iron, copper and aluminum. We believe that our sources of raw materials are adequate for our needs for the foreseeable future and the loss of any one supplier would not have a material adverse effect on our business or results of operations.

Seasonality

Our European operations typically experience a slowdown during the July, August and December vacation seasons for our business. However, the business impact caused by the COVID-19 pandemic, as well as general economic conditions, may distort the effects of historical seasonality patterns and impact future seasonal variations.

Working Capital

We maintain an adequate level of working capital to support our business needs. There are no unusual industry practices or requirements related to working capital items.

Regulatory Environment

We face extensive government regulation both within and outside the United States relating to the development, manufacture, marketing, sale and distribution of our products, software and services. The following sections describe certain significant regulations that we are subject to. These are not the only regulations that our businesses must comply with. For a description of risks related to the regulations that our businesses are subject to, please refer to “Risk Factors—Risks Related to Our Business.”

Some of our gas control products are related to medical device products and are subject to extensive regulation by the United States Food and Drug Administration (the “FDA”), EU Medical Device Regulation (the “EU MDR”), and numerous other federal, state, and foreign governmental authorities. These regulations include significant new requirements for medical devices, including enhanced requirements for clinical evidence and documentation, increased focus on device identification and traceability, and additional post-market surveillance and diligence. The process of obtaining regulatory approvals to market these products can be costly and time consuming, and approvals might not be granted for future products on a timely basis, if at all. Additionally, modifications to our existing products may require new regulatory approvals and we may be required to cease marketing or to recall any modified product until we obtain clearance or approval.

Environmental Laws and Regulations

Our operations and properties are subject to laws and regulations relating to environmental protection, including those governing air emissions, water discharges and waste management, and workplace health and safety.
Our Quality, Environmental, and Occupational Health & Safety (“QEHS”) Management Systems apply to all of ESAB’s operations, activities, people, and units globally. We have achieved external certification of our QEHS Management Systems to the ISO 9001, ISO 14001 and ISO 45001 standards for the majority of ESAB’s operations, activities, people, and units globally.



8

We maintain an Environment, Health & Safety Policy to ensure compliance with all applicable laws and regulations and promote safety and environmental protection as core business values. We are committed to continual improvement of our environment, health and safety management system through assessments, actionable planning and implementation of best practices. We establish objectives and appropriate targets for significant environmental aspects of our business operations and activities including, but not limited to, the reduction of energy and water consumed, and waste minimization.

For a discussion of risks related to compliance with environmental and health and safety laws and risks related to past or future releases of, or exposures to, hazardous substances, please refer to “Risk Factors—Risks Related to Business.”

Export/Import Compliance

We are required to comply with various U.S. export/import control and economic sanctions laws, including:

•the International Traffic in Arms Regulations administered by the U.S. Department of State, Directorate of Defense Trade Controls, which, among other things, imposes license requirements on the export from the United States of defense articles and defense services (which are items specifically designed or adapted for a military application and/or listed on the United States Munitions List);
•the Export Administration Regulations administered by the U.S. Department of Commerce, Bureau of Industry and Security, which, among other things, impose licensing requirements on the export or re-export of certain dual-use goods, technology and software (which are items that potentially have both commercial and military applications);
•the regulations administered by the U.S. Department of Treasury, Office of Foreign Assets Control, which implement economic sanctions imposed against designated countries, governments and persons based on United States foreign policy and national security considerations; and
•the import regulatory activities of the U.S. Customs and Border Protection.

Other nations’ governments have implemented similar export and import control regulations, which may affect our operations or transactions subject to their jurisdictions. For a discussion of risks related to export/import control and economic sanctions laws, please refer to “Risk Factors—Risks Related to Litigation and Regulatory Compliance—We have done and may continue to do business in countries subject to U.S. sanctions and embargoes. Failure to comply with various sanction and embargo laws may result in enforcement or other regulatory actions” and “Risk Factors—Risks Related to Litigation and Regulatory Compliance—If we fail to comply with export control regulations, we could be subject to substantial fines or other sanctions, which could have a material adverse effect on our business, financial condition and results of operations.”

Human Capital Management

Employee Profile

As of December 31, 2022, we employed approximately 9,000 persons, of whom approximately 1,200 were employed in the United States and approximately 7,800 were employed outside of the United States.


Talent Development

In our effort to enable our purpose, “Shaping the World We Imagine”, we strive to find extraordinary people and support them across their entire associate lifecycle, so they stay engaged in building, growing and sustaining the company. As a result, we’re committed to a “Talent First” strategy which starts with our associates’ health and safety. Our talent strategy is also about attracting great talent, elevating the associate experience, retaining our workforce, and building the leadership bench strength needed for our future growth and success.

Employee Safety

The safety and well-being of ESAB's colleagues around the world has been, and always will be, a top priority. Guided by the Company's Environment, Health & Safety Policy, ESAB strives every day to foster a proactive safety culture. The Company is committed to continual improvement of its environment, health and safety management system through assessments, actionable planning and implementation of best practices.




9

Compensation and Benefits

As a global employer, the Company is committed to providing market-competitive compensation and benefits to attract and retain great talent across its global footprint. Specific compensation and benefits vary worldwide and are based on regional practices.

Diversity and Inclusion

As a world leader for welding, cutting, fabrication, and gas control technology solutions, ESAB is dedicated to creating an inclusive, welcoming culture in which every voice is valued. To advance this commitment, we have developed our Diversity, Equity and Inclusion Strategy. Our strategy is about embracing diversity & inclusion in our everyday actions while empowering and elevating others, leading inclusively, learning about celebrating our differences and ensuring every voice is valued.

Labor Relations

Approximately 18% of our U.S. associates are covered by collective bargaining agreements with U.S. trade unions. In addition, approximately 37% of our non-U.S. associates are represented by foreign trade unions and work councils in Europe, Asia, Central and South America, Canada, Africa and Australia, which could subject us to arrangements very similar to collective bargaining agreements. We have not experienced any work stoppages or strikes that have had a material adverse impact on operations. We consider our relations with our associates to be good.

Company Information and Access to SEC Reports

We were organized as a Delaware corporation in 2021. Our principal executive offices are located at 909 Rose Avenue, 8th Floor, North Bethesda, MD 20852, and our main telephone number at that address is (301) 323-9099. Our corporate website address is www.esabcorporation.com.

We make available, free of charge through our website at https://investors.esabcorporation.com/overview, our annual and quarterly reports on Form 10-K and Form 10-Q (including related filings in XBRL format), current reports on Form 8-K and any amendments to those reports as soon as practicable after filing or furnishing the material to the SEC. You may also request a copy of these filings, at no cost, by writing or telephoning us at: Investor Relations, ESAB Corporation, 909 Rose Avenue, 8th Floor, Bethesda, MD 20852, telephone (301) 323-9099. Information contained on our website is not incorporated by reference in this report. Additionally, the SEC maintains an Internet site that contains our reports, proxy statements and other information that we electronically file with, or furnish to, the SEC at www.sec.gov.
10

Item 1A. Risk Factors

An investment in our Common stock involves a high degree of risk. The following discussion addresses material factors that make an investment in the Company speculative or risky. In determining whether to buy, hold or sell any of our securities you should carefully consider the risks and uncertainties described below, together with the information included elsewhere in this Form 10-K and other documents we file with the SEC. If any of the following risks were to occur, our business, financial condition, results of operations and liquidity could be materially adversely affected, the value of our Common stock could decline and investors could lose all or part of the value of their investment in ESAB shares. Furthermore, the risks and uncertainties described below are those that we have identified as material, but may not be the only risks to which ESAB might be exposed. Additional risks and uncertainties, which are currently unknown to us or that we do not currently consider to be material, could have material adverse effects on our business, financial condition and results of operations.

Risks Related to our Business

The cyclical nature and maturity of the welding and cutting industry in developed markets may adversely affect our performance.

The welding and cutting industry is generally a mature industry in developed markets such as North America and Western Europe and is cyclical in nature. Overall demand for welding and cutting products is largely determined by the level of capital spending in manufacturing and other industrial sectors, and the welding industry has historically experienced contraction during periods of slowing industrial activity. If economic, business and industry conditions deteriorate, capital spending in those sectors may be substantially decreased, which could reduce demand for our products and have an adverse impact on our revenues and results of operations.

A significant or sustained decline in the levels of new capital investment and maintenance expenditures by certain of our customers could reduce the demand for our products and services and harm our operations and financial performance.

Demand for our products and services depends significantly on the level of new capital investment and planned maintenance expenditures by certain of our customers. The level of new capital expenditures by our customers is dependent upon many factors, including general economic conditions, availability of credit, economic conditions and investment activities within their respective industries and expectations of future market behavior. In addition, volatility in commodity prices can negatively affect the level of these new activities and can result in postponement of capital spending decisions or the delay or cancellation of existing orders. A reduction in demand for our products and services has resulted in the past, and in the future could result in the delay or cancellation of existing orders or lead to excess manufacturing capacity, which unfavorably impacts our absorption of fixed manufacturing costs. For example, in 2020, we experienced a decline in customer demand for our products and services as a result of the COVID-19 pandemic. Any reduced demand could have a material adverse effect on our business, financial condition and results of operations.

The majority of our sales are derived from international operations. We are subject to specific risks associated with international operations.

In the year ended December 31, 2022, we derived 78% of our sales from operations outside of the United States and, as of that date, we had principal manufacturing facilities in 25 countries in addition to the United States. For the year ended December 31, 2022, 44% and 56% of our Net sales were derived from the Americas and EMEA & APAC, respectively. Sales from international operations, export sales and the use of manufacturing facilities outside of the United States by us are subject to risks inherent in doing business outside the United States. These risks include: economic or political instability; partial or total expropriation of international assets; limitations on ownership or participation in local enterprises; trade protection measures by the United States or other nations including China, including tariffs or import-export restrictions or licensing requirements, and other changes in trade relations; currency exchange rate fluctuations and restrictions on currency repatriation; inflation; labor, employment and environmental, health and safety laws and regulations that may be more restrictive than in the United States; changes in laws and regulations, including taxation policies, or in how such provisions are interpreted or administered difficulties in enforcing our rights outside the United States, including intellectual property rights; difficulties in hiring and maintaining qualified staff and managing geographically diverse operations; the disruption of operations from natural disasters or adverse weather conditions (including events that may be caused or exacerbated by climate change), world health events, including the COVID-19 pandemic, labor or political disturbances, terrorist activities, insurrection or war; the imposition of additional foreign governmental controls or regulations on the sale of our products;
11

increased costs of transportation or shipping; the transition away from LIBOR to the Secured Overnight Financing Rate as a benchmark reference for short-term interests; and uncertainties arising from local business practices and cultural considerations.

If any of these risks were to materialize, they could have a material adverse effect on our business, financial condition and results of operations. See also “—Our operations in Russia are exposed to risks related to the Russian invasion of Ukraine and the international response to the invasion.”

Additionally, changes in U.S. policy regarding international trade, including import and export regulation and international trade agreements, could also negatively impact our business. In 2018, the United States imposed tariffs on steel and aluminum as well as on goods imported from China and certain other countries, which has resulted in retaliatory tariffs by China and other countries. Additional tariffs imposed by the United States on a broader range of imports, or further retaliatory trade measures taken by China or other countries in response, could result in an increase in supply chain costs that we may not be able to offset or otherwise adversely impact our results of operations.

The impact of the United Kingdom’s withdrawal from the European Union and its full effects are still uncertain and will depend on, among other things, the financial, trade, regulatory, and legal implications of the trade and cooperation agreement entered into by United Kingdom and the European Union and any future agreements. This uncertainty regarding the economic outlook of the United Kingdom has caused, and may continue to cause, volatility in foreign exchange rates, which could have an adverse effect on our revenue growth in future periods. Any trade barriers resulting from the exit may disrupt distribution channels, increase our Cost of sales, and limit our ability to achieve future product margin growth. We may also face new regulatory costs, employee retention, and other challenges that could have an adverse effect on our business.

In many foreign countries, particularly in those with developing economies, there are companies that engage in business practices prohibited by laws and regulations applicable to us, such as the Foreign Corrupt Practices Act of 1977, as amended, and the U.K. Bribery Act. Although we implement policies, procedures and training designed to facilitate compliance with these laws, our employees, contractors and agents, as well as those of the companies to which we outsource certain of our business operations, may take actions in violation of our policies, which could result in civil or criminal enforcement actions and penalties, create a substantial liability for us and also cause a loss of reputation in the market.

Our operations in Russia are exposed to risks related to the Russian invasion of Ukraine and the international response to the invasion.

The Russian invasion of Ukraine has significantly escalated tensions among the United States, the North Atlantic Treaty Organization (“NATO”) member states, and Russia, and has led to macroeconomic and geopolitical instability. In response to Russia’s invasion of Ukraine, the United States and other countries have imposed numerous sanctions on Russia, including its major financial institutions and certain other businesses and individuals. The conflict may also result in additional sanctions being enacted by the United States, other NATO member states, or other countries. The impact of these sanctions, along with the spillover effect of ongoing civil, political and economic disturbances on surrounding areas, may significantly devalue currencies utilized by the Company or have other adverse impacts including increased costs of raw materials and inputs, manufacturing or shipping delays, or result in reputational harm. While local and global supply chains have been impacted by the conflict, particularly with respect to the sourcing and cost of certain raw materials, our supply chain has not been materially adversely impacted as of the date of this Form 10-K. Further, we have incorporated the recently enacted sanctions and export controls into our existing screening and monitoring procedures in Russia. As of the date of this Form 10-K, the recently enacted sanctions and export controls have not materially impacted our ability to service our existing customer base.

The Russian invasion of Ukraine and the sanctions imposed in response to this crisis have increased the level of economic and political uncertainty in Russia. While we continue to closely monitor the situation and evaluate options, we are meeting current contractual obligations while addressing applicable laws and regulations. For the year ended December 31, 2022, our operations in Russia represented approximately 6% of our total revenue, and approximately $20 million in Net income. Russia also had approximately 5% of our total net assets as of December 31, 2022.

Our operations in Russia had a cumulative translation loss of approximately $90 million, which could be realized upon a transition out. We are closely monitoring the developments in Ukraine and Russia. Changes in laws and regulations or other factors impacting our ability to fulfill our contractual obligations could have an adverse effect on our results of operations.

12

We cannot predict the impact of these events and any heightened military conflict or geopolitical instability that may follow, including heightened operating risks and production disruptions in Russia and Europe, additional sanctions or counter-sanctions, heightened inflation, cyber-disruptions or attacks, higher energy costs, higher manufacturing costs, disruptions in raw materials supplies, increased raw material costs and higher supply chain costs. Such events may negatively impact our results of operations, cash flows and financial condition.

The effects of the COVID-19 pandemic have adversely impacted, and may in the future adversely impact, our results of operations, financial condition, and overall financial performance.

The COVID-19 pandemic and actions taken by governments, businesses and individuals in response have resulted in widespread economic disruptions, significantly affecting broader economies, financial markets, and overall demand for our products. Although our customers have increased operating levels, since the early stages of the pandemic, such customers may be forced to close or limit operations should a resurgence of COVID-19 cases occur in their region. The longer the period of economic and global supply chain and related disruption continues, the more adverse the impact would be on our business operations and financial performance.

To the extent that conditions surrounding the COVID-19 pandemic continue to improve, the duration and sustainability of any such improvements may be uncertain and continuing adverse impacts and/or the degree of improvement may vary dramatically by geography and line of business.

Our restructuring activities may subject us to additional uncertainty in our operating results.
We have implemented, and plan to continue to implement, restructuring programs designed to facilitate key strategic initiatives and maintain long-term sustainable growth. As such, we have incurred and expect to continue to incur expenses relating to restructuring activities. We may not achieve or sustain the anticipated benefits, including any anticipated savings, of these restructuring programs or initiatives. Further, restructuring efforts are inherently risky, and we may not be able to predict the cost and timing of such actions accurately or properly estimate their impact.

Any impairment in the value of our intangible assets, including Goodwill, would negatively affect our operating results and total capitalization.

Our Total assets reflect substantial intangible assets, primarily Goodwill. The Goodwill results from our acquisitions, representing the excess of cost over the fair value of the net assets we have acquired. We assess at least annually whether there has been impairment in the value of our indefinite-lived intangible assets. If future operating performance at one or more of our business units were to fall significantly below current levels, if competing or alternative technologies emerge, or if market conditions for an acquired business decline, we could incur, under current applicable accounting rules, a non-cash charge to operating earnings for Goodwill impairment. Any determination requiring the write-off of a significant portion of unamortized intangible assets would adversely affect our business, financial condition, results of operations and total capitalization, the effect of which could be material.

Our business subjects us to the possibility of product liability lawsuits, which could harm our business.

As the manufacturer of equipment for use in industrial markets, we may be subject to product liability claims. Component failures, manufacturing nonconformances, design defects, or inadequate disclosure of product-related risks or product-related information with respect to our products could result in unsafe conditions, injury or death. In addition, some of our products contain components manufactured by third parties, which may also have defects. Our product liability insurance policies have limits that may not be sufficient to cover claims made. In addition, this insurance may not continue to be available at a reasonable cost. With respect to components manufactured by third-party suppliers, the contractual indemnification that we seek from our third-party suppliers may be limited and thus insufficient to cover claims made against us. If insurance coverage or contractual indemnification is insufficient to satisfy product liability claims made against us, the claims could have an adverse effect on our business and financial condition. Even claims without merit could harm our reputation, reduce demand for our products, cause us to incur substantial legal costs and distract the attention of our management. The occurrence of any of the foregoing could have a material adverse effect on our business, financial condition and results of operations.


13

Our information technology infrastructure has been and could in the future be, subject to service interruptions, data corruption, cyber-based attacks or network security breaches. Significant disruptions in, or breaches in security of, our information technology infrastructure or data can adversely affect our business and financial statements.

We rely on information technology networks and systems, including the Internet, cloud-based services and third-party service providers, to process, transmit and store electronic information, personally identifiable information, credit card and other financial information, and to manage or support a variety of business processes and activities, including procurement, manufacturing, distribution, invoicing, collection, communication with our employees, customers, dealers and suppliers, business acquisitions and other corporate transactions, compliance with regulatory, legal and tax requirements, and research and development. These information technology networks and systems may be susceptible to damage, disruptions or shutdowns due to failures during the process of upgrading or replacing software, databases or components, power outages, hardware failures or computer viruses. If these information technology systems suffer severe damage, disruption or shutdown and business continuity plans do not effectively resolve the issues in a timely manner, our business, financial condition, results of operations, and liquidity could be materially adversely affected.

In addition, our information technology networks and system and those of third parties upon which we rely are subject to security threats and sophisticated cyber-based attacks, including, but not limited to, denial-of-service attacks, hacking, “phishing” attacks, computer viruses, ransomware, malware, employee or insider error, malfeasance, social engineering, or physical breaches, that can cause deliberate or unintentional damage, destruction or misuse, manipulation, denial of access to or disclosure of confidential or important information, either directly or by our employees, suppliers or third-party service providers. Additionally, advanced persistent attempts to gain unauthorized access or deny access to, or otherwise disrupt, our systems and those of third-party service providers we rely on are increasing in sophistication and frequency. We expect to continue to confront efforts by hackers and other third parties to gain unauthorized access or deny access to, or otherwise disrupt, our information technology systems and networks and those of third parties upon which we rely. Any such attacks could have a material adverse effect on our business, financial condition, results of operations or liquidity. We can provide no assurance that our efforts to actively manage technology risks potentially affecting our systems and networks will be successful in eliminating or mitigating risks to or intrusions into our systems, networks and data or in effectively detecting or resolving such risks or intrusions when they materialize. A failure of or breach in information technology security of our own systems, or those of our third-party vendors, could expose us and our employees, customers, dealers and suppliers to risks of misuse of information or systems, the compromise of confidential information, denial of access to, manipulation or destruction of data, defective products, production downtimes and operations disruptions. Any of these events in turn could adversely affect our business or prospects, reputation and competitive position, including a material loss of customers and revenue, business, results of operations and liquidity. In addition, such breaches in security could result in litigation, regulatory action and potential liability, including liability under federal or state laws that protect the privacy of personal information, as well as the costs and operational consequences of implementing further data protection measures.

As of December 31, 2022, we have approximately $1.2 billion of outstanding indebtedness with the ability to borrow incremental $500 million under the credit facility and an additional $77 million of indebtedness pursuant to certain uncommitted credit lines. This indebtedness could adversely affect our businesses and our ability to meet our obligations and pay dividends.

We entered into a $1.75 billion credit facility, $1.2 billion of which was outstanding at the time of the Distribution. We also have the ability to incur an additional $77 million of indebtedness pursuant to certain uncommitted credit lines, and in the future we may incur additional indebtedness. See “Description of Certain Indebtedness.” This debt could have important, adverse consequences to us and our investors, including:

•requiring a substantial portion of our cash flow from operations to make interest payments;
•making it more difficult to satisfy other obligations;
•increasing the risk of a future credit ratings downgrade of our debt, which could increase future debt costs and limit the future availability of debt financing;
•increasing our vulnerability to general adverse economic and industry conditions;
•reducing the cash flow available to fund capital expenditures and other corporate purposes and to grow our businesses;
•limiting our ability to pay dividends;
•limiting our flexibility in planning for, or reacting to, changes in our businesses and industries; and
•limiting our ability to borrow additional funds as needed or take advantage of business opportunities as they arise, pay cash dividends or repurchase shares of our common stock.
14

The instruments governing the debt financing contain restrictive covenants that limit our ability to engage in activities that may be in our long-term interest, including for example EBITDA-based leverage and interest coverage ratios. If we breach any of these restrictions and cannot obtain a waiver from the lenders on favorable terms, subject to applicable cure periods, the outstanding indebtedness (and any other indebtedness with cross-default provisions) could be declared immediately due and payable, which would adversely affect our liquidity and financial statements. In addition, any failure to obtain and maintain credit ratings from independent rating agencies would adversely affect our cost of funds and could adversely affect our liquidity and access to the capital markets. See “Description of Certain Indebtedness.”

The risks described above will increase with the amount of indebtedness we incur, and in the future we may incur significant indebtedness in addition to the indebtedness described above. In addition, our actual cash requirements in the future may be greater than expected. Our cash flow from operations may not be sufficient to service our outstanding debt or to repay the outstanding debt as it becomes due, and we may not be able to borrow money, sell assets or otherwise raise funds on acceptable terms, or at all, to service or refinance our debt.

We may be unable to generate sufficient cash to service all of our indebtedness and may be forced to take other actions to satisfy our obligations under our indebtedness, which may not be successful.

Our ability to make scheduled payments on or refinance our debt obligations depends on our financial condition and operating performance, which are subject to prevailing economic and competitive conditions and to certain financial, business, legislative, regulatory and other factors beyond our control. We may be unable to maintain a level of cash flows from operating activities sufficient to permit us to pay the principal and interest on our indebtedness.

If our cash flows and capital resources are insufficient to fund our debt service obligations, we could face substantial liquidity problems and could be forced to reduce or delay investments and capital expenditures, or to dispose of material assets or operations, alter our dividend policy, seek additional debt or equity capital or restructure or refinance our indebtedness. We may not be able to effect any such alternative measures on commercially reasonable terms or at all and, even if successful, those alternative actions may not allow us to meet our scheduled debt service obligations. The instruments that govern our indebtedness restrict our ability to dispose of assets and may restrict the use of proceeds from those dispositions. We may not be able to consummate those dispositions or to obtain proceeds in an amount sufficient to meet any debt service obligations when due.

In addition, we conduct our operations through our subsidiaries. Accordingly, repayment of our indebtedness will depend on the generation of cash flow by our subsidiaries, including certain international subsidiaries, and their ability to make such cash available to us, by dividend, debt repayment or otherwise. Our subsidiaries may not have any obligation to pay amounts due on our indebtedness or to make funds available for that purpose. Our subsidiaries may not be able to, or may not be permitted to, make adequate distributions to enable us to make payments in respect of our indebtedness. Each subsidiary is a distinct legal entity and, under certain circumstances, legal, tax and contractual restrictions may limit our ability to obtain cash from our subsidiaries. In the event that we do not receive distributions from our subsidiaries, we may be unable to make required principal and interest payments on our indebtedness.

Our inability to generate sufficient cash flows to satisfy our debt obligations, or to refinance our indebtedness on commercially reasonable terms or at all, may materially adversely affect our business, financial condition and results of operations and our ability to satisfy our obligations under our indebtedness or pay dividends on our common stock.

A material disruption at any of our manufacturing facilities could adversely affect our ability to generate sales and meet customer demand.

If operations at any of our manufacturing facilities were to be disrupted as a result of a significant equipment failure, natural disaster or adverse weather conditions (including events that may be caused or exacerbated by climate change), power outage, fire, explosion, terrorism, cyber-based attack, pandemic or other contagious outbreak (such as the COVID-19 pandemic), labor dispute or shortage or other reason, our financial performance could be adversely affected as a result of our inability to meet customer demand for our products.

Interruptions in production could increase our costs and reduce our sales. Any interruption in production capability could require us to make substantial capital expenditures to remedy the situation or rely on third-party manufacturers, which could negatively affect our profitability and financial condition.

15

Any recovery under our property damage and business interruption insurance policies may not offset the lost sales or increased costs that may be experienced during the disruption of operations, which could adversely affect our business, financial condition and results of operations.

If our associates represented by trade unions or works councils engage in a strike, work stoppage or other slowdown or if the representation committees responsible for negotiating with such trade unions or works councils are unsuccessful in negotiating new and acceptable agreements when the existing agreements with associates covered by collective bargaining expire, we could experience business disruptions or increased costs.

As of December 31, 2022, approximately 34% of our associates were represented by a number of different trade unions and works councils. Further, as of that date, we had approximately 7,800 associates, representing approximately 87% of our worldwide associate base, in foreign locations. In Canada, Australia and various countries in Europe, Asia, and Central and South America, by law, certain of our associates are represented by a number of different trade unions and works councils, which subject us to employment arrangements very similar to collective bargaining agreements. Further, the laws of certain foreign countries may place restrictions on our ability to take certain employee-related actions or require that we conduct additional negotiations with trade unions, works councils or other governmental authorities before we can take such actions.

If our associates represented by trade unions or works councils were to engage in a strike, work stoppage or other slowdown in the future, we could experience a significant disruption of our operations. Such disruption could interfere with our business operations and could lead to decreased productivity, increased labor costs and lost revenue as well as adversely impact our reputation. The representation committees that negotiate with the foreign trade unions or works councils on our behalf may not be successful in negotiating new collective bargaining agreements or other employment arrangements when the current ones expire. Furthermore, future labor negotiations could result in significant increases in our labor costs. The occurrence of any of the foregoing could have a material adverse effect on our business, financial condition and results of operations.

Failure to maintain and protect our intellectual property rights or challenges to these rights by third parties may affect our operations and financial performance.

The market for many of our products is, in part, dependent upon patent, trademark, copyright and trade secret laws, agreements with employees, customers and other third parties including confidentiality agreements, invention assignment agreements and proprietary information agreements, to establish and maintain our intellectual property rights, and the Goodwill engendered by our trademarks and trade names. The protection and enforcement of these intellectual property rights is therefore material to our business. The failure to protect these rights may have a material adverse effect on our business, financial condition and results of operations. Litigation may be required to enforce our intellectual property rights, protect our trade secrets or determine the validity and scope of proprietary rights of others. It may be particularly difficult to enforce our intellectual property rights in countries where such rights are not highly developed or protected. Any action we take to protect or enforce our intellectual property rights could be costly and could absorb significant management time and attention. As a result of any such litigation, we could lose our proprietary rights.

In addition, third parties may claim that we or our customers are infringing upon their intellectual property rights. Any claims of intellectual property infringement may subject us to costly and time-consuming defense actions and, should our defenses not be successful, may result in the payment of damages, redesign of affected products, entry into settlement or license agreements, or a temporary or permanent injunction prohibiting us from manufacturing, marketing or selling certain of our products. It is also possible that others will independently develop technology that will compete with our patented or unpatented technology. The occurrence of any of the foregoing could have a material adverse effect on our business, financial condition and results of operations.

Our defined benefit pension plans and post-retirement medical and death benefit plans are or may become subject to funding requirements or obligations that could adversely affect our business, financial condition and results of operations.

We operate defined benefit pension plans and post-retirement medical and death benefit plans for current and former employees worldwide. Each plan’s funding position is affected by the investment performance of the plan’s investments, changes in the fair value of the plan’s assets, the type of investments, the life expectancy of the plan’s members, changes in the actuarial assumptions used to value the plan’s liabilities, changes in the rate of inflation and interest rates, our financial position, as well as other changes in economic conditions.
16

Furthermore, since a significant proportion of the plans’ assets are invested in publicly traded debt and equity securities, they are, and will be, affected by market risks. Any detrimental change in any of the above factors is likely to worsen the funding position of each of the relevant plans, and this would likely require the plans’ sponsoring employers to increase the contributions currently made to the plans to satisfy our obligations. Any requirement to increase the level of contributions currently made could have a material adverse effect on our business, financial condition and results of operations.

Significant movements in foreign currency exchange rates have adversely impacted our financial results in the past and may adversely impact our results in the future.

We are exposed to fluctuations in currency exchange rates. During the year ended December 31, 2022, approximately 78% of our sales were derived from operations outside the United States. A significant portion of our revenues and income are denominated in foreign currencies. Large fluctuations in the rate of exchange between foreign currencies and the U.S. dollar could have a material adverse effect on our business, financial condition and results of operations. Changes in the currency exchange rates may impact our financial results positively or negatively in one period and not another, which may make it difficult to compare our operating results from different periods. For example, during 2018, Argentina became a highly inflationary economy, resulting in the remeasurement of our Argentinian operations. Future impacts to earnings of applying highly inflationary accounting for Argentina on our financial statements will be dependent upon movements in the applicable exchange rates.

We also face exchange risk from transactions with customers in countries outside the United States and from intercompany transactions between affiliates. Although we use the U.S. dollar as our functional currency for reporting purposes, we have manufacturing sites throughout the world and a substantial portion of our costs are incurred and sales are generated in foreign currencies. Costs incurred and sales recorded by subsidiaries operating outside of the United States are translated into U.S. dollars using exchange rates effective during the respective period. As a result, we are exposed to movements in the exchange rates of various currencies against the U.S. dollar. Further, we may be subject to foreign currency translation losses depending upon whether foreign nations devalue their currencies.

We are dependent on the availability of raw materials, as well as parts and components used in our products.

While we manufacture many of the parts and components used in our products, we purchase a substantial amount of raw materials, parts and components from suppliers. The availability and prices for raw materials, parts and components may be subject to curtailment or change due to, among other things, suppliers’ allocations to other purchasers, interruptions in production by suppliers, changes in exchange rates and prevailing price levels, trade disputes and increased tariffs. Any significant change in the supply of, or price for, these raw materials, parts or components could materially affect our business, financial condition and results of operations. In addition, delays in the delivery of raw materials, parts or components by suppliers could cause delays in our delivery of products to our customers.

Additionally, political and economic instability and changes in government regulations in China and other parts of Asia or any pandemics or other contagious outbreaks (such as the COVID-19 pandemic), could affect our ability to continue to receive materials from suppliers there. The loss of suppliers in these areas, any other interruption or delay in the supply of required materials or our inability to obtain these materials at acceptable prices and within a reasonable amount of time could impair our ability to meet scheduled product deliveries to our customers and could hurt our reputation and cause customers to cancel orders.

The markets we serve are highly competitive and some of our competitors may have superior resources. If we are unable to respond successfully to this competition, this could reduce our sales and operating margins.

Our business operates in highly fragmented and competitive markets. In order to maintain and enhance our competitive position, we intend to, among other things, continue investing in manufacturing quality, marketing, customer service and support, distribution networks, and research and development. We may not have sufficient resources to continue to make these investments and we may not be able to maintain our competitive position. Our competitors may develop products that are superior to our products or more widely accepted, develop methods of more efficiently and effectively providing products and services, adapt more quickly than us to new technologies or evolving customer requirements or have a larger product portfolio.

Some of our competitors may also have greater financial, marketing and research and development resources than we have or stronger name recognition. As a result, those competitors may be better able to withstand the effects of periodic economic downturns.
17

In addition, pricing pressures could cause us to adjust the prices of some of our products to stay competitive. The development of new technologies by competitors that may compete with our technologies could reduce demand for our products and affect our financial performance. Should we not be able to maintain or enhance the competitive values of our products or develop and introduce new products or technologies successfully, or if new products or technologies fail to generate sufficient revenues to offset research and development costs, our business, financial condition and operating results could be materially adversely affected.

We may not be able to compete successfully with our existing competitors or with new competitors. If we fail to compete successfully, the failure may have a material adverse effect on our business, financial condition and results of operations. Please see “Business—Industry and Competition” for additional information about the competitive markets in which we operate.

Changes in our tax rates or exposure to additional income tax liabilities could adversely affect our financial results.

Our future effective income tax rates could be unfavorably affected by various factors, including, among others, changes in the tax rates, rules and regulations in jurisdictions in which we generate income. A number of countries where we do business, including the United States and many countries in the European Union, have implemented, and are considering implementing, changes in relevant tax, accounting and other laws, regulations and interpretations. Additionally, longstanding international tax norms that determine each country’s jurisdiction to tax cross-border international trade are subject to potential evolution. For example, an outgrowth of the Organization for Economic Co-operation and Development’s (“OECD”) original Base Erosion and Profit Shifting (“BEPS”) project is an ongoing project undertaken by the 139 member countries of the expanded OECD Inclusive Framework focused on “Addressing the Challenges of the Digitalization of the Economy,” which may impact all multinational businesses by potentially redefining jurisdictional taxation rights with Pillar One and Pillar Two blueprints. As these and other tax laws, regulations and norms change or evolve, our financial results could be materially impacted. Given the unpredictability of these possible changes, it is very difficult to assess whether the overall effect of such potential tax changes would be cumulatively positive or negative for our earnings and cash flow, but such changes could adversely impact our financial results.

In addition, the amount of income taxes we pay is subject to ongoing audits by U.S. federal, state and local tax authorities and by non-U.S. tax authorities. If these audits result in assessments different from amounts recorded, our future financial results may include unfavorable tax adjustments.

Acquisitions are expected to be a significant part of our growth strategy. If we are unable to identify suitable acquisition candidates, complete any proposed acquisitions or successfully integrate the businesses we acquire, our growth strategy may not succeed and we may not realize the anticipated benefits of our acquisitions.

We intend to seek acquisition opportunities both to expand into new markets and to enhance our position in our existing markets. However, our ability to do so will depend on a number of steps, including our ability to: obtain debt or equity financing that we may need to complete proposed acquisitions; identify suitable acquisition candidates; negotiate appropriate acquisition terms; complete the proposed acquisitions; and integrate the acquired business into our existing operations. If we fail to achieve any of these steps, our growth strategy may not be successful.

Acquisitions involve numerous risks, including difficulties in the assimilation of the operations, systems, controls, technologies, personnel, services and products of the acquired company, the potential loss of key employees, customers, suppliers and distributors of the acquired company, and the diversion of our management’s attention from other business concerns. The failure to successfully integrate acquired businesses in a timely manner, or at all, or the incurrence of significant unanticipated expenses associated with integration activities, including information technology integration fees, legal compliance costs, facility closure costs and other restructuring expenses, could have an adverse effect on our business, financial condition and results of operations.

In addition, the anticipated benefits of an acquisition may not be realized fully or at all, or may take longer to realize than we expect. Actual operating, technological, strategic and sales synergies, if achieved at all, may be less significant than we expect or may take longer to achieve than anticipated. If we are not able to realize the anticipated benefits and synergies from our acquisitions within a reasonable time, our business, financial condition and results of operations may be adversely affected.

18

Additionally, we may underestimate or fail to discover liabilities relating to acquisitions during our due diligence investigations, and we, as the successor owner of an acquired company, might be responsible for those liabilities. Such liabilities could have a material adverse effect on our business, financial condition and results of operations.

We may require additional capital to finance our operating needs and to finance our growth, including acquisitions. If the terms on which the additional capital is available are unsatisfactory, if the additional capital is not available at all or if we are not able to fully access credit under future credit agreements, we may not be able to pursue our growth strategy.

Our growth strategy will require additional capital investment to complete acquisitions, integrate the completed acquisitions into our existing operations and expand into new markets. We intend to pay for future acquisitions using cash, capital stock, notes, assumption of indebtedness or any combination of the foregoing. To the extent that we do not generate sufficient cash internally to provide the capital we require to fund our growth strategy and future operations, we will require additional debt or equity financing. This additional financing may not be available or, if available, may not be on terms acceptable to us. Further, high volatility in the capital markets and in our stock price may make it difficult for us to access the capital markets at attractive prices, if at all. If we are unable to obtain sufficient additional capital in the future, it may limit our ability to fully implement our growth strategy. Even if future debt financing is available, it may result in (i) increased interest expense, (ii) increased term loan payments, (iii) increased leverage and (iv) decreased income available to fund further acquisitions and expansion. It may also limit our ability to withstand competitive pressures and make us more vulnerable to economic downturns. If future equity financing is available, issuances of our equity securities may significantly dilute our existing stockholders.

Our hedging activity could negatively impact our results of operations, cash flows, or leverage.

We have entered into derivatives to manage our exposure to interest rate and currency movements. If we do not accurately forecast our results of operations, execute contracts that do not effectively mitigate our economic exposure to interest rates, elect to not apply hedge accounting, or fail to comply with the complex accounting requirements for hedging, our results of operations and cash flows could be volatile, as well as negatively impacted. Additionally, some of our hedging activity addresses long-term exposures, such as our net investment in our subsidiaries. If we fail to comply with hedge accounting requirements, the gains or losses on those hedges could be recognized before the offsetting exposure materializes to offset them, potentially causing volatility in our cash or debt balances and therefore our leverage.

The loss of key leadership could have a material adverse effect on our ability to run our business.

We may be adversely affected if we lose members of our senior leadership. We are highly dependent on our senior leadership team as a result of their expertise in our industry and our business. The loss of key leadership or the inability to attract, retain and motivate sufficient numbers of qualified management personnel could have a material adverse effect on our business, financial condition and results of operations.

Risks Related to Litigation and Regulatory Compliance

Available insurance coverage, the number of future asbestos-related claims and the average settlement value of current and future asbestos-related claims of certain subsidiaries could be different than current estimates, which could materially and adversely affect our business, financial condition and results of operations.

Certain subsidiaries contributed by the Former Parent immediately prior to the consummation of the Separation and pursuant to the terms of the Separation Agreement are one of many defendants in a large number of lawsuits that claim personal injury as a result of exposure to asbestos from products manufactured or used with components that are alleged to have contained asbestos. Such components were acquired from third-party suppliers and were not manufactured by any of these subsidiaries nor were these subsidiaries producers or direct suppliers of asbestos. Additionally, pursuant to the definitive purchase agreements related to the sale of the Former Parent’s Fluid Handling (“FH”) and Air and Gas Handling (“AGH”) businesses, the Former Parent and its subsidiaries retained the asbestos-related contingencies and insurance coverage related to these businesses, even though the Former Parent sold the operating assets of the FH and AGH businesses. In connection with the Separation, we agreed to indemnify the Former Parent for, among other things, the retained asbestos-related contingencies and liabilities related to these businesses. See “Business—Legal Proceedings” and “Note 19 Commitments and Contingencies.”

19

For purposes of our financial statements, we have estimated the future claims exposure and the amount of insurance available based upon certain assumptions with respect to future claims and liability costs. We estimate the liability costs to be incurred in resolving pending and forecasted claims for the next 15-year period as well as the amount of insurance proceeds available for such claims. We reevaluate these estimates regularly. Although we believe our current estimates are reasonable, a change in the time period used for forecasting liability costs, the actual number of future claims brought, the cost of resolving these claims, the likelihood of payment by, and the solvency of, insurers and the amount of remaining insurance available could be substantially different than the estimates, and future revaluation of liabilities and insurance recoveries could result in material adjustments to these estimates, any of which could materially and adversely affect our business, financial condition and results of operations.

In addition, we incur defense, settlement and/or judgment costs related to those claims, a portion of which has historically been reimbursed by insurers. We also incur legal costs in connection with efforts to recover insurance from certain of the contributed subsidiaries’ insurers relating to insurance coverage. These costs may be significant, and we may not be able to predict the amount or duration of such costs. Additionally, we may experience delays in receiving reimbursement from insurers, during which time we may be required to pay cash for settlement or legal defense costs. Any increase in the actual number of future claims brought against us, the costs of defending or resolving these claims, the costs of pursuing claims against our insurers, the likelihood and timing of payment by, and the solvency of, insurers and the amount of remaining insurance available, could materially and adversely affect our business, financial condition and results of operations. See “Business—Legal Proceedings.”

We have done and may continue to do business in countries subject to U.S. sanctions and embargoes. Failure to comply with various sanction and embargo laws may result in enforcement or other regulatory actions.

Certain of our independent foreign subsidiaries have conducted and may continue to conduct business in countries subject to U.S. sanctions and embargoes or may engage in business dealings with parties whose property or property interests may be blocked under non-country-specific U.S. sanctions programs. Failure to comply properly with various sanction and embargo laws to which we and our operations may be subject may result in enforcement or other regulatory actions. Specifically, from time to time, certain of our independent foreign subsidiaries sell products to companies and entities located in, or controlled by the governments of, certain countries that are or have previously been subject to sanctions and embargoes imposed by the U.S. government, the United Nations or other countries where we maintain operations. With the exception of the U.S. sanctions against Cuba and Iran, the applicable sanctions and embargoes generally do not prohibit our foreign subsidiaries from selling non-U.S.-origin products and services to countries that are or have previously been subject to sanctions and embargoes. However, our U.S. personnel, each of our domestic subsidiaries, as well as our employees of foreign subsidiaries who are U.S. citizens, are prohibited from participating in, approving or otherwise facilitating any aspect of the business activities in those countries or with persons prohibited under U.S. sanctions. These constraints impose compliance costs and risks on our
operations and may negatively affect the financial or operating performance of such business activities. In addition, the invasion of Ukraine by Russia and the sanctions imposed in response to this crisis have increased the level of economic and political uncertainty. For information about our business in Russia, see also “—Our operations in Russia are exposed to risks related to the Russian invasion of Ukraine and the international response to the invasion.”

Our efforts to comply with U.S. and other applicable sanction and embargo laws may not be effective, and as a consequence we may face enforcement or other actions if our compliance efforts are not or are perceived as not being wholly effective. Actual or alleged violations of these laws could lead to substantial fines or other sanctions which could result in substantial costs. In addition, Syria, Sudan and Iran and certain other sanctioned countries currently are identified by the U.S. State Department as state sponsors of terrorism and have been subject to restrictive sanctions. Because certain of our independent foreign subsidiaries may have contact with and transact limited business in certain U.S. sanctioned countries, including sales to enterprises controlled by agencies of the governments of such countries, our reputation may suffer due to our association with these countries, which may have a material adverse effect on the price of our common stock and our business, financial condition and results of operations.

In addition, certain U.S. states and municipalities have enacted legislation regarding investments by pension funds and other retirement systems in companies that have business activities or contacts with countries that have been identified as state sponsors of terrorism and similar legislation may be pending in other states. As a result, pension funds and other retirement systems may be subject to reporting requirements with respect to investments in companies such as ESAB or may be subject to limits or prohibitions with respect to those investments that may have a material adverse effect on the price of our common stock and our business, financial condition and results of operations.

20

If we fail to comply with export control regulations, we could be subject to substantial fines or other sanctions, which could have a material adverse effect on our business, financial condition and results of operations.

Some of our products manufactured or assembled in the United States are subject to the U.S. Export Administration Regulations, administered by the U.S. Department of Commerce, Bureau of Industry and Security (“BIS”), which require that an export license is obtained before such products can be exported to certain countries, and the U.S. Treasury Department’s Office of Foreign Assets Control’s (“OFAC”) trade and economic sanctions programs. Additionally, some of our products are subject to the International Traffic in Arms Regulations, which restrict the export of certain military or intelligence-related items, technologies and services to non-U.S. persons. Such regulations may prohibit or restrict our ability to, directly or indirectly, conduct activities or dealings in or with certain countries or territories that are the subject of comprehensive embargoes, as well as with certain individuals or entities. Failure to comply with these laws could harm our business by subjecting us to sanctions by the U.S. government, including substantial monetary penalties, denial of export privileges and debarment from U.S. government contracts. For example, from 2016 through 2020, one of our foreign subsidiaries engaged in certain transactions, a limited number of which included U.S. origin goods, either directly or indirectly through distributors, involving sales to specially designated nationals and/or to the Crimea region of Ukraine, which may have been made in violation of relevant trade sanctions or export control laws. We submitted a voluntary disclosure report to relevant U.S. government agencies regarding these transactions. On March 26, 2021 and August 26, 2021, Colfax received letters from BIS and OFAC, respectively, warning Colfax against future violations, and closing their respective matters without further action. No further communications from any other relevant U.S. government agencies have been received.

We are subject to a variety of continuously evolving and developing laws and regulations regarding privacy, data protection and data security.

To conduct our operations, we regularly move data across national borders, and consequently we are subject to a variety of continuously evolving and developing laws and regulations in the United States and foreign jurisdictions regarding privacy, data protection and data security. The scope of the laws that may be applicable to us is often uncertain and may be conflicting, particularly with respect to foreign laws. Foreign laws we are subject to include the European Union’s General Data Protection Regulation (the “GDPR”), the domestic version of the GDPR adopted by the United Kingdom in January 2021, following its exit from the European Union, which currently imposes the same obligations as the GDPR in most material respects. Other countries have enacted or are enacting data localization laws that require data to stay within their borders. The United States has also recently seen a significantly increased focus on the regulation of personal data, led by the passage of various comprehensive privacy and data protection laws at the state level. For example, the California Consumer Privacy Act (the “CCPA”), requires, among other things, that covered companies provide new disclosures to California consumers and affords such consumers certain rights, including the ability to opt out of certain types of data sharing and sales of their personal information. The California Privacy Rights Act, which went into effect in January 2023, amended the CCPA to provide for additional privacy protections. Similar legislation has been adopted in Virginia, Colorado, Utah and Connecticut, all of which will go into effect in 2023. The wave of similar legislative developments in other states in the United States creates the potential for a patchwork of overlapping but different state laws and could mark the beginning of a trend toward more stringent privacy legislation in the United States. All of these evolving compliance and operational requirements impose significant costs that are likely to increase over time.

We are subject to a variety of increasingly stringent environmental and health and safety laws for which compliance, or related liabilities, could be costly.

We and our business are subject to international, federal, state and local environmental and safety laws and regulations, including laws and regulations governing emissions of regulated air pollutants and greenhouse gases; discharges of wastewater and storm water; storage and handling of raw materials; the use, manufacture, handling, storage and disposal of hazardous materials; generation, storage, transportation and disposal of regulated wastes; and laws and regulations governing worker safety.
These requirements impose certain responsibilities on our business, including the obligation to obtain and maintain various environmental permits. If we were to fail to comply with these requirements or fail to obtain or maintain a required permit, we could be subject to penalties and be required to undertake corrective action measures to achieve compliance.

In addition, under various federal, state and local laws, regulations and ordinances, and, in some instances, international laws, relating to the protection of the environment, a current or former owner or operator of real property may be liable for the cost to remove or remediate contamination on, under, or released from such property and for any damage to natural resources, such as soil or groundwater, resulting from such contamination.
21

Similarly, a generator of waste can be held responsible for contamination resulting from the treatment or disposal of such waste at any off-site location (such as a landfill), regardless of whether the generator arranged for the treatment or disposal of the waste in compliance with applicable laws. Costs associated with liability for removal or remediation of contamination or damage to natural resources could be substantial and liability under these laws may attach without regard to whether the responsible party knew of, or was responsible for, the presence of the contaminants. Moreover, noncompliance could subject us to private claims for property damage or personal injury based on exposure to hazardous materials or unsafe working conditions. In addition, changes in applicable requirements or stricter interpretation of existing requirements may result in costly compliance requirements or otherwise subject us to future liabilities.

In addition, any environmental liability may be joint and several. Moreover, the presence of contamination or the failure to remediate contamination at our properties, or properties for which we are deemed responsible, may expose us to liability for property damage or personal injury, or materially adversely affect our ability to sell our real property interests or to borrow using the real property as collateral. We could be subject to environmental liabilities in the future as a result of historic or current operations that have resulted or will result in contamination.

The occurrence of any of the foregoing could have a material adverse effect on our business, financial condition and results of operations.

We are exposed to certain regulatory and financial risks related to climate change, which could adversely affect our business, financial condition, results of operations and cash flows.

Continuing political and social attention to the issue of climate change has resulted in both existing and pending international agreements and national, regional or local legislation and regulatory measures to limit greenhouse gas emissions, such as cap and trade regimes, carbon taxes, restrictive permitting, increased fuel efficiency standards and incentives or mandates for renewable energy. Such measures could subject us to additional costs and restrictions and require significant operating and capital expenditures, which could impact our business, financial condition, results of operations and cash flows. Additionally, such measures may impact our customers, which could impact their ability or desire to continue to operate at similar levels in certain jurisdictions as historically seen or as currently anticipated, which could negatively impact their demand for our products and services.

Our businesses are subject to extensive regulation; failure to comply with those regulations could adversely affect our reputation and our business, financial condition and results of operations.

In addition to the environmental, health, safety, anti-corruption, export control, privacy, data protection, data security and other regulations noted above, our businesses are also subject to extensive regulation by U.S. and non-U.S. governmental and self-regulatory entities at the supranational, federal, state, local, and other jurisdictional levels. Certain of our gas control products are classified as medical devices that are subject to regulation by the U.S. Food and Drug Administration and under the European Union Medical Device Regulation, as well as by other federal and local governmental agencies, and by certain accrediting bodies. To varying degrees, these regulators require us to comply with laws and regulations governing the development, testing, manufacturing, labeling, marketing, distribution, and post-marketing surveillance of such products. We are also required to comply with ever changing labor and employment laws and regulations in multiple jurisdictions. These changes could negatively impact our business or financial position.

These are not the only regulations that our businesses must comply with. The regulations we are subject to have tended to become more stringent over time and may be inconsistent across jurisdictions. Failure to comply with the regulations referenced above or any other regulations could result in civil and criminal, monetary and non-monetary penalties, and any such failure or alleged failure could also damage our reputation, disrupt our business, limit our ability to manufacture, import, export, and sell products and services, result in loss of customers and cause us to incur significant legal and investigatory fees.

Compliance with these and other regulations may also affect our returns on investment, require us to incur significant expenses, or modify our business model or impair our flexibility in modifying product, marketing, pricing, or other strategies for growing our business. Our products and operations are also often subject to the rules of industrial standards bodies such as the International Standards Organization, and failure to comply with these rules could result in withdrawal of certifications needed to sell our products and services and otherwise adversely impact our reputation and our business, financial condition and results of operations.


22

Risks Related to the Separation and Our Relationship with Enovis

We have a limited history of operating as a separate, publicly traded company, and our historical financial information is not necessarily representative of the results that we would have achieved as a separate, publicly traded company and may not be a reliable indicator of our future results.

The historical information about us in this Form 10-K for periods prior to the Separation refers to our businesses as operated by and integrated with Colfax. Our historical financial information for such periods included in this Form 10-K is derived from the consolidated financial statements and accounting records of Colfax. Accordingly, the historical financial information for periods prior to the Separation included in this Form 10-K does not necessarily reflect the financial condition, results of operations or cash flows that we would have achieved as a separate, publicly traded company during the periods presented or those that we will achieve in the future primarily as a result of the factors described below:

•prior to the Separation, our businesses were operated by Colfax as part of its broader corporate organization, rather than as a separate, publicly traded company. Colfax or one of its affiliates performed various corporate functions for us such as legal, treasury, accounting, internal audit, human resources and finance. Our historical financial results reflect allocations of corporate expenses from Colfax for such functions and are likely to be less than the expenses we would have incurred had we operated as a separate publicly traded company during those periods. As a result of the Separation, our cost related to such functions previously performed by Colfax therefore have and may continue to increase;
•prior to the Separation, our businesses were integrated with the other businesses of Colfax. Historically, we shared economies of scope and scale in costs, employees, vendor relationships and customer relationships. Although we entered into transition agreements with Enovis, these arrangements may not fully capture the benefits that we previously enjoyed as a result of being integrated with Colfax and may result in us paying higher charges than in the past for these services. This could have an adverse effect on our results of operations and financial condition as a result of the Separation;
•generally, our working capital requirements and capital for our general corporate purposes, including acquisitions and capital expenditures, historically were satisfied as part of the corporate-wide cash management policies of Colfax. Following the completion of the Separation, we may need to obtain additional financing from banks, through public offerings or private placements of debt or equity securities, strategic relationships or other arrangements;
•as a result of the Separation, the cost of capital for our businesses may be higher than Colfax’s cost of capital prior to the Separation; and our historical financial information does not reflect the debt or the associated interest expense that we incurred as part of the Separation and Distribution.

Other significant changes may occur in our cost structure, management, financing and business operations as a result of operating as a company separate from Enovis. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our audited consolidated and combined financial statements and notes thereto included elsewhere in this Form 10-K.

As a separate, publicly traded company, we may not enjoy the same benefits that we did as a part of Colfax.

As a separate, publicly traded company, we may be more susceptible to market fluctuations and other adverse events than we would have been if we were still a part of the current Enovis organizational structure. As part of Colfax, we were able to enjoy certain benefits from Colfax’s operating diversity, purchasing power and opportunities to pursue integrated strategies with Colfax’s other businesses. As a separate, publicly traded company, we do not have similar diversity or integration opportunities and may not have similar purchasing power or access to capital markets.

Our stock price may fluctuate significantly, including from future sales of our common stock or the perception that such sales or resales may occur.

The trading market for our common stock has existed only since the Separation. The price and trading volume of our common stock has been and may continue to be volatile and the value of an investment in our common stock could decline. Prior to the Separation, there was no public market for our common stock. An active trading market for our common stock may not be sustainable. The market price and trading volume of our common stock has fluctuated substantially and may continue to do so due to a number of factors, some of which may be beyond our control, including:

•our quarterly or annual earnings, or those of other companies in our industry;
23

•the failure of securities analysts to cover our common stock;
•actual or anticipated fluctuations in our operating results;
•changes in earnings estimated by securities analysts or our ability to meet those estimates;
•the operating and stock price performance of other comparable companies;
•changes to the regulatory and legal environment in which we operate;
•the effects of COVID-19;
•overall market fluctuations and domestic and worldwide economic conditions; and
•other factors described in these “Risk Factors” and elsewhere in this Form 10-K.

Pursuant to that certain registration rights agreement we entered into with Mitchell P. Rales and Steven M. Rales (together, the “Rales Holders”), the Rales Holders and their permitted transferees have registration rights for the resale of certain shares of our common stock. These registration rights, which pursuant to the agreement will become available to the Rales Holders one year post the Distribution, would facilitate the resale of such securities into the public market, and any such resale would increase the number of shares of our common stock available for public trading. Sales by the Rales Holders or their permitted transferees of a substantial number of shares of our common stock in the public market, or the perception that such sales might occur, could have a material adverse effect on the price of our common stock.

Stock markets in general have experienced volatility that has often been unrelated to the operating performance of a particular company. These broad market fluctuations may adversely affect the trading price of our common stock.

Potential indemnification obligations to Enovis pursuant to the Separation Agreement could materially and adversely affect our businesses, financial condition, results of operations and cash flows.

The separation and certain other agreements with Enovis, which we entered into with Enovis on April 4, 2022 in connection with the Separation (the “Separation Agreement”), provides for, among other things, indemnification obligations (for uncapped amounts) designed to make us financially responsible for all liabilities that Enovis may incur or may exist relating to our business activities (as currently and historically conducted) and those of Colfax’s divested FH and AGH businesses, whether incurred prior to or after the Separation. For example, pursuant to the Separation Agreement, we have agreed to indemnify Enovis for, among other things, the retained asbestos-related contingencies and liabilities related to the sale of Colfax’s FH and AGH businesses. See “—Risks Related to Litigation and Regulatory Compliance—Available insurance coverage, the number of future asbestos-related claims and the average settlement value of current and future asbestos-related claims of certain subsidiaries could be different than current estimates, which could materially and adversely affect our business, financial condition and results of operations.”

If we are required to indemnify Enovis under the circumstances set forth in the separation agreement, we may be subject to substantial liabilities. See “Business—Legal Proceedings.”

In connection with the Separation, Enovis agreed to indemnify us for certain liabilities. However, there can be no assurance that such indemnity will be sufficient to insure us against the full amount of such liabilities, or that Enovis’s ability to satisfy its indemnification obligations will not be impaired in the future.

Pursuant to the Separation Agreement, the tax matters agreement, and certain other agreements with Enovis, Enovis has agreed to indemnify us for certain liabilities. However, third parties could also seek to hold us responsible for any of the liabilities that Enovis has agreed to retain, and there can be no assurance that the indemnity from Enovis will be sufficient to protect us against the full amount of such liabilities, or that Enovis will be able to fully satisfy its indemnification obligations.

In addition, Enovis’s insurance will not necessarily be available to us for liabilities associated with occurrences of indemnified liabilities prior to the Separation, and in any event Enovis’s insurers may deny coverage to us for liabilities associated with certain occurrences of indemnified liabilities prior to the Separation. Moreover, even if we ultimately succeed in recovering from Enovis or such insurance providers any amounts for which we are held liable, we may be temporarily required to bear these losses. Each of these risks could negatively affect our businesses, financial position, results of operations and cash flows.

If the Distribution, together with certain related transactions, fails to qualify as a reorganization under Sections 355 and 368(a)(1)(D) of the Code, Enovis and its stockholders could incur significant tax liabilities, and we could be required to indemnify Enovis for taxes that could be material pursuant to indemnification obligations under the tax matters agreement that we entered into with Enovis on April 4, 2022.
24

The Distribution was conditioned upon, among other things, Colfax’s receipt of a private letter ruling from the IRS and the opinion of Latham & Watkins LLP, tax counsel to Colfax, both of which Colfax received, regarding the qualification of the Distribution, together with certain related transactions, as a reorganization under Sections 355 and 368(a)(1)(D) of the Code. The private letter ruling and the opinion were based on, among other things, certain factual assumptions, representations and undertakings from Colfax and us, including those regarding the past and future conduct of the companies’ respective businesses and other matters. If any of these factual assumptions, representations, or undertakings are incorrect or not satisfied, Enovis may not be able to rely on the private letter ruling or opinion, and Enovis and its stockholders could be subject to significant U.S. federal income tax liabilities. In addition, the private letter ruling does not address all the requirements for determining whether the Distribution will qualify for tax-free treatment, and the opinion, which addresses all such requirements, relies on the private letter ruling as to matters covered by the ruling and is not binding on the IRS or the courts. Notwithstanding any private letter ruling or opinion of tax counsel, the IRS could determine on audit that the Distribution does not qualify for tax free treatment if it determines that any of these factual assumptions, representations or undertakings are not correct or have been violated or that the Distribution should be taxable for other reasons, including as a result of a significant change in stock or asset ownership after the Distribution.

If the Distribution is ultimately determined not to so qualify for tax free treatment, the Distribution could be treated as a taxable disposition of shares of ESAB stock by Enovis and as a taxable dividend or capital gain to Enovis’s stockholders for U.S. federal income tax purposes. In such case, Enovis and its stockholders that are subject to U.S. federal income tax could incur significant U.S. federal income tax liabilities.

Under the tax matters agreement that we entered into with Enovis on April 4, 2022, we are generally required to indemnify Enovis against taxes incurred by Enovis that arise as a result of actions or omissions by us that prevent the Distribution, together with certain related transactions, from qualifying as a reorganization under Sections 355 and 368(a)(1)(D) of the Code.

We might not be able to engage in certain transactions and equity issuances as a result of the Distribution.

Our ability to engage in equity transactions could be limited or restricted in order to preserve, for U.S. federal income tax purposes, the qualification of the Distribution, together with certain related transactions, as a reorganization under Sections 355 and 368(a)(1)(D) of the Code. Even if the Distribution otherwise qualifies for tax-free treatment to Enovis’s stockholders under Section 355 of the Code, it may result in corporate-level taxable gain to Enovis if there is a 50% or greater change in ownership, by vote or value, of shares of ESAB’s stock, Enovis’s stock or the stock of a successor of either occurring as part of a plan or series of related transactions that includes the Distribution. Any acquisitions or issuances of ESAB’s stock or Enovis’s stock within two years of the Distribution are generally presumed to be part of such a plan, although Enovis may be able to rebut that presumption.

Under the tax matters agreement that we entered into with Enovis on April 4, 2022, we are required to comply with the representations made in the private letter ruling Colfax has received and in materials submitted to the IRS in connection therewith and to legal counsel in connection with the tax opinion Colfax received regarding the intended tax treatment of the Distribution and certain related transactions. The tax matters agreement also restricts our ability to take or fail to take any action if such action or failure to act could adversely affect the intended tax treatment. In particular, except in specific circumstances, in the two years following the Distribution, we are restricted from, among other things, (i) entering into any transaction pursuant to which all or a portion of our equity would be acquired, whether by merger or otherwise, and (ii) ceasing to actively conduct certain of our businesses.

These restrictions may limit for a period of time our ability to pursue certain transactions that we may believe to be in the best interests of our stockholders or that might increase the value of our businesses. For more information, see the section entitled “Certain Relationships and Related Person Transactions—Agreements with Enovis—Tax Matters Agreement.”

Certain of our executive officers and directors may have actual or potential conflicts of interest because of their equity interests in Enovis. Also, Christopher Hix, in addition to having served as Enovis’s Executive Vice President, Finance and Chief Financial Officer and continuing to serve as an advisor to Enovis, serves as an ESAB director, which may create the appearance of or actual conflicts of interest.

Because of their current or former positions with Enovis, certain of our executive officers and directors own equity interests in Enovis. Continuing ownership of shares of Enovis common stock and equity awards could create, or appear to create, potential conflicts of interest if we and Enovis face decisions that could have implications for both Enovis and us.
25

In addition, one of Enovis’s former executive officers is a member of our Board, and two members of Enovis’s board of directors serve on our Board, any of which could create, or appear to create, potential conflicts of interest when we and Enovis encounter opportunities or face decisions that could have implications for both companies or in connection with the allocation of such director’s time between Enovis and us.

We may not achieve some or all of the expected benefits of the Separation, and the Separation may adversely affect our businesses.

We may not be able to achieve the full strategic and financial benefits expected to result from the Separation, or such benefits may be delayed or not occur at all. The Separation is expected to provide the following benefits, among others:

•allow investors to separately value Enovis and us based on Enovis’s and our distinct investment identities. Our businesses differ from Enovis’s businesses in several respects, such as the market for products and manufacturing processes.
•enable investors to evaluate the merits, performance and future prospects of each company’s respective businesses and to invest in each company separately based on their distinct characteristics;
•create an independent equity structure to afford us direct access to the capital markets and facilitate our ability to capitalize on our unique growth opportunities;
•facilitate incentive compensation arrangements for employees tied to the performance of the relevant company’s businesses, and enhance employee hiring and retention by, among other things, improving the alignment of management and employee incentives with performance and growth objectives;
•permit each company to concentrate its financial resources solely on its own operations without having to compete internally for investment capital which may provide each company with greater flexibility to invest capital in its businesses in a time and manner appropriate for its distinct strategy and business needs; and
•allow us and Enovis to more effectively pursue our respective and distinct operating priorities and strategies and enable management of each company to focus on unique opportunities for long-term growth and profitability. Our and Enovis’s separate management teams are able to focus on executing each company’s differing strategic plans without diverting attention from the other businesses.

We may not achieve these and other anticipated benefits for a variety of reasons, including, among others, factors addressed elsewhere in these Risk Factors. If we fail to achieve some or all of the benefits expected to result from the Separation, or if such benefits are delayed, our businesses, operating results and financial condition could be adversely affected.

We may have received better terms from unaffiliated third parties than the terms we received in our agreements with Enovis.

The agreements we entered into with Enovis in connection with the Separation, including the separation agreement, transition services agreement, employee matters agreement, tax matters agreement, intellectual property matters agreement, EBS license agreement and a stockholder’s and registration rights agreement, were prepared in the context of our Separation from Colfax while we were still a wholly owned subsidiary of Colfax. Accordingly, during the period in which the terms of those agreements were prepared, we did not have a separate or independent board of directors or a management team that was separate from or independent of Colfax. As a result, the terms of those agreements may not reflect terms that would have resulted from arm’s length negotiations between unaffiliated third parties.
Arm’s-length negotiations between Colfax and an unaffiliated third party in another form of transaction, such as a buyer in a sale of a business transaction, may have resulted in more favorable terms to the unaffiliated third party.

We or Enovis may fail to perform under various transaction agreements that were executed as part of the Separation or we may fail to have necessary systems and services in place when certain of the transaction agreements expire.

The Separation Agreement and other agreements entered into in connection with the Separation determined the allocation of assets and liabilities between the companies following the Separation and include any necessary indemnifications related to liabilities and obligations. The transition services agreement provides for the performance of certain services by each company for the benefit of the other for a period of time after the Separation. We rely on Enovis after the Separation to satisfy its performance and payment obligations under these agreements. If Enovis is unable to satisfy its obligations under these agreements, including its indemnification obligations, we could incur operational difficulties or losses. If we do not have in
26

place our own systems and services, or if we do not have agreements with other providers of these services once certain transaction agreements expire, we may not be able to operate our businesses effectively and our profitability may decline. We have created our own, or engaged third parties to provide, systems and services to replace many of the systems and services that Colfax previously provided to us. However, we may not be successful in implementing these systems and services or in transitioning data from Colfax’s systems to us. In addition, we expect this process to be complex, time-consuming and costly.

We also established or expanded our own tax, treasury, internal audit, investor relations, corporate governance and public company compliance and other corporate functions. We have incurred costs to replicate, or outsource from other providers, these corporate functions to replace the corporate services that Colfax historically provided us prior to the Separation. Any failure or significant downtime in our own financial, administrative or other support systems or in Enovis’s financial, administrative or other support systems during the transitional period during which Enovis provides us with support could negatively impact our results of operations or prevent us from paying our suppliers and employees, executing business combinations and foreign currency transactions or performing administrative or other services on a timely basis, which could negatively affect our results of operations.

In particular, our day-to-day business operations rely on information technology systems. A significant portion of the communications among our personnel, customers and suppliers take place on information technology platforms. As a result of our reliance on information technology systems, the cost of such information technology integration and transfer and any such loss of key data could have an adverse effect on our business, financial condition and results of operations.

Risks Related to Shares of Our Common Stock

If we are unable to implement and maintain effective internal control over financial reporting in the future, investors may lose confidence in the accuracy and completeness of our financial reports and the market price of our common stock may be negatively affected.

As a public company, we are required to maintain internal controls over financial reporting and to report any material weaknesses in such internal controls. In addition, beginning with our second annual report on Form 10-K, we will be required to furnish a report by management on the effectiveness of our internal control over financial reporting, pursuant to Section 404 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”). Our independent registered public accounting firm will also be required to express an opinion as to the effectiveness of our internal control over financial reporting. At such time, our independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level at which our internal control over financial reporting is documented, designed or operated.

The process of designing, implementing, and testing the internal control over financial reporting required to comply with this obligation is time consuming, costly, and complicated. If we identify material weaknesses in our internal control over financial reporting, if we are unable to comply with the requirements of Section 404 of the Sarbanes-Oxley Act in a timely manner or to assert that our internal control over financial reporting is effective, or if our independent registered public accounting firm is unable to express an opinion as to the effectiveness of our internal control over financial reporting, investors may lose confidence in the accuracy and completeness of our financial reports and the market price of our common stock could be negatively affected, and we could become subject to investigations by the stock exchange on which our securities are listed, the SEC, or other regulatory authorities, which could require additional financial and management resources.

The obligations associated with being a public company require significant resources and management attention.

We are directly subject to the reporting and other requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the rules of the New York Stock Exchange (“NYSE”). As a separate public company, we are required to, among other things:

•prepare and distribute periodic reports, proxy statements and other stockholder communications in compliance with the federal securities laws and rules;
•have our own board of directors and committees thereof, which comply with federal securities laws and rules and applicable stock exchange requirements;
•maintain an internal audit function;
•maintain our own financial reporting and disclosure compliance functions;
•maintain an investor relations function;
27

•maintain and administer internal policies, including those relating to trading in our securities and disclosure controls and procedures; and comply with the rules and regulations implemented by the SEC, the Sarbanes-Oxley Act, the Dodd-Frank Act, the Public Company Accounting Oversight Board and the NYSE.

These reporting and other obligations place significant demands on our management and our administrative and operational resources, and we face increased legal, accounting, administrative and other costs and expenses relating to these demands that we had not incurred as a segment of Colfax. Our investment in compliance with existing and evolving regulatory requirements has resulted in increased administrative expenses and a diversion of management’s time and attention from sales-generating activities to compliance activities, which could have an adverse effect on our business, financial position, results of operations and cash flows.

We cannot guarantee the payment of dividends on our common stock, or the timing or amount of any such dividends.

We declared and paid a quarterly cash dividend of $0.05 per share of ESAB’s common stock to our stockholders of record for the second, third and fourth quarters of 2022. In addition, on March 2, 2023, our Board declared a quarterly cash dividend of $0.05 per share of ESAB’s common stock to our shareholders of record as of March 31, 2023. We cannot guarantee that we will continue to pay a dividend in the future. The payment of any dividends in the future, and the timing and amount thereof, to our stockholders will fall within the discretion of our Board.

The Board’s decisions regarding the payment of dividends will depend on many factors, such as our financial condition, earnings, capital requirements, debt service obligations, restrictive covenants in our then existing debt agreements, industry practice, legal requirements and other factors that the Board deems relevant. Our ability to pay dividends will depend on our ongoing ability to generate cash from operations and on our access to the capital markets.

Your percentage ownership in us may be diluted in the future.

In the future, your percentage ownership in us may be diluted because of equity issuances for acquisitions, capital market transactions or otherwise, including equity awards that we will be granting to our directors, officers and employees. These additional awards will have a dilutive effect on our earnings per share, which could adversely affect the market price of our common stock.

In addition, our amended and restated certificate of incorporation (our “certificate of incorporation”) authorizes us to issue, without the approval of our stockholders, one or more classes or series of preferred stock having such designation, powers, preferences and relative, participating, optional and other special rights, including preferences over our common stock respecting dividends and distributions, as the Board generally may determine. The terms of one or more classes or series of preferred stock could dilute the voting power or reduce the value of our common stock. For example, we could grant the holders of preferred stock the right to elect some number of our directors in all events or on the happening of specified events or the right to veto specified transactions. Similarly, the repurchase or redemption rights or liquidation preferences that we could assign to holders of preferred stock could affect the residual value of the common stock.

Certain provisions in our certificate of incorporation and amended and restated bylaws (our “bylaws”), and of Delaware law, may prevent or delay an acquisition of us, which could decrease the trading price of our common stock.

Our certificate of incorporation and bylaws contain, and Delaware law contains, provisions that are intended to deter coercive takeover practices and inadequate takeover bids and to encourage prospective acquirers to negotiate with the Board rather than to attempt an unsolicited takeover not approved by the Board. These provisions include, among others:

•the inability of our stockholders to call a special meeting;
•the inability of our stockholders to act by written consent;
•rules regarding how stockholders may present proposals or nominate directors for election at stockholder meetings;
•the right of the Board to issue preferred stock without stockholder approval;
•the division of the Board into three classes of directors, with each class serving a staggered three-year term, and this classified board provision could have the effect of making the replacement of incumbent directors more time consuming and difficult;
•provision that stockholders may only remove directors with cause; and
28

•the ability of our directors, and not stockholders, to fill vacancies (including those resulting from an enlargement of the Board) on the Board.

In addition, because we have not chosen to be exempt from Section 203 of the Delaware General Corporation Law (the “DGCL”), this provision could also delay or prevent a change of control that you may favor. Section 203 provides that, subject to limited exceptions, persons that acquire, or are affiliated with a person that acquires, more than 15% of the outstanding voting stock of a Delaware corporation (an “interested stockholder”) shall not engage in any business combination with that corporation, including by merger, consolidation or acquisitions of additional shares, for a three-year period following the date on which the person became an interested stockholder, unless (i) prior to such time, the Board of Directors of such corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder; (ii) upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of such corporation at the time the transaction commenced (excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) the voting stock owned by directors who are also officers or held in employee benefit plans in which the employees do not have a confidential right to tender or vote stock held by the plan); or (iii) on or subsequent to such time the business combination is approved by the Board of Directors of such corporation and authorized at a meeting of stockholders by the affirmative vote of at least two-thirds of the outstanding voting stock of such corporation not owned by the interested stockholder.

We believe these provisions will protect our stockholders from coercive or otherwise unfair takeover tactics by requiring potential acquirers to negotiate with the Board and by providing the Board with more time to assess any acquisition proposal. These provisions are not intended to make us immune from takeovers. However, these provisions will apply even if the offer may be considered beneficial by some stockholders and could delay or prevent an acquisition that the Board determines is not in the best interests of us and our stockholders. These provisions may also prevent or discourage attempts to remove and replace incumbent directors.

Our certificate of incorporation designates the state courts in the State of Delaware or, if no state court located within the State of Delaware has jurisdiction, the federal court for the District of Delaware, as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders. Our certificate of incorporation further designates the federal district courts of the United States of America as the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. These forum selection provisions could discourage lawsuits against us and our directors, officers, employees and stockholders.

Our certificate of incorporation provides that, unless we consent otherwise, the state courts in the State of Delaware or, if no state court located within the State of Delaware has jurisdiction, the federal court for the District of Delaware, shall be the sole and exclusive forum for any derivative action or proceeding brought on behalf of us, any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers, employees or stockholders to us or our stockholders, any action asserting a claim arising pursuant to any provision of the DGCL or our certificate of incorporation or bylaws, or any action asserting a claim governed by the internal affairs doctrine. This provision does not apply to claims brought to enforce a duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction.

This forum selection clause may impose additional litigation costs on stockholders in pursuing any such claims, particularly if the stockholders do not reside in or near the State of Delaware. Our certificate of incorporation further provides that, unless we consent otherwise, the federal district courts of the United States of America shall, to the fullest extent permitted by law, be the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. These forum selection provisions may limit the ability of our stockholders to bring a claim in a judicial forum that such stockholders find favorable for disputes with us or our directors or officers, which may discourage such lawsuits against us and our directors, officers, employees and stockholders. It is possible that a court may find these provisions of our certificate of incorporation inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, in which case we may incur additional costs associated with resolving such matters in other jurisdictions. This could materially adversely affect our business, financial condition, or results of operations and result in a diversion of the time and resources of our management and Board of Directors.

29

Item 1B. Unresolved Staff Comments

None.

Item 2. Properties

Our corporate headquarters are located in North Bethesda, Maryland in a facility that we lease. As of December 31, 2022 we had a total of five production facilities in the United States, representing a total of 0.6 million and 0.5 million square feet of owned and leased space, respectively, and 25 production facilities outside the U.S., representing a total of 9.9 million and 1.9 million square feet of owned and leased space, respectively, in 14 countries in Central and Eastern Europe, Central and South America and Asia.

Item 3. Legal Proceedings

Discussion of legal matters is incorporated by reference to Part II, Item 8, Note 19, “Commitments and Contingencies,” in the Notes to Consolidated and Combined Financial Statements.

Item 4. Mine Safety Disclosures

None.

30

INFORMATION ABOUT OUR EXECUTIVE OFFICERS

Set forth below are the names, ages, positions and experience of our executive officers. All of our executive officers hold office at the pleasure of our Board of Directors.
NameAgePosition
Shyam P. Kambeyanda52President and Chief Executive Officer and Director
Kevin Johnson47Chief Financial Officer
Olivier Biebuyck52President, Fabrication Technology
Michele Campion46Chief Human Resources Officer
John Dion58Senior Vice President, ESAB Business Excellence
Curtis Jewell41Senior Vice President, General Counsel and Corporate Secretary
Eleanor Lukens58President, Americas
Vusa Mlingo53Senior Vice President, Strategy and Business Development

Shyam P. Kambeyanda has served as a member of our Board of Directors since April 2022. Mr. Kambeyanda has been President and Chief Executive Officer of ESAB since May 2016. As the leader of ESAB, Mr. Kambeyanda has overseen the growth of the fabrication technology business, expanding ESAB’s global operations, improving financial performance and driving EBX throughout the business. Prior to joining ESAB, Mr. Kambeyanda most recently served as the President Americas for Eaton Corporation’s Hydraulics Group. Mr. Kambeyanda joined Eaton in 1995 and held a variety of positions of increasing responsibility in engineering, quality, e-commerce, product strategy, and operations management in the U.S., Mexico, Europe and Asia. Mr. Kambeyanda maintains a keen international perspective on driving growth and business development in emerging markets. Mr. Kambeyanda holds bachelor’s degrees in Physics and General Science from Coe College in Iowa and in Electrical Engineering from Iowa State University. Mr. Kambeyanda also earned his M.B.A from Kellogg School of Management at Northwestern University and is a Six Sigma Green Belt.

Kevin Johnson has been Chief Financial Officer of ESAB since May 2019. From 2017 to 2019, he served as Vice President, Finance, of Colfax, where his responsibilities included leading investor relations, financial planning and analysis and supporting acquisition diligence and integration. Prior to that, Mr. Johnson held a number of senior finance and system implementation roles at Colfax companies from 2001 to 2017, during which time he gained extensive global experience in roles of increasing responsibility including as Chief Financial Officer for Howden Africa, a South African publicly-listed company. Mr. Johnson is qualified as a CPA in Australia and holds an undergraduate degree (BSSc) from Queens University, Northern Ireland, a master’s degree in accounting (MAcc) from Macquarie University, Australia, and an M.B.A. from Hasselt University, Belgium.

Olivier Biebuyck has been President, Fabrication Technology of ESAB since January 2023. Prior to his current role, Mr. Biebuyck served as President, EMEA of ESAB from April 2021 to January 2023. Mr. Biebuyck joined ESAB in May 2017 as VP/GM of ESAB’s filler metals business and served in senior global positions with the company. Before joining ESAB, Mr. Biebuyck was an executive at Honeywell where he served as VP/GM of Honeywell Electronics Materials from July 2015 until April 2017 after being the Chief Marketing Officer of Honeywell Process Solutions from 2013 to 2015. Prior to that, Mr. Biebuyck was an executive at Lafarge where he held several P&L leadership roles and a senior management consultant with McKinsey & Company. Mr. Biebuyck holds a master’s degree in commercial engineering from the Solvay Business School at the Brussels University in Belgium.

Michele Campion has been ESAB’s Chief Human Resources Officer since April 2022 and previously served as Vice President, Human Resources of ESAB. Ms. Campion leads ESAB’s global human resources strategy in partnership with the executive team. Prior to joining ESAB, she served as Vice President, Human Resources at Under Armour, Inc. from November 2014 to September 2020. She also held a variety of roles of increasing responsibility in human resources at McCormick & Co., BP, International Partnership for Microbicides and Areas Global TB Vaccine Foundation. Ms. Campion earned a bachelor’s degree in Biology from University of Pittsburgh at Johnstown and an M.S. degree in Biotechnology with a concentration in Biotech Enterprise from Johns Hopkins University.


31

John Dion has been Senior Vice President, ESAB Business Excellence (EBX) since February 2023. Mr. Dion joined ESAB in May 2022 as Vice President, ESAB Business Excellence. Mr. Dion is responsible for leading ESAB’s EBX journey globally. In this role, he develops and leads the strategy and roadmap for strengthening and scaling the EBX culture. He is an industry executive with 35 years of industrial and life sciences experience. For over twenty years, Mr. Dion held positions of increasing responsibility at Danaher Corporation, most recently serving as a Senior Vice President with responsibility for service, customer service and the Danaher Business System within Danaher’s Pall business from May 2016 to April 2019 and Chief Transition Officer and Danaher Business System Leader in connection with Danaher’s acquisition of GE BioPharma from April 2019 until May 2021. Mr. Dion provided consulting services to ESAB and PHC Holdings Corporation from February 2022 until he joined ESAB in May 2022. Mr. Dion earned degrees in Electrical Engineering and Business Administration from the University of Connecticut.

Curtis Jewell has been Senior Vice President and Corporate Secretary of ESAB Corporation since April 2022 and previously served as General Counsel of ESAB. He has significant experience leading legal teams through complex acquisitions and crossborder initiatives while driving process improvement. Prior to his appointment at ESAB, he was the Corporate Secretary of Colfax Corporation, where he held roles of increasing responsibility since joining in February 2011. Before joining Colfax, Mr. Jewell was in private practice at Hogan Lovells LLP, where he focused on securities law and corporate governance, mergers and acquisitions, and capital market transactions. He began his legal career at Schulte Roth & Zabel LLP in New York. Mr. Jewell earned his bachelor’s degree in Philosophy and Political Science from Washington University in St. Louis, and his law degree from The University of Pennsylvania Carey Law School, where he also received a Certificate in Business and Public Policy from The Wharton School.

Eleanor Lukens has been President, Americas of ESAB Corporation since January 2023. Ms. Lukens oversees ESAB’s fabrication technology business in North America and South America. Before joining ESAB, Ms. Lukens served in multiple leadership roles at AMETEK, a leading global manufacturer of electronic instruments and electromechanical devices, for fifteen years. Most recently, she was Vice President and General Manager at AMETEK from August 2020 until January 2023, with global responsibility for four operating business units serving commercial aerospace, defense, aftermarket, and business jet, and Vice President, General Manager for AMETEK’s measurement and power systems division from September 2016 to July 2020. Earlier in her career, Ms. Lukens worked for Teleflex Incorporated and Drexelbrook Engineering. Ms. Lukens earned a Bachelor of Science in mechanical engineering technology from Spring Garden College and a Master of Business Administration with honors from Temple University, Fox School of Management.

Vusa Mlingo has been the Senior Vice President, Strategy and Business Development of ESAB Corporation since January 2022. Mr. Mlingo oversees ESAB’s strategic planning, market and growth opportunity assessments, and ESAB’s global acquisition pipeline. Prior to ESAB, Mr. Mlingo served as Vice President of Corporate Development & Strategy at SPX FLOW, Inc., a leading provider of process solution components and systems, from April 2019 to January 2022 and previously led the company’s mergers and acquisitions as Vice President of Business Development from March 2018 to April 2019. From 2006 to March 2019, Mr. Mlingo worked for Ingersoll Rand, where he served in various roles of increasing responsibility within corporate development and strategy, product management, and capital markets. Mr. Mlingo holds a bachelor’s degree with Honors from the University of Zimbabwe and an MBA from Howard University.


















32

PART II
Item 5. Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Our common stock began trading on the New York Stock Exchange under the symbol ESAB on April 5, 2022. As of February 28, 2023, there were 1,337 holders of record of our Common stock. The number of holders of record is based upon the actual number of holders registered at such date and does not include holders of shares in “street name” or persons, partnerships, associates, corporations or other entities identified in security position listings maintained by depositories.

We declared and paid a quarterly dividend of $0.05 per share of ESAB’s common stock to our stockholders of record for the second, third and fourth quarters of 2022. In addition, on March 2, 2023, our Board declared a quarterly cash dividend of $0.05 per share of ESAB’s common stock to our stockholders of record as of March 31, 2023.

The payment of dividends in the future and the timing and amount thereof, to our stockholders will fall within the discretion of our Board. The Board’s decisions regarding the payment of dividends will depend on many factors, such as our financial condition, earnings, capital requirements, debt service obligations, restrictive covenants in our then existing debt agreements, industry practice, legal requirements and other factors that the Board deems relevant.

Issuer Repurchase of Equity Securities
 
None

Recent Issuances of Unregistered Securities

None

Stock Performance Graph

The graph below compares the cumulative total return of holders of our common stock with the cumulative total return of the S&P MidCap 400 Index ("S&P 400") and the S&P MidCap 400 Industrials Index ("S&P 400 Industrials”). The graph tracks the performance of a $100 investment, assuming reinvestment of dividends, in our common stock and in each index from April 5, 2022, the date our stock commenced regular-way trading on the New York Stock Exchange, to December 31, 2022.
cfx-20221231_g1.jpg
Item 6. [Reserved]
33

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is designed to provide a reader of our financial statements with a narrative from the perspective of Company’s management. This MD&A is divided into five main sections:

•Basis of Presentation;
•Overview;
•Results of Operations;
•Liquidity and Capital Resources; and
•Critical Accounting Policies.

The following MD&A should be read together with Part I, Item 1A. “Risk Factors” and the accompanying Consolidated and Combined Financial Statements and Notes to Consolidated and Combined Financial Statements (“Notes”) included in Item 8. of this Form 10-K. The MD&A includes forward-looking statements. For a discussion of important factors that could cause actual results to differ materially from the results referred to in these forward-looking statements, see “Special Note Regarding Forward-Looking Statements.”

Separation from Enovis

On April 4, 2022 (the “Distribution Date”), Colfax Corporation completed the spin-off of Colfax’s Fabrication Technology business and certain other corporate entities as discussed in the “Separation from Enovis” section within Note 1, “Organization and Basis of Presentation” in the accompanying Notes contained elsewhere in this Form 10-K through a tax-free, pro rata distribution (the “Distribution”) of 90% of the outstanding common stock of ESAB to Colfax stockholders (the “Separation”). To effect the Separation, each Colfax stockholder of record as of close of business on March 23, 2022 received one share of ESAB common stock for every three shares of Colfax common stock held on the record date. Upon completion of the Distribution, Colfax changed its name to Enovis Corporation and continued to hold 10% of the outstanding common stock of ESAB. In November 2022 Enovis sold a total of 6.0 million shares of our common stock as part of a secondary offering. After the secondary offering, Enovis no longer owned any of our outstanding common stock.
On April 4, 2022, ESAB and Enovis entered into a separation and distribution agreement as well as various other related agreements that govern the Separation and the relationships between the parties going forward, including a transition services agreement, an employee matters agreement, a tax matters agreement, an intellectual property matters agreement, and license agreement for ESAB Business Excellence System ("EBX").

In conjunction with the Separation on April 4, 2022, the Company entered into a credit agreement as amended and restated from time-to-time, (the “Credit Agreement”). The Credit Agreement initially consisted of (i) a $750 million revolving credit facility (the “Revolving Facility”) with a maturity date of April 4, 2027, (ii) a Term A-1 loan with an initial aggregate principal amount of $400 million (the “Term Loan A-1 Facility”), with a maturity date of April 4, 2027; and (iii) a $600 million 364-day senior term loan facility (the “Term Loan A-2 Facility”) with a maturity date of April 3, 2023. The Company drew down $1.2 billion under the Credit Agreement and used these proceeds to make payments to Enovis of $1.2 billion, which were used as part of the consideration for the contribution of certain assets and liabilities to the Company by Enovis in connection with the Separation. Refer to Note 15, “Debt” in the accompanying Notes contained elsewhere in this Form 10-K for additional information on the Credit Agreement.

Basis of Presentation

The accompanying Consolidated and Combined Financial Statements present our historical financial position, results of operations, changes in equity and cash flows in accordance with generally accepted accounting principles in the United States of America (“GAAP”). The combined financial statements for periods prior to the Separation were derived from Enovis’s consolidated financial statements and accounting records and prepared in accordance with GAAP for the preparation of carved-out combined financial statements. Through the date of the Separation, all revenues and costs as well as assets and liabilities directly associated with ESAB and certain corporate entities have been included in the Combined financial statements. Prior to the Separation, the Combined financial statements also included allocations of certain general, administrative, sales and marketing expenses from Enovis’s corporate office and from other Enovis businesses to us and allocations of related assets, liabilities, and the Former Parent’s investment, as applicable.
34

The allocations were determined on a reasonable basis, however, the amounts are not necessarily representative of the amounts that would have been reflected in the financial statements had we been an entity that operated independently of Enovis during the applicable periods.

Certain factors could impact the nature and amount of these separate public company costs, including the finalization of our staffing and infrastructure needs. Following the Separation, pursuant to agreements with Enovis, Enovis continues to provide us with some of the services related to these functions on a transitional basis in exchange for agreed‑upon fees, and we incur other costs to replace the services and resources that are not provided by Enovis. Costs associated with services provided by Enovis on a transitional basis are immaterial. Related party allocations are discussed further in Note 21, “Related Party Transactions” in the accompanying Notes contained elsewhere in this Form 10-K. We also incur additional costs as a separate public company. These additional costs are primarily for the following:

•additional personnel costs, including salaries, benefits and potential bonuses and/or stock-based compensation awards for staff additions to replace support provided by the Former Parent that is not covered by the transition services agreement; and

•corporate governance costs, including board of director compensation and expenses, audit and other professional services fees, annual report and proxy statement costs, SEC filing fees, transfer agent fees, consulting and legal fees and stock exchange listing fees.

Certain factors could impact the nature and amount of these separate public company costs, including the finalization of our staffing and infrastructure needs.

During the year ended December 31, 2022, these separate public company costs exceeded the costs that have been historically allocated to us. During the three months ended April 1, 2022, the Former Parent allocated costs were $6.0 million, as included in the accompanying Notes contained elsewhere in this Form 10-K.

Following the Separation, the Consolidated and Combined Financial Statements include the accounts of ESAB and its wholly-owned subsidiaries and no longer include any allocations of expenses from Enovis. Accordingly:

•The Consolidated Balance Sheet as of December 31, 2022 consists of our consolidated balances, while the Combined Balance Sheet as of December 31, 2021 consists of the combined balances of the former Fabrication Technology business of Enovis.

•The Consolidated and Combined Statement of Operations and Statement of Comprehensive Income for the year ended December 31, 2022 consist of our consolidated results for the nine months ended December 31, 2022 and the combined results of the former Fabrication Technology business of Enovis and the certain entities discussed in the “Separation from Enovis” section within Note 1, “Organization and Basis of Presentation” contained elsewhere in this Form 10-K for the three months ended April 1, 2022. The Combined Statement of Operations and Statement of Comprehensive Income for the years ended December 31, 2021 and 2020 consist of the combined results of the former Fabrication Technology business of Enovis.

•The Consolidated and Combined Statement of Changes in Equity for the year December 31, 2022 consists of the consolidated activities of ESAB for the nine months ended December 31, 2022 and the combined activity of the former Fabrication Technology business of Enovis and the certain entities discussed in the “Separation from Enovis” section above for the three months ended April 1, 2022. The Combined Statements of Changes in Equity for the year ended December 31, 2021 and 2020 consist of the combined activity of the former Fabrication Technology business of Enovis.

•The Consolidated and Combined Statement of Cash Flows for the year ended December 31, 2022 consists of the consolidated activities of ESAB for the nine months ended December 31, 2022 and the combined activity of ESAB and the former Fabrication Technology business of Enovis and the certain entities discussed in the “Separation from Enovis” section above for the three months ended April 1, 2022. The Combined Statement of Cash Flows for the years ended December 31, 2021 and 2020 consist of the combined activity of the former Fabrication Technology business of Enovis.
35

Our Consolidated and Combined Financial Statements may not be indicative of our results had we been a separate stand-alone entity throughout the periods presented, nor are the results stated herein indicative of what our financial position, results of operations and cash flows may be in the future.

Prior to the Separation, we were dependent on Enovis for all of our working capital and financing requirements under Enovis’s centralized approach to cash management and financing of its operations. With the exception of cash, cash equivalents and borrowings clearly associated with ESAB and related to the Separation, financing transactions relating to us during the period prior to the Separation were accounted for through our Former Parent’s investment account. Accordingly, none of Enovis’s cash, cash equivalents or debt at the corporate level has been assigned to us in these financial statements.
Former Parent’s investment, which included retained earnings, represented Enovis’s interest in our recorded net assets. All significant transactions between us and the Former Parent prior to the Separation have been included in the accompanying Financial Statements. Transactions with the Former Parent are reflected in the accompanying Consolidated and Combined Statements of Equity as “Transfers to Former Parent, net” and in the accompanying Consolidated and Combined Balance Sheets within “Former Parent’s investment”.

Overview

Included below are year-over-year comparisons between 2022 and 2021. For further information on year-over-year comparisons between 2021 and 2020 not covered in the results below, refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s Form 10 for the period which was filed with the SEC on March 17, 2022.

Please see Part I, Item 1. “Business” in our Form 10-K, for a discussion of ESAB’s objectives and methodologies for delivering stockholder value.

General

We are a world leader in connected fabrication technology and gas control solutions. Our rich history of innovative products and workflow solutions and our business system (EBX) allows us to realize our purpose of Shaping the world we imagine. The Company’s products are utilized to solve challenges in a wide range of industries, including cutting, joining and automated welding.

We conduct our operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America, and “EMEA & APAC,” which includes Europe, Middle East, India, Africa and Asia Pacific. We serve a global customer base across multiple markets through a combination of direct sales and third-party distribution channels. Our customer base is highly diversified in the industrial end markets.

Integral to our operations is EBX, our business management system. EBX is our culture and includes our values, a comprehensive set of tools, and repeatable, teachable processes that we use to drive continuous improvement and create superior value for our customers, stockholders and associates. We believe that our management team’s access to, and experience in, the application of the EBX methodology is one of our primary competitive strengths.

Outlook

We believe that we are well positioned to grow our businesses organically over the long term by enhancing our product offerings and expanding our customer base. We believe that our business mix is well balanced between sales in emerging and developed markets, and equipment and consumables. We intend to continue to utilize our strong global presence and worldwide network of salespeople and distributors to capitalize on growth opportunities by selling regionally-developed and/or marketed products and solutions throughout our served markets. We believe that our geographic and end market diversity helps mitigate the effects from cyclical industrial market exposures. Given this balance, management does not use indices other than general economic trends and business initiatives to predict the overall outlook for the Company. Instead, our individual businesses monitor key competitors and customers, including to the extent possible their sales, to gauge relative performance and outlook for the future.

36

We face a number of challenges and opportunities, including the successful integration of acquired businesses, the application and expansion of our EBX tools to improve business performance, the ability to realize the expected benefits of the Separation and operate as an independent, public company, and the rationalization of assets and costs.

We expect strategic acquisitions to contribute to our growth. We believe that the extensive experience of our leadership team in acquiring and effectively integrating acquisition targets should enable us to capitalize on future opportunities. We believe the recent acquisitions of Ohio Medical, LLC, on October 14, 2022, and Swift Cut Automation Limited, on October 31, 2022, are aligned with this strategic direction. Refer to Note 5, “Acquisitions” in the accompanying Notes contained elsewhere in this Form 10-K for additional information.

The discussion that follows includes a comparison of our results of operations and liquidity and capital resources for the years ended December 31, 2022 and 2021.

Results of Operations

The following discussion of Results of Operations addresses the comparison of the periods presented. Our management evaluates the operating results of each of its reportable segments based upon Net sales, Adjusted EBITDA and Core adjusted EBITDA as defined in the “Non-GAAP Measures” section.

Items Affecting Comparability of Reported Results

The comparability of our operating results for the years ended December 31, 2022 and 2021 are affected by the following additional significant items:

The COVID-19 Pandemic

The Company continues to actively monitor the COVID-19 pandemic, and the impacts on our results and operations. As reflected in the discussions that follow, the pandemic and actions taken in response to it have had a variety of impacts on our results of operations during 2021 and 2022, including sales levels, and together with other market dynamics has contributed to ongoing inflation and supply chain challenges, including labor, raw material, and component shortages.

For additional information on the risks of COVID-19 to the Company’s operations, refer to the “Part I. Item 1A. Risk Factors” section.

Russia and Ukraine conflict

The invasion of Ukraine by Russia and the sanctions imposed in response to this crisis have increased the level of economic and political uncertainty. While we continue to closely monitor the situation and evaluate options, we are meeting current contractual obligations while addressing applicable laws and regulations. For the year ended December 31, 2022, Russia represented approximately 6% of our total revenue, and approximately $20 million in Net Income. Russia also has approximately 5% of our total net assets excluding any goodwill allocation as of December 31, 2022. In case of the disposition of the Russia business, a portion of goodwill would need to be allocated and disposed of in the relative fair value attributable to the Russia business. Russia has a cumulative translation loss of approximately $90 million as of December 31, 2022, which could be realized upon a transition out. We are closely monitoring the developments in Ukraine and Russia. Changes in laws and regulations or other factors impacting our ability to fulfill contractual obligations could have an adverse effect on the results of operations.

Acquisitions

We complement our organic growth plans with acquisitions and other investments. Acquisitions can significantly affect our reported results, and we report the change in our Net sales between periods both from existing and acquired businesses. The change in Net sales due to acquisitions for the periods presented in this filing represents the incremental sales as a result of acquisitions.

On October 14, 2022, we completed the acquisition of Ohio Medical, LLC, a U.S. based global leader in oxygen regulators and central gas systems, for $127 million. In connection with this acquisition, we expect to realize an additional cash tax benefit with a net present value of approximately $15 million.
37

This acquisition expands our presence in industrial specialty gas applications and products and broadens our U.S. presence.

On October 31, 2022, we completed the acquisition of Swift Cut Automation Limited for $22 million, net of cash received. Swift-Cut is a provider of light industrial cutting systems and combined with ESAB provides a market-leading automated cutting portfolio.

These acquisitions have combined sales of approximately $60 million on an annual basis.

Global Operations
 
Our products and services are available worldwide. The manner in which our products and services are sold differs by region. During 2022 and 2021, 78% of our Net sales were derived from operations outside of the United States. During 2022 and 2021, 44% and 41% of our Net sales, respectively, were derived from the Americas and 56% and 59%, respectively, from EMEA & APAC. Accordingly, we are affected by market demand, economic and political factors in countries throughout the world. Our ability to grow and our financial performance will be affected by our ability to address a variety of challenges and opportunities that are a consequence of our global operations, including efficiently utilizing our global sales, manufacturing and distribution capabilities, participating in the expansion of market opportunities in emerging markets, successfully completing global acquisitions and engineering innovative new product applications for end users in a variety of geographic markets. However, we believe that our geographic, end market, customer and product diversification may limit the impact that any one country or economy could have on our combined results.
 
Foreign Currency Fluctuations
 
As discussed above, a significant portion of our Net sales are outside the United States, with the majority of those sales denominated in currencies other than the U.S. dollar. Because much of our manufacturing and employee costs are outside the United States, a significant portion of our costs are also denominated in currencies other than the U.S. dollar. Changes in foreign exchange rates can impact our results of operations and are quantified when significant.

For the year ended December 31, 2022 compared to 2021, fluctuations in foreign currencies reduced Net sales by 4.2%, Gross profit by 4.6% and Selling, general and administrative expenses by 5.4%.

Seasonality

Our European operations typically experience a slowdown during the July, August and December vacation seasons.

Material Costs

Our results may be sensitive to cost changes in our raw materials. Our largest material purchases are for components and raw materials including steel, iron, copper and aluminum. Historically, we have been generally successful in passing raw material cost increases on to our customers in the form of higher prices. While we seek to take actions to manage this risk, future changes in component and raw material costs may adversely impact earnings. In 2022, we have experienced increasing raw material costs due to inflation, which we have passed through to customers to maintain our profit, but has resulted in some margin compression. These increased costs are expected to continue to remain at elevated levels for at least the near term.
 
Sales and Cost Mix
 
The Gross profit margins within our business vary in relation to the relative mix of many factors, including the type of product, the location in which the product is manufactured, the end market application for which the product is designed, and the percentage of total revenue represented by consumables, which often have lower margins than equipment.

The mix of sales was as follows for the periods presented:
Year Ended December 31,
20222021
Consumables71 %69 %
Equipment29 %31 %
38


Non-GAAP Measures

Adjusted EBITDA is a non-GAAP performance measure that we include in this report because it is a key metric used by our management to assess our operating performance. ESAB presents this non-GAAP financial measure including and excluding Russia due to economic and political volatility caused by the Russia and Ukraine conflict, which results in enhanced investor interest in this information. Core adjusted EBITDA is a non-GAAP measure that includes Russia for the three months ended April 1, 2022 and April 2, 2021, and due to the Russia Ukraine conflict that started at the end of the first quarter, excludes Russia for the nine months ended December 31, 2022 and December 31, 2021. Adjusted EBITDA excludes from Net income from continuing operations the effect of Income tax expense, Interest expense (income) and other, net, Pension settlement gains, Restructuring and other related charges, separation costs, acquisition-amortization and other related charges and depreciation and other amortization. We also present Adjusted EBITDA margins, which is subject to the same adjustments as Adjusted EBITDA. Further, we present these non-GAAP performance measures on a segment basis, where we exclude the impact of Restructuring and other related charges, separation costs, acquisition-amortization and other related charges and depreciation and other amortization from operating income. We also present Core Adjusted EBITDA and Core Adjusted EBITDA margins which are subject to the same adjustments as Adjusted EBITDA and Adjusted EBITDA margins, respectively, further removing the impact of Russia for the nine months ended December 31, 2022 and December 31, 2021, respectively. Adjusted EBITDA, Adjusted EBITDA margin, Core adjusted EBITDA and Core adjusted EBITDA margin assist management in comparing our operating performance over time because certain items may obscure underlying business trends and make comparisons of long-term performance difficult, as they are of a nature and/or size that occur with inconsistent frequency or relate to unusual events or discrete restructuring plans and other initiatives that are fundamentally different from our ongoing productivity and core business. Management also believes that presenting these measures allows investors to view our performance using the same measures that we use in evaluating our financial and business performance and trends.

Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with U.S. GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable U.S. GAAP financial measures.
The following tables set forth a reconciliation of Net income from continuing operations, the most directly comparable financial statement measure, to Adjusted EBITDA, Adjusted EBITDA margin, Core adjusted EBITDA and Core adjusted EBITDA margin by segment for the years ended December 31, 2022 and 2021.

Year Ended December 31, 2022
AmericasEMEA & APACTotal
(Dollars in millions)(1)
Net income from continuing operations (GAAP)$231.1 
Income tax expense69.2 
Interest expense (income) and other, net38.0 
Pension settlement gain(9.1)
Operating income (GAAP)$136.2 $192.8 $329.1 
Operating income margin12.1 %13.2 %12.7 %
Adjusted to add:
Restructuring and other related charges(2)
11.4 11.7 23.1 
Separation costs(3)(4)
7.5 8.1 15.5 
Acquisition-amortization and other related charges(5)
20.1 14.1 34.2 
Depreciation and other amortization13.4 21.5 34.9 
Adjusted EBITDA (non-GAAP)$188.6 $248.2 $436.8 
Adjusted EBITDA attributable to Russia (non-GAAP)(6)
— 20.0 20.0 
Core adjusted EBITDA (non-GAAP)$188.6 $228.2 $416.8 
Adjusted EBITDA margin (non-GAAP)16.7 %16.9 %16.8 %
Core adjusted EBITDA margin (non-GAAP)(7)
16.7 %17.0 %16.9 %
(1) Numbers may not sum due to rounding.
39

(2) Includes severance and other termination benefits, including outplacement services as well as the cost of relocating associates, relocating equipment, lease termination expenses, and other costs in connection with the closure and optimization of facilities and product lines.
(3) Includes non-recurring charges and employee costs related to the planning and execution of the separation from Enovis within the Selling, general and administrative expense line within the Consolidated and Combined Statements of Operations.
(4) Amounts are allocated to the segments as a percentage of revenue as the costs or gain are not discrete to either segment.
(5) Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses.
(6) Adjusted EBITDA relating to Russia from April 2, 2022 to December 31, 2022, respectively.
(7) Net sales were $122.6 million relating to Russia from April 2, 2022 to December 31, 2022.



Year Ended December 31, 2021
AmericasEMEA & APACTotal
(Dollars in millions)
Net income from continuing operations (GAAP)$238.7 
    Income tax expense80.4 
    Interest expense (income) and other, net(1.7)
    Pension settlement gain(11.2)
Operating income (GAAP)$111.2 $195.0 $306.2 
Operating income margin11.1 %13.7 %12.6 %
Adjusted to add (deduct):
Restructuring and other related charges(1)
11.6 7.4 19.0 
Separation costs(2)(3)
1.2 1.7 2.9 
Acquisition-amortization and other related charges(4)
18.5 17.4 35.9 
Depreciation and other amortization15.0 23.5 38.5 
Other(5)
2.1 (0.4)1.7 
Adjusted EBITDA (non-GAAP)$159.6 $244.6 $404.2 
Adjusted EBITDA attributable to Russia (non-GAAP)(6)
— 28.0 28.0 
Core adjusted EBITDA (non-GAAP)$159.6 $216.6 $376.2 
Adjusted EBITDA margin (non-GAAP)15.9 %17.2 %16.6 %
Core adjusted EBITDA margin (non-GAAP)(7)
15.9 %16.8 %16.4 %
(1) Includes severance and other termination benefits, including outplacement services as well as the cost of relocating associates, relocating equipment, lease termination expenses, and other costs in connection with the closure and optimization of facilities and product lines.
(2) Includes non-recurring charges and employee costs related to the planning and execution of the separation from Enovis within the Selling, general and administrative expense line within the Consolidated and Combined Statements of Operations.
(3) Amounts are allocated to the segments as a percentage of revenue as the costs or gain are not discrete to either segment.
(4) Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses.
(5) Relates to the adjustment for certain items included within the Interest expense (income) and other, net line within the Consolidated and Combined Statements of Operations.
(6) Adjusted EBITDA relating to Russia from April 3, 2021 to December 31, 2021,
(7) Net sales were $137.0 million relating to Russia from April 3, 2021 to December 31, 2021.













40

Total Company

Sales

Net sales increased to $2,593.5 million in 2022 from $2,428.1 million in 2021. The following table presents the components of changes in our consolidated and combined Net sales.
Net Sales
$%
(Dollars in millions)
For the year ended December 31, 2021
$2,428.1 
Components of Change:
Existing businesses (organic sales growth)(1)
254.2 10.5 %
Acquisitions(2)
13.5 0.6 %
Foreign currency translation(3)
(102.3)(4.2)%
Total sales growth165.4 6.8 %
For the year ended December 31, 2022
$2,593.5 
(1) Excludes the impact of acquisitions and foreign exchange rate fluctuations, thus providing a measure of change due to factors such as price, product mix and volume.
(2) Represents the incremental sales in comparison to the portion of the prior period during which we did not own the business.
(3) Represents the difference between prior year sales valued at the actual prior year foreign exchange rates and prior year sales valued at current year foreign exchange rates.

Net sales from existing businesses increased $254.2 million during 2022 compared to 2021 primarily due to inflation-related customer pricing increases of $270.4 million and new product initiatives, respectively, partially offset by reduced sales volumes mainly due to the Russia and Ukraine conflict. The strengthening of the U.S. dollar relative to other currencies caused a $102.3 million unfavorable currency translation impact during the year.


Sales excluding Russia

Sales excluding Russia (“Core Sales”) for ESAB increased for the year ended December 31, 2022 as compared with the year ended December 31, 2021. The following table presents the components of changes in our consolidated and combined Net sales.

Core Sales(4)
$ %
(Dollars in millions)
For the year ended December 31, 2021
$2,291.1 
Components of Change:
Existing businesses (core organic sales growth)(1)
290.5 12.7 %
Acquisitions(2)
13.5 0.6 %
Foreign Currency translation(3)
(124.2)(5.4)%
Total core sales growth179.8 7.8 %
For the year ended December 31, 2022
$2,470.9 
(1) Excludes the impact of acquisitions and foreign exchange rate fluctuations, thus providing a measure of change due to organic growth factors such as price, product mix and volume.
(2) Represents the incremental sales in comparison to the portion of the prior period during which we did not own the business.
(3) Represents the difference between prior year sales valued at the actual prior year foreign exchange rates and prior year sales valued at current year foreign exchange rates.
(4) Represents sales excluding Russia from April 2, 2022 to December 31, 2022, and April 3, 2021 to December 31, 2021.


41

Core Sales from existing businesses for ESAB increased $290.5 million during the year ended December 31, 2022, compared to the year ended December 31, 2021 primarily due to inflation-related customer pricing increases of $259.2 million and new product initiatives during the year ended December 31, 2022. The strengthening of the U.S. Dollar relative to other currencies caused a $124.2 million unfavorable currency translation impact during the year ended December 31, 2022.

Operating Results

The following table summarizes our results for the comparable periods.
Year Ended December 31,
20222021
(Dollars in millions)
Gross profit$885.5 $838.0 
Gross profit margin34.1 %34.5 %
Selling, general and administrative expense$533.4 $512.8 
Net income from continuing operations$231.1 $238.7 
Net income margin from continuing operations8.9 %9.8 %
Adjusted EBITDA (non-GAAP)$436.8 $404.2 
Adjusted EBITDA margin (non-GAAP)16.8 %16.6 %
Core adjusted EBITDA (non-GAAP)$416.8 $376.2 
Core adjusted EBITDA margin (non-GAAP)16.9 %16.4 %
Items excluded from Adjusted EBITDA:
Restructuring and other related charges(1)
$23.1 $19.0 
Pension settlement gain$(9.1)$(11.2)
Separation costs(2)(3)
$15.5 $2.9 
Acquisition - amortization and other related charges(4)
$34.2 $35.9 
Interest expense (income) and other, net(5)
$38.0 $— 
Income tax expense$69.2 $80.4 
Depreciation and other amortization$34.9 $38.5 
Items excluded from Core adjusted EBITDA:
Adjusted EBITDA attributable to Russia (non-GAAP)(6)
$20.0 $28.0 
(1) Includes severance and other termination benefits, including outplacement services as well as the cost of relocating associates, relocating equipment, lease termination expense, and other costs in connection with the closure and optimization of facilities and product lines.
(2) Includes non-recurring charges and employee costs related to the planning and execution of the separation from Enovis within the Selling, general and administrative expense line within the Consolidated and Combined Statements of Operations.
(3) Amounts are allocated to the segments as a percentage of revenue as the costs or gain are not discrete to either segment.
(4) Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses.
(5) Mainly relates to the removal of interest expense and income included within the Interest expense (income) and other, net line within the Consolidated and Combined Statement of Operations.
(6) Adjusted EBITDA relating to Russia from April 2, 2022 to December 31, 2022, and April 3, 2021 to December 31, 2021 respectively.

2022 Compared to 2021

Gross profit increased $47.5 million during 2022 in comparison to 2021, primarily attributable to benefit from price increases and new product initiatives partially offset by inflation-related costs increases, approximately $44 million of unfavorable foreign currency impacts and, to a lesser extent, reduced sales volume due to the Russia and Ukraine conflict. Gross profit margin declined primarily due to dilution effect caused by customer inflation-related pricing and cost increases, which compressed the margin.

Selling, general and administrative expense increased primarily due to inflation-related cost increases and increased costs related to being an independent public company, partially offset by currency fluctuations.

42

During the year ended December 31, 2022, the Company recognized a Pension settlement gain of $9.1 million related to a completed buy-out of a foreign defined benefit plan by a third party plus the merger of two Company pension plans resulting in one plan benefiting from the surplus assets in the other plan. During the year ended December 31, 2021, the Company recognized a Pension settlement gain of $11.2 million when the trustees of a Company pension plan agreed to merge the plan with another Company pension plan and contribute the plan’s surplus assets.

The effective tax rate for 2022 and 2021 was 23.0% and 25.2%, respectively. This difference is primarily due to the tax impact of items related to the Separation from Enovis. In 2022, the effective tax rate was higher than the U.S. federal statutory tax rate of 21.0% primarily due to withholding taxes on dividends and permanent differences relating to foreign subsidiaries, partially offset by Company earnings outside the United States that are taxed at different rates than the U.S. federal statutory tax rate of 21.0%.

Net income from continuing operations decreased in 2022 compared to 2021, due to changes discussed above as well as the interest expense related to our new Term Facility and Revolving Facility offset by improved Gross profit. Net income margin from continuing operations decreased primarily due to the items discussed above.

Adjusted EBITDA, Core adjusted EBITDA and related margins increased primarily due to improved sales, partially offset by inflation-related pricing and cost increases.

Business Segments

We formulate, develop, manufacture, and supply consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Our products are marketed under several brand names, most notably ESAB, providing a wide range of products with innovative technologies to solve challenges in virtually any industry. ESAB’s comprehensive range of welding consumables includes electrodes, cored and solid wires, and fluxes using a wide range of specialty and other materials, and cutting consumables including electrodes, nozzles, shields, and tips. ESAB’s equipment ranges from portable welding machines to large customized automated cutting and welding systems. ESAB also offers a range of software and digital solutions to help its customers increase their productivity, remotely monitor their welding operations, and digitize their documentation. Products are sold into a wide range of end markets, including general industry, infrastructure, renewable energy, medical & life sciences, transportation, construction and energy.

We report results in two reportable segments: Americas and EMEA & APAC.

Americas

The following table summarizes selected financial data for our Americas segment:
Year Ended December 31,
20222021
(Dollars in millions)
Net sales$1,128.3 $1,004.2 
Gross profit$357.7 $342.5 
Gross profit margin31.7 %34.1 %
Selling, general and administrative expense$228.0 $219.6 
Adjusted EBITDA (non-GAAP)$188.6 $159.6 
Adjusted EBITDA margin (non-GAAP)16.7 %15.9 %
Items excluded from Adjusted EBITDA:
Restructuring and other related charges$11.4 $11.6 
Acquisition - amortization and other related charges$20.1 $18.5 
Separation costs$7.5 $1.2 
Depreciation and other amortization$13.4 $15.0 

43

2022 Compared to 2021

Net sales in our Americas segment increased $124.1 million during 2022 compared to 2021. Net sales from existing business increased $127.3 million primarily due to inflation-related pricing increases. Gross profit increased primarily due to benefit from price increases partially offset by inflation-related cost increases, while gross profit margin decreased 240 basis points due to dilution effect caused by inflation-related pricing and cost increases. Selling, general and administrative expense increased mainly due to inflation-related cost increases and costs related to becoming a separately traded public company. Adjusted EBITDA, and related margins improved primarily due to improved sales, partially offset by inflation-related pricing and cost increases.

EMEA & APAC

The following table summarizes the selected financial data for our EMEA & APAC segment:
Year Ended December 31,
20222021
(Dollars in millions)
Net sales$1,465.2 $1,423.9 
Gross profit$509.9 $495.5 
Gross profit margin34.8 %34.8 %
Selling, general and administrative expense$305.4 $293.2 
Adjusted EBITDA (non-GAAP)$248.2 $244.6 
Adjusted EBITDA margin (non-GAAP)16.9 %17.2 %
Core adjusted EBITDA (non-GAAP)$228.2 $216.6 
Core adjusted EBITDA margin (non-GAAP)17.0 %16.8 %
Items excluded from Adjusted EBITDA:
Restructuring and other related charges$11.7 $7.4 
Acquisition - amortization and other related charges$14.1 $17.4 
Separation costs$8.1 $1.7 
Depreciation and other amortization$21.5 $23.5 
Items excluded from Core adjusted EBITDA:
Adjusted EBITDA attributable to Russia (non-GAAP)$20.0 $28.0 

2022 Compared to 2021

Net sales increased for our EMEA & APAC segment by $41.3 million during 2022 compared to 2021. Net sales from existing business increased $126.9 million offset by $88.5 million in unfavorable currency translation. The increase in Net sales from existing business was primarily due to inflation-related pricing increases and, to a lesser extent, new product initiatives partially offset by reduced sales volumes due to the Russia and Ukraine conflict. Gross profit increased due primarily to benefit from price increases and restructuring benefits partially offset by inflation-related cost increases, and an unfavorable currency translation impact. Gross profit margin remained largely consistent compared to the same period in 2021. Selling, general and administrative expense increased over the same period primarily driven by inflation related costs. Adjusted EBITDA remained relatively consistent compared to 2021 while related margins declined primarily due to higher Gross profit being mostly offset by increased Selling, general and administrative expenses and unfavorable currency translations. Core adjusted EBITDA increased from $216.6 million to $228.2 million, and the related Core adjusted EBITDA margins expanded by 20 basis points from 16.8% to 17.0%.

Liquidity and Capital Resources

Overview

Prior to the completion of the Separation, we financed our working capital requirements through cash flows from operating activities and arrangements with our Former Parent. We currently expect to finance our working capital requirements through cash flows from operating activities.
44

We expect that our primary ongoing requirements for cash will be for working capital, funding of acquisitions, capital expenditures and restructuring related cash outflows, asbestos-related cash outflows, and debt service and required amortization of principal and, pending Board approval, payment of cash dividends.

In conjunction with the Separation on April 4, 2022, we drew down $1.2 billion under the Credit Agreement and used these proceeds to make payments to Enovis of $1.2 billion, which was used as part of the consideration for the contribution of certain assets and liabilities to us by Enovis in connection with the Separation.

On June 28, 2022, we amended and restated the Credit Agreement by entering into Amendment No. 2 to Credit Agreement (“Credit Agreement Amendment”). The Credit Agreement Amendment provides for a $600 million Term Loan A-3 Facility with a maturity date of April 3, 2025 to refinance our existing Term Loan A-2 Facility (the “Term Loan A-3 Facility” and, together with the Term Loan A-1 Facility, the “Term Loans”).
Also on June 28, 2022, we borrowed the entire $600 million under Term Loan A-3 Facility to fund the repayment of the Term Loan A-2 Facility. The Company’s total borrowing capacity under the Credit Agreement remains unchanged.

As of December 31, 2022, we were in compliance with the covenants under Credit Agreement. As of December 31, 2022, the weighted average interest rate of borrowings under the Credit Agreement was 4.54%, excluding accretion of deferred financing fees. Refer to Note 16, “Derivatives” in the accompanying Notes contained elsewhere in this Form 10-K for more information related to swap agreements.

As of end of the year, we had the capacity for additional indebtedness of up to $529 million available on the Revolving Facility. Additionally, we have the ability to incur $77 million of indebtedness pursuant to certain uncommitted credit lines, consisting of an uncommitted credit line that we currently have in place which we have used from time to time in the past for short-term working capital needs. Refer to Note 15, “Debt” in the accompanying Notes contained elsewhere in this Form 10-K for more information related to the Credit Facilities. We believe that we could raise additional funds in the form of debt or equity if it was determined to be appropriate for strategic acquisitions or other corporate purposes. We believe that our sources of liquidity between debt and cash flows from operating activities are adequate to fund our operations for the next twelve months.

45

Cash Flows

As of December 31, 2022, we had $72.0 million of Cash and cash equivalents, an increase of $30.8 million from $41.2 million as of December 31, 2021. The following table summarizes the change in Cash and cash equivalents during the periods indicated:

Year Ended December 31,
20222021
(Dollars in millions)(1)
Net cash provided by operating activities$214.4 $250.7 
Purchases of property, plant and equipment(40.2)(35.6)
Proceeds from sale of property, plant and equipment4.8 5.2 
Acquisitions, net of cash received(149.0)(4.9)
Net cash used in investing activities(184.4)(35.3)
Proceeds from borrowings on term credit facility1,000.0 — 
Proceeds from borrowings on revolving credit facility and other805.9 0.7 
Repayments of borrowings on revolving credit facility and other(585.5)— 
Payment of deferred financing fees and other(4.7)— 
Payment of deferred consideration (1.5)— 
Payment of dividends(6.1)— 
Distributions to noncontrolling interest holders(3.4)(3.7)
Consideration to Former Parent in connection with the Separation(1,200.0)— 
Transfers from (to) Former Parent, net2.8 (218.5)
Net cash provided by (used in) financing activities7.6 (221.5)
Effect of foreign exchange rates on Cash and cash equivalents(6.7)(1.9)
Increase (decrease) in Cash and cash equivalents$30.8 $(8.0)
(1) Numbers may not sum due to rounding.

Cash flows from operating activities can fluctuate significantly from period to period due to changes in working capital and the timing of payments for items such as pension funding, asbestos-related costs and restructuring program funding. Changes in significant operating cash flow items are discussed below.

•Cash used in operating activities related to discontinued operations for the year ended December 31, 2022 was $23.1 million, which was mainly asbestos related. In prior years, these payments were made by our Former Parent and not reflected in our cash flow statements.

•Separation payments of $19.0 million for the year ended December 31, 2022 related to one-time non-recurring professional fees and employee costs incurred in the planning and execution of the Separation from Enovis.

•Restructuring initiatives of $22.7 million for the year ended December 31, 2022 and $15.4 million for the year ended December 31, 2021, which includes severance and other termination benefits, including outplacement services as well as the cost of relocating associates, relocating equipment, lease termination expense, and other cost in connection with the closure and optimization of facilities and product lines.

•Interest payments of $34.7 million for the year ended December 31, 2022 related to our Term Loans and Revolving Facility. Prior to the completion of the Separation on April 4, 2022 we financed our working capital requirements through cash flows from operating activities and arrangements with our Former Parent.
.
Cash flows used in investing activities during 2022 includes $149.0 million of cash used for two acquisitions. Refer to Note 5, “Acquisitions” in the accompanying Notes contained elsewhere in this Form 10-K for additional information.

46

Cash flows used in financing activities in 2022, primarily relates to the receipt of proceeds from the issuance of our debt of $1.8 billion of which $1.2 billion was paid to our Former Parent in connection with the Separation. Transfers from (to) Former Parent, net also significantly decreased compared to the prior period. The remaining change was primarily due to a $585.5 million repayment on the Revolving Facility. Cash Flows used in financing activities for 2021 primarily relates to our activity with the Former Parent.
During the year ended December 31, 2022, we paid two cash dividends of $0.05 per share or $3.0 million and $3.0 million, to our stockholders of record as of July 1, 2022 and September 30, 2022, respectively.
Our Cash and cash equivalents as of December 31, 2022 include $62.7 million held in jurisdictions outside the United States. Cash repatriation of non-U.S. cash into the United States may be subject to taxes, other local statutory restrictions, and minority owner distributions.
Contractual Obligations

Debt

As of December 31, 2022, the Company’s Term Loans and Revolving Facility had principal amounts outstanding of $997.6 million and $221.0 million, respectively. There are no required principal payments due on the Term Loan or Revolving Facility within 12 months. In addition to the outstanding principal on our debt, we are subject to contractual obligations and commitments to make future interest payments on the Term Loans and the Revolving Facility on various payment dates as provided in the Credit Agreement Amendment. Refer to Note 15, “Debt” in the accompanying Notes contained elsewhere in this Form 10-K for expiration dates and maturity schedules on our outstanding debt obligations for the next five years.

Operating Leases

The Company leases certain office spaces, warehouses, facilities, vehicles, and equipment. As of December 31, 2022, the Company had fixed lease payment obligations of $108.2 million, with $21.6 million payable within 12 months.

Purchase Obligations

As of December 31, 2022, the Company had other purchase obligations of $104.8 million, with $100.4 million payable within 12 months.

We have funding requirements associated with our pension and other post-retirement benefit plans as of December 31, 2022, which are estimated to be $5.2 million for the year ending December 31, 2023. Other long-term liabilities, such as those for other legal claims, employee benefit plan obligations, deferred income taxes and liabilities for unrecognized income tax benefits, are excluded from this disclosure since they are not contractually fixed as to timing and amount.

Off-Balance Sheet Arrangements
 
We do not have any off-balance sheet arrangements that provide liquidity, capital resources, market or credit risk support that expose us to any liability that is not reflected in our Consolidated and Combined Financial Statements at December 31, 2022 other than outstanding letters of credit of $31.5 million and unconditional purchase obligations with suppliers of $104.8 million.
 


47

Critical Accounting Policies

The methods, estimates and judgments we use in applying our critical accounting policies have a significant impact on our results of operations and financial position. We evaluate our estimates and judgments on an ongoing basis. Our estimates are based upon our historical experience, our evaluation of business and macroeconomic trends and information from other outside sources, as appropriate. Our experience and assumptions form the basis for our judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may vary from what our management anticipates and different assumptions or estimates about the future could have a material impact on our results of operations and financial position.
 
We believe the following accounting policies are the most critical in that they are important to the financial statements and they require the most difficult, subjective or complex judgments in the preparation of the financial statements. For a detailed discussion on the application of these and other accounting policies, see Note 2, “Summary of Significant Accounting Policies” in the accompanying Notes included elsewhere in this Form 10-K.
 
Impairment of Goodwill and Indefinite-Lived Intangible Assets
 
Goodwill represents the costs in excess of the fair value of net assets acquired associated with our business acquisitions. Indefinite-lived intangible assets consist of certain trade names.
 
We evaluate the recoverability of Goodwill and indefinite-lived intangible assets annually or more frequently if an event occurs or circumstances change in the interim that would more likely than not reduce the fair value of the asset below its carrying amount. The annual impairment test date elected by the Company is the first day of the fourth quarter. Goodwill and indefinite-lived intangible assets are considered to be impaired when the carrying value of a reporting unit or asset exceeds its fair value. As of the annual impairment test date, the Company had three reporting units: Americas, EMEA & APAC and Gas Control Equipment (“GCE”).
 
In the evaluation of Goodwill for impairment, we first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting entity is less than its carrying value. If we determine that it is more likely than not for a reporting unit’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If we determine that it is more likely than not for a reporting unit’s fair value to be less than its carrying value, a calculation of the fair value is performed and compared to the carrying value of that reporting unit. In certain instances, we may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying value of a reporting unit exceeds its fair value, Goodwill of that reporting unit is impaired and an impairment loss is recorded equal to the excess of the carrying value over its fair value.

Generally, we measure fair value of reporting units based on a present value of future discounted cash flows. The discounted cash flow models indicate the fair value of the reporting units based on the present value of the cash flows that the reporting units are expected to generate in the future. Significant estimates in the discounted cash flow models include the weighted average cost of capital, revenue growth rates, long-term rate of growth and profitability of our business.

An evaluation of Goodwill for impairment was performed for the three reporting units for the years ended December 31, 2022 and 2021, which indicated no impairment existed.

For the year ended December 31, 2022 a qualitative assessment was performed for the three reporting units. The carrying amount of Goodwill of the Americas, EMEA & APAC and Gas Control Equipment reporting units as of December 31, 2022, were $585.8 million, $829.0 million, and $114.9 million respectively. For the year ended December 31, 2021 a quantitative annual impairment test of Goodwill was performed for the Gas Control Equipment reporting unit, while qualitative assessments were performed for the remaining two reporting units. Determining the fair value of a reporting unit requires the application of judgment and involves the use of significant estimates and assumptions which can be affected by changes in business climate, economic conditions, the competitive environment and other factors. We base these fair value estimates on assumptions our management believes to be reasonable but which are unpredictable and inherently uncertain. Future changes in the judgment, assumptions and estimates could result in significantly different estimates of fair value in the future. An increase in discount rates, a reduction in projected cash flows due to lower revenue growth rates or lower margins compared to our projections, or a combination of the two could lead to a reduction in the estimated fair values, which may result in impairment charges that could materially affect our financial statements in any given year.

48

In the evaluation of indefinite-lived intangible assets for impairment, we first assess qualitative factors to determine whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying value. If we determine that it is more likely than not for the indefinite-lived intangible asset’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If we determine that it is more likely than not that the indefinite-lived intangible asset’s fair value is less than its carrying value, a calculation is performed and compared to the carrying value of the asset. If the carrying amount of the indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. We measure the fair value of our indefinite-lived intangible assets using the “relief from royalty” method. Significant estimates in this approach include projected revenues and royalty and discount rates for each trade name evaluated.

A quantitative impairment test was performed for all the indefinite-lived trade name brands for the years ended December 31, 2022 and 2021, which indicated no impairment existed.

A sustained decline in our end-markets and geographic markets could increase the risk of impairments in future years. Actual results could differ from our estimates and projections, which would also affect the assessment of impairment. As of December 31, 2022, we have Goodwill of $1,529.8 million and indefinite lived trade names of $180.7 million that are subject to at least annual review for impairment. See Note 9, “Goodwill and Intangible Assets” in the accompanying Notes for further information.

Income Taxes

Prior to the Separation, our domestic and foreign operating results were included in the income tax returns of Enovis. We accounted for income taxes under the separate return method. Under this approach, the Company determined its deferred tax assets and liabilities and related tax expense as if it were filing separate tax returns. The accompanying Combined Balance Sheets for the year ended December 31, 2021 did not contain current income tax payable or other long-term income tax payable liabilities, with the exception of certain unrecognized tax benefits for which ESAB could have reasonably be considered to be the primary obligor. The amounts are deemed settled with Enovis when they were due and therefore were included in Parent’s equity.

We account for income taxes under ASC 740, Income Taxes (“ASC 740”) which requires recognition of deferred income tax assets and liabilities reflecting the tax consequences attributable to differences between the carrying amounts of existing assets and liabilities in the Consolidated and Combined Financial Statements and their respective tax basis. Deferred income tax assets and liabilities are measured using enacted tax rates expected to be applied to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred income tax assets and liabilities are reported in Other assets and Other liabilities in the Consolidated and Combined Balance Sheets, respectively. The effect on deferred income tax assets and liabilities of a change in tax rates is generally recognized in Income tax expense in the period that includes the enactment date. Global Intangible Low-Taxed Income (“GILTI”) is accounted for as a current tax expense in the year the tax is incurred.
Valuation allowances are recorded if it is more likely than not that some portion of the deferred income tax assets will not be realized. In evaluating the need for a valuation allowance, we consider various factors, including the expected level of future taxable income and available tax planning strategies. Any changes in judgment about the valuation allowance are recorded through Income tax expense and are based on changes in facts and circumstances regarding realizability of deferred tax assets.
We must presume that an income tax position taken in a tax return will be examined by the relevant tax authority and determine whether it is more likely than not that the tax position will be sustained upon examination based upon the technical merits of the position. An income tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. We establish a liability for unrecognized income tax benefits for income tax positions for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority to the extent such tax positions reduce our income tax liability. We recognize interest and penalties related to unrecognized income tax benefits in Income tax expense in the Consolidated and Combined Statements of Operations.

Net liabilities for unrecognized income tax benefits, including accrued interest and penalties, were $20.2 million and $37.7 million as of December 31, 2022 and 2021, respectively, and are included in Other liabilities or as a reduction to deferred tax assets in the accompanying Consolidated and Combined Balance Sheet.


49

Revenue Recognition
 
We recognize revenue when control of promised goods or services is transferred to the customer. The amount of revenue recognized reflects the consideration to which we expect to be entitled in exchange for transferring the goods or services.

We provide a variety of products and services to our customers. Most of our contracts consist of a single, distinct performance obligation or promise to transfer goods or services to a customer. For contracts that include multiple performance obligations, we allocate the total transaction price to each performance obligation using our best estimate of the stand-alone selling price of each identified performance obligation. A significant majority of our revenue relates to the shipment of off-the-shelf products that is recognized when control is transferred to the customer. On a limited basis, we have agreements with customers that have multiple performance obligations. In determining whether there are multiple performance obligations, we first assess the goods or services promised in the customer arrangement and then consider the guidance in ASC 606, Revenue from Contracts with Customers, to evaluate whether goods and services are capable of being distinct and are considered distinct within the customer arrangement.

To determine whether promised goods or services are separately identifiable (i.e., whether a promise to transfer a good or service is distinct in the context of the contract), we evaluate whether the contract is to deliver (1) multiple promised goods or services or (2) a combined item that comprises the individual goods or services promised in the contract. Substantially all revenue involving development and application engineering projects consists of a single performance obligation and is recognized at a point in time.

A majority of the revenue we recognize relates to contracts with customers for standard or off-the-shelf products. As control typically transfers to the customer upon shipment of the product in these circumstances, revenue is generally recognized at that point in time. For service contracts, we recognize revenue ratably over the period of performance as the customer simultaneously receives and consumes the benefits of the services provided.

Any recognized revenues in excess of customer billings are recorded as a component of Trade receivables. Billings to customers in excess of recognized revenues are recorded as a component of Accrued liabilities. Each contract is evaluated individually to determine the net asset or net liability position. Substantially all of our revenue is recognized at a point in time, and revenue recognition and billing typically occur simultaneously.

The period of benefit for our incremental costs of obtaining a contract would generally have less than a one-year duration; therefore, we apply the practical expedient available and expense costs to obtain a contract when incurred.
 
Trade receivables are presented net of an allowance for credit losses. We adopted ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments as of January 1, 2020. The estimate of current expected credit losses on trade receivables considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. The allowance for credit losses was $23.5 million as of December 31, 2022 compared to $23.9 million as of December 31, 2021.

Asbestos Liabilities and Insurance Assets

Certain entities that became our subsidiaries in connection with the Separation are the legal obligor for certain asbestos obligations including long-term asbestos insurance assets, long-term asbestos insurance receivables, accrued asbestos liabilities, long-term asbestos liabilities, asbestos indemnity expenses, asbestos-related defense costs and asbestos insurance recoveries related to the asbestos obligations from our Former Parent’s other legacy industrial businesses. As a result, we hold certain asbestos-related contingencies and insurance coverages.

These subsidiaries are each one of many defendants in a large number of lawsuits that claim personal injury as a result of exposure to asbestos from products manufactured or used with components that are alleged to have contained asbestos. Such components were acquired from third-party suppliers, and were not manufactured by any of our, or our Former Parent’s, subsidiaries nor were the subsidiaries, producers or direct suppliers of asbestos. The manufactured products that are alleged to have contained or used asbestos generally were provided to meet the specifications of the subsidiaries’ customers, including the U.S. Navy. The subsidiaries settle asbestos claims for amounts we consider reasonable given the facts and circumstances of each claim. The annual average settlement payment per asbestos claimant has fluctuated during the past several years while the number of cases has steadily declined.
50

We expect such fluctuations to continue in the future based upon, among other things, the number and type of claims settled in a particular period and the jurisdictions in which such claims arise. To date, the majority of settled claims have been dismissed for no payment.

We have projected future asbestos-related liability costs with regard to pending and future unasserted claims based upon the Nicholson methodology. The Nicholson methodology is a standard approach used by experts and has been accepted by numerous courts. This methodology is based upon risk equations, exposed population estimates, mortality rates, and other demographic statistics. In applying the Nicholson methodology for each subsidiary we performed: (1) an analysis of the estimated population likely to have been exposed or claim to have been exposed to products manufactured by the subsidiaries based upon national studies undertaken of the population of workers believed to have been exposed to asbestos; (2) a review of epidemiological and demographic studies to estimate the number of potentially exposed people that would be likely to develop asbestos-related diseases in each year; (3) an analysis of the subsidiaries’ recent claims history to estimate likely filing rates for these diseases and (4) an analysis of the historical asbestos liability costs to develop average values, which vary by disease type, jurisdiction and the nature of claim, to determine an estimate of costs likely to be associated with currently pending and projected asbestos claims. Our projections, based upon the Nicholson methodology, estimate both claims and the estimated cash outflows related to the resolution of such claims for periods up to and including the endpoint of asbestos studies referred to in item (2) above.

It is our policy to record a liability for asbestos-related liability costs for the longest period of time that we can reasonably estimate. Accordingly, no accrual has been recorded for any costs which may be paid after the next 15 years.

Projecting future asbestos-related liability costs is subject to numerous variables that are difficult to predict, including, among others, the number of future claims that might be received, the type and severity of the disease alleged by each claimant, the latency period associated with asbestos exposure, dismissal rates, costs of medical treatment, the financial resources of other companies that are co-defendants in the claims, funds available in post-bankruptcy trusts, uncertainties surrounding the litigation process from jurisdiction to jurisdiction and from case to case, including fluctuations in the timing of court actions and rulings, and the impact of potential changes in legislative or judicial standards, including potential tort reform. Furthermore, any projections with respect to these variables are subject to even greater uncertainty as the projection period lengthens. These trend factors have both positive and negative effects on the dynamics of asbestos litigation in the tort system and the related best estimate of our asbestos liability, and these effects do not move in linear fashion but rather change over multiple year periods. Accordingly, we monitor these trend factors over time and periodically assess whether an alternative forecast period is appropriate. Taking these factors into account and the inherent uncertainties, we believe that we can reasonably estimate the asbestos-related liability for pending and future claims that will be resolved in the next 15 years and have recorded that liability as our best estimate. While it is reasonably possible that the subsidiaries will incur costs after this period, we do not believe the reasonably possible loss or range of reasonably possible loss is estimable at the current time. Accordingly, no accrual has been recorded for any costs which may be paid after the next 15 years. Defense costs associated with asbestos-related liabilities as well as costs incurred in connection with pursuing insurance coverage from these subsidiaries’ insurers are expensed as incurred.

We assessed these subsidiaries’ existing insurance arrangements and agreements, estimated the applicability of insurance coverage for existing and expected future claims, analyzed publicly available information bearing on the current creditworthiness and solvency of the various insurers, and employed such insurance allocation methodologies as we believed appropriate to ascertain the probable insurance recoveries for asbestos liabilities. The analysis took into account self-insurance retentions, policy exclusions, pending litigation, liability caps and gaps in coverage, existing and potential insolvencies of insurers as well as how legal and defense costs will be covered under the insurance policies.

Each subsidiary has separate insurance coverage acquired prior to our ownership of each independent entity. In our evaluation of the insurance asset, we use differing insurance allocation methodologies for each subsidiary based upon the applicable law pertaining to the affected subsidiary.

Our analyses are based on currently known facts and a number of assumptions. However, projecting future events, such as new claims to be filed each year, the average cost of resolving each claim, coverage issues among layers of insurers, the method in which losses will be allocated to the various insurance policies, interpretation of the effect on coverage of various policy terms and limits and their interrelationships, the continuing solvency of various insurance companies and collectability of claims tendered, the amount of remaining insurance available, as well as the numerous uncertainties inherent in asbestos litigation could cause the actual liabilities and insurance recoveries to be higher or lower than those projected or recorded which could materially affect our financial condition, results of operations or cash flow.
51

See Note 19, “Commitments and Contingencies” in the accompanying Notes for additional information regarding our asbestos liabilities and insurance assets.

Corporate Allocations

Prior to the Separation, we operated as part of Enovis Corporation and not as a stand-alone company. Accordingly, certain shared costs have been allocated to us and are reflected as expenses in the accompanying financial statements. We consider the allocation methodologies used to be reasonable and appropriate reflections of the related expenses attributable to us for purposes of the carve-out financial statements; however, the expenses reflected in these financial statements may not be indicative of the actual expenses that would have been incurred during the periods presented if we had operated as a separate stand-alone entity. In addition, the expenses reflected in the financial statements may not be indicative of expenses that will be incurred in the future by us. Refer to Note 21, “Related Party Transactions” in the accompanying Notes for a description of our corporate allocations and related-party transactions.

Recently Issued Accounting Pronouncements
 
For detailed information regarding recently issued accounting pronouncements and the expected impact on our financial statements, see Note 3, “Recently Issued Accounting Pronouncements” in the accompanying Notes included elsewhere in this Form 10-K.

52

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to market risk from changes in foreign currency exchange rates and commodity prices that could impact our results of operations and financial condition. We address our exposure to these risks through our normal operating and financing activities. We do not enter into derivative contracts for trading purposes.

Interest Rate Risk

We entered into certain credit facilities pursuant to the terms of a credit agreement on April 4, 2022. Please refer to Note 15, “Debt” in our Notes included in this Form 10-K for additional information regarding our credit facilities. We are exposed to interest rate risk on the new variable-rate term loans under these facilities. A hypothetical increase in interest rates of 1% during the year ended December 31, 2022 would have increased interest expense by approximately $6.2 million. In order to mitigate our interest risk, in July 2022, we entered into interest rate swaps to hedge approximately $600 million of our variable interest rate debt. See Note 16 “Derivatives” in our Notes included in this Form 10-K for additional information.

Exchange Rate Risk

We have manufacturing sites throughout the world and sell our products globally. As a result, we are exposed to movements in the exchange rates of various currencies against the U.S. Dollar and against the currencies of other countries in which we manufacture and sell products and services. During 2022, approximately 78% of our sales were derived from operations outside the U.S. We have significant manufacturing operations in European countries that are not part of the Eurozone. Sales are more highly weighted toward the Euro and U.S. Dollar. We also have significant contractual obligations in U.S. Dollars that are met with cash flows in other currencies as well as U.S. Dollars. To better match revenue and expense as well as cash needs from contractual liabilities, we regularly enter into foreign currency swaps and forward contracts.

We also face exchange rate risk from our investments in subsidiaries owned and operated in foreign countries. The effect of a change in currency exchange rates on our net investment in international subsidiaries is reflected in the Accumulated other comprehensive loss component of Equity. A 10% depreciation in major currencies, relative to the U.S. Dollar as of December 31, 2022, would result in a reduction in Equity of approximately $151 million. During 2022 we entered into two fixed-to-fixed cross-currency swaps which will provide a hedge to a portion of our European net asset position. See Note 16 “Derivatives” in our Notes included in this Form 10-K for additional information.

We also face exchange rate risk from transactions from intercompany transactions between affiliates. Although we use the U.S. Dollar as our functional currency for reporting purposes, we have manufacturing sites throughout the world, and a substantial portion of our costs are incurred and sales are generated in foreign currencies. Costs incurred and sales recorded by subsidiaries operating outside of the United States are translated into U.S. Dollars using exchange rates effective during the respective period. As a result, we are exposed to movements in the exchange rates of various currencies against the U.S. Dollar. Similarly, tax costs may increase or decrease as local currencies strengthen or weaken against the U.S. Dollar.

Commodity Price Risk

We are exposed to changes in the prices of raw materials used in our production processes. In order to manage commodity price risk, we periodically enter into fixed price contracts directly with suppliers.

See Note 16, “Derivatives” in the accompanying Notes to Consolidated and Combined Financial Statements included in this 10-K for additional information regarding our derivative instruments.

53

Item 8. Financial Statements and Supplementary data

INDEX TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
 Page
  
Report of Independent Registered Public Accounting Firm - Consolidated and Combined Financial Statements (Ernst & Young LLP, Baltimore, MD, Auditor Firm ID:42)
Consolidated and Combined Statements of Operations
Consolidated and Combined Statements of Comprehensive (Loss) Income
Consolidated and Combined Balance Sheets
Consolidated and Combined Statements of Equity
Consolidated and Combined Statements of Cash Flows
Notes to Consolidated and Combined Financial Statements
Note 1. Organization and Basis of Presentation
Note 2. Summary of Significant Accounting Policies
Note 3. Recently Issued Accounting Pronouncements
Note 4. Discontinued Operations
Note 5. Acquisitions
Note 6. Revenue
Note 7. Earnings per Share from Continuing Operations
Note 8. Income Taxes
Note 9. Goodwill and Intangible Assets
Note 10. Property, Plant and Equipment, Net
Note 11. Inventories, Net
Note 12. Leases
Note 13. Accrued and Other Liabilities
Note 14. Benefit Plans
Note 15. Debt
Note 16. Derivatives
Note 17. Fair Value Measurements
Note 18. Equity
Note 19. Commitments and Contingencies
Note 20. Segment Information
Note 21. Related Party Transactions
Note 22. Subsequent Events
 

54

Report of Independent Registered Public Accounting Firm
Consolidated and Combined Financial Statements

To the Shareholders and the Board of Directors of ESAB Corporation

Opinion on the Financial Statements

We have audited the accompanying consolidated and combined balance sheets of ESAB Corporation (the Company) as of December 31, 2022 and 2021, the related consolidated and combined statements of operations, comprehensive income (loss), equity and cash flows for each of the three years in the period ended December 31, 2022, and the related notes and financial statement schedule listed in the Index at Item 15(a)(2) (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

55

Asbestos Liability
Description of the Matter
At December 31, 2022, the Company’s asbestos liability balance was $260.7 million. As discussed in Note 19 of the consolidated financial statements, certain of the Company’s subsidiaries are defendants in a large number of lawsuits that claim personal injury as a result of exposure to asbestos from products manufactured with components that are alleged to have contained asbestos. The Company records an asbestos liability for probable pending and future claims over the period that the Company believes it can reasonably estimate such claims.

Auditing the asbestos liability was complex and highly judgmental due to the significant estimation of numerous variables required in determining the asbestos obligation. In particular, the estimates were sensitive to significant assumptions such as the period of time over which claims activity can be reasonably predicted, the number of future asbestos-related claims that may be received, the type and severity of disease alleged by each claimant, dismissal rates, the latency period associated with asbestos exposure, and settlement values. These assumptions have a significant effect on the asbestos liability.
How We Addressed the Matter in Our AuditWe obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company’s process to estimate the asbestos liability, including controls related to estimates of expected future claims and other key assumptions underlying the calculation of the obligation. We also tested management’s controls over the completeness and accuracy of the data used in the calculation.

To audit the asbestos liability recorded by management, we performed procedures that included, among others, evaluating the methodology applied and the significant assumptions used in the Company’s calculation. For example, we assessed management’s assumptions for the nature and rate of future claims, claims disposition and settlement patterns by comparing these assumptions to the Company’s historical experience and industry data. We considered the Company’s historical data and industry data in evaluating the adequacy of the Company’s projections. We developed, with the assistance of an internal actuarial specialist, an independent range of estimated asbestos liability. We tested the completeness and accuracy of the claims data used by management. We also performed analyses to determine the sensitivity of changes in certain assumptions, such as the period over which claims can be estimated, to the calculated liability.


/s/ Ernst & Young LLP

We have served as the Company’s auditor since 2021.

Baltimore, Maryland
March 7, 2023

56

ESAB CORPORATION
CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS
Dollars in thousands, except per share amounts

Year Ended December 31,
202220212020
Net sales$2,593,480 $2,428,115 $1,950,069 
Cost of sales1,707,950 1,590,132 1,267,604 
Gross profit885,530 837,983 682,465 
Selling, general and administrative expense533,369 512,815 458,706 
Restructuring and other related charges23,096 18,954 21,633 
Operating income329,065 306,214 202,126 
Pension settlement gain(9,136)(11,208)— 
Interest expense (income) and other, net37,950 (1,666)(3,713)
Income from continuing operations before income taxes300,251 319,088 205,839 
Income tax expense69,170 80,409 45,971 
Net income from continuing operations231,081 238,679 159,868 
Loss from discontinued operations, net of taxes(3,068)— — 
Net income 228,013 238,679 159,868 
Less: Income attributable to noncontrolling interest, net of taxes4,266 3,569 2,454 
Net income attributable to ESAB Corporation$223,747 $235,110 $157,414 
Earnings (loss) per share - basic
Income from continuing operations$3.75 $3.92 $2.62 
Loss on discontinued operations$(0.05)$— $— 
Net income per share$3.70 $3.92 $2.62 
Earnings (loss) per share - diluted
Income from continuing operations$3.74 $3.92 $2.62 
Loss on discontinued operations$(0.05)$— $— 
Net income per share - diluted$3.69 $3.92 $2.62 


See Notes to Consolidated and Combined Financial Statements.

57

ESAB CORPORATION
CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME
Dollars in thousands
Year Ended December 31,
202220212020
Net income$228,013 $238,679 $159,868 
Other comprehensive (loss) income:
Foreign currency translation, net of tax (benefit) expense of $(2,930), $740 and $(1,598)
(175,719)(72,398)30,903 
Unrealized gain on derivatives designated and qualifying as cash flow hedges, net of tax expense of $3,240
11,102 — — 
Defined benefit pension and other post-retirement plan activity, net of tax benefit of $1,840, $1,192 and $367
6,192 6,657 (3,725)
Other comprehensive (loss) income(158,425)(65,741)27,178 
Comprehensive income69,588 172,938 187,046 
Less: comprehensive income attributable to noncontrolling interest678 2,513 2,307 
Comprehensive income attributable to ESAB Corporation$68,910 $170,425 $184,739 


See Notes to Consolidated and Combined Financial Statements.
58

ESAB CORPORATION
CONSOLIDATED AND COMBINED BALANCE SHEETS
Dollars in thousands, except share and per share amounts

December 31,
20222021
ASSETS
CURRENT ASSETS:
Cash and cash equivalents$72,024 $41,209 
Trade receivables, less allowance for credit losses of $23,471 and $23,912
374,329 383,496
Inventories, net416,829 420,062
Prepaid expenses56,637 51,949
Other current assets68,851 67,357
Total current assets988,670 964,073
Property, plant and equipment, net284,226 286,278
Goodwill1,529,767 1,532,993
Intangible assets, net517,167 521,434
Lease asset - right of use92,033 107,944
Other assets342,152 48,540
Total assets$3,754,015 $3,461,262 
LIABILITIES AND EQUITY
CURRENT LIABILITIES:
Accounts payable$316,265 $345,480 
Accrued liabilities285,310 251,109 
Total current liabilities601,575 596,589 
Long-term debt1,218,643 — 
Other liabilities545,339 362,945 
Total liabilities2,365,557 959,534 
Equity:
Common stock - $0.001 par value - Authorized 600,000,000; 60,094,725 and 100 shares outstanding as of December 31, 2022 and December 31, 2021, respectively
60 — 
Additional paid-in capital1,865,904 — 
Retained earnings159,231 — 
Former Parent's investment— 2,921,623 
Accumulated other comprehensive loss(674,988)(460,888)
Total ESAB Corporation equity1,350,207 2,460,735 
Noncontrolling interest38,251 40,993 
Total equity1,388,458 2,501,728 
Total liabilities and equity$3,754,015 $3,461,262 


See Notes to Consolidated and Combined Financial Statements.
59

ESAB CORPORATION
CONSOLIDATED AND COMBINED STATEMENTS OF EQUITY
Dollars in thousands, except share and per share amounts
Common StockAdditional Paid in CapitalRetained EarningsFormer Parent’s InvestmentAccumulated Other Comprehensive LossNoncontrolling InterestTotal
SharesAmount
Balance at January 1, 2020— $— $— $— $3,058,666 $(423,528)$46,065 $2,681,203 
Cumulative effect of accounting change— — — — (3,716)— (18)(3,734)
Net income— — — — 157,414 — 2,454 159,868 
Distributions to noncontrolling owners— — — — — — (4,297)(4,297)
Other comprehensive income (loss), net of tax benefit of $1,965
— — — — — 27,325 (147)27,178 
Former Parent Common stock-based award activity— — — — 6,436 — — 6,436 
Transfers to Former Parent, net— — — — (319,969)— (1,918)(321,887)
Balance at December 31, 2020— $— $— $— $2,898,831 $(396,203)$42,139 $2,544,767 
Net income— — — — 235,110 — 3,569 238,679 
Distributions to noncontrolling owners— — — — — — (3,713)(3,713)
Other comprehensive loss, net of tax benefit of $452
— — — — — (64,685)(1,056)(65,741)
Former Parent Common stock-based award activity— — — — 6,267 — — 6,267 
Transfers to Former Parent, net— — — — (218,585)— 54 (218,531)
Balance at December 31, 2021— $— $— $— $2,921,623 $(460,888)$40,993 $2,501,728 
Net income— — — 168,310 55,437 — 4,266 228,013 
Dividends declared ($0.15 per share)
— — — (9,079)— — — (9,079)
Former Parent Common stock-based award activity— — — — 1,728 — — 1,728 
Net Transfers from Former Parent, including Separation Adjustments— — 4,346 — 70,643 (59,263)— 15,726 
Net consideration paid to Former Parent, in connection with the Separation— — — — (1,200,000)— — (1,200,000)
Issuance of common stock in connection with the Separation and reclassification of Net Investment from Former Parent60,034,311 60 1,849,371 — (1,849,431)— — — 
Distributions to noncontrolling owners— — — — — — (3,420)(3,420)
Other comprehensive loss, net of tax benefit of $1,530
— — — — — (154,837)(3,588)(158,425)
Common stock-based award activity60,414 — 12,187 — — — — 12,187 
Balance at December 31, 202260,094,725 $60 $1,865,904 $159,231 $— $(674,988)$38,251 $1,388,458 

See Notes to Consolidated and Combined Financial Statements.
60

ESAB CORPORATION
CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS
Dollars in thousands
Year Ended December 31,
202220212020
Cash flows from operating activities:
Net income $228,013 $238,679 $159,868 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and other impairment charges65,978 75,899 76,644 
Loss (gain) on sale of property, plant and equipment239 (447)(3,370)
Pension settlement gain(9,136)(11,208)— 
Stock-based compensation expense12,964 6,267 6,436 
Deferred income tax(20,199)(8,644)(14,031)
Non-cash interest expense1,972 — — 
Changes in operating assets and liabilities:
Trade receivables, net(8,142)(67,850)27,734 
Inventories, net(10,066)(117,350)34,839 
Accounts payable(28,794)114,502 7,056 
Other operating assets and liabilities(18,471)20,889 14,005 
Net cash provided by operating activities214,358 250,737 309,181 
Cash flows from investing activities:
Purchases of property, plant and equipment(40,243)(35,584)(40,138)
Proceeds from sale of property, plant and equipment4,849 5,204 5,565 
Acquisitions, net of cash received(149,029)(4,885)— 
Net cash used in investing activities(184,423)(35,265)(34,573)
Cash flows from financing activities:
Proceeds from borrowings on term credit facility1,000,000 — — 
Proceeds from borrowings on revolving credit facility and other805,881 673 — 
Repayments of borrowings on revolving credit facility and other(585,491)— (190)
Payment of deferred financing fees and other(4,706)— — 
Payment of deferred consideration (1,500)— (49)
Payment of dividends(6,054)— — 
Distributions to noncontrolling interest holders(3,420)(3,713)(4,297)
Consideration to Former Parent in connection with the Separation(1,200,000)— — 
Transfers from (to) Former Parent, net2,847 (218,531)(321,887)
Net cash provided by (used in) financing activities7,557 (221,571)(326,423)
Effect of foreign exchange rates on Cash and cash equivalents(6,677)(1,901)(3,810)
Increase (decrease) in Cash and cash equivalents30,815 (8,000)(55,625)
Cash and cash equivalents, beginning of period41,209 49,209 104,834 
Cash and cash equivalents, end of period$72,024 $41,209 $49,209 
Supplemental disclosures:
Interest payments, net$34,678 $— $— 
Income tax payments, net$85,659 $— $— 



See Notes to Consolidated and Combined Financial Statements.
61
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS

1. Organization and Basis of Presentation
Founded in 1904, ESAB Corporation (“ESAB” or the “Company”) is a world leader in connected fabrication technology and gas control solutions. ESAB provides its partners with advanced equipment, consumables, gas control equipment, robotics, and digital solutions. The Company’s rich history of innovative products and workflow solutions and its business system (EBX) allows the Company to realize its purpose of Shaping the world it imagines. The Company’s products are utilized to solve challenges in a wide range of industries, including cutting, joining and automated welding. The Company conducts its operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America, and “EMEA & APAC,” which includes Europe, Middle East, India, Africa and Asia Pacific. Historically, these businesses had operated as part of Enovis Corporation’s (“Former Parent” or “Enovis”) Fabrication Technologies reportable segment.

The Company’s fiscal year ends December 31. The Company’s first three quarters end on the last business day of the 13th week after the end of the prior quarter.

Separation from Enovis

On January 31, 2022, all remaining legal entities which were part of the Fabrication Technology segment of the Former Parent along with certain entities that were part of the Corporate segment of the Former Parent became subsidiaries of ESAB through a legal entity restructuring. This reorganization resulted in the inclusion of the following entities and pension plans in ESAB for the three months ending April 1, 2022:

•Certain operating entities that form the historical Fabrication Technology business.

•Certain entities which historically have been a part of the Former Parent’s Corporate reportable segment, including components of the Former Parent’s legal human resources, tax and other finance functions that served the entirety of the Former Parent.

•Certain entities relating to the Former Parent’s previously divested Fluid Handling businesses which hold certain asbestos assets, liabilities, costs and insurance recoveries related to the asbestos obligations of these legacy industrial businesses. Refer to Note 4, “Discontinued Operations” and Note 19, “Commitments and Contingencies” for additional information.

•Certain pension plan assets and liabilities due to transfer of sponsorship of two U.S. defined benefit plans and a U.S. other post-retirement benefit plan from the Former Parent to ESAB as of March 21, 2022. Refer to Note 14, “Benefit Plans” for additional information on the benefit plans transferred to ESAB.

With the exception of the operating entities that form the historical Fabrication Technology business, the other contributions from the Former Parent were not previously included in the Company’s 2019 to 2021 historical carve-out financial statements. These historical carve-out financial statements in ESAB’s Registration Statement on Form 10-12B/A filed with the SEC on March 17, 2022 (the “Form 10”), were presented on a combined basis. Such basis of accounting differences before and after the legal entity contributions may impact the comparability between periods in these Consolidated and Combined Financial Statements.

ESAB Corporation, which was incorporated on May 19, 2021, became the new ultimate parent company for the Former Parent’s Fabrication Technology business and certain other corporate entities during the three months ended April 1, 2022.

On April 4, 2022 (the “Distribution Date”), Colfax Corporation (“Colfax” or the “Former Parent”) completed the spin-off of Colfax’s Fabrication Technology business and certain other corporate entities as described above, through a tax-free, pro rata distribution (the “Distribution”) of 90% of the outstanding common stock of ESAB to Colfax stockholders (the “Separation”). To effect the Separation, each Colfax stockholder of record as of close of business on March 23, 2022 received one share of ESAB common stock for every three shares of Colfax common stock held on the record date. Upon completion of the Distribution, Colfax changed its name to Enovis Corporation and continued to hold 10% of the outstanding common stock of ESAB. In November 2022, Enovis sold a total of 6.0 million shares of the Company’s common stock as part of a secondary offering. After the secondary offering, Enovis no longer owned any of the Company’s outstanding common stock.

62
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
In connection with the Separation, on April 4, 2022, ESAB and Enovis entered into a separation and distribution agreement as well as various other related agreements (collectively the “Agreements”) that govern the Separation and the relationships between the parties going forward, including a transition services agreement, an employee matters agreement, a tax matters agreement, an intellectual property matters agreement, and license agreement for the ESAB Business Excellence System ("EBX").

In conjunction with the Separation on April 4, 2022, the Company entered into a credit agreement (the “Credit Agreement”). The Company drew down $1.2 billion under the Credit Agreement and used these proceeds to make payments to Enovis of $1.2 billion, which was used as part of the consideration for the contribution of certain assets and liabilities to the Company by Enovis in connection with the Separation. To manage pre-existing currency rate exposures and interest risks arising from these credit facilities, during the third quarter, the Company entered into interest rate swap agreements and cross currency swap agreements, refer to Note 15, “Debt” and Note 16, “Derivatives” for additional information.

Russia and Ukraine Conflict

The invasion of Ukraine by Russia and the sanctions imposed in response have increased the level of economic and political uncertainty. While ESAB continues to closely monitor the situation and evaluate options, the Company is meeting current contractual obligations while addressing applicable laws and regulations. For the year ended December 31, 2022, Russia represented approximately 6% of the Company’s total revenue, and approximately $20 million in Net Income, respectively. Russia also has approximately 5% of the Company’s total net assets excluding any goodwill allocation as of December 31, 2022. In case of the disposition of the Russia business, a portion of goodwill would need to be allocated and disposed of in the relative fair value attributable to the Russia business. Russia has a cumulative translation loss of approximately $90 million as of December 31, 2022, which could be realized upon a transition out. The Company is closely monitoring developments in Ukraine and Russia. Changes in laws and regulations or other factors impacting the Company’s ability to fulfill contractual obligations could have an adverse effect on the results of operations.

Basis of Presentation

The accompanying Consolidated and Combined Financial Statements present the Company’s historical financial position, results of operations, changes in equity and cash flows in accordance with generally accepted accounting principles in the United States of America (“GAAP”). The combined financial statements for periods prior to the Separation were derived from Enovis’s consolidated financial statements and accounting records and prepared in accordance with GAAP for the preparation of carved-out combined financial statements. Through the date of the Separation, all revenues and costs as well as assets and liabilities directly associated with ESAB have been included in the combined financial statements. Prior to the Separation, the combined financial statements also included allocations of certain general, administrative, sales and marketing expenses from Enovis’s corporate office and from other Enovis businesses to the Company and allocations of related assets, liabilities, and the Former Parent’s investment, as applicable. The allocations were determined on a reasonable basis, however, the amounts are not necessarily representative of the amounts that would have been reflected in the financial statements had the Company been an entity that operated independently of Enovis during the applicable periods. Related party allocations prior to the Separation, including the method for such allocation, are discussed further in Note 21, “Related Party Transactions.”

Following the Separation, the consolidated financial statements include ESAB and its wholly-owned subsidiaries and no longer include any allocations of expenses from Enovis. Accordingly:

•The Consolidated Balance Sheet as of December 31, 2022 consists of the consolidated balances of ESAB, while the Combined Balance Sheet as of December 31, 2021 consists of the combined balances of the former Fabrication Technology business of Enovis.

•The Consolidated and Combined Statement of Operations and Statement of Comprehensive (Loss) Income for the year ended December 31, 2022 consists of the consolidated results of ESAB for the nine months ended December 31, 2022 and the combined results of the former Fabrication Technology business of Enovis and the certain entities discussed in the “Separation from Enovis” section above for the three months ended April 1, 2022. The Combined Statement of Operations and Statement of Comprehensive (Loss) Income for the years ended December 31, 2021 and 2020 consist of the combined results of the former Fabrication Technology business of Enovis.


63
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
•The Consolidated and Combined Statement of Changes in Equity for the year December 31, 2022 consists of the consolidated activities of ESAB for the nine months ended December 31, 2022 and the combined activity of the former Fabrication Technology business of Enovis and the certain entities discussed in the “Separation from Enovis” section above for the three months ended April 1, 2022. The Combined Statements of Changes in Equity for the year ended December 31, 2021 and 2020 consist of the combined activity of the former Fabrication Technology business of Enovis.

•The Consolidated and Combined Statement of Cash Flows for the year ended December 31, 2022 consists of the consolidated activities of ESAB for the nine months ended December 31, 2022 and the combined activity of ESAB and the former Fabrication Technology business of Enovis and the certain entities discussed in the “Separation from Enovis” section above for the three months ended April 1, 2022. The Combined Statement of Cash Flows for the years ended December 31, 2021 and 2020 consist of the combined activity of the former Fabrication Technology business of Enovis.

The Consolidated and Combined Financial Statements of ESAB for the years ended December 31, 2020 and 2021 and the three months ended April 1, 2022 may not be indicative of the Company's results had it been a separate stand-alone entity throughout the periods presented, nor are the results stated herein indicative of what the Company's financial position, results of operations and cash flows may be in the future.

Prior to the Separation, the Company was dependent on the Former Parent for all of its working capital and financing requirements under Enovis’s centralized approach to cash management and financing of its operations. With the exception of cash, cash equivalents and borrowings clearly associated with ESAB and related to the Separation, financing transactions relating to the Company during the period prior to the Separation were accounted for through the Former Parent’s investment account of the Company. Accordingly, none of Enovis’s cash, cash equivalents or debt at the corporate level has been assigned to the Company in these financial statements.
Former Parent’s Investment, which included retained earnings, represented Enovis’s interest in the recorded net assets of the Company. All significant transactions between the Company and the Former Parent prior to the Separation have been included in the accompanying Financial Statements. Transactions with the Former Parent are reflected in the accompanying Consolidated and Combined Statements of Equity as “Transfers to Former Parent, net” and in the accompanying Consolidated and Combined Balance Sheets within “Former Parent’s investment”.
The Consolidated and Combined Financial Statements reflect, in the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly the Company’s financial position and results of operations as of and for the periods indicated. Intercompany transactions and accounts are eliminated in consolidation.

The Company makes certain estimates and assumptions in preparing its Consolidated and Combined Financial Statements in accordance with U.S. generally accepted accounting principles, or “GAAP”. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the Consolidated and Combined Financial Statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from those estimates.

These Consolidated and Combined Financial Statements included in this annual report have been prepared by the Company in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) in conformity with GAAP, for the preparation of the Consolidated and Combined Financial Statements.

2. Summary of Significant Accounting Policies
 
Principles of Consolidation

The Company’s Consolidated and Combined Financial Statements are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include all majority-owned subsidiaries over which the Company exercises control and, when applicable, entities or joint ventures for which the Company has a controlling financial interest or is the primary beneficiary. When protective rights, substantive rights or other factors exist, further analysis is performed in order to determine whether or not there is a controlling financial interest. The Consolidated and Combined Financial Statements reflect the assets, liabilities, revenues and expenses of consolidated subsidiaries and the noncontrolling parties’ ownership share is presented as a noncontrolling interest.
64
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
All significant intercompany accounts and transactions have been eliminated.

Equity Method Investments

Investments accounted for under the equity method are initially recorded at the amount of the Company’s initial investment and adjusted each period for the Company’s share of the investee’s income or loss and dividends paid. All equity investments are reviewed periodically for indications of other-than-temporary impairment, including, but not limited to, significant and sustained decreases in quoted market prices or a series of historic and projected operating losses by investees. If the decline in fair value is considered to be other-than-temporary, an impairment loss is recorded and the investment is written down to a new carrying value.

Revenue Recognition

The Company recognizes revenue when control of promised goods or services is transferred to the customer. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled in exchange for transferring the goods or services.

The Company provides a variety of products and services to its customers. Most of the Company’s contracts consist of a single, distinct performance obligation or promise to transfer goods or services to a customer. For contracts that include multiple performance obligations, we allocate the total transaction price to each performance obligation using our best estimate of the stand-alone selling price of each identified performance obligation. A significant majority of our revenue relates to the shipment of off-the-shelf products that is recognized when control is transferred to the customer. On a limited basis, we have agreements with customers that have multiple performance obligations. In determining whether there are multiple performance obligations, we first assess the goods or services promised in the customer arrangement and then consider the guidance in ASC 606, Revenue from Contracts with Customers, to evaluate whether goods and services are capable of being distinct and are considered distinct within the customer arrangement. To determine whether promised goods or services are separately identifiable (i.e., whether a promise to transfer a good or service is distinct in the context of the contract), we evaluate whether the contract is to deliver (1) multiple promised goods or services or (2) a combined item that comprises the individual goods or services promised in the contract. Substantially all revenue involving development and application engineering projects consists of a single performance obligation and is recognized at a point in time.

As mentioned above, a majority of revenue recognized by the Company relates to contracts with customers for standard or off-the-shelf products. As control typically transfers to the customer upon shipment of the product in these circumstances, revenue is generally recognized at that point in time. Revenue recognition and billing typically occur simultaneously for contracts recognized at a point in time. Therefore, we do not have material revenues in excess of customer billings or billings to customers in excess of recognized revenues. Refer to Note 13, “Accrued and Other Liabilities” for additional information on the Company’s contract liability balances.

For service contracts, the Company recognizes revenue ratably over the period of performance as the customer simultaneously receives and consumes the benefits of the services provided. The Company applies the available practical expedient involving the existence of a significant financing component. As the Company generally does not receive payments greater than one year in advance or arrears of revenue recognition, the Company does not consider any arrangements to include financing components.

The period of benefit for the Company’s incremental costs of obtaining a contract generally have less than a one-year duration; therefore, the Company applies the practical expedient available and expenses costs to obtain a contract when incurred.

Taxes Collected from Customers and Remitted to Governmental Authorities
 
The Company collects various taxes and fees as an agent in connection with the sale of products and remits these amounts to the respective taxing authorities. These taxes and fees have been presented on a net basis within Net sales in the Consolidated and Combined Statements of Operations and are recorded as a component of Accrued liabilities in the Consolidated and Combined Balance Sheets until remitted to the respective taxing authority.



65
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
Research and Development Expense
 
Research and development costs of $36.0 million, $39.7 million and $34.8 million for the years ended December 31, 2022, 2021 and 2020, respectively, are expensed as incurred and are included in Selling, general and administrative expense in the Consolidated and Combined Statements of Operations. These amounts do not include development and application engineering costs incurred in conjunction with fulfilling customer orders and executing customer projects.

Cash and Cash Equivalents
 
Cash and cash equivalents include all financial instruments purchased with an initial maturity of three months or less.

Trade Receivables
 
Trade receivables are presented net of an allowance for credit losses. The estimate of current expected credit losses on trade receivables considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. Estimated credit losses are reviewed periodically.
 
Inventories

Inventories are valued at the lower of cost or net realizable value. Fixed manufacturing overhead costs are allocated to inventory based on normal production capacity and abnormal manufacturing activities are recognized as period costs. Cost for a substantial portion of U.S. inventories is determined using the last-in, first-out method (“LIFO”). The value of inventory stated on a LIFO basis as of December 31, 2022 and 2021 was $131.1 million and $142.4 million, respectively. The valuation of LIFO inventories is made at the end of each year based on inventory levels and costs at that time. Cost of other inventories is determined by costing methods that approximate a first-in, first-out basis.

Reserves are maintained for estimated obsolescence or excess inventory equal to the difference between the cost of inventory and the net realizable value based upon assumptions about future demand and market conditions. The reserve for excess and obsolete inventory was $40.1 million and $37.9 million as of December 31, 2022 and 2021, respectively.

Property, Plant and Equipment
 
Property, plant and equipment, net is stated at historical cost, which includes the fair values of such assets acquired through acquisitions. Repair and maintenance expenditures are expensed as incurred unless the repair extends the useful life of the asset.

Impairment of Goodwill and Indefinite-Lived Intangible Assets
 
Goodwill represents the costs in excess of the fair value of net assets acquired through acquisitions by the Company.
 
The Company evaluates the recoverability of Goodwill and indefinite-lived intangible assets annually or more frequently if an event occurs or circumstances change in the interim that would more likely than not reduce the fair value of the asset below its carrying amount. The annual impairment test date elected by the Company is the first day of its fourth quarter. Goodwill and indefinite-lived intangible assets are considered to be impaired when the carrying value of a reporting unit or asset exceeds its fair value. As of the annual impairment test date, the Company had three reporting units: Americas, EMEA & APAC and Gas Control Equipment (“GCE”).

In the evaluation of goodwill for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting entity is less than its carrying value. If the Company determines that it is more likely than not for a reporting unit’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not for a reporting unit’s fair value to be less than its carrying value, a calculation of the reporting unit’s fair value is performed and compared to the carrying value of that reporting unit. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying value of a reporting unit exceeds its fair value, goodwill of that reporting unit is impaired and an impairment loss is recorded equal to the excess of the reporting unit’s carrying value over its fair value.



66
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
When a quantitative impairment test is needed, the Company measures fair value of reporting units based on a present value of future discounted cash flows. The discounted cash flow models indicate the fair value of the reporting units based on the present value of the cash flows that the reporting units are expected to generate in the future. Significant estimates in the discounted cash flow models include the weighted-average cost of capital, net sales and profitability of our business.

For the year ended December 31, 2022 a qualitative Goodwill impairment assessment was performed for the three reporting units. For the year ended December 31, 2021 a quantitative annual impairment test of Goodwill was performed for the GCE reporting unit while qualitative assessments were performed for the remaining two reporting units. A quantitative annual impairment test of Goodwill for each of the Company’s three reporting units was performed for the year ended December 31, 2020. All of the above tests indicated no impairment existed. Therefore, no impairment charges were recorded for the three years ended December 31, 2022. No material events that would represent impairment indicators have occurred subsequent to the performance of the 2022 annual impairment test.

In the evaluation of indefinite-lived intangible assets for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying value. If the Company determines that it is more likely than not for the indefinite-lived intangible asset’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not that the indefinite-lived intangible asset’s fair value is less than its carrying value, a fair value calculation is performed and compared to the carrying value of the asset. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying amount of the indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The Company measures the fair value of its indefinite-lived intangible assets using the “relief from royalty” method. Significant estimates in this approach include projected revenues and royalty and discount rates for each trade name evaluated. At the impairment testing date, the first day of the fourth quarter, quantitative impairment tests were performed for all the indefinite-lived trade name brands for the years ended December 31, 2022, 2021 and 2020, all of which indicated no impairment existed.

Impairment of Long-Lived Assets Other than Goodwill and Indefinite-Lived Intangible Assets
 
Definite-lived intangible assets primarily represent acquired trade names, customer relationships, acquired technology and software license agreements. The Company uses accelerated and straight-line methods of amortization with lives ranging from ten to thirty years.

The Company assesses its long-lived assets and definite-lived intangible assets for impairment whenever facts and circumstances indicate that the carrying amounts may not be fully recoverable. To analyze recoverability, the Company projects undiscounted net future cash flows over the remaining lives of such assets. If these projected cash flows are less than the carrying amounts, an impairment loss equal to the difference between the carrying amount of the asset and its fair value would be recognized, resulting in a write-down of the assets with a corresponding charge to earnings. Assets held for sale are reported at the lower of the carrying amounts or fair value less cost to sell. The Company determines fair value using the discounted cash flow method or other accepted valuation techniques. The Company determined that no impairment indicators were evident during the years ended December 31, 2022, 2021 and 2020.

Derivatives

The Company uses derivative instruments to manage exposures to interest rates and net investment exposures. The Company does not enter into derivatives for trading or speculative purposes.

All derivatives are recognized at fair value on the Company’s Consolidated and Combined Balance Sheets. The accounting for gains and losses resulting from changes in fair value depends on the use of the derivative and whether it is designated and qualifies for hedge accounting. The Company formally documents the relationship of the hedge with the hedged item as well as the risk-management strategy for all designated hedges. Both at inception and on an ongoing basis, the hedging instrument is assessed as to its effectiveness, when applicable. If and when a derivative is determined not to be highly effective as a hedge, the underlying hedged transaction is no longer likely to occur, or the derivative is terminated, hedge accounting is discontinued.

The Company is subject to the credit risk of the counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. The Company manages individual counterparty exposure by monitoring the credit rating of the counterparty and the size of financial commitments and exposures between the Company and the counterparty.

67
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
Certain interest rate swap agreements are qualified and designated as cash flow hedges. The effective portion of the fair value unrealized gain or loss on cash flow hedges are reported as a component of Accumulated other comprehensive income ("AOCI") with offsetting amounts recorded in the Company’s Consolidated and Combined Balance Sheet depending on the position and the duration of the contract. The gain or loss on the derivative instrument due to the change in fair value is reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. If a derivative is deemed to be ineffective, the change in fair value of the derivative is recognized directly in earnings.

Certain cross-currency swap agreements are designated and qualify as a net investment hedge, the changes in the fair value of these instruments are recorded in AOCI in equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCI. Offsetting amounts are recorded in the Company’s Consolidated and Combined Balance Sheet depending on the position and the duration of the contract.

The Company has certain foreign currency contracts which are not designated as hedges. These derivatives are held as offsets to certain balance sheet exposures. The gains or losses on these contracts are recognized in Interest expense (income) and other, net, in the Company’s Consolidated and Combined Statement of Operations.

Warranty Costs
 
Estimated expenses related to product warranties are accrued as the revenue is recognized on products sold to customers and included in Cost of sales in the Consolidated and Combined Statements of Operations. Estimates are established using historical information as to the nature, frequency, and average costs of warranty claims.
 
Income Taxes
 
Prior to the Separation, the Company’s domestic and foreign operating results were included in the income tax returns of Enovis. The Company accounted for income taxes under the separate return method. Under this approach, the Company determined its deferred tax assets and liabilities and related tax expense as if it were filing separate tax returns. The accompanying Combined Balance Sheets for the year ended December 31, 2021 did not contain current income tax payable or other long-term income tax payable liabilities, with the exception of certain unrecognized tax benefits for which ESAB could have reasonably be considered to be the primary obligor. The amounts are deemed settled with Enovis when they were due and therefore were included in Parent’s equity.

The Company accounts for income taxes under ASC 740, Income Taxes (“ASC 740”) which requires recognition of deferred income tax assets and liabilities reflecting the tax consequences attributable to differences between the carrying amounts of existing assets and liabilities in the Consolidated and Combined Financial Statements and their respective tax basis. Deferred income tax assets and liabilities are measured using enacted tax rates expected to be applied to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred income tax assets and liabilities are reported in Other assets and Other liabilities in the Consolidated and Combined Balance Sheets, respectively. The effect on deferred income tax assets and liabilities of a change in tax rates is generally recognized in Income tax expense in the period that includes the enactment date. Global Intangible Low-Taxed Income (“GILTI”) is accounted for as a current tax expense in the year the tax is incurred.
 
Valuation allowances are recorded if it is more likely than not that some portion of the deferred income tax assets will not be realized. In evaluating the need for a valuation allowance, the Company considers various factors, including the expected level of future taxable income and available tax planning strategies. Any changes in judgment about the valuation allowance are recorded through Income tax expense and are based on changes in facts and circumstances regarding realizability of deferred tax assets.
 
The Company must presume that an income tax position taken in a tax return will be examined by the relevant tax authority and determine whether it is more likely than not that the tax position will be sustained upon examination based upon the technical merits of the position. An income tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The Company establishes a liability for unrecognized income tax benefits for income tax positions for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority to the extent such tax positions reduce the Company’s income tax liability. The Company recognizes interest and penalties related to unrecognized income tax benefits in Income tax expense in the Consolidated and Combined Statements of Operations.

68
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
Interest expense (income) and Other, Net

Interest expense (income) and other, net is comprised of interest-bearing deposits of certain foreign subsidiaries, interest costs for the Company’s debt, amortization of debt issuance costs and interest income or expense of derivatives designated in hedging relationships.

In addition, it is comprised of other non-operating income items, including certain pension-related activities, foreign exchange exposure on cash and intercompany positions and interest income or expense on foreign currency contracts not designated in hedging relationships. See “Foreign Currency Exchange Gains and Losses” policy below for additional information.

Foreign Currency Exchange Gains and Losses
 
The Company’s financial statements are presented in U.S. dollars. The functional currencies of the Company’s operating subsidiaries are generally the local currencies of the countries in which each subsidiary is located. Assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the balance sheet date. The amounts recorded in each year in Foreign currency translation are net of income taxes to the extent the unrealized foreign exchange is taxed currently or the underlying equity balances in the entities are not deemed to be permanently reinvested. Revenues and expenses are translated at average rates of exchange in effect during the year.

Transactions in foreign currencies are translated at the exchange rate in effect at the date of each transaction. Differences in exchange rates during the period between the date a transaction denominated in a foreign currency is consummated and the date on which it is either settled or translated for inclusion in the Consolidated and Combined Balance Sheets are recognized in Selling, general and administrative expense or Interest expense (income) and other, net in the Consolidated and Combined Statements of Operations for that period.

The following table summarizes the Company’s net foreign transaction gains and losses included within the Consolidated and Combined Statements of Operations:

Year Ended December 31,
202220212020
(In thousands)(1)
Selling, general and administrative expense$2,597 $2,195 $788 
Interest (income) expense and other, net109 191 313 
Foreign currency transaction loss (gain), net$2,706 $2,386 $1,101 
(1) This table excludes the impact of the foreign exchange loss due to the remeasurement of the Company’s Argentinian operations, as described in the “Argentina Currency” paragraph below.
Argentina Currency

Argentina is deemed to have a highly inflationary economy, resulting in the remeasurement of the company’s Argentinian operations into Brazilian real, the functional currency of the Argentinian entity’s direct parent. Gains and losses from the remeasurement are recorded in the Company’s Consolidated and Combined Statements of Operations each year. For the year ended December 31, 2022 the remeasurement of the financial statements of the Company’s subsidiary operating in a highly inflationary economy has resulted in a transaction foreign exchange loss to Cost of sales of $6.6 million, Selling, general and administrative expense of $3.3 million and Interest (income) expense and other, net of $2.4 million. The impact to the Company’s Combined Statements of Operations for the years ended December 31, 2021 and 2020 were not material.

Debt Issuance Costs

Costs directly related to the placement of debt are capitalized and amortized to Interest expense primarily using the straight-line method over the term of the related obligation. See Note 15, “Debt” for additional discussion regarding the Company’s borrowing arrangements.

69
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
Use of Estimates
 
The Company makes certain estimates and assumptions in preparing its Consolidated and Combined Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the Consolidated and Combined Financial Statements and the reported amounts of revenues and expenses for the period presented. Actual results may differ from those estimates.

Reclassification

Certain prior period amounts have been reclassified to conform to current year presentations, including certain items within the Consolidated and Combined Statements of Comprehensive Income.

3. Recently Issued Accounting Pronouncements

The Company assesses the adoption impacts of recently issued accounting pronouncements on the Company’s Consolidated and Combined financial statements as well as material updates to previous assessments. There were no new material accounting standards issued or adopted in the year of 2022 that impacted the Company.

4. Discontinued Operations

The Company holds certain asbestos-related contingencies and insurance coverages from divested businesses for which it does not have an interest in the ongoing operations. The entities that hold these assets and liabilities became subsidiaries of the Company during the year ended December 31, 2022 in connection with the Separation. These assets and liabilities were not included in the Company’s historical Combined Financial Statements for 2021 or 2020 as the Company did not have legal title to these assets, nor was the Company the legal obligor of these liabilities. The 2022 amounts reflect income, expenses, assets and liabilities historically recorded within the Former Parent’s divested businesses that were not part of Former Parent’s Fabrication Technology segment. Refer to “Note 1, Organization and Basis of Presentation” for additional information.

The Company has classified asbestos-related activity included in its Consolidated and Combined Statements of Operations, as part of Loss from discontinued operations, net of taxes.

Loss from discontinued operations, net of taxes consists of Selling, general and administrative expenses of $7.5 million net of a tax benefit of $4.4 million. See Note 19, “Commitments and Contingencies” for further information.

Cash used in operating activities related to discontinued operations for the year ended December 31, 2022 was $23.1 million.

5. Acquisitions

On October 14, 2022, the Company completed the acquisition of Ohio Medical, LLC, a U.S. based global leader in oxygen regulators and central gas systems, for $127 million, net of cash received. In connection with the acquisition, the Company expects to realize an additional cash tax benefit with a net present value of approximately $15 million. This acquisition expands the Company’s presence in industrial specialty gas applications and products and broadens the Company’s U.S. presence.

On October 31, 2022, the Company completed the acquisition of Swift Cut Automation Limited, for $22 million, net of cash received. Swift-Cut is a provider of light industrial cutting systems and combined with ESAB provides a market-leading automated cutting portfolio.

Acquisitions consummated during the year ended December 31, 2022 are accounted for under the acquisition method of accounting. The assets acquired and liabilities assumed reported on the Consolidated Balance Sheets represent the Company’s best estimate. These amounts are based upon certain valuations and studies that have yet to be finalized and are subject to adjustment once the detailed analyses are completed within twelve months from the respective acquisition dates.






70
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
6. Revenue

The Company develops, manufactures and supplies consumable welding and cutting products and equipment, as well as gas control equipment. The Company provides a wide range of products with innovative technologies to solve challenges in a range of industries, including cutting, joining and automated welding. Substantially all revenue is recognized at a point in time. The Company disaggregates its revenue into the following product groups:

Year Ended December 31,
202220212020
(In thousands)
Equipment$740,824 $758,267 $607,504 
Consumables1,852,656 1,669,848 1,342,565 
Total$2,593,480 $2,428,115 $1,950,069 

The sales mix in the above table is relatively consistent across both reportable segments. The consumables product grouping generally has less production complexity and shorter production cycles than equipment products.

Given the nature of the business, the total amount of unsatisfied performance obligations with an original contract duration of greater than one year as of December 31, 2022 is immaterial.

In some circumstances, customers are billed in advance of revenue recognition, resulting in contract liabilities. As of December 31, 2022, 2021 and 2020, total contract liabilities were $25.9 million, $22.3 million and $21.6 million, respectively, and are included in Accrued liabilities on the Consolidated and Combined Balance Sheets. During the years ended December 31, 2022 and 2021, substantially all amounts included in the contract liability balance at the beginning of the respective year were recognized as revenue in the following year.

Allowance for Credit Losses

A summary of the activity in the Company’s allowance for credit losses included within Trade receivables in the Consolidated and Combined Balance Sheets is as follows:
Year Ended December 31, 2022
Balance at
Beginning
of Period		Charged to Expense, netWrite-Offs and DeductionsForeign
Currency
Translation		Balance at
End of
Period
(In thousands)
Allowance for credit losses $23,912 $4,526 $(4,978)$11 $23,471 

71
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
7. Earnings per Share from Continuing Operations

The Company has unvested share-based payment awards with a right to receive non-forfeitable dividends which are considered participating securities. The Company allocates earnings to participating securities and computed earnings per share using the two-class method as follows:
Year Ended December 31,
202220212020
(In thousands, except share and per share data)
Computation of earnings per share from continuing operations - basic:
Income from continuing operations attributable to ESAB Corporation(1)
$226,815 $235,110 $157,414 
Less: distributed and undistributed earnings allocated to nonvested shares(1,600)— — 
Income from continuing operations attributable to common stockholders$225,215 $235,110 $157,414 
Weighted-average shares of Common stock outstanding – basic(2)
60,054,930 60,034,311 60,034,311 
Income per share from continuing operations – basic
$3.75 $3.92 $2.62 
Computation of earnings (loss) per share from continuing operations - diluted:
Income from continuing operations attributable to common stockholders$225,215 $235,110 $157,414 
Weighted-average shares of Common stock outstanding – basic(2)
60,054,930 60,034,311 60,034,311 
Net effect of potentially dilutive securities(3)
98,129 — — 
Weighted-average shares of Common stock outstanding – dilution
60,153,059 60,034,311 60,034,311 
Net income per share from continuing operations – diluted
$3.74 $3.92 $2.62 
(1) Net income from continuing operations attributable to ESAB Corporation for the respective periods is calculated using Net income from continuing operations, less Income attributable to noncontrolling interest, net of taxes, of $4.3 million, $3.6 million and $2.5 million for the years ended December 31, 2022, 2021 and 2020 respectively.
(2) The total number of shares outstanding on April 4, 2022 was 60,034,311 which is being utilized for the calculation of both basic and diluted earnings per share for the years ended December 31, 2021 and December 31, 2020 as no ESAB common stock equivalents were outstanding prior to the Separation.
(3) Potentially dilutive securities include stock options, performance-based restricted stock units and non performance-based restricted stock units.

8. Income Taxes

Separation from Enovis

Prior to the Separation, our operating results were included in the Former Parent’s various consolidated U.S. federal and certain state income tax returns, as well as certain non-U.S. returns. For periods prior to the Separation, our combined financial statements reflect Income tax expense and deferred tax balances as if we had filed tax returns on a standalone basis separate from the Former Parent. The separate return method applies the accounting guidance for income taxes to the standalone financial statements as if we were a separate taxpayer and a standalone enterprise for the periods prior to the Separation. For periods prior to the Separation, our pretax operating results include any transactions with the Former Parent as if it were an unrelated party.

In connection with the Separation, we entered into agreements with the Former Parent, including a Tax Matters Agreement. The Tax Matters Agreement distinguishes between the treatment of tax matters for “joint” filings compared to “separate” and “unitary state” filings prior to the Separation. “Joint” filings are returns, such as the U.S. federal return, that include operations from both Former Parent legal entities and the Company. By contrast, “separate” filings are tax returns (primarily U.S. state returns and non-U.S. returns) that exclusively include either the Former Parent’s or the Company’s operations. “Unitary state” filings are state tax returns which may include legal entities of both the Company and the Former Parent. In accordance with the Tax Matters Agreement, the Company is liable for and has indemnified the Former Parent against all income tax liabilities involving “separate” and “unitary state” filings for periods prior to the Separation, except to the extent a unitary state filing includes a legal entity of the Former Parent and the adjustment relates to that legal entity. The Company is also liable for fifty percent of all cash taxes paid as a result of any adjustment or redetermination or otherwise in connection with any tax contest relating to any joint return.
72
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
In connection with the Separation, the Company was required to enter into a transfer agreement under Section 965(h) and to become the primary obligor of the remaining installment payments associated with the Section 965 liability. The Former Parent is obligated under the Tax Matters Agreement for fifty percent of the installment obligation. Under the Separation Agreement, the Company is responsible for any tax indemnity related to the discontinued operations by the Former Parent.

Income from continuing operations before income taxes and Income tax expense consisted of the following:
 
 Year Ended December 31,
 202220212020
 (In thousands)
Income from continuing operations before income taxes:  
Domestic operations$(19,234)$10,140 $14,505 
Foreign operations319,485 308,948 191,334 
 $300,251 $319,088 $205,839 
Income tax expense:
Current:
Federal$8,928 $18,477 $9,262 
State2,451 1,797 921 
Foreign77,728 68,779 49,819 
 89,107 89,053 60,002 
Deferred:
Federal(7,501)(12,700)(8,698)
State358 161 (677)
Foreign(12,794)3,895 (4,656)
 (19,937)(8,644)(14,031)
 $69,170 $80,409 $45,971 

The Company’s Income tax expense differs from the amount that would be computed by applying the U.S. federal statutory rate as follows:
Year Ended December 31,
202220212020
(In thousands)
Taxes calculated at the U.S. federal statutory rate$63,053 $67,008 $42,820 
State taxes2,809 1,933 245 
Effect of tax rates on international operations(9,010)(8,879)(572)
Changes in tax reserves(350)2,734 1,346 
Non-taxable dividends— (46)(2,675)
Research and development tax credits(542)(587)(1,351)
Effect of U.S. taxation on international operations310 (313)(1,634)
Permanent differences, net
7,209 483 1,284 
Provision to return(7,055)(7,415)1,053 
Withholding taxes12,133 9,567 6,108 
Capital gain(3,655)12,371 — 
Valuation Allowance4,503 3,737 
Other(235)(184)(653)
Income tax expense$69,170 $80,409 $45,971 

73
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
The Company’s effective tax rate for each of 2022, 2021, and 2020 differs from the U.S. Federal statutory rate of 21% due to withholding taxes and permanent differences relating to foreign subsidiaries, partially offset by the favorable impact from the Company’s earnings outside the U.S. taxed at different rates than the U.S. federal statutory rate.

Prior to the Separation, a portion of the Company’s income tax payable or receivable computed under the separate return method is adjusted to equity as it does not represent a liability or asset with the relevant taxing authorities since the Company activity for this period will be included as part of the Former Parent’s tax return, primarily the U.S. Federal Income Tax return, filed with taxing authorities.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. All deferred tax assets and liabilities have been classified as noncurrent and are included in Other assets and Other liabilities in the accompanying Consolidated and Combined Balance Sheets. The temporary differences that gave rise to the significant components of deferred tax assets and liabilities are presented below:
December 31,
20222021
(In thousands)
Deferred tax assets:
Post-retirement benefit obligation$5,761 $4,430 
Expenses currently not deductible36,320 29,245 
Net operating loss carryforward111,497 22,374 
Tax credit carryforward10,320 — 
Depreciation and amortization9,124 16,450 
Inventory5,685 138 
Other36,873 24,648 
Valuation allowance(88,202)(15,465)
Deferred tax assets, net$127,378 $81,820 
Deferred tax liabilities:
Depreciation and amortization$(121,858)$(135,726)
Outside basis differences and other (102,336)(108,542)
Total deferred tax liabilities $(224,194)$(244,268)
Total deferred tax liabilities, net$(96,816)$(162,448)

Deferred tax assets and liabilities have been classified as noncurrent and are included in Other assets and Other liabilities in the accompanying Consolidated and Combined Balance Sheets on a net jurisdictional basis as follows:

December 31,
20222021
(In thousands)
Other assets$42,860 $9,357 
Other liabilities(139,676)(171,805)
Deferred tax liability, net$(96,816)$(162,448)

The Company evaluates the recoverability of its deferred tax assets on a jurisdictional basis by considering whether deferred tax assets will be realized on a more likely than not basis. To the extent a portion or all of the applicable deferred tax assets do not meet the more likely than not threshold, a valuation allowance is recorded. During the year ended December 31, 2022, the valuation allowance increased from $15.5 million to $88.2 million with a net increase of $4.5 million recognized as an increase to Income tax expense, and a $0.6 million decrease related to changes in foreign currency rates. The increase in net operating loss carryforward, tax credit carryforward and valuation allowances was primary due to transfer from the Former Parent. In determining how much of the relevant deferred tax asset could be realized on a more likely than not basis, consideration was given to tax planning strategies and, when applicable, future taxable income.
 
74
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
The Company has U.S. Federal net operating loss carryforwards of $18.1 million as of December 31, 2022 expiring in years 2028 through 2036. The Company’s ability to use these various carryforwards to offset any taxable income generated in future taxable periods may be limited under Section 382 and other federal tax provisions. At December 31, 2022 the Company also has $424.3 million foreign net operating loss carryforwards primarily in the United Kingdom, Germany, the Netherlands and Sweden that may be subject to local tax restrictive limitations including as a result of changes in ownership. The foreign net operating losses can be carried forward indefinitely, except in applicable jurisdictions that make up less than five percent of the available net operating losses.

For the year ended December 31, 2022, the Company has changed its indefinite reinvestment assertion on $57.5 million of the undistributed earnings of the Company’s foreign subsidiaries. The remaining earnings continue to be indefinitely reinvested outside the United States. The Company has assessed a total deferred tax liability of $4.5 million as of December 31, 2022 on such earnings that have not been indefinitely reinvested. This is an increase of $4.5 million as compared to the deferred tax liability as of December 31, 2021. The Company has made no provision for U.S. income taxes or additional non-U.S. taxes on certain undistributed earnings of non-U.S. subsidiaries. These earnings could become subject to additional tax if the Company were to dividend those earnings or sell the Company's interest in the non-U.S. subsidiary. The Company cannot practically determine the amount of additional taxes that might be payable on those earnings. During the first quarter of 2023, the Company began to evaluate opportunities for repatriation of certain foreign earnings and will record a withholding tax charge accordingly during 2023 of approximately $11 million.

The Company records a liability for certain unrecognized income tax benefits for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority (“uncertain tax positions”). This liability for such uncertain tax positions includes the amount of benefit included in (i) its previously filed income tax returns and (ii) its financial results expected to be included in income tax returns to be filed for periods through the date of its Consolidated and Combined Financial Statements. The Company’s total unrecognized tax benefits were $20.2 million, $37.7 million and $35.2 million as of December 31, 2022, 2021 and 2020, respectively, inclusive of $5.6 million, $6.2 million and $5.2 million, respectively, of interest and penalties. The Company records interest and penalties on uncertain tax positions as a component of Income tax expense, which was a benefit of $0.7 million, expense of $0.9 million and $0.7 million for the years ended December 31, 2022, 2021 and 2020, respectively.
A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows (inclusive of associated interest and penalties):

 (In thousands)
Balance, January 1, 2020
$34,014 
Addition for tax positions taken in prior periods2,785 
Addition for tax positions taken in the current period569 
Reductions resulting from a lapse of applicable statute of limitations(1,827)
Other, including the impact of foreign currency translation and U.S. tax rate changes(340)
Balance, December 31, 2020
35,201 
Addition for tax positions taken in prior periods738 
Addition for tax positions taken in the current period2,987 
Reductions related to settlements with taxing authorities(425)
Reductions resulting from a lapse of applicable statute of limitations(565)
Other, including the impact of foreign currency translation and U.S. tax rate changes(255)
Balance, December 31, 2021
37,681 
Addition for tax positions taken in prior periods1,971 
Addition for tax positions taken in the current period1,171 
Reductions related to settlements with taxing authorities(922)
Transfer from Former Parent, impact of foreign currency translation and other(2,801)
Other, including the impact of foreign currency translation(16,897)
Balance, December 31, 2022
$20,203 
 
75
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
The Company files numerous group and separate tax returns in U.S. federal and state jurisdictions, as well as international jurisdictions. The Company is routinely examined by various U.S. and non-U.S. taxing authorities. The Company is subject to audit by the U.S., various states and foreign jurisdictions. In accordance with the Tax Matters Agreement with Former Parent, the Company is the primary obligor for (i) ESAB separate company state returns for all periods; (ii) unitary state returns that include only ESAB legal entities for all periods, and (iii) ESAB separate foreign returns for all periods. The Company also has an obligation with respect to certain liabilities associated with unitary state tax returns that include both ESAB legal entities and Former Parent legal entities for all periods, certain liabilities associated with pre-separation joint returns, fifty percent of the remaining Section 965 installment payments, and any tax indemnity associated with discontinued operations.

Pursuant to U.S. tax law, the Company will file its initial U.S. federal income tax return for the post-Separation period by October 2023. The IRS has not yet begun examination of the Company. The Company reviews its global tax provisions on a quarterly basis. Based on these reviews, the results of discussions and resolutions of matters with certain tax authorities, tax rulings and court decisions and the expiration of the statutes of limitations for continent tax liabilities are accrued or adjusted.
 
Due to the difficulty in predicting with reasonable certainty when tax audits will be fully resolved and closed, the range of reasonably possible significant increases or decreases in the liability for unrecognized tax benefits that may occur within the next 12 months is difficult to ascertain. The Company does not believe the total amount of unrecognized benefits will change by a material amount within the next 12 months due to the settlement of audits and expirations of statutes of limitations.

9. Goodwill and Intangible Assets
 

The following table summarizes Goodwill activity by segment for the years ended December 31, 2022 and 2021: 

 Americas
EMEA & APAC
Total
 (In thousands)
Balance, January 1, 2021
$522,777 $1,030,454 $1,553,231 
Goodwill attributable to acquisition4,159 — 4,159 
Impact of foreign currency translation(7,782)(16,615)(24,397)
Balance, December 31, 2021
519,154 1,013,839 1,532,993 
Goodwill attributable to acquisitions63,183 13,047 76,230 
Impact of foreign currency translation3,508 (82,964)(79,456)
Balance, December 31, 2022
$585,845 $943,922 $1,529,767 

The following table summarizes the Company’s Intangible assets, excluding Goodwill: 
 December 31,
 20222021
 Gross
Carrying
Amount		Accumulated
Amortization		Gross
Carrying
Amount		Accumulated
Amortization
 (In thousands)
Indefinite-Lived Intangible Assets
Trade names$180,691 $— $199,484 $— 
Definite-Lived Intangible Assets
Customer relationships482,499 (203,041)448,839 (185,071)
Technology71,192 (50,005)71,503 (49,276)
Trade names22,464 (9,412)16,550 (8,754)
Software94,904 (74,799)91,547 (67,888)
Other intangible assets22,800 (20,126)22,800 (18,300)
 $874,550 $(357,383)$850,723 $(329,289)
 
76
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
Amortization expense related to intangible assets of $35.6 million, $42.1 million and $41.8 million for the years ended December 31, 2022, 2021 and 2020, respectively, are included in the Selling, general and administrative expense in the Consolidated and Combined Statements of Operations.

Expected Amortization Expense
 
The Company’s expected annual amortization expense for intangible assets for the next five years is as follows: 
 December 31, 2022
 (In thousands)
2023$33,812 
202428,249 
202527,204 
202626,116 
202721,651 

10. Property, Plant and Equipment, Net
  December 31,
 Depreciable Life20222021
 (In years)(In thousands)
Landn/a$15,839 $16,028 
Buildings and improvements
5-40
164,472 172,835 
Machinery and equipment
3-15
382,830 362,074 
  563,141 550,937 
Accumulated depreciation (278,915)(264,659)
 $284,226 $286,278 

Depreciation expense for the years ended December 31, 2022, 2021 and 2020 was $29.5 million, $32.5 million and $32.9 million, respectively.

11. Inventories, Net

Inventories, net consisted of the following:
December 31,
20222021
(In thousands)
Raw materials$153,099 $148,376 
Work in process44,086 39,595 
Finished goods261,902 268,831 
459,087 456,802 
LIFO reserve(2,168)1,129 
Less: allowance for excess, slow-moving and obsolete inventory(40,090)(37,869)
$416,829 $420,062 

At December 31, 2022 and 2021, approximately 31.5% and 33.9% of total inventories, respectively, were valued using the LIFO method.





77
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
12. Leases

The Company leases certain office spaces, warehouses, production facilities, vehicles, and equipment. Leases with an initial term of twelve months or less are not recorded on the balance sheet. Most leases include renewal options, which can extend the lease term into the future. The Company determines the lease term by assuming options that are reasonably certain of being renewed will be exercised. Certain of the Company’s leases include rental payments adjusted for inflation. The right-of-use lease asset is recorded on the Consolidated and Combined Balance Sheets, with the current lease liability being included in Accrued liabilities and noncurrent lease liability being included in Other liabilities. Operating lease expense was $21.3 million, $23.0 million and $21.6 million for the years ended December 31, 2022, 2021 and 2020, respectively.
December 31, 2022
(In thousands)
Future lease payments by year:
2023$21,603 
202416,876 
202513,127 
202610,502 
20278,221 
Thereafter37,867 
Total108,196 
Less: present value discount(13,369)
Present value of lease liabilities$94,827 
Weighted-average remaining lease term (in years):
  Operating leases7.55
Weighted-average discount rate:
  Operating leases3.5 %

13. Accrued and Other Liabilities

Accrued and Other liabilities in the Consolidated and Combined Balance Sheets consisted of the following:
December 31, 2022December 31, 2021
CurrentNoncurrentCurrentNoncurrent
(In thousands)
Accrued taxes and deferred tax liabilities$49,615 $161,500 $58,920 $203,760 
Compensation and related benefits74,794 57,438 74,587 62,215 
Asbestos liability 30,108 230,581 — — 
Contract liability25,899 — 22,265 — 
Lease liability18,664 76,163 20,467 88,777 
Warranty liability 12,946 — 14,954 — 
Third-party commissions18,315 — 16,130 — 
Restructuring liability7,533 285 7,834 275 
Other47,436 19,372 35,952 7,918 
$285,310 $545,339 $251,109 $362,945 










78
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
Accrued Warranty Liability

A summary of the activity in the Company’s warranty liability included in Accrued liabilities in the Company’s Consolidated and Combined Balance Sheets is as follows:
Year Ended December 31,
20222021
(In thousands)
Warranty liability, beginning of period$14,954 $14,022 
Accrued warranty expense5,322 6,707 
Changes in estimates related to pre-existing warranties2,821 2,416 
Cost of warranty service work performed(9,680)(7,909)
Foreign exchange translation effect(471)(282)
Warranty liability, end of period$12,946 $14,954 

Accrued Restructuring Liability

The Company’s restructuring programs include a series of actions to reduce the structural costs of the Company. A summary of the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Consolidated and Combined Balance Sheets is as follows:
Year Ended December 31, 2022
Balance at Beginning of PeriodChargesPaymentsForeign Currency TranslationBalance at End of Period
(In thousands)
Restructuring and other related charges:
Americas
Termination benefits(1)
$2,044 $1,970 $(4,235)$(14)$(235)
Facility closure costs and other(2)
50 9,451 (9,382)— 119 
Subtotal2,094 11,421 (13,617)(14)(116)
Non-cash charges(2)
(37)
Segment Total11,384 
EMEA & APAC
Termination benefits(1)
5,774 2,672 (3,391)90 5,145 
Facility closure costs(2)
241 8,205 (5,686)29 2,789 
Subtotal6,015 10,877 (9,077)119 7,934 
Non-cash charges(2)
835 
Segment Total11,712 
Total$8,109 22,298 $(22,694)$105 $7,818 
Non-cash charges(2)
798 
Total Provision$23,096 
(1) Includes severance and other termination benefits, including outplacement services.
(2) Includes the cost of relocating associates, relocating equipment, lease termination expense, and other costs in connection with the closure and optimization of facilities and product lines.


79
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
Year Ended December 31, 2021
Balance at Beginning of PeriodChargesPaymentsForeign Currency TranslationBalance at End of Period
(In thousands)
Restructuring and other related charges:
Americas
Termination benefits(1)
$1,089 $5,414 $(4,455)$(4)$2,044 
Facility closure costs(2)
469 5,978 (6,397)— 50 
Subtotal1,558 11,392 (10,852)(4)2,094 
Non-cash charges(2)
220 
Segment Total11,612 
EMEA & APAC
Termination benefits(1)
4,247 4,219 (2,641)(51)5,774 
Facility closure costs(2)
122 2,090 (1,954)(17)241 
Subtotal4,369 6,309 (4,595)(68)6,015 
Non-cash charges(2)
1,033 
Segment Total7,342 
Total$5,927 17,701 $(15,447)$(72)$8,109 
Non-cash charges(2)
1,253 
Total Provision$18,954 
(1) Includes severance and other termination benefits, including outplacement services.
(2) Includes the cost of relocating associates, relocating equipment, lease termination expense, and other costs in connection with the closure and optimization of facilities and product lines.

14. Benefit Plans

The Company sponsors various defined benefit plans and other post-retirement benefits plans, including health and life insurance, for certain eligible employees or former employees. The Company uses December 31st as the measurement date for all of its employee benefit plans.

Prior to the Separation, the Former Parent offered both funded and unfunded noncontributory defined benefit pension plans in the United States that were shared amongst its businesses, including the Company prior to becoming plan sponsor. The participation of the Company’s employees and retirees in this plan was as though it participated in a multiemployer plan with the Former Parent. As a result, prior to the Separation, a proportionate share of the cost associated with this defined benefit plan was allocated to the Company based on the Company’s share of total Former Parent headcount. This allocation is reflected within Interest expense (income) and other, net, in the Consolidated and Combined Statements of Operations., while any assets and liabilities associated with this defined benefit plan were retained by the Former Parent and were not recorded on the Company’s historical Combined Financial Statements.

As part of the Separation, certain U.S. defined benefit and other post-retirement plans, formerly sponsored by the Former Parent were transferred to the Company as of March 21, 2022.

The transferred plans include a defined benefit pension plan with assets of $201.3 million and projected benefit liabilities of $200.7 million, one unfunded defined benefit plan with liabilities of less than $0.1 million and one other post-retirement benefit plan with liabilities of $11.7 million, all of which were recorded in the financial statements of the Former Parent at December 31, 2021.

During the year ended December 31, 2022, the Company recognized a Pension settlement gain of $9.1 million related to a completed buy-out of a foreign defined benefit plan by a third party plus the merger of two Company pension plans resulting in one plan benefiting from the surplus assets in the other plan. During the year ended December 31, 2021, the Company recognized a Pension settlement gain of $11.2 million when the trustees of a Company pension plan agreed to merge the plan with another Company pension plan and contribute the plan’s surplus assets.
80
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
These amounts are reflected in Pension settlement gain in the Consolidated and Combined Statements of Operations.

The following table summarizes the total changes in the Company’s pension and accrued post-retirement benefits and plan assets and includes a statement of the plans’ funded status:
 Pension BenefitsOther Post-Retirement Benefits
 
Year Ended December 31,
Year Ended December 31,
 2022202120222021
 (In thousands)
Change in benefit obligation:    
Projected benefit obligation, beginning of year$142,914 $155,914 $382 $388 
Transfer from Former Parent200,690 — 11,697 — 
Service cost1,684 1,785 15 14 
Interest cost5,874 1,668 234 22 
Plan amendments862 911 — — 
Actuarial gain(60,148)(1,866)(2,807)(25)
Foreign exchange effect(12,452)(6,653)(35)(7)
Benefits paid(23,385)(8,168)(636)(10)
Settlements(283)(847)— — 
Other266 170 — — 
Projected benefit obligation, end of year$256,022 $142,914 $8,850 $382 
Accumulated benefit obligation, end of year$253,123 $139,513 $8,850 $382 
Change in plan assets:
Fair value of plan assets, beginning of year$84,503 $73,114 $— $— 
Transfer from Former Parent201,259 — — — 
Actual return on plan assets(51,266)4,706 — — 
Employer contributions5,315 5,210 636 10 
Foreign exchange effect(7,583)(1,594)— — 
Benefits paid(23,385)(8,168)(636)(10)
Settlements(1)
9,947 11,272 — — 
Other260 (37)— — 
Fair value of plan assets, end of year$219,050 $84,503 $— $— 
Funded status, end of year$(36,972)$(58,411)$(8,850)$(382)
Amounts recognized on the Consolidated and Combined Balance Sheets as of December 31:
Non-current assets$15,701 $7,119 $— $— 
Current liabilities(3,025)(3,393)(824)(23)
Non-current liabilities(49,648)(62,137)(8,026)(359)
Total$(36,972)$(58,411)$(8,850)$(382)
    
(1) Settlements includes gains of $9.1 million and $11.2 million classified as Pension settlement gain on the Company’s Consolidated Statement of Operations for the years ended December 31, 2022 and December 31, 2021, respectively.

For pension plans with accumulated benefit obligations in excess of plan assets, the accumulated benefit obligation and fair value of plan assets were $201.1 million and $149.8 million, respectively, as of December 31, 2022 and $68.5 million and $5.2 million, respectively, as of December 31, 2021.

 For pensions plans with projected benefit obligations in excess of plan assets, the projected benefit obligation and fair value of plan assets were $206.8 million and $154.1 million, respectively, as of December 31, 2022 and $76.2 million and $10.7 million, respectively, as of December 31, 2021.

81
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
The following table summarizes the changes in the Company’s foreign pension benefit obligations and plan assets, included in the table above, and includes a statement of the plans’ funded status:
 
 Foreign Pension Benefits
 
Year Ended December 31,
 20222021
 (In thousands)
Change in benefit obligation:  
Projected benefit obligation, beginning of year$141,278 $154,075 
Service cost1,684 1,785 
Interest cost2,161 1,646 
Plan amendments862 911 
Actuarial gain(25,131)(1,787)
Foreign exchange effect(12,452)(6,653)
Benefits paid(8,984)(8,022)
Settlements(283)(847)
Other266 170 
Projected benefit obligation, end of year$99,401 $141,278 
Accumulated benefit obligation, end of year$96,500 $137,876 
Change in plan assets:
Fair value of plan assets, beginning of year$84,503 $73,114 
Actual return on plan assets(12,494)4,706 
Employer contributions5,170 5,064 
Foreign exchange effect(7,581)(1,594)
Benefits paid(8,984)(8,022)
Settlements9,947 11,272 
Other260 (37)
Fair value of plan assets, end of year$70,821 $84,503 
Funded status, end of year$(28,580)$(56,775)

Expected contributions to the Company’s pension and other post-employment benefit plans for the year ending December 31, 2023 are $5.2 million. The following benefit payments are expected to be paid during each respective fiscal year:
 Pension BenefitsOther Post-Retirement Benefits
 All PlansForeign Plans
 (In thousands)
2023$22,709 $7,551 $824 
202421,890 7,125 783 
202521,625 7,271 779 
202621,564 7,651 774 
202720,830 7,388 766 
2028 - 203296,928 37,424 3,326 

82
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
The Company’s primary investment objective for its pension plan assets is to provide a source of retirement income for the plans’ participants and beneficiaries. The assets are invested with the goal of preserving principal while providing a reasonable rate of return over the long term. Diversification of assets is achieved through strategic allocations to various asset classes. Actual allocations to each asset class vary due to periodic investment strategy changes, market value fluctuations, the length of time it takes to fully implement investment allocation positions, and the timing of benefit payments and contributions. The asset allocation is monitored and rebalanced as required, as frequently as on a quarterly basis in some instances. The target allocation for plan assets varies by plan and jurisdiction. The actual allocation percentages as of December 31, 2022 and 2021 are consistent with the target allocation ranges of the plans.

The following are the actual allocation percentages for the Company’s pension plan assets:
 
Actual Asset Allocation
December 31,
 20222021
U.S. Plans:
Equity securities:
U.S.36 %— %
International13 %— %
Fixed income50 %— %
Cash and cash equivalents1 %— %
Foreign Plans:
Equity securities4 %23 %
Fixed income securities34 %25 %
Cash and cash equivalents16 %1 %
Insurance contracts34 %38 %
Investment funds(1)
12 %13 %
 
(1) Represents various fixed income and equity securities.

A summary of the Company’s pension plan assets for each fair value hierarchy level for the periods presented follows (see Note 17, “Fair Value Measurements” for further description of the levels within the fair value hierarchy):
 
83
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
 December 31, 2022
 
Measured at Net Asset Value (1)
Level
One		Level
Two		Level
Three		 
Total
 (In thousands)
U.S. Plans:
Cash and cash equivalents $— $1,591 $— $— $1,591 
Equity securities:
U.S. large cap31,018 — — — 31,018 
U.S. small/mid cap10,789 11,289 — — 22,078 
International18,928 — — — 18,928 
Fixed income mutual funds:
U.S. government and corporate73,497 — — — 73,497 
Other — 1,118 — — 1,118 
Foreign Plans:
Cash and cash equivalents (2)
— 11,348 — — 11,348 
Equity securities— 2,475 — — 2,475 
Non-U.S. government and corporate bonds— 24,289 — — 24,289 
Insurance contracts— — 24,236 — 24,236 
Investment funds— — 8,400 — 8,400 
Other— 33 39 — 72 
 $134,232 $52,143 $32,675 $— $219,050 
(1)Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient (the “NAV”) have not been classified in the fair value hierarchy. These investments, consisting of common/collective trusts, are valued using the NAV provided by the Trustee. The NAV is based on the underlying investments held by the fund, that are traded in an active market, less its liabilities. These investments are able to be redeemed in the near-term.
(2) The weighted-average interest crediting rates received in Cash and cash equivalents of foreign plans are immaterial relative to total plan assets.
 December 31, 2021
 Measured at Net Asset Value Level
One		Level
Two		Level
Three		 
Total
 (In thousands)
Foreign Plans:
Cash and cash equivalents (1)
$— $442 $— $— $442 
Equity securities— 19,305 — — 19,305 
Non-U.S. government and corporate bonds— 21,310 — — 21,310 
Insurance contracts— — 32,570 — 32,570 
Investment funds— — 10,836 — 10,836 
Other— — 40 — 40 
 $— $41,057 $43,446 $— $84,503 
 
(1)The weighted-average interest crediting rates received in Cash and cash equivalents of foreign plans are immaterial relative to total plan assets.

84
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
The following table sets forth the components of net periodic benefit cost and Other comprehensive income of the Company’s defined benefit pension plans and other post-retirement employee benefit plans:
 
 Pension BenefitsOther Post-Retirement Benefits
 
Year Ended December 31,
Year Ended December 31,
 202220212020202220212020
 (In thousands)
Components of Net Periodic Benefit (Income) Cost:    
Service cost$1,684 $1,785 $1,577 $15 $14 $8 
Interest cost5,874 1,668 2,260 234 22 16 
Amortization4,313 1,220 785 (181)— (8)
Settlement gain(9,114)(11,195)— — 8 — 
Other92 2 154 — — — 
Expected return on plan assets(11,519)(2,258)(2,397)— — — 
Net periodic benefit (income) cost$(8,670)$(8,778)$2,379 $68 $44 $16 
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:
Transfer from Former Parent$53,134 $— $— $(2,629)$— $— 
Current year net actuarial (gain) loss949 (5,788)6,533 (2,807)(27)157 
Current year prior service cost862 — 95 — — — 
Less amounts included in net periodic benefit cost:
Amortization of net (gain) loss(4,340)(1,228)(785)181 (8)8 
Settlement/divestiture/other gain(67)— (89)— — — 
Amortization of prior service cost(1,067)(5)— — — — 
Total recognized in Other comprehensive (gain) loss$49,471 $(7,021)$5,754 $(5,255)$(35)$165 

Each component of net periodic benefit (income) cost is included in the Company’s Consolidated and Combined Statements of Operations for the years ended December 31, 2022, 2021 and 2020. Service cost is included within Selling, general and administrative expense with the non-service costs included within Interest expense (income) and other, net. Settlement gains of $9.1 million and $11.2 million are recorded within Pension settlement gain on the Company’s Consolidated Statement of Operations for the years ended December 31, 2022 and 2021, respectively.

The following table sets forth the components of net periodic benefit cost and Other comprehensive income of the foreign defined benefit pension plans, included in the table above:
85
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
 Foreign Pension Benefits
 
Year Ended December 31,
 202220212020
 (In thousands)
Components of Net Periodic Benefit (Income) Cost: 
Service cost$1,684 $1,785 $1,577 
Interest cost2,161 1,646 2,218 
Amortization687 1,118 692 
Settlement gain(9,114)(11,195)— 
Other92 2 154 
Expected return on plan assets(2,063)(2,258)(2,397)
Net periodic benefit (income) cost$(6,553)$(8,902)$2,244 
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:
Current year net actuarial loss (gain)$(12,262)$(5,710)$6,389 
Current year prior service cost862 — 101 
Less amounts included in net periodic benefit (income) cost:
Amortization of net loss(714)(1,126)(692)
Settlement/divestiture/other gain(67)— (89)
Amortization of prior service cost(1,067)(5)— 
Total recognized in Other comprehensive (gain) loss$(13,248)$(6,841)$5,709 

The components of net unrecognized pension and other post-retirement benefit cost included in Accumulated other comprehensive loss in the Consolidated and Combined Balance Sheets that have not been recognized as a component of net periodic benefit cost are as follows:
 Pension BenefitsOther Post-Retirement
Benefits
 
December 31,
December 31,
 2022202120222021
 (In thousands)
Net actuarial loss (gain)71,066 21,388 (5,199)56 
Prior service (income) cost(112)95 — — 
Total$70,954 $21,483 $(5,199)$56 
 
The key economic assumptions used in the measurement of the Company’s pension and other post-retirement benefit obligations are as follows:
 Pension BenefitsOther Post-Retirement
Benefits
 
December 31,
December 31,
 2022202120222021
Weighted-average discount rate:    
All plans4.6 %1.9 %5.0 %6.6 %
Foreign plans4.3 %1.9 %— %— %
Weighted-average rate of increase in compensation levels for active foreign plans(1)
3.2 %0.6 %— %— %
 
(1)Weighted-average rate of increase is only applicable to plans with compensation increase assumptions.
 
The key economic assumptions used in the computation of net periodic benefit cost are as follows: 
86
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
Pension BenefitsOther Post-Retirement Benefits
 
Year Ended December 31,
Year Ended December 31,
 202220212020202220212020
Weighted-average discount rate:    
All plans2.2 %1.3 %2.0 %2.6 %6.0 %7.6 %
Foreign plans1.9 %1.3 %1.9 %— %— %— %
Weighted-average expected return on plan assets:
All plans4.8 %3.6 %4.1 %— %— %— %
Foreign plans3.2 %3.6 %4.1 %— %— %— %
Weighted-average rate of increase in compensation levels for active foreign plans(1)
3.2 %3.4 %3.7 %— %— %— %
 
(1)Weighted-average rate of increase is only applicable to plans with compensation increase assumptions.
 
 In determining discount rates, the Company utilizes the single discount rate equivalent to discounting the expected future cash flows from each plan using the yields at each duration from a published yield curve as of the measurement date.
 
For measurement purposes, a weighted-average annual rate of increase in the per capita cost of covered health care benefits of 7.5% was assumed. The rate was assumed to decrease gradually to 4.1% by 2075 and remain at that level thereafter for benefits covered under the plans. 

The expected long-term rate of return on plan assets was based on the Company’s investment policy target allocation of the asset portfolio between various asset classes and the expected real returns of each asset class over various periods of time that are consistent with the long-term nature of the underlying obligations of these plans.

The Company maintains defined contribution plans covering certain union and non-union employees. The Company’s expense for the years ended December 31, 2022, 2021 and 2020 was $8.7 million, $7.9 million and $9.8 million, respectively.

15. Debt

Long-term debt consisted of the following:
December 31, 2022
(In thousands)
Term loans$1,000,000 
Revolving credit facilities221,000 
Total debt1,221,000 
Unamortized deferred financing fees(1)
(2,357)
Long-term debt$1,218,643 
 
(1)In the Company’s Consolidated Balance sheet, $1.2 million of deferred financing fees related to the Revolving Facility are included in Other assets and $2.4 million of deferred financing fees related to the Term Facilities are recorded as a contra-liability within Long-term debt.

Term Loans and Revolving Credit Facility

On April 4, 2022, the Company entered into a credit agreement (as amended and restated from time-to-time, the “Credit Agreement”) in connection with the Separation. The Credit Agreement initially consisted of the following facilities;

• A $750 million revolving credit facility (the “Revolving Facility”) with a maturity date of April 4, 2027

•A Term A-1 loan with an initial aggregate principal amount of $400 million (the “Term Loan A-1 Facility”), with a maturity date of April 4, 2027; and,

•A $600 million 364-day senior term loan facility (the “Term Loan A-2 Facility”) with a maturity date of April 3, 2023.
87
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
The Revolving Facility contains a $300 million letter of credit foreign currency sublimit and a $50 million swing line loan sub-facility.

On April 4, 2022, the Company drew down $1.2 billion available under the credit facilities made up of (i) $200 million under the Revolving Facility, (ii) $400 million under the Term Loan A-1 Facility and (iii) $600 million under the Term Loan A-2 Facility. The Company used these proceeds to make payments to Enovis of $1.2 billion, which was used as part of the consideration for the contribution of certain assets and liabilities to the Company by Enovis in connection with the Separation.

On June 28, 2022, the Company amended and restated the Credit Agreement by entering into Amendment No. 2 to Credit Agreement (“Credit Agreement Amendment”). The Credit Agreement Amendment provides for a $600 million term loan facility (the “Term Loan A-3 Facility” and, together with the Term Loan A-1 Facility, the “Term Facilities”, and together with the Revolving Facility, the “Facilities”) with a maturity date of April 3, 2025 to refinance the Company’s existing Term Loan A-2 Facility. Also on June 28, 2022, the Company borrowed the entire $600 million under Term Loan A-3 Facility to fund the repayment of the Term Loan A-2 Facility. The Company’s total borrowing capacity under the Credit Agreement remained unchanged. The draw-down and repayment related to these term facilities are presented net within the Consolidated and Combined Statements of Cash Flows.

The Credit Agreement contains customary covenants limiting the ability of the Company and its subsidiaries to, among other things, incur debt or liens, merge or consolidate with others, dispose of assets, make investments or pay dividends. In addition, the Credit Agreement contains financial covenants requiring the Company to maintain (i) a maximum total leverage ratio of not more than 4.00:1.00, with step-downs to, commencing with the fiscal quarter ending June 30, 2023, 3.75:1.00, and commencing with the fiscal quarter ending June 30, 2024, 3.50:1.00, and (ii) a minimum interest coverage ratio of 3.00:1:00. The Credit Agreement contains various events of default (including failure to comply with the covenants under the Credit Agreement and related agreements) and upon an event of default the lenders may, subject to various customary cure rights, require the immediate payment of all amounts outstanding under the Term Facilities and the Revolving Facility. Certain U.S. subsidiaries of the Company have agreed to guarantee the obligations of the Company under the Credit Agreement.

Loans made under the Term Facilities will bear interest, at the election of the Company, at either the base rate (as defined in the Credit Agreement) or at the term Secured Overnight Financing Rate (“SOFR”) rate plus an adjustment (as defined in the Credit Agreement), in each case, plus the applicable interest rate margin. Loans made under the Revolving Facility will bear interest, at the election of the Company, at either the base rate or, (i) in the case of loans denominated in dollars, the term SOFR rate plus an adjustment or the daily simple SOFR plus an adjustment, (ii) in the case of loans denominated in euros, the adjusted Euro Interbank Offered Rate (“EURIBOR”) rate and, (iii) in the case of loans denominated in sterling, Sterling Overnight Index Average (“SONIA”) plus an adjustment (as all such rates are defined in the Credit Agreement Amendment), in each case, plus the applicable interest rate margin. The applicable interest rate margin changes based upon the Company’s total leverage ratio (ranging from 1.125% to 1.750% or in the case of the base rate margin, 0.125% to 0.750%). Each swing line loan denominated in dollars will bear interest at the base rate plus the applicable interest rate margin.

To manage exposures to currency exchange rates and interest rates arising in Long term debt, the Company entered into interest rate and cross currency swap agreements during the year ended December 31, 2022. Refer to Note 16, “Derivatives” for additional information.

As of December 31, 2022, the weighted-average interest rate of borrowings under the Credit Agreement was 4.54%, including the net impact from the interest rate and cross currency swaps and excluding accretion of deferred financing fees, and there was $529 million of borrowing capacity available on the Revolving Facility.

Other Indebtedness

In addition to the debt agreements discussed above, the Company also has the ability to incur approximately $77 million of indebtedness pursuant to certain uncommitted credit lines, consisting of an uncommitted credit line that the Company currently has in place that the Company has used from time to time in the past for short-term working capital needs.

The Company is party to letter of credit facilities with an aggregate capacity of $102.9 million. Total letters of credit of $31.5 million were outstanding as of December 31, 2022.



88
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
Deferred Financing Fees

In total, the Company had deferred financing fees of $3.6 million included in its Consolidated and Combined Balance Sheet as of December 31, 2022, which will be charged to Interest expense (income) and other, net, using the straight-line method. The costs associated with the Term Facilities will be amortized over the contractual term of the Term Facilities and the costs associated with the Revolving Facility will be amortized over the life of the Credit Agreement. Of the $3.6 million, $1.2 million of deferred financing fees relating to the Revolving Facility are included in Other assets and $2.4 million of deferred financing fees relating to the Term Facilities are recorded as a contra-liability within Long-term debt.

Contractual Maturities

The contractual maturities of the Company’s debt is as follows:

December 31, 2022
(in thousands)
2023$— 
2024— 
2025600,000 
2026— 
2027621,000 
Total debt(1)
$1,221,000 
 
(1)Total debt excludes $3.6 million of related unamortized deferred financing fees.

16. Derivatives

The Company uses derivative instruments to manage exposures to currency exchange rates and interest rates arising in connection with Long-term debt and the normal course of business. The Company has established policies and procedures that govern the risk management of these exposures. Both at inception and on an ongoing basis, the derivative instruments that qualify for hedge accounting are assessed as to their effectiveness, when applicable.

The Company is subject to the credit risk of counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. None of the concentrations of risk with an individual counterparty was considered significant as of December 31, 2022. The Company does not expect any counterparties to fail to meet their obligations. The Company records derivatives in the Consolidated and Combined Balance Sheets at fair value.

Cash Flow Hedges

On July 14, 2022, the Company entered into two interest rate swap agreements to manage interest rate risk exposure. The aggregate notional amount of these contracts is $600 million and they mature in April 2025. These interest rate swap agreements utilized by the Company effectively modify the Company’s exposure to interest rate risk by converting a portion of the Company’s floating-rate debt to a fixed rate of 3.293%, plus a spread, thus reducing the impact of interest-rate changes on future interest expense. The applicable spread may vary between 1.125% to 1.750%, depending on the total leverage ratio of the Company. The spread is 1.250% as of December 31, 2022. These agreements involve the receipt of floating-rate amounts in exchange for fixed-rate interest payments over the life of the agreement without an exchange of the underlying principal amount.

The above interest rate swap agreements are designated and qualify as a cash flow hedge, and as such the gain or loss on the derivative instrument due to the change in fair value is reported as a component of accumulated other comprehensive income (“AOCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. If a derivative is deemed to be ineffective, the change in fair value of the derivative is recognized directly in earnings. The Company did not have any ineffectiveness related to cash flow hedges during the year ended December 31, 2022.

The cash inflows and outflows associated with the Company’s interest rate swap agreements designated as cash flow hedges are classified in cash flows from operating activities in the accompanying Consolidated and Combined Statements of Cash Flows.
89
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
The Company expects a gain of $7.3 million, net of tax, related to interest rate swap agreements to be reclassified from AOCI to earnings over the next 12 months as the hedged transactions are realized. The expected gain to be reclassified is based on current forward rates in active markets as of December 31, 2022.

The effects of designated cash flow hedges on the Company’s Consolidated and Combined Statements of Operations consisted of the following:

Year Ended December 31,
Derivative typeLoss recognized in the Consolidated and Combined Statements of Operations:2022
(In thousands)
Interest rate swap agreementsInterest expense (income) and other, net$413 

Net Investment Hedges

On July 22, 2022 the Company entered into two cross-currency swap agreements to partially hedge its net investment in its Euro denominated subsidiaries against adverse movements in exchange rates between the U.S. Dollar and the Euro. In addition, the cross-currency swap agreements include provisions to exchange fixed-rate payments in U.S. Dollar for fixed-rate payments in Euro and are designated and qualify as a net investment hedge. These contracts have a Euro aggregate notional amount of approximately €270 million and a U.S. Dollar aggregate notional amount of $275 million at December 31, 2022, and they mature in April 2025.

The changes in the spot rate of these instruments are recorded in AOCI in equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCI. The Company uses the spot method of assessing hedge effectiveness and as such, the initial value of the hedge components excluded from the assessment of effectiveness is recognized in the Interest expense (income) and other, net line item in the Consolidated and Combined Statement of Operations under a systematic and rational method over the life of the cross-currency swap agreements. Any ineffective portions of net investment hedges are reclassified from AOCI into earnings during the period of change. The Company did not have any ineffectiveness related to net investment hedges during the year ended December 31, 2022.

The cash inflows and outflows associated with the excluded components of the Company’s cross-currency swap agreements designated as net investment hedges are classified in operating activities in the accompanying Consolidated and Combined Statements of Cash Flows.

The effects of the excluded components of designated net investment hedges on the Company’s Consolidated and Combined Statements of Operations consisted of the following:

Year Ended December 31,
Derivative typeGain recognized in the Consolidated and Combined Statements of Operations:2022
(In thousands)
Cross currency swap agreementsInterest expense (income) and other, net$(2,181)

The table below shows the fair value of the derivatives recognized in the Consolidated Balance Sheet:

December 31, 2022
Designated as hedging instrumentsOther LiabilitiesOther Assets
(In thousands)
Cross currency swap agreements $10,769 $— 
Interest rate swap agreements— 14,342 
Total$10,769 $14,342 




90
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
Derivatives Not Designated as Hedging Instruments

The Company has certain foreign currency contracts that are not designated as hedges. As of December 31, 2022 and December 31, 2021, the Company had foreign currency contracts related to purchases and sales with notional values of $260.0 million and $180.8 million, respectively.

The Company recognized the following in its Consolidated and Combined Financial Statements related to its derivative instruments not designated in a hedging relationship:
Year Ended December 31,
Foreign currency contracts202220212020
(In thousands)
Change in unrealized gains1,338 177 1,426 
Realized loss(1)
(17,601)(5,631)(469)
(1) The year ended December 31, 2022 includes realized losses relating to certain corporate entities contributed to ESAB Corporation which are reflected within Interest expense (income) and other, net, in the Consolidated and Combined Statements of Operations. See Note 1, “Organization and Basis of Presentation” for additional details. These realized losses are offset by unrealized gains which are also reflected within Interest expense (income) and other, net, in the Consolidated and Combined Statements of Operations.

17. Fair Value Measurements

The Company utilizes fair value measurement guidance prescribed by accounting standards to value its financial instruments. The guidance establishes a fair value hierarchy based on the inputs used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows:

Level One: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets.

Level Two: Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

Level Three: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

The carrying values of financial instruments, including Trade receivables and Accounts payable, approximate their fair values due to their short-term maturities. The estimated fair values may not represent actual values of the financial instruments that could be realized as of the balance sheet date or that will be realized in the future.

A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is as follows (see Note 14, “Benefit Plans” for classification of the assets of the Company’s benefit plans within the fair value hierarchy):
91
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
December 31, 2022
Level
One		Level
Two		Level
Three		Total
(In thousands)
Assets:
Cash equivalents$8,195 $— $— $8,195 
Foreign currency contracts - not designated as hedges(1)
— 3,682 — 3,682 
Interest rate swap agreements— 14,342 — 14,342 
Deferred compensation plans— 2,501 — 2,501 
$8,195 $20,525 $— $28,720 
Liabilities:
Foreign currency contracts - not designated as hedges(2)
$— $2,166 $— $2,166 
Cross currency swap agreements— 10,769 — 10,769 
Deferred compensation plans— 2,501 — 2,501 
$— $15,436 $— $15,436 
(1) Included within Other Current Assets in the Consolidated Balance Sheet.
(2) Included within Accrued Liabilities in the Consolidated Balance Sheet.
December 31, 2021
Level
One		Level
Two		Level
Three		Total
(In thousands)
Assets:
Cash equivalents$8,133 $— $— $8,133 
Foreign currency contracts - not designated as hedges(1)
— 2,487 — 2,487 
$8,133 $2,487 $— $10,620 
Liabilities:
Foreign currency contracts - not designated as hedges(2)
$— $2,309 $— $2,309 
(1) Included within Other Current Assets in the Consolidated Balance Sheet.
(2) Included within Accrued Liabilities in the Consolidated Balance Sheet.

The Company’s cash equivalents consist of investments in interest-bearing deposit accounts and money market mutual funds which are valued based on quoted market prices. The fair value of these investments approximate cost due to their short-term maturities and the high credit quality of the issuers of the underlying securities.

The Company measures the fair value of foreign currency contracts, cross currency swap agreements and interest rate swap agreements using Level Two inputs based on observable spot and forward rates in active markets. Additionally, the fair value of derivatives designated in hedging relationships includes a credit valuation adjustment to appropriately incorporate nonperformance risk for the Company and the respective counterparty. For the year ended December 31, 2022, the impact of the credit valuation adjustment on the Company’s derivatives is immaterial. Refer to Note 16, “Derivatives” for additional information.

There were no transfers in or out of Level One, Two or Three during the years ended December 31, 2022 and 2021.









92
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
Concentration of Credit Risk

Financial instruments which potentially subject the Company to concentrations of credit risk consist primarily of trade accounts receivable. Concentrations of credit risk are considered to exist when there are amounts collectible from multiple counterparties with similar characteristics, which could cause their ability to meet contractual obligations to be similarly impacted by economic or other conditions. The Company performs credit evaluations of its customers prior to delivery or commencement of services and normally does not require collateral. Letters of credit are occasionally required when the Company deems necessary. There are no customers which represent more than 10% of the Company’s Accounts receivable, net as of December 31, 2022 and 2021.

93
FABRICATION TECHNOLOGY BUSINESS OF COLFAX CORPORATION
NOTES TO COMBINED FINANCIAL STATEMENTS — (Continued)
18. Equity

Accumulated Other Comprehensive Loss

The following table presents the changes in the balances of each component of Accumulated other comprehensive loss including reclassifications out of Accumulated other comprehensive loss for the years ended December 31, 2022, 2021 and 2020. All amounts are net of tax and noncontrolling interest, if any.

Accumulated Other Comprehensive Loss Components
Net Unrecognized Pension and Other Post-Retirement Benefit CostForeign Currency Translation AdjustmentLoss on Net Investment Hedges Gain on Cash Flow HedgesTotal
(In thousands)
Balance at January 1, 2020$(23,887)$(399,641)$— $— $(423,528)
Other comprehensive income (loss) before reclassifications:— 
Net actuarial loss(4,328)— — — (4,328)
Foreign currency translation adjustment(1,791)32,816 — — 31,025 
Other comprehensive (loss) income before reclassifications(6,119)32,816 — — 26,697 
Amounts reclassified from Accumulated other comprehensive loss(1)
628 — — — 628 
Net current period Other comprehensive (loss) income(5,491)32,816 — — 27,325 
Balance at December 31, 2020(29,378)(366,825)— — (396,203)
Other comprehensive income (loss) before reclassifications:— 
Net actuarial gain7,479 — — — 7,479 
Foreign currency translation adjustment1,534 (72,867)— — (71,333)
Other comprehensive (loss) income before reclassifications9,013 (72,867)— — (63,854)
Amounts reclassified from Accumulated other comprehensive loss(1)
(831)— — — (831)
Net current period Other comprehensive (loss) income8,182 (72,867)— — (64,685)
Balance at December 31, 2021(21,196)(439,692)— — (460,888)
Other comprehensive income (loss) before reclassifications:
Amounts contributed by Former Parent(2)
(50,504)(8,759)— — (59,263)
Net actuarial gain 113 — — — 113 
Foreign currency translation adjustment1,712 (82,351)(8,336)— (88,975)
Loss on long-term intra-entity foreign currency transactions— (83,105)— — (83,105)
Unrealized gain on cash flow hedges— — — 10,782 10,782 
Other comprehensive (loss) income before reclassifications(48,679)(174,215)(8,336)10,782 (220,448)
Amounts reclassified from Accumulated other comprehensive loss(1)(3)
6,028 — — 320 6,348 
Net current period Other comprehensive (loss) income(42,651)(174,215)(8,336)11,102 (214,100)
Balance at December 31, 2022$(63,847)$(613,907)$(8,336)$11,102 $(674,988)
94
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
(1) The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost. See Note 14,
“Benefit Plans” for additional details.
(2) Includes unrecognized pension and other post-retirement costs and accumulated currency translation adjustments of certain entities which were part of the Corporate segment of the Former
Parent and were transferred to ESAB Corporation in anticipation of the Separation. Please see Note 1, “Organization and Basis of Presentation” for more information on the entities
contributed from the Former Parent.
(3) During the year ended December 31, 2022, the amount on this line within the Gain on Cash Flow Hedges column is a component of Interest expense (income) and other, net. See Note 16, “Derivatives”, for additional details.

During the years ended December 31, 2022, 2021 and 2020, Noncontrolling interest decreased by $3.6 million, $1.1 million and $0.1 million, respectively, as a result of Other comprehensive loss, primarily due to foreign currency translation adjustments.

Share-Based Payments

Prior to the Separation, the Company had no stock-based compensation plans; however, certain employees of the Company participated in the Former Parent’s stock-based compensation plans which provided for the grants of stock options and restricted stock units (“RSUs”). Prior to the Separation, the Former Parent allocated stock-based compensation expense to the Company based on ESAB employees participating in Former Parent plans. This is reflected in the accompanying Consolidated and Combined Statements of Operations and Comprehensive Income for the period prior to the Separation. Prior to the Separation, in addition to stock compensation expense related to direct employees of the Company, stock compensation expense related to certain corporate employees of the Former Parent was allocated to the Company based on the Company’s proportional share of total Former Parent revenues. For the three months ended April 1, 2022, $0.7 million of stock-based compensation expense was allocated to the Company. For the years ended December 31, 2021 and 2020, $2.6 million and $3.0 million, respectively, was allocated to the Company. Following the Separation, the company independently incurs stock compensation expenses as a stand-alone company.

In connection with the Separation, the Company adopted the 2022 Omnibus Incentive Plan (the “Stock Plan”) that became effective upon the Separation. Outstanding equity awards of the Former Parent held by ESAB employees at the Separation date were converted into or replaced with awards of ESAB common stock under the Stock Plan, with the intent to maintain the economic value of the equity awards immediately before and after the Distribution. The terms of the equity awards period, exercisability and vesting schedule, as applicable, generally continued unchanged. Other than converted or replacement equity awards of ESAB issued in replacement of the Former Parent’s restricted stock units (“RSUs”) and stock options, the terms of the converted or replacement equity awards of ESAB (e.g. vesting date and expiration date) continued unchanged.

The Company measures and recognizes compensation expense related to share-based payments based on the fair value of the instruments issued. Stock-based compensation expense is generally recognized as a component of Selling, general and administrative expense in the Consolidated and Combined Statements of Operations.

As of December 31, 2022, the Company had $19.0 million of unrecognized compensation expense related to stock-based awards that will be recognized over a weighted-average period of 2.30 years.  

Stock Options

 Under the Stock Plan, the Company may grant options to purchase common stock, with a maximum term of 10 years at a purchase price equal to the market value of the Company’s common stock on the date of grant. Stock-based compensation expense for stock option awards is based upon the grant-date fair value using the Black-Scholes option pricing model. The Company recognizes compensation expense for stock option awards on a straight-line basis over the requisite service period of the entire award. For the year ended December 31, 2022 the Stock-based compensation expense for the stock option awards was $1.8 million.


95
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
Restricted Stock Units

During the year ended December 31, 2022, the Company granted certain employees performance-based restricted stock units (“PRSUs”), the vesting of which is fully based on company specific profit performance metrics over a three-year performance period. The awards also have a service requirement that equals the respective performance periods.

These PRSUs are valued at the market value of a share of Common stock on the date of grant taking into consideration the probability of achieving the specified performance goal. The ultimate payout of PRSUs with a profit performance metric adjusts the cumulative expense based on its estimate and the percent of the requisite service period that has elapsed.

Under the Stock Plan, the Compensation Committee may also award non-performance-based restricted stock units (“RSUs”) to select executives, employees and outside directors, which typically vest over three years after the date of grant. With limited exceptions, the employee must remain in service until the vesting date. The Compensation Committee determines the terms and conditions of each award, including any restriction period and other criteria applicable to the awards.

The activity of the Company’s PRSUs and RSUs is as follows:
 PRSUsRSUs
 Number
of Units		Weighted-
Average
Grant-Date
Fair Value		Number
of Units		Weighted-
Average
Grant-Date
Fair Value
Balance at December 31, 2021— $— — $— 
Awards converted from Former Parent plan58,636 58.03 333,223 52.89 
Granted51,652 49.40 187,556 47.28 
Vested— — (27,354)48.11 
Forfeited and expired— — (29,147)52.40 
Balance at December 31, 2022110,288 53.99 464,278 50.80 

The fair value of shares vested during the year ended December 31, 2022 was $1.3 million.

96

19. Commitments and Contingencies

Asbestos Contingencies

Certain entities that became subsidiaries of ESAB Corporation in connection with the Separation are the legal obligor for certain asbestos obligations including long-term asbestos insurance assets, long-term asbestos insurance receivables, accrued asbestos liabilities, long-term asbestos liabilities, asbestos indemnity expenses, asbestos-related defense costs and asbestos insurance recoveries related to the asbestos obligations from the Former Parent’s other legacy industrial businesses. As a result, the Company holds certain asbestos-related contingencies and insurance coverages.

These subsidiaries are each one of many defendants in a large number of lawsuits that claim personal injury as a result of exposure to asbestos from products manufactured or used with components that are alleged to have contained asbestos. Such components were acquired from third-party suppliers, and were not manufactured by any of the Company’s, or Former Parent’s, subsidiaries nor were the subsidiaries producers or direct suppliers of asbestos. The manufactured products that are alleged to have contained or used asbestos generally were provided to meet the specifications of the subsidiaries’ customers, including the U.S. Navy. The subsidiaries settle asbestos claims for amounts the Company considers reasonable given the facts and circumstances of each claim. The annual average settlement payment per asbestos claimant has fluctuated during the past several years while the number of cases has steadily declined. The Company expects such fluctuations to continue in the future based upon, among other things, the number and type of claims settled in a particular period and the jurisdictions in which such claims arise. To date, the majority of settled claims have been dismissed for no payment.

The Company has classified asbestos-related activity in Loss from discontinued operations in the Consolidated and Combined Statements of Operations. This is consistent with the Former Parent’s classification on the basis that, pursuant to the purchase agreement from the Former Parent’s Fluid Handling business divestiture, the Former Parent retained its asbestos-related contingencies and insurance coverages. However, as the Former Parent did not retain an interest in the ongoing operations of the business subject to the contingencies, asbestos-related activity was classified as part of Loss from discontinued operations, net of taxes in the Consolidated Statements of Operations of the Former Parent.

The Company has projected each subsidiary’s future asbestos-related liability costs with regard to pending and future unasserted claims based upon the Nicholson methodology. The Nicholson methodology is a standard approach used by experts and has been accepted by numerous courts. Consistent with the Former Parent, it is ESAB’s policy to record a liability for asbestos-related liability costs for the longest period of time that ESAB management can reasonably estimate.

The Company believes that it can reasonably estimate the asbestos-related liability for pending and future claims that will be resolved in the next 15 years and has recorded that liability as its best estimate. While it is reasonably possible that the subsidiaries will incur costs after this period, the Company does not believe the reasonably possible loss or a range of reasonably possible losses is estimable at the current time. Accordingly, no accrual has been recorded for any costs which may be paid after the next 15 years. Defense costs associated with asbestos-related liabilities as well as costs incurred related to efforts to recover insurance from the subsidiaries’ insurers are expensed as incurred.

Each subsidiary has separate insurance coverage acquired prior to Company ownership. The Company estimates the insurance assets for each subsidiary based upon the applicable policy language, expected recoveries and allocation methodologies, and law pertaining to the affected subsidiary’s insurance policies.

97
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
Asbestos-related claims activity since December 31, 2021 is as follows:
Year Ended
December 31, 2022
(Number of claims)
Claims unresolved, beginning of period14,559 
Claims filed(1)
4,338 
Claims resolved(2)
(4,791)
Claims unresolved, end of period14,106 
(In dollars)
Average cost of resolved claims(3)
$10,017 
(1) Claims filed include all asbestos claims for which notification has been received or a file has been opened.
(2) Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based
upon agreements or understandings in place with counsel for the claimants.
(3) Excludes claims settled in Mississippi for which the majority of claims have historically been resolved for no payment and insurance recoveries.

The Company’s Consolidated and Combined Balance Sheet included the following amounts related to asbestos-related litigation:
December 31, 2022
(In thousands)
Long-term asbestos insurance asset(1)
$215,112 
Long-term asbestos insurance receivable(1)
17,231 
Accrued asbestos liability(2)
30,108 
Long-term asbestos liability(3)
230,581 
(1) Included in Other assets in the Consolidated and Combined Balance Sheet.
(2) Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay, and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Consolidated and Combined Balance Sheet.
(3) Included in Other liabilities in the Consolidated and Combined Balance Sheet.

Management’s analyses are based on currently known facts and assumptions. Projecting future events, such as new claims to be filed each year, the average cost of resolving each claim, coverage issues among layers of insurers, the method in which losses will be allocated to the various insurance policies, interpretation of the effect on coverage of various policy terms and limits and their interrelationships, the continuing solvency of various insurance companies, the amount of remaining insurance available, as well as the numerous uncertainties inherent in asbestos litigation could cause the actual liabilities and insurance recoveries to be higher or lower than those projected or recorded which could materially affect the Company’s financial condition, results of operations or cash flow.

General Litigation

The Company is involved in various pending legal proceedings arising out of the ordinary course of the Company’s business. None of these legal proceedings is expected to have a material adverse effect on the financial condition, results of operations or cash flow of the Company. With respect to these proceedings, and the litigation and claims described in the proceeding paragraphs, management of the Company believes that it will either prevail, has adequate insurance coverage or has established appropriate accruals to cover potential liabilities. Legal costs related to proceedings or claims are recorded when incurred. Other costs that management estimates may be paid related to the claims are accrued when the liability is considered probable and the amount can be reasonably estimated. There can be no assurance, however, as to the ultimate outcome of any of these matters, and if all or substantially all of these legal proceedings were to be determined adverse to the Company, there could be a material adverse effect on the financial condition, results of operations or cash flow of the Company.




98
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
Off-Balance Sheet Arrangements

As of December 31, 2022, the Company had $104.8 million of unconditional purchase obligations with suppliers, the majority of which is expected to be paid by December 31, 2023.

20. Segment Information

ESAB is a world leader in fabrication and gas control technology, providing our partners with advanced equipment, consumables, gas control equipment, robotics, and digital solutions, which enable the everyday and extraordinary work that shapes our world. The Company’s products are utilized to solve challenges in a wide range of industries, including cutting, joining and automated welding.

The Company conducts its operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America, and “EMEA & APAC,” which includes Europe, Middle East, India, Africa and Asia Pacific.

The Company’s management evaluates the operating results of each of its reportable segments based upon Net sales and segment Adjusted EBITDA, which represents Operating income excluding the impact of Restructuring and other related charges, separation costs, transaction and integration costs, acquisition-related amortization and other non-cash charges, and depreciation and other amortization.

The Company’s segment results were as follows:
Year Ended December 31,
202220212020
(In thousands)
Net sales(1):
     Americas$1,128,306 $1,004,208 $767,414 
EMEA & APAC1,465,174 1,423,907 1,182,655 
$2,593,480 $2,428,115 $1,950,069 
Adjusted EBITDA(2):
     Americas$188,577 $159,623 $111,588 
EMEA & APAC248,177 244,458 189,558 
$436,754 $404,081 $301,146 
Depreciation, amortization and other impairment charges:
     Americas$29,281 $33,890 $36,380 
EMEA & APAC36,697 42,009 40,264 
$65,978 $75,899 $76,644 
Capital expenditures:
     Americas$18,005 $14,095 $15,244 
EMEA & APAC22,238 21,489 24,894 
$40,243 $35,584 $40,138 
(1) For the years ended December 31, 2022, 2021 and 2020, the total Net sales originating from the United States were $583.0 million, $533.5 million and $443.7 million, respectively. The remainder of the sales were derived from foreign countries.
(2) The following is a reconciliation of Net income from continuing operations to Adjusted EBITDA:
99
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
Year Ended December 31,
202220212020
(In thousands)
Net income from continuing operations$231,081 $238,679 $159,868 
Income tax expense69,170 80,40945,971
Interest expense (income) and other, net (1)
37,950 (29)(1,023)
Pension settlement gain(9,136)(11,208)— 
Restructuring and other related charges
23,096 18,954 21,633 
Separation costs(2)
15,545 2,865 — 
Acquisition - amortization and other related charges(3)
34,196 35,949 36,331 
Depreciation and other amortization34,852 38,462 38,366 
Adjusted EBITDA$436,754 $404,081 $301,146 
(1) Relates to removal of interest expense, net included within the Interest expense (income) and other, net line within the Consolidated and Combined Statements of Operations
(2) Includes non-recurring charges and employee costs related to the planning and execution of the separation from Enovis within the Selling, general and administrative expense line within the Consolidated and Combined Statements of Operations.
(3) Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses.

December 31,
20222021
(In thousands)
Investments in Equity Method Investees:
     Americas$— $— 
     EMEA & APAC28,527 28,180 
$28,527 $28,180 
Total Assets:
     Americas$1,666,799 $1,304,797 
     EMEA & APAC2,087,216 2,156,465 
$3,754,015 $3,461,262 

December 31,
20222021
(In thousands)
Property, Plant and Equipment, Net(1):
United States$68,380 $64,136 
Czech Republic60,278 63,273 
India34,892 37,312 
Russia19,111 18,797 
Mexico17,666 14,720 
Other foreign countries83,899 88,040 
$284,226 $286,278 
(1) As the Company does not allocate all long-lived assets, specifically intangible assets, to each individual country, evaluation of long-lived assets in total is impracticable.









100
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
21. Related Party Transactions

Related Party Agreements

On April 4, 2022, in connection with the Separation, the Company entered into several agreements with Enovis that govern the Separation and provide a framework for the relationship between the parties going forward including a separation and distribution agreement, a transition services agreement, tax matters agreement, employee matters agreements, a stockholder’s and registration rights agreement, an intellectual property matters agreement and a license agreement for Enovis Growth Excellence Business System (“EGX”).

The Separation and Distribution Agreement

The Company entered into a separation and distribution agreement (the “Separation Agreement”) with Enovis immediately prior to the distribution of the Company’s common stock to Enovis stockholders. The Separation Agreement sets forth the Company’s agreements with Enovis regarding the principal actions to be taken in connection with the Separation. The Separation Agreement contains provisions that, among other things, relate to (i) assets, liabilities and contracts to be transferred, assumed and assigned to each of ESAB and Enovis as part of the Separation, (ii) cash distribution made to Enovis in partial consideration of the transfer of ESAB Assets to the Company in connection with the Separation, and (iii) cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of ESAB’s business with ESAB and financial responsibility for the obligations and liabilities of Enovis’s remaining business with Enovis.

Transition Services Agreement

The transition services agreement ("TSA") sets forth the terms and conditions pursuant to which the Company and its subsidiaries and Enovis and its subsidiaries will provide to each other various services. The services to be provided include human resources, payroll, certain information technology services, treasury services and financial reporting services. The charges for the transition services generally are expected to allow the providing company to fully recover all internal and external costs and expenses it actually incurs in connection with providing the service (including a reasonable allocation of overhead) provided in the manner and at a level substantially consistent with that provided by the respective providing company immediately preceding the Distribution Date.

Tax Matters Agreement

The tax matters agreement governs the Company’s and Enovis’s respective rights, responsibilities and obligations after the Separation with respect to tax liabilities and benefits, tax attributes, the preparation and filing of tax returns, the control of audits and other tax proceedings and certain other matters regarding taxes.

Employee Matters Agreement

The employee matters agreement sets forth, among other things, the allocation of assets, liabilities and responsibilities relating to employee compensation and benefit plans and programs and other related matters in connection with the Separation, including the treatment of outstanding equity and other incentive awards and certain retirement and welfare benefit obligations.

Stockholders and Registration Rights Agreement

The stockholders and registration rights agreement sets forth the right of the stockholders when requiring the Company to facilitate the resale of shares.

Intellectual Property Matters Agreement

The intellectual property matters agreement sets forth the terms and conditions pursuant to which Enovis and the Company have mutually granted certain personal, generally irrevocable, non-exclusive, worldwide, and royalty-free rights to use certain intellectual property. The Company and Enovis are able to sublicense their rights in connection with activities relating to their businesses, but not for independent use by third parties.



101
ESAB CORPORATION
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS — (Continued)
EGX License Agreement

The EGX license agreement sets forth the terms and conditions pursuant to which Enovis has granted a royalty-free, non-exclusive, worldwide, and nontransferable license to the Company to use EGX, solely in support of its businesses. The Company will be able to sublicense such license solely to direct and indirect wholly-owned subsidiaries. In addition, under the EGX license agreement, Enovis and the Company each license to each other improvements made by such party to EGX during the first two years of the term of the EGX license agreement.

Allocated Expenses

Prior to the Separation, the Company operated as part of the Former Parent and not as a stand-alone company. Accordingly, the Former Parent allocated certain shared costs to the Company that are reflected as expenses in these financial statements. These amounts included, but were not limited to, items such as general management and executive oversight, compliance, human resources, procurement, and legal functions and financial management, including public company reporting, consolidated tax filings and tax planning. Management considered the allocation methodologies used by the Former Parent to be reasonable and to appropriately reflect the related expenses attributable to the Company for purposes of the three months ended April 1, 2022 and the years ended December 31, 2021, and 2020 combined financial statements; however, the expenses reflected in these financial statements may not be indicative of the actual expenses that would have been incurred during the periods presented if the Company had operated as a separate stand-alone entity. In addition, the expenses reflected in the financial statements may not be indicative of expenses the Company will incur in the future. Allocation methodologies utilized include the Company’s relative share of total Former Parent revenues and headcount.

All of the Company’s transactions with the Former Parent were considered to be financing transactions, which are presented as Transfers from (to) Former Parent, net in the accompanying Consolidated and Combined Statements of Cash Flows.

The Company had no stock-based compensation plans prior to the Separation; however, certain employees of the Company participated in the Former Parent’s stock-based compensation plans, which provided for the grants of stock options and RSUs among other types of awards. The expense associated with the Company's employees who participated in the plans of the Former Parent was allocated to the Company in the accompanying Consolidated and Combined Statements of Operations through the date of Separation.

The Company’s allocated expenses from the Former Parent were $6.0 million for the three months ended April 1, 2022, and $29.5 million and $24.2 million for the years ended December 31, 2021 and 2020, respectively, and are included in the Selling, general and administrative expense in the Consolidated and Combined Statements of Operations. Following the Separation, the company independently incurs expenses as a stand-alone company.

Refer to Note 14, “Benefit Plans,” for allocations of net periodic benefit associated with a Former Parent sponsored benefit plan.

22. Subsequent Events

The dividend of $3.0 million included in Accrued liabilities in the Consolidated Balance Sheet at December 31, 2022 was paid on January 13, 2023, to stockholders of record as of Decembers 30, 2022. In addition, on March 2, 2023, the Board of Directors declared a quarterly cash dividend of $0.05 per share of ESAB’s common stock payable on April 14, 2023, to stockholders of record as of March 31, 2023.

On January 11, 2023, the Company completed the acquisition of Therapy Equipment Limited, a regional leader in oxygen regulators, for approximately $16 million.








102

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.

Item 9A. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, these disclosure controls and procedures were effective.

This Annual Report does not include a report of management’s assessment regarding internal control over financial reporting or an attestation report of our registered public accounting firm due to a transition period established by the rules of the Securities and Exchange Commission for newly public companies.

Changes in Internal Control over Financial Reporting

There have been no changes in the Company’s internal control over financial reporting that have occurred during the most recent completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Item 9B. Other Information

None

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

None

PART III

Item 10. Directors, Executive Officers and Corporate Governance

Information relating to our Executive Officers is set forth in Part I of this Form 10-K under the caption “Information About Our Executive Officers”. Additional information regarding our Directors, Audit Committee and compliance with Section 16(a) of the Exchange Act, if necessary, is incorporated by reference to such information included in our proxy statement for our 2023 annual meeting to be filed with the SEC within 120 days after the end of the fiscal year covered by this Form 10-K (the “2023 Proxy Statement”) under the captions “Election of Directors”, “Board of Directors and its Committees - Audit Committee” and “Delinquent Section 16(a) Reports”.

As part of our system of corporate governance, our Board of Directors has adopted a code of ethics that applies to all employees, including our principal executive officer, our principal financial officer, principal accounting officer or other persons performing similar functions. A copy of the code of ethics is available on the Corporate Governance page of the Investor Relations section of our website at www.esabcorporation.com. We intend to satisfy any disclosure requirement under Item 5.05 of Form 8-K regarding an amendment to, or a waiver from, a provision of our code of ethics by posting such information on our website at the address above.

Item 11. Executive Compensation

Information responsive to this item is incorporated by reference to such information included in our 2023 Proxy Statement under the captions “Executive Compensation,” “Director Compensation,” “Compensation Discussion and Analysis,” “Compensation Committee Report,” and “Compensation Committee Interlocks and Insider Participation.”

103

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Information responsive to this item is incorporated by reference to such information included in our 2023 Proxy Statement under the captions “Beneficial Ownership of Our Common Stock” and “Equity Compensation Plan Information.”

Item 13. Certain Relationships and Related Transactions, and Director Independence

Information responsive to this item is incorporated by reference to such information included in our 2023 Proxy Statement under the captions “Certain Relationships and Related Person Transactions” and “Director Independence.”

Item 14. Principal Accountant Fees and Services

Information responsive to this item is incorporated by reference to such information included in our 2023 Proxy Statement under the captions “Independent Registered Public Accounting Firm Fees and Services” and “Audit Committee’s Pre-Approval Policies and Procedures.”

104

PART IV

Item 15. Exhibits and Financial Statement Schedules

(A)    The following documents are filed as part of this report.

(1) Financial Statements. The financial statements are set forth under “Item 8. Financial Statements and Supplementary Data” of this report on Form 10-K.
(2) Schedules. An index of Exhibits and Schedules begins on page 105
of this report. Schedules other than those listed below have been omitted from this Annual Report because they are not required, are not applicable or the required information is included in the financial statements or the notes thereto.
(3) Exhibits: See exhibits listed under Part (B) below.

(B)    Exhibits.

INDEX TO FINANCIAL STATEMENTS, SUPPLEMENTARY DATA AND FINANCIAL STATEMENT SCHEDULE
Schedule: Page Number in Form 10-K
Valuation and Qualifying Accounts
EXHIBIT INDEX
Exhibit
No.		  
Description		  
Location
Separation and Distribution Agreement, dated April 4, 2022, between Enovis Corporation and ESAB CorporationIncorporated by reference to Exhibit 2.1 to ESAB Corporation’s Form 8-K (File No. 001-41297) as filed with the SEC on April 8, 2022
 Amended and Restated Certificate of Incorporation of ESAB Corporation Incorporated by reference to Exhibit 3.1 to ESAB Corporation’s Form 8-K (File No. 001-41297) as filed with the SEC on April 8, 2022
 Amended and Restated Bylaws of ESAB Corporation Incorporated by reference to Exhibit 3.2 to ESAB Corporation’s Form 8-K (File No. 001-41297) as filed with the SEC on April 8, 2022
 Description of Securities registered under Section 12 of the Exchange Act Filed herewith
 Transition Services Agreement, dated April 4, 2022, between Enovis Corporation and ESAB CorporationIncorporated by reference to Exhibit 10.1 to ESAB Corporation’s Form 8-K (File No. 001-41297) as filed with the SEC on April 8, 2022
 Tax Matters Agreement, dated April 4, 2022, between Enovis Corporation and ESAB Corporation Incorporated by reference to Exhibit 10.2 to ESAB Corporation’s Form 8-K (File No. 001-41297) as filed with the SEC on April 8, 2022
Employee Matters Agreement, dated April 4, 2022, between Enovis Corporation and ESAB CorporationIncorporated by reference to Exhibit 10.3 to ESAB Corporation’s Form 8-K (File No. 001-41297) as filed with the SEC on April 8, 2022
 Intellectual Property Matters Agreement, dated April 4, 2022, between Enovis Corporation and ESAB Corporation Incorporated by reference to Exhibit 10.4 to ESAB Corporation’s Form 8-K (File No. 001-41297) as filed with the SEC on April 8, 2022
EBS License Agreement, dated April 4, 2022, between Enovis Corporation and ESAB CorporationIncorporated by reference to Exhibit 10.5 to ESAB Corporation’s Form 8-K (File No. 001-41297) as filed with the SEC on April 8, 2022
Stockholder’s and Registration Rights Agreement, dated April 4, 2022, between Enovis Corporation and ESAB CorporationIncorporated by reference to Exhibit 10.6 to ESAB Corporation’s Form 8-K (File No. 001-41297) as filed with the SEC on April 8, 2022
105

Registration Rights Agreement, dated March 17, 2022, among ESAB Corporation, Mitchell P. Rales and Steven M. Rales Incorporated by reference to Exhibit 10.7 to ESAB Corporation’s registration statement on Form S-1 (File No. 333-268325) as filed with the SEC on November 14, 2022
 Credit Agreement, dated April 4, 2022, by and among ESAB Corporation, as the lead borrower, the other loan parties from time to time party thereto, including any designated subsidiary borrower party thereto pursuant to the terms thereof and certain subsidiaries of the Company identified therein, as guarantors, each of the lenders from time to time party thereto, Bank of America, N.A., as administrative agent, and the co-syndication agents, joint bookrunners and joint lead arrangers named therein Incorporated by reference to Exhibit 10.7 to ESAB Corporation’s Form 8-K (File No. 001-41297) as filed with the SEC on April 8, 2022
Amendment No. 2 to Credit Agreement, dated June 28, 2022Incorporated by reference to Exhibit 10.1 to ESAB Corporation’s Form 8-K (File No. 001-41297) as filed with the SEC on June 28, 2022
ESAB Corporation 2022 Omnibus Incentive PlanIncorporated by reference to Exhibit 10.8 to ESAB Corporation’s Form 8-K (File No. 001-41297) as filed with the SEC on April 8, 2022
ESAB Corporation Annual Incentive PlanIncorporated by reference to Exhibit 10.9 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
 The ESAB Group, Inc. Excess Benefits Plan Incorporated by reference to Exhibit 10.10 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
 The ESAB Group, Inc. Nonqualified Deferred Compensation Plan Incorporated by reference to Exhibit 10.11 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
 ESAB Corporation Executive Officer Severance Plan Incorporated by reference to Exhibit 10.12 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
 Letter Agreement, effective as of May 15, 2016, between Colfax Corporation and Shyam Kambeyanda Incorporated by reference to Exhibit 10.13 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
 Letter Agreement, dated April 26, 2019, between Colfax Corporation and Kevin Johnson Incorporated by reference to Exhibit 10.14 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
Letter Agreement, dated April 4, 2017, between Colfax Corporation and Olivier BiebuyckIncorporated by reference to Exhibit 10.15 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
Letter Agreement, dated December 17, 2021, between ESAB Corporation and Kevin JohnsonIncorporated by reference to Exhibit 10.17 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
Letter Agreement, dated December 12, 2021, between ESAB Corporation and Olivier BiebuyckIncorporated by reference to Exhibit 10.18 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
Letter Agreement, dated December 10, 2021, between ESAB Corporation and Curtis JewellIncorporated by reference to Exhibit 10.20 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
106

Letter Agreement, dated December 10, 2021, between ESAB Corporation and Michele CampionFiled herewith
Employment Agreement, dated February 21, 2022, between ESAB Corporation and Shyam KambeyandaIncorporated by reference to Exhibit 10.21 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
Form of Change in Control Agreement, effective October 27, 2020 (Colfax)Incorporated by reference to Exhibit 10.22 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
Change in Control Agreement, dated October 30, 2020, between Colfax Corporation and Shyam KambeyandaIncorporated by reference to Exhibit 10.23 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
Form of Change in Control Agreement, effective March 5, 2021 (ESAB)Incorporated by reference to Exhibit 10.24 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
Change in Control Agreement, dated March 5, 2021, between Colfax Corporation and Shyam KambeyandaIncorporated by reference to Exhibit 10.25 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
Change in Control Agreement, dated March 5, 2021, between Colfax Corporation and Olivier BiebuyckIncorporated by reference to Exhibit 10.27 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
 Change in Control Agreement, dated March 5, 2021, between Colfax Corporation and Curtis Jewell Incorporated by reference to Exhibit 10.28 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
Retention Agreement, dated March 5, 2021, between Colfax Corporation and Shyam KambeyandaIncorporated by reference to Exhibit 10.29 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
Form of Retention Agreement, dated March 5, 2021Incorporated by reference to Exhibit 10.30 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
Form of Change in Control Agreement, effective February 17, 2022 (ESAB)Incorporated by reference to Exhibit 10.31 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
Amended and Restated Retention Agreement, dated November 30, 2021, by and between Colfax Corporation and Kevin JohnsonIncorporated by reference to Exhibit 10.32 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
Amended and Restated Retention Agreement, dated November 30, 2021, by and between Colfax Corporation and Olivier BiebuyckIncorporated by reference to Exhibit 10.33 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
Amended and Restated Retention Agreement, dated November 30, 2021, by and between Colfax Corporation and Curtis JewellIncorporated by reference to Exhibit 10.36 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
Amended and Restated Retention Agreement, dated November 30, 2021, by and between Colfax Corporation and Michele CampionFiled herewith
Form of ESAB Corporation Officer Non-Qualified Stock Option AgreementIncorporated by reference to Exhibit 10.38 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
107

 Form of ESAB Corporation Officer Performance Stock Unit Agreement Incorporated by reference to Exhibit 10.39 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
 Form of ESAB Corporation Officer Restricted Stock Unit Agreement Incorporated by reference to Exhibit 10.40 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
Form of ESAB Corporation Outside Director Non-Qualified Stock Option AgreementIncorporated by reference to Exhibit 10.41 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
Form of ESAB Corporation Outside Director Restricted Stock Unit AgreementIncorporated by reference to Exhibit 10.42 to ESAB Corporation’s registration statement on Form 10-12B/A (File No. 001-41297) as filed with the SEC on March 11, 2022
Exhibit
No.		DescriptionLocation
Subsidiaries of the Registrant.Filed herewith
Consent of Ernst & Young LLP.Filed herewith
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934Filed herewith
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002Filed herewith
Certification of Chief Executive Officer, Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002Filed herewith
Certification of Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002Filed herewith
101.INSInline XBRL Instance DocumentFiled herewith
101.SCHInline XBRL Taxonomy Extension Schema DocumentFiled herewith
Exhibit
No.		DescriptionLocation
101.CALInline XBRL Extension Calculation Linkbase DocumentFiled herewith
101.DEFInline XBRL Taxonomy Extension Definition Linkbase DocumentFiled herewith
101.LABInline XBRL Taxonomy Extension Label Linkbase DocumentFiled herewith
101.PREInline XBRL Taxonomy Extension Presentation Linkbase DocumentFiled herewith
104Cover Page Interactive Data File - The cover page from this Annual Report on Form 10-K for the fiscal year ended December 31, 2022 is formatted in Inline XBRL (included as Exhibit 101).Filed herewith

# Indicates management contract or compensatory plan, contract or arrangement.

Item 16. Form 10-K Summary

None.
108
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on March 7, 2023.

                                    ESAB CORPORATION
                                    By: /s/ SHYAM P. KAMBEYANDA
                                     Shyam P. Kambeyanda
                                     President and Chief Executive Officer

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the date indicated.
Date:     March 7, 2023
/s/ SHYAM P. KAMBEYANDA
Shyam P. Kambeyanda
President, Chief Executive Officer and Director
(Principal Executive Officer)
/s/ KEVIN JOHNSON
Kevin Johnson
Chief Financial Officer
(Principal Financial Officer)
/s/ RENATO NEGRO
Renato Negro
 Chief Accounting Officer
(Principal Accounting Officer)
/s/ MITCHELL P. RALES
Mitchell P. Rales
Chairman of the Board
/s/ PATRICK W. ALLENDER
Patrick W. Allender
Director
/s/ MELISSA CUMMINGS
Melissa Cummings
Director
/s/ CHRISTOPHER M. HIX
Christopher M. Hix
Director
/s/ RHONDA L. JORDAN
Rhonda L. Jordan
Director
/s/ ROBERT S. LUTZ
Robert S. Lutz
Director
/s/ STEPHANIE M. PHILLIPPS
Stephanie M. Phillipps
Director
/s/ DIDIER TEIRLINCK
Didier Teirlinck
Director
/s/ RAJIV VINNAKOTA
Rajiv Vinnakota
Director

109

Schedule II - Valuation and Qualifying Accounts
Balance at
Beginning
of Period
Charged to Cost and
Expense (1)
Write-Offs Write-Downs
Deductions and Other(2)
Foreign
Currency
Translation		Balance at
End of
Period
(Dollars in thousands)
Year Ended December 31, 2022:
Allowance for credit losses$23,912 $4,526 $(4,978)$11 $23,471 
Valuation allowance for deferred tax assets15,465 4,503 68,876 (642)88,202 
Year Ended December 31, 2021:
Allowance for credit losses(3)
$32,311 $(494)$(6,931)$(974)$23,912 
Valuation allowance for deferred tax assets12,647 3,738 — (920)15,465 
Year Ended December 31, 2020:
Allowance for credit losses$32,008 $4,936 $(3,448)$(1,185)$32,311 
Valuation allowance for deferred tax assets17,855 — (4,738)(470)12,647 
(1)    Amounts charged to expense are net of recoveries for the respective period.
(2)    As of December 31, 2022, valuation allowance for deferred tax assets “Other” of $68.9 million is primarily due to valuation allowance transferred from Former Parent.
(3)    The Allowance for credit losses as of January 1, 2020 includes the cumulative-effect adjustment of the adoption of ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.



110
 EX-4.1 2 exhibit41-descriptionofsec.htm EX-4.1 Document

EXHIBIT 4.1

Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

ESAB Corporation (the “Company”, “we”, “us” or “our”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): our common stock, $0.001 par value per share (the “common stock”).

The following summary description sets forth some of the general terms and provisions of the common stock. Because this is a summary description, it does not contain all of the information that may be important to you. For a more detailed description of the common stock, you should refer to the provisions of our Amended and Restated Certificate of Incorporation (the “amended and restated certificate of incorporation”) and our Amended and Restated Bylaws (the “amended and restated bylaws”), each of which is an exhibit to the Annual Report on Form 10-K to which this description is an exhibit.

Our authorized capital stock consists of 600,000,000 shares of common stock, $0.001 par value per share, and 20,000,000 shares of preferred stock, $0.001 par value per share.

Common Stock

Subject to the rights of the holders of any series of preferred stock, the holders of shares of common stock are entitled to one vote per share held on all matters submitted to a vote at a meeting of stockholders. Each stockholder may exercise its vote either in person or by proxy. Subject to any preferences to which holders of shares of preferred stock may be entitled, the holders of outstanding shares of common stock are entitled to receive ratably the dividends, if any, as may be declared from time to time by our Board of Directors (our “Board”) out of funds legally available therefor. In the event that we liquidate, dissolve or wind up, the holders of outstanding shares of common stock are entitled to share ratably in all of our assets which are legally available for distribution to stockholders, subject to the prior rights on liquidation of creditors and to preferences, if any, to which holders of shares of preferred stock may be entitled. The holders of outstanding shares of common stock do not have any preemptive, subscription, redemption or sinking fund rights. All outstanding shares of our common stock are duly authorized, validly issued, fully paid and nonassessable.

Preferred Stock

We are authorized to issue up to 20,000,000 shares of preferred stock, in one or more series and containing the rights, privileges and limitations, including dividend rights, voting rights, conversion privileges, redemption rights, liquidation rights or sinking fund rights, as may from time to time be determined by our Board. Preferred stock may be issued in the future in connection with acquisitions, financings or other matters as our Board deems to be appropriate. In the event that any shares of preferred stock shall be issued, a certificate of designations, setting forth the series of the preferred stock and the relative rights, privileges and limitations with respect thereto, is required to be filed with the Secretary of State of the State of Delaware. The effect of having preferred stock authorized is that our Board alone, within the bounds of and subject to the federal securities laws and the Delaware General Corporation Law (“DGCL”), may be able to authorize the issuance of preferred stock, which may adversely affect the voting and other rights of holders of common stock. The issuance of preferred stock may also have the effect of delaying or preventing a change in control of our company.

Anti-Takeover Provisions of the DGCL and our Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws

Delaware General Corporation Law

We are subject to Section 203 of the DGCL, which, with specified exceptions, prohibits a Delaware corporation from engaging in any “business combination” with any “interested stockholder” for a period of three years following the time that the stockholder became an interested stockholder unless:


a.before that time, the Board approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;
b.upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding those shares owned by persons who are directors and also officers and by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or
c.at or after that time, the business combination is approved by the Board and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock that is not owned by the interested stockholder.
Section 203 defines business combination to include the following:
a.any merger or consolidation of the corporation with the interested stockholder;
b.any sale, lease, exchange, mortgage, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder;
c.subject to specified exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;
d.any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; or
e.any receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.
Subject to certain exceptions, an “interested stockholder” is a person who, together with that person’s affiliates and associates, owns, or within the previous three years owned, 15% or more of our voting stock.
The application of Section 203 may make it difficult and expensive for a third party to pursue a takeover attempt we do not approve, even if a change in control would be beneficial to the interests of our stockholders.

Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws Provisions

Director Elections

The Company’s board of directors is divided into three classes. The directors designated as Class I directors have terms expiring at the first annual meeting of stockholders following the distribution, which the Company expects to hold in 2023. The directors designated as Class II directors will have terms expiring at the following year’s annual meeting of stockholders, which the Company expects to hold in 2024, and the directors designated as Class III directors will have terms expiring at the following year’s annual meeting of stockholders, which the Company expects to hold in 2025. The directors serve for a term of three years each. Notwithstanding the foregoing, at the 2024 annual meeting of stockholders, the directors whose terms expire at that meeting shall be elected to hold office for a two-year term and at the 2025 annual meeting of stockholders, the directors whose terms expire at that meeting shall be elected to hold office for a one-year term. Consequently, by 2026, all of our directors will stand for election each year for one year terms, and our board will therefore no longer be divided into three classes. Thereafter each director will serve for a term of one year and until his or her successor is duly elected and qualified, or until his or her earlier resignation or removal.

At any meeting of stockholders for the election of directors at which a quorum is present, the election will be determined by a majority of the votes cast by the stockholders entitled to vote in the election, with directors not receiving a majority of the votes cast required to tender their resignations for consideration by the board, except that in the case of a contested election, the election will be determined by a plurality of the votes cast by the stockholders entitled to vote in the election. Before the board is declassified, it would take at least two elections of directors for any individual or group to gain control of the Company’s board of directors. Accordingly, while the classified board is in effect, these provisions could discourage a third party from initiating a proxy contest, making a tender offer or otherwise attempting to gain control of the Company.





Number of Directors; Removal; Filling Vacancies

Our amended and restated bylaws provide that, subject to any rights of holders of preferred stock to elect additional directors under specified circumstances, the number of directors constituting our entire Board will be fixed from time to time by action of not less than a majority of the directors then in office. Our amended and restated certificate of incorporation provides that prior to the board being fully declassified, stockholders are permitted to remove a director only for cause, and after the board has been fully declassified, stockholders may remove the Company’s directors with or without cause. Removal requires the affirmative vote of a least two-thirds of the Company’s voting stock. In addition, our amended and restated bylaws provides that, subject to any rights of holders of preferred stock, newly created directorships resulting from an increase in the authorized number of directors or vacancies on our Board resulting from death, resignation, retirement, disqualification or removal of directors or any other cause may be filled only by our Board (and not by the stockholders unless there are no directors then in office), provided that a quorum is then in office and present, or by a majority of the directors then in office, if less than a quorum is then in office, or by the sole remaining director. Accordingly, our Board could prevent any stockholder from enlarging the Board and filling the new directorships with that stockholder’s own nominees.

Limitation on Special Meetings; No Stockholder Action by Written Consent

Our amended and restated certificate of incorporation and our amended and restated bylaws provide that (subject to the rights, if any, of holders of any class or series of preferred stock then outstanding) (i) only the chairman of our Board or a majority of our Board is able to call a special meeting of stockholders; (ii) the business permitted to be conducted at a special meeting of stockholders shall be limited to matters properly brought before the meeting by or at the direction of our Board; and (iii) stockholder action may be taken only at a duly called and convened annual or special meeting of stockholders and may not be taken by written consent. These provisions, taken together, prevent stockholders from forcing consideration by the stockholders of stockholder proposals over the opposition of our Board, except at an annual meeting.

Advance Notice Provisions for Stockholder Nominations and Stockholder Proposals

Our amended and restated bylaws establish an advance notice procedure for stockholders to nominate candidates for election as director, or to bring other business before an annual meeting of our stockholders.

This procedure provides that, subject to the rights of any holders of preferred stock, only persons who are nominated by or at the direction of our Board, any committee appointed by our Board, or by a stockholder who has given timely written notice to our secretary prior to the meeting at which directors are to be elected, will be eligible for election as directors. The procedure provides that at an annual meeting only that business may be conducted as has been brought before the meeting by, or at the direction of, our Board, any committee appointed by our Board, or by a stockholder who has given timely written notice to our secretary of the stockholder’s intention to bring that business before the meeting. Under the procedure, to be timely, notice of stockholder nominations or proposals to be made at an annual or special meeting must be received by the secretary at our principal executive offices on or before the deadline determined as specified in the amended and restated bylaws. A stockholder’s notice proposing to nominate a person for election as director must contain specific information about the nominating stockholder and the proposed nominee. A stockholder’s notice relating to the conduct of business other than the nomination of directors must contain specific information about the business and about the proposing stockholder. If the chairman of the Board or other officer presiding at a meeting determines that a person was not nominated, or other business was not brought before the meeting, in accordance with the procedure, the person will not be eligible for election as a director, or the business will not be conducted at the meeting, as the case may be.

Although our amended and restated bylaws do not give our Board any power to approve or disapprove stockholder nominations for the election of directors or proposals for action, the foregoing provisions may have the effect of precluding a contest for the election of directors or the consideration of stockholder proposals and of discouraging or deterring a third party from conducting a solicitation of proxies to elect its own slate of directors or to approve its own proposal, if the proper advance notice procedures are not followed, without regard to whether consideration of the nominees or proposals might be harmful or beneficial to us or our stockholders.
Limitation of Liability of Directors



Our amended and restated bylaws provide that we must indemnify officers and directors against losses that they may incur in investigations and legal proceedings resulting from their services provided to us, which may include services in connection with takeover defense measures. These provisions may have the effect of preventing changes in our management.

Our amended and restated certificate of incorporation contains provisions permitted under Delaware law relating to the liability of directors. These provisions eliminate a director’s personal liability for monetary damages resulting from a breach of fiduciary duty, except in circumstances involving:

a.any breach of the director’s duty of loyalty;
b.acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of the law;
c.payment of dividends or approval of stock repurchases or redemptions that are unlawful under Delaware law; or
d.any transaction from which the director derives an improper personal benefit.
These provisions do not limit or eliminate our rights or any stockholder’s rights to seek non-monetary relief, such as an injunction or rescission, in the event of a breach of director’s fiduciary duty. These provisions do not alter a director’s liability under federal securities laws.

Our amended and restated bylaws require us to indemnify our directors and officers to the fullest extent not prohibited by Delaware law. We may decline to indemnify any director or executive officer in connection with any proceeding initiated by any director or executive officer or any proceeding by any director or executive officer against us or our directors, officers, employees or other agents, unless indemnification is expressly required to be made by law or the proceeding was authorized by our Board.

We have entered into agreements with our directors and certain of our executive officers to give the directors and officers additional contractual assurances regarding the scope of the indemnification set forth in our amended and restated bylaws and to provide additional procedural protections. These indemnification agreements provide that we shall indemnify or advance the indemnitee for expenses, judgments, fines or amounts paid in settlement, as applicable, if they are, by reason of their corporate status as a director or executive officer, (a) made or threatened to be made party to or a participant in any threatened, pending or completed action, suit, claim, counterclaim, cross claim, arbitration, mediation, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding by reason of their actions (or failure to take action); (b) a party or a participant in any proceeding by or in the right of ESAB to procure a judgment in our favor; or (c) a witness, subject to discovery requests or otherwise asked to participate in any proceeding to which they are not a party. The indemnification agreements will terminate upon the later of ten years after the date that the indemnitee ceased serving as our director or officer or one year after the final termination of any pending proceeding for which the indemnitee is granted rights of indemnification or advancement of expenses.

Exclusive Forum

Our amended and restated certificate of incorporation and amended and restated bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware will be the exclusive forum for the following types of actions or proceedings under Delaware statutory or common law: (i) any derivative action or proceeding brought on our behalf; (ii) any action asserting a claim of breach of fiduciary duty owed by any of our directors, officers or stockholders to us or to our stockholders; (iii) any action asserting a claim against us arising pursuant to the DGCL, our amended and restated certificate of incorporation or our amended and restated bylaws (as either may be amended from time to time); and (iv) any action asserting a claim against us that is governed by the internal affairs doctrine. As a result, any action brought by any of our stockholders with regard to any of these matters will need to be filed in the Court of Chancery of the State of Delaware and cannot be filed in any other jurisdiction; provided that, the exclusive forum provision will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction; and provided further that, if and only if the Court of Chancery of the State of Delaware dismisses any such action for lack of subject matter jurisdiction, such action may be brought in another state or federal court sitting in the State of Delaware. Our amended and restated certificate of incorporation and amended and restated bylaws also provide that the federal district courts of the United States of America will be the exclusive forum for the resolution of any complaint asserting a cause or causes of action against us or any defendant arising under the


Securities Act. Such provision is intended to benefit and may be enforced by us, our officers and directors, employees and agents. Nothing in our amended and restated certificate of incorporation and amended and restated bylaws preclude stockholders that assert claims under the Exchange Act from bringing such claims in state or federal court, subject to applicable law.

If any action the subject matter of which is within the scope described above is filed in a court other than a court located within the State of Delaware (a “Foreign Action”) in the name of any stockholder, such stockholder shall be deemed to have consented to the personal jurisdiction of the state and federal courts located within the State of Delaware in connection with any action brought in any such court to enforce the applicable provisions of our amended and restated certificate of incorporation and amended and restated bylaws and having service of process made upon such stockholder in any such action by service upon such stockholder’s counsel in the Foreign Action as agent for such stockholder. Although our amended and restated certificate of incorporation and amended and restated bylaws contain the choice of forum provision described above, it is possible that a court could find that such a provision is inapplicable for a particular claim or action or that such provision is unenforceable.

This choice of forum provision may limit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our directors, officers, other employees or stockholders, which may discourage lawsuits with respect to such claims or make such lawsuits more costly for stockholders, although our stockholders will not be deemed to have waived our compliance with federal securities laws and the rules and regulations thereunder.



 EX-10.21 3 exhibit1021letteragreement.htm EX-10.21 Document

Exhibit 10.21
esabcorplogo.jpg

November 30, 2021


Michele Campion
Via Email

Dear Michele,

As you know, Colfax Corporation announced on March 4, 2021 to separate its ESAB business into a standalone publicly-traded company, whether by distribution of all or the majority of the ESAB business' equity owned by the Company to the Company's shareholders or otherwise (the "Transaction"). Contingent on the consummation of the Transaction, we are very pleased to extend you an employment offer for the position of Chief Human Resources Officer for ESAB Corporation ("ESAB"), reporting to Shyam Kambeyanda, Chief Executive Officer, in ESAB's headquarters at 909 Rose Avenue, Suite 800, North Bethesda, MD 20852.

We are excited about you joining our team as you bring a unique set of skills, experiences and overall talent to our Company. We believe that you will grow and thrive within our organization enabling you to further your career success and grow wealth as you and the Company both continue to prosper together. At ESAB, our values and behaviors are critical to our success. Our core value of Continuous Improvement is our way of life. Continuous improvement is at the heart of who we are. It's in our DNA and it's what makes us great. We know that the power to create better – for our customers, our shareholders and each other – begins with having the best team, united in its pursuits, operating at the highest levels and delivering extraordinary outcomes. We are unique individuals who work together to create sustained performance to the benefit of our customers,associates and the communities where we work.

Date of Employment -We anticipate that you will begin employment on the date of the consummation of the Transaction
Base Salary - Your starting annual salary will be $425,000.00 payable bi-weekly.
Annual Cash Bonus -You will be eligible to participate in our Management Incentive Compensation Plan (MIP) with a target of 65% of your base salary beginning January 1, 2022. The actual MIP payout is based on the achievement of ESAB financial performance against pre-set thresholds, targets, maximums, and your individual performance factor of up to 1.5 times the financial factor. The maximum payout is 250% of target.
Equity Awards -You will be eligible for an equity grant for 2022 in an amount equal to $680,000.00. In subsequent years you will be eligible for equity grants based on your position and performance in accordance with our equity guidelines.The terms and conditions of equity awards will be in accordance with ESAB's 2022 Omnibus Incentive Plan or successor plan.
401(k) -You will have the opportunity to participate in the ESAB 401(k) Savings Plan Plus plan with matching contributions. ESAB matches 100% of the first 4% that you contribute, and these matching contributions vest immediately. In addition, at its discretion, ESAB will make non elective contributions of 2% into your account, vesting immediately.


NQ Deferred Comp - You will have the opportunity to defer up to 50% of base salary and 75% bonus in the non qualified deferred compensation and optimize the company matching contribution above the IRS thresholds in 401(k). ESAB matches 100% of the first 4% that you contribute, and these matching contributions vest immediately. In addition, at its discretion, ESAB will make non-elective contributions of 2% into your account as long as you contribute at least 1% of base salary. These non-elective contributions vest immediately.
Health Benefits -You and your family will be eligible to participate in the health & welfare benefits including medical, dental, vision, short and long-term disability, life and accidental death and dismemberment insurance
Vacation & Holidays - You will be eligible for 20 days of vacation, floating holidays and company-paid holidays.

Michele, we also want to confirm that your employment is "at will". This means that your employment Is for no definite period of time, and either you or the company may terminate your employment at any time, with or without cause or notice. In accordance with ESAB policy, this offer is contingent upon acceptance of the ESAB code of conduct agreement, as well as acceptance of the Confidentiality and Non-Competition Agreement.

It will be an excellent opportunity to work together to take the business to the next level of growth and success!


Sincerely,

Shyam Kambeyanda
Chief Executive Officer

ACKNOWLEGED & ACCEPTED:

/s/ Michele Campion12/10/21
Michele CampionDate


















 EX-10.35 4 exhibit1035amendedandresta.htm EX-10.35 Document

Exhibit 10.35

image.jpg
November 30, 2021

Michele Campion
420 National Business Parkway
5th Floor
Annapolis Junction, MD 20701

Re: Amended and Restated Retention Agreement

Dear Michele:

In light of the strategic decision announce by Colfax Corporation ("Colfax") on March 4, 2021 to separate its ESAB business into a standalone publicly-traded company, whether by distribution of all or the majority of the ESAB business' equity owned by the Company to the Company's shareholders or otherwise (the "Transaction"), Colfax considers your continued services to be essential to protecting and enhancing the best interests of Colfax and its stockholders. For this reason Colfax would like to extend the following offer to you, in order to encourage your continued employment during the period prior to the completion of the Transaction. Except as otherwise provided in this Retention Agreement, your acceptance of this offer (the "Retention Agreement") shall rescind and replace all prior and contemporaneous understandings, discussions, agreements, representations, and warranties, both written and oral, with respect to any retention payment or benefit, including the previous Retention Agreement dated March 5, 2021; provided, however, that this Retention Agreement shall not supersede any other agreements between Colfax and you, and any employment letter, severance agreement, change in control agreement, and/or restrictive covenant agreement to which you and Colfax are a party shall remain in full force and effect. Further, this Retention Agreement does not supersede or effect your ability for benefits under any severance plan.

1. Retention Bonus. Subject to the conditions set forth below, you will be eligible for a retention bonus pursuant to either paragraph l(a) or paragraph l(b).

a.     In the event that (i) the Transaction is not consummated on or before the End Date, and (ii) you remain employed with Colfax or a Successor through the End Date, subject to the conditions provided in this Retention Agreement, then you shall receive a payment of $472,400.00 (your "Retention Bonus"), less applicable withholdings, to be paid in a lump-sum on the first regular payroll following the End Date (the "Payment Date"), subject to any applicable requirements of Internal Revenue Code §409A.

b.     In the event that the Transaction is consummated prior to the End Date and you remain employed with Colfax, a Successor or the Spin Company through the twelve (12) month anniversary of the consummation of the Transaction (the "Spin Retention Date"), subject to the conditions provided in this Retention Agreement, then you shall receive a payment of $324,450.00 (your "Spin Retention Bonus"), less applicable withholdings, to be paid in a lump-sum on the first regular payroll following the six (6) month anniversary of the consummation of the Transaction (the "Spin Payment Date"), subject to any applicable requirements of Internal Revenue Code §409A. However, in the event that you receive the Spin Retention Bonus but, prior to the Spin Retention Date, (y) your employment is terminated by you without Good Reason or (z) Colfax, Successor, or the Spin Company terminates your employment for Cause, then you will be required to repay fifty percent (50%) of the Spin Retention Bonus, less applicable withholdings (the "Repayment Amount") to Colfax, Successor or Spin Company, within thirty (30) days following your separation from employment with Colfax, Successor or Spin Company. You agree that Colfax, Successor or Spin Company may deduct the Repayment Amount from any compensation or expenses owed to you.




2.     Payment of Retention Bonus or Spin Retention Bonus Upon Termination. In the event that, prior to the End Date or Spin Payment Date, (a) your employment is terminated with mutual consent by Colfax, a Successor, or the Spin Company, (b) your employment is terminated by you with Good Reason after the consummation of the Transaction, (c) Colfax, a Successor, or the Spin Company terminates your employment without Cause, or (d) upon your death, then Colfax, a Successor, or the Spin Company shall pay you (or your estate) the Retention Bonus or the Spin Retention Bonus if the Transaction has been consummated, less applicable withholdings, to be paid in a lump-sum within sixty (60) days following your separation from employment. The payment of the Retention Bonus or the Spin Retention Bonus pursuant to this paragraph 2 shall be subject to and conditioned upon you (or your estate) delivering to Colfax, a Successor, or the Spin Company an executed copy of a general release of any and all claims you may have against Colfax, a Successor and the Spin Company, their successors, assigns, affiliates, employees, officers, and directors, in form and substance satisfactory to Colfax, a Successor or the Spin Company (the “Release”). The revocation period required by applicable law expiring without your revocation of the Release, and the Release becoming effective, enforceable, and irrevocable in accordance with its terms on or before the 60th day after the date of termination of employment.

3.    Equity. In connection with the Transaction and in accordance with the agreements related thereto, all outstanding awards of Colfax equity held by you will be adjusted in accordance with the terms of the applicable long-term incentive compensation plan and applicable law. In the event that (a) your employment is terminated with mutual consent by Colfax, a Successor or the Spin Company, (b) you terminate your employment with Good Reason after the Transaction, (c) Colfax, a Successor, or the Spin Company terminates your employment without Cause, or (d) upon your death, then, subject to your execution and non-revocation of a Release, all unvested NonQualified Stock Options and unvested Restricted Stock Units will immediately become one hundred percent (100%) vested.

4.     Early Termination Provisions. You further understand that this Retention Agreement shall immediately terminate (an "Early Termination without a Retention Benefit"), and Colfax, a Successor, or the Spin Company shall be relieved of any obligation to provide the Retention Bonus or the Spin Retention Bonus to you or your estate if any of the following occurs prior to the Payment Date or the Spin Payment Date:

i.you voluntarily terminate your employment with Colfax, Successor or Spin Company without mutual consent by Colfax, Successor or Spin Company or without Good Reason that occurs after the date of the Transaction;
ii.your employment is terminated by Colfax, a Successor or the Spin Company as a result of your refusal to accept employment in a new or different position with Colfax, a Successor or the Spin Company as a result of your refusal to accept employment in a new or different position with Colfax a Successor or the Spin Company, except if such change in position would give rise to you having Good Reason to terminate your employment that occurs after the date of the Transaction;
iii.you violate the confidentiality provisions contained in this Retention Agreement; or
iv.Colfax, or Successor or the Spin Company terminates your employment for Cause.

5.     Termination of Retention Agreement. The Retention Agreement shall terminate on the earlier of (i) the twelve (12) month anniversary of the date the Transaction is consummated; (ii)    the date on which an Early Termination without a Retention Benefit occurs; or (iii) if the Transaction has not been consummated prior to the End Date, the End Date; provided, however, that the confidentiality provisions of this Retention Agreement and any obligations on the part of Colfax or the Spin Company which arise under this Retention Agreement, or triggered under this Retention Agreement on the date of its termination, shall survive the termination of this Retention Agreement.

6.     Assignment. You understand and agree that Colfax shall assign this Retention Agreement to any successor in interest to Colfax, whether by merger, reorganization, acquisition, sale or otherwise, to which you become employed (a ''Successor''), and thereby require such Successor to expressly assume and agree to perform this Retention Agreement. You also understand and agree that Colfax shall assign this Retention Agreement to the Spin Company upon the consummation of the Transaction, and thereby require Spin Company to expressly assume and agree to perform this Retention Agreement.

7.     Employment. This Retention Agreement does not, in any way, constitute a contract or agreement guaranteeing your continued employment. Colfax reserves the right to terminate your employment at any time, with or without Cause or notice.



8.     Confidentiality. You agree that you shall keep the terms of this Retention Agreement completely confidential, and that you shall not disclose any information concerning this Retention Agreement to anyone except your immediate family, financial advisor and/or attorney, each of whom shall be required to agree in advance to keep this information confidential and not disclose it to others.

9.     Change in Control Agreement. You agree that for purposes of any Change in Control Agreement to which you are a party with Colfax, a ''Change in Control'' as defined in such agreement shall not be deemed to have occurred by virtue of the consummation of the Transaction and such Change in Control Agreement will remain in effect in accordance with its terms after consummation of the Transaction.

10.     Modification. This Retention Agreement may be modified or amended only by a writing signed by both parties.

11.     Governing Law. This Retention Agreement shall be governed by, and construed in accordance with, the substantive laws of the State of Delaware, without regard to principles of conflicts of laws, except to the extent governed by federal law in which case federal law shall govern.

12.     Definitions. For purposes of this Retention Agreement, the term:

''Cause'' means you shall have committed: (i) an intentional act of fraud, embezzlement or theft in connection with your duties or in the course of your employment with Colfax, a Successor, or the Spin Company· (ii) intentional wrongful damage to property of Colfax, a Successor, or the Spin Company; (iii) intentional wrongful disclosure of secret processes or confidential information of Colfax, a Successor, or the Spin Company; (iv) an act or omission resulting in conviction of a criminal offense (other than minor traffic offenses); (v) intentional wrongful engagement in any competitive activity which would constitute a material breach of the duty of loyalty; or (vi) any such act which shall have been materially harmful to Colfax, a Successor, or the Spin Company taken as a whole.

“End Date” shall mean December 31, 2022.

''Good Reason'' shall be defined as (i) a material reduction in the nature or scope of the responsibilities or duties attached to the position or positions with Colfax which you held immediately prior to entering into this Retention Agreement (which will not include any new position with the Spin Company), a material reduction in the aggregate of your base salary and incentive pay opportunity to which you were entitled immediately prior to entering into this Retention Agreement or the termination of your rights to any material employee benefits to which you were entitled immediately prior to the entering into this Retention Agreement or a material reduction in scope or value thereof without your prior written consent; (ii) Colfax, a Successor or the Spin Company (whichever you are employed by) shall relocate its principal executive offices, or Colfax, a Successor, or the Spin Company shall require you to have your assigned principal location of work changed, to any location which shall be in excess of fifty (50) miles from the location thereof immediately prior to entering into this Retention Agreement or Colfax, a Successor, or the Spin Company shall require you to travel away from your office in the course of discharging your responsibilities or duties significantly more (in terms of either consecutive days or aggregate days in any calendar year) than was required of you prior to you entering into this Retention Agreement without, in either case, your prior written consent; or (iii) without limiting the generality of or the effect of the foregoing, any material breach of this Retention Agreement by Colfax, a Successor, or the Spin Company; provided, that Good Reason shall not exist unless and until you provide Colfax, a Successor, or the Spin Company with written notice of the act(s) alleged to constitute Good Reason within thirty (30) calendar days of the occurrence of such act(s) and describing such act(s) in reasonably sufficient detail to allow Colfax, a Successor, or the Spin Company to cure the act(s), and Colfax, a Successor, or the Spin Company fails to cure such act(s) within thirty (30) calendar days of receipt of such notice. Further, you must then exercise your right to terminate your employment for Good Reason within sixty (60) calendar days thereafter, in order for the termination to be for Good Reason.

''Spin Company'' shall mean the standalone publicly traded company created for the fabrication technology business division under the ESAB brand pursuant to the completion of the transaction announced by Colfax on March 4, 2021.

If you agree with the foregoing, please sign and date this Retention Agreement in the space provided for your signature, and return a signed copy to Patricia Lang prior to November __ , 2021.



We look forward to your continued employment with Colfax.


Sincerely,
Colfax Corporation
By:/s/ Mathew L Trerotola
Name: Matthew L. Trerotola
Title:President and Chief Executive Officer

Agreed to and accepted by:

/s/ Michele Campion
Name: Michele Campion







 EX-21.1 5 exhibit211listofsubsidiari.htm EX-21.1 Document

Exhibit 21.1
ESAB Corporation
Subsidiaries of the Registrant
Entity NameCountry
Agridzaar LimitedCyprus
Airgare LimitedUnited Kingdom
Arc Machines GmbHGermany
AS ESABNorway
Canadian Cylinder Company Ltd.Canada
CAST LimitedUnited Kingdom
CAST Resources LimitedUnited Kingdom
Central Mining Finance LimitedUnited Kingdom
Charter Central Finance LimitedUnited Kingdom
Charter Central Services LimitedUnited Kingdom
Charter Consolidated Holdings LimitedUnited Kingdom
Charter Consolidated LimitedUnited Kingdom
Charter Finance S.a.r.l.Luxembourg
Charter International LimitedJersey
Charter LimitedUnited Kingdom
Charter Overseas Holdings LimitedUnited Kingdom
Charter Pension Trustee LimitedUnited Kingdom
Cigweld Pty Ltd.Australia
CLFX Sweden CVNetherlands
Colfax (Wuxi) Pump Company LimitedChina
Colfax Fluid Handling Finance LimitedIreland
Colfax Jersey Finance LimitedJersey
Colfax UK Finance LimitedUnited Kingdom
Colfax UK Holdings LimitedUnited Kingdom
Comercializadora Thermadyne S. de R.L. de C.V.Mexico
Conarco Alambres y Soldaduras SAArgentina
Condor Equipamentos Industriais LtdaBrazil
EMSA Holdings Inc.United States
ESAB ABSweden
ESAB ApSDenmark
ESAB Asia/Pacific Pte.Ltd.Singapore
ESAB Bulgaria EADBulgaria
ESAB CentroAmerica SAPanama
ESAB Comercio e Industria de Soldadura LdaPortugal
ESAB CorporationUnited States
ESAB CZ, s.r.o. člen koncernuCzech Republic
ESAB Europe GmbHSwitzerland
ESAB Finance Holdings LimitedUnited Kingdom
ESAB Finance Holdings LLCUnited States
ESAB France SASFrance
ESAB GCE Holdings ABSweden
ESAB Gesellschaft m.b.H.Austria
ESAB Group (Ireland) LimitedIreland
ESAB Group (UK) LimitedUnited Kingdom
ESAB Group Canada Inc.Canada
ESAB Group Russia LimitedUnited Kingdom
ESAB Holdings LimitedUnited Kingdom


ESAB Iberica, S.A.U.Spain
ESAB India LimitedIndia
ESAB Industria e Comercio LtdaBrazil
ESAB International Holdings LLCUnited States
ESAB Kazakhstan LLCKazakhstan
ESAB Kft.Hungary
ESAB Limited (Thailand)Thailand
ESAB Limited Liability CompanyRussian Federation
ESAB Mexico SA de CVMexico
ESAB Mexico Services SA de CVMexico
ESAB Middle East FZEUnited Arab Emirates
ESAB Middle East LLCUnited Arab Emirates
ESAB Nederland B.V.Netherlands
ESAB Pensions LimitedUnited Kingdom
ESAB Polska Sp. z.o.o.Poland
ESAB Romania Trading SRLRomania
ESAB Saldatura SpAItaly
ESAB SAUDI TRADING COMPANYSaudi Arabia
ESAB SeAH CorporationKorea, Republic Of
ESAB SeAH Welding Products (Yantai) Co. LimitedChina
ESAB Slovakia sroSlovakia
ESAB Sp. z.o.o.Poland
ESAB Sweden Holdings ABSweden
ESAB Ukraine LLCUkraine
ESAB VAMBERK, s.r.o., člen koncernuCzech Republic
ESAB Welding & Cutting GmbHGermany
ESAB Welding & Cutting Products (Shanghai) Management Company LimitedChina
ESAB Welding Products (Jiangsu) Co LimitedChina
ESAB-Mor Welding KftHungary
Evrador Trading LimitedCyprus
EWAC Alloys LimitedIndia
Exelvia (Bermuda) LimitedBermuda
Exelvia CompanyUnited Kingdom
Exelvia Cyprus LimitedCyprus
Exelvia Group India BVNetherlands
Exelvia Holding LimitadaBrazil
Exelvia Holdings BVNetherlands
Exelvia International Holdings BVNetherlands
Exelvia Investments LimitedUnited Kingdom
Exelvia Netherlands BVNetherlands
Exelvia Properties LimitedUnited Kingdom
Gas Control Equipment Iberica S.L.Spain
Gas Control Equipment LimitedUnited Kingdom
Gas-Arc Group LimitedUnited Kingdom
GCE Gas Control Equipment (Shanghai) Co., Ltd.China
GCE Gas Control Equipment Co., Ltd.China
GCE Gas Control Equipment S.A. de C.V.Mexico
GCE Gas Control Equipment, Inc.United States
GCE GmbHGermany
GCE Group ABSweden


GCE Hungaria Kft.Hungary
GCE India Private Ltd.India
GCE Krass LLCRussian Federation
GCE Latin America SAPanama
GCE Mujelli S.p.A.Italy
GCE Norden ABSweden
GCE Portugal Unipessoal LDAPortugal
GCE Romania s.r.l.Romania
GCE S.A.S.France
GCE Sp. z.o.o.Poland
GCE Technology (Shanghai) Co. Ltd.China
GCE, s.r.o.Czech Republic
H UK Engineering LimitedUnited Kingdom
HE Deutschland Holdings GmbHGermany
HKS-Prozesstechnik GmbHGermany
Hobart Place Investments LimitedUnited Kingdom
Howden North America Inc.United States
HTP Beteiligungs AGSwitzerland
Imo Holdings, Inc.United States
Imo Industries Inc.United States
Jinan Red Hawk International Trading Co., Ltd.China
MT FOREIGN HOLDINGS, INC.United States
NV E.S.A.B.Belgium
Ohio Medical, LLCUnited States
Oxiprof LLCRussian Federation
Oy ESABFinland
OZAS-ESAB Sp. z o.o.Poland
PT Karya Yasantara CaktiIndonesia
PT Victor Teknologi IndonesiaIndonesia
Shawebone Holdings Inc.United States
SIAM ESAB Welding & Cutting LimitedThailand
Soldaduras West Arco S.A.S.Colombia
Soldex Holdings I LLCUnited States
Soldex S.A.Peru
Swift-Cut Automation LimitedUnited Kingdom
Swift-Cut Automation USA, Inc.United States
Swift-Cut Europe BVNetherlands
TBI Industries GmbHGermany
TBI Industries s.r.o.Czech Republic
TBI Shandong Industries Co., Ltd.China
The British South Africa CompanyUnited Kingdom
The Central Mining & Investment Corporation LimitedUnited Kingdom
The ESAB Group Inc.United States
Therapy Equipment LimitedUnited Kingdom
Thermadyne Brazil Holdings Ltd.Cayman Islands
Thermadyne de Mexico S.A. de C.V.Mexico
Thermadyne South America Holdings Ltd.Cayman Islands
Thermadyne Victor Ltda.Brazil
Thermal Dynamics Europe SrlItaly
Victor Equipment CompanyUnited States


Victor Equipment de Mexico S.A. de C.V.Mexico
Victor Technologies Asia SDN BHDMalaysia
Victor Technologies Australia Pty Ltd.Australia
Victor Technologies Canada Ltd.Canada
Victor Technologies Group, Inc.United States
Victor Technologies Holdings, Inc.United States
Victor Technologies International, Inc.United States
Warren Pumps LLCUnited States
Welding & Cutting Products LLCUnited States
Weldnote LDAPortugal

 EX-23.1 6 exhibit231consentofindepen.htm EX-23.1 Document

Exhibit 23.1
Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statement:

(1) Registration Statement (Form S-8 No. 333-264047) pertaining to the ESAB Corporation 2022 Omnibus Incentive Plan and The ESAB Group, Inc. 401(k) Retirement Savings Plan

of our report dated March 7, 2023, with respect to the consolidated and combined financial statements and schedule of ESAB Corporation included in this Annual Report (Form 10-K) of ESAB Corporation for the year ended December 31, 2022.

/s/ Ernst & Young LLP

Baltimore, Maryland
March 7, 2023

 EX-31.1 7 exhibit3101ceocertificatio.htm EX-31.1 Document

Exhibit 31.01
CERTIFICATIONS
I, Shyam P. Kambeyanda, certify that:
1.I have reviewed this annual report on Form 10-K of ESAB Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 (a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 (b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 (c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 (d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 (a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 (b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: March 7, 2023
/s/ Shyam P. Kambeyanda
Shyam P. Kambeyanda
President and Chief Executive Officer
(Principal Executive Officer)

 EX-31.2 8 exhibit3102cfocertificatio.htm EX-31.2 Document

Exhibit 31.02
CERTIFICATIONS
I, Kevin Johnson, certify that:
1.I have reviewed this annual report on Form 10-K of ESAB Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 (a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 (b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 (c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 (d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 (a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 (b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: March 7, 2023
/s/ Kevin Johnson
Kevin Johnson
Chief Financial Officer
(Principal Financial Officer)


 EX-32.1 9 exhibit3201ceocertificatio.htm EX-32.1 Document

Exhibit 32.01

Certification Pursuant to 18 U.S.C. Section 1350
(as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002)

I, Shyam P. Kambeyanda, as President and Chief Executive Officer of ESAB Corporation (the “Company”), certify, pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), that to my knowledge:

1.the annual report on Form 10-K of the Company for the period ended December 31, 2022 (the "Report"), filed with the U.S. Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: March 7, 2023
/s/ Shyam P. Kambeyanda
Shyam P. Kambeyanda
President and Chief Executive Officer
(Principal Executive Officer)


 EX-32.2 10 exhibit3202cfocertificatio.htm EX-32.2 Document

Exhibit 32.02

Certification Pursuant to 18 U.S.C. Section 1350
(as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002)
I, Kevin Johnson, as Executive Vice President, Finance, Chief Financial Officer of ESAB Corporation (the “Company”), certify, pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), that to my knowledge:

1.the annual report on Form 10-K of the Company for the period ended December 31, 2022 (the "Report"), filed with the U.S. Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: March 7, 2023
/s/ Kevin Johnson
Kevin Johnson
Chief Financial Officer
(Principal Financial Officer)


 EX-101.SCH 11 cfx-20221231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - COVER PAGE link:presentationLink link:calculationLink link:definitionLink 0000002 - Document - AUDIT INFORMATION link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME [Parenthetical] link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONSOLIDATED AND COMBINED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - CONSOLIDATED AND COMBINED BALANCE SHEETS [Parenthetical] link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF EQUITY link:presentationLink link:calculationLink link:definitionLink 0000009 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF EQUITY [Parenthetical] link:presentationLink link:calculationLink link:definitionLink 0000010 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Organization and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Recently Issued Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Discontinued Operations link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Earnings per Share from Continuing Operations link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Property, Plant and Equipment, Net link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Inventories, Net link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Accrued and Other Liabilities link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Benefit Plans link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Derivatives link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 0000033 - Disclosure - Schedule II - Valuation and Qualifying Accounts link:presentationLink link:calculationLink link:definitionLink 0000034 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 0000035 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 0000036 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 0000037 - Disclosure - Earnings per Share from Continuing Operations (Tables) link:presentationLink link:calculationLink link:definitionLink 0000038 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 0000039 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 0000040 - Disclosure - Property, Plant and Equipment, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 0000041 - Disclosure - Inventories, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 0000042 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 0000043 - Disclosure - Accrued and Other Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 0000044 - Disclosure - Benefit Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 0000045 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 0000046 - Disclosure - Derivatives (Tables) link:presentationLink link:calculationLink link:definitionLink 0000047 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 0000048 - Disclosure - Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 0000049 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 0000050 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 0000051 - Disclosure - Organization and Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 0000052 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000053 - Disclosure - Summary of Significant Accounting Policies - Net Foreign Transaction Gains and Losses (Details) link:presentationLink link:calculationLink link:definitionLink 0000054 - Disclosure - Discontinued Operations - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000055 - Disclosure - Acquisitions - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000056 - Disclosure - Revenue - Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 0000057 - Disclosure - Revenue - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000058 - Disclosure - Revenue - Allowance for Credit Loss Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 0000059 - Disclosure - Earnings per Share from Continuing Operations (Details) link:presentationLink link:calculationLink link:definitionLink 0000060 - Disclosure - Income Taxes - Components of Income Before Taxes and Income Tax Expense (Details) link:presentationLink link:calculationLink link:definitionLink 0000061 - Disclosure - Income Taxes - Effective Income Tax Rate Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 0000062 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000063 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities Balance Sheet Items (Details) link:presentationLink link:calculationLink link:definitionLink 0000064 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000065 - Disclosure - Income Taxes - Gross Unrecognized Tax Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 0000066 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 0000067 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000068 - Disclosure - Goodwill and Intangible Assets - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000069 - Disclosure - Goodwill and Intangible Assets - Expected Amortization Expense (Details ) link:presentationLink link:calculationLink link:definitionLink 0000070 - Disclosure - Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 0000071 - Disclosure - Property, Plant and Equipment, Net - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000072 - Disclosure - Inventories, Net (Details) link:presentationLink link:calculationLink link:definitionLink 0000073 - Disclosure - Leases (Details) link:presentationLink link:calculationLink link:definitionLink 0000073 - Disclosure - Leases (Details) link:presentationLink link:calculationLink link:definitionLink 0000074 - Disclosure - Accrued and Other Liabilities - Current and Noncurrent (Details) link:presentationLink link:calculationLink link:definitionLink 0000075 - Disclosure - Accrued and Other Liabilities - Warranty Liability Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 0000076 - Disclosure - Accrued and Other Liabilities - Restructuring Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 0000077 - Disclosure - Benefit Plans - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000078 - Disclosure - Benefit Plans - Obligation and Asset Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 0000079 - Disclosure - Benefit Plans - Expected Benefit Payments (Details) link:presentationLink link:calculationLink link:definitionLink 0000080 - Disclosure - Benefit Plans - Plan Asset Allocation (Details) link:presentationLink link:calculationLink link:definitionLink 0000081 - Disclosure - Benefit Plans - Plan Asset Allocation, Fair Value Hierarchy (Details) link:presentationLink link:calculationLink link:definitionLink 0000082 - Disclosure - Benefit Plans - Net Periodic Benefit Cost (Details) link:presentationLink link:calculationLink link:definitionLink 0000083 - Disclosure - Benefit Plans - Accumulated Other Comprehensive Income (Details) link:presentationLink link:calculationLink link:definitionLink 0000084 - Disclosure - Benefit Plans - Key Economic Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 0000085 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 0000086 - Disclosure - Debt - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000087 - Disclosure - Debt - Schedule of Debt Maturities (Details) link:presentationLink link:calculationLink link:definitionLink 0000088 - Disclosure - Derivatives - Narratives (Details) link:presentationLink link:calculationLink link:definitionLink 0000089 - Disclosure - Derivatives - Summary of the Effects of Designated Cash Flow Hedges on the Company’s Consolidated and Combined Statements of Operations (Details) link:presentationLink link:calculationLink link:definitionLink 0000090 - Disclosure - Derivatives - Schedule of Fair Values of Derivative Instruments in the Financial Statements (Details) link:presentationLink link:calculationLink link:definitionLink 0000091 - Disclosure - Derivatives - Not Designated as Hedging Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 0000092 - Disclosure - Fair Value Measurements - Fair Value Hierarchy (Details) link:presentationLink link:calculationLink link:definitionLink 0000093 - Disclosure - Equity - Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 0000094 - Disclosure - Equity - Narratives (Details) link:presentationLink link:calculationLink link:definitionLink 0000095 - Disclosure - Equity - PRSU and RSU Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000096 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000097 - Disclosure - Commitments and Contingencies - Claims Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 0000098 - Disclosure - Commitments and Contingencies - Asbestos Litigation (Details) link:presentationLink link:calculationLink link:definitionLink 0000099 - Disclosure - Segment Information - Narratives (Details) link:presentationLink link:calculationLink link:definitionLink 0000100 - Disclosure - Segment Information - Segment Reporting Information, by Segment (Details) link:presentationLink link:calculationLink link:definitionLink 0000101 - Disclosure - Segment Information - Net Sales and PPE by Geography (Details) link:presentationLink link:calculationLink link:definitionLink 0000102 - Disclosure - Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 0000103 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink 0000104 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 12 cfx-20221231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 13 cfx-20221231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 14 cfx-20221231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Geographic Concentration Risk Geographic Concentration Risk [Member] Business Acquisition [Axis] Business Acquisition [Axis] Foreign Current Foreign Tax Expense (Benefit) Foreign Currency Exchange Gains and Losses Foreign Currency Transactions and Translations Policy [Policy Text Block] Claims unresolved, beginning of period Claims unresolved, end of period Loss Contingency, Pending Claims, Number Related Party Transactions [Abstract] Other assets Deferred Income Tax Assets, Net Total debt Long-term debt Long-Term Debt, Gross Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Deferred: Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Debt Instrument [Axis] Debt Instrument [Axis] Schedule of Indefinite-Lived Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Property, plant and equipment, gross Property, Plant and Equipment, Gross Cross currency swap agreements Foreign Exchange Contract [Member] Additional paid-in capital Additional Paid in Capital Basis spread on variable rate (as a percent) Debt Instrument, Basis Spread on Variable Rate Depreciation and other amortization Depreciation Intangible Assets Schedule [Table] Schedule of Indefinite-Lived Intangible Assets [Table] Operating leases Operating Lease, Weighted Average Discount Rate, Percent Schedule of Long-Lived Assets, by Geographical Areas Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Schedule of Net Foreign Transaction Gains and Losses Derivative Instruments, Gain (Loss) [Table Text Block] State Current State and Local Tax Expense (Benefit) Settlements Defined Benefit Plan, Plan Assets, Payment for Settlement Equity securities: Defined Benefit Plan, Equity Securities [Member] Future lease payments by year: Lessee, Operating Lease, Liability, to be Paid [Abstract] Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five U.S. U.S. Equity Securities [Member] U.S. Equity Securities [Member] Cash used in operating activities, discontinued operations Cash Provided by (Used in) Operating Activities, Discontinued Operations Equity Component [Domain] Equity Component [Domain] Asbestos liability Loss Contingency, Accrual, Noncurrent Subsequent Event Type [Domain] Subsequent Event Type [Domain] Term loans Secured Debt [Member] Ownership [Axis] Ownership [Axis] Addition for tax positions taken in the current period Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Schedule of Income Tax Contingencies Summary of Income Tax Contingencies [Table Text Block] Related Party [Domain] Related Party [Domain] Schedule Of Loss Contingencies By Claims Quantities Schedule Of Loss Contingencies By Claims Quantities [Table Text Block] Tabular disclosure of the rollforward of asbestos claims activity during the year, including claims filed and resolved. Hedging Designation [Domain] Hedging Designation [Domain] Transfer from Former Parent Fair value of plan assets, beginning of year Fair value of plan assets, end of year Defined Benefit Plan, Plan Assets, Amount Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Supplemental disclosures: Supplemental Cash Flow Information [Abstract] Valuation Allowance by Deferred Tax Asset [Axis] Valuation Allowance by Deferred Tax Asset [Axis] Entity Address, State or Province Entity Address, State or Province Undistributed foreign earnings Deferred Tax Liabilities, Undistributed Foreign Earnings Other comprehensive (loss) income: Other Comprehensive Income (Loss), Net of Tax [Abstract] Therapy Equipment Limited Therapy Equipment Limited [Member] Therapy Equipment Limited Warranty liability Product Warranty Accrual, Noncurrent Award Type [Axis] Award Type [Axis] Actuarial gain Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) 2027 Defined Benefit Plan, Expected Future Benefit Payment, Year Five Reductions related to settlements with taxing authorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Transfer from Former Parent Defined Benefit Plan, Benefit Obligation, Transfer From Former Parent Defined Benefit Plan, Benefit Obligation, Transfer From Former Parent Total recognized in Other comprehensive (gain) loss Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Lease liability Operating Lease, Liability, Current SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] Increase in valuation allowance Valuation Allowance, Deferred Tax Asset, Increase, Amount Swing Line Loan Sub-Facility Bridge Loan [Member] All Currencies [Domain] All Currencies [Domain] Long-term debt Long-Term Debt, Excluding Current Maturities Total liabilities Liabilities Auditor Information [Abstract] Auditor Information Operating leases Operating Lease, Weighted Average Remaining Lease Term Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Schedule of Expected Benefit Payments Schedule of Expected Benefit Payments [Table Text Block] Schedule of Changes in Projected Benefit Obligations Schedule of Changes in Projected Benefit Obligations [Table Text Block] Cost of warranty service work performed Standard and Extended Product Warranty Accrual, Decrease for Payments Current year prior service cost Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax Entity Common Stock Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Number of shares recapitalized (in shares) Conversion of Stock, Shares Converted Revolving credit facilities Revolving Credit Facility [Member] Asbestos liability Accrued asbestos liability Loss Contingency, Accrual, Current Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Current: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Document Type Document Type Depreciable Life Property, Plant and Equipment, Useful Life Components of Net Periodic Benefit (Income) Cost: Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract] Assets: Assets, Fair Value Disclosure [Abstract] Capital gain Effective Income Tax Rate Reconciliation, Disposition of Asset, Amount Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Separation costs Severance Costs Weighted-average grant date fair value, nonvested, beginning balance (in usd per share) Weighted-average grant date fair value, nonvested, ending balance (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Provision to return Income Tax Reconciliation, Income Tax Expense Provision To Return Income Tax Reconciliation, Income Tax Expense Provision To Return Decrease in valuation allowance Valuation Allowance, Deferred Tax Asset, Decrease, Amount Deferred Income Tax Deferred Income Tax Expense (Benefit) Non-current assets Assets for Plan Benefits, Defined Benefit Plan Income Tax Examination [Table] Income Tax Examination [Table] Former Parent Former Parent [Member] Former Parent Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Write-Offs and Deductions Accounts Receivable, Allowance for Credit Loss, Writeoff Debt Disclosure [Abstract] Debt Disclosure [Abstract] International International Equity Securities [Member] International member Income Statement Location [Axis] Income Statement Location [Axis] Employer contributions Defined Benefit Plan, Plan Assets, Contributions by Employer Accrued liabilities Accrued liabilities Accrued Liabilities, Current Restructuring liability Restructuring Reserve, Noncurrent Computation of earnings per share from continuing operations - basic: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Accounting Policies [Abstract] Line of Credit Line of Credit [Member] Plans with accumulated benefit obligations in excess of plan assets, fair value of plan assets Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Loss on Net Investment Hedges Accumulated Gain (Loss), Net Investment Hedges, Parent [Member] Accumulated Gain (Loss), Net Investment Hedges, Parent Interest cost Defined Benefit Plan, Interest Cost Third-party commissions Accrued Sales Commission, Current Related Party Transaction [Line Items] Related Party Transaction [Line Items] Schedule of Derivative Instruments in Statement of Financial Position, Fair Value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Schedule of Components of Income Tax Expense (Benefit) Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Unrecognized compensation cost, period for recognition (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Cash consideration Payments to Acquire Businesses, Gross Derivative Contract [Domain] Derivative Contract [Domain] Gross profit Gross Profit Entity Registrant Name Entity Registrant Name 2026 Defined Benefit Plan, Expected Future Benefit Payment, Year Four Subsequent Events Subsequent Events [Text Block] Benefits paid Defined Benefit Plan, Benefit Obligation, Benefits Paid Leases [Abstract] Leases [Abstract] Total equity Beginning balance Ending balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Net operating loss carryforward Deferred Tax Assets, Operating Loss Carryforwards Separation from Enovis and Principles of Consolidation Consolidation, Policy [Policy Text Block] Insurance contracts Defined Benefit Plan, Insurance Contracts [Member] Defined Benefit Plan, Insurance Contracts Transfer from Former Parent, impact of foreign currency translation and other Unrecognized Tax Benefits, Decrease Resulting From Transfer from Former Parent, Impact Of Foreign Currency Translation And Other Unrecognized Tax Benefits, Decrease Resulting From Transfer from Former Parent, Impact Of Foreign Currency Translation And Other Minimum Minimum [Member] Entity Emerging Growth Company Entity Emerging Growth Company Non-cash interest expense Non-Cash Interest Expense Non-Cash Interest Expense Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Less amounts included in net periodic benefit cost: Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax [Abstract] Accrued and Other Liabilities Accrued Liabilities Disclosure [Text Block] The entire disclosure for the accrued liabilities during the reporting period. Loss on discontinued operations (in dollars per share) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] Income Tax Examination [Line Items] Income Tax Examination [Line Items] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Trading Symbol Trading Symbol Entity File Number Entity File Number Other Liabilities Other Liabilities [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Four Accrued Liabilities [Abstract] Accrued Liabilities [Abstract] Percentage of outstanding stock after spin-off (as a percent) Sale of Stock, Percentage of Ownership after Transaction Less: comprehensive income attributable to noncontrolling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Foreign Deferred Foreign Income Tax Expense (Benefit) Expenses currently not deductible Deferred Tax Assets, Tax Deferred Expense, Other Derivatives Derivatives, Policy [Policy Text Block] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Expected employer contributions in the next fiscal year Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year Use of Estimates Use of Estimates, Policy [Policy Text Block] Acquisitions Business Combination Disclosure [Text Block] Raw materials Inventory, Raw Materials, Gross Accounts payable Increase (Decrease) in Accounts Payable Concentration risk (as a percent) Concentration Risk, Percentage Settlements Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement Income Taxes Income Tax Disclosure [Text Block] Credit Facility [Domain] Credit Facility [Domain] Total intangible assets Intangible Assets, Gross (Excluding Goodwill) Net income per share (in dollars per share) Earnings Per Share, Basic Settlement/divestiture/other gain Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax Fair value of vested shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Awards converted from Former Parent plan (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Awards Converted From Former Parent, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Awards Converted From Former Parent, Weighted Average Grant Date Fair Value Loss related to interest rate swap agreements Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax Distributions to noncontrolling interest holders Payments to Noncontrolling Interests Transfer from Former Parent Other Comprehensive (Income) Loss, Transfer from Former Parent, before Tax Other Comprehensive (Income) Loss, Transfer from Former Parent, before Tax Deferred compensation plans Deferred Compensation Liability, Current and Noncurrent Indefinite-lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Prepaid expenses Prepaid Expense, Current Current year net actuarial (gain) loss Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax Ownership [Domain] Ownership [Domain] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Transfer from Former Parent Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan Entity Interactive Data Current Entity Interactive Data Current Number of defined benefit plans Number Of Defined Benefit Plans Number Of Defined Benefit Plans Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Transferred From Former Parent Transferred From Former Parent [Member] Transferred From Former Parent Interest (income) expense and other, net Other Nonoperating Income (Expense) [Member] Net current period Other comprehensive (loss) income Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Common stock-based award activity Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Other comprehensive (loss) income before reclassifications OCI, before Reclassifications, Net of Tax, Attributable to Parent Class of Stock [Axis] Class of Stock [Axis] Income Taxes Income Tax, Policy [Policy Text Block] Other comprehensive income (loss) before reclassifications: OCI, Before Reclassifications, Net Of Tax, Attributable To Parent [Abstract] OCI, Before Reclassifications, Net Of Tax, Attributable To Parent Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Axis] Discontinued Operations and Disposal Groups [Abstract] CURRENT ASSETS: Assets, Current [Abstract] Unrecognized tax (benefits), income tax penalties and interest expense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Long-term asbestos insurance asset Loss Contingency, Receivable, Current Retained earnings Retained Earnings (Accumulated Deficit) Pension settlement gain Pension settlement gain Pension settlement gain Pension settlement gain Settlement gain Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement Scenario [Domain] Scenario [Domain] Number of shares sold (in shares) Sale Of Stock By Non-Controlling Interest, Number Of Shares Sold Sale Of Stock By Non-Controlling Interest, Number Of Shares Sold Related Party Transactions Related Party Transactions Disclosure [Text Block] Income from continuing operations before income taxes: Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract] Transfers from (to) Former Parent, net Transfers To (From) Parent, Net Transfers To (From) Parent, Net Document Fiscal Year Focus Document Fiscal Year Focus Foreign Plan Foreign Plan [Member] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Proceeds from borrowings on term credit facility Proceeds from Issuance of Other Long-Term Debt Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Recently Issued Accounting Pronouncements Accounting Standards Update and Change in Accounting Principle [Text Block] Current income tax Current Income Tax Expense (Benefit) Impairment of Long-Lived Assets Other than Goodwill and Indefinite-Lived Intangible Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Capital expenditures: Payments to Acquire Productive Assets Enovis Corporation Enovis Corporation [Member] Enovis Corporation Non cash charges Non Cash Impairment Restructuring Provisions The aggregate amount of impairment charges recognized during the period as a result of restructuring activities. Inventories, net Increase (Decrease) in Inventories Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Inventories, gross Inventory, Gross Goodwill Balance beginning of period Balance end of period Goodwill Movement in Standard Product Warranty Accrual [Roll Forward] Movement in Standard Product Warranty Accrual [Roll Forward] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Actual return on plan assets Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) Award performance period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period Income tax expense Income tax expense Income Tax Expense (Benefit) Geographical [Domain] Geographical [Domain] Other liabilities Accrued taxes and deferred tax liabilities Deferred Income Tax Liabilities, Net Valuation allowance Valuation allowance Deferred Tax Assets, Valuation Allowance EMEA & APAC EMEA & APAC EMEA and APAC Segment [Member] EMEA and APAC Segment Hedging Relationship [Axis] Hedging Relationship [Axis] Entity Public Float Entity Public Float Balance Sheet Location [Domain] Balance Sheet Location [Domain] Cost of sales Cost of Goods and Services Sold Derivative liabilities Derivative Liability Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Other Liabilities Derivative Liability, Subject to Master Netting Arrangement, before Offset 2023 Defined Benefit Plan, Expected Future Benefit Payment, Year One Accounts Receivable, Allowance for Credit Loss [Roll Forward] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Common stock - $0.001 par value - Authorized 600,000,000; 60,094,725 and 100 shares outstanding as of December 31, 2022 and December 31, 2021, respectively Common Stock, Value, Issued Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Interest expense (income) and Other, Net Interest Expense, Policy [Policy Text Block] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Accrued warranty expense Standard and Extended Product Warranty Accrual, Increase for Warranties Issued Senior Notes Senior Notes [Member] Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Current liabilities Liability, Defined Benefit Plan, Current Plans with accumulated benefit obligations in excess of plan assets, accumulated benefit obligation Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation U.S. government and corporate US Government Agencies Debt Securities and Corporate Debt Securities [Member] US Government Agencies Debt Securities and Corporate Debt Securities Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Foreign currency translation, net of tax (benefit) expense of $(2,930), $740 and $(1,598) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Foreign operations Income (Loss) from Continuing Operations before Income Taxes, Foreign CURRENT LIABILITIES: Liabilities, Current [Abstract] Other Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Contract liability Contract with Customer, Liability, Current Retirement Plan Type [Domain] Retirement Plan Type [Domain] Income Statement Location [Domain] Income Statement Location [Domain] Amendment Flag Amendment Flag Basis spread on variable rate (as a percent) Derivative, Basis Spread on Variable Rate Intangible asset, useful life (in years) Finite-Lived Intangible Asset, Useful Life Operating lease expense Operating Lease, Cost Investment Type [Axis] Investment Type [Axis] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Other comprehensive (loss) income Other comprehensive (loss) income Other Comprehensive Income (Loss), Net of Tax Goodwill attributable to acquisition Goodwill, Acquired During Period Restructuring liability Restructuring Reserve, Current Schedule of Amounts Recognized in Other Comprehensive Income (Loss) Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Other assets Other Assets, Noncurrent Depreciation, amortization and other impairment charges: Depreciation, Depletion and Amortization Counterparty Name [Axis] Counterparty Name [Axis] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Unamortized deferred financing fees Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net State Deferred Federal, State and Local, Tax Expense (Benefit) Number of derivative instruments held Derivative, Number of Instruments Held Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Former Parent’s Investment Former Parent Investment [Member] Former Parent Investment Currency [Axis] Currency [Axis] Option Share-Based Payment Arrangement, Option [Member] Domestic Plan Domestic Plan [Member] Long-term Debt Long-Term Debt [Member] Defined benefit pension and other post-retirement plan activity, net of tax benefit of $1,840, $1,192 and $367 Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Allowance for credit losses Balance at Beginning of Period Balance at End of Period Accounts Receivable, Allowance for Credit Loss, Current Common stock, authorized (in shares) Common Stock, Shares Authorized Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Cash tax benefit Effective Income Tax Rate Reconciliation, Business Combination, Expected Tax Deductible Amount Effective Income Tax Rate Reconciliation, Business Combination, Expected Tax Deductible Amount Maximum Maximum [Member] Equipment Equipment Products [Member] Equipment Products [Member] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Work in process Inventory, Work in Process, Gross Fiscal Period Fiscal Period, Policy [Policy Text Block] Designated as Hedging Instrument Designated as Hedging Instrument [Member] Weighted-average remaining lease term (in years): Weighted Average Remaining Lease Term [Abstract] Weighted Average Remaining Lease Term [Abstract] Business Acquisition [Line Items] Business Acquisition [Line Items] Unrealized gain on cash flow hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent Schedule of Net Benefit Costs Schedule of Net Benefit Costs [Table Text Block] Software Computer Software, Intangible Asset [Member] U.S. large cap Defined Benefit Plan, Equity Securities, US, Large Cap [Member] Actual asset allocation Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage Intangible Assets Schedule [Line Items] Intangible Assets Schedule [Line Items] [Line Items] for Intangible Assets Schedule [Table] Trade receivables, net Increase (Decrease) in Accounts Receivable Title of 12(b) Security Title of 12(b) Security Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Organization and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Fixed income Fixed Income Securities [Member] Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Subsequent Event [Line Items] Subsequent Event [Line Items] Schedule of Assumptions Used Defined Benefit Plan, Assumptions [Table Text Block] Segment Information Segment Reporting Disclosure [Text Block] Selling, general and administrative expense Selling, General and Administrative Expenses [Member] Total deferred tax liabilities, net Total deferred tax liabilities, net Deferred Tax Liabilities, Net LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Benefit Plans Defined Benefit Plan [Text Block] Inventories, net Inventories, net Inventory, Net Accounts payable Accounts Payable, Current Income Tax Authority [Axis] Income Tax Authority [Axis] Other Other Accrued Liabilities, Noncurrent Long-term asbestos insurance receivable Loss Contingency, Receivable, Noncurrent Income from continuing operations (in dollars per share) Income per share from continuing operations – basic (in dollars per share) Income (Loss) from Continuing Operations, Per Basic Share Americas Americas Business Segment [Member] Americas Business Segment Weighted-average shares of common stock outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Change in plan assets: Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] Defined Benefit Plan, Funding Status [Axis] Defined Benefit Plan, Funding Status [Axis] Notional amount Derivative, Notional Amount Weighted-average annual rate of increase (as a percent) Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year Net Transfers from Former Parent, including Separation Adjustments Net Transfers From (To) Former Parent, Including Separation Adjustments Net Transfers From (To) Former Parent, Including Separation Adjustments Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Allocated expenses Costs and Expenses, Related Party Short-Term Debt, Type [Domain] Short-Term Debt, Type [Domain] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Level Three Fair Value, Inputs, Level 3 [Member] Permanent differences, net Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount Foreign exchange effect Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss) Consideration to Former Parent in connection with the Separation Payments To Former Parent, Consideration Transferred Payments To Former Parent, Consideration Transferred Noncontrolling Interest Noncontrolling Interest [Member] Debt term (in days) Debt Instrument, Term Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Related Party [Axis] Related Party [Axis] Goodwill [Roll Forward] Goodwill [Roll Forward] Repayments of borrowings on revolving credit facility and other Repayments of Long-Term Lines of Credit Land Land [Member] Earnings (loss) per share - diluted Computation of earnings (loss) per share from continuing operations - diluted: Earnings Per Share, Diluted [Abstract] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Withholding taxes Effective Income Tax Rate Reconciliation, Withholding Taxes, Amount Effective Income Tax Rate Reconciliation, Withholding Taxes, Amount Disposal Group Name [Domain] Disposal Group Name [Domain] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Acquisitions, net of cash received Cash consideration, net Payments to Acquire Businesses, Net of Cash Acquired Level Two Fair Value, Inputs, Level 2 [Member] Debt Issuance Costs Debt, Policy [Policy Text Block] Current Fiscal Year End Date Current Fiscal Year End Date Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Loss (gain) on sale of property, plant and equipment Gain (Loss) on Disposition of Property Plant Equipment Concentration Risk Type [Axis] Concentration Risk Type [Axis] Total current liabilities Liabilities, Current Average cost of resolved claims Loss Contingency Average Cost Resolved Claims Average cost of asbestos claims resolved excluding claims settled in Mississippi for which the majority of claims have historically been resolved for no payment. Schedule of Net Periodic Benefit Cost Not yet Recognized Schedule of Net Periodic Benefit Cost Not yet Recognized [Table Text Block] U.S. small/mid cap Defined Benefit Plan, Equity Securities, US, Mid/Small Cap [Member] US small to mid-cap securities. Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Net operating loss carryforward, subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration Discontinued Operations Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Maximum total leverage ratio Debt Instrument, Covenant, Leverage Ratio, Maximum Debt Instrument, Covenant, Leverage Ratio, Maximum Maximum term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Less: distributed and undistributed earnings allocated to nonvested shares Participating Securities, Distributed and Undistributed Earnings (Loss), Basic Schedule of Derivative Instruments Schedule of Derivative Instruments [Table Text Block] Revenue from Contract with Customer Benchmark Revenue from Contract with Customer Benchmark [Member] Changes in tax reserves Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount Income Tax Authority [Domain] Income Tax Authority [Domain] Future claims period (in years) Future Claims Period Period for which the Company believes it can reasonably estimate the asbestos-related liability for pending and future claims that will be resolved. Valuation allowance on deferred taxes Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Foreign Currency Translation Restructuring Reserve, Foreign Currency Translation Gain (Loss) Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Line of credit facility, remaining borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Derivative Instruments and Hedging Activities Disclosure [Abstract] Credit Facility [Axis] Credit Facility [Axis] Reserve for excess and obsolete inventory Less: allowance for excess, slow-moving and obsolete inventory Inventory Valuation Reserves Equity [Abstract] Equity [Abstract] Subsequent Event [Table] Subsequent Event [Table] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Entity Tax Identification Number Entity Tax Identification Number Schedule of Nonvested Share Activity Schedule of Nonvested Share Activity [Table Text Block] Fixed interest rate Derivative, Fixed Interest Rate Foreign Currency Translation SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment Net actuarial loss (gain) Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax Amounts contributed by Former Parent Other Comprehensive Income (Loss), Net of Tax, Contributions from Parent Other Comprehensive Income (Loss), Net of Tax, Contributions from Parent Schedule of Effective Income Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Increase (decrease) in Cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Other Defined Benefit Plan, Other Assets [Member] State taxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Interest income and other, net Investment Income, Nonoperating Entity Central Index Key Entity Central Index Key Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Purchase price Business Combination, Consideration Transferred Entity [Domain] Entity [Domain] City Area Code City Area Code ASSETS Assets [Abstract] Other operating assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net Unconditional purchase obligation Purchase Obligation Total Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position Decrease in noncontrolling interest Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest Weighted-average interest rate (as a percent) Long-Term Debt, Weighted Average Interest Rate, at Point in Time 2023 Long-Term Debt, Maturity, Year One Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Variable Rate [Axis] Variable Rate [Axis] Other liabilities Total accrued and other liabilities, Noncurrent Other Liabilities, Noncurrent Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment 2023 Finite-Lived Intangible Asset, Expected Amortization, Year One Change in benefit obligation: Projected benefit obligation, beginning of year Projected benefit obligation, end of year Defined Benefit Plan, Benefit Obligation Schedule of Earnings Per Share from Continuing Operations Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Other Post-Retirement Benefits Other Postretirement Benefits Plan [Member] Changes in estimates related to pre-existing warranties Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Weighted-average rate of increase in compensation levels for active foreign plans, net periodic benefit cost Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase Total Lessee, Operating Lease, Liability, to be Paid Net income Net income Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Plans with projected benefit obligations in excess of plan assets, projected benefit obligation Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation Entity Address, Postal Zip Code Entity Address, Postal Zip Code EMEA & APAC EMEA & APAC Business Segment [Member] EMEA & APAC Business Segment 2024 Long-Term Debt, Maturity, Year Two Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Other Defined Benefit Plan, Other Fixed Income Mutual Funds [Member] Defined Benefit Plan, Other Fixed Income Mutual Funds Effect of U.S. taxation on international operations Effective Income Tax Rate Reconciliation, GILTI, FDII And SubPart F of Foreign Tax Credits, Amount Effective Income Tax Rate Reconciliation, GILTI, FDII And SubPart F of Foreign Tax Credits, Amount Plan amendments Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment Former Parent Common stock-based award activity Shares Issued, Value, Share-Based Payment Arrangement with Former Parent Company Shares Issued, Value, Share-Based Payment Arrangement with Former Parent Company Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Write-Offs Write-Downs Deductions and Other SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction Balance at Beginning of Period Balance at End of Period Restructuring Reserve Net actuarial gain (loss) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Deferred Compensation Plan Assets Deferred Compensation Plan Assets Schedule Of Asbestos Related Litigation Schedule Of Asbestos Related Litigation [Table Text Block] Tabular disclosure of the presentation of asbestos litigation on the statement of financial position, including the amounts and location of such amounts. Range [Domain] Statistical Measurement [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Short-Term Debt, Type [Axis] Short-Term Debt, Type [Axis] Reductions resulting from a lapse of applicable statute of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Net periodic benefit (income) cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Net income attributable to ESAB Corporation Net income Net Income (Loss) Attributable to Parent Other intangible assets Other Intangible Assets [Member] Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Schedule of the Contractual Maturities of the Company's Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Weighted-average rate of increase in compensation levels for active foreign plans Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase Scenario [Axis] Scenario [Axis] Total assets at fair value Assets, Fair Value Disclosure Valuation Allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Leases Lessee, Operating Leases [Text Block] Depreciation and amortization Deferred Tax Asset, Property Plant and Equipment and Goodwill and Intangible Assets Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from depreciation and amortization. Asbestos Related Activity Asbestos Related Activity [Member] Asbestos Related Activity Income from continuing operations (in dollars per share) Income per share from continuing operations – assuming dilution (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Derivative Instrument [Axis] Derivative Instrument [Axis] Goodwill [Line Items] Goodwill [Line Items] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Level One Fair Value, Inputs, Level 1 [Member] Prior service (income) cost Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Repatriation of foreign earnings Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount Income from continuing operations attributable to ESAB Corporation Net Income (Loss) from Continuing Operations Attributable to Parent Net Income (Loss) from Continuing Operations Attributable to Parent Derivative Asset Derivative Asset Property, Plant and Equipment Property, Plant and Equipment [Member] ESAB Corporation ESAB Corporation [Member] ESAB Corporation Acquisition - amortization and other related charges Amortization of Acquired Intangible Assets and Acquisition Costs Amortization of Acquired Intangible Assets and Acquisition Costs Document Annual Report Document Annual Report Legal Entity [Axis] Legal Entity [Axis] Other Defined Benefit Plan, Other Cost (Credit) Loss recognized in the Consolidated and Combined Statements of Operations: Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Geographical [Axis] Geographical [Axis] Non-current liabilities Liability, Defined Benefit Plan, Noncurrent Technology Technology-Based Intangible Assets [Member] Schedule of Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Loss on discontinued operations (in dollars per share) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share Number of Units Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Schedule of Change in Accounting Estimate [Table] Schedule of Change in Accounting Estimate [Table] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] 2025 Defined Benefit Plan, Expected Future Benefit Payment, Year Three Restructuring Cost and Reserve [Axis] Restructuring Type [Axis] Swift Cut Automation Limited Swift Cut Automation Limited [Member] Swift Cut Automation Limited Business Segments [Axis] Segments [Axis] Debt Debt Disclosure [Text Block] Product and Service [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company Interest expense (income) and other, net Interest Expense (Income) And Other, Net [Member] Interest Expense (Income) And Other, Net Schedule of Allocation of Plan Assets Schedule of Allocation of Plan Assets [Table Text Block] Concentration Risk [Table] Concentration Risk [Table] 2023 Lessee, Operating Lease, Liability, to be Paid, Year One Weighted-average discount rate: Leases, Weighted Average Discount Rate [Abstract] Leases, Weighted Average Discount Rate [Abstract] 2025 Long-Term Debt, Maturity, Year Three Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] Former Partner Affiliated Entity [Member] Subsequent Event Subsequent Event [Member] Document Period End Date Document Period End Date Warranty liability Product Warranty Accrual, Current Amortization of prior service cost Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Schedule of Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Total assets Total Assets: Assets Earnings Per Share [Abstract] Earnings Per Share [Abstract] PRSUs Performance Shares [Member] Interest rate swap agreements Interest Rate Swap [Member] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] 2027 Lessee, Operating Lease, Liability, to be Paid, Year Five Amounts reclassified from Accumulated other comprehensive loss Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent Compensation and related benefits Employee-related Liabilities, Current Interest expense (income) and other, net Interest Expense (Income) and Other, Net Interest Expense (Income) and Other, Net Income from continuing operations before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Segments [Domain] Segments [Domain] Deferred income tax Deferred Income Taxes and Tax Credits Members' Equity, Transfers to (from) Parent, Net Members' Equity, Transfers To (From) Parent, Net Members' Equity, Transfers To (From) Parent, Net Schedule of Goodwill [Table] Schedule of Goodwill [Table] Earnings per Share from Continuing Operations Earnings Per Share [Text Block] Outside basis differences and other Deferred Tax Liabilities, Other Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Comprehensive income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Equity Award [Domain] Award Type [Domain] Deferred tax liability, increase (decrease) Deferred Tax Liabilities, Undistributed Foreign Earnings, Increase (Decrease) In Liability From Prior Year Deferred Tax Liabilities, Undistributed Foreign Earnings, Increase (Decrease) In Liability From Prior Year Trade Receivables Receivable [Policy Text Block] Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block] Finished goods Inventory, Finished Goods, Gross Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Impact of foreign currency translation Goodwill, Foreign Currency Translation Gain (Loss) Other foreign countries Other Foreign Countries [Member] Other Foreign Countries Foreign Currency Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Customer relationships Customer Relationships [Member] Entity Address, City or Town Entity Address, City or Town Czech Republic CZECHIA Gain on Cash Flow Hedges Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Foreign exchange effect Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) 2028 - 2032 Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years Noncontrolling interest Stockholders' Equity Attributable to Noncontrolling Interest Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Other Defined Benefit Plan, Plan Assets, Period Increase (Decrease) Change in unrealized gains Unrealized Gain (Loss) on Derivatives Unamortized deferred financing fees Debt Issuance Costs, Net Schedule of Segment Reporting Information [Table] Schedule of Segment Reporting Information, by Segment [Table] Auditor Name Auditor Name Pension Benefits Pension Plan [Member] Operating loss carryforwards Operating Loss Carryforwards Contract liability Contract with Customer, Liability, Noncurrent Research and development costs Research and Development Expense Addition for tax positions taken in prior periods Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Measured at Net Asset Value Fair Value Measured at Net Asset Value Per Share [Member] Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Issuance of common stock in connection with the Separation and reclassification of Net Investment from Former Parent (in shares) Issuance of Common Stock, Shares, Separation and Reclassification of Net Investment from Former Parent Issuance of Common Stock, Shares, Separation and Reclassification of Net Investment from Former Parent RSUs Restricted Stock Units (RSUs) [Member] Research and development tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Net sales Revenues Subsequent Events [Abstract] Subsequent Events [Abstract] Unrealized gain on derivatives designated and qualifying as cash flow hedges, net of tax expense of $3,240 Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Warranty liability, beginning of period Warranty liability, end of period Standard and Extended Product Warranty Accrual Net income from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Percentage of inventory valued at LIFO Percentage of LIFO Inventory Amortization expense Amortization of Intangible Assets Schedule of Goodwill Schedule of Goodwill [Table Text Block] Interest payments, net Interest Paid, Excluding Capitalized Interest, Operating Activities International Defined Benefit Plan, Equity Securities, Non-US [Member] 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Uncommitted Credit Line Uncommitted Credit Line [Member] Uncommitted Credit Line Other Assets Other Assets [Member] Net Unrecognized Pension and Other Post-Retirement Benefit Cost Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Plans with projected benefit obligations in excess of plan assets, fair value of plan assets Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets Depreciation and amortization Deferred Tax Liabilities, Property Plant and Equipment and Goodwill and Intangible Assets Amount of deferred tax consequences attributable to taxable temporary differences derived from depreciation and amortization. Inventories Inventory, Policy [Policy Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Counterparty Name [Domain] Counterparty Name [Domain] Total ESAB Corporation equity Stockholders' Equity Attributable to Parent Stockholders' Equity Attributable to Parent Derivatives Derivative Instruments and Hedging Activities Disclosure [Text Block] Forfeited and expired (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Dividends declared ($0.15 per share) Dividends, Common Stock Tax credit carryforward Deferred Tax Assets, Tax Credit Carryforwards Other Deferred Tax Assets, Other Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Deferred Tax Asset [Domain] Deferred Tax Asset [Domain] Equity Shareholders' Equity and Share-Based Payments [Text Block] India INDIA 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Three 2027 Long-Term Debt, Maturity, Year Five Payment of dividends Dividends paid Payments of Dividends Retained Earnings Retained Earnings [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Common Stock Common Stock [Member] Number of reportable segments Number of Reportable Segments Statement [Table] Statement [Table] Vested (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Letter of Credit Letter of Credit [Member] Lease liability Operating Lease, Liability, Noncurrent Net actuarial gain (loss) Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent Defined contribution plan, cost Defined Contribution Plan, Cost Range [Axis] Statistical Measurement [Axis] Payment of deferred consideration Payment for Contingent Consideration Liability, Financing Activities Disposal Group Name [Axis] Disposal Group Name [Axis] Trade receivables, less allowance for credit losses of $23,471 and $23,912 Accounts Receivable, after Allowance for Credit Loss, Current Equity Components [Axis] Equity Components [Axis] Weighted- Average Grant-Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value, Amount Per Share [Abstract] Statement [Line Items] Statement [Line Items] Number of units, nonvested, beginning balance (in shares) Number of units, nonvested, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Variable Rate [Domain] Variable Rate [Domain] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Selling, general and administrative expense Selling, General and Administrative Expense Former Parent's investment Former Parent Investment Former Parent Investment Lease asset - right of use Operating Lease, Right-of-Use Asset Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Auditor Firm ID Auditor Firm ID Type of Restructuring [Domain] Type of Restructuring [Domain] Document Transition Report Document Transition Report 2024 Defined Benefit Plan, Expected Future Benefit Payment, Year Two Foreign Tax Authority Foreign Tax Authority [Member] Local Phone Number Local Phone Number Operating income Operating Income (Loss) Inventory Deferred Tax Assets, Inventory Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Consumables Consumable Products [Member] Consumable Products [Member] Charges Restructuring, Settlement And Impairment Provisions Before Non-Cash Charges The aggregate amount provided for estimated restructuring charges, remediation costs, before non-cash asset impairment charges during an accounting period. Generally, these items are either unusual or infrequent, but not both (in which case they would be extraordinary items). Income tax benefit Discontinued Operation, Tax Effect of Discontinued Operation Total liabilities at fair value Liabilities, Fair Value Disclosure Amortization of net (gain) loss Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax Indefinite-Lived Intangible Assets Indefinite-Lived Intangible Assets Acquired Effect of tax rates on international operations Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Non-taxable dividends Effective Income Tax Rate Reconciliation, Deduction, Dividends, Amount Property, Plant and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Schedule of Product Warranty Liability Schedule of Product Warranty Liability [Table Text Block] 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four Income Statement [Abstract] Income Statement [Abstract] Federal Deferred Federal Income Tax Expense (Benefit) Additional Paid in Capital Additional Paid-in Capital [Member] Document Fiscal Period Focus Document Fiscal Period Focus Earnings (loss) per share - basic Earnings Per Share, Basic [Abstract] Weighted-average shares of common stock outstanding - assuming dilution (in shares) Weighted Average Number of Shares Outstanding, Diluted Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Ohio Medical, LLC, Ohio Medical, LLC, [Member] Ohio Medical, LLC, Buildings and improvements Building and Building Improvements [Member] ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Base Rate Base Rate [Member] Granted (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Schedule of Assets and Liabilities Measured at Fair Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Post-retirement benefit obligation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits Less: Income attributable to noncontrolling interest, net of taxes Income attributable to noncontrolling interest, net of taxes Net Income (Loss) Attributable to Noncontrolling Interest Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Net Income (Loss) Available to Common Stockholders Net Income (Loss) Available to Common Stockholders, Basic Indebtedness incurred Proceeds from Issuance of Long-Term Debt Investments in Equity Method Investees: Equity Method Investments Concentration Risk [Line Items] Concentration Risk [Line Items] Unrealized gain on derivatives designated and qualifying as cash flow hedges, net of tax expense Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax The Credit Agreement The Credit Agreement [Member] The Credit Agreement Foreign currency transaction loss (gain), net Foreign Currency Transaction Gain (Loss), before Tax Cash Flow Hedging Cash Flow Hedging [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Facility Closure Costs Facility Closing [Member] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Principal amount Debt Instrument, Face Amount Claims filed Loss Contingency, New Claims Filed, Number Proceeds from borrowings on revolving credit facility and other Proceeds from Long-Term Lines of Credit Comprehensive income attributable to ESAB Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Defined benefit pension and other post-retirement plan activity, net of tax benefit Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax Entity Current Reporting Status Entity Current Reporting Status Payments Payments for Restructuring Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Termination Benefits Employee Severance [Member] Foreign exchange translation effect Standard and Extended Product Warranty Accrual, Foreign Currency Translation Gain (Loss) Charged to Expense, net SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Effect of foreign exchange rates on Cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Property, plant and equipment, net Property, plant and equipment, net Property, Plant and Equipment, Net Americas Americas Segment [Member] Americas Segment LIFO inventory amount LIFO Inventory Amount Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Forfeited and expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Long-term debt Long-Term Debt Balance Sheet Location [Axis] Balance Sheet Location [Axis] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Weighted-average expected return on plan assets, net periodic benefit cost Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets Total current assets Assets, Current Accrued taxes and deferred tax liabilities Taxes Payable, Current Income tax payments, net Income Taxes Paid, Net Entity Small Business Entity Small Business Number of reporting units Number of Reporting Units Dividends on common stock (in dollars per share) Common Stock, Dividends, Per Share, Declared Distributions to noncontrolling owners Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Unrecognized stock-based compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Defined Benefit Plan, Funding Status [Domain] Defined Benefit Plan, Funding Status [Domain] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] Property, Plant and Equipment, Net Property, Plant and Equipment Disclosure [Text Block] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Retirement Plan Sponsor Location [Domain] Retirement Plan Sponsor Location [Domain] Compensation and related benefits Employee-Related Liabilities, Noncurrent Employee-Related Liabilities, Noncurrent Mexico MEXICO Debt Instrument [Line Items] Debt Instrument [Line Items] Business Combination and Asset Acquisition [Abstract] Common stock-based award activity (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Payment of deferred financing fees and other Payments of Debt Issuance Costs Present value of lease liabilities Operating Lease, Liability Balance at Beginning of Period Balance at End of Period SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Non-U.S. government and corporate bonds Debt Security, Government, Non-US And Debt Security, Corporate, Non-US [Member] Non-government bonds Health care cost trend rate (as a percent) Defined Benefit Plan, Ultimate Health Care Cost Trend Rate Realized loss Derivative, Gain (Loss) on Derivative, Net Fixed income mutual funds: Fixed Income Funds [Member] Third-party commissions Accrued Third-Party Commisions, Noncurrent Accrued Third-Party Commisions, Noncurrent 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Two Benefits paid Defined Benefit Plan, Plan Assets, Benefits Paid Change in Accounting Estimate [Line Items] Change in Accounting Estimate [Line Items] Assets, Total Assets, Total [Member] Deferred tax assets: Deferred Tax Assets, Net [Abstract] Restructuring and other related charges Total Provision Restructuring Charges Hedging Relationship [Domain] Hedging Relationship [Domain] 2026 Long-Term Debt, Maturity, Year Four Hedging Designation [Axis] Hedging Designation [Axis] Acquired Trade names, Customer Relationships, Acquired Technology and Software License Agreements Acquired Trade names, Customer Relationships, Acquired Technology and Software License Agreements [Member] Acquired Trade names, Customer Relationships, Acquired Technology and Software License Agreements Auditor Location Auditor Location Entity Filer Category Entity Filer Category Equity: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Federal Current Federal Tax Expense (Benefit) United States UNITED STATES Loss Contingency Accrual [Roll Forward] Loss Contingency Accrual [Roll Forward] Liabilities: Liabilities, Fair Value Disclosure [Abstract] Stock-based compensation expenses Share-Based Payment Arrangement, Expense Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss: Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract] Security Exchange Name Security Exchange Name Depreciation and other amortization Depreciation and Other Amortization Depreciation and Other Amortization Letters of credit outstanding amount Letters of Credit Outstanding, Amount Net sales Revenue from Contract with Customer, Excluding Assessed Tax Service cost Defined Benefit Plan, Service Cost Valuation allowance for deferred tax assets SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] Cash and cash equivalents Cash and Cash Equivalents [Member] Liabilities, Noncurrent [Abstract] Liabilities, Noncurrent [Abstract] Cover [Abstract] Cover [Abstract] Entity Voluntary Filers Entity Voluntary Filers Depreciation, amortization and other impairment charges Depreciation, Depletion and Amortization, Nonproduction Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Undistributed earnings of foreign subsidiaries Undistributed Earnings of Foreign Subsidiaries Revenue Revenue from Contract with Customer [Text Block] Segment Reporting [Abstract] Segment Reporting [Abstract] Change in benefit obligation: Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] Foreign Currency Translation Accounts Receivable, Allowance For Credit Loss, Foreign Currency Translation Accounts Receivable, Allowance For Credit Loss, Foreign Currency Translation Investments [Domain] Investments [Domain] Other Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change Forecast Forecast [Member] Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Weighted-average discount rate, benefit obligation Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Amortization Defined Benefit Plan, Amortization of Gain (Loss) Issuance of common stock in connection with the Separation and reclassification of Net Investment from Former Parent Issuance Of Common Stock, Value, Separation And Reclassification Of Net Investment From Former Parent Issuance Of Common Stock, Value, Separation And Reclassification Of Net Investment From Former Parent Total liabilities and equity Liabilities and Equity Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Defined Benefit Plan, Unfunded Plan Defined Benefit Plan, Unfunded Plan [Member] Warranty Costs Standard Product Warranty, Policy [Policy Text Block] Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Schedule of Income before Income Tax, Domestic and Foreign Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Unrecognized tax benefits, income tax penalties and interest accrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Less: present value discount Lessee, Operating Lease, Liability, Undiscounted Excess Amount Net income per share - diluted (in dollars per share) Earnings Per Share, Diluted Proceeds from sale of property, plant and equipment Proceeds from Sale of Property, Plant, and Equipment Accumulated benefit obligation, end of year Defined Benefit Plan, Accumulated Benefit Obligation Performance vesting period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Other current assets Other Assets, Current Other, including the impact of foreign currency translation and U.S. tax rate changes Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation Unrecognized tax benefits Beginning Balance Ending Balance Unrecognized Tax Benefits Deferred tax assets, net Deferred Tax Assets, Net of Valuation Allowance Equity securities Equity Securities [Member] Argentina, Pesos Argentina, Pesos Russia RUSSIAN FEDERATION Domestic operations Income (Loss) from Continuing Operations before Income Taxes, Domestic Interest expense and other, net Investment Income, Investment Expense Cumulative Effect, Period of Adoption, Adjustment Cumulative Effect, Period of Adoption, Adjustment [Member] Weighted-average discount rate, net periodic benefit cost Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate Schedule of Accounts Receivable, Allowance for Credit Loss Accounts Receivable, Allowance for Credit Loss [Table Text Block] Loss from discontinued operations, net of taxes Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Other Assets Derivative Asset, Subject to Master Netting Arrangement, before Offset Schedule of Future Minimum Lease Payments Lessee, Operating Lease, Liability, Maturity [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One Other comprehensive income (loss) Other Comprehensive Income (Loss), Tax Contract liability Contract with Customer, Liability Product and Service [Axis] Product and Service [Axis] Investment funds Defined Benefit Plan, Investment Funds [Member] Defined Benefit Plan, Investment Funds Deferred tax liabilities: Deferred Tax Liabilities, Net [Abstract] Class of Stock [Domain] Class of Stock [Domain] Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Trade names Trade Names [Member] Equity Method Investments Equity Method Investments [Policy Text Block] Adjusted EBITDA Adjusted Earnings Before Interest, Taxes And Amortization Adjusted Earnings Before Interest, Taxes And Amortization Retirement Plan Type [Axis] Retirement Plan Type [Axis] Schedule of Accrued and Other Liabilities Schedule of Accrued Liabilities [Table Text Block] Inventories, Net Inventory Disclosure [Text Block] Schedule of Long-Term Debt Schedule of Long-Term Debt Instruments [Table Text Block] Machinery and equipment Machinery and Equipment [Member] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Funded status, end of year Defined Benefit Plan, Funded (Unfunded) Status of Plan LIFO reserve Inventory, LIFO Reserve Reclassification Reclassification, Comparability Adjustment [Policy Text Block] Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Total deferred tax liabilities Deferred Tax Liabilities, Gross Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Dividends payable Dividends Payable, Current Awards converted from Former Parent plan (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Awards Converted From Former Parent Plan Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Awards Converted From Former Parent Plan Schedule of Restructuring Reserve by Type of Cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Net effect of potentially dilutive securities (in shares) Weighted Average Number of Shares Outstanding, Diluted, Adjustment Schedule II - Valuation and Qualifying Accounts SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Impairment of Goodwill and Indefinite-Lived Intangible Assets Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Five Minimum interest coverage ratio Debt Instrument, Covenant, Interest Coverage Ratio, Minimum Debt Instrument, Covenant, Interest Coverage Ratio, Minimum Research and Development Expense Research and Development Expense, Policy [Policy Text Block] Allowance for credit losses SEC Schedule, 12-09, Allowance, Credit Loss [Member] Other Other Accrued Liabilities, Current Pretax net unrecognized pension and other post-retirement benefit cost included in accumulated other comprehensive loss Total Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Claims resolved Loss Contingency, Claims Settled and Dismissed, Number Taxes calculated at the U.S. federal statutory rate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Foreign currency translation, tax expense (benefit) Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax EX-101.PRE 15 cfx-20221231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 16 cfx-20221231_g1.jpg begin 644 cfx-20221231_g1.jpg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end GRAPHIC 17 esabcorplogo.jpg begin 644 esabcorplogo.jpg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end GRAPHIC 18 image.jpg begin 644 image.jpg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end XML 19 R1.htm IDEA: XBRL DOCUMENT v3.22.4
COVER PAGE - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Feb. 28, 2023
Jul. 01, 2022
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2022    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-41297    
Entity Registrant Name ESAB CORPORATION    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 87-0923837    
Entity Address, Address Line One 909 Rose Avenue 8th Floor    
Entity Address, City or Town North Bethesda    
Entity Address, State or Province MD    
Entity Address, Postal Zip Code 20852    
City Area Code 301    
Local Phone Number 323-9099    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Trading Symbol ESAB    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Entity Shell Company false    
Entity Public Float     $ 2,625
Entity Common Stock Shares Outstanding   60,194,601  
Documents Incorporated by Reference
DOCUMENTS INCORPORATED BY REFERENCE

Part III incorporates certain information by reference from the Registrant’s definitive proxy statement for its 2023 annual meeting of stockholders (the “2023 Proxy Statement”) to be filed pursuant to Regulation 14A within 120 days after the end of the Registrant’s fiscal year covered by this report. With the exception of the sections of the 2023 Proxy Statement specifically incorporated herein by reference, the 2023 Proxy Statement is not deemed to be filed as part of this Form 10-K.
    
Entity Central Index Key 0001877322    
Amendment Flag false    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
XML 20 R2.htm IDEA: XBRL DOCUMENT v3.22.4
AUDIT INFORMATION
 12 Months Ended
Dec. 31, 2022
Auditor Information [Abstract]  
Auditor Name Ernst & Young LLP
Auditor Location Baltimore, Maryland
Auditor Firm ID 42
XML 21 R3.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Net sales $ 2,593,480 $ 2,428,115 $ 1,950,069
Cost of sales 1,707,950 1,590,132 1,267,604
Gross profit 885,530 837,983 682,465
Selling, general and administrative expense 533,369 512,815 458,706
Restructuring and other related charges 23,096 18,954 21,633
Operating income 329,065 306,214 202,126
Pension settlement gain (9,136) (11,208) 0
Interest expense (income) and other, net 37,950 (1,666) (3,713)
Income from continuing operations before income taxes 300,251 319,088 205,839
Income tax expense 69,170 80,409 45,971
Net income from continuing operations 231,081 238,679 159,868
Loss from discontinued operations, net of taxes (3,068) 0 0
Net income 228,013 238,679 159,868
Less: Income attributable to noncontrolling interest, net of taxes 4,266 3,569 2,454
Net income attributable to ESAB Corporation $ 223,747 $ 235,110 $ 157,414
Earnings (loss) per share - basic      
Income from continuing operations (in dollars per share) $ 3.75 $ 3.92 $ 2.62
Loss on discontinued operations (in dollars per share) (0.05) 0 0
Net income per share (in dollars per share) 3.70 3.92 2.62
Earnings (loss) per share - diluted      
Income from continuing operations (in dollars per share) 3.74 3.92 2.62
Loss on discontinued operations (in dollars per share) (0.05) 0 0
Net income per share - diluted (in dollars per share) $ 3.69 $ 3.92 $ 2.62
XML 22 R4.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement of Comprehensive Income [Abstract]      
Net income $ 228,013 $ 238,679 $ 159,868
Other comprehensive (loss) income:      
Foreign currency translation, net of tax (benefit) expense of $(2,930), $740 and $(1,598) (175,719) (72,398) 30,903
Unrealized gain on derivatives designated and qualifying as cash flow hedges, net of tax expense of $3,240 11,102 0 0
Defined benefit pension and other post-retirement plan activity, net of tax benefit of $1,840, $1,192 and $367 6,192 6,657 (3,725)
Other comprehensive (loss) income (158,425) (65,741) 27,178
Comprehensive income 69,588 172,938 187,046
Less: comprehensive income attributable to noncontrolling interest 678 2,513 2,307
Comprehensive income attributable to ESAB Corporation $ 68,910 $ 170,425 $ 184,739
XML 23 R5.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME [Parenthetical] - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement of Comprehensive Income [Abstract]      
Foreign currency translation, tax expense (benefit) $ (2,930) $ 740 $ (1,598)
Unrealized gain on derivatives designated and qualifying as cash flow hedges, net of tax expense 3,240    
Defined benefit pension and other post-retirement plan activity, net of tax benefit $ 1,840 $ 1,192 $ 367
XML 24 R6.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED AND COMBINED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
CURRENT ASSETS:    
Cash and cash equivalents $ 72,024 $ 41,209
Trade receivables, less allowance for credit losses of $23,471 and $23,912 374,329 383,496
Inventories, net 416,829 420,062
Prepaid expenses 56,637 51,949
Other current assets 68,851 67,357
Total current assets 988,670 964,073
Property, plant and equipment, net 284,226 286,278
Goodwill 1,529,767 1,532,993
Intangible assets, net 517,167 521,434
Lease asset - right of use 92,033 107,944
Other assets 342,152 48,540
Total assets 3,754,015 3,461,262
CURRENT LIABILITIES:    
Accounts payable 316,265 345,480
Accrued liabilities 285,310 251,109
Total current liabilities 601,575 596,589
Long-term debt 1,218,643 0
Other liabilities 545,339 362,945
Total liabilities 2,365,557 959,534
Equity:    
Common stock - $0.001 par value - Authorized 600,000,000; 60,094,725 and 100 shares outstanding as of December 31, 2022 and December 31, 2021, respectively 60 0
Additional paid-in capital 1,865,904 0
Retained earnings 159,231 0
Former Parent's investment 0 2,921,623
Accumulated other comprehensive loss (674,988) (460,888)
Total ESAB Corporation equity 1,350,207 2,460,735
Noncontrolling interest 38,251 40,993
Total equity 1,388,458 2,501,728
Total liabilities and equity $ 3,754,015 $ 3,461,262
XML 25 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED AND COMBINED BALANCE SHEETS [Parenthetical] - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Allowance for credit losses $ 23,471 $ 23,912
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, authorized (in shares) 600,000,000 600,000,000
Common stock, shares outstanding (in shares) 60,094,725 100
XML 26 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED AND COMBINED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid in Capital
Retained Earnings
Former Parent’s Investment
Former Parent’s Investment
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Noncontrolling Interest
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2019     0              
Beginning balance at Dec. 31, 2019 $ 2,681,203 $ (3,734) $ 0 $ 0 $ 0 $ 3,058,666 $ (3,716) $ (423,528) $ 46,065 $ (18)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 159,868         157,414     2,454  
Distributions to noncontrolling owners (4,297)               (4,297)  
Other comprehensive (loss) income 27,178             27,325 (147)  
Former Parent Common stock-based award activity 6,436         6,436        
Members' Equity, Transfers to (from) Parent, Net (321,887)         (319,969)     (1,918)  
Ending balance (in shares) at Dec. 31, 2020     0              
Ending balance at Dec. 31, 2020 2,544,767   $ 0 0 0 2,898,831   (396,203) 42,139  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 238,679         235,110     3,569  
Distributions to noncontrolling owners (3,713)               (3,713)  
Other comprehensive (loss) income (65,741)             (64,685) (1,056)  
Former Parent Common stock-based award activity 6,267         6,267        
Members' Equity, Transfers to (from) Parent, Net $ (218,531)         (218,585)     54  
Ending balance (in shares) at Dec. 31, 2021 100   0              
Ending balance at Dec. 31, 2021 $ 2,501,728   $ 0 0 0 2,921,623   (460,888) 40,993  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 228,013       168,310 55,437     4,266  
Distributions to noncontrolling owners (3,420)               (3,420)  
Other comprehensive (loss) income (158,425)             (154,837) (3,588)  
Former Parent Common stock-based award activity 1,728         1,728        
Members' Equity, Transfers to (from) Parent, Net (1,200,000)         (1,200,000)        
Dividends declared ($0.15 per share) (9,079)       (9,079)          
Net Transfers from Former Parent, including Separation Adjustments 15,726     4,346   70,643   (59,263)    
Issuance of common stock in connection with the Separation and reclassification of Net Investment from Former Parent (in shares)     60,034,311,000              
Issuance of common stock in connection with the Separation and reclassification of Net Investment from Former Parent 0   $ 60 1,849,371   (1,849,431)        
Common stock-based award activity (in shares)     60,414,000              
Common stock-based award activity $ 12,187     12,187            
Ending balance (in shares) at Dec. 31, 2022 60,094,725   60,094,725,000              
Ending balance at Dec. 31, 2022 $ 1,388,458   $ 60 $ 1,865,904 $ 159,231 $ 0   $ (674,988) $ 38,251  
XML 27 R9.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED AND COMBINED STATEMENTS OF EQUITY [Parenthetical] - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement of Stockholders' Equity [Abstract]      
Other comprehensive income (loss) $ 1,530 $ 452 $ 1,965
Dividends on common stock (in dollars per share) $ 0.15    
XML 28 R10.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net income $ 228,013 $ 238,679 $ 159,868
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation, amortization and other impairment charges 65,978 75,899 76,644
Loss (gain) on sale of property, plant and equipment 239 (447) (3,370)
Pension settlement gain (9,136) (11,208) 0
Stock-based compensation expense 12,964 6,267 6,436
Deferred income tax (20,199) (8,644) (14,031)
Non-cash interest expense 1,972 0 0
Changes in operating assets and liabilities:      
Trade receivables, net (8,142) (67,850) 27,734
Inventories, net (10,066) (117,350) 34,839
Accounts payable (28,794) 114,502 7,056
Other operating assets and liabilities (18,471) 20,889 14,005
Net cash provided by operating activities 214,358 250,737 309,181
Cash flows from investing activities:      
Purchases of property, plant and equipment (40,243) (35,584) (40,138)
Proceeds from sale of property, plant and equipment 4,849 5,204 5,565
Acquisitions, net of cash received (149,029) (4,885) 0
Net cash used in investing activities (184,423) (35,265) (34,573)
Cash flows from financing activities:      
Proceeds from borrowings on term credit facility 1,000,000 0 0
Proceeds from borrowings on revolving credit facility and other 805,881 673 0
Repayments of borrowings on revolving credit facility and other (585,491) 0 (190)
Payment of deferred financing fees and other (4,706) 0 0
Payment of deferred consideration (1,500) 0 (49)
Payment of dividends (6,054) 0 0
Distributions to noncontrolling interest holders (3,420) (3,713) (4,297)
Consideration to Former Parent in connection with the Separation (1,200,000) 0 0
Transfers from (to) Former Parent, net 2,847 (218,531) (321,887)
Net cash provided by (used in) financing activities 7,557 (221,571) (326,423)
Effect of foreign exchange rates on Cash and cash equivalents (6,677) (1,901) (3,810)
Increase (decrease) in Cash and cash equivalents 30,815 (8,000) (55,625)
Cash and cash equivalents, beginning of period 41,209 49,209 104,834
Cash and cash equivalents, end of period 72,024 41,209 49,209
Supplemental disclosures:      
Interest payments, net 34,678 0 0
Income tax payments, net $ 85,659 $ 0 $ 0
XML 29 R11.htm IDEA: XBRL DOCUMENT v3.22.4
Organization and Basis of Presentation
 12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Basis of Presentation Organization and Basis of Presentation
Founded in 1904, ESAB Corporation (“ESAB” or the “Company”) is a world leader in connected fabrication technology and gas control solutions. ESAB provides its partners with advanced equipment, consumables, gas control equipment, robotics, and digital solutions. The Company’s rich history of innovative products and workflow solutions and its business system (EBX) allows the Company to realize its purpose of Shaping the world it imagines. The Company’s products are utilized to solve challenges in a wide range of industries, including cutting, joining and automated welding. The Company conducts its operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America, and “EMEA & APAC,” which includes Europe, Middle East, India, Africa and Asia Pacific. Historically, these businesses had operated as part of Enovis Corporation’s (“Former Parent” or “Enovis”) Fabrication Technologies reportable segment.

The Company’s fiscal year ends December 31. The Company’s first three quarters end on the last business day of the 13th week after the end of the prior quarter.

Separation from Enovis

On January 31, 2022, all remaining legal entities which were part of the Fabrication Technology segment of the Former Parent along with certain entities that were part of the Corporate segment of the Former Parent became subsidiaries of ESAB through a legal entity restructuring. This reorganization resulted in the inclusion of the following entities and pension plans in ESAB for the three months ending April 1, 2022:

•Certain operating entities that form the historical Fabrication Technology business.

•Certain entities which historically have been a part of the Former Parent’s Corporate reportable segment, including components of the Former Parent’s legal human resources, tax and other finance functions that served the entirety of the Former Parent.

•Certain entities relating to the Former Parent’s previously divested Fluid Handling businesses which hold certain asbestos assets, liabilities, costs and insurance recoveries related to the asbestos obligations of these legacy industrial businesses. Refer to Note 4, “Discontinued Operations” and Note 19, “Commitments and Contingencies” for additional information.

•Certain pension plan assets and liabilities due to transfer of sponsorship of two U.S. defined benefit plans and a U.S. other post-retirement benefit plan from the Former Parent to ESAB as of March 21, 2022. Refer to Note 14, “Benefit Plans” for additional information on the benefit plans transferred to ESAB.

With the exception of the operating entities that form the historical Fabrication Technology business, the other contributions from the Former Parent were not previously included in the Company’s 2019 to 2021 historical carve-out financial statements. These historical carve-out financial statements in ESAB’s Registration Statement on Form 10-12B/A filed with the SEC on March 17, 2022 (the “Form 10”), were presented on a combined basis. Such basis of accounting differences before and after the legal entity contributions may impact the comparability between periods in these Consolidated and Combined Financial Statements.

ESAB Corporation, which was incorporated on May 19, 2021, became the new ultimate parent company for the Former Parent’s Fabrication Technology business and certain other corporate entities during the three months ended April 1, 2022.

On April 4, 2022 (the “Distribution Date”), Colfax Corporation (“Colfax” or the “Former Parent”) completed the spin-off of Colfax’s Fabrication Technology business and certain other corporate entities as described above, through a tax-free, pro rata distribution (the “Distribution”) of 90% of the outstanding common stock of ESAB to Colfax stockholders (the “Separation”). To effect the Separation, each Colfax stockholder of record as of close of business on March 23, 2022 received one share of ESAB common stock for every three shares of Colfax common stock held on the record date. Upon completion of the Distribution, Colfax changed its name to Enovis Corporation and continued to hold 10% of the outstanding common stock of ESAB. In November 2022, Enovis sold a total of 6.0 million shares of the Company’s common stock as part of a secondary offering. After the secondary offering, Enovis no longer owned any of the Company’s outstanding common stock.
In connection with the Separation, on April 4, 2022, ESAB and Enovis entered into a separation and distribution agreement as well as various other related agreements (collectively the “Agreements”) that govern the Separation and the relationships between the parties going forward, including a transition services agreement, an employee matters agreement, a tax matters agreement, an intellectual property matters agreement, and license agreement for the ESAB Business Excellence System ("EBX").

In conjunction with the Separation on April 4, 2022, the Company entered into a credit agreement (the “Credit Agreement”). The Company drew down $1.2 billion under the Credit Agreement and used these proceeds to make payments to Enovis of $1.2 billion, which was used as part of the consideration for the contribution of certain assets and liabilities to the Company by Enovis in connection with the Separation. To manage pre-existing currency rate exposures and interest risks arising from these credit facilities, during the third quarter, the Company entered into interest rate swap agreements and cross currency swap agreements, refer to Note 15, “Debt” and Note 16, “Derivatives” for additional information.

Russia and Ukraine Conflict

The invasion of Ukraine by Russia and the sanctions imposed in response have increased the level of economic and political uncertainty. While ESAB continues to closely monitor the situation and evaluate options, the Company is meeting current contractual obligations while addressing applicable laws and regulations. For the year ended December 31, 2022, Russia represented approximately 6% of the Company’s total revenue, and approximately $20 million in Net Income, respectively. Russia also has approximately 5% of the Company’s total net assets excluding any goodwill allocation as of December 31, 2022. In case of the disposition of the Russia business, a portion of goodwill would need to be allocated and disposed of in the relative fair value attributable to the Russia business. Russia has a cumulative translation loss of approximately $90 million as of December 31, 2022, which could be realized upon a transition out. The Company is closely monitoring developments in Ukraine and Russia. Changes in laws and regulations or other factors impacting the Company’s ability to fulfill contractual obligations could have an adverse effect on the results of operations.

Basis of Presentation

The accompanying Consolidated and Combined Financial Statements present the Company’s historical financial position, results of operations, changes in equity and cash flows in accordance with generally accepted accounting principles in the United States of America (“GAAP”). The combined financial statements for periods prior to the Separation were derived from Enovis’s consolidated financial statements and accounting records and prepared in accordance with GAAP for the preparation of carved-out combined financial statements. Through the date of the Separation, all revenues and costs as well as assets and liabilities directly associated with ESAB have been included in the combined financial statements. Prior to the Separation, the combined financial statements also included allocations of certain general, administrative, sales and marketing expenses from Enovis’s corporate office and from other Enovis businesses to the Company and allocations of related assets, liabilities, and the Former Parent’s investment, as applicable. The allocations were determined on a reasonable basis, however, the amounts are not necessarily representative of the amounts that would have been reflected in the financial statements had the Company been an entity that operated independently of Enovis during the applicable periods. Related party allocations prior to the Separation, including the method for such allocation, are discussed further in Note 21, “Related Party Transactions.”

Following the Separation, the consolidated financial statements include ESAB and its wholly-owned subsidiaries and no longer include any allocations of expenses from Enovis. Accordingly:

•The Consolidated Balance Sheet as of December 31, 2022 consists of the consolidated balances of ESAB, while the Combined Balance Sheet as of December 31, 2021 consists of the combined balances of the former Fabrication Technology business of Enovis.

•The Consolidated and Combined Statement of Operations and Statement of Comprehensive (Loss) Income for the year ended December 31, 2022 consists of the consolidated results of ESAB for the nine months ended December 31, 2022 and the combined results of the former Fabrication Technology business of Enovis and the certain entities discussed in the “Separation from Enovis” section above for the three months ended April 1, 2022. The Combined Statement of Operations and Statement of Comprehensive (Loss) Income for the years ended December 31, 2021 and 2020 consist of the combined results of the former Fabrication Technology business of Enovis.
•The Consolidated and Combined Statement of Changes in Equity for the year December 31, 2022 consists of the consolidated activities of ESAB for the nine months ended December 31, 2022 and the combined activity of the former Fabrication Technology business of Enovis and the certain entities discussed in the “Separation from Enovis” section above for the three months ended April 1, 2022. The Combined Statements of Changes in Equity for the year ended December 31, 2021 and 2020 consist of the combined activity of the former Fabrication Technology business of Enovis.

•The Consolidated and Combined Statement of Cash Flows for the year ended December 31, 2022 consists of the consolidated activities of ESAB for the nine months ended December 31, 2022 and the combined activity of ESAB and the former Fabrication Technology business of Enovis and the certain entities discussed in the “Separation from Enovis” section above for the three months ended April 1, 2022. The Combined Statement of Cash Flows for the years ended December 31, 2021 and 2020 consist of the combined activity of the former Fabrication Technology business of Enovis.

The Consolidated and Combined Financial Statements of ESAB for the years ended December 31, 2020 and 2021 and the three months ended April 1, 2022 may not be indicative of the Company's results had it been a separate stand-alone entity throughout the periods presented, nor are the results stated herein indicative of what the Company's financial position, results of operations and cash flows may be in the future.

Prior to the Separation, the Company was dependent on the Former Parent for all of its working capital and financing requirements under Enovis’s centralized approach to cash management and financing of its operations. With the exception of cash, cash equivalents and borrowings clearly associated with ESAB and related to the Separation, financing transactions relating to the Company during the period prior to the Separation were accounted for through the Former Parent’s investment account of the Company. Accordingly, none of Enovis’s cash, cash equivalents or debt at the corporate level has been assigned to the Company in these financial statements.
Former Parent’s Investment, which included retained earnings, represented Enovis’s interest in the recorded net assets of the Company. All significant transactions between the Company and the Former Parent prior to the Separation have been included in the accompanying Financial Statements. Transactions with the Former Parent are reflected in the accompanying Consolidated and Combined Statements of Equity as “Transfers to Former Parent, net” and in the accompanying Consolidated and Combined Balance Sheets within “Former Parent’s investment”.
The Consolidated and Combined Financial Statements reflect, in the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly the Company’s financial position and results of operations as of and for the periods indicated. Intercompany transactions and accounts are eliminated in consolidation.

The Company makes certain estimates and assumptions in preparing its Consolidated and Combined Financial Statements in accordance with U.S. generally accepted accounting principles, or “GAAP”. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the Consolidated and Combined Financial Statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from those estimates.

These Consolidated and Combined Financial Statements included in this annual report have been prepared by the Company in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) in conformity with GAAP, for the preparation of the Consolidated and Combined Financial Statements.
XML 30 R12.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
 
Principles of Consolidation

The Company’s Consolidated and Combined Financial Statements are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include all majority-owned subsidiaries over which the Company exercises control and, when applicable, entities or joint ventures for which the Company has a controlling financial interest or is the primary beneficiary. When protective rights, substantive rights or other factors exist, further analysis is performed in order to determine whether or not there is a controlling financial interest. The Consolidated and Combined Financial Statements reflect the assets, liabilities, revenues and expenses of consolidated subsidiaries and the noncontrolling parties’ ownership share is presented as a noncontrolling interest.
All significant intercompany accounts and transactions have been eliminated.

Equity Method Investments

Investments accounted for under the equity method are initially recorded at the amount of the Company’s initial investment and adjusted each period for the Company’s share of the investee’s income or loss and dividends paid. All equity investments are reviewed periodically for indications of other-than-temporary impairment, including, but not limited to, significant and sustained decreases in quoted market prices or a series of historic and projected operating losses by investees. If the decline in fair value is considered to be other-than-temporary, an impairment loss is recorded and the investment is written down to a new carrying value.

Revenue Recognition

The Company recognizes revenue when control of promised goods or services is transferred to the customer. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled in exchange for transferring the goods or services.

The Company provides a variety of products and services to its customers. Most of the Company’s contracts consist of a single, distinct performance obligation or promise to transfer goods or services to a customer. For contracts that include multiple performance obligations, we allocate the total transaction price to each performance obligation using our best estimate of the stand-alone selling price of each identified performance obligation. A significant majority of our revenue relates to the shipment of off-the-shelf products that is recognized when control is transferred to the customer. On a limited basis, we have agreements with customers that have multiple performance obligations. In determining whether there are multiple performance obligations, we first assess the goods or services promised in the customer arrangement and then consider the guidance in ASC 606, Revenue from Contracts with Customers, to evaluate whether goods and services are capable of being distinct and are considered distinct within the customer arrangement. To determine whether promised goods or services are separately identifiable (i.e., whether a promise to transfer a good or service is distinct in the context of the contract), we evaluate whether the contract is to deliver (1) multiple promised goods or services or (2) a combined item that comprises the individual goods or services promised in the contract. Substantially all revenue involving development and application engineering projects consists of a single performance obligation and is recognized at a point in time.

As mentioned above, a majority of revenue recognized by the Company relates to contracts with customers for standard or off-the-shelf products. As control typically transfers to the customer upon shipment of the product in these circumstances, revenue is generally recognized at that point in time. Revenue recognition and billing typically occur simultaneously for contracts recognized at a point in time. Therefore, we do not have material revenues in excess of customer billings or billings to customers in excess of recognized revenues. Refer to Note 13, “Accrued and Other Liabilities” for additional information on the Company’s contract liability balances.

For service contracts, the Company recognizes revenue ratably over the period of performance as the customer simultaneously receives and consumes the benefits of the services provided. The Company applies the available practical expedient involving the existence of a significant financing component. As the Company generally does not receive payments greater than one year in advance or arrears of revenue recognition, the Company does not consider any arrangements to include financing components.

The period of benefit for the Company’s incremental costs of obtaining a contract generally have less than a one-year duration; therefore, the Company applies the practical expedient available and expenses costs to obtain a contract when incurred.

Taxes Collected from Customers and Remitted to Governmental Authorities
 
The Company collects various taxes and fees as an agent in connection with the sale of products and remits these amounts to the respective taxing authorities. These taxes and fees have been presented on a net basis within Net sales in the Consolidated and Combined Statements of Operations and are recorded as a component of Accrued liabilities in the Consolidated and Combined Balance Sheets until remitted to the respective taxing authority.
Research and Development Expense
 
Research and development costs of $36.0 million, $39.7 million and $34.8 million for the years ended December 31, 2022, 2021 and 2020, respectively, are expensed as incurred and are included in Selling, general and administrative expense in the Consolidated and Combined Statements of Operations. These amounts do not include development and application engineering costs incurred in conjunction with fulfilling customer orders and executing customer projects.

Cash and Cash Equivalents
 
Cash and cash equivalents include all financial instruments purchased with an initial maturity of three months or less.

Trade Receivables
 
Trade receivables are presented net of an allowance for credit losses. The estimate of current expected credit losses on trade receivables considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. Estimated credit losses are reviewed periodically.
 
Inventories

Inventories are valued at the lower of cost or net realizable value. Fixed manufacturing overhead costs are allocated to inventory based on normal production capacity and abnormal manufacturing activities are recognized as period costs. Cost for a substantial portion of U.S. inventories is determined using the last-in, first-out method (“LIFO”). The value of inventory stated on a LIFO basis as of December 31, 2022 and 2021 was $131.1 million and $142.4 million, respectively. The valuation of LIFO inventories is made at the end of each year based on inventory levels and costs at that time. Cost of other inventories is determined by costing methods that approximate a first-in, first-out basis.

Reserves are maintained for estimated obsolescence or excess inventory equal to the difference between the cost of inventory and the net realizable value based upon assumptions about future demand and market conditions. The reserve for excess and obsolete inventory was $40.1 million and $37.9 million as of December 31, 2022 and 2021, respectively.

Property, Plant and Equipment
 
Property, plant and equipment, net is stated at historical cost, which includes the fair values of such assets acquired through acquisitions. Repair and maintenance expenditures are expensed as incurred unless the repair extends the useful life of the asset.

Impairment of Goodwill and Indefinite-Lived Intangible Assets
 
Goodwill represents the costs in excess of the fair value of net assets acquired through acquisitions by the Company.
 
The Company evaluates the recoverability of Goodwill and indefinite-lived intangible assets annually or more frequently if an event occurs or circumstances change in the interim that would more likely than not reduce the fair value of the asset below its carrying amount. The annual impairment test date elected by the Company is the first day of its fourth quarter. Goodwill and indefinite-lived intangible assets are considered to be impaired when the carrying value of a reporting unit or asset exceeds its fair value. As of the annual impairment test date, the Company had three reporting units: Americas, EMEA & APAC and Gas Control Equipment (“GCE”).

In the evaluation of goodwill for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting entity is less than its carrying value. If the Company determines that it is more likely than not for a reporting unit’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not for a reporting unit’s fair value to be less than its carrying value, a calculation of the reporting unit’s fair value is performed and compared to the carrying value of that reporting unit. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying value of a reporting unit exceeds its fair value, goodwill of that reporting unit is impaired and an impairment loss is recorded equal to the excess of the reporting unit’s carrying value over its fair value.
When a quantitative impairment test is needed, the Company measures fair value of reporting units based on a present value of future discounted cash flows. The discounted cash flow models indicate the fair value of the reporting units based on the present value of the cash flows that the reporting units are expected to generate in the future. Significant estimates in the discounted cash flow models include the weighted-average cost of capital, net sales and profitability of our business.

For the year ended December 31, 2022 a qualitative Goodwill impairment assessment was performed for the three reporting units. For the year ended December 31, 2021 a quantitative annual impairment test of Goodwill was performed for the GCE reporting unit while qualitative assessments were performed for the remaining two reporting units. A quantitative annual impairment test of Goodwill for each of the Company’s three reporting units was performed for the year ended December 31, 2020. All of the above tests indicated no impairment existed. Therefore, no impairment charges were recorded for the three years ended December 31, 2022. No material events that would represent impairment indicators have occurred subsequent to the performance of the 2022 annual impairment test.

In the evaluation of indefinite-lived intangible assets for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying value. If the Company determines that it is more likely than not for the indefinite-lived intangible asset’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not that the indefinite-lived intangible asset’s fair value is less than its carrying value, a fair value calculation is performed and compared to the carrying value of the asset. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying amount of the indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The Company measures the fair value of its indefinite-lived intangible assets using the “relief from royalty” method. Significant estimates in this approach include projected revenues and royalty and discount rates for each trade name evaluated. At the impairment testing date, the first day of the fourth quarter, quantitative impairment tests were performed for all the indefinite-lived trade name brands for the years ended December 31, 2022, 2021 and 2020, all of which indicated no impairment existed.

Impairment of Long-Lived Assets Other than Goodwill and Indefinite-Lived Intangible Assets
 
Definite-lived intangible assets primarily represent acquired trade names, customer relationships, acquired technology and software license agreements. The Company uses accelerated and straight-line methods of amortization with lives ranging from ten to thirty years.

The Company assesses its long-lived assets and definite-lived intangible assets for impairment whenever facts and circumstances indicate that the carrying amounts may not be fully recoverable. To analyze recoverability, the Company projects undiscounted net future cash flows over the remaining lives of such assets. If these projected cash flows are less than the carrying amounts, an impairment loss equal to the difference between the carrying amount of the asset and its fair value would be recognized, resulting in a write-down of the assets with a corresponding charge to earnings. Assets held for sale are reported at the lower of the carrying amounts or fair value less cost to sell. The Company determines fair value using the discounted cash flow method or other accepted valuation techniques. The Company determined that no impairment indicators were evident during the years ended December 31, 2022, 2021 and 2020.

Derivatives

The Company uses derivative instruments to manage exposures to interest rates and net investment exposures. The Company does not enter into derivatives for trading or speculative purposes.

All derivatives are recognized at fair value on the Company’s Consolidated and Combined Balance Sheets. The accounting for gains and losses resulting from changes in fair value depends on the use of the derivative and whether it is designated and qualifies for hedge accounting. The Company formally documents the relationship of the hedge with the hedged item as well as the risk-management strategy for all designated hedges. Both at inception and on an ongoing basis, the hedging instrument is assessed as to its effectiveness, when applicable. If and when a derivative is determined not to be highly effective as a hedge, the underlying hedged transaction is no longer likely to occur, or the derivative is terminated, hedge accounting is discontinued.

The Company is subject to the credit risk of the counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. The Company manages individual counterparty exposure by monitoring the credit rating of the counterparty and the size of financial commitments and exposures between the Company and the counterparty.
Certain interest rate swap agreements are qualified and designated as cash flow hedges. The effective portion of the fair value unrealized gain or loss on cash flow hedges are reported as a component of Accumulated other comprehensive income ("AOCI") with offsetting amounts recorded in the Company’s Consolidated and Combined Balance Sheet depending on the position and the duration of the contract. The gain or loss on the derivative instrument due to the change in fair value is reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. If a derivative is deemed to be ineffective, the change in fair value of the derivative is recognized directly in earnings.

Certain cross-currency swap agreements are designated and qualify as a net investment hedge, the changes in the fair value of these instruments are recorded in AOCI in equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCI. Offsetting amounts are recorded in the Company’s Consolidated and Combined Balance Sheet depending on the position and the duration of the contract.

The Company has certain foreign currency contracts which are not designated as hedges. These derivatives are held as offsets to certain balance sheet exposures. The gains or losses on these contracts are recognized in Interest expense (income) and other, net, in the Company’s Consolidated and Combined Statement of Operations.

Warranty Costs
 
Estimated expenses related to product warranties are accrued as the revenue is recognized on products sold to customers and included in Cost of sales in the Consolidated and Combined Statements of Operations. Estimates are established using historical information as to the nature, frequency, and average costs of warranty claims.
 
Income Taxes
 
Prior to the Separation, the Company’s domestic and foreign operating results were included in the income tax returns of Enovis. The Company accounted for income taxes under the separate return method. Under this approach, the Company determined its deferred tax assets and liabilities and related tax expense as if it were filing separate tax returns. The accompanying Combined Balance Sheets for the year ended December 31, 2021 did not contain current income tax payable or other long-term income tax payable liabilities, with the exception of certain unrecognized tax benefits for which ESAB could have reasonably be considered to be the primary obligor. The amounts are deemed settled with Enovis when they were due and therefore were included in Parent’s equity.

The Company accounts for income taxes under ASC 740, Income Taxes (“ASC 740”) which requires recognition of deferred income tax assets and liabilities reflecting the tax consequences attributable to differences between the carrying amounts of existing assets and liabilities in the Consolidated and Combined Financial Statements and their respective tax basis. Deferred income tax assets and liabilities are measured using enacted tax rates expected to be applied to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred income tax assets and liabilities are reported in Other assets and Other liabilities in the Consolidated and Combined Balance Sheets, respectively. The effect on deferred income tax assets and liabilities of a change in tax rates is generally recognized in Income tax expense in the period that includes the enactment date. Global Intangible Low-Taxed Income (“GILTI”) is accounted for as a current tax expense in the year the tax is incurred.
 
Valuation allowances are recorded if it is more likely than not that some portion of the deferred income tax assets will not be realized. In evaluating the need for a valuation allowance, the Company considers various factors, including the expected level of future taxable income and available tax planning strategies. Any changes in judgment about the valuation allowance are recorded through Income tax expense and are based on changes in facts and circumstances regarding realizability of deferred tax assets.
 
The Company must presume that an income tax position taken in a tax return will be examined by the relevant tax authority and determine whether it is more likely than not that the tax position will be sustained upon examination based upon the technical merits of the position. An income tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The Company establishes a liability for unrecognized income tax benefits for income tax positions for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority to the extent such tax positions reduce the Company’s income tax liability. The Company recognizes interest and penalties related to unrecognized income tax benefits in Income tax expense in the Consolidated and Combined Statements of Operations.
Interest expense (income) and Other, Net

Interest expense (income) and other, net is comprised of interest-bearing deposits of certain foreign subsidiaries, interest costs for the Company’s debt, amortization of debt issuance costs and interest income or expense of derivatives designated in hedging relationships.

In addition, it is comprised of other non-operating income items, including certain pension-related activities, foreign exchange exposure on cash and intercompany positions and interest income or expense on foreign currency contracts not designated in hedging relationships. See “Foreign Currency Exchange Gains and Losses” policy below for additional information.

Foreign Currency Exchange Gains and Losses
 
The Company’s financial statements are presented in U.S. dollars. The functional currencies of the Company’s operating subsidiaries are generally the local currencies of the countries in which each subsidiary is located. Assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the balance sheet date. The amounts recorded in each year in Foreign currency translation are net of income taxes to the extent the unrealized foreign exchange is taxed currently or the underlying equity balances in the entities are not deemed to be permanently reinvested. Revenues and expenses are translated at average rates of exchange in effect during the year.

Transactions in foreign currencies are translated at the exchange rate in effect at the date of each transaction. Differences in exchange rates during the period between the date a transaction denominated in a foreign currency is consummated and the date on which it is either settled or translated for inclusion in the Consolidated and Combined Balance Sheets are recognized in Selling, general and administrative expense or Interest expense (income) and other, net in the Consolidated and Combined Statements of Operations for that period.

The following table summarizes the Company’s net foreign transaction gains and losses included within the Consolidated and Combined Statements of Operations:

Year Ended December 31,
202220212020
(In thousands)(1)
Selling, general and administrative expense$2,597 $2,195 $788 
Interest (income) expense and other, net109 191 313 
Foreign currency transaction loss (gain), net$2,706 $2,386 $1,101 
(1) This table excludes the impact of the foreign exchange loss due to the remeasurement of the Company’s Argentinian operations, as described in the “Argentina Currency” paragraph below.
Argentina Currency

Argentina is deemed to have a highly inflationary economy, resulting in the remeasurement of the company’s Argentinian operations into Brazilian real, the functional currency of the Argentinian entity’s direct parent. Gains and losses from the remeasurement are recorded in the Company’s Consolidated and Combined Statements of Operations each year. For the year ended December 31, 2022 the remeasurement of the financial statements of the Company’s subsidiary operating in a highly inflationary economy has resulted in a transaction foreign exchange loss to Cost of sales of $6.6 million, Selling, general and administrative expense of $3.3 million and Interest (income) expense and other, net of $2.4 million. The impact to the Company’s Combined Statements of Operations for the years ended December 31, 2021 and 2020 were not material.

Debt Issuance Costs

Costs directly related to the placement of debt are capitalized and amortized to Interest expense primarily using the straight-line method over the term of the related obligation. See Note 15, “Debt” for additional discussion regarding the Company’s borrowing arrangements.
Use of Estimates
 
The Company makes certain estimates and assumptions in preparing its Consolidated and Combined Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the Consolidated and Combined Financial Statements and the reported amounts of revenues and expenses for the period presented. Actual results may differ from those estimates.

Reclassification

Certain prior period amounts have been reclassified to conform to current year presentations, including certain items within the Consolidated and Combined Statements of Comprehensive Income.
XML 31 R13.htm IDEA: XBRL DOCUMENT v3.22.4
Recently Issued Accounting Pronouncements
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Recently Issued Accounting Pronouncements Recently Issued Accounting PronouncementsThe Company assesses the adoption impacts of recently issued accounting pronouncements on the Company’s Consolidated and Combined financial statements as well as material updates to previous assessments. There were no new material accounting standards issued or adopted in the year of 2022 that impacted the Company.
XML 32 R14.htm IDEA: XBRL DOCUMENT v3.22.4
Discontinued Operations
 12 Months Ended
Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations Discontinued Operations
The Company holds certain asbestos-related contingencies and insurance coverages from divested businesses for which it does not have an interest in the ongoing operations. The entities that hold these assets and liabilities became subsidiaries of the Company during the year ended December 31, 2022 in connection with the Separation. These assets and liabilities were not included in the Company’s historical Combined Financial Statements for 2021 or 2020 as the Company did not have legal title to these assets, nor was the Company the legal obligor of these liabilities. The 2022 amounts reflect income, expenses, assets and liabilities historically recorded within the Former Parent’s divested businesses that were not part of Former Parent’s Fabrication Technology segment. Refer to “Note 1, Organization and Basis of Presentation” for additional information.

The Company has classified asbestos-related activity included in its Consolidated and Combined Statements of Operations, as part of Loss from discontinued operations, net of taxes.

Loss from discontinued operations, net of taxes consists of Selling, general and administrative expenses of $7.5 million net of a tax benefit of $4.4 million. See Note 19, “Commitments and Contingencies” for further information.

Cash used in operating activities related to discontinued operations for the year ended December 31, 2022 was $23.1 million.
XML 33 R15.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisitions
 12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
Acquisitions Acquisitions
On October 14, 2022, the Company completed the acquisition of Ohio Medical, LLC, a U.S. based global leader in oxygen regulators and central gas systems, for $127 million, net of cash received. In connection with the acquisition, the Company expects to realize an additional cash tax benefit with a net present value of approximately $15 million. This acquisition expands the Company’s presence in industrial specialty gas applications and products and broadens the Company’s U.S. presence.

On October 31, 2022, the Company completed the acquisition of Swift Cut Automation Limited, for $22 million, net of cash received. Swift-Cut is a provider of light industrial cutting systems and combined with ESAB provides a market-leading automated cutting portfolio.

Acquisitions consummated during the year ended December 31, 2022 are accounted for under the acquisition method of accounting. The assets acquired and liabilities assumed reported on the Consolidated Balance Sheets represent the Company’s best estimate. These amounts are based upon certain valuations and studies that have yet to be finalized and are subject to adjustment once the detailed analyses are completed within twelve months from the respective acquisition dates.
XML 34 R16.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue
 12 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
The Company develops, manufactures and supplies consumable welding and cutting products and equipment, as well as gas control equipment. The Company provides a wide range of products with innovative technologies to solve challenges in a range of industries, including cutting, joining and automated welding. Substantially all revenue is recognized at a point in time. The Company disaggregates its revenue into the following product groups:

Year Ended December 31,
202220212020
(In thousands)
Equipment$740,824 $758,267 $607,504 
Consumables1,852,656 1,669,848 1,342,565 
Total$2,593,480 $2,428,115 $1,950,069 

The sales mix in the above table is relatively consistent across both reportable segments. The consumables product grouping generally has less production complexity and shorter production cycles than equipment products.

Given the nature of the business, the total amount of unsatisfied performance obligations with an original contract duration of greater than one year as of December 31, 2022 is immaterial.

In some circumstances, customers are billed in advance of revenue recognition, resulting in contract liabilities. As of December 31, 2022, 2021 and 2020, total contract liabilities were $25.9 million, $22.3 million and $21.6 million, respectively, and are included in Accrued liabilities on the Consolidated and Combined Balance Sheets. During the years ended December 31, 2022 and 2021, substantially all amounts included in the contract liability balance at the beginning of the respective year were recognized as revenue in the following year.

Allowance for Credit Losses

A summary of the activity in the Company’s allowance for credit losses included within Trade receivables in the Consolidated and Combined Balance Sheets is as follows:
Year Ended December 31, 2022
Balance at
Beginning
of Period		Charged to Expense, netWrite-Offs and DeductionsForeign
Currency
Translation		Balance at
End of
Period
(In thousands)
Allowance for credit losses $23,912 $4,526 $(4,978)$11 $23,471 
XML 35 R17.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings per Share from Continuing Operations
 12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Earnings per Share from Continuing Operations Earnings per Share from Continuing Operations
The Company has unvested share-based payment awards with a right to receive non-forfeitable dividends which are considered participating securities. The Company allocates earnings to participating securities and computed earnings per share using the two-class method as follows:
Year Ended December 31,
202220212020
(In thousands, except share and per share data)
Computation of earnings per share from continuing operations - basic:
Income from continuing operations attributable to ESAB Corporation(1)
$226,815 $235,110 $157,414 
Less: distributed and undistributed earnings allocated to nonvested shares(1,600)— — 
Income from continuing operations attributable to common stockholders$225,215 $235,110 $157,414 
Weighted-average shares of Common stock outstanding – basic(2)
60,054,930 60,034,311 60,034,311 
Income per share from continuing operations – basic
$3.75 $3.92 $2.62 
Computation of earnings (loss) per share from continuing operations - diluted:
Income from continuing operations attributable to common stockholders$225,215 $235,110 $157,414 
Weighted-average shares of Common stock outstanding – basic(2)
60,054,930 60,034,311 60,034,311 
Net effect of potentially dilutive securities(3)
98,129 — — 
Weighted-average shares of Common stock outstanding – dilution
60,153,059 60,034,311 60,034,311 
Net income per share from continuing operations – diluted
$3.74 $3.92 $2.62 
(1) Net income from continuing operations attributable to ESAB Corporation for the respective periods is calculated using Net income from continuing operations, less Income attributable to noncontrolling interest, net of taxes, of $4.3 million, $3.6 million and $2.5 million for the years ended December 31, 2022, 2021 and 2020 respectively.
(2) The total number of shares outstanding on April 4, 2022 was 60,034,311 which is being utilized for the calculation of both basic and diluted earnings per share for the years ended December 31, 2021 and December 31, 2020 as no ESAB common stock equivalents were outstanding prior to the Separation.
(3) Potentially dilutive securities include stock options, performance-based restricted stock units and non performance-based restricted stock units.
XML 36 R18.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Separation from Enovis

Prior to the Separation, our operating results were included in the Former Parent’s various consolidated U.S. federal and certain state income tax returns, as well as certain non-U.S. returns. For periods prior to the Separation, our combined financial statements reflect Income tax expense and deferred tax balances as if we had filed tax returns on a standalone basis separate from the Former Parent. The separate return method applies the accounting guidance for income taxes to the standalone financial statements as if we were a separate taxpayer and a standalone enterprise for the periods prior to the Separation. For periods prior to the Separation, our pretax operating results include any transactions with the Former Parent as if it were an unrelated party.

In connection with the Separation, we entered into agreements with the Former Parent, including a Tax Matters Agreement. The Tax Matters Agreement distinguishes between the treatment of tax matters for “joint” filings compared to “separate” and “unitary state” filings prior to the Separation. “Joint” filings are returns, such as the U.S. federal return, that include operations from both Former Parent legal entities and the Company. By contrast, “separate” filings are tax returns (primarily U.S. state returns and non-U.S. returns) that exclusively include either the Former Parent’s or the Company’s operations. “Unitary state” filings are state tax returns which may include legal entities of both the Company and the Former Parent. In accordance with the Tax Matters Agreement, the Company is liable for and has indemnified the Former Parent against all income tax liabilities involving “separate” and “unitary state” filings for periods prior to the Separation, except to the extent a unitary state filing includes a legal entity of the Former Parent and the adjustment relates to that legal entity. The Company is also liable for fifty percent of all cash taxes paid as a result of any adjustment or redetermination or otherwise in connection with any tax contest relating to any joint return.
In connection with the Separation, the Company was required to enter into a transfer agreement under Section 965(h) and to become the primary obligor of the remaining installment payments associated with the Section 965 liability. The Former Parent is obligated under the Tax Matters Agreement for fifty percent of the installment obligation. Under the Separation Agreement, the Company is responsible for any tax indemnity related to the discontinued operations by the Former Parent.

Income from continuing operations before income taxes and Income tax expense consisted of the following:
 
 Year Ended December 31,
 202220212020
 (In thousands)
Income from continuing operations before income taxes:  
Domestic operations$(19,234)$10,140 $14,505 
Foreign operations319,485 308,948 191,334 
 $300,251 $319,088 $205,839 
Income tax expense:
Current:
Federal$8,928 $18,477 $9,262 
State2,451 1,797 921 
Foreign77,728 68,779 49,819 
 89,107 89,053 60,002 
Deferred:
Federal(7,501)(12,700)(8,698)
State358 161 (677)
Foreign(12,794)3,895 (4,656)
 (19,937)(8,644)(14,031)
 $69,170 $80,409 $45,971 

The Company’s Income tax expense differs from the amount that would be computed by applying the U.S. federal statutory rate as follows:
Year Ended December 31,
202220212020
(In thousands)
Taxes calculated at the U.S. federal statutory rate$63,053 $67,008 $42,820 
State taxes2,809 1,933 245 
Effect of tax rates on international operations(9,010)(8,879)(572)
Changes in tax reserves(350)2,734 1,346 
Non-taxable dividends— (46)(2,675)
Research and development tax credits(542)(587)(1,351)
Effect of U.S. taxation on international operations310 (313)(1,634)
Permanent differences, net
7,209 483 1,284 
Provision to return(7,055)(7,415)1,053 
Withholding taxes12,133 9,567 6,108 
Capital gain(3,655)12,371 — 
Valuation Allowance4,503 3,737 
Other(235)(184)(653)
Income tax expense$69,170 $80,409 $45,971 
The Company’s effective tax rate for each of 2022, 2021, and 2020 differs from the U.S. Federal statutory rate of 21% due to withholding taxes and permanent differences relating to foreign subsidiaries, partially offset by the favorable impact from the Company’s earnings outside the U.S. taxed at different rates than the U.S. federal statutory rate.

Prior to the Separation, a portion of the Company’s income tax payable or receivable computed under the separate return method is adjusted to equity as it does not represent a liability or asset with the relevant taxing authorities since the Company activity for this period will be included as part of the Former Parent’s tax return, primarily the U.S. Federal Income Tax return, filed with taxing authorities.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. All deferred tax assets and liabilities have been classified as noncurrent and are included in Other assets and Other liabilities in the accompanying Consolidated and Combined Balance Sheets. The temporary differences that gave rise to the significant components of deferred tax assets and liabilities are presented below:
December 31,
20222021
(In thousands)
Deferred tax assets:
Post-retirement benefit obligation$5,761 $4,430 
Expenses currently not deductible36,320 29,245 
Net operating loss carryforward111,497 22,374 
Tax credit carryforward10,320 — 
Depreciation and amortization9,124 16,450 
Inventory5,685 138 
Other36,873 24,648 
Valuation allowance(88,202)(15,465)
Deferred tax assets, net$127,378 $81,820 
Deferred tax liabilities:
Depreciation and amortization$(121,858)$(135,726)
Outside basis differences and other (102,336)(108,542)
Total deferred tax liabilities $(224,194)$(244,268)
Total deferred tax liabilities, net$(96,816)$(162,448)

Deferred tax assets and liabilities have been classified as noncurrent and are included in Other assets and Other liabilities in the accompanying Consolidated and Combined Balance Sheets on a net jurisdictional basis as follows:

December 31,
20222021
(In thousands)
Other assets$42,860 $9,357 
Other liabilities(139,676)(171,805)
Deferred tax liability, net$(96,816)$(162,448)

The Company evaluates the recoverability of its deferred tax assets on a jurisdictional basis by considering whether deferred tax assets will be realized on a more likely than not basis. To the extent a portion or all of the applicable deferred tax assets do not meet the more likely than not threshold, a valuation allowance is recorded. During the year ended December 31, 2022, the valuation allowance increased from $15.5 million to $88.2 million with a net increase of $4.5 million recognized as an increase to Income tax expense, and a $0.6 million decrease related to changes in foreign currency rates. The increase in net operating loss carryforward, tax credit carryforward and valuation allowances was primary due to transfer from the Former Parent. In determining how much of the relevant deferred tax asset could be realized on a more likely than not basis, consideration was given to tax planning strategies and, when applicable, future taxable income.
 
The Company has U.S. Federal net operating loss carryforwards of $18.1 million as of December 31, 2022 expiring in years 2028 through 2036. The Company’s ability to use these various carryforwards to offset any taxable income generated in future taxable periods may be limited under Section 382 and other federal tax provisions. At December 31, 2022 the Company also has $424.3 million foreign net operating loss carryforwards primarily in the United Kingdom, Germany, the Netherlands and Sweden that may be subject to local tax restrictive limitations including as a result of changes in ownership. The foreign net operating losses can be carried forward indefinitely, except in applicable jurisdictions that make up less than five percent of the available net operating losses.

For the year ended December 31, 2022, the Company has changed its indefinite reinvestment assertion on $57.5 million of the undistributed earnings of the Company’s foreign subsidiaries. The remaining earnings continue to be indefinitely reinvested outside the United States. The Company has assessed a total deferred tax liability of $4.5 million as of December 31, 2022 on such earnings that have not been indefinitely reinvested. This is an increase of $4.5 million as compared to the deferred tax liability as of December 31, 2021. The Company has made no provision for U.S. income taxes or additional non-U.S. taxes on certain undistributed earnings of non-U.S. subsidiaries. These earnings could become subject to additional tax if the Company were to dividend those earnings or sell the Company's interest in the non-U.S. subsidiary. The Company cannot practically determine the amount of additional taxes that might be payable on those earnings. During the first quarter of 2023, the Company began to evaluate opportunities for repatriation of certain foreign earnings and will record a withholding tax charge accordingly during 2023 of approximately $11 million.

The Company records a liability for certain unrecognized income tax benefits for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority (“uncertain tax positions”). This liability for such uncertain tax positions includes the amount of benefit included in (i) its previously filed income tax returns and (ii) its financial results expected to be included in income tax returns to be filed for periods through the date of its Consolidated and Combined Financial Statements. The Company’s total unrecognized tax benefits were $20.2 million, $37.7 million and $35.2 million as of December 31, 2022, 2021 and 2020, respectively, inclusive of $5.6 million, $6.2 million and $5.2 million, respectively, of interest and penalties. The Company records interest and penalties on uncertain tax positions as a component of Income tax expense, which was a benefit of $0.7 million, expense of $0.9 million and $0.7 million for the years ended December 31, 2022, 2021 and 2020, respectively.
A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows (inclusive of associated interest and penalties):

 (In thousands)
Balance, January 1, 2020
$34,014 
Addition for tax positions taken in prior periods2,785 
Addition for tax positions taken in the current period569 
Reductions resulting from a lapse of applicable statute of limitations(1,827)
Other, including the impact of foreign currency translation and U.S. tax rate changes(340)
Balance, December 31, 2020
35,201 
Addition for tax positions taken in prior periods738 
Addition for tax positions taken in the current period2,987 
Reductions related to settlements with taxing authorities(425)
Reductions resulting from a lapse of applicable statute of limitations(565)
Other, including the impact of foreign currency translation and U.S. tax rate changes(255)
Balance, December 31, 2021
37,681 
Addition for tax positions taken in prior periods1,971 
Addition for tax positions taken in the current period1,171 
Reductions related to settlements with taxing authorities(922)
Transfer from Former Parent, impact of foreign currency translation and other(2,801)
Other, including the impact of foreign currency translation(16,897)
Balance, December 31, 2022
$20,203 
 
The Company files numerous group and separate tax returns in U.S. federal and state jurisdictions, as well as international jurisdictions. The Company is routinely examined by various U.S. and non-U.S. taxing authorities. The Company is subject to audit by the U.S., various states and foreign jurisdictions. In accordance with the Tax Matters Agreement with Former Parent, the Company is the primary obligor for (i) ESAB separate company state returns for all periods; (ii) unitary state returns that include only ESAB legal entities for all periods, and (iii) ESAB separate foreign returns for all periods. The Company also has an obligation with respect to certain liabilities associated with unitary state tax returns that include both ESAB legal entities and Former Parent legal entities for all periods, certain liabilities associated with pre-separation joint returns, fifty percent of the remaining Section 965 installment payments, and any tax indemnity associated with discontinued operations.

Pursuant to U.S. tax law, the Company will file its initial U.S. federal income tax return for the post-Separation period by October 2023. The IRS has not yet begun examination of the Company. The Company reviews its global tax provisions on a quarterly basis. Based on these reviews, the results of discussions and resolutions of matters with certain tax authorities, tax rulings and court decisions and the expiration of the statutes of limitations for continent tax liabilities are accrued or adjusted.
 
Due to the difficulty in predicting with reasonable certainty when tax audits will be fully resolved and closed, the range of reasonably possible significant increases or decreases in the liability for unrecognized tax benefits that may occur within the next 12 months is difficult to ascertain. The Company does not believe the total amount of unrecognized benefits will change by a material amount within the next 12 months due to the settlement of audits and expirations of statutes of limitations.
XML 37 R19.htm IDEA: XBRL DOCUMENT v3.22.4
Goodwill and Intangible Assets
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
 

The following table summarizes Goodwill activity by segment for the years ended December 31, 2022 and 2021: 

 Americas
EMEA & APAC
Total
 (In thousands)
Balance, January 1, 2021
$522,777 $1,030,454 $1,553,231 
Goodwill attributable to acquisition4,159 — 4,159 
Impact of foreign currency translation(7,782)(16,615)(24,397)
Balance, December 31, 2021
519,154 1,013,839 1,532,993 
Goodwill attributable to acquisitions63,183 13,047 76,230 
Impact of foreign currency translation3,508 (82,964)(79,456)
Balance, December 31, 2022
$585,845 $943,922 $1,529,767 

The following table summarizes the Company’s Intangible assets, excluding Goodwill: 
 December 31,
 20222021
 Gross
Carrying
Amount		Accumulated
Amortization		Gross
Carrying
Amount		Accumulated
Amortization
 (In thousands)
Indefinite-Lived Intangible Assets
Trade names$180,691 $— $199,484 $— 
Definite-Lived Intangible Assets
Customer relationships482,499 (203,041)448,839 (185,071)
Technology71,192 (50,005)71,503 (49,276)
Trade names22,464 (9,412)16,550 (8,754)
Software94,904 (74,799)91,547 (67,888)
Other intangible assets22,800 (20,126)22,800 (18,300)
 $874,550 $(357,383)$850,723 $(329,289)
 
Amortization expense related to intangible assets of $35.6 million, $42.1 million and $41.8 million for the years ended December 31, 2022, 2021 and 2020, respectively, are included in the Selling, general and administrative expense in the Consolidated and Combined Statements of Operations.

Expected Amortization Expense
 
The Company’s expected annual amortization expense for intangible assets for the next five years is as follows: 
 December 31, 2022
 (In thousands)
2023$33,812 
202428,249 
202527,204 
202626,116 
202721,651 
XML 38 R20.htm IDEA: XBRL DOCUMENT v3.22.4
Property, Plant and Equipment, Net
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment, Net Property, Plant and Equipment, Net
  December 31,
 Depreciable Life20222021
 (In years)(In thousands)
Landn/a$15,839 $16,028 
Buildings and improvements
5-40
164,472 172,835 
Machinery and equipment
3-15
382,830 362,074 
  563,141 550,937 
Accumulated depreciation (278,915)(264,659)
 $284,226 $286,278 

Depreciation expense for the years ended December 31, 2022, 2021 and 2020 was $29.5 million, $32.5 million and $32.9 million, respectively.
XML 39 R21.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories, Net
 12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
Inventories, Net Inventories, Net
Inventories, net consisted of the following:
December 31,
20222021
(In thousands)
Raw materials$153,099 $148,376 
Work in process44,086 39,595 
Finished goods261,902 268,831 
459,087 456,802 
LIFO reserve(2,168)1,129 
Less: allowance for excess, slow-moving and obsolete inventory(40,090)(37,869)
$416,829 $420,062 
At December 31, 2022 and 2021, approximately 31.5% and 33.9% of total inventories, respectively, were valued using the LIFO method.
XML 40 R22.htm IDEA: XBRL DOCUMENT v3.22.4
Leases
 12 Months Ended
Dec. 31, 2022
Leases [Abstract]  
Leases Leases
The Company leases certain office spaces, warehouses, production facilities, vehicles, and equipment. Leases with an initial term of twelve months or less are not recorded on the balance sheet. Most leases include renewal options, which can extend the lease term into the future. The Company determines the lease term by assuming options that are reasonably certain of being renewed will be exercised. Certain of the Company’s leases include rental payments adjusted for inflation. The right-of-use lease asset is recorded on the Consolidated and Combined Balance Sheets, with the current lease liability being included in Accrued liabilities and noncurrent lease liability being included in Other liabilities. Operating lease expense was $21.3 million, $23.0 million and $21.6 million for the years ended December 31, 2022, 2021 and 2020, respectively.
December 31, 2022
(In thousands)
Future lease payments by year:
2023$21,603 
202416,876 
202513,127 
202610,502 
20278,221 
Thereafter37,867 
Total108,196 
Less: present value discount(13,369)
Present value of lease liabilities$94,827 
Weighted-average remaining lease term (in years):
  Operating leases7.55
Weighted-average discount rate:
  Operating leases3.5 %
XML 41 R23.htm IDEA: XBRL DOCUMENT v3.22.4
Accrued and Other Liabilities
 12 Months Ended
Dec. 31, 2022
Accrued Liabilities [Abstract]  
Accrued and Other Liabilities Accrued and Other Liabilities
Accrued and Other liabilities in the Consolidated and Combined Balance Sheets consisted of the following:
December 31, 2022December 31, 2021
CurrentNoncurrentCurrentNoncurrent
(In thousands)
Accrued taxes and deferred tax liabilities$49,615 $161,500 $58,920 $203,760 
Compensation and related benefits74,794 57,438 74,587 62,215 
Asbestos liability 30,108 230,581 — — 
Contract liability25,899 — 22,265 — 
Lease liability18,664 76,163 20,467 88,777 
Warranty liability 12,946 — 14,954 — 
Third-party commissions18,315 — 16,130 — 
Restructuring liability7,533 285 7,834 275 
Other47,436 19,372 35,952 7,918 
$285,310 $545,339 $251,109 $362,945 
Accrued Warranty Liability

A summary of the activity in the Company’s warranty liability included in Accrued liabilities in the Company’s Consolidated and Combined Balance Sheets is as follows:
Year Ended December 31,
20222021
(In thousands)
Warranty liability, beginning of period$14,954 $14,022 
Accrued warranty expense5,322 6,707 
Changes in estimates related to pre-existing warranties2,821 2,416 
Cost of warranty service work performed(9,680)(7,909)
Foreign exchange translation effect(471)(282)
Warranty liability, end of period$12,946 $14,954 

Accrued Restructuring Liability

The Company’s restructuring programs include a series of actions to reduce the structural costs of the Company. A summary of the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Consolidated and Combined Balance Sheets is as follows:
Year Ended December 31, 2022
Balance at Beginning of PeriodChargesPaymentsForeign Currency TranslationBalance at End of Period
(In thousands)
Restructuring and other related charges:
Americas
Termination benefits(1)
$2,044 $1,970 $(4,235)$(14)$(235)
Facility closure costs and other(2)
50 9,451 (9,382)— 119 
Subtotal2,094 11,421 (13,617)(14)(116)
Non-cash charges(2)
(37)
Segment Total11,384 
EMEA & APAC
Termination benefits(1)
5,774 2,672 (3,391)90 5,145 
Facility closure costs(2)
241 8,205 (5,686)29 2,789 
Subtotal6,015 10,877 (9,077)119 7,934 
Non-cash charges(2)
835 
Segment Total11,712 
Total$8,109 22,298 $(22,694)$105 $7,818 
Non-cash charges(2)
798 
Total Provision$23,096 
(1) Includes severance and other termination benefits, including outplacement services.
(2) Includes the cost of relocating associates, relocating equipment, lease termination expense, and other costs in connection with the closure and optimization of facilities and product lines.
Year Ended December 31, 2021
Balance at Beginning of PeriodChargesPaymentsForeign Currency TranslationBalance at End of Period
(In thousands)
Restructuring and other related charges:
Americas
Termination benefits(1)
$1,089 $5,414 $(4,455)$(4)$2,044 
Facility closure costs(2)
469 5,978 (6,397)— 50 
Subtotal1,558 11,392 (10,852)(4)2,094 
Non-cash charges(2)
220 
Segment Total11,612 
EMEA & APAC
Termination benefits(1)
4,247 4,219 (2,641)(51)5,774 
Facility closure costs(2)
122 2,090 (1,954)(17)241 
Subtotal4,369 6,309 (4,595)(68)6,015 
Non-cash charges(2)
1,033 
Segment Total7,342 
Total$5,927 17,701 $(15,447)$(72)$8,109 
Non-cash charges(2)
1,253 
Total Provision$18,954 
(1) Includes severance and other termination benefits, including outplacement services.
(2) Includes the cost of relocating associates, relocating equipment, lease termination expense, and other costs in connection with the closure and optimization of facilities and product lines.
XML 42 R24.htm IDEA: XBRL DOCUMENT v3.22.4
Benefit Plans
 12 Months Ended
Dec. 31, 2022
Retirement Benefits [Abstract]  
Benefit Plans Benefit Plans
The Company sponsors various defined benefit plans and other post-retirement benefits plans, including health and life insurance, for certain eligible employees or former employees. The Company uses December 31st as the measurement date for all of its employee benefit plans.

Prior to the Separation, the Former Parent offered both funded and unfunded noncontributory defined benefit pension plans in the United States that were shared amongst its businesses, including the Company prior to becoming plan sponsor. The participation of the Company’s employees and retirees in this plan was as though it participated in a multiemployer plan with the Former Parent. As a result, prior to the Separation, a proportionate share of the cost associated with this defined benefit plan was allocated to the Company based on the Company’s share of total Former Parent headcount. This allocation is reflected within Interest expense (income) and other, net, in the Consolidated and Combined Statements of Operations., while any assets and liabilities associated with this defined benefit plan were retained by the Former Parent and were not recorded on the Company’s historical Combined Financial Statements.

As part of the Separation, certain U.S. defined benefit and other post-retirement plans, formerly sponsored by the Former Parent were transferred to the Company as of March 21, 2022.

The transferred plans include a defined benefit pension plan with assets of $201.3 million and projected benefit liabilities of $200.7 million, one unfunded defined benefit plan with liabilities of less than $0.1 million and one other post-retirement benefit plan with liabilities of $11.7 million, all of which were recorded in the financial statements of the Former Parent at December 31, 2021.

During the year ended December 31, 2022, the Company recognized a Pension settlement gain of $9.1 million related to a completed buy-out of a foreign defined benefit plan by a third party plus the merger of two Company pension plans resulting in one plan benefiting from the surplus assets in the other plan. During the year ended December 31, 2021, the Company recognized a Pension settlement gain of $11.2 million when the trustees of a Company pension plan agreed to merge the plan with another Company pension plan and contribute the plan’s surplus assets.
These amounts are reflected in Pension settlement gain in the Consolidated and Combined Statements of Operations.

The following table summarizes the total changes in the Company’s pension and accrued post-retirement benefits and plan assets and includes a statement of the plans’ funded status:
 Pension BenefitsOther Post-Retirement Benefits
 
Year Ended December 31,
Year Ended December 31,
 2022202120222021
 (In thousands)
Change in benefit obligation:    
Projected benefit obligation, beginning of year$142,914 $155,914 $382 $388 
Transfer from Former Parent200,690 — 11,697 — 
Service cost1,684 1,785 15 14 
Interest cost5,874 1,668 234 22 
Plan amendments862 911 — — 
Actuarial gain(60,148)(1,866)(2,807)(25)
Foreign exchange effect(12,452)(6,653)(35)(7)
Benefits paid(23,385)(8,168)(636)(10)
Settlements(283)(847)— — 
Other266 170 — — 
Projected benefit obligation, end of year$256,022 $142,914 $8,850 $382 
Accumulated benefit obligation, end of year$253,123 $139,513 $8,850 $382 
Change in plan assets:
Fair value of plan assets, beginning of year$84,503 $73,114 $— $— 
Transfer from Former Parent201,259 — — — 
Actual return on plan assets(51,266)4,706 — — 
Employer contributions5,315 5,210 636 10 
Foreign exchange effect(7,583)(1,594)— — 
Benefits paid(23,385)(8,168)(636)(10)
Settlements(1)
9,947 11,272 — — 
Other260 (37)— — 
Fair value of plan assets, end of year$219,050 $84,503 $— $— 
Funded status, end of year$(36,972)$(58,411)$(8,850)$(382)
Amounts recognized on the Consolidated and Combined Balance Sheets as of December 31:
Non-current assets$15,701 $7,119 $— $— 
Current liabilities(3,025)(3,393)(824)(23)
Non-current liabilities(49,648)(62,137)(8,026)(359)
Total$(36,972)$(58,411)$(8,850)$(382)
    
(1) Settlements includes gains of $9.1 million and $11.2 million classified as Pension settlement gain on the Company’s Consolidated Statement of Operations for the years ended December 31, 2022 and December 31, 2021, respectively.

For pension plans with accumulated benefit obligations in excess of plan assets, the accumulated benefit obligation and fair value of plan assets were $201.1 million and $149.8 million, respectively, as of December 31, 2022 and $68.5 million and $5.2 million, respectively, as of December 31, 2021.

 For pensions plans with projected benefit obligations in excess of plan assets, the projected benefit obligation and fair value of plan assets were $206.8 million and $154.1 million, respectively, as of December 31, 2022 and $76.2 million and $10.7 million, respectively, as of December 31, 2021.
The following table summarizes the changes in the Company’s foreign pension benefit obligations and plan assets, included in the table above, and includes a statement of the plans’ funded status:
 
 Foreign Pension Benefits
 
Year Ended December 31,
 20222021
 (In thousands)
Change in benefit obligation:  
Projected benefit obligation, beginning of year$141,278 $154,075 
Service cost1,684 1,785 
Interest cost2,161 1,646 
Plan amendments862 911 
Actuarial gain(25,131)(1,787)
Foreign exchange effect(12,452)(6,653)
Benefits paid(8,984)(8,022)
Settlements(283)(847)
Other266 170 
Projected benefit obligation, end of year$99,401 $141,278 
Accumulated benefit obligation, end of year$96,500 $137,876 
Change in plan assets:
Fair value of plan assets, beginning of year$84,503 $73,114 
Actual return on plan assets(12,494)4,706 
Employer contributions5,170 5,064 
Foreign exchange effect(7,581)(1,594)
Benefits paid(8,984)(8,022)
Settlements9,947 11,272 
Other260 (37)
Fair value of plan assets, end of year$70,821 $84,503 
Funded status, end of year$(28,580)$(56,775)

Expected contributions to the Company’s pension and other post-employment benefit plans for the year ending December 31, 2023 are $5.2 million. The following benefit payments are expected to be paid during each respective fiscal year:
 Pension BenefitsOther Post-Retirement Benefits
 All PlansForeign Plans
 (In thousands)
2023$22,709 $7,551 $824 
202421,890 7,125 783 
202521,625 7,271 779 
202621,564 7,651 774 
202720,830 7,388 766 
2028 - 203296,928 37,424 3,326 
The Company’s primary investment objective for its pension plan assets is to provide a source of retirement income for the plans’ participants and beneficiaries. The assets are invested with the goal of preserving principal while providing a reasonable rate of return over the long term. Diversification of assets is achieved through strategic allocations to various asset classes. Actual allocations to each asset class vary due to periodic investment strategy changes, market value fluctuations, the length of time it takes to fully implement investment allocation positions, and the timing of benefit payments and contributions. The asset allocation is monitored and rebalanced as required, as frequently as on a quarterly basis in some instances. The target allocation for plan assets varies by plan and jurisdiction. The actual allocation percentages as of December 31, 2022 and 2021 are consistent with the target allocation ranges of the plans.

The following are the actual allocation percentages for the Company’s pension plan assets:
 
Actual Asset Allocation
December 31,
 20222021
U.S. Plans:
Equity securities:
U.S.36 %— %
International13 %— %
Fixed income50 %— %
Cash and cash equivalents1 %— %
Foreign Plans:
Equity securities4 %23 %
Fixed income securities34 %25 %
Cash and cash equivalents16 %1 %
Insurance contracts34 %38 %
Investment funds(1)
12 %13 %
 
(1) Represents various fixed income and equity securities.

A summary of the Company’s pension plan assets for each fair value hierarchy level for the periods presented follows (see Note 17, “Fair Value Measurements” for further description of the levels within the fair value hierarchy):
 
 December 31, 2022
 
Measured at Net Asset Value (1)
Level
One		Level
Two		Level
Three		 
Total
 (In thousands)
U.S. Plans:
Cash and cash equivalents $— $1,591 $— $— $1,591 
Equity securities:
U.S. large cap31,018 — — — 31,018 
U.S. small/mid cap10,789 11,289 — — 22,078 
International18,928 — — — 18,928 
Fixed income mutual funds:
U.S. government and corporate73,497 — — — 73,497 
Other — 1,118 — — 1,118 
Foreign Plans:
Cash and cash equivalents (2)
— 11,348 — — 11,348 
Equity securities— 2,475 — — 2,475 
Non-U.S. government and corporate bonds— 24,289 — — 24,289 
Insurance contracts— — 24,236 — 24,236 
Investment funds— — 8,400 — 8,400 
Other— 33 39 — 72 
 $134,232 $52,143 $32,675 $— $219,050 
(1)Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient (the “NAV”) have not been classified in the fair value hierarchy. These investments, consisting of common/collective trusts, are valued using the NAV provided by the Trustee. The NAV is based on the underlying investments held by the fund, that are traded in an active market, less its liabilities. These investments are able to be redeemed in the near-term.
(2) The weighted-average interest crediting rates received in Cash and cash equivalents of foreign plans are immaterial relative to total plan assets.
 December 31, 2021
 Measured at Net Asset Value Level
One		Level
Two		Level
Three		 
Total
 (In thousands)
Foreign Plans:
Cash and cash equivalents (1)
$— $442 $— $— $442 
Equity securities— 19,305 — — 19,305 
Non-U.S. government and corporate bonds— 21,310 — — 21,310 
Insurance contracts— — 32,570 — 32,570 
Investment funds— — 10,836 — 10,836 
Other— — 40 — 40 
 $— $41,057 $43,446 $— $84,503 
 
(1)The weighted-average interest crediting rates received in Cash and cash equivalents of foreign plans are immaterial relative to total plan assets.
The following table sets forth the components of net periodic benefit cost and Other comprehensive income of the Company’s defined benefit pension plans and other post-retirement employee benefit plans:
 
 Pension BenefitsOther Post-Retirement Benefits
 
Year Ended December 31,
Year Ended December 31,
 202220212020202220212020
 (In thousands)
Components of Net Periodic Benefit (Income) Cost:    
Service cost$1,684 $1,785 $1,577 $15 $14 $8 
Interest cost5,874 1,668 2,260 234 22 16 
Amortization4,313 1,220 785 (181)— (8)
Settlement gain(9,114)(11,195)— — 8 — 
Other92 2 154 — — — 
Expected return on plan assets(11,519)(2,258)(2,397)— — — 
Net periodic benefit (income) cost$(8,670)$(8,778)$2,379 $68 $44 $16 
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:
Transfer from Former Parent$53,134 $— $— $(2,629)$— $— 
Current year net actuarial (gain) loss949 (5,788)6,533 (2,807)(27)157 
Current year prior service cost862 — 95 — — — 
Less amounts included in net periodic benefit cost:
Amortization of net (gain) loss(4,340)(1,228)(785)181 (8)8 
Settlement/divestiture/other gain(67)— (89)— — — 
Amortization of prior service cost(1,067)(5)— — — — 
Total recognized in Other comprehensive (gain) loss$49,471 $(7,021)$5,754 $(5,255)$(35)$165 

Each component of net periodic benefit (income) cost is included in the Company’s Consolidated and Combined Statements of Operations for the years ended December 31, 2022, 2021 and 2020. Service cost is included within Selling, general and administrative expense with the non-service costs included within Interest expense (income) and other, net. Settlement gains of $9.1 million and $11.2 million are recorded within Pension settlement gain on the Company’s Consolidated Statement of Operations for the years ended December 31, 2022 and 2021, respectively.

The following table sets forth the components of net periodic benefit cost and Other comprehensive income of the foreign defined benefit pension plans, included in the table above:
 Foreign Pension Benefits
 
Year Ended December 31,
 202220212020
 (In thousands)
Components of Net Periodic Benefit (Income) Cost: 
Service cost$1,684 $1,785 $1,577 
Interest cost2,161 1,646 2,218 
Amortization687 1,118 692 
Settlement gain(9,114)(11,195)— 
Other92 2 154 
Expected return on plan assets(2,063)(2,258)(2,397)
Net periodic benefit (income) cost$(6,553)$(8,902)$2,244 
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:
Current year net actuarial loss (gain)$(12,262)$(5,710)$6,389 
Current year prior service cost862 — 101 
Less amounts included in net periodic benefit (income) cost:
Amortization of net loss(714)(1,126)(692)
Settlement/divestiture/other gain(67)— (89)
Amortization of prior service cost(1,067)(5)— 
Total recognized in Other comprehensive (gain) loss$(13,248)$(6,841)$5,709 

The components of net unrecognized pension and other post-retirement benefit cost included in Accumulated other comprehensive loss in the Consolidated and Combined Balance Sheets that have not been recognized as a component of net periodic benefit cost are as follows:
 Pension BenefitsOther Post-Retirement
Benefits
 
December 31,
December 31,
 2022202120222021
 (In thousands)
Net actuarial loss (gain)71,066 21,388 (5,199)56 
Prior service (income) cost(112)95 — — 
Total$70,954 $21,483 $(5,199)$56 
 
The key economic assumptions used in the measurement of the Company’s pension and other post-retirement benefit obligations are as follows:
 Pension BenefitsOther Post-Retirement
Benefits
 
December 31,
December 31,
 2022202120222021
Weighted-average discount rate:    
All plans4.6 %1.9 %5.0 %6.6 %
Foreign plans4.3 %1.9 %— %— %
Weighted-average rate of increase in compensation levels for active foreign plans(1)
3.2 %0.6 %— %— %
 
(1)Weighted-average rate of increase is only applicable to plans with compensation increase assumptions.
 
The key economic assumptions used in the computation of net periodic benefit cost are as follows: 
Pension BenefitsOther Post-Retirement Benefits
 
Year Ended December 31,
Year Ended December 31,
 202220212020202220212020
Weighted-average discount rate:    
All plans2.2 %1.3 %2.0 %2.6 %6.0 %7.6 %
Foreign plans1.9 %1.3 %1.9 %— %— %— %
Weighted-average expected return on plan assets:
All plans4.8 %3.6 %4.1 %— %— %— %
Foreign plans3.2 %3.6 %4.1 %— %— %— %
Weighted-average rate of increase in compensation levels for active foreign plans(1)
3.2 %3.4 %3.7 %— %— %— %
 
(1)Weighted-average rate of increase is only applicable to plans with compensation increase assumptions.
 
 In determining discount rates, the Company utilizes the single discount rate equivalent to discounting the expected future cash flows from each plan using the yields at each duration from a published yield curve as of the measurement date.
 
For measurement purposes, a weighted-average annual rate of increase in the per capita cost of covered health care benefits of 7.5% was assumed. The rate was assumed to decrease gradually to 4.1% by 2075 and remain at that level thereafter for benefits covered under the plans. 

The expected long-term rate of return on plan assets was based on the Company’s investment policy target allocation of the asset portfolio between various asset classes and the expected real returns of each asset class over various periods of time that are consistent with the long-term nature of the underlying obligations of these plans.

The Company maintains defined contribution plans covering certain union and non-union employees. The Company’s expense for the years ended December 31, 2022, 2021 and 2020 was $8.7 million, $7.9 million and $9.8 million, respectively.
XML 43 R25.htm IDEA: XBRL DOCUMENT v3.22.4
Debt
 12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
Debt Debt
Long-term debt consisted of the following:
December 31, 2022
(In thousands)
Term loans$1,000,000 
Revolving credit facilities221,000 
Total debt1,221,000 
Unamortized deferred financing fees(1)
(2,357)
Long-term debt$1,218,643 
 
(1)In the Company’s Consolidated Balance sheet, $1.2 million of deferred financing fees related to the Revolving Facility are included in Other assets and $2.4 million of deferred financing fees related to the Term Facilities are recorded as a contra-liability within Long-term debt.

Term Loans and Revolving Credit Facility

On April 4, 2022, the Company entered into a credit agreement (as amended and restated from time-to-time, the “Credit Agreement”) in connection with the Separation. The Credit Agreement initially consisted of the following facilities;

• A $750 million revolving credit facility (the “Revolving Facility”) with a maturity date of April 4, 2027

•A Term A-1 loan with an initial aggregate principal amount of $400 million (the “Term Loan A-1 Facility”), with a maturity date of April 4, 2027; and,

•A $600 million 364-day senior term loan facility (the “Term Loan A-2 Facility”) with a maturity date of April 3, 2023.
The Revolving Facility contains a $300 million letter of credit foreign currency sublimit and a $50 million swing line loan sub-facility.

On April 4, 2022, the Company drew down $1.2 billion available under the credit facilities made up of (i) $200 million under the Revolving Facility, (ii) $400 million under the Term Loan A-1 Facility and (iii) $600 million under the Term Loan A-2 Facility. The Company used these proceeds to make payments to Enovis of $1.2 billion, which was used as part of the consideration for the contribution of certain assets and liabilities to the Company by Enovis in connection with the Separation.

On June 28, 2022, the Company amended and restated the Credit Agreement by entering into Amendment No. 2 to Credit Agreement (“Credit Agreement Amendment”). The Credit Agreement Amendment provides for a $600 million term loan facility (the “Term Loan A-3 Facility” and, together with the Term Loan A-1 Facility, the “Term Facilities”, and together with the Revolving Facility, the “Facilities”) with a maturity date of April 3, 2025 to refinance the Company’s existing Term Loan A-2 Facility. Also on June 28, 2022, the Company borrowed the entire $600 million under Term Loan A-3 Facility to fund the repayment of the Term Loan A-2 Facility. The Company’s total borrowing capacity under the Credit Agreement remained unchanged. The draw-down and repayment related to these term facilities are presented net within the Consolidated and Combined Statements of Cash Flows.

The Credit Agreement contains customary covenants limiting the ability of the Company and its subsidiaries to, among other things, incur debt or liens, merge or consolidate with others, dispose of assets, make investments or pay dividends. In addition, the Credit Agreement contains financial covenants requiring the Company to maintain (i) a maximum total leverage ratio of not more than 4.00:1.00, with step-downs to, commencing with the fiscal quarter ending June 30, 2023, 3.75:1.00, and commencing with the fiscal quarter ending June 30, 2024, 3.50:1.00, and (ii) a minimum interest coverage ratio of 3.00:1:00. The Credit Agreement contains various events of default (including failure to comply with the covenants under the Credit Agreement and related agreements) and upon an event of default the lenders may, subject to various customary cure rights, require the immediate payment of all amounts outstanding under the Term Facilities and the Revolving Facility. Certain U.S. subsidiaries of the Company have agreed to guarantee the obligations of the Company under the Credit Agreement.

Loans made under the Term Facilities will bear interest, at the election of the Company, at either the base rate (as defined in the Credit Agreement) or at the term Secured Overnight Financing Rate (“SOFR”) rate plus an adjustment (as defined in the Credit Agreement), in each case, plus the applicable interest rate margin. Loans made under the Revolving Facility will bear interest, at the election of the Company, at either the base rate or, (i) in the case of loans denominated in dollars, the term SOFR rate plus an adjustment or the daily simple SOFR plus an adjustment, (ii) in the case of loans denominated in euros, the adjusted Euro Interbank Offered Rate (“EURIBOR”) rate and, (iii) in the case of loans denominated in sterling, Sterling Overnight Index Average (“SONIA”) plus an adjustment (as all such rates are defined in the Credit Agreement Amendment), in each case, plus the applicable interest rate margin. The applicable interest rate margin changes based upon the Company’s total leverage ratio (ranging from 1.125% to 1.750% or in the case of the base rate margin, 0.125% to 0.750%). Each swing line loan denominated in dollars will bear interest at the base rate plus the applicable interest rate margin.

To manage exposures to currency exchange rates and interest rates arising in Long term debt, the Company entered into interest rate and cross currency swap agreements during the year ended December 31, 2022. Refer to Note 16, “Derivatives” for additional information.

As of December 31, 2022, the weighted-average interest rate of borrowings under the Credit Agreement was 4.54%, including the net impact from the interest rate and cross currency swaps and excluding accretion of deferred financing fees, and there was $529 million of borrowing capacity available on the Revolving Facility.

Other Indebtedness

In addition to the debt agreements discussed above, the Company also has the ability to incur approximately $77 million of indebtedness pursuant to certain uncommitted credit lines, consisting of an uncommitted credit line that the Company currently has in place that the Company has used from time to time in the past for short-term working capital needs.

The Company is party to letter of credit facilities with an aggregate capacity of $102.9 million. Total letters of credit of $31.5 million were outstanding as of December 31, 2022.
Deferred Financing Fees

In total, the Company had deferred financing fees of $3.6 million included in its Consolidated and Combined Balance Sheet as of December 31, 2022, which will be charged to Interest expense (income) and other, net, using the straight-line method. The costs associated with the Term Facilities will be amortized over the contractual term of the Term Facilities and the costs associated with the Revolving Facility will be amortized over the life of the Credit Agreement. Of the $3.6 million, $1.2 million of deferred financing fees relating to the Revolving Facility are included in Other assets and $2.4 million of deferred financing fees relating to the Term Facilities are recorded as a contra-liability within Long-term debt.

Contractual Maturities

The contractual maturities of the Company’s debt is as follows:

December 31, 2022
(in thousands)
2023$— 
2024— 
2025600,000 
2026— 
2027621,000 
Total debt(1)
$1,221,000 
 
(1)Total debt excludes $3.6 million of related unamortized deferred financing fees.
XML 44 R26.htm IDEA: XBRL DOCUMENT v3.22.4
Derivatives
 12 Months Ended
Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivatives Derivatives
The Company uses derivative instruments to manage exposures to currency exchange rates and interest rates arising in connection with Long-term debt and the normal course of business. The Company has established policies and procedures that govern the risk management of these exposures. Both at inception and on an ongoing basis, the derivative instruments that qualify for hedge accounting are assessed as to their effectiveness, when applicable.

The Company is subject to the credit risk of counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. None of the concentrations of risk with an individual counterparty was considered significant as of December 31, 2022. The Company does not expect any counterparties to fail to meet their obligations. The Company records derivatives in the Consolidated and Combined Balance Sheets at fair value.

Cash Flow Hedges

On July 14, 2022, the Company entered into two interest rate swap agreements to manage interest rate risk exposure. The aggregate notional amount of these contracts is $600 million and they mature in April 2025. These interest rate swap agreements utilized by the Company effectively modify the Company’s exposure to interest rate risk by converting a portion of the Company’s floating-rate debt to a fixed rate of 3.293%, plus a spread, thus reducing the impact of interest-rate changes on future interest expense. The applicable spread may vary between 1.125% to 1.750%, depending on the total leverage ratio of the Company. The spread is 1.250% as of December 31, 2022. These agreements involve the receipt of floating-rate amounts in exchange for fixed-rate interest payments over the life of the agreement without an exchange of the underlying principal amount.

The above interest rate swap agreements are designated and qualify as a cash flow hedge, and as such the gain or loss on the derivative instrument due to the change in fair value is reported as a component of accumulated other comprehensive income (“AOCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. If a derivative is deemed to be ineffective, the change in fair value of the derivative is recognized directly in earnings. The Company did not have any ineffectiveness related to cash flow hedges during the year ended December 31, 2022.

The cash inflows and outflows associated with the Company’s interest rate swap agreements designated as cash flow hedges are classified in cash flows from operating activities in the accompanying Consolidated and Combined Statements of Cash Flows.
The Company expects a gain of $7.3 million, net of tax, related to interest rate swap agreements to be reclassified from AOCI to earnings over the next 12 months as the hedged transactions are realized. The expected gain to be reclassified is based on current forward rates in active markets as of December 31, 2022.

The effects of designated cash flow hedges on the Company’s Consolidated and Combined Statements of Operations consisted of the following:

Year Ended December 31,
Derivative typeLoss recognized in the Consolidated and Combined Statements of Operations:2022
(In thousands)
Interest rate swap agreementsInterest expense (income) and other, net$413 

Net Investment Hedges

On July 22, 2022 the Company entered into two cross-currency swap agreements to partially hedge its net investment in its Euro denominated subsidiaries against adverse movements in exchange rates between the U.S. Dollar and the Euro. In addition, the cross-currency swap agreements include provisions to exchange fixed-rate payments in U.S. Dollar for fixed-rate payments in Euro and are designated and qualify as a net investment hedge. These contracts have a Euro aggregate notional amount of approximately €270 million and a U.S. Dollar aggregate notional amount of $275 million at December 31, 2022, and they mature in April 2025.

The changes in the spot rate of these instruments are recorded in AOCI in equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCI. The Company uses the spot method of assessing hedge effectiveness and as such, the initial value of the hedge components excluded from the assessment of effectiveness is recognized in the Interest expense (income) and other, net line item in the Consolidated and Combined Statement of Operations under a systematic and rational method over the life of the cross-currency swap agreements. Any ineffective portions of net investment hedges are reclassified from AOCI into earnings during the period of change. The Company did not have any ineffectiveness related to net investment hedges during the year ended December 31, 2022.

The cash inflows and outflows associated with the excluded components of the Company’s cross-currency swap agreements designated as net investment hedges are classified in operating activities in the accompanying Consolidated and Combined Statements of Cash Flows.

The effects of the excluded components of designated net investment hedges on the Company’s Consolidated and Combined Statements of Operations consisted of the following:

Year Ended December 31,
Derivative typeGain recognized in the Consolidated and Combined Statements of Operations:2022
(In thousands)
Cross currency swap agreementsInterest expense (income) and other, net$(2,181)

The table below shows the fair value of the derivatives recognized in the Consolidated Balance Sheet:

December 31, 2022
Designated as hedging instrumentsOther LiabilitiesOther Assets
(In thousands)
Cross currency swap agreements $10,769 $— 
Interest rate swap agreements— 14,342 
Total$10,769 $14,342 
Derivatives Not Designated as Hedging Instruments

The Company has certain foreign currency contracts that are not designated as hedges. As of December 31, 2022 and December 31, 2021, the Company had foreign currency contracts related to purchases and sales with notional values of $260.0 million and $180.8 million, respectively.

The Company recognized the following in its Consolidated and Combined Financial Statements related to its derivative instruments not designated in a hedging relationship:
Year Ended December 31,
Foreign currency contracts202220212020
(In thousands)
Change in unrealized gains1,338 177 1,426 
Realized loss(1)
(17,601)(5,631)(469)
(1) The year ended December 31, 2022 includes realized losses relating to certain corporate entities contributed to ESAB Corporation which are reflected within Interest expense (income) and other, net, in the Consolidated and Combined Statements of Operations. See Note 1, “Organization and Basis of Presentation” for additional details. These realized losses are offset by unrealized gains which are also reflected within Interest expense (income) and other, net, in the Consolidated and Combined Statements of Operations.
XML 45 R27.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements
 12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The Company utilizes fair value measurement guidance prescribed by accounting standards to value its financial instruments. The guidance establishes a fair value hierarchy based on the inputs used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows:

Level One: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets.

Level Two: Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

Level Three: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

The carrying values of financial instruments, including Trade receivables and Accounts payable, approximate their fair values due to their short-term maturities. The estimated fair values may not represent actual values of the financial instruments that could be realized as of the balance sheet date or that will be realized in the future.

A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is as follows (see Note 14, “Benefit Plans” for classification of the assets of the Company’s benefit plans within the fair value hierarchy):
December 31, 2022
Level
One		Level
Two		Level
Three		Total
(In thousands)
Assets:
Cash equivalents$8,195 $— $— $8,195 
Foreign currency contracts - not designated as hedges(1)
— 3,682 — 3,682 
Interest rate swap agreements— 14,342 — 14,342 
Deferred compensation plans— 2,501 — 2,501 
$8,195 $20,525 $— $28,720 
Liabilities:
Foreign currency contracts - not designated as hedges(2)
$— $2,166 $— $2,166 
Cross currency swap agreements— 10,769 — 10,769 
Deferred compensation plans— 2,501 — 2,501 
$— $15,436 $— $15,436 
(1) Included within Other Current Assets in the Consolidated Balance Sheet.
(2) Included within Accrued Liabilities in the Consolidated Balance Sheet.
December 31, 2021
Level
One		Level
Two		Level
Three		Total
(In thousands)
Assets:
Cash equivalents$8,133 $— $— $8,133 
Foreign currency contracts - not designated as hedges(1)
— 2,487 — 2,487 
$8,133 $2,487 $— $10,620 
Liabilities:
Foreign currency contracts - not designated as hedges(2)
$— $2,309 $— $2,309 
(1) Included within Other Current Assets in the Consolidated Balance Sheet.
(2) Included within Accrued Liabilities in the Consolidated Balance Sheet.

The Company’s cash equivalents consist of investments in interest-bearing deposit accounts and money market mutual funds which are valued based on quoted market prices. The fair value of these investments approximate cost due to their short-term maturities and the high credit quality of the issuers of the underlying securities.

The Company measures the fair value of foreign currency contracts, cross currency swap agreements and interest rate swap agreements using Level Two inputs based on observable spot and forward rates in active markets. Additionally, the fair value of derivatives designated in hedging relationships includes a credit valuation adjustment to appropriately incorporate nonperformance risk for the Company and the respective counterparty. For the year ended December 31, 2022, the impact of the credit valuation adjustment on the Company’s derivatives is immaterial. Refer to Note 16, “Derivatives” for additional information.

There were no transfers in or out of Level One, Two or Three during the years ended December 31, 2022 and 2021.
Concentration of Credit Risk

Financial instruments which potentially subject the Company to concentrations of credit risk consist primarily of trade accounts receivable. Concentrations of credit risk are considered to exist when there are amounts collectible from multiple counterparties with similar characteristics, which could cause their ability to meet contractual obligations to be similarly impacted by economic or other conditions. The Company performs credit evaluations of its customers prior to delivery or commencement of services and normally does not require collateral. Letters of credit are occasionally required when the Company deems necessary. There are no customers which represent more than 10% of the Company’s Accounts receivable, net as of December 31, 2022 and 2021.
XML 46 R28.htm IDEA: XBRL DOCUMENT v3.22.4
Equity
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Equity Equity
Accumulated Other Comprehensive Loss

The following table presents the changes in the balances of each component of Accumulated other comprehensive loss including reclassifications out of Accumulated other comprehensive loss for the years ended December 31, 2022, 2021 and 2020. All amounts are net of tax and noncontrolling interest, if any.

Accumulated Other Comprehensive Loss Components
Net Unrecognized Pension and Other Post-Retirement Benefit CostForeign Currency Translation AdjustmentLoss on Net Investment Hedges Gain on Cash Flow HedgesTotal
(In thousands)
Balance at January 1, 2020$(23,887)$(399,641)$— $— $(423,528)
Other comprehensive income (loss) before reclassifications:— 
Net actuarial loss(4,328)— — — (4,328)
Foreign currency translation adjustment(1,791)32,816 — — 31,025 
Other comprehensive (loss) income before reclassifications(6,119)32,816 — — 26,697 
Amounts reclassified from Accumulated other comprehensive loss(1)
628 — — — 628 
Net current period Other comprehensive (loss) income(5,491)32,816 — — 27,325 
Balance at December 31, 2020(29,378)(366,825)— — (396,203)
Other comprehensive income (loss) before reclassifications:— 
Net actuarial gain7,479 — — — 7,479 
Foreign currency translation adjustment1,534 (72,867)— — (71,333)
Other comprehensive (loss) income before reclassifications9,013 (72,867)— — (63,854)
Amounts reclassified from Accumulated other comprehensive loss(1)
(831)— — — (831)
Net current period Other comprehensive (loss) income8,182 (72,867)— — (64,685)
Balance at December 31, 2021(21,196)(439,692)— — (460,888)
Other comprehensive income (loss) before reclassifications:
Amounts contributed by Former Parent(2)
(50,504)(8,759)— — (59,263)
Net actuarial gain 113 — — — 113 
Foreign currency translation adjustment1,712 (82,351)(8,336)— (88,975)
Loss on long-term intra-entity foreign currency transactions— (83,105)— — (83,105)
Unrealized gain on cash flow hedges— — — 10,782 10,782 
Other comprehensive (loss) income before reclassifications(48,679)(174,215)(8,336)10,782 (220,448)
Amounts reclassified from Accumulated other comprehensive loss(1)(3)
6,028 — — 320 6,348 
Net current period Other comprehensive (loss) income(42,651)(174,215)(8,336)11,102 (214,100)
Balance at December 31, 2022$(63,847)$(613,907)$(8,336)$11,102 $(674,988)
(1) The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost. See Note 14,
“Benefit Plans” for additional details.
(2) Includes unrecognized pension and other post-retirement costs and accumulated currency translation adjustments of certain entities which were part of the Corporate segment of the Former
Parent and were transferred to ESAB Corporation in anticipation of the Separation. Please see Note 1, “Organization and Basis of Presentation” for more information on the entities
contributed from the Former Parent.
(3) During the year ended December 31, 2022, the amount on this line within the Gain on Cash Flow Hedges column is a component of Interest expense (income) and other, net. See Note 16, “Derivatives”, for additional details.

During the years ended December 31, 2022, 2021 and 2020, Noncontrolling interest decreased by $3.6 million, $1.1 million and $0.1 million, respectively, as a result of Other comprehensive loss, primarily due to foreign currency translation adjustments.

Share-Based Payments

Prior to the Separation, the Company had no stock-based compensation plans; however, certain employees of the Company participated in the Former Parent’s stock-based compensation plans which provided for the grants of stock options and restricted stock units (“RSUs”). Prior to the Separation, the Former Parent allocated stock-based compensation expense to the Company based on ESAB employees participating in Former Parent plans. This is reflected in the accompanying Consolidated and Combined Statements of Operations and Comprehensive Income for the period prior to the Separation. Prior to the Separation, in addition to stock compensation expense related to direct employees of the Company, stock compensation expense related to certain corporate employees of the Former Parent was allocated to the Company based on the Company’s proportional share of total Former Parent revenues. For the three months ended April 1, 2022, $0.7 million of stock-based compensation expense was allocated to the Company. For the years ended December 31, 2021 and 2020, $2.6 million and $3.0 million, respectively, was allocated to the Company. Following the Separation, the company independently incurs stock compensation expenses as a stand-alone company.

In connection with the Separation, the Company adopted the 2022 Omnibus Incentive Plan (the “Stock Plan”) that became effective upon the Separation. Outstanding equity awards of the Former Parent held by ESAB employees at the Separation date were converted into or replaced with awards of ESAB common stock under the Stock Plan, with the intent to maintain the economic value of the equity awards immediately before and after the Distribution. The terms of the equity awards period, exercisability and vesting schedule, as applicable, generally continued unchanged. Other than converted or replacement equity awards of ESAB issued in replacement of the Former Parent’s restricted stock units (“RSUs”) and stock options, the terms of the converted or replacement equity awards of ESAB (e.g. vesting date and expiration date) continued unchanged.

The Company measures and recognizes compensation expense related to share-based payments based on the fair value of the instruments issued. Stock-based compensation expense is generally recognized as a component of Selling, general and administrative expense in the Consolidated and Combined Statements of Operations.

As of December 31, 2022, the Company had $19.0 million of unrecognized compensation expense related to stock-based awards that will be recognized over a weighted-average period of 2.30 years.  

Stock Options

 Under the Stock Plan, the Company may grant options to purchase common stock, with a maximum term of 10 years at a purchase price equal to the market value of the Company’s common stock on the date of grant. Stock-based compensation expense for stock option awards is based upon the grant-date fair value using the Black-Scholes option pricing model. The Company recognizes compensation expense for stock option awards on a straight-line basis over the requisite service period of the entire award. For the year ended December 31, 2022 the Stock-based compensation expense for the stock option awards was $1.8 million.
Restricted Stock Units

During the year ended December 31, 2022, the Company granted certain employees performance-based restricted stock units (“PRSUs”), the vesting of which is fully based on company specific profit performance metrics over a three-year performance period. The awards also have a service requirement that equals the respective performance periods.

These PRSUs are valued at the market value of a share of Common stock on the date of grant taking into consideration the probability of achieving the specified performance goal. The ultimate payout of PRSUs with a profit performance metric adjusts the cumulative expense based on its estimate and the percent of the requisite service period that has elapsed.

Under the Stock Plan, the Compensation Committee may also award non-performance-based restricted stock units (“RSUs”) to select executives, employees and outside directors, which typically vest over three years after the date of grant. With limited exceptions, the employee must remain in service until the vesting date. The Compensation Committee determines the terms and conditions of each award, including any restriction period and other criteria applicable to the awards.

The activity of the Company’s PRSUs and RSUs is as follows:
 PRSUsRSUs
 Number
of Units		Weighted-
Average
Grant-Date
Fair Value		Number
of Units		Weighted-
Average
Grant-Date
Fair Value
Balance at December 31, 2021— $— — $— 
Awards converted from Former Parent plan58,636 58.03 333,223 52.89 
Granted51,652 49.40 187,556 47.28 
Vested— — (27,354)48.11 
Forfeited and expired— — (29,147)52.40 
Balance at December 31, 2022110,288 53.99 464,278 50.80 
The fair value of shares vested during the year ended December 31, 2022 was $1.3 million.
XML 47 R29.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments and Contingencies
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Asbestos Contingencies

Certain entities that became subsidiaries of ESAB Corporation in connection with the Separation are the legal obligor for certain asbestos obligations including long-term asbestos insurance assets, long-term asbestos insurance receivables, accrued asbestos liabilities, long-term asbestos liabilities, asbestos indemnity expenses, asbestos-related defense costs and asbestos insurance recoveries related to the asbestos obligations from the Former Parent’s other legacy industrial businesses. As a result, the Company holds certain asbestos-related contingencies and insurance coverages.

These subsidiaries are each one of many defendants in a large number of lawsuits that claim personal injury as a result of exposure to asbestos from products manufactured or used with components that are alleged to have contained asbestos. Such components were acquired from third-party suppliers, and were not manufactured by any of the Company’s, or Former Parent’s, subsidiaries nor were the subsidiaries producers or direct suppliers of asbestos. The manufactured products that are alleged to have contained or used asbestos generally were provided to meet the specifications of the subsidiaries’ customers, including the U.S. Navy. The subsidiaries settle asbestos claims for amounts the Company considers reasonable given the facts and circumstances of each claim. The annual average settlement payment per asbestos claimant has fluctuated during the past several years while the number of cases has steadily declined. The Company expects such fluctuations to continue in the future based upon, among other things, the number and type of claims settled in a particular period and the jurisdictions in which such claims arise. To date, the majority of settled claims have been dismissed for no payment.

The Company has classified asbestos-related activity in Loss from discontinued operations in the Consolidated and Combined Statements of Operations. This is consistent with the Former Parent’s classification on the basis that, pursuant to the purchase agreement from the Former Parent’s Fluid Handling business divestiture, the Former Parent retained its asbestos-related contingencies and insurance coverages. However, as the Former Parent did not retain an interest in the ongoing operations of the business subject to the contingencies, asbestos-related activity was classified as part of Loss from discontinued operations, net of taxes in the Consolidated Statements of Operations of the Former Parent.

The Company has projected each subsidiary’s future asbestos-related liability costs with regard to pending and future unasserted claims based upon the Nicholson methodology. The Nicholson methodology is a standard approach used by experts and has been accepted by numerous courts. Consistent with the Former Parent, it is ESAB’s policy to record a liability for asbestos-related liability costs for the longest period of time that ESAB management can reasonably estimate.

The Company believes that it can reasonably estimate the asbestos-related liability for pending and future claims that will be resolved in the next 15 years and has recorded that liability as its best estimate. While it is reasonably possible that the subsidiaries will incur costs after this period, the Company does not believe the reasonably possible loss or a range of reasonably possible losses is estimable at the current time. Accordingly, no accrual has been recorded for any costs which may be paid after the next 15 years. Defense costs associated with asbestos-related liabilities as well as costs incurred related to efforts to recover insurance from the subsidiaries’ insurers are expensed as incurred.

Each subsidiary has separate insurance coverage acquired prior to Company ownership. The Company estimates the insurance assets for each subsidiary based upon the applicable policy language, expected recoveries and allocation methodologies, and law pertaining to the affected subsidiary’s insurance policies.
Asbestos-related claims activity since December 31, 2021 is as follows:
Year Ended
December 31, 2022
(Number of claims)
Claims unresolved, beginning of period14,559 
Claims filed(1)
4,338 
Claims resolved(2)
(4,791)
Claims unresolved, end of period14,106 
(In dollars)
Average cost of resolved claims(3)
$10,017 
(1) Claims filed include all asbestos claims for which notification has been received or a file has been opened.
(2) Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based
upon agreements or understandings in place with counsel for the claimants.
(3) Excludes claims settled in Mississippi for which the majority of claims have historically been resolved for no payment and insurance recoveries.

The Company’s Consolidated and Combined Balance Sheet included the following amounts related to asbestos-related litigation:
December 31, 2022
(In thousands)
Long-term asbestos insurance asset(1)
$215,112 
Long-term asbestos insurance receivable(1)
17,231 
Accrued asbestos liability(2)
30,108 
Long-term asbestos liability(3)
230,581 
(1) Included in Other assets in the Consolidated and Combined Balance Sheet.
(2) Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay, and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Consolidated and Combined Balance Sheet.
(3) Included in Other liabilities in the Consolidated and Combined Balance Sheet.

Management’s analyses are based on currently known facts and assumptions. Projecting future events, such as new claims to be filed each year, the average cost of resolving each claim, coverage issues among layers of insurers, the method in which losses will be allocated to the various insurance policies, interpretation of the effect on coverage of various policy terms and limits and their interrelationships, the continuing solvency of various insurance companies, the amount of remaining insurance available, as well as the numerous uncertainties inherent in asbestos litigation could cause the actual liabilities and insurance recoveries to be higher or lower than those projected or recorded which could materially affect the Company’s financial condition, results of operations or cash flow.

General Litigation

The Company is involved in various pending legal proceedings arising out of the ordinary course of the Company’s business. None of these legal proceedings is expected to have a material adverse effect on the financial condition, results of operations or cash flow of the Company. With respect to these proceedings, and the litigation and claims described in the proceeding paragraphs, management of the Company believes that it will either prevail, has adequate insurance coverage or has established appropriate accruals to cover potential liabilities. Legal costs related to proceedings or claims are recorded when incurred. Other costs that management estimates may be paid related to the claims are accrued when the liability is considered probable and the amount can be reasonably estimated. There can be no assurance, however, as to the ultimate outcome of any of these matters, and if all or substantially all of these legal proceedings were to be determined adverse to the Company, there could be a material adverse effect on the financial condition, results of operations or cash flow of the Company.
Off-Balance Sheet Arrangements

As of December 31, 2022, the Company had $104.8 million of unconditional purchase obligations with suppliers, the majority of which is expected to be paid by December 31, 2023.
XML 48 R30.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Segment Information Segment Information
ESAB is a world leader in fabrication and gas control technology, providing our partners with advanced equipment, consumables, gas control equipment, robotics, and digital solutions, which enable the everyday and extraordinary work that shapes our world. The Company’s products are utilized to solve challenges in a wide range of industries, including cutting, joining and automated welding.

The Company conducts its operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America, and “EMEA & APAC,” which includes Europe, Middle East, India, Africa and Asia Pacific.

The Company’s management evaluates the operating results of each of its reportable segments based upon Net sales and segment Adjusted EBITDA, which represents Operating income excluding the impact of Restructuring and other related charges, separation costs, transaction and integration costs, acquisition-related amortization and other non-cash charges, and depreciation and other amortization.

The Company’s segment results were as follows:
Year Ended December 31,
202220212020
(In thousands)
Net sales(1):
     Americas$1,128,306 $1,004,208 $767,414 
EMEA & APAC1,465,174 1,423,907 1,182,655 
$2,593,480 $2,428,115 $1,950,069 
Adjusted EBITDA(2):
     Americas$188,577 $159,623 $111,588 
EMEA & APAC248,177 244,458 189,558 
$436,754 $404,081 $301,146 
Depreciation, amortization and other impairment charges:
     Americas$29,281 $33,890 $36,380 
EMEA & APAC36,697 42,009 40,264 
$65,978 $75,899 $76,644 
Capital expenditures:
     Americas$18,005 $14,095 $15,244 
EMEA & APAC22,238 21,489 24,894 
$40,243 $35,584 $40,138 
(1) For the years ended December 31, 2022, 2021 and 2020, the total Net sales originating from the United States were $583.0 million, $533.5 million and $443.7 million, respectively. The remainder of the sales were derived from foreign countries.
(2) The following is a reconciliation of Net income from continuing operations to Adjusted EBITDA:
Year Ended December 31,
202220212020
(In thousands)
Net income from continuing operations$231,081 $238,679 $159,868 
Income tax expense69,170 80,40945,971
Interest expense (income) and other, net (1)
37,950 (29)(1,023)
Pension settlement gain(9,136)(11,208)— 
Restructuring and other related charges
23,096 18,954 21,633 
Separation costs(2)
15,545 2,865 — 
Acquisition - amortization and other related charges(3)
34,196 35,949 36,331 
Depreciation and other amortization34,852 38,462 38,366 
Adjusted EBITDA$436,754 $404,081 $301,146 
(1) Relates to removal of interest expense, net included within the Interest expense (income) and other, net line within the Consolidated and Combined Statements of Operations
(2) Includes non-recurring charges and employee costs related to the planning and execution of the separation from Enovis within the Selling, general and administrative expense line within the Consolidated and Combined Statements of Operations.
(3) Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses.

December 31,
20222021
(In thousands)
Investments in Equity Method Investees:
     Americas$— $— 
     EMEA & APAC28,527 28,180 
$28,527 $28,180 
Total Assets:
     Americas$1,666,799 $1,304,797 
     EMEA & APAC2,087,216 2,156,465 
$3,754,015 $3,461,262 

December 31,
20222021
(In thousands)
Property, Plant and Equipment, Net(1):
United States$68,380 $64,136 
Czech Republic60,278 63,273 
India34,892 37,312 
Russia19,111 18,797 
Mexico17,666 14,720 
Other foreign countries83,899 88,040 
$284,226 $286,278 
(1) As the Company does not allocate all long-lived assets, specifically intangible assets, to each individual country, evaluation of long-lived assets in total is impracticable.
XML 49 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Related Party Transactions
 12 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]  
Related Party Transactions Related Party Transactions
Related Party Agreements

On April 4, 2022, in connection with the Separation, the Company entered into several agreements with Enovis that govern the Separation and provide a framework for the relationship between the parties going forward including a separation and distribution agreement, a transition services agreement, tax matters agreement, employee matters agreements, a stockholder’s and registration rights agreement, an intellectual property matters agreement and a license agreement for Enovis Growth Excellence Business System (“EGX”).

The Separation and Distribution Agreement

The Company entered into a separation and distribution agreement (the “Separation Agreement”) with Enovis immediately prior to the distribution of the Company’s common stock to Enovis stockholders. The Separation Agreement sets forth the Company’s agreements with Enovis regarding the principal actions to be taken in connection with the Separation. The Separation Agreement contains provisions that, among other things, relate to (i) assets, liabilities and contracts to be transferred, assumed and assigned to each of ESAB and Enovis as part of the Separation, (ii) cash distribution made to Enovis in partial consideration of the transfer of ESAB Assets to the Company in connection with the Separation, and (iii) cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of ESAB’s business with ESAB and financial responsibility for the obligations and liabilities of Enovis’s remaining business with Enovis.

Transition Services Agreement

The transition services agreement ("TSA") sets forth the terms and conditions pursuant to which the Company and its subsidiaries and Enovis and its subsidiaries will provide to each other various services. The services to be provided include human resources, payroll, certain information technology services, treasury services and financial reporting services. The charges for the transition services generally are expected to allow the providing company to fully recover all internal and external costs and expenses it actually incurs in connection with providing the service (including a reasonable allocation of overhead) provided in the manner and at a level substantially consistent with that provided by the respective providing company immediately preceding the Distribution Date.

Tax Matters Agreement

The tax matters agreement governs the Company’s and Enovis’s respective rights, responsibilities and obligations after the Separation with respect to tax liabilities and benefits, tax attributes, the preparation and filing of tax returns, the control of audits and other tax proceedings and certain other matters regarding taxes.

Employee Matters Agreement

The employee matters agreement sets forth, among other things, the allocation of assets, liabilities and responsibilities relating to employee compensation and benefit plans and programs and other related matters in connection with the Separation, including the treatment of outstanding equity and other incentive awards and certain retirement and welfare benefit obligations.

Stockholders and Registration Rights Agreement

The stockholders and registration rights agreement sets forth the right of the stockholders when requiring the Company to facilitate the resale of shares.

Intellectual Property Matters Agreement

The intellectual property matters agreement sets forth the terms and conditions pursuant to which Enovis and the Company have mutually granted certain personal, generally irrevocable, non-exclusive, worldwide, and royalty-free rights to use certain intellectual property. The Company and Enovis are able to sublicense their rights in connection with activities relating to their businesses, but not for independent use by third parties.
EGX License Agreement

The EGX license agreement sets forth the terms and conditions pursuant to which Enovis has granted a royalty-free, non-exclusive, worldwide, and nontransferable license to the Company to use EGX, solely in support of its businesses. The Company will be able to sublicense such license solely to direct and indirect wholly-owned subsidiaries. In addition, under the EGX license agreement, Enovis and the Company each license to each other improvements made by such party to EGX during the first two years of the term of the EGX license agreement.

Allocated Expenses

Prior to the Separation, the Company operated as part of the Former Parent and not as a stand-alone company. Accordingly, the Former Parent allocated certain shared costs to the Company that are reflected as expenses in these financial statements. These amounts included, but were not limited to, items such as general management and executive oversight, compliance, human resources, procurement, and legal functions and financial management, including public company reporting, consolidated tax filings and tax planning. Management considered the allocation methodologies used by the Former Parent to be reasonable and to appropriately reflect the related expenses attributable to the Company for purposes of the three months ended April 1, 2022 and the years ended December 31, 2021, and 2020 combined financial statements; however, the expenses reflected in these financial statements may not be indicative of the actual expenses that would have been incurred during the periods presented if the Company had operated as a separate stand-alone entity. In addition, the expenses reflected in the financial statements may not be indicative of expenses the Company will incur in the future. Allocation methodologies utilized include the Company’s relative share of total Former Parent revenues and headcount.

All of the Company’s transactions with the Former Parent were considered to be financing transactions, which are presented as Transfers from (to) Former Parent, net in the accompanying Consolidated and Combined Statements of Cash Flows.

The Company had no stock-based compensation plans prior to the Separation; however, certain employees of the Company participated in the Former Parent’s stock-based compensation plans, which provided for the grants of stock options and RSUs among other types of awards. The expense associated with the Company's employees who participated in the plans of the Former Parent was allocated to the Company in the accompanying Consolidated and Combined Statements of Operations through the date of Separation.

The Company’s allocated expenses from the Former Parent were $6.0 million for the three months ended April 1, 2022, and $29.5 million and $24.2 million for the years ended December 31, 2021 and 2020, respectively, and are included in the Selling, general and administrative expense in the Consolidated and Combined Statements of Operations. Following the Separation, the company independently incurs expenses as a stand-alone company.

Refer to Note 14, “Benefit Plans,” for allocations of net periodic benefit associated with a Former Parent sponsored benefit plan.
XML 50 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Subsequent Events
 12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events
The dividend of $3.0 million included in Accrued liabilities in the Consolidated Balance Sheet at December 31, 2022 was paid on January 13, 2023, to stockholders of record as of Decembers 30, 2022. In addition, on March 2, 2023, the Board of Directors declared a quarterly cash dividend of $0.05 per share of ESAB’s common stock payable on April 14, 2023, to stockholders of record as of March 31, 2023.

On January 11, 2023, the Company completed the acquisition of Therapy Equipment Limited, a regional leader in oxygen regulators, for approximately $16 million.
XML 51 R33.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule II - Valuation and Qualifying Accounts
 12 Months Ended
Dec. 31, 2022
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II - Valuation and Qualifying Accounts
Balance at
Beginning
of Period
Charged to Cost and
Expense (1)
Write-Offs Write-Downs
Deductions and Other(2)
Foreign
Currency
Translation		Balance at
End of
Period
(Dollars in thousands)
Year Ended December 31, 2022:
Allowance for credit losses$23,912 $4,526 $(4,978)$11 $23,471 
Valuation allowance for deferred tax assets15,465 4,503 68,876 (642)88,202 
Year Ended December 31, 2021:
Allowance for credit losses(3)
$32,311 $(494)$(6,931)$(974)$23,912 
Valuation allowance for deferred tax assets12,647 3,738 — (920)15,465 
Year Ended December 31, 2020:
Allowance for credit losses$32,008 $4,936 $(3,448)$(1,185)$32,311 
Valuation allowance for deferred tax assets17,855 — (4,738)(470)12,647 
(1)    Amounts charged to expense are net of recoveries for the respective period.
(2)    As of December 31, 2022, valuation allowance for deferred tax assets “Other” of $68.9 million is primarily due to valuation allowance transferred from Former Parent.
(3)    The Allowance for credit losses as of January 1, 2020 includes the cumulative-effect adjustment of the adoption of ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.
XML 52 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Fiscal Period The Company’s fiscal year ends December 31. The Company’s first three quarters end on the last business day of the 13th week after the end of the prior quarter.
Separation from Enovis and Principles of Consolidation
Separation from Enovis

On January 31, 2022, all remaining legal entities which were part of the Fabrication Technology segment of the Former Parent along with certain entities that were part of the Corporate segment of the Former Parent became subsidiaries of ESAB through a legal entity restructuring. This reorganization resulted in the inclusion of the following entities and pension plans in ESAB for the three months ending April 1, 2022:

•Certain operating entities that form the historical Fabrication Technology business.

•Certain entities which historically have been a part of the Former Parent’s Corporate reportable segment, including components of the Former Parent’s legal human resources, tax and other finance functions that served the entirety of the Former Parent.

•Certain entities relating to the Former Parent’s previously divested Fluid Handling businesses which hold certain asbestos assets, liabilities, costs and insurance recoveries related to the asbestos obligations of these legacy industrial businesses. Refer to Note 4, “Discontinued Operations” and Note 19, “Commitments and Contingencies” for additional information.

•Certain pension plan assets and liabilities due to transfer of sponsorship of two U.S. defined benefit plans and a U.S. other post-retirement benefit plan from the Former Parent to ESAB as of March 21, 2022. Refer to Note 14, “Benefit Plans” for additional information on the benefit plans transferred to ESAB.

With the exception of the operating entities that form the historical Fabrication Technology business, the other contributions from the Former Parent were not previously included in the Company’s 2019 to 2021 historical carve-out financial statements. These historical carve-out financial statements in ESAB’s Registration Statement on Form 10-12B/A filed with the SEC on March 17, 2022 (the “Form 10”), were presented on a combined basis. Such basis of accounting differences before and after the legal entity contributions may impact the comparability between periods in these Consolidated and Combined Financial Statements.

ESAB Corporation, which was incorporated on May 19, 2021, became the new ultimate parent company for the Former Parent’s Fabrication Technology business and certain other corporate entities during the three months ended April 1, 2022.

On April 4, 2022 (the “Distribution Date”), Colfax Corporation (“Colfax” or the “Former Parent”) completed the spin-off of Colfax’s Fabrication Technology business and certain other corporate entities as described above, through a tax-free, pro rata distribution (the “Distribution”) of 90% of the outstanding common stock of ESAB to Colfax stockholders (the “Separation”). To effect the Separation, each Colfax stockholder of record as of close of business on March 23, 2022 received one share of ESAB common stock for every three shares of Colfax common stock held on the record date. Upon completion of the Distribution, Colfax changed its name to Enovis Corporation and continued to hold 10% of the outstanding common stock of ESAB. In November 2022, Enovis sold a total of 6.0 million shares of the Company’s common stock as part of a secondary offering. After the secondary offering, Enovis no longer owned any of the Company’s outstanding common stock.
In connection with the Separation, on April 4, 2022, ESAB and Enovis entered into a separation and distribution agreement as well as various other related agreements (collectively the “Agreements”) that govern the Separation and the relationships between the parties going forward, including a transition services agreement, an employee matters agreement, a tax matters agreement, an intellectual property matters agreement, and license agreement for the ESAB Business Excellence System ("EBX").

In conjunction with the Separation on April 4, 2022, the Company entered into a credit agreement (the “Credit Agreement”). The Company drew down $1.2 billion under the Credit Agreement and used these proceeds to make payments to Enovis of $1.2 billion, which was used as part of the consideration for the contribution of certain assets and liabilities to the Company by Enovis in connection with the Separation. To manage pre-existing currency rate exposures and interest risks arising from these credit facilities, during the third quarter, the Company entered into interest rate swap agreements and cross currency swap agreements, refer to Note 15, “Debt” and Note 16, “Derivatives” for additional information.
Principles of Consolidation

The Company’s Consolidated and Combined Financial Statements are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include all majority-owned subsidiaries over which the Company exercises control and, when applicable, entities or joint ventures for which the Company has a controlling financial interest or is the primary beneficiary. When protective rights, substantive rights or other factors exist, further analysis is performed in order to determine whether or not there is a controlling financial interest. The Consolidated and Combined Financial Statements reflect the assets, liabilities, revenues and expenses of consolidated subsidiaries and the noncontrolling parties’ ownership share is presented as a noncontrolling interest.
All significant intercompany accounts and transactions have been eliminated.
Basis of Presentation
Basis of Presentation

The accompanying Consolidated and Combined Financial Statements present the Company’s historical financial position, results of operations, changes in equity and cash flows in accordance with generally accepted accounting principles in the United States of America (“GAAP”). The combined financial statements for periods prior to the Separation were derived from Enovis’s consolidated financial statements and accounting records and prepared in accordance with GAAP for the preparation of carved-out combined financial statements. Through the date of the Separation, all revenues and costs as well as assets and liabilities directly associated with ESAB have been included in the combined financial statements. Prior to the Separation, the combined financial statements also included allocations of certain general, administrative, sales and marketing expenses from Enovis’s corporate office and from other Enovis businesses to the Company and allocations of related assets, liabilities, and the Former Parent’s investment, as applicable. The allocations were determined on a reasonable basis, however, the amounts are not necessarily representative of the amounts that would have been reflected in the financial statements had the Company been an entity that operated independently of Enovis during the applicable periods. Related party allocations prior to the Separation, including the method for such allocation, are discussed further in Note 21, “Related Party Transactions.”

Following the Separation, the consolidated financial statements include ESAB and its wholly-owned subsidiaries and no longer include any allocations of expenses from Enovis. Accordingly:

•The Consolidated Balance Sheet as of December 31, 2022 consists of the consolidated balances of ESAB, while the Combined Balance Sheet as of December 31, 2021 consists of the combined balances of the former Fabrication Technology business of Enovis.

•The Consolidated and Combined Statement of Operations and Statement of Comprehensive (Loss) Income for the year ended December 31, 2022 consists of the consolidated results of ESAB for the nine months ended December 31, 2022 and the combined results of the former Fabrication Technology business of Enovis and the certain entities discussed in the “Separation from Enovis” section above for the three months ended April 1, 2022. The Combined Statement of Operations and Statement of Comprehensive (Loss) Income for the years ended December 31, 2021 and 2020 consist of the combined results of the former Fabrication Technology business of Enovis.
•The Consolidated and Combined Statement of Changes in Equity for the year December 31, 2022 consists of the consolidated activities of ESAB for the nine months ended December 31, 2022 and the combined activity of the former Fabrication Technology business of Enovis and the certain entities discussed in the “Separation from Enovis” section above for the three months ended April 1, 2022. The Combined Statements of Changes in Equity for the year ended December 31, 2021 and 2020 consist of the combined activity of the former Fabrication Technology business of Enovis.

•The Consolidated and Combined Statement of Cash Flows for the year ended December 31, 2022 consists of the consolidated activities of ESAB for the nine months ended December 31, 2022 and the combined activity of ESAB and the former Fabrication Technology business of Enovis and the certain entities discussed in the “Separation from Enovis” section above for the three months ended April 1, 2022. The Combined Statement of Cash Flows for the years ended December 31, 2021 and 2020 consist of the combined activity of the former Fabrication Technology business of Enovis.

The Consolidated and Combined Financial Statements of ESAB for the years ended December 31, 2020 and 2021 and the three months ended April 1, 2022 may not be indicative of the Company's results had it been a separate stand-alone entity throughout the periods presented, nor are the results stated herein indicative of what the Company's financial position, results of operations and cash flows may be in the future.

Prior to the Separation, the Company was dependent on the Former Parent for all of its working capital and financing requirements under Enovis’s centralized approach to cash management and financing of its operations. With the exception of cash, cash equivalents and borrowings clearly associated with ESAB and related to the Separation, financing transactions relating to the Company during the period prior to the Separation were accounted for through the Former Parent’s investment account of the Company. Accordingly, none of Enovis’s cash, cash equivalents or debt at the corporate level has been assigned to the Company in these financial statements.
Former Parent’s Investment, which included retained earnings, represented Enovis’s interest in the recorded net assets of the Company. All significant transactions between the Company and the Former Parent prior to the Separation have been included in the accompanying Financial Statements. Transactions with the Former Parent are reflected in the accompanying Consolidated and Combined Statements of Equity as “Transfers to Former Parent, net” and in the accompanying Consolidated and Combined Balance Sheets within “Former Parent’s investment”.
The Consolidated and Combined Financial Statements reflect, in the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly the Company’s financial position and results of operations as of and for the periods indicated. Intercompany transactions and accounts are eliminated in consolidation.
Use of Estimates The Company makes certain estimates and assumptions in preparing its Consolidated and Combined Financial Statements in accordance with U.S. generally accepted accounting principles, or “GAAP”. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the Consolidated and Combined Financial Statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from those estimates.
Use of Estimates
 
The Company makes certain estimates and assumptions in preparing its Consolidated and Combined Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the Consolidated and Combined Financial Statements and the reported amounts of revenues and expenses for the period presented. Actual results may differ from those estimates.
Equity Method Investments Equity Method InvestmentsInvestments accounted for under the equity method are initially recorded at the amount of the Company’s initial investment and adjusted each period for the Company’s share of the investee’s income or loss and dividends paid. All equity investments are reviewed periodically for indications of other-than-temporary impairment, including, but not limited to, significant and sustained decreases in quoted market prices or a series of historic and projected operating losses by investees. If the decline in fair value is considered to be other-than-temporary, an impairment loss is recorded and the investment is written down to a new carrying value.
Revenue Recognition
Revenue Recognition

The Company recognizes revenue when control of promised goods or services is transferred to the customer. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled in exchange for transferring the goods or services.

The Company provides a variety of products and services to its customers. Most of the Company’s contracts consist of a single, distinct performance obligation or promise to transfer goods or services to a customer. For contracts that include multiple performance obligations, we allocate the total transaction price to each performance obligation using our best estimate of the stand-alone selling price of each identified performance obligation. A significant majority of our revenue relates to the shipment of off-the-shelf products that is recognized when control is transferred to the customer. On a limited basis, we have agreements with customers that have multiple performance obligations. In determining whether there are multiple performance obligations, we first assess the goods or services promised in the customer arrangement and then consider the guidance in ASC 606, Revenue from Contracts with Customers, to evaluate whether goods and services are capable of being distinct and are considered distinct within the customer arrangement. To determine whether promised goods or services are separately identifiable (i.e., whether a promise to transfer a good or service is distinct in the context of the contract), we evaluate whether the contract is to deliver (1) multiple promised goods or services or (2) a combined item that comprises the individual goods or services promised in the contract. Substantially all revenue involving development and application engineering projects consists of a single performance obligation and is recognized at a point in time.

As mentioned above, a majority of revenue recognized by the Company relates to contracts with customers for standard or off-the-shelf products. As control typically transfers to the customer upon shipment of the product in these circumstances, revenue is generally recognized at that point in time. Revenue recognition and billing typically occur simultaneously for contracts recognized at a point in time. Therefore, we do not have material revenues in excess of customer billings or billings to customers in excess of recognized revenues. Refer to Note 13, “Accrued and Other Liabilities” for additional information on the Company’s contract liability balances.

For service contracts, the Company recognizes revenue ratably over the period of performance as the customer simultaneously receives and consumes the benefits of the services provided. The Company applies the available practical expedient involving the existence of a significant financing component. As the Company generally does not receive payments greater than one year in advance or arrears of revenue recognition, the Company does not consider any arrangements to include financing components.

The period of benefit for the Company’s incremental costs of obtaining a contract generally have less than a one-year duration; therefore, the Company applies the practical expedient available and expenses costs to obtain a contract when incurred.

Taxes Collected from Customers and Remitted to Governmental Authorities
 
The Company collects various taxes and fees as an agent in connection with the sale of products and remits these amounts to the respective taxing authorities. These taxes and fees have been presented on a net basis within Net sales in the Consolidated and Combined Statements of Operations and are recorded as a component of Accrued liabilities in the Consolidated and Combined Balance Sheets until remitted to the respective taxing authority.
Research and Development Expense
Research and Development Expense
 
Research and development costs of $36.0 million, $39.7 million and $34.8 million for the years ended December 31, 2022, 2021 and 2020, respectively, are expensed as incurred and are included in Selling, general and administrative expense in the Consolidated and Combined Statements of Operations. These amounts do not include development and application engineering costs incurred in conjunction with fulfilling customer orders and executing customer projects.
Cash and Cash Equivalents
Cash and Cash Equivalents
 
Cash and cash equivalents include all financial instruments purchased with an initial maturity of three months or less.
Trade Receivables
Trade Receivables
 
Trade receivables are presented net of an allowance for credit losses. The estimate of current expected credit losses on trade receivables considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. Estimated credit losses are reviewed periodically.
Inventories
Inventories

Inventories are valued at the lower of cost or net realizable value. Fixed manufacturing overhead costs are allocated to inventory based on normal production capacity and abnormal manufacturing activities are recognized as period costs. Cost for a substantial portion of U.S. inventories is determined using the last-in, first-out method (“LIFO”). The value of inventory stated on a LIFO basis as of December 31, 2022 and 2021 was $131.1 million and $142.4 million, respectively. The valuation of LIFO inventories is made at the end of each year based on inventory levels and costs at that time. Cost of other inventories is determined by costing methods that approximate a first-in, first-out basis.

Reserves are maintained for estimated obsolescence or excess inventory equal to the difference between the cost of inventory and the net realizable value based upon assumptions about future demand and market conditions. The reserve for excess and obsolete inventory was $40.1 million and $37.9 million as of December 31, 2022 and 2021, respectively.
Property, Plant and Equipment
Property, Plant and Equipment
 
Property, plant and equipment, net is stated at historical cost, which includes the fair values of such assets acquired through acquisitions. Repair and maintenance expenditures are expensed as incurred unless the repair extends the useful life of the asset.
Impairment of Goodwill and Indefinite-Lived Intangible Assets
Impairment of Goodwill and Indefinite-Lived Intangible Assets
 
Goodwill represents the costs in excess of the fair value of net assets acquired through acquisitions by the Company.
 
The Company evaluates the recoverability of Goodwill and indefinite-lived intangible assets annually or more frequently if an event occurs or circumstances change in the interim that would more likely than not reduce the fair value of the asset below its carrying amount. The annual impairment test date elected by the Company is the first day of its fourth quarter. Goodwill and indefinite-lived intangible assets are considered to be impaired when the carrying value of a reporting unit or asset exceeds its fair value. As of the annual impairment test date, the Company had three reporting units: Americas, EMEA & APAC and Gas Control Equipment (“GCE”).

In the evaluation of goodwill for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting entity is less than its carrying value. If the Company determines that it is more likely than not for a reporting unit’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not for a reporting unit’s fair value to be less than its carrying value, a calculation of the reporting unit’s fair value is performed and compared to the carrying value of that reporting unit. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying value of a reporting unit exceeds its fair value, goodwill of that reporting unit is impaired and an impairment loss is recorded equal to the excess of the reporting unit’s carrying value over its fair value.
When a quantitative impairment test is needed, the Company measures fair value of reporting units based on a present value of future discounted cash flows. The discounted cash flow models indicate the fair value of the reporting units based on the present value of the cash flows that the reporting units are expected to generate in the future. Significant estimates in the discounted cash flow models include the weighted-average cost of capital, net sales and profitability of our business.

For the year ended December 31, 2022 a qualitative Goodwill impairment assessment was performed for the three reporting units. For the year ended December 31, 2021 a quantitative annual impairment test of Goodwill was performed for the GCE reporting unit while qualitative assessments were performed for the remaining two reporting units. A quantitative annual impairment test of Goodwill for each of the Company’s three reporting units was performed for the year ended December 31, 2020. All of the above tests indicated no impairment existed. Therefore, no impairment charges were recorded for the three years ended December 31, 2022. No material events that would represent impairment indicators have occurred subsequent to the performance of the 2022 annual impairment test.

In the evaluation of indefinite-lived intangible assets for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying value. If the Company determines that it is more likely than not for the indefinite-lived intangible asset’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not that the indefinite-lived intangible asset’s fair value is less than its carrying value, a fair value calculation is performed and compared to the carrying value of the asset. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying amount of the indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The Company measures the fair value of its indefinite-lived intangible assets using the “relief from royalty” method. Significant estimates in this approach include projected revenues and royalty and discount rates for each trade name evaluated. At the impairment testing date, the first day of the fourth quarter, quantitative impairment tests were performed for all the indefinite-lived trade name brands for the years ended December 31, 2022, 2021 and 2020, all of which indicated no impairment existed.
Impairment of Long-Lived Assets Other than Goodwill and Indefinite-Lived Intangible Assets
Impairment of Long-Lived Assets Other than Goodwill and Indefinite-Lived Intangible Assets
 
Definite-lived intangible assets primarily represent acquired trade names, customer relationships, acquired technology and software license agreements. The Company uses accelerated and straight-line methods of amortization with lives ranging from ten to thirty years.

The Company assesses its long-lived assets and definite-lived intangible assets for impairment whenever facts and circumstances indicate that the carrying amounts may not be fully recoverable. To analyze recoverability, the Company projects undiscounted net future cash flows over the remaining lives of such assets. If these projected cash flows are less than the carrying amounts, an impairment loss equal to the difference between the carrying amount of the asset and its fair value would be recognized, resulting in a write-down of the assets with a corresponding charge to earnings. Assets held for sale are reported at the lower of the carrying amounts or fair value less cost to sell. The Company determines fair value using the discounted cash flow method or other accepted valuation techniques. The Company determined that no impairment indicators were evident during the years ended December 31, 2022, 2021 and 2020.
Derivatives
Derivatives

The Company uses derivative instruments to manage exposures to interest rates and net investment exposures. The Company does not enter into derivatives for trading or speculative purposes.

All derivatives are recognized at fair value on the Company’s Consolidated and Combined Balance Sheets. The accounting for gains and losses resulting from changes in fair value depends on the use of the derivative and whether it is designated and qualifies for hedge accounting. The Company formally documents the relationship of the hedge with the hedged item as well as the risk-management strategy for all designated hedges. Both at inception and on an ongoing basis, the hedging instrument is assessed as to its effectiveness, when applicable. If and when a derivative is determined not to be highly effective as a hedge, the underlying hedged transaction is no longer likely to occur, or the derivative is terminated, hedge accounting is discontinued.

The Company is subject to the credit risk of the counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. The Company manages individual counterparty exposure by monitoring the credit rating of the counterparty and the size of financial commitments and exposures between the Company and the counterparty.
Certain interest rate swap agreements are qualified and designated as cash flow hedges. The effective portion of the fair value unrealized gain or loss on cash flow hedges are reported as a component of Accumulated other comprehensive income ("AOCI") with offsetting amounts recorded in the Company’s Consolidated and Combined Balance Sheet depending on the position and the duration of the contract. The gain or loss on the derivative instrument due to the change in fair value is reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. If a derivative is deemed to be ineffective, the change in fair value of the derivative is recognized directly in earnings.

Certain cross-currency swap agreements are designated and qualify as a net investment hedge, the changes in the fair value of these instruments are recorded in AOCI in equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCI. Offsetting amounts are recorded in the Company’s Consolidated and Combined Balance Sheet depending on the position and the duration of the contract.

The Company has certain foreign currency contracts which are not designated as hedges. These derivatives are held as offsets to certain balance sheet exposures. The gains or losses on these contracts are recognized in Interest expense (income) and other, net, in the Company’s Consolidated and Combined Statement of Operations.
Warranty Costs
Warranty Costs
 
Estimated expenses related to product warranties are accrued as the revenue is recognized on products sold to customers and included in Cost of sales in the Consolidated and Combined Statements of Operations. Estimates are established using historical information as to the nature, frequency, and average costs of warranty claims.
Income Taxes
Income Taxes
 
Prior to the Separation, the Company’s domestic and foreign operating results were included in the income tax returns of Enovis. The Company accounted for income taxes under the separate return method. Under this approach, the Company determined its deferred tax assets and liabilities and related tax expense as if it were filing separate tax returns. The accompanying Combined Balance Sheets for the year ended December 31, 2021 did not contain current income tax payable or other long-term income tax payable liabilities, with the exception of certain unrecognized tax benefits for which ESAB could have reasonably be considered to be the primary obligor. The amounts are deemed settled with Enovis when they were due and therefore were included in Parent’s equity.

The Company accounts for income taxes under ASC 740, Income Taxes (“ASC 740”) which requires recognition of deferred income tax assets and liabilities reflecting the tax consequences attributable to differences between the carrying amounts of existing assets and liabilities in the Consolidated and Combined Financial Statements and their respective tax basis. Deferred income tax assets and liabilities are measured using enacted tax rates expected to be applied to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred income tax assets and liabilities are reported in Other assets and Other liabilities in the Consolidated and Combined Balance Sheets, respectively. The effect on deferred income tax assets and liabilities of a change in tax rates is generally recognized in Income tax expense in the period that includes the enactment date. Global Intangible Low-Taxed Income (“GILTI”) is accounted for as a current tax expense in the year the tax is incurred.
 
Valuation allowances are recorded if it is more likely than not that some portion of the deferred income tax assets will not be realized. In evaluating the need for a valuation allowance, the Company considers various factors, including the expected level of future taxable income and available tax planning strategies. Any changes in judgment about the valuation allowance are recorded through Income tax expense and are based on changes in facts and circumstances regarding realizability of deferred tax assets.
 
The Company must presume that an income tax position taken in a tax return will be examined by the relevant tax authority and determine whether it is more likely than not that the tax position will be sustained upon examination based upon the technical merits of the position. An income tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The Company establishes a liability for unrecognized income tax benefits for income tax positions for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority to the extent such tax positions reduce the Company’s income tax liability. The Company recognizes interest and penalties related to unrecognized income tax benefits in Income tax expense in the Consolidated and Combined Statements of Operations.
Interest expense (income) and Other, Net
Interest expense (income) and Other, Net

Interest expense (income) and other, net is comprised of interest-bearing deposits of certain foreign subsidiaries, interest costs for the Company’s debt, amortization of debt issuance costs and interest income or expense of derivatives designated in hedging relationships.
In addition, it is comprised of other non-operating income items, including certain pension-related activities, foreign exchange exposure on cash and intercompany positions and interest income or expense on foreign currency contracts not designated in hedging relationships. See “Foreign Currency Exchange Gains and Losses” policy below for additional information.
Foreign Currency Exchange Gains and Losses
Foreign Currency Exchange Gains and Losses
 
The Company’s financial statements are presented in U.S. dollars. The functional currencies of the Company’s operating subsidiaries are generally the local currencies of the countries in which each subsidiary is located. Assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the balance sheet date. The amounts recorded in each year in Foreign currency translation are net of income taxes to the extent the unrealized foreign exchange is taxed currently or the underlying equity balances in the entities are not deemed to be permanently reinvested. Revenues and expenses are translated at average rates of exchange in effect during the year.

Transactions in foreign currencies are translated at the exchange rate in effect at the date of each transaction. Differences in exchange rates during the period between the date a transaction denominated in a foreign currency is consummated and the date on which it is either settled or translated for inclusion in the Consolidated and Combined Balance Sheets are recognized in Selling, general and administrative expense or Interest expense (income) and other, net in the Consolidated and Combined Statements of Operations for that period.
Debt Issuance Costs
Debt Issuance Costs

Costs directly related to the placement of debt are capitalized and amortized to Interest expense primarily using the straight-line method over the term of the related obligation. See Note 15, “Debt” for additional discussion regarding the Company’s borrowing arrangements.
Reclassification
Reclassification

Certain prior period amounts have been reclassified to conform to current year presentations, including certain items within the Consolidated and Combined Statements of Comprehensive Income.
Recently Issued Accounting Pronouncements Recently Issued Accounting PronouncementsThe Company assesses the adoption impacts of recently issued accounting pronouncements on the Company’s Consolidated and Combined financial statements as well as material updates to previous assessments. There were no new material accounting standards issued or adopted in the year of 2022 that impacted the Company.
XML 53 R35.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location
The effects of the excluded components of designated net investment hedges on the Company’s Consolidated and Combined Statements of Operations consisted of the following:

Year Ended December 31,
Derivative typeGain recognized in the Consolidated and Combined Statements of Operations:2022
(In thousands)
Cross currency swap agreementsInterest expense (income) and other, net$(2,181)
Schedule of Net Foreign Transaction Gains and Losses
The following table summarizes the Company’s net foreign transaction gains and losses included within the Consolidated and Combined Statements of Operations:

Year Ended December 31,
202220212020
(In thousands)(1)
Selling, general and administrative expense$2,597 $2,195 $788 
Interest (income) expense and other, net109 191 313 
Foreign currency transaction loss (gain), net$2,706 $2,386 $1,101 
(1) This table excludes the impact of the foreign exchange loss due to the remeasurement of the Company’s Argentinian operations, as described in the “Argentina Currency” paragraph below.
XML 54 R36.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue (Tables)
 12 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue The Company disaggregates its revenue into the following product groups:
Year Ended December 31,
202220212020
(In thousands)
Equipment$740,824 $758,267 $607,504 
Consumables1,852,656 1,669,848 1,342,565 
Total$2,593,480 $2,428,115 $1,950,069 
Schedule of Accounts Receivable, Allowance for Credit Loss
A summary of the activity in the Company’s allowance for credit losses included within Trade receivables in the Consolidated and Combined Balance Sheets is as follows:
Year Ended December 31, 2022
Balance at
Beginning
of Period		Charged to Expense, netWrite-Offs and DeductionsForeign
Currency
Translation		Balance at
End of
Period
(In thousands)
Allowance for credit losses $23,912 $4,526 $(4,978)$11 $23,471 
XML 55 R37.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings per Share from Continuing Operations (Tables)
 12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share from Continuing Operations The Company allocates earnings to participating securities and computed earnings per share using the two-class method as follows:
Year Ended December 31,
202220212020
(In thousands, except share and per share data)
Computation of earnings per share from continuing operations - basic:
Income from continuing operations attributable to ESAB Corporation(1)
$226,815 $235,110 $157,414 
Less: distributed and undistributed earnings allocated to nonvested shares(1,600)— — 
Income from continuing operations attributable to common stockholders$225,215 $235,110 $157,414 
Weighted-average shares of Common stock outstanding – basic(2)
60,054,930 60,034,311 60,034,311 
Income per share from continuing operations – basic
$3.75 $3.92 $2.62 
Computation of earnings (loss) per share from continuing operations - diluted:
Income from continuing operations attributable to common stockholders$225,215 $235,110 $157,414 
Weighted-average shares of Common stock outstanding – basic(2)
60,054,930 60,034,311 60,034,311 
Net effect of potentially dilutive securities(3)
98,129 — — 
Weighted-average shares of Common stock outstanding – dilution
60,153,059 60,034,311 60,034,311 
Net income per share from continuing operations – diluted
$3.74 $3.92 $2.62 
(1) Net income from continuing operations attributable to ESAB Corporation for the respective periods is calculated using Net income from continuing operations, less Income attributable to noncontrolling interest, net of taxes, of $4.3 million, $3.6 million and $2.5 million for the years ended December 31, 2022, 2021 and 2020 respectively.
(2) The total number of shares outstanding on April 4, 2022 was 60,034,311 which is being utilized for the calculation of both basic and diluted earnings per share for the years ended December 31, 2021 and December 31, 2020 as no ESAB common stock equivalents were outstanding prior to the Separation.
(3) Potentially dilutive securities include stock options, performance-based restricted stock units and non performance-based restricted stock units.
XML 56 R38.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign
Income from continuing operations before income taxes and Income tax expense consisted of the following:
 
 Year Ended December 31,
 202220212020
 (In thousands)
Income from continuing operations before income taxes:  
Domestic operations$(19,234)$10,140 $14,505 
Foreign operations319,485 308,948 191,334 
 $300,251 $319,088 $205,839 
Income tax expense:
Current:
Federal$8,928 $18,477 $9,262 
State2,451 1,797 921 
Foreign77,728 68,779 49,819 
 89,107 89,053 60,002 
Deferred:
Federal(7,501)(12,700)(8,698)
State358 161 (677)
Foreign(12,794)3,895 (4,656)
 (19,937)(8,644)(14,031)
 $69,170 $80,409 $45,971 
Schedule of Components of Income Tax Expense (Benefit)
Income from continuing operations before income taxes and Income tax expense consisted of the following:
 
 Year Ended December 31,
 202220212020
 (In thousands)
Income from continuing operations before income taxes:  
Domestic operations$(19,234)$10,140 $14,505 
Foreign operations319,485 308,948 191,334 
 $300,251 $319,088 $205,839 
Income tax expense:
Current:
Federal$8,928 $18,477 $9,262 
State2,451 1,797 921 
Foreign77,728 68,779 49,819 
 89,107 89,053 60,002 
Deferred:
Federal(7,501)(12,700)(8,698)
State358 161 (677)
Foreign(12,794)3,895 (4,656)
 (19,937)(8,644)(14,031)
 $69,170 $80,409 $45,971 
Schedule of Effective Income Tax Rate Reconciliation
The Company’s Income tax expense differs from the amount that would be computed by applying the U.S. federal statutory rate as follows:
Year Ended December 31,
202220212020
(In thousands)
Taxes calculated at the U.S. federal statutory rate$63,053 $67,008 $42,820 
State taxes2,809 1,933 245 
Effect of tax rates on international operations(9,010)(8,879)(572)
Changes in tax reserves(350)2,734 1,346 
Non-taxable dividends— (46)(2,675)
Research and development tax credits(542)(587)(1,351)
Effect of U.S. taxation on international operations310 (313)(1,634)
Permanent differences, net
7,209 483 1,284 
Provision to return(7,055)(7,415)1,053 
Withholding taxes12,133 9,567 6,108 
Capital gain(3,655)12,371 — 
Valuation Allowance4,503 3,737 
Other(235)(184)(653)
Income tax expense$69,170 $80,409 $45,971 
Schedule of Deferred Tax Assets and Liabilities The temporary differences that gave rise to the significant components of deferred tax assets and liabilities are presented below:
December 31,
20222021
(In thousands)
Deferred tax assets:
Post-retirement benefit obligation$5,761 $4,430 
Expenses currently not deductible36,320 29,245 
Net operating loss carryforward111,497 22,374 
Tax credit carryforward10,320 — 
Depreciation and amortization9,124 16,450 
Inventory5,685 138 
Other36,873 24,648 
Valuation allowance(88,202)(15,465)
Deferred tax assets, net$127,378 $81,820 
Deferred tax liabilities:
Depreciation and amortization$(121,858)$(135,726)
Outside basis differences and other (102,336)(108,542)
Total deferred tax liabilities $(224,194)$(244,268)
Total deferred tax liabilities, net$(96,816)$(162,448)

Deferred tax assets and liabilities have been classified as noncurrent and are included in Other assets and Other liabilities in the accompanying Consolidated and Combined Balance Sheets on a net jurisdictional basis as follows:

December 31,
20222021
(In thousands)
Other assets$42,860 $9,357 
Other liabilities(139,676)(171,805)
Deferred tax liability, net$(96,816)$(162,448)
Schedule of Income Tax Contingencies A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows (inclusive of associated interest and penalties):
 (In thousands)
Balance, January 1, 2020
$34,014 
Addition for tax positions taken in prior periods2,785 
Addition for tax positions taken in the current period569 
Reductions resulting from a lapse of applicable statute of limitations(1,827)
Other, including the impact of foreign currency translation and U.S. tax rate changes(340)
Balance, December 31, 2020
35,201 
Addition for tax positions taken in prior periods738 
Addition for tax positions taken in the current period2,987 
Reductions related to settlements with taxing authorities(425)
Reductions resulting from a lapse of applicable statute of limitations(565)
Other, including the impact of foreign currency translation and U.S. tax rate changes(255)
Balance, December 31, 2021
37,681 
Addition for tax positions taken in prior periods1,971 
Addition for tax positions taken in the current period1,171 
Reductions related to settlements with taxing authorities(922)
Transfer from Former Parent, impact of foreign currency translation and other(2,801)
Other, including the impact of foreign currency translation(16,897)
Balance, December 31, 2022
$20,203 
XML 57 R39.htm IDEA: XBRL DOCUMENT v3.22.4
Goodwill and Intangible Assets (Tables)
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The following table summarizes Goodwill activity by segment for the years ended December 31, 2022 and 2021: 

 Americas
EMEA & APAC
Total
 (In thousands)
Balance, January 1, 2021
$522,777 $1,030,454 $1,553,231 
Goodwill attributable to acquisition4,159 — 4,159 
Impact of foreign currency translation(7,782)(16,615)(24,397)
Balance, December 31, 2021
519,154 1,013,839 1,532,993 
Goodwill attributable to acquisitions63,183 13,047 76,230 
Impact of foreign currency translation3,508 (82,964)(79,456)
Balance, December 31, 2022
$585,845 $943,922 $1,529,767 
Schedule of Indefinite-Lived Intangible Assets
The following table summarizes the Company’s Intangible assets, excluding Goodwill: 
 December 31,
 20222021
 Gross
Carrying
Amount		Accumulated
Amortization		Gross
Carrying
Amount		Accumulated
Amortization
 (In thousands)
Indefinite-Lived Intangible Assets
Trade names$180,691 $— $199,484 $— 
Definite-Lived Intangible Assets
Customer relationships482,499 (203,041)448,839 (185,071)
Technology71,192 (50,005)71,503 (49,276)
Trade names22,464 (9,412)16,550 (8,754)
Software94,904 (74,799)91,547 (67,888)
Other intangible assets22,800 (20,126)22,800 (18,300)
 $874,550 $(357,383)$850,723 $(329,289)
Schedule of Finite-Lived Intangible Assets
The following table summarizes the Company’s Intangible assets, excluding Goodwill: 
 December 31,
 20222021
 Gross
Carrying
Amount		Accumulated
Amortization		Gross
Carrying
Amount		Accumulated
Amortization
 (In thousands)
Indefinite-Lived Intangible Assets
Trade names$180,691 $— $199,484 $— 
Definite-Lived Intangible Assets
Customer relationships482,499 (203,041)448,839 (185,071)
Technology71,192 (50,005)71,503 (49,276)
Trade names22,464 (9,412)16,550 (8,754)
Software94,904 (74,799)91,547 (67,888)
Other intangible assets22,800 (20,126)22,800 (18,300)
 $874,550 $(357,383)$850,723 $(329,289)
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
The Company’s expected annual amortization expense for intangible assets for the next five years is as follows: 
 December 31, 2022
 (In thousands)
2023$33,812 
202428,249 
202527,204 
202626,116 
202721,651 
XML 58 R40.htm IDEA: XBRL DOCUMENT v3.22.4
Property, Plant and Equipment, Net (Tables)
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment
  December 31,
 Depreciable Life20222021
 (In years)(In thousands)
Landn/a$15,839 $16,028 
Buildings and improvements
5-40
164,472 172,835 
Machinery and equipment
3-15
382,830 362,074 
  563,141 550,937 
Accumulated depreciation (278,915)(264,659)
 $284,226 $286,278 
XML 59 R41.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories, Net (Tables)
 12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
Schedule of Inventory
Inventories, net consisted of the following:
December 31,
20222021
(In thousands)
Raw materials$153,099 $148,376 
Work in process44,086 39,595 
Finished goods261,902 268,831 
459,087 456,802 
LIFO reserve(2,168)1,129 
Less: allowance for excess, slow-moving and obsolete inventory(40,090)(37,869)
$416,829 $420,062 
XML 60 R42.htm IDEA: XBRL DOCUMENT v3.22.4
Leases (Tables)
 12 Months Ended
Dec. 31, 2022
Leases [Abstract]  
Schedule of Future Minimum Lease Payments
December 31, 2022
(In thousands)
Future lease payments by year:
2023$21,603 
202416,876 
202513,127 
202610,502 
20278,221 
Thereafter37,867 
Total108,196 
Less: present value discount(13,369)
Present value of lease liabilities$94,827 
Weighted-average remaining lease term (in years):
  Operating leases7.55
Weighted-average discount rate:
  Operating leases3.5 %
XML 61 R43.htm IDEA: XBRL DOCUMENT v3.22.4
Accrued and Other Liabilities (Tables)
 12 Months Ended
Dec. 31, 2022
Accrued Liabilities [Abstract]  
Schedule of Accrued and Other Liabilities
Accrued and Other liabilities in the Consolidated and Combined Balance Sheets consisted of the following:
December 31, 2022December 31, 2021
CurrentNoncurrentCurrentNoncurrent
(In thousands)
Accrued taxes and deferred tax liabilities$49,615 $161,500 $58,920 $203,760 
Compensation and related benefits74,794 57,438 74,587 62,215 
Asbestos liability 30,108 230,581 — — 
Contract liability25,899 — 22,265 — 
Lease liability18,664 76,163 20,467 88,777 
Warranty liability 12,946 — 14,954 — 
Third-party commissions18,315 — 16,130 — 
Restructuring liability7,533 285 7,834 275 
Other47,436 19,372 35,952 7,918 
$285,310 $545,339 $251,109 $362,945 
Schedule of Product Warranty Liability
A summary of the activity in the Company’s warranty liability included in Accrued liabilities in the Company’s Consolidated and Combined Balance Sheets is as follows:
Year Ended December 31,
20222021
(In thousands)
Warranty liability, beginning of period$14,954 $14,022 
Accrued warranty expense5,322 6,707 
Changes in estimates related to pre-existing warranties2,821 2,416 
Cost of warranty service work performed(9,680)(7,909)
Foreign exchange translation effect(471)(282)
Warranty liability, end of period$12,946 $14,954 
Schedule of Restructuring Reserve by Type of Cost A summary of the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Consolidated and Combined Balance Sheets is as follows:
Year Ended December 31, 2022
Balance at Beginning of PeriodChargesPaymentsForeign Currency TranslationBalance at End of Period
(In thousands)
Restructuring and other related charges:
Americas
Termination benefits(1)
$2,044 $1,970 $(4,235)$(14)$(235)
Facility closure costs and other(2)
50 9,451 (9,382)— 119 
Subtotal2,094 11,421 (13,617)(14)(116)
Non-cash charges(2)
(37)
Segment Total11,384 
EMEA & APAC
Termination benefits(1)
5,774 2,672 (3,391)90 5,145 
Facility closure costs(2)
241 8,205 (5,686)29 2,789 
Subtotal6,015 10,877 (9,077)119 7,934 
Non-cash charges(2)
835 
Segment Total11,712 
Total$8,109 22,298 $(22,694)$105 $7,818 
Non-cash charges(2)
798 
Total Provision$23,096 
(1) Includes severance and other termination benefits, including outplacement services.
(2) Includes the cost of relocating associates, relocating equipment, lease termination expense, and other costs in connection with the closure and optimization of facilities and product lines.
Year Ended December 31, 2021
Balance at Beginning of PeriodChargesPaymentsForeign Currency TranslationBalance at End of Period
(In thousands)
Restructuring and other related charges:
Americas
Termination benefits(1)
$1,089 $5,414 $(4,455)$(4)$2,044 
Facility closure costs(2)
469 5,978 (6,397)— 50 
Subtotal1,558 11,392 (10,852)(4)2,094 
Non-cash charges(2)
220 
Segment Total11,612 
EMEA & APAC
Termination benefits(1)
4,247 4,219 (2,641)(51)5,774 
Facility closure costs(2)
122 2,090 (1,954)(17)241 
Subtotal4,369 6,309 (4,595)(68)6,015 
Non-cash charges(2)
1,033 
Segment Total7,342 
Total$5,927 17,701 $(15,447)$(72)$8,109 
Non-cash charges(2)
1,253 
Total Provision$18,954 
(1) Includes severance and other termination benefits, including outplacement services.
(2) Includes the cost of relocating associates, relocating equipment, lease termination expense, and other costs in connection with the closure and optimization of facilities and product lines.
XML 62 R44.htm IDEA: XBRL DOCUMENT v3.22.4
Benefit Plans (Tables)
 12 Months Ended
Dec. 31, 2022
Retirement Benefits [Abstract]  
Schedule of Changes in Projected Benefit Obligations
The following table summarizes the total changes in the Company’s pension and accrued post-retirement benefits and plan assets and includes a statement of the plans’ funded status:
 Pension BenefitsOther Post-Retirement Benefits
 
Year Ended December 31,
Year Ended December 31,
 2022202120222021
 (In thousands)
Change in benefit obligation:    
Projected benefit obligation, beginning of year$142,914 $155,914 $382 $388 
Transfer from Former Parent200,690 — 11,697 — 
Service cost1,684 1,785 15 14 
Interest cost5,874 1,668 234 22 
Plan amendments862 911 — — 
Actuarial gain(60,148)(1,866)(2,807)(25)
Foreign exchange effect(12,452)(6,653)(35)(7)
Benefits paid(23,385)(8,168)(636)(10)
Settlements(283)(847)— — 
Other266 170 — — 
Projected benefit obligation, end of year$256,022 $142,914 $8,850 $382 
Accumulated benefit obligation, end of year$253,123 $139,513 $8,850 $382 
Change in plan assets:
Fair value of plan assets, beginning of year$84,503 $73,114 $— $— 
Transfer from Former Parent201,259 — — — 
Actual return on plan assets(51,266)4,706 — — 
Employer contributions5,315 5,210 636 10 
Foreign exchange effect(7,583)(1,594)— — 
Benefits paid(23,385)(8,168)(636)(10)
Settlements(1)
9,947 11,272 — — 
Other260 (37)— — 
Fair value of plan assets, end of year$219,050 $84,503 $— $— 
Funded status, end of year$(36,972)$(58,411)$(8,850)$(382)
Amounts recognized on the Consolidated and Combined Balance Sheets as of December 31:
Non-current assets$15,701 $7,119 $— $— 
Current liabilities(3,025)(3,393)(824)(23)
Non-current liabilities(49,648)(62,137)(8,026)(359)
Total$(36,972)$(58,411)$(8,850)$(382)
    
(1) Settlements includes gains of $9.1 million and $11.2 million classified as Pension settlement gain on the Company’s Consolidated Statement of Operations for the years ended December 31, 2022 and December 31, 2021, respectively.
The following table summarizes the changes in the Company’s foreign pension benefit obligations and plan assets, included in the table above, and includes a statement of the plans’ funded status:
 
 Foreign Pension Benefits
 
Year Ended December 31,
 20222021
 (In thousands)
Change in benefit obligation:  
Projected benefit obligation, beginning of year$141,278 $154,075 
Service cost1,684 1,785 
Interest cost2,161 1,646 
Plan amendments862 911 
Actuarial gain(25,131)(1,787)
Foreign exchange effect(12,452)(6,653)
Benefits paid(8,984)(8,022)
Settlements(283)(847)
Other266 170 
Projected benefit obligation, end of year$99,401 $141,278 
Accumulated benefit obligation, end of year$96,500 $137,876 
Change in plan assets:
Fair value of plan assets, beginning of year$84,503 $73,114 
Actual return on plan assets(12,494)4,706 
Employer contributions5,170 5,064 
Foreign exchange effect(7,581)(1,594)
Benefits paid(8,984)(8,022)
Settlements9,947 11,272 
Other260 (37)
Fair value of plan assets, end of year$70,821 $84,503 
Funded status, end of year$(28,580)$(56,775)
Schedule of Expected Benefit Payments The following benefit payments are expected to be paid during each respective fiscal year:
 Pension BenefitsOther Post-Retirement Benefits
 All PlansForeign Plans
 (In thousands)
2023$22,709 $7,551 $824 
202421,890 7,125 783 
202521,625 7,271 779 
202621,564 7,651 774 
202720,830 7,388 766 
2028 - 203296,928 37,424 3,326 
Schedule of Allocation of Plan Assets
The following are the actual allocation percentages for the Company’s pension plan assets:
 
Actual Asset Allocation
December 31,
 20222021
U.S. Plans:
Equity securities:
U.S.36 %— %
International13 %— %
Fixed income50 %— %
Cash and cash equivalents1 %— %
Foreign Plans:
Equity securities4 %23 %
Fixed income securities34 %25 %
Cash and cash equivalents16 %1 %
Insurance contracts34 %38 %
Investment funds(1)
12 %13 %
 
(1) Represents various fixed income and equity securities.

A summary of the Company’s pension plan assets for each fair value hierarchy level for the periods presented follows (see Note 17, “Fair Value Measurements” for further description of the levels within the fair value hierarchy):
 
 December 31, 2022
 
Measured at Net Asset Value (1)
Level
One		Level
Two		Level
Three		 
Total
 (In thousands)
U.S. Plans:
Cash and cash equivalents $— $1,591 $— $— $1,591 
Equity securities:
U.S. large cap31,018 — — — 31,018 
U.S. small/mid cap10,789 11,289 — — 22,078 
International18,928 — — — 18,928 
Fixed income mutual funds:
U.S. government and corporate73,497 — — — 73,497 
Other — 1,118 — — 1,118 
Foreign Plans:
Cash and cash equivalents (2)
— 11,348 — — 11,348 
Equity securities— 2,475 — — 2,475 
Non-U.S. government and corporate bonds— 24,289 — — 24,289 
Insurance contracts— — 24,236 — 24,236 
Investment funds— — 8,400 — 8,400 
Other— 33 39 — 72 
 $134,232 $52,143 $32,675 $— $219,050 
(1)Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient (the “NAV”) have not been classified in the fair value hierarchy. These investments, consisting of common/collective trusts, are valued using the NAV provided by the Trustee. The NAV is based on the underlying investments held by the fund, that are traded in an active market, less its liabilities. These investments are able to be redeemed in the near-term.
(2) The weighted-average interest crediting rates received in Cash and cash equivalents of foreign plans are immaterial relative to total plan assets.
 December 31, 2021
 Measured at Net Asset Value Level
One		Level
Two		Level
Three		 
Total
 (In thousands)
Foreign Plans:
Cash and cash equivalents (1)
$— $442 $— $— $442 
Equity securities— 19,305 — — 19,305 
Non-U.S. government and corporate bonds— 21,310 — — 21,310 
Insurance contracts— — 32,570 — 32,570 
Investment funds— — 10,836 — 10,836 
Other— — 40 — 40 
 $— $41,057 $43,446 $— $84,503 
 
(1)The weighted-average interest crediting rates received in Cash and cash equivalents of foreign plans are immaterial relative to total plan assets.
Schedule of Net Benefit Costs
The following table sets forth the components of net periodic benefit cost and Other comprehensive income of the Company’s defined benefit pension plans and other post-retirement employee benefit plans:
 
 Pension BenefitsOther Post-Retirement Benefits
 
Year Ended December 31,
Year Ended December 31,
 202220212020202220212020
 (In thousands)
Components of Net Periodic Benefit (Income) Cost:    
Service cost$1,684 $1,785 $1,577 $15 $14 $8 
Interest cost5,874 1,668 2,260 234 22 16 
Amortization4,313 1,220 785 (181)— (8)
Settlement gain(9,114)(11,195)— — 8 — 
Other92 2 154 — — — 
Expected return on plan assets(11,519)(2,258)(2,397)— — — 
Net periodic benefit (income) cost$(8,670)$(8,778)$2,379 $68 $44 $16 
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:
Transfer from Former Parent$53,134 $— $— $(2,629)$— $— 
Current year net actuarial (gain) loss949 (5,788)6,533 (2,807)(27)157 
Current year prior service cost862 — 95 — — — 
Less amounts included in net periodic benefit cost:
Amortization of net (gain) loss(4,340)(1,228)(785)181 (8)8 
Settlement/divestiture/other gain(67)— (89)— — — 
Amortization of prior service cost(1,067)(5)— — — — 
Total recognized in Other comprehensive (gain) loss$49,471 $(7,021)$5,754 $(5,255)$(35)$165 
The following table sets forth the components of net periodic benefit cost and Other comprehensive income of the foreign defined benefit pension plans, included in the table above:
 Foreign Pension Benefits
 
Year Ended December 31,
 202220212020
 (In thousands)
Components of Net Periodic Benefit (Income) Cost: 
Service cost$1,684 $1,785 $1,577 
Interest cost2,161 1,646 2,218 
Amortization687 1,118 692 
Settlement gain(9,114)(11,195)— 
Other92 2 154 
Expected return on plan assets(2,063)(2,258)(2,397)
Net periodic benefit (income) cost$(6,553)$(8,902)$2,244 
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:
Current year net actuarial loss (gain)$(12,262)$(5,710)$6,389 
Current year prior service cost862 — 101 
Less amounts included in net periodic benefit (income) cost:
Amortization of net loss(714)(1,126)(692)
Settlement/divestiture/other gain(67)— (89)
Amortization of prior service cost(1,067)(5)— 
Total recognized in Other comprehensive (gain) loss$(13,248)$(6,841)$5,709 
Schedule of Amounts Recognized in Other Comprehensive Income (Loss)
The following table sets forth the components of net periodic benefit cost and Other comprehensive income of the Company’s defined benefit pension plans and other post-retirement employee benefit plans:
 
 Pension BenefitsOther Post-Retirement Benefits
 
Year Ended December 31,
Year Ended December 31,
 202220212020202220212020
 (In thousands)
Components of Net Periodic Benefit (Income) Cost:    
Service cost$1,684 $1,785 $1,577 $15 $14 $8 
Interest cost5,874 1,668 2,260 234 22 16 
Amortization4,313 1,220 785 (181)— (8)
Settlement gain(9,114)(11,195)— — 8 — 
Other92 2 154 — — — 
Expected return on plan assets(11,519)(2,258)(2,397)— — — 
Net periodic benefit (income) cost$(8,670)$(8,778)$2,379 $68 $44 $16 
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:
Transfer from Former Parent$53,134 $— $— $(2,629)$— $— 
Current year net actuarial (gain) loss949 (5,788)6,533 (2,807)(27)157 
Current year prior service cost862 — 95 — — — 
Less amounts included in net periodic benefit cost:
Amortization of net (gain) loss(4,340)(1,228)(785)181 (8)8 
Settlement/divestiture/other gain(67)— (89)— — — 
Amortization of prior service cost(1,067)(5)— — — — 
Total recognized in Other comprehensive (gain) loss$49,471 $(7,021)$5,754 $(5,255)$(35)$165 
The following table sets forth the components of net periodic benefit cost and Other comprehensive income of the foreign defined benefit pension plans, included in the table above:
 Foreign Pension Benefits
 
Year Ended December 31,
 202220212020
 (In thousands)
Components of Net Periodic Benefit (Income) Cost: 
Service cost$1,684 $1,785 $1,577 
Interest cost2,161 1,646 2,218 
Amortization687 1,118 692 
Settlement gain(9,114)(11,195)— 
Other92 2 154 
Expected return on plan assets(2,063)(2,258)(2,397)
Net periodic benefit (income) cost$(6,553)$(8,902)$2,244 
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:
Current year net actuarial loss (gain)$(12,262)$(5,710)$6,389 
Current year prior service cost862 — 101 
Less amounts included in net periodic benefit (income) cost:
Amortization of net loss(714)(1,126)(692)
Settlement/divestiture/other gain(67)— (89)
Amortization of prior service cost(1,067)(5)— 
Total recognized in Other comprehensive (gain) loss$(13,248)$(6,841)$5,709 
Schedule of Net Periodic Benefit Cost Not yet Recognized
The components of net unrecognized pension and other post-retirement benefit cost included in Accumulated other comprehensive loss in the Consolidated and Combined Balance Sheets that have not been recognized as a component of net periodic benefit cost are as follows:
 Pension BenefitsOther Post-Retirement
Benefits
 
December 31,
December 31,
 2022202120222021
 (In thousands)
Net actuarial loss (gain)71,066 21,388 (5,199)56 
Prior service (income) cost(112)95 — — 
Total$70,954 $21,483 $(5,199)$56 
Schedule of Assumptions Used
The key economic assumptions used in the measurement of the Company’s pension and other post-retirement benefit obligations are as follows:
 Pension BenefitsOther Post-Retirement
Benefits
 
December 31,
December 31,
 2022202120222021
Weighted-average discount rate:    
All plans4.6 %1.9 %5.0 %6.6 %
Foreign plans4.3 %1.9 %— %— %
Weighted-average rate of increase in compensation levels for active foreign plans(1)
3.2 %0.6 %— %— %
 
(1)Weighted-average rate of increase is only applicable to plans with compensation increase assumptions.
 
The key economic assumptions used in the computation of net periodic benefit cost are as follows: 
Pension BenefitsOther Post-Retirement Benefits
 
Year Ended December 31,
Year Ended December 31,
 202220212020202220212020
Weighted-average discount rate:    
All plans2.2 %1.3 %2.0 %2.6 %6.0 %7.6 %
Foreign plans1.9 %1.3 %1.9 %— %— %— %
Weighted-average expected return on plan assets:
All plans4.8 %3.6 %4.1 %— %— %— %
Foreign plans3.2 %3.6 %4.1 %— %— %— %
Weighted-average rate of increase in compensation levels for active foreign plans(1)
3.2 %3.4 %3.7 %— %— %— %
  (1)Weighted-average rate of increase is only applicable to plans with compensation increase assumptions.
XML 63 R45.htm IDEA: XBRL DOCUMENT v3.22.4
Debt (Tables)
 12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
Schedule of Long-Term Debt
Long-term debt consisted of the following:
December 31, 2022
(In thousands)
Term loans$1,000,000 
Revolving credit facilities221,000 
Total debt1,221,000 
Unamortized deferred financing fees(1)
(2,357)
Long-term debt$1,218,643 
 
(1)In the Company’s Consolidated Balance sheet, $1.2 million of deferred financing fees related to the Revolving Facility are included in Other assets and $2.4 million of deferred financing fees related to the Term Facilities are recorded as a contra-liability within Long-term debt.
Schedule of the Contractual Maturities of the Company's Debt
The contractual maturities of the Company’s debt is as follows:

December 31, 2022
(in thousands)
2023$— 
2024— 
2025600,000 
2026— 
2027621,000 
Total debt(1)
$1,221,000 
 
(1)Total debt excludes $3.6 million of related unamortized deferred financing fees.
XML 64 R46.htm IDEA: XBRL DOCUMENT v3.22.4
Derivatives (Tables)
 12 Months Ended
Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)
The effects of designated cash flow hedges on the Company’s Consolidated and Combined Statements of Operations consisted of the following:

Year Ended December 31,
Derivative typeLoss recognized in the Consolidated and Combined Statements of Operations:2022
(In thousands)
Interest rate swap agreementsInterest expense (income) and other, net$413 
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The table below shows the fair value of the derivatives recognized in the Consolidated Balance Sheet:

December 31, 2022
Designated as hedging instrumentsOther LiabilitiesOther Assets
(In thousands)
Cross currency swap agreements $10,769 $— 
Interest rate swap agreements— 14,342 
Total$10,769 $14,342 
Schedule of Derivative Instruments
The Company recognized the following in its Consolidated and Combined Financial Statements related to its derivative instruments not designated in a hedging relationship:
Year Ended December 31,
Foreign currency contracts202220212020
(In thousands)
Change in unrealized gains1,338 177 1,426 
Realized loss(1)
(17,601)(5,631)(469)
(1) The year ended December 31, 2022 includes realized losses relating to certain corporate entities contributed to ESAB Corporation which are reflected within Interest expense (income) and other, net, in the Consolidated and Combined Statements of Operations. See Note 1, “Organization and Basis of Presentation” for additional details. These realized losses are offset by unrealized gains which are also reflected within Interest expense (income) and other, net, in the Consolidated and Combined Statements of Operations
Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location
The effects of the excluded components of designated net investment hedges on the Company’s Consolidated and Combined Statements of Operations consisted of the following:

Year Ended December 31,
Derivative typeGain recognized in the Consolidated and Combined Statements of Operations:2022
(In thousands)
Cross currency swap agreementsInterest expense (income) and other, net$(2,181)
XML 65 R47.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements (Tables)
 12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is as follows (see Note 14, “Benefit Plans” for classification of the assets of the Company’s benefit plans within the fair value hierarchy):
December 31, 2022
Level
One		Level
Two		Level
Three		Total
(In thousands)
Assets:
Cash equivalents$8,195 $— $— $8,195 
Foreign currency contracts - not designated as hedges(1)
— 3,682 — 3,682 
Interest rate swap agreements— 14,342 — 14,342 
Deferred compensation plans— 2,501 — 2,501 
$8,195 $20,525 $— $28,720 
Liabilities:
Foreign currency contracts - not designated as hedges(2)
$— $2,166 $— $2,166 
Cross currency swap agreements— 10,769 — 10,769 
Deferred compensation plans— 2,501 — 2,501 
$— $15,436 $— $15,436 
(1) Included within Other Current Assets in the Consolidated Balance Sheet.
(2) Included within Accrued Liabilities in the Consolidated Balance Sheet.
December 31, 2021
Level
One		Level
Two		Level
Three		Total
(In thousands)
Assets:
Cash equivalents$8,133 $— $— $8,133 
Foreign currency contracts - not designated as hedges(1)
— 2,487 — 2,487 
$8,133 $2,487 $— $10,620 
Liabilities:
Foreign currency contracts - not designated as hedges(2)
$— $2,309 $— $2,309 
(1) Included within Other Current Assets in the Consolidated Balance Sheet.
(2) Included within Accrued Liabilities in the Consolidated Balance Sheet.
XML 66 R48.htm IDEA: XBRL DOCUMENT v3.22.4
Equity (Tables)
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Loss
The following table presents the changes in the balances of each component of Accumulated other comprehensive loss including reclassifications out of Accumulated other comprehensive loss for the years ended December 31, 2022, 2021 and 2020. All amounts are net of tax and noncontrolling interest, if any.

Accumulated Other Comprehensive Loss Components
Net Unrecognized Pension and Other Post-Retirement Benefit CostForeign Currency Translation AdjustmentLoss on Net Investment Hedges Gain on Cash Flow HedgesTotal
(In thousands)
Balance at January 1, 2020$(23,887)$(399,641)$— $— $(423,528)
Other comprehensive income (loss) before reclassifications:— 
Net actuarial loss(4,328)— — — (4,328)
Foreign currency translation adjustment(1,791)32,816 — — 31,025 
Other comprehensive (loss) income before reclassifications(6,119)32,816 — — 26,697 
Amounts reclassified from Accumulated other comprehensive loss(1)
628 — — — 628 
Net current period Other comprehensive (loss) income(5,491)32,816 — — 27,325 
Balance at December 31, 2020(29,378)(366,825)— — (396,203)
Other comprehensive income (loss) before reclassifications:— 
Net actuarial gain7,479 — — — 7,479 
Foreign currency translation adjustment1,534 (72,867)— — (71,333)
Other comprehensive (loss) income before reclassifications9,013 (72,867)— — (63,854)
Amounts reclassified from Accumulated other comprehensive loss(1)
(831)— — — (831)
Net current period Other comprehensive (loss) income8,182 (72,867)— — (64,685)
Balance at December 31, 2021(21,196)(439,692)— — (460,888)
Other comprehensive income (loss) before reclassifications:
Amounts contributed by Former Parent(2)
(50,504)(8,759)— — (59,263)
Net actuarial gain 113 — — — 113 
Foreign currency translation adjustment1,712 (82,351)(8,336)— (88,975)
Loss on long-term intra-entity foreign currency transactions— (83,105)— — (83,105)
Unrealized gain on cash flow hedges— — — 10,782 10,782 
Other comprehensive (loss) income before reclassifications(48,679)(174,215)(8,336)10,782 (220,448)
Amounts reclassified from Accumulated other comprehensive loss(1)(3)
6,028 — — 320 6,348 
Net current period Other comprehensive (loss) income(42,651)(174,215)(8,336)11,102 (214,100)
Balance at December 31, 2022$(63,847)$(613,907)$(8,336)$11,102 $(674,988)
(1) The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost. See Note 14,
“Benefit Plans” for additional details.
(2) Includes unrecognized pension and other post-retirement costs and accumulated currency translation adjustments of certain entities which were part of the Corporate segment of the Former
Parent and were transferred to ESAB Corporation in anticipation of the Separation. Please see Note 1, “Organization and Basis of Presentation” for more information on the entities
contributed from the Former Parent.
(3) During the year ended December 31, 2022, the amount on this line within the Gain on Cash Flow Hedges column is a component of Interest expense (income) and other, net. See Note 16, “Derivatives”, for additional details.
Schedule of Nonvested Share Activity
The activity of the Company’s PRSUs and RSUs is as follows:
 PRSUsRSUs
 Number
of Units		Weighted-
Average
Grant-Date
Fair Value		Number
of Units		Weighted-
Average
Grant-Date
Fair Value
Balance at December 31, 2021— $— — $— 
Awards converted from Former Parent plan58,636 58.03 333,223 52.89 
Granted51,652 49.40 187,556 47.28 
Vested— — (27,354)48.11 
Forfeited and expired— — (29,147)52.40 
Balance at December 31, 2022110,288 53.99 464,278 50.80 
XML 67 R49.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments and Contingencies (Tables)
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Schedule Of Loss Contingencies By Claims Quantities
Asbestos-related claims activity since December 31, 2021 is as follows:
Year Ended
December 31, 2022
(Number of claims)
Claims unresolved, beginning of period14,559 
Claims filed(1)
4,338 
Claims resolved(2)
(4,791)
Claims unresolved, end of period14,106 
(In dollars)
Average cost of resolved claims(3)
$10,017 
(1) Claims filed include all asbestos claims for which notification has been received or a file has been opened.
(2) Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based
upon agreements or understandings in place with counsel for the claimants.
(3) Excludes claims settled in Mississippi for which the majority of claims have historically been resolved for no payment and insurance recoveries.
Schedule Of Asbestos Related Litigation
The Company’s Consolidated and Combined Balance Sheet included the following amounts related to asbestos-related litigation:
December 31, 2022
(In thousands)
Long-term asbestos insurance asset(1)
$215,112 
Long-term asbestos insurance receivable(1)
17,231 
Accrued asbestos liability(2)
30,108 
Long-term asbestos liability(3)
230,581 
(1) Included in Other assets in the Consolidated and Combined Balance Sheet.
(2) Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay, and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Consolidated and Combined Balance Sheet.
(3) Included in Other liabilities in the Consolidated and Combined Balance Sheet.
XML 68 R50.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information (Tables)
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The Company’s segment results were as follows:
Year Ended December 31,
202220212020
(In thousands)
Net sales(1):
     Americas$1,128,306 $1,004,208 $767,414 
EMEA & APAC1,465,174 1,423,907 1,182,655 
$2,593,480 $2,428,115 $1,950,069 
Adjusted EBITDA(2):
     Americas$188,577 $159,623 $111,588 
EMEA & APAC248,177 244,458 189,558 
$436,754 $404,081 $301,146 
Depreciation, amortization and other impairment charges:
     Americas$29,281 $33,890 $36,380 
EMEA & APAC36,697 42,009 40,264 
$65,978 $75,899 $76,644 
Capital expenditures:
     Americas$18,005 $14,095 $15,244 
EMEA & APAC22,238 21,489 24,894 
$40,243 $35,584 $40,138 
(1) For the years ended December 31, 2022, 2021 and 2020, the total Net sales originating from the United States were $583.0 million, $533.5 million and $443.7 million, respectively. The remainder of the sales were derived from foreign countries.
(2) The following is a reconciliation of Net income from continuing operations to Adjusted EBITDA:
Year Ended December 31,
202220212020
(In thousands)
Net income from continuing operations$231,081 $238,679 $159,868 
Income tax expense69,170 80,40945,971
Interest expense (income) and other, net (1)
37,950 (29)(1,023)
Pension settlement gain(9,136)(11,208)— 
Restructuring and other related charges
23,096 18,954 21,633 
Separation costs(2)
15,545 2,865 — 
Acquisition - amortization and other related charges(3)
34,196 35,949 36,331 
Depreciation and other amortization34,852 38,462 38,366 
Adjusted EBITDA$436,754 $404,081 $301,146 
(1) Relates to removal of interest expense, net included within the Interest expense (income) and other, net line within the Consolidated and Combined Statements of Operations
(2) Includes non-recurring charges and employee costs related to the planning and execution of the separation from Enovis within the Selling, general and administrative expense line within the Consolidated and Combined Statements of Operations.
(3) Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses.

December 31,
20222021
(In thousands)
Investments in Equity Method Investees:
     Americas$— $— 
     EMEA & APAC28,527 28,180 
$28,527 $28,180 
Total Assets:
     Americas$1,666,799 $1,304,797 
     EMEA & APAC2,087,216 2,156,465 
$3,754,015 $3,461,262 
Schedule of Long-Lived Assets, by Geographical Areas
December 31,
20222021
(In thousands)
Property, Plant and Equipment, Net(1):
United States$68,380 $64,136 
Czech Republic60,278 63,273 
India34,892 37,312 
Russia19,111 18,797 
Mexico17,666 14,720 
Other foreign countries83,899 88,040 
$284,226 $286,278 
(1) As the Company does not allocate all long-lived assets, specifically intangible assets, to each individual country, evaluation of long-lived assets in total is impracticable.
XML 69 R51.htm IDEA: XBRL DOCUMENT v3.22.4
Organization and Basis of Presentation (Details)
$ in Thousands
 12 Months Ended
Apr. 04, 2022
USD ($)
shares
Mar. 21, 2022
plan
Dec. 31, 2022
USD ($)
segment
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Concentration Risk [Line Items]          
Number of reportable segments | segment     2    
Net income     $ 223,747 $ 235,110 $ 157,414
Stockholders' Equity Attributable to Parent     (1,350,207) $ (2,460,735)  
Foreign Currency Translation Adjustment          
Concentration Risk [Line Items]          
Stockholders' Equity Attributable to Parent     90,000    
Russia          
Concentration Risk [Line Items]          
Net income     $ 20,000    
Russia | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk          
Concentration Risk [Line Items]          
Concentration risk (as a percent)     6.00%    
Russia | Assets, Total | Geographic Concentration Risk          
Concentration Risk [Line Items]          
Concentration risk (as a percent)     5.00%    
The Credit Agreement          
Concentration Risk [Line Items]          
Indebtedness incurred $ 1,200,000        
Enovis Corporation          
Concentration Risk [Line Items]          
Number of shares sold (in shares) | shares 6,000,000        
ESAB Corporation | Enovis Corporation          
Concentration Risk [Line Items]          
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners 10.00%        
Common Stock          
Concentration Risk [Line Items]          
Percentage of outstanding stock after spin-off (as a percent) 90.00%        
Common Stock | Enovis Corporation          
Concentration Risk [Line Items]          
Number of shares recapitalized (in shares) | shares 0.333        
Defined Benefit Plan, Unfunded Plan          
Concentration Risk [Line Items]          
Number of defined benefit plans | plan   2      
XML 70 R52.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies - Narrative (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
USD ($)
reporting_unit
Dec. 31, 2021
USD ($)
reporting_unit
Dec. 31, 2020
USD ($)
reporting_unit
Research and development costs $ 36,000 $ 39,700 $ 34,800
LIFO inventory amount 131,100 142,400  
Reserve for excess and obsolete inventory $ (40,090) $ (37,869)  
Number of reporting units | reporting_unit 3 2 3
Minimum | Acquired Trade names, Customer Relationships, Acquired Technology and Software License Agreements      
Intangible asset, useful life (in years) 10 years    
Maximum | Acquired Trade names, Customer Relationships, Acquired Technology and Software License Agreements      
Intangible asset, useful life (in years) 30 years    
XML 71 R53.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies - Net Foreign Transaction Gains and Losses (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Change in Accounting Estimate [Line Items]      
Foreign currency transaction loss (gain), net $ 2,706 $ 2,386 $ 1,101
Argentina, Pesos      
Change in Accounting Estimate [Line Items]      
Foreign currency transaction loss (gain), net 2,400    
Selling, general and administrative expense      
Change in Accounting Estimate [Line Items]      
Foreign currency transaction loss (gain), net 2,597 2,195 788
Selling, general and administrative expense | Argentina, Pesos      
Change in Accounting Estimate [Line Items]      
Foreign currency transaction loss (gain), net 6,600    
Interest (income) expense and other, net      
Change in Accounting Estimate [Line Items]      
Foreign currency transaction loss (gain), net 109 $ 191 $ 313
Interest (income) expense and other, net | Argentina, Pesos      
Change in Accounting Estimate [Line Items]      
Foreign currency transaction loss (gain), net $ 3,300    
XML 72 R54.htm IDEA: XBRL DOCUMENT v3.22.4
Discontinued Operations - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Loss from discontinued operations, net of taxes $ (3,068) $ 0 $ 0
Cash used in operating activities, discontinued operations 23,100    
Asbestos Related Activity      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Loss from discontinued operations, net of taxes 7,500    
Income tax benefit $ 4,400    
XML 73 R55.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisitions - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Oct. 31, 2022
Oct. 17, 2022
Oct. 14, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Business Acquisition [Line Items]            
Cash consideration, net       $ 149,029 $ 4,885 $ 0
Swift Cut Automation Limited            
Business Acquisition [Line Items]            
Cash consideration, net $ 22,000          
Ohio Medical, LLC,            
Business Acquisition [Line Items]            
Cash consideration, net   $ 127,000        
Cash tax benefit     $ 15,000      
XML 74 R56.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disaggregation of Revenue [Line Items]      
Net sales $ 2,593,480 $ 2,428,115 $ 1,950,069
Equipment      
Disaggregation of Revenue [Line Items]      
Net sales 1,852,656 758,267 607,504
Consumables      
Disaggregation of Revenue [Line Items]      
Net sales $ 740,824 $ 1,669,848 $ 1,342,565
XML 75 R57.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue - Narrative (Details) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenue from Contract with Customer [Abstract]      
Contract liability $ 25.9 $ 22.3 $ 21.6
XML 76 R58.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue - Allowance for Credit Loss Rollforward (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
USD ($)
Accounts Receivable, Allowance for Credit Loss [Roll Forward]  
Balance at Beginning of Period $ 23,912
Charged to Expense, net 4,526
Write-Offs and Deductions (4,978)
Foreign Currency Translation 11
Balance at End of Period $ 23,471
XML 77 R59.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings per Share from Continuing Operations (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Apr. 04, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Computation of earnings per share from continuing operations - basic:        
Income from continuing operations attributable to ESAB Corporation   $ 226,815    
Less: distributed and undistributed earnings allocated to nonvested shares   (1,600) $ 0 $ 0
Net Income (Loss) Available to Common Stockholders   $ 225,215 $ 235,110 $ 157,414
Weighted-average shares of common stock outstanding - basic (in shares) 60,034,311 60,054,930,000 60,034,311 60,034,311
Income per share from continuing operations – basic (in dollars per share)   $ 3.75 $ 3.92 $ 2.62
Computation of earnings (loss) per share from continuing operations - diluted:        
Net effect of potentially dilutive securities (in shares)   98,129,000 0 0
Weighted-average shares of common stock outstanding - assuming dilution (in shares)   60,153,059,000 60,034,311 60,034,311
Income per share from continuing operations – assuming dilution (in dollars per share)   $ 3.74 $ 3.92 $ 2.62
Income attributable to noncontrolling interest, net of taxes   $ 4,266 $ 3,569 $ 2,454
XML 78 R60.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Components of Income Before Taxes and Income Tax Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income from continuing operations before income taxes:      
Domestic operations $ (19,234) $ 10,140 $ 14,505
Foreign operations 319,485 308,948 191,334
Income from continuing operations before income taxes 300,251 319,088 205,839
Current:      
Federal 8,928 18,477 9,262
State 2,451 1,797 921
Foreign 77,728 68,779 49,819
Current income tax 89,107 89,053 60,002
Deferred:      
Federal (7,501) (12,700) (8,698)
State 358 161 (677)
Foreign (12,794) 3,895 (4,656)
Deferred Income Tax (19,937) (8,644) (14,031)
Income tax expense $ 69,170 $ 80,409 $ 45,971
XML 79 R61.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Effective Income Tax Rate Reconciliation (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]      
Taxes calculated at the U.S. federal statutory rate $ 63,053 $ 67,008 $ 42,820
State taxes 2,809 1,933 245
Effect of tax rates on international operations (9,010) (8,879) (572)
Changes in tax reserves (350) 2,734 1,346
Non-taxable dividends 0 (46) (2,675)
Research and development tax credits (542) (587) (1,351)
Effect of U.S. taxation on international operations 310 (313) (1,634)
Permanent differences, net 7,209 483 1,284
Provision to return (7,055) (7,415) 1,053
Withholding taxes 12,133 9,567 6,108
Capital gain (3,655) 12,371 0
Valuation Allowance 4,503 3,737
Other (235) (184) (653)
Income tax expense $ 69,170 $ 80,409 $ 45,971
XML 80 R62.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Deferred tax assets:    
Post-retirement benefit obligation $ 5,761 $ 4,430
Expenses currently not deductible 36,320 29,245
Net operating loss carryforward 111,497 22,374
Tax credit carryforward 10,320 0
Depreciation and amortization 9,124 16,450
Inventory 5,685 138
Other 36,873 24,648
Valuation allowance (88,202) (15,465)
Deferred tax assets, net 127,378 81,820
Deferred tax liabilities:    
Depreciation and amortization (121,858) (135,726)
Outside basis differences and other (102,336) (108,542)
Total deferred tax liabilities (224,194) (244,268)
Total deferred tax liabilities, net $ (96,816) $ (162,448)
XML 81 R63.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Deferred Tax Assets and Liabilities Balance Sheet Items (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Income Tax Examination [Line Items]    
Other liabilities $ (161,500) $ (203,760)
Total deferred tax liabilities, net (96,816) (162,448)
Other Assets    
Income Tax Examination [Line Items]    
Other assets 42,860 9,357
Other Liabilities    
Income Tax Examination [Line Items]    
Other liabilities $ (139,676) $ (171,805)
XML 82 R64.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Apr. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Tax Examination [Line Items]          
Valuation allowance   $ 88,202 $ 15,465    
Increase in valuation allowance   4,500      
Decrease in valuation allowance   600      
Net operating loss carryforward, subject to expiration   18,100      
Deferred tax liability, increase (decrease)   4,500      
Unrecognized tax benefits   20,203 37,681 $ 35,201 $ 34,014
Unrecognized tax benefits, income tax penalties and interest accrued   5,600 6,200 5,200  
Unrecognized tax (benefits), income tax penalties and interest expense   (700) $ 900 $ 700  
Undistributed foreign earnings   4,500      
Forecast          
Income Tax Examination [Line Items]          
Repatriation of foreign earnings $ 11,000        
Foreign Tax Authority          
Income Tax Examination [Line Items]          
Operating loss carryforwards   424,300      
Undistributed earnings of foreign subsidiaries   $ 57,500      
XML 83 R65.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Gross Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Beginning Balance $ 37,681 $ 35,201 $ 34,014
Addition for tax positions taken in prior periods 1,971 738 2,785
Addition for tax positions taken in the current period 1,171 2,987 569
Reductions resulting from a lapse of applicable statute of limitations   (565) (1,827)
Reductions related to settlements with taxing authorities (922) (425)  
Transfer from Former Parent, impact of foreign currency translation and other (2,801)    
Other, including the impact of foreign currency translation and U.S. tax rate changes (16,897) (255) (340)
Ending Balance $ 20,203 $ 37,681 $ 35,201
XML 84 R66.htm IDEA: XBRL DOCUMENT v3.22.4
Goodwill and Intangible Assets - Goodwill (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Goodwill [Roll Forward]    
Balance beginning of period $ 1,532,993 $ 1,553,231
Goodwill attributable to acquisition 76,230 4,159
Impact of foreign currency translation (79,456) (24,397)
Balance end of period 1,529,767 1,532,993
Americas    
Goodwill [Roll Forward]    
Balance beginning of period 519,154 522,777
Goodwill attributable to acquisition 63,183 4,159
Impact of foreign currency translation 3,508 (7,782)
Balance end of period 585,845 519,154
EMEA & APAC    
Goodwill [Roll Forward]    
Balance beginning of period 1,013,839 1,030,454
Goodwill attributable to acquisition 13,047 0
Impact of foreign currency translation (82,964) (16,615)
Balance end of period $ 943,922 $ 1,013,839
XML 85 R67.htm IDEA: XBRL DOCUMENT v3.22.4
Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Intangible Assets Schedule [Line Items]    
Accumulated Amortization $ (357,383) $ (329,289)
Total intangible assets 874,550 850,723
Trade names    
Intangible Assets Schedule [Line Items]    
Gross Carrying Amount 22,464 16,550
Accumulated Amortization (9,412) (8,754)
Customer relationships    
Intangible Assets Schedule [Line Items]    
Gross Carrying Amount 482,499 448,839
Accumulated Amortization (203,041) (185,071)
Technology    
Intangible Assets Schedule [Line Items]    
Gross Carrying Amount 71,192 71,503
Accumulated Amortization (50,005) (49,276)
Software    
Intangible Assets Schedule [Line Items]    
Gross Carrying Amount 94,904 91,547
Accumulated Amortization (74,799) (67,888)
Other intangible assets    
Intangible Assets Schedule [Line Items]    
Gross Carrying Amount 22,800 22,800
Accumulated Amortization (20,126) (18,300)
Trade names    
Intangible Assets Schedule [Line Items]    
Indefinite-Lived Intangible Assets $ 180,691 $ 199,484
XML 86 R68.htm IDEA: XBRL DOCUMENT v3.22.4
Goodwill and Intangible Assets - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]      
Amortization expense $ 35.6 $ 42.1 $ 41.8
XML 87 R69.htm IDEA: XBRL DOCUMENT v3.22.4
Goodwill and Intangible Assets - Expected Amortization Expense (Details )
$ in Thousands
Dec. 31, 2022
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
2023 $ 33,812
2024 28,249
2025 27,204
2026 26,116
2027 $ 21,651
XML 88 R70.htm IDEA: XBRL DOCUMENT v3.22.4
Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 563,141 $ 550,937
Accumulated depreciation (278,915) (264,659)
Property, plant and equipment, net 284,226 286,278
Land    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 15,839 16,028
Buildings and improvements    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 164,472 172,835
Buildings and improvements | Minimum    
Property, Plant and Equipment [Line Items]    
Depreciable Life 5 years  
Buildings and improvements | Maximum    
Property, Plant and Equipment [Line Items]    
Depreciable Life 40 years  
Machinery and equipment    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 382,830 $ 362,074
Machinery and equipment | Minimum    
Property, Plant and Equipment [Line Items]    
Depreciable Life 3 years  
Machinery and equipment | Maximum    
Property, Plant and Equipment [Line Items]    
Depreciable Life 15 years  
XML 89 R71.htm IDEA: XBRL DOCUMENT v3.22.4
Property, Plant and Equipment, Net - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Property, Plant and Equipment      
Property, Plant and Equipment [Line Items]      
Depreciation and other amortization $ 29.5 $ 32.5 $ 32.9
XML 90 R72.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories, Net (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Inventory Disclosure [Abstract]    
Raw materials $ 153,099 $ 148,376
Work in process 44,086 39,595
Finished goods 261,902 268,831
Inventories, gross 459,087 456,802
LIFO reserve (2,168) 1,129
Less: allowance for excess, slow-moving and obsolete inventory (40,090) (37,869)
Inventories, net $ 416,829 $ 420,062
Percentage of inventory valued at LIFO 31.50% 33.90%
XML 91 R73.htm IDEA: XBRL DOCUMENT v3.22.4
Leases (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Leases [Abstract]      
Operating lease expense $ 21,300 $ 23,000 $ 21,600
Future lease payments by year:      
2023 21,603    
2024 16,876    
2025 13,127    
2026 10,502    
2027 8,221    
Thereafter 37,867    
Total 108,196    
Less: present value discount (13,369)    
Present value of lease liabilities $ 94,827    
Weighted-average remaining lease term (in years):      
Operating leases 7 years 6 months 18 days    
Weighted-average discount rate:      
Operating leases 3.50%    
XML 92 R74.htm IDEA: XBRL DOCUMENT v3.22.4
Accrued and Other Liabilities - Current and Noncurrent (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
CURRENT LIABILITIES:    
Accrued taxes and deferred tax liabilities $ 49,615 $ 58,920
Compensation and related benefits 74,794 74,587
Asbestos liability 30,108 0
Contract liability 25,899 22,265
Lease liability 18,664 20,467
Warranty liability 12,946 14,954
Third-party commissions 18,315 16,130
Restructuring liability 7,533 7,834
Other 47,436 35,952
Accrued liabilities $ 285,310 $ 251,109
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Accrued liabilities Accrued liabilities
Liabilities, Noncurrent [Abstract]    
Accrued taxes and deferred tax liabilities $ 161,500 $ 203,760
Compensation and related benefits 57,438 62,215
Asbestos liability 230,581 0
Contract liability $ 0 $ 0
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Total accrued and other liabilities, Noncurrent Total accrued and other liabilities, Noncurrent
Lease liability $ 76,163 $ 88,777
Warranty liability 0 0
Third-party commissions 0 0
Restructuring liability 285 275
Other 19,372 7,918
Total accrued and other liabilities, Noncurrent $ 545,339 $ 362,945
XML 93 R75.htm IDEA: XBRL DOCUMENT v3.22.4
Accrued and Other Liabilities - Warranty Liability Rollforward (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Movement in Standard Product Warranty Accrual [Roll Forward]    
Warranty liability, beginning of period $ 14,954 $ 14,022
Accrued warranty expense 5,322 6,707
Changes in estimates related to pre-existing warranties 2,821 2,416
Cost of warranty service work performed (9,680) (7,909)
Foreign exchange translation effect (471) (282)
Warranty liability, end of period $ 12,946 $ 14,954
XML 94 R76.htm IDEA: XBRL DOCUMENT v3.22.4
Accrued and Other Liabilities - Restructuring Rollforward (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Restructuring Reserve [Roll Forward]      
Balance at Beginning of Period $ 8,109 $ 5,927  
Charges 22,298 17,701  
Payments (22,694) (15,447)  
Foreign Currency Translation 105 (72)  
Balance at End of Period 7,818 8,109 $ 5,927
Non cash charges 798 1,253  
Total Provision 23,096 18,954 21,633
Americas      
Restructuring Reserve [Roll Forward]      
Balance at Beginning of Period 2,094 1,558  
Charges 11,421 11,392  
Payments (13,617) (10,852)  
Foreign Currency Translation (14) (4)  
Balance at End of Period (116) 2,094 1,558
Non cash charges (37) 220  
Total Provision 11,384 11,612  
EMEA & APAC      
Restructuring Reserve [Roll Forward]      
Balance at Beginning of Period 6,015 4,369  
Charges 10,877 6,309  
Payments (9,077) (4,595)  
Foreign Currency Translation 119 (68)  
Balance at End of Period 7,934 6,015 4,369
Non cash charges 835 1,033  
Total Provision 11,712 7,342  
Termination Benefits | Americas      
Restructuring Reserve [Roll Forward]      
Balance at Beginning of Period 2,044 1,089  
Charges 1,970 5,414  
Payments (4,235) (4,455)  
Foreign Currency Translation (14) (4)  
Balance at End of Period (235) 2,044 1,089
Termination Benefits | EMEA & APAC      
Restructuring Reserve [Roll Forward]      
Balance at Beginning of Period 5,774 4,247  
Charges 2,672 4,219  
Payments (3,391) (2,641)  
Foreign Currency Translation 90 (51)  
Balance at End of Period 5,145 5,774 4,247
Facility Closure Costs | Americas      
Restructuring Reserve [Roll Forward]      
Balance at Beginning of Period 50 469  
Charges 9,451 5,978  
Payments (9,382) (6,397)  
Foreign Currency Translation 0 0  
Balance at End of Period 119 50 469
Facility Closure Costs | EMEA & APAC      
Restructuring Reserve [Roll Forward]      
Balance at Beginning of Period 241 122  
Charges 8,205 2,090  
Payments (5,686) (1,954)  
Foreign Currency Translation 29 (17)  
Balance at End of Period $ 2,789 $ 241 $ 122
XML 95 R77.htm IDEA: XBRL DOCUMENT v3.22.4
Benefit Plans - Narrative (Details)
$ in Thousands
 12 Months Ended
Mar. 21, 2022
plan
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
plan
Dec. 31, 2020
USD ($)
Defined Benefit Plan Disclosure [Line Items]        
Pension settlement gain   $ 9,136 $ 11,208 $ 0
Plans with accumulated benefit obligations in excess of plan assets, accumulated benefit obligation   201,100 68,500  
Plans with accumulated benefit obligations in excess of plan assets, fair value of plan assets   149,800 5,200  
Plans with projected benefit obligations in excess of plan assets, projected benefit obligation   206,800 76,200  
Plans with projected benefit obligations in excess of plan assets, fair value of plan assets   154,100 10,700  
Expected employer contributions in the next fiscal year   $ 5,200    
Weighted-average annual rate of increase (as a percent)   7.50%    
Health care cost trend rate (as a percent)   4.10%    
Defined contribution plan, cost   $ 8,700 7,900 9,800
Foreign Plan        
Defined Benefit Plan Disclosure [Line Items]        
Transfer from Former Parent   219,050 84,503  
Defined Benefit Plan, Unfunded Plan        
Defined Benefit Plan Disclosure [Line Items]        
Number of defined benefit plans | plan 2      
Pension Benefits        
Defined Benefit Plan Disclosure [Line Items]        
Transfer from Former Parent   219,050 84,503 73,114
Change in benefit obligation:   256,022 142,914 155,914
Pretax net unrecognized pension and other post-retirement benefit cost included in accumulated other comprehensive loss   70,954 21,483  
Pension settlement gain   9,114 11,195 0
Pension Benefits | Former Parent        
Defined Benefit Plan Disclosure [Line Items]        
Transfer from Former Parent     201,300  
Change in benefit obligation:     200,700  
Pension Benefits | Foreign Plan        
Defined Benefit Plan Disclosure [Line Items]        
Transfer from Former Parent   70,821 84,503 73,114
Change in benefit obligation:   99,401 141,278 154,075
Pension settlement gain   9,114 $ 11,195 0
Pension Benefits | Defined Benefit Plan, Unfunded Plan | Former Parent        
Defined Benefit Plan Disclosure [Line Items]        
Number of defined benefit plans | plan     1  
Pretax net unrecognized pension and other post-retirement benefit cost included in accumulated other comprehensive loss     $ 100  
Other Post-Retirement Benefits        
Defined Benefit Plan Disclosure [Line Items]        
Transfer from Former Parent   0 0 0
Change in benefit obligation:   8,850 382 388
Pretax net unrecognized pension and other post-retirement benefit cost included in accumulated other comprehensive loss   (5,199) 56  
Pension settlement gain   $ 0 (8) $ 0
Other Post-Retirement Benefits | Former Parent        
Defined Benefit Plan Disclosure [Line Items]        
Change in benefit obligation:     $ 11,700  
Number of defined benefit plans | plan     1  
XML 96 R78.htm IDEA: XBRL DOCUMENT v3.22.4
Benefit Plans - Obligation and Asset Rollforward (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Change in plan assets:      
Pension settlement gain $ 9,136 $ 11,208 $ 0
Foreign Plan      
Change in plan assets:      
Fair value of plan assets, beginning of year 84,503    
Fair value of plan assets, end of year 219,050 84,503  
Pension Benefits      
Change in benefit obligation:      
Projected benefit obligation, beginning of year 142,914 155,914  
Transfer from Former Parent 200,690 0  
Service cost 1,684 1,785 1,577
Interest cost 5,874 1,668 2,260
Plan amendments 862 911  
Actuarial gain (60,148) (1,866)  
Foreign exchange effect (12,452) (6,653)  
Benefits paid (23,385) (8,168)  
Settlements (283) (847)  
Other 266 170  
Projected benefit obligation, end of year 256,022 142,914 155,914
Accumulated benefit obligation, end of year 253,123 139,513  
Change in plan assets:      
Fair value of plan assets, beginning of year 84,503 73,114  
Transfer from Former Parent 201,259 0  
Actual return on plan assets (51,266) 4,706  
Employer contributions 5,315 5,210  
Foreign exchange effect (7,583) (1,594)  
Benefits paid (23,385) (8,168)  
Settlements 9,947 11,272  
Other 260 (37)  
Fair value of plan assets, end of year 219,050 84,503 73,114
Funded status, end of year (36,972) (58,411)  
Non-current assets 15,701 7,119  
Current liabilities (3,025) (3,393)  
Non-current liabilities (49,648) (62,137)  
Total (36,972) (58,411)  
Pension settlement gain 9,114 11,195 0
Pension Benefits | Foreign Plan      
Change in benefit obligation:      
Projected benefit obligation, beginning of year 141,278 154,075  
Service cost 1,684 1,785 1,577
Interest cost 2,161 1,646 2,218
Plan amendments 862 911  
Actuarial gain (25,131) (1,787)  
Foreign exchange effect (12,452) (6,653)  
Benefits paid (8,984) (8,022)  
Settlements (283) (847)  
Other 266 170  
Projected benefit obligation, end of year 99,401 141,278 154,075
Accumulated benefit obligation, end of year 96,500 137,876  
Change in plan assets:      
Fair value of plan assets, beginning of year 84,503 73,114  
Actual return on plan assets (12,494) 4,706  
Employer contributions 5,170 5,064  
Foreign exchange effect (7,581) (1,594)  
Benefits paid (8,984) (8,022)  
Settlements 9,947 11,272  
Other 260 (37)  
Fair value of plan assets, end of year 70,821 84,503 73,114
Funded status, end of year (28,580) (56,775)  
Pension settlement gain 9,114 11,195 0
Other Post-Retirement Benefits      
Change in benefit obligation:      
Projected benefit obligation, beginning of year 382 388  
Transfer from Former Parent 11,697 0  
Service cost 15 14 8
Interest cost 234 22 16
Plan amendments 0 0  
Actuarial gain (2,807) (25)  
Foreign exchange effect (35) (7)  
Benefits paid (636) (10)  
Settlements 0 0  
Other 0 0  
Projected benefit obligation, end of year 8,850 382 388
Accumulated benefit obligation, end of year 8,850 382  
Change in plan assets:      
Fair value of plan assets, beginning of year 0 0  
Transfer from Former Parent 0 0  
Actual return on plan assets 0 0  
Employer contributions 636 10  
Foreign exchange effect 0 0  
Benefits paid (636) (10)  
Settlements 0 0  
Other 0 0  
Fair value of plan assets, end of year 0 0 0
Funded status, end of year (8,850) (382)  
Non-current assets 0 0  
Current liabilities (824) (23)  
Non-current liabilities (8,026) (359)  
Total (8,850) (382)  
Pension settlement gain $ 0 $ (8) $ 0
XML 97 R79.htm IDEA: XBRL DOCUMENT v3.22.4
Benefit Plans - Expected Benefit Payments (Details)
$ in Thousands
Dec. 31, 2022
USD ($)
Pension Benefits  
Defined Benefit Plan Disclosure [Line Items]  
2023 $ 22,709
2024 21,890
2025 21,625
2026 21,564
2027 20,830
2028 - 2032 96,928
Pension Benefits | Foreign Plan  
Defined Benefit Plan Disclosure [Line Items]  
2023 7,551
2024 7,125
2025 7,271
2026 7,651
2027 7,388
2028 - 2032 37,424
Other Post-Retirement Benefits  
Defined Benefit Plan Disclosure [Line Items]  
2023 824
2024 783
2025 779
2026 774
2027 766
2028 - 2032 $ 3,326
XML 98 R80.htm IDEA: XBRL DOCUMENT v3.22.4
Benefit Plans - Plan Asset Allocation (Details)
Dec. 31, 2022
Dec. 31, 2021
Equity securities | Foreign Plan    
Defined Benefit Plan Disclosure [Line Items]    
Actual asset allocation 4.00% 23.00%
U.S. | United States    
Defined Benefit Plan Disclosure [Line Items]    
Actual asset allocation 36.00% 0.00%
International | United States    
Defined Benefit Plan Disclosure [Line Items]    
Actual asset allocation 13.00% 0.00%
Fixed income | United States    
Defined Benefit Plan Disclosure [Line Items]    
Actual asset allocation 50.00% 0.00%
Fixed income | Foreign Plan    
Defined Benefit Plan Disclosure [Line Items]    
Actual asset allocation 34.00% 25.00%
Cash and cash equivalents | United States    
Defined Benefit Plan Disclosure [Line Items]    
Actual asset allocation 1.00% 0.00%
Cash and cash equivalents | Foreign Plan    
Defined Benefit Plan Disclosure [Line Items]    
Actual asset allocation 16.00% 1.00%
Insurance contracts | Foreign Plan    
Defined Benefit Plan Disclosure [Line Items]    
Actual asset allocation 34.00% 38.00%
Investment funds | Foreign Plan    
Defined Benefit Plan Disclosure [Line Items]    
Actual asset allocation 12.00% 13.00%
XML 99 R81.htm IDEA: XBRL DOCUMENT v3.22.4
Benefit Plans - Plan Asset Allocation, Fair Value Hierarchy (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
United States | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent $ 1,591  
United States | U.S. large cap    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 31,018  
United States | U.S. small/mid cap    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 22,078  
United States | International    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 18,928  
United States | U.S. government and corporate    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 73,497  
United States | Other    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 1,118  
United States | Measured at Net Asset Value | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0  
United States | Measured at Net Asset Value | U.S. large cap    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 31,018  
United States | Measured at Net Asset Value | U.S. small/mid cap    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 10,789  
United States | Measured at Net Asset Value | International    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 18,928  
United States | Measured at Net Asset Value | U.S. government and corporate    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 73,497  
United States | Measured at Net Asset Value | Other    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0  
United States | Level One | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 1,591  
United States | Level One | U.S. large cap    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0  
United States | Level One | U.S. small/mid cap    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 11,289  
United States | Level One | International    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0  
United States | Level One | U.S. government and corporate    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0  
United States | Level One | Other    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 1,118  
United States | Level Two | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0  
United States | Level Two | U.S. large cap    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0  
United States | Level Two | U.S. small/mid cap    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0  
United States | Level Two | International    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0  
United States | Level Two | U.S. government and corporate    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0  
United States | Level Two | Other    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0  
United States | Level Three | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0  
United States | Level Three | U.S. large cap    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0  
United States | Level Three | U.S. small/mid cap    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0  
United States | Level Three | International    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0  
United States | Level Three | U.S. government and corporate    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0  
United States | Level Three | Other    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0  
Foreign Plan    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 219,050 $ 84,503
Foreign Plan | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 11,348 442
Foreign Plan | Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 2,475 19,305
Foreign Plan | Non-U.S. government and corporate bonds    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 24,289 21,310
Foreign Plan | Insurance contracts    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 24,236 32,570
Foreign Plan | Investment funds    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 8,400 10,836
Foreign Plan | Other    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 72 40
Foreign Plan | Measured at Net Asset Value    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 134,232 0
Foreign Plan | Measured at Net Asset Value | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0 0
Foreign Plan | Measured at Net Asset Value | Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0 0
Foreign Plan | Measured at Net Asset Value | Non-U.S. government and corporate bonds    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0 0
Foreign Plan | Measured at Net Asset Value | Insurance contracts    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0 0
Foreign Plan | Measured at Net Asset Value | Investment funds    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0 0
Foreign Plan | Measured at Net Asset Value | Other    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0 0
Foreign Plan | Level One    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 52,143 41,057
Foreign Plan | Level One | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 11,348 442
Foreign Plan | Level One | Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 2,475 19,305
Foreign Plan | Level One | Non-U.S. government and corporate bonds    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 24,289 21,310
Foreign Plan | Level One | Insurance contracts    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0 0
Foreign Plan | Level One | Investment funds    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0 0
Foreign Plan | Level One | Other    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 33 0
Foreign Plan | Level Two    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 32,675 43,446
Foreign Plan | Level Two | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0 0
Foreign Plan | Level Two | Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0 0
Foreign Plan | Level Two | Non-U.S. government and corporate bonds    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0 0
Foreign Plan | Level Two | Insurance contracts    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 24,236 32,570
Foreign Plan | Level Two | Investment funds    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 8,400 10,836
Foreign Plan | Level Two | Other    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 39 40
Foreign Plan | Level Three    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0 0
Foreign Plan | Level Three | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0 0
Foreign Plan | Level Three | Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0 0
Foreign Plan | Level Three | Non-U.S. government and corporate bonds    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0 0
Foreign Plan | Level Three | Insurance contracts    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0 0
Foreign Plan | Level Three | Investment funds    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent 0 0
Foreign Plan | Level Three | Other    
Defined Benefit Plan Disclosure [Line Items]    
Transfer from Former Parent $ 0 $ 0
XML 100 R82.htm IDEA: XBRL DOCUMENT v3.22.4
Benefit Plans - Net Periodic Benefit Cost (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Components of Net Periodic Benefit (Income) Cost:      
Settlement gain $ (9,136) $ (11,208) $ 0
Pension Benefits      
Components of Net Periodic Benefit (Income) Cost:      
Service cost 1,684 1,785 1,577
Interest cost 5,874 1,668 2,260
Amortization 4,313 1,220 785
Settlement gain (9,114) (11,195) 0
Other 92 2 154
Expected return on plan assets (11,519) (2,258) (2,397)
Net periodic benefit (income) cost (8,670) (8,778) 2,379
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:      
Transfer from Former Parent 53,134 0 0
Current year net actuarial (gain) loss 949 (5,788) 6,533
Current year prior service cost 862 0 95
Less amounts included in net periodic benefit cost:      
Amortization of net (gain) loss (4,340) (1,228) (785)
Settlement/divestiture/other gain (67) 0 (89)
Amortization of prior service cost (1,067) (5) 0
Total recognized in Other comprehensive (gain) loss 49,471 (7,021) 5,754
Other Post-Retirement Benefits      
Components of Net Periodic Benefit (Income) Cost:      
Service cost 15 14 8
Interest cost 234 22 16
Amortization (181) 0 (8)
Settlement gain 0 8 0
Other 0 0 0
Expected return on plan assets 0 0 0
Net periodic benefit (income) cost 68 44 16
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:      
Transfer from Former Parent (2,629) 0 0
Current year net actuarial (gain) loss (2,807) (27) 157
Current year prior service cost 0 0 0
Less amounts included in net periodic benefit cost:      
Amortization of net (gain) loss 181 (8) 8
Settlement/divestiture/other gain 0 0 0
Amortization of prior service cost 0 0 0
Total recognized in Other comprehensive (gain) loss (5,255) (35) 165
Foreign Plan | Pension Benefits      
Components of Net Periodic Benefit (Income) Cost:      
Service cost 1,684 1,785 1,577
Interest cost 2,161 1,646 2,218
Amortization 687 1,118 692
Settlement gain (9,114) (11,195) 0
Other 92 2 154
Expected return on plan assets (2,063) (2,258) (2,397)
Net periodic benefit (income) cost (6,553) (8,902) 2,244
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:      
Current year net actuarial (gain) loss (12,262) (5,710) 6,389
Current year prior service cost 862 0 101
Less amounts included in net periodic benefit cost:      
Amortization of net (gain) loss (714) (1,126) (692)
Settlement/divestiture/other gain (67) 0 (89)
Amortization of prior service cost (1,067) (5) 0
Total recognized in Other comprehensive (gain) loss $ (13,248) $ (6,841) $ 5,709
XML 101 R83.htm IDEA: XBRL DOCUMENT v3.22.4
Benefit Plans - Accumulated Other Comprehensive Income (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Pension Benefits    
Defined Benefit Plan Disclosure [Line Items]    
Net actuarial loss (gain) $ 71,066 $ 21,388
Prior service (income) cost (112) 95
Total 70,954 21,483
Other Post-Retirement Benefits    
Defined Benefit Plan Disclosure [Line Items]    
Net actuarial loss (gain) (5,199) 56
Prior service (income) cost 0 0
Total $ (5,199) $ 56
XML 102 R84.htm IDEA: XBRL DOCUMENT v3.22.4
Benefit Plans - Key Economic Assumptions (Details)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Pension Benefits      
Defined Benefit Plan Disclosure [Line Items]      
Weighted-average discount rate, benefit obligation 4.60% 1.90%  
Weighted-average discount rate, net periodic benefit cost 2.20% 1.30% 2.00%
Weighted-average expected return on plan assets, net periodic benefit cost 4.80% 3.60% 4.10%
Other Post-Retirement Benefits      
Defined Benefit Plan Disclosure [Line Items]      
Weighted-average discount rate, benefit obligation 5.00% 6.60%  
Weighted-average discount rate, net periodic benefit cost 2.60% 6.00% 7.60%
Weighted-average expected return on plan assets, net periodic benefit cost 0.00% 0.00% 0.00%
Foreign Plan | Pension Benefits      
Defined Benefit Plan Disclosure [Line Items]      
Weighted-average discount rate, benefit obligation 4.30% 1.90%  
Weighted-average rate of increase in compensation levels for active foreign plans 3.20% 0.60%  
Weighted-average discount rate, net periodic benefit cost 1.90% 1.30% 1.90%
Weighted-average expected return on plan assets, net periodic benefit cost 3.20% 3.60% 4.10%
Weighted-average rate of increase in compensation levels for active foreign plans, net periodic benefit cost 3.20% 3.40% 3.70%
Foreign Plan | Other Post-Retirement Benefits      
Defined Benefit Plan Disclosure [Line Items]      
Weighted-average discount rate, benefit obligation 0.00% 0.00%  
Weighted-average rate of increase in compensation levels for active foreign plans 0.00% 0.00%  
Weighted-average discount rate, net periodic benefit cost 0.00% 0.00% 0.00%
Weighted-average expected return on plan assets, net periodic benefit cost 0.00% 0.00% 0.00%
Weighted-average rate of increase in compensation levels for active foreign plans, net periodic benefit cost 0.00% 0.00% 0.00%
XML 103 R85.htm IDEA: XBRL DOCUMENT v3.22.4
Debt - Schedule of Debt (Details)
$ in Thousands
Dec. 31, 2022
USD ($)
Debt Instrument [Line Items]  
Total debt $ 1,221,000
Unamortized deferred financing fees (2,357)
Long-term debt 1,218,643
Unamortized deferred financing fees 3,600
Other Assets  
Debt Instrument [Line Items]  
Unamortized deferred financing fees 1,200
Long-term Debt  
Debt Instrument [Line Items]  
Unamortized deferred financing fees 2,400
Term loans | The Credit Agreement | Line of Credit  
Debt Instrument [Line Items]  
Total debt 1,000,000
Unamortized deferred financing fees 2,400
Revolving credit facilities | The Credit Agreement | Line of Credit  
Debt Instrument [Line Items]  
Total debt 221,000
Unamortized deferred financing fees $ 1,200
XML 104 R86.htm IDEA: XBRL DOCUMENT v3.22.4
Debt - Narrative (Details)
 12 Months Ended
Apr. 04, 2022
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Jun. 30, 2024
Jun. 30, 2023
Jun. 28, 2022
USD ($)
Debt Instrument [Line Items]              
Proceeds from borrowings on revolving credit facility and other   $ 805,881,000 $ 673,000 $ 0      
Letters of credit outstanding amount   31,500,000          
Unamortized deferred financing fees   3,600,000          
Other Assets              
Debt Instrument [Line Items]              
Unamortized deferred financing fees   1,200,000          
Long-term Debt              
Debt Instrument [Line Items]              
Unamortized deferred financing fees   $ 2,400,000          
Enovis Corporation              
Debt Instrument [Line Items]              
Cash consideration $ 1,200,000,000            
The Credit Agreement              
Debt Instrument [Line Items]              
Indebtedness incurred $ 1,200,000,000            
Weighted-average interest rate (as a percent)   4.54%          
The Credit Agreement | Minimum              
Debt Instrument [Line Items]              
Basis spread on variable rate (as a percent) 1.125%            
The Credit Agreement | Minimum | Base Rate              
Debt Instrument [Line Items]              
Basis spread on variable rate (as a percent) 0.125%            
The Credit Agreement | Maximum              
Debt Instrument [Line Items]              
Basis spread on variable rate (as a percent) 1.75%            
The Credit Agreement | Maximum | Base Rate              
Debt Instrument [Line Items]              
Basis spread on variable rate (as a percent) 0.75%            
The Credit Agreement | Line of Credit              
Debt Instrument [Line Items]              
Maximum total leverage ratio   4.00          
Minimum interest coverage ratio   3.00          
The Credit Agreement | Line of Credit | Forecast              
Debt Instrument [Line Items]              
Maximum total leverage ratio         3.50 3.75  
Revolving credit facilities | The Credit Agreement | Line of Credit              
Debt Instrument [Line Items]              
Line of credit facility, maximum borrowing capacity $ 750,000,000            
Proceeds from borrowings on revolving credit facility and other 200,000,000            
Line of credit facility, remaining borrowing capacity   $ 529,000,000          
Unamortized deferred financing fees   1,200,000          
Term loans | The Credit Agreement | Senior Notes              
Debt Instrument [Line Items]              
Principal amount $ 600,000,000           $ 600,000,000
Debt term (in days) 364 days            
Indebtedness incurred $ 600,000,000            
Term loans | The Credit Agreement | Line of Credit              
Debt Instrument [Line Items]              
Principal amount 400,000,000            
Indebtedness incurred 400,000,000            
Unamortized deferred financing fees   2,400,000          
Letter of Credit              
Debt Instrument [Line Items]              
Line of credit facility, maximum borrowing capacity   102,900,000          
Letter of Credit | The Credit Agreement | Line of Credit              
Debt Instrument [Line Items]              
Line of credit facility, maximum borrowing capacity 300,000,000            
Letter of Credit | Uncommitted Credit Line              
Debt Instrument [Line Items]              
Line of credit facility, maximum borrowing capacity   $ 77,000,000          
Swing Line Loan Sub-Facility | The Credit Agreement | Line of Credit              
Debt Instrument [Line Items]              
Line of credit facility, maximum borrowing capacity $ 50,000,000            
XML 105 R87.htm IDEA: XBRL DOCUMENT v3.22.4
Debt - Schedule of Debt Maturities (Details)
$ in Thousands
Dec. 31, 2022
USD ($)
Debt Disclosure [Abstract]  
2023 $ 0
2024 0
2025 600,000
2026 0
2027 621,000
Long-term debt 1,221,000
Unamortized deferred financing fees $ 3,600
XML 106 R88.htm IDEA: XBRL DOCUMENT v3.22.4
Derivatives - Narratives (Details)
€ in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2022
USD ($)
Dec. 31, 2022
EUR (€)
Jul. 22, 2022
agreement
Jul. 14, 2022
USD ($)
agreement
Dec. 31, 2021
USD ($)
Interest rate swap agreements          
Derivative Instruments and Hedging Activities Disclosures [Line Items]          
Number of derivative instruments held | agreement       2  
Notional amount       $ 600.0  
Fixed interest rate       3.293%  
Basis spread on variable rate (as a percent) 1.25% 1.25%      
Interest rate swap agreements | Cash Flow Hedging          
Derivative Instruments and Hedging Activities Disclosures [Line Items]          
Loss related to interest rate swap agreements $ 7.3        
Interest rate swap agreements | Minimum          
Derivative Instruments and Hedging Activities Disclosures [Line Items]          
Basis spread on variable rate (as a percent)       1.125%  
Interest rate swap agreements | Maximum          
Derivative Instruments and Hedging Activities Disclosures [Line Items]          
Basis spread on variable rate (as a percent)       1.75%  
Cross currency swap agreements          
Derivative Instruments and Hedging Activities Disclosures [Line Items]          
Number of derivative instruments held | agreement     2    
Cross currency swap agreements | Designated as Hedging Instrument          
Derivative Instruments and Hedging Activities Disclosures [Line Items]          
Notional amount 275.0 € 270      
Cross currency swap agreements | Not Designated as Hedging Instrument          
Derivative Instruments and Hedging Activities Disclosures [Line Items]          
Notional amount $ 260.0       $ 180.8
XML 107 R89.htm IDEA: XBRL DOCUMENT v3.22.4
Derivatives - Summary of the Effects of Designated Cash Flow Hedges on the Company’s Consolidated and Combined Statements of Operations (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
USD ($)
Interest rate swap agreements | Interest expense (income) and other, net  
Derivative Instruments and Hedging Activities Disclosures [Line Items]  
Loss recognized in the Consolidated and Combined Statements of Operations: $ 413
XML 108 R90.htm IDEA: XBRL DOCUMENT v3.22.4
Derivatives - Schedule of Fair Values of Derivative Instruments in the Financial Statements (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
USD ($)
Derivative Instruments and Hedging Activities Disclosures [Line Items]  
Other Liabilities $ 10,769
Other Assets 14,342
Cross currency swap agreements  
Derivative Instruments and Hedging Activities Disclosures [Line Items]  
Other Liabilities 10,769
Other Assets 0
Interest rate swap agreements  
Derivative Instruments and Hedging Activities Disclosures [Line Items]  
Realized loss (2,181)
Other Liabilities 0
Other Assets $ 14,342
XML 109 R91.htm IDEA: XBRL DOCUMENT v3.22.4
Derivatives - Not Designated as Hedging Instruments (Details) - Cross currency swap agreements - Not Designated as Hedging Instrument - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Derivative Instruments, Gain (Loss) [Line Items]      
Change in unrealized gains $ 1,338 $ 177 $ 1,426
Realized loss $ (17,601) $ (5,631) $ (469)
XML 110 R92.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements - Fair Value Hierarchy (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Assets:    
Cash equivalents $ 8,195 $ 8,133
Deferred Compensation Plan Assets 2,501  
Total assets at fair value 28,720 10,620
Liabilities:    
Deferred compensation plans 2,501  
Total liabilities at fair value 15,436  
Cross currency swap agreements | Not Designated as Hedging Instrument    
Assets:    
Derivative Asset 3,682 2,487
Liabilities:    
Derivative liabilities 2,166 2,309
Cross currency swap agreements | Designated as Hedging Instrument    
Liabilities:    
Derivative liabilities 10,769  
Interest rate swap agreements    
Assets:    
Derivative Asset 14,342  
Level One    
Assets:    
Cash equivalents 8,195 8,133
Deferred Compensation Plan Assets 0  
Total assets at fair value 8,195 8,133
Liabilities:    
Deferred compensation plans 0  
Total liabilities at fair value 0  
Level One | Cross currency swap agreements | Not Designated as Hedging Instrument    
Assets:    
Derivative Asset 0 0
Liabilities:    
Derivative liabilities 0 0
Level One | Cross currency swap agreements | Designated as Hedging Instrument    
Liabilities:    
Derivative liabilities 0  
Level One | Interest rate swap agreements    
Assets:    
Derivative Asset 0  
Level Two    
Assets:    
Cash equivalents 0 0
Deferred Compensation Plan Assets 2,501  
Total assets at fair value 20,525 2,487
Liabilities:    
Deferred compensation plans 2,501  
Total liabilities at fair value 15,436  
Level Two | Cross currency swap agreements | Not Designated as Hedging Instrument    
Assets:    
Derivative Asset 3,682 2,487
Liabilities:    
Derivative liabilities 2,166 2,309
Level Two | Cross currency swap agreements | Designated as Hedging Instrument    
Liabilities:    
Derivative liabilities 10,769  
Level Two | Interest rate swap agreements    
Assets:    
Derivative Asset 14,342  
Level Three    
Assets:    
Cash equivalents 0 0
Deferred Compensation Plan Assets 0  
Total assets at fair value 0 0
Liabilities:    
Deferred compensation plans 0  
Total liabilities at fair value 0  
Level Three | Cross currency swap agreements | Not Designated as Hedging Instrument    
Assets:    
Derivative Asset 0 0
Liabilities:    
Derivative liabilities 0 $ 0
Level Three | Cross currency swap agreements | Designated as Hedging Instrument    
Liabilities:    
Derivative liabilities 0  
Level Three | Interest rate swap agreements    
Assets:    
Derivative Asset $ 0  
XML 111 R93.htm IDEA: XBRL DOCUMENT v3.22.4
Equity - Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning balance $ 2,501,728 $ 2,544,767 $ 2,681,203
Other comprehensive income (loss) before reclassifications:      
Net actuarial gain (loss) (88,975) 7,479 (4,328)
Foreign currency translation adjustment (83,105) (71,333) 31,025
Unrealized gain on cash flow hedges 10,782    
Other comprehensive (loss) income before reclassifications (220,448) (63,854) 26,697
Amounts contributed by Former Parent (59,263)    
Net actuarial gain (loss) 113    
Amounts reclassified from Accumulated other comprehensive loss 6,348 (831) 628
Net current period Other comprehensive (loss) income (214,100) (64,685) 27,325
Ending balance 1,388,458 2,501,728 2,544,767
Accumulated Other Comprehensive Loss      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning balance (460,888) (396,203) (423,528)
Other comprehensive income (loss) before reclassifications:      
Ending balance (674,988) (460,888) (396,203)
Net Unrecognized Pension and Other Post-Retirement Benefit Cost      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning balance (21,196) (29,378) (23,887)
Other comprehensive income (loss) before reclassifications:      
Net actuarial gain (loss) 1,712 7,479 (4,328)
Foreign currency translation adjustment 0 1,534 (1,791)
Unrealized gain on cash flow hedges 0    
Other comprehensive (loss) income before reclassifications (48,679) 9,013 (6,119)
Amounts contributed by Former Parent (50,504)    
Net actuarial gain (loss) 113    
Amounts reclassified from Accumulated other comprehensive loss 6,028 (831) 628
Net current period Other comprehensive (loss) income (42,651) 8,182 (5,491)
Ending balance (63,847) (21,196) (29,378)
Foreign Currency Translation Adjustment      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning balance (439,692) (366,825) (399,641)
Other comprehensive income (loss) before reclassifications:      
Net actuarial gain (loss) (82,351)    
Foreign currency translation adjustment (83,105) (72,867) 32,816
Unrealized gain on cash flow hedges 0    
Other comprehensive (loss) income before reclassifications (174,215) (72,867) 32,816
Amounts contributed by Former Parent (8,759)    
Net actuarial gain (loss) 0    
Amounts reclassified from Accumulated other comprehensive loss 0 0 0
Net current period Other comprehensive (loss) income (174,215) (72,867) 32,816
Ending balance (613,907) (439,692) (366,825)
Loss on Net Investment Hedges      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning balance 0 0 0
Other comprehensive income (loss) before reclassifications:      
Net actuarial gain (loss) (8,336) 0 0
Foreign currency translation adjustment 0 0 0
Unrealized gain on cash flow hedges 0    
Other comprehensive (loss) income before reclassifications (8,336) 0 0
Amounts contributed by Former Parent 0    
Net actuarial gain (loss) 0    
Amounts reclassified from Accumulated other comprehensive loss 0 0 0
Net current period Other comprehensive (loss) income (8,336) 0 0
Ending balance (8,336) 0 0
Gain on Cash Flow Hedges      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning balance 0 0 0
Other comprehensive income (loss) before reclassifications:      
Net actuarial gain (loss) 0 0 0
Foreign currency translation adjustment 0 0 0
Unrealized gain on cash flow hedges 10,782    
Other comprehensive (loss) income before reclassifications 10,782 0 0
Amounts contributed by Former Parent 0    
Net actuarial gain (loss) 0    
Amounts reclassified from Accumulated other comprehensive loss 320 0 0
Net current period Other comprehensive (loss) income 11,102 0 0
Ending balance $ 11,102 $ 0 $ 0
XML 112 R94.htm IDEA: XBRL DOCUMENT v3.22.4
Equity - Narratives (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Apr. 01, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Decrease in noncontrolling interest   $ 3.6 $ 1.1 $ 0.1
Stock-based compensation expenses $ 0.7   $ 2.6 $ 3.0
Unrecognized stock-based compensation expense   $ 19.0    
Unrecognized compensation cost, period for recognition (in years)   2 years 3 months 18 days    
Fair value of vested shares   $ 1.3    
Option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expenses   $ 1.8    
PRSUs        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award performance period   3 years    
RSUs        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Performance vesting period (in years)   3 years    
Maximum | Option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Maximum term (in years)   10 years    
XML 113 R95.htm IDEA: XBRL DOCUMENT v3.22.4
Equity - PRSU and RSU Activity (Details)
 12 Months Ended
Dec. 31, 2022
$ / shares
shares
PRSUs  
Number of Units  
Number of units, nonvested, beginning balance (in shares) | shares 0
Awards converted from Former Parent plan (in shares) | shares 58,636
Granted (in shares) | shares 51,652
Vested (in shares) | shares 0
Forfeited and expired (in shares) | shares 0
Number of units, nonvested, ending balance (in shares) | shares 110,288
Weighted- Average Grant-Date Fair Value  
Weighted-average grant date fair value, nonvested, beginning balance (in usd per share) | $ / shares $ 0
Awards converted from Former Parent plan (in usd per share) | $ / shares 58.03
Granted (in usd per share) | $ / shares 49.40
Vested (in usd per share) | $ / shares 0
Forfeited and expired (in usd per share) | $ / shares 0
Weighted-average grant date fair value, nonvested, ending balance (in usd per share) | $ / shares $ 53.99
RSUs  
Number of Units  
Number of units, nonvested, beginning balance (in shares) | shares 0
Awards converted from Former Parent plan (in shares) | shares 333,223
Granted (in shares) | shares 187,556
Vested (in shares) | shares (27,354)
Forfeited and expired (in shares) | shares (29,147)
Number of units, nonvested, ending balance (in shares) | shares 464,278
Weighted- Average Grant-Date Fair Value  
Weighted-average grant date fair value, nonvested, beginning balance (in usd per share) | $ / shares $ 0
Awards converted from Former Parent plan (in usd per share) | $ / shares 52.89
Granted (in usd per share) | $ / shares 47.28
Vested (in usd per share) | $ / shares 48.11
Forfeited and expired (in usd per share) | $ / shares 52.40
Weighted-average grant date fair value, nonvested, ending balance (in usd per share) | $ / shares $ 50.80
XML 114 R96.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments and Contingencies - Narrative (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2022
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Future claims period (in years) 15 years
Unconditional purchase obligation $ 104.8
XML 115 R97.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments and Contingencies - Claims Rollforward (Details)
 12 Months Ended
Dec. 31, 2022
USD ($)
claim
Loss Contingency Accrual [Roll Forward]  
Claims unresolved, beginning of period 14,559
Claims filed 4,338
Claims resolved (4,791)
Claims unresolved, end of period 14,106
Average cost of resolved claims | $ $ 10,017
XML 116 R98.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments and Contingencies - Asbestos Litigation (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]    
Long-term asbestos insurance asset $ 215,112  
Long-term asbestos insurance receivable 17,231  
Accrued asbestos liability 30,108 $ 0
Asbestos liability $ 230,581 $ 0
XML 117 R99.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information - Narratives (Details)
 12 Months Ended
Dec. 31, 2022
segment
Segment Reporting [Abstract]  
Number of reportable segments 2
XML 118 R100.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information - Segment Reporting Information, by Segment (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Segment Reporting Information [Line Items]      
Net sales $ 2,593,480 $ 2,428,115 $ 1,950,069
Adjusted EBITDA 436,754 404,081 301,146
Depreciation, amortization and other impairment charges: 65,978 75,899 76,644
Capital expenditures: 40,243 35,584 40,138
Net income from continuing operations 231,081 238,679 159,868
Income tax expense 69,170 80,409 45,971
Interest expense and other, net 37,950    
Interest income and other, net   (29) (1,023)
Pension settlement gain (9,136) (11,208) 0
Restructuring and other related charges 23,096 18,954 21,633
Separation costs 15,545 2,865 0
Acquisition - amortization and other related charges 34,196 35,949 36,331
Depreciation and other amortization 34,852 38,462 38,366
Investments in Equity Method Investees: 28,527 28,180  
Total Assets: 3,754,015 3,461,262  
United States      
Segment Reporting Information [Line Items]      
Net sales 583,000 533,500 443,700
Americas      
Segment Reporting Information [Line Items]      
Net sales 1,128,306 1,004,208 767,414
Adjusted EBITDA 188,577 159,623 111,588
Depreciation, amortization and other impairment charges: 29,281 33,890 36,380
Capital expenditures: 18,005 14,095 15,244
Investments in Equity Method Investees: 0 0  
Total Assets: 1,666,799 1,304,797  
EMEA & APAC      
Segment Reporting Information [Line Items]      
Net sales 1,465,174 1,423,907 1,182,655
Adjusted EBITDA 248,177 244,458 189,558
Depreciation, amortization and other impairment charges: 36,697 42,009 40,264
Capital expenditures: 22,238 21,489 $ 24,894
Restructuring and other related charges 11,712 7,342  
Investments in Equity Method Investees: 28,527 28,180  
Total Assets: $ 2,087,216 $ 2,156,465  
XML 119 R101.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information - Net Sales and PPE by Geography (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Segment Reporting Information [Line Items]    
Property, plant and equipment, net $ 284,226 $ 286,278
United States    
Segment Reporting Information [Line Items]    
Property, plant and equipment, net 68,380 64,136
Czech Republic    
Segment Reporting Information [Line Items]    
Property, plant and equipment, net 60,278 63,273
India    
Segment Reporting Information [Line Items]    
Property, plant and equipment, net 34,892 37,312
Russia    
Segment Reporting Information [Line Items]    
Property, plant and equipment, net 19,111 18,797
Mexico    
Segment Reporting Information [Line Items]    
Property, plant and equipment, net 17,666 14,720
Other foreign countries    
Segment Reporting Information [Line Items]    
Property, plant and equipment, net $ 83,899 $ 88,040
XML 120 R102.htm IDEA: XBRL DOCUMENT v3.22.4
Related Party Transactions (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Apr. 01, 2022
Dec. 31, 2021
Dec. 31, 2020
Former Partner      
Related Party Transaction [Line Items]      
Allocated expenses $ 6.0 $ 29.5 $ 24.2
XML 121 R103.htm IDEA: XBRL DOCUMENT v3.22.4
Subsequent Events (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Mar. 02, 2023
Jan. 13, 2023
Jan. 11, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Subsequent Event [Line Items]            
Dividends payable       $ 3,000    
Dividends paid       $ 6,054 $ 0 $ 0
Dividends on common stock (in dollars per share)       $ 0.15    
Subsequent Event            
Subsequent Event [Line Items]            
Dividends paid   $ 3,000        
Dividends on common stock (in dollars per share) $ 0.05          
Subsequent Event | Therapy Equipment Limited            
Subsequent Event [Line Items]            
Purchase price     $ 16,000      
XML 122 R104.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Charged to Expense, net $ 4,526    
Transferred From Former Parent      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Valuation allowance on deferred taxes 68,900    
Allowance for credit losses      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 23,912 $ 32,311 $ 32,008
Charged to Expense, net 4,526 (494) 4,936
Write-Offs Write-Downs Deductions and Other (4,978) (6,931) (3,448)
Foreign Currency Translation 11 (974) (1,185)
Balance at End of Period 23,471 23,912 32,311
Valuation allowance for deferred tax assets      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 15,465 12,647 17,855
Charged to Expense, net 4,503 3,738 0
Write-Offs Write-Downs Deductions and Other 68,876 0 (4,738)
Foreign Currency Translation (642) (920) (470)
Balance at End of Period $ 88,202 $ 15,465 $ 12,647
XML 123 cfx-20221231_htm.xml IDEA: XBRL DOCUMENT 0001877322 2022-01-01 2022-12-31 0001877322 2022-07-01 0001877322 2023-02-28 0001877322 2021-01-01 2021-12-31 0001877322 2020-01-01 2020-12-31 0001877322 2022-12-31 0001877322 2021-12-31 0001877322 us-gaap:CommonStockMember 2019-12-31 0001877322 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001877322 us-gaap:RetainedEarningsMember 2019-12-31 0001877322 cfx:FormerParentInvestmentMember 2019-12-31 0001877322 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001877322 us-gaap:NoncontrollingInterestMember 2019-12-31 0001877322 2019-12-31 0001877322 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember cfx:FormerParentInvestmentMember 2019-12-31 0001877322 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:NoncontrollingInterestMember 2019-12-31 0001877322 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0001877322 cfx:FormerParentInvestmentMember 2020-01-01 2020-12-31 0001877322 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-12-31 0001877322 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001877322 us-gaap:CommonStockMember 2020-12-31 0001877322 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001877322 us-gaap:RetainedEarningsMember 2020-12-31 0001877322 cfx:FormerParentInvestmentMember 2020-12-31 0001877322 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001877322 us-gaap:NoncontrollingInterestMember 2020-12-31 0001877322 2020-12-31 0001877322 cfx:FormerParentInvestmentMember 2021-01-01 2021-12-31 0001877322 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0001877322 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001877322 us-gaap:CommonStockMember 2021-12-31 0001877322 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001877322 us-gaap:RetainedEarningsMember 2021-12-31 0001877322 cfx:FormerParentInvestmentMember 2021-12-31 0001877322 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001877322 us-gaap:NoncontrollingInterestMember 2021-12-31 0001877322 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001877322 cfx:FormerParentInvestmentMember 2022-01-01 2022-12-31 0001877322 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0001877322 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001877322 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001877322 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001877322 us-gaap:CommonStockMember 2022-12-31 0001877322 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001877322 us-gaap:RetainedEarningsMember 2022-12-31 0001877322 cfx:FormerParentInvestmentMember 2022-12-31 0001877322 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001877322 us-gaap:NoncontrollingInterestMember 2022-12-31 0001877322 us-gaap:UnfundedPlanMember 2022-03-21 2022-03-21 0001877322 us-gaap:CommonStockMember 2022-04-04 2022-04-04 0001877322 cfx:ESABCorporationMember cfx:EnovisCorporationMember 2022-04-04 0001877322 cfx:EnovisCorporationMember 2022-04-04 0001877322 cfx:TheCreditAgreementMember 2022-04-04 2022-04-04 0001877322 cfx:EnovisCorporationMember 2022-04-04 2022-04-04 0001877322 country:RU us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2022-01-01 2022-12-31 0001877322 country:RU 2022-01-01 2022-12-31 0001877322 country:RU us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2022-01-01 2022-12-31 0001877322 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001877322 us-gaap:CommonStockMember cfx:EnovisCorporationMember 2022-04-04 2022-04-04 0001877322 srt:MinimumMember cfx:AcquiredTradeNamesCustomerRelationshipsAcquiredTechnologyAndSoftwareLicenseAgreementsMember 2022-01-01 2022-12-31 0001877322 srt:MaximumMember cfx:AcquiredTradeNamesCustomerRelationshipsAcquiredTechnologyAndSoftwareLicenseAgreementsMember 2022-01-01 2022-12-31 0001877322 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-12-31 0001877322 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001877322 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001877322 us-gaap:OtherNonoperatingIncomeExpenseMember 2022-01-01 2022-12-31 0001877322 us-gaap:OtherNonoperatingIncomeExpenseMember 2021-01-01 2021-12-31 0001877322 us-gaap:OtherNonoperatingIncomeExpenseMember 2020-01-01 2020-12-31 0001877322 currency:ARS us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-12-31 0001877322 currency:ARS us-gaap:OtherNonoperatingIncomeExpenseMember 2022-01-01 2022-12-31 0001877322 currency:ARS 2022-01-01 2022-12-31 0001877322 cfx:AsbestosRelatedActivityMember 2022-01-01 2022-12-31 0001877322 cfx:OhioMedicalLLCMember 2022-10-17 2022-10-17 0001877322 cfx:OhioMedicalLLCMember 2022-10-14 2022-10-14 0001877322 cfx:SwiftCutAutomationLimitedMember 2022-10-31 2022-10-31 0001877322 cfx:ConsumableProductsMember 2022-01-01 2022-12-31 0001877322 cfx:EquipmentProductsMember 2021-01-01 2021-12-31 0001877322 cfx:EquipmentProductsMember 2020-01-01 2020-12-31 0001877322 cfx:EquipmentProductsMember 2022-01-01 2022-12-31 0001877322 cfx:ConsumableProductsMember 2021-01-01 2021-12-31 0001877322 cfx:ConsumableProductsMember 2020-01-01 2020-12-31 0001877322 2022-04-04 2022-04-04 0001877322 us-gaap:OtherAssetsMember 2022-12-31 0001877322 us-gaap:OtherAssetsMember 2021-12-31 0001877322 us-gaap:OtherLiabilitiesMember 2022-12-31 0001877322 us-gaap:OtherLiabilitiesMember 2021-12-31 0001877322 us-gaap:ForeignCountryMember 2022-12-31 0001877322 srt:ScenarioForecastMember 2023-01-01 2023-04-01 0001877322 cfx:AmericasBusinessSegmentMember 2020-12-31 0001877322 cfx:EMEAAPACBusinessSegmentMember 2020-12-31 0001877322 cfx:AmericasBusinessSegmentMember 2021-01-01 2021-12-31 0001877322 cfx:EMEAAPACBusinessSegmentMember 2021-01-01 2021-12-31 0001877322 cfx:AmericasBusinessSegmentMember 2021-12-31 0001877322 cfx:EMEAAPACBusinessSegmentMember 2021-12-31 0001877322 cfx:AmericasBusinessSegmentMember 2022-01-01 2022-12-31 0001877322 cfx:EMEAAPACBusinessSegmentMember 2022-01-01 2022-12-31 0001877322 cfx:AmericasBusinessSegmentMember 2022-12-31 0001877322 cfx:EMEAAPACBusinessSegmentMember 2022-12-31 0001877322 us-gaap:TradeNamesMember 2022-01-01 2022-12-31 0001877322 us-gaap:TradeNamesMember 2021-01-01 2021-12-31 0001877322 us-gaap:CustomerRelationshipsMember 2022-12-31 0001877322 us-gaap:CustomerRelationshipsMember 2021-12-31 0001877322 us-gaap:TechnologyBasedIntangibleAssetsMember 2022-12-31 0001877322 us-gaap:TechnologyBasedIntangibleAssetsMember 2021-12-31 0001877322 us-gaap:TradeNamesMember 2022-12-31 0001877322 us-gaap:TradeNamesMember 2021-12-31 0001877322 us-gaap:ComputerSoftwareIntangibleAssetMember 2022-12-31 0001877322 us-gaap:ComputerSoftwareIntangibleAssetMember 2021-12-31 0001877322 us-gaap:OtherIntangibleAssetsMember 2022-12-31 0001877322 us-gaap:OtherIntangibleAssetsMember 2021-12-31 0001877322 us-gaap:LandMember 2022-12-31 0001877322 us-gaap:LandMember 2021-12-31 0001877322 srt:MinimumMember us-gaap:BuildingAndBuildingImprovementsMember 2022-01-01 2022-12-31 0001877322 srt:MaximumMember us-gaap:BuildingAndBuildingImprovementsMember 2022-01-01 2022-12-31 0001877322 us-gaap:BuildingAndBuildingImprovementsMember 2022-12-31 0001877322 us-gaap:BuildingAndBuildingImprovementsMember 2021-12-31 0001877322 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-12-31 0001877322 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-12-31 0001877322 us-gaap:MachineryAndEquipmentMember 2022-12-31 0001877322 us-gaap:MachineryAndEquipmentMember 2021-12-31 0001877322 us-gaap:PropertyPlantAndEquipmentMember 2022-01-01 2022-12-31 0001877322 us-gaap:PropertyPlantAndEquipmentMember 2021-01-01 2021-12-31 0001877322 us-gaap:PropertyPlantAndEquipmentMember 2020-01-01 2020-12-31 0001877322 us-gaap:EmployeeSeveranceMember cfx:AmericasBusinessSegmentMember 2021-12-31 0001877322 us-gaap:EmployeeSeveranceMember cfx:AmericasBusinessSegmentMember 2022-01-01 2022-12-31 0001877322 us-gaap:EmployeeSeveranceMember cfx:AmericasBusinessSegmentMember 2022-12-31 0001877322 us-gaap:FacilityClosingMember cfx:AmericasBusinessSegmentMember 2021-12-31 0001877322 us-gaap:FacilityClosingMember cfx:AmericasBusinessSegmentMember 2022-01-01 2022-12-31 0001877322 us-gaap:FacilityClosingMember cfx:AmericasBusinessSegmentMember 2022-12-31 0001877322 us-gaap:EmployeeSeveranceMember cfx:EMEAAndAPACSegmentMember 2021-12-31 0001877322 us-gaap:EmployeeSeveranceMember cfx:EMEAAndAPACSegmentMember 2022-01-01 2022-12-31 0001877322 us-gaap:EmployeeSeveranceMember cfx:EMEAAndAPACSegmentMember 2022-12-31 0001877322 us-gaap:FacilityClosingMember cfx:EMEAAndAPACSegmentMember 2021-12-31 0001877322 us-gaap:FacilityClosingMember cfx:EMEAAndAPACSegmentMember 2022-01-01 2022-12-31 0001877322 us-gaap:FacilityClosingMember cfx:EMEAAndAPACSegmentMember 2022-12-31 0001877322 cfx:EMEAAndAPACSegmentMember 2021-12-31 0001877322 cfx:EMEAAndAPACSegmentMember 2022-01-01 2022-12-31 0001877322 cfx:EMEAAndAPACSegmentMember 2022-12-31 0001877322 us-gaap:EmployeeSeveranceMember cfx:AmericasBusinessSegmentMember 2020-12-31 0001877322 us-gaap:EmployeeSeveranceMember cfx:AmericasBusinessSegmentMember 2021-01-01 2021-12-31 0001877322 us-gaap:FacilityClosingMember cfx:AmericasBusinessSegmentMember 2020-12-31 0001877322 us-gaap:FacilityClosingMember cfx:AmericasBusinessSegmentMember 2021-01-01 2021-12-31 0001877322 us-gaap:EmployeeSeveranceMember cfx:EMEAAndAPACSegmentMember 2020-12-31 0001877322 us-gaap:EmployeeSeveranceMember cfx:EMEAAndAPACSegmentMember 2021-01-01 2021-12-31 0001877322 us-gaap:FacilityClosingMember cfx:EMEAAndAPACSegmentMember 2020-12-31 0001877322 us-gaap:FacilityClosingMember cfx:EMEAAndAPACSegmentMember 2021-01-01 2021-12-31 0001877322 cfx:EMEAAndAPACSegmentMember 2020-12-31 0001877322 cfx:EMEAAndAPACSegmentMember 2021-01-01 2021-12-31 0001877322 cfx:FormerParentMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001877322 cfx:FormerParentMember us-gaap:UnfundedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001877322 cfx:FormerParentMember us-gaap:UnfundedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001877322 cfx:FormerParentMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001877322 cfx:FormerParentMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-12-31 0001877322 us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-12-31 0001877322 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001877322 us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001877322 us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001877322 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-12-31 0001877322 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0001877322 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-01-01 2022-12-31 0001877322 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001877322 us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001877322 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-12-31 0001877322 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-12-31 0001877322 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001877322 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001877322 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001877322 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001877322 cfx:U.S.EquitySecuritiesMember country:US 2022-12-31 0001877322 cfx:U.S.EquitySecuritiesMember country:US 2021-12-31 0001877322 cfx:InternationalEquitySecuritiesMember country:US 2022-12-31 0001877322 cfx:InternationalEquitySecuritiesMember country:US 2021-12-31 0001877322 us-gaap:FixedIncomeSecuritiesMember country:US 2022-12-31 0001877322 us-gaap:FixedIncomeSecuritiesMember country:US 2021-12-31 0001877322 us-gaap:CashAndCashEquivalentsMember country:US 2022-12-31 0001877322 us-gaap:CashAndCashEquivalentsMember country:US 2021-12-31 0001877322 us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FixedIncomeSecuritiesMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FixedIncomeSecuritiesMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 cfx:DefinedBenefitPlanInsuranceContractsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 cfx:DefinedBenefitPlanInsuranceContractsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 cfx:DefinedBenefitPlanInvestmentFundsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 cfx:DefinedBenefitPlanInvestmentFundsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:CashAndCashEquivalentsMember country:US 2022-12-31 0001877322 us-gaap:FairValueInputsLevel1Member us-gaap:CashAndCashEquivalentsMember country:US 2022-12-31 0001877322 us-gaap:FairValueInputsLevel2Member us-gaap:CashAndCashEquivalentsMember country:US 2022-12-31 0001877322 us-gaap:FairValueInputsLevel3Member us-gaap:CashAndCashEquivalentsMember country:US 2022-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember country:US 2022-12-31 0001877322 us-gaap:FairValueInputsLevel1Member us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember country:US 2022-12-31 0001877322 us-gaap:FairValueInputsLevel2Member us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember country:US 2022-12-31 0001877322 us-gaap:FairValueInputsLevel3Member us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember country:US 2022-12-31 0001877322 us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember country:US 2022-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember cfx:DefinedBenefitPlanEquitySecuritiesUSMidSmallCapMember country:US 2022-12-31 0001877322 us-gaap:FairValueInputsLevel1Member cfx:DefinedBenefitPlanEquitySecuritiesUSMidSmallCapMember country:US 2022-12-31 0001877322 us-gaap:FairValueInputsLevel2Member cfx:DefinedBenefitPlanEquitySecuritiesUSMidSmallCapMember country:US 2022-12-31 0001877322 us-gaap:FairValueInputsLevel3Member cfx:DefinedBenefitPlanEquitySecuritiesUSMidSmallCapMember country:US 2022-12-31 0001877322 cfx:DefinedBenefitPlanEquitySecuritiesUSMidSmallCapMember country:US 2022-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember country:US 2022-12-31 0001877322 us-gaap:FairValueInputsLevel1Member us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember country:US 2022-12-31 0001877322 us-gaap:FairValueInputsLevel2Member us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember country:US 2022-12-31 0001877322 us-gaap:FairValueInputsLevel3Member us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember country:US 2022-12-31 0001877322 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember country:US 2022-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember cfx:USGovernmentAgenciesDebtSecuritiesAndCorporateDebtSecuritiesMember country:US 2022-12-31 0001877322 us-gaap:FairValueInputsLevel1Member cfx:USGovernmentAgenciesDebtSecuritiesAndCorporateDebtSecuritiesMember country:US 2022-12-31 0001877322 us-gaap:FairValueInputsLevel2Member cfx:USGovernmentAgenciesDebtSecuritiesAndCorporateDebtSecuritiesMember country:US 2022-12-31 0001877322 us-gaap:FairValueInputsLevel3Member cfx:USGovernmentAgenciesDebtSecuritiesAndCorporateDebtSecuritiesMember country:US 2022-12-31 0001877322 cfx:USGovernmentAgenciesDebtSecuritiesAndCorporateDebtSecuritiesMember country:US 2022-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember cfx:DefinedBenefitPlanOtherFixedIncomeMutualFundsMember country:US 2022-12-31 0001877322 us-gaap:FairValueInputsLevel1Member cfx:DefinedBenefitPlanOtherFixedIncomeMutualFundsMember country:US 2022-12-31 0001877322 us-gaap:FairValueInputsLevel2Member cfx:DefinedBenefitPlanOtherFixedIncomeMutualFundsMember country:US 2022-12-31 0001877322 us-gaap:FairValueInputsLevel3Member cfx:DefinedBenefitPlanOtherFixedIncomeMutualFundsMember country:US 2022-12-31 0001877322 cfx:DefinedBenefitPlanOtherFixedIncomeMutualFundsMember country:US 2022-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel1Member us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel2Member us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel3Member us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember cfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel1Member cfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel2Member cfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel3Member cfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 cfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember cfx:DefinedBenefitPlanInsuranceContractsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel1Member cfx:DefinedBenefitPlanInsuranceContractsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel2Member cfx:DefinedBenefitPlanInsuranceContractsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel3Member cfx:DefinedBenefitPlanInsuranceContractsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember cfx:DefinedBenefitPlanInvestmentFundsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel1Member cfx:DefinedBenefitPlanInvestmentFundsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel2Member cfx:DefinedBenefitPlanInvestmentFundsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel3Member cfx:DefinedBenefitPlanInvestmentFundsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember cfx:DefinedBenefitPlanOtherAssetsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel1Member cfx:DefinedBenefitPlanOtherAssetsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel2Member cfx:DefinedBenefitPlanOtherAssetsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel3Member cfx:DefinedBenefitPlanOtherAssetsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 cfx:DefinedBenefitPlanOtherAssetsMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:ForeignPlanMember 2022-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel1Member us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel2Member us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel3Member us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember cfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel1Member cfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel2Member cfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel3Member cfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 cfx:DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember cfx:DefinedBenefitPlanInsuranceContractsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel1Member cfx:DefinedBenefitPlanInsuranceContractsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel2Member cfx:DefinedBenefitPlanInsuranceContractsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel3Member cfx:DefinedBenefitPlanInsuranceContractsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember cfx:DefinedBenefitPlanInvestmentFundsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel1Member cfx:DefinedBenefitPlanInvestmentFundsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel2Member cfx:DefinedBenefitPlanInvestmentFundsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel3Member cfx:DefinedBenefitPlanInvestmentFundsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember cfx:DefinedBenefitPlanOtherAssetsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel1Member cfx:DefinedBenefitPlanOtherAssetsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel2Member cfx:DefinedBenefitPlanOtherAssetsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel3Member cfx:DefinedBenefitPlanOtherAssetsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 cfx:DefinedBenefitPlanOtherAssetsMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:ForeignPlanMember 2021-12-31 0001877322 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001877322 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001877322 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001877322 us-gaap:ForeignPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-12-31 0001877322 us-gaap:ForeignPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-12-31 0001877322 us-gaap:ForeignPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-01-01 2022-12-31 0001877322 us-gaap:ForeignPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001877322 us-gaap:ForeignPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001877322 us-gaap:SecuredDebtMember cfx:TheCreditAgreementMember us-gaap:LineOfCreditMember 2022-12-31 0001877322 us-gaap:RevolvingCreditFacilityMember cfx:TheCreditAgreementMember us-gaap:LineOfCreditMember 2022-12-31 0001877322 us-gaap:RevolvingCreditFacilityMember cfx:TheCreditAgreementMember us-gaap:LineOfCreditMember 2022-04-04 0001877322 us-gaap:SecuredDebtMember cfx:TheCreditAgreementMember us-gaap:LineOfCreditMember 2022-04-04 0001877322 us-gaap:SecuredDebtMember cfx:TheCreditAgreementMember us-gaap:SeniorNotesMember 2022-04-04 0001877322 us-gaap:SecuredDebtMember cfx:TheCreditAgreementMember us-gaap:SeniorNotesMember 2022-04-04 2022-04-04 0001877322 us-gaap:LetterOfCreditMember cfx:TheCreditAgreementMember us-gaap:LineOfCreditMember 2022-04-04 0001877322 us-gaap:BridgeLoanMember cfx:TheCreditAgreementMember us-gaap:LineOfCreditMember 2022-04-04 0001877322 us-gaap:RevolvingCreditFacilityMember cfx:TheCreditAgreementMember us-gaap:LineOfCreditMember 2022-04-04 2022-04-04 0001877322 us-gaap:SecuredDebtMember cfx:TheCreditAgreementMember us-gaap:LineOfCreditMember 2022-04-04 2022-04-04 0001877322 us-gaap:SecuredDebtMember cfx:TheCreditAgreementMember us-gaap:SeniorNotesMember 2022-06-28 0001877322 cfx:TheCreditAgreementMember us-gaap:LineOfCreditMember 2022-12-31 0001877322 srt:ScenarioForecastMember cfx:TheCreditAgreementMember us-gaap:LineOfCreditMember 2023-06-30 0001877322 srt:ScenarioForecastMember cfx:TheCreditAgreementMember us-gaap:LineOfCreditMember 2024-06-30 0001877322 srt:MinimumMember cfx:TheCreditAgreementMember 2022-04-04 2022-04-04 0001877322 srt:MaximumMember cfx:TheCreditAgreementMember 2022-04-04 2022-04-04 0001877322 srt:MinimumMember cfx:TheCreditAgreementMember us-gaap:BaseRateMember 2022-04-04 2022-04-04 0001877322 srt:MaximumMember cfx:TheCreditAgreementMember us-gaap:BaseRateMember 2022-04-04 2022-04-04 0001877322 cfx:TheCreditAgreementMember 2022-12-31 0001877322 us-gaap:LetterOfCreditMember cfx:UncommittedCreditLineMember 2022-12-31 0001877322 us-gaap:LetterOfCreditMember 2022-12-31 0001877322 us-gaap:LongTermDebtMember 2022-12-31 0001877322 us-gaap:InterestRateSwapMember 2022-07-14 0001877322 srt:MinimumMember us-gaap:InterestRateSwapMember 2022-07-14 0001877322 srt:MaximumMember us-gaap:InterestRateSwapMember 2022-07-14 0001877322 us-gaap:InterestRateSwapMember 2022-12-31 0001877322 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2022-01-01 2022-12-31 0001877322 us-gaap:InterestRateSwapMember cfx:InterestExpenseIncomeAndOtherNetMember 2022-01-01 2022-12-31 0001877322 us-gaap:ForeignExchangeContractMember 2022-07-22 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001877322 us-gaap:InterestRateSwapMember 2022-01-01 2022-12-31 0001877322 us-gaap:ForeignExchangeContractMember 2022-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2022-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2021-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2022-01-01 2022-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2021-01-01 2021-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0001877322 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001877322 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001877322 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:NondesignatedMember 2022-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:NondesignatedMember 2022-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:NondesignatedMember 2022-12-31 0001877322 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001877322 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001877322 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001877322 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001877322 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001877322 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:NondesignatedMember 2021-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:NondesignatedMember 2021-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:NondesignatedMember 2021-12-31 0001877322 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0001877322 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001877322 cfx:AccumulatedGainLossNetInvestmentHedgesParentMember 2019-12-31 0001877322 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-31 0001877322 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-12-31 0001877322 cfx:AccumulatedGainLossNetInvestmentHedgesParentMember 2020-01-01 2020-12-31 0001877322 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-12-31 0001877322 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-12-31 0001877322 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0001877322 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001877322 cfx:AccumulatedGainLossNetInvestmentHedgesParentMember 2020-12-31 0001877322 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0001877322 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-12-31 0001877322 cfx:AccumulatedGainLossNetInvestmentHedgesParentMember 2021-01-01 2021-12-31 0001877322 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-12-31 0001877322 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-12-31 0001877322 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0001877322 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001877322 cfx:AccumulatedGainLossNetInvestmentHedgesParentMember 2021-12-31 0001877322 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0001877322 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-12-31 0001877322 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-12-31 0001877322 cfx:AccumulatedGainLossNetInvestmentHedgesParentMember 2022-01-01 2022-12-31 0001877322 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-12-31 0001877322 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0001877322 cfx:AccumulatedGainLossNetInvestmentHedgesParentMember 2022-12-31 0001877322 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0001877322 2022-01-01 2022-04-01 0001877322 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001877322 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001877322 us-gaap:PerformanceSharesMember 2022-01-01 2022-12-31 0001877322 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001877322 us-gaap:PerformanceSharesMember 2021-12-31 0001877322 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001877322 us-gaap:PerformanceSharesMember 2022-12-31 0001877322 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001877322 cfx:AmericasSegmentMember 2022-01-01 2022-12-31 0001877322 cfx:AmericasSegmentMember 2021-01-01 2021-12-31 0001877322 cfx:AmericasSegmentMember 2020-01-01 2020-12-31 0001877322 cfx:EMEAAndAPACSegmentMember 2020-01-01 2020-12-31 0001877322 country:US 2022-01-01 2022-12-31 0001877322 country:US 2021-01-01 2021-12-31 0001877322 country:US 2020-01-01 2020-12-31 0001877322 cfx:AmericasSegmentMember 2022-12-31 0001877322 cfx:AmericasSegmentMember 2021-12-31 0001877322 country:US 2022-12-31 0001877322 country:US 2021-12-31 0001877322 country:CZ 2022-12-31 0001877322 country:CZ 2021-12-31 0001877322 country:IN 2022-12-31 0001877322 country:IN 2021-12-31 0001877322 country:RU 2022-12-31 0001877322 country:RU 2021-12-31 0001877322 country:MX 2022-12-31 0001877322 country:MX 2021-12-31 0001877322 cfx:OtherForeignCountriesMember 2022-12-31 0001877322 cfx:OtherForeignCountriesMember 2021-12-31 0001877322 srt:AffiliatedEntityMember 2022-01-01 2022-04-01 0001877322 srt:AffiliatedEntityMember 2021-01-01 2021-12-31 0001877322 srt:AffiliatedEntityMember 2020-01-01 2020-12-31 0001877322 us-gaap:SubsequentEventMember 2023-01-13 2023-01-13 0001877322 us-gaap:SubsequentEventMember 2023-03-02 2023-03-02 0001877322 cfx:TherapyEquipmentLimitedMember us-gaap:SubsequentEventMember 2023-01-11 2023-01-11 0001877322 us-gaap:AllowanceForCreditLossMember 2021-12-31 0001877322 us-gaap:AllowanceForCreditLossMember 2022-01-01 2022-12-31 0001877322 us-gaap:AllowanceForCreditLossMember 2022-12-31 0001877322 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-12-31 0001877322 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2022-01-01 2022-12-31 0001877322 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2022-12-31 0001877322 us-gaap:AllowanceForCreditLossMember 2020-12-31 0001877322 us-gaap:AllowanceForCreditLossMember 2021-01-01 2021-12-31 0001877322 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-12-31 0001877322 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-01-01 2021-12-31 0001877322 us-gaap:AllowanceForCreditLossMember 2019-12-31 0001877322 us-gaap:AllowanceForCreditLossMember 2020-01-01 2020-12-31 0001877322 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-12-31 0001877322 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-01-01 2020-12-31 0001877322 cfx:TransferredFromFormerParentMember 2022-01-01 2022-12-31 iso4217:USD shares iso4217:USD shares cfx:segment cfx:plan pure cfx:reporting_unit cfx:agreement iso4217:EUR cfx:claim 0001877322 false FY 2022 0.333 P10Y http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent 10-K true 2022-12-31 --12-31 false 001-41297 ESAB CORPORATION DE 87-0923837 909 Rose Avenue 8th Floor North Bethesda MD 20852 301 323-9099 Common Stock, par value $0.001 per share ESAB NYSE No No Yes Yes Non-accelerated Filer false false false false 2625000000 60194601 <div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="text-align:center;text-indent:9pt"><span><br/></span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Part III incorporates certain information by reference from the Registrant’s definitive proxy statement for its 2023 annual meeting of stockholders (the “2023 Proxy Statement”) to be filed pursuant to Regulation 14A within 120 days after the end of the Registrant’s fiscal year covered by this report. With the exception of the sections of the 2023 Proxy Statement specifically incorporated herein by reference, the 2023 Proxy Statement is not deemed to be filed as part of this Form 10-K.</span></div> 42 Ernst & Young LLP Baltimore, Maryland 2593480000 2428115000 1950069000 1707950000 1590132000 1267604000 885530000 837983000 682465000 533369000 512815000 458706000 23096000 18954000 21633000 329065000 306214000 202126000 9136000 11208000 0 37950000 -1666000 -3713000 300251000 319088000 205839000 69170000 80409000 45971000 231081000 238679000 159868000 -3068000 0 0 228013000 238679000 159868000 4266000 3569000 2454000 223747000 235110000 157414000 3.75 3.92 2.62 -0.05 0 0 3.70 3.92 2.62 3.74 3.92 2.62 -0.05 0 0 3.69 3.92 2.62 228013000 238679000 159868000 -2930000 740000 -1598000 -175719000 -72398000 30903000 3240000 11102000 0 0 1840000 1192000 367000 -6192000 -6657000 3725000 -158425000 -65741000 27178000 69588000 172938000 187046000 678000 2513000 2307000 68910000 170425000 184739000 72024000 41209000 23471000 23912000 374329000 383496000 416829000 420062000 56637000 51949000 68851000 67357000 988670000 964073000 284226000 286278000 1529767000 1532993000 517167000 521434000 92033000 107944000 342152000 48540000 3754015000 3461262000 316265000 345480000 285310000 251109000 601575000 596589000 1218643000 0 545339000 362945000 2365557000 959534000 0.001 0.001 600000000 600000000 60094725 100 60000 0 1865904000 0 159231000 0 0 2921623000 -674988000 -460888000 1350207000 2460735000 38251000 40993000 1388458000 2501728000 3754015000 3461262000 0 0 0 0 3058666000 -423528000 46065000 2681203000 -3716000 -18000 -3734000 157414000 2454000 159868000 4297000 4297000 -1965000 27325000 -147000 27178000 6436000 6436000 319969000 1918000 321887000 0 0 0 0 2898831000 -396203000 42139000 2544767000 235110000 3569000 238679000 3713000 3713000 -452000 -64685000 -1056000 -65741000 6267000 6267000 218585000 -54000 218531000 0 0 0 0 2921623000 -460888000 40993000 2501728000 168310000 55437000 4266000 228013000 0.15 9079000 9079000 1728000 1728000 -4346000 -70643000 59263000 -15726000 1200000000 1200000000 60034311000 60000 1849371000 -1849431000 0 3420000 3420000 -1530000 -154837000 -3588000 -158425000 60414000 12187000 12187000 60094725000 60000 1865904000 159231000 0 -674988000 38251000 1388458000 228013000 238679000 159868000 65978000 75899000 76644000 -239000 447000 3370000 9136000 11208000 0 12964000 6267000 6436000 -20199000 -8644000 -14031000 1972000 0 0 8142000 67850000 -27734000 10066000 117350000 -34839000 -28794000 114502000 7056000 18471000 -20889000 -14005000 214358000 250737000 309181000 40243000 35584000 40138000 4849000 5204000 5565000 149029000 4885000 0 -184423000 -35265000 -34573000 1000000000 0 0 805881000 673000 0 585491000 0 190000 4706000 0 0 1500000 0 49000 6054000 0 0 3420000 3713000 4297000 1200000000 0 0 -2847000 218531000 321887000 7557000 -221571000 -326423000 -6677000 -1901000 -3810000 30815000 -8000000 -55625000 41209000 49209000 104834000 72024000 41209000 49209000 34678000 0 0 85659000 0 0 Organization and Basis of Presentation<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Founded in 1904, ESAB Corporation (“ESAB” or the “Company”) is a world leader in connected fabrication technology and gas control solutions. ESAB provides its partners with advanced equipment, consumables, gas control equipment, robotics, and digital solutions. The Company’s rich history of innovative products and workflow solutions and its business system (EBX) allows the Company to realize its purpose of Shaping the world it imagines. The Company’s products are utilized to solve challenges in a wide range of industries, including cutting, joining and automated welding. The Company conducts its operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America, and “EMEA &amp; APAC,” which includes Europe, Middle East, India, Africa and Asia Pacific. Historically, these businesses had operated as part of Enovis Corporation’s (“Former Parent” or “Enovis”) Fabrication Technologies reportable segment. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s fiscal year ends December 31. The Company’s first three quarters end on the last business day of the 13th week after the end of the prior quarter.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Separation from Enovis</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2022, all remaining legal entities which were part of the Fabrication Technology segment of the Former Parent along with certain entities that were part of the Corporate segment of the Former Parent became subsidiaries of ESAB through a legal entity restructuring. This reorganization resulted in the inclusion of the following entities and pension plans in ESAB for the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> three months ending April 1, 2022:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain operating entities that form the historical Fabrication Technology business.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain entities which historically have been a part of the Former Parent’s Corporate reportable segment, including components of the Former Parent’s legal human resources, tax and other finance functions that served the entirety of the Former Parent. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain entities relating to the Former Parent’s previously divested Fluid Handling businesses which hold certain asbestos assets, liabilities, costs and insurance recoveries related to the asbestos obligations of these legacy industrial businesses. Refer to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 4, “Discontinued Operations” and Note 19,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> “Commitments and Contingencies” for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain pension plan assets and liabilities due to transfer of sponsorship of two U.S. defined benefit plans and a U.S. other post-retirement benefit plan from the Former Parent to ESAB as of March 21, 2022. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to Note 14, “Benefit Plans” for additional information on the benefit plans transferred to ESAB. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the exception of the operatin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g entities that form the historical Fabrication Technology business, the other contributions from the Former Parent wer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e not previously included in the Company’s 2019 to 2021 historical carve-out financial statements. These historical carve-out financial statements in ESAB’s Registration Statement on Form 10-12B/A filed with the SEC on March 17, 2022 (the “Form 10”), were presented on a combined basis. Such basis of accounting differences before and after the legal entity contributions may impact the comparability between periods in these Consolidated and Combined Financial Statements.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ESAB Corporation, which was incorporated on May 19, 2021, became the new ultimate parent company for the Former Parent’s Fabrication Technology business and certain other corporate entities during the three months ended April 1, 2022.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 4, 2022 (the “Distribution Date”), Colfax Corporation (“Colfax” or the “Former Parent”) completed the spin-off of Colfax’s Fabrication Technology business and certain other corporate entities as described above, through a tax-free, pro rata distribution (the “Distribution”) of 90% of the outstanding common stock of ESAB to Colfax stockholders (the “Separation”). To effect the Separation, each Colfax stockholder of record as of close of business on March 23, 2022 received one share of ESAB common stock for every three shares of Colfax common stock held on the record date. Upon completion of the Distribution, Colfax changed its name to Enovis Corporation and continued to hold 10% of the outstanding common stock of ESAB. In November 2022, Enovis sold a total of 6.0 million shares of the Company’s common stock as part of a secondary offering. After the secondary offering, Enovis no longer owned any of the Company’s outstanding common stock. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Separation, on April 4, 2022, ESAB and Enovis entered into a separation and distribution agreement as well as various other related agreements (collectively the “Agreements”) that govern the Separation and the relationships between the parties going forward, including a transition services agreement, an employee matters agreement, a tax matters agreement, an intellectual property matters agreement, and license agreement for the ESAB Business Excellence System ("EBX").</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the Separation on April 4, 2022, the Company entered into a credit agreement (the “Credit Agreement”). The Company drew down $1.2 billion under the Credit Agreement and used these proceeds to make payments to Enovis of $1.2 billion, which was used as part of the consideration for the contribution of certain assets and liabilities to the Company by Enovis in connection with the Separation. To manage pre-existing currency rate exposures and interest risks arising from these credit facilities, during the third quarter, the Company entered into interest rate swap agreements and cross currency swap agreements, ref</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">er </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to Note 15, “De</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">bt” and Note 16, “Derivatives” for additional information.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Russia and Ukraine Conflict</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The invasion of Ukraine by Russia and the sanctions imposed in response have increased the level of economic and political uncertainty. While ESAB continues to closely monitor the situation and evaluate options, t</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he Company is meeting current contractual obligations while addressing applicable laws and regulations. For the year ended December 31, 2022, Russia represented approximately 6% of the Company’s total revenue, and approxim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$20 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Net Income, respectively. Russia also has approximately 5% of the Company’s total net assets excluding any goodwill allocation as of December 31, 2022. In case of the disposition of the Russia business, a portion of goodw</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ill would nee</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d to be allocated and disposed of in the relative fair value attributable to the Russia busin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ess. Russia has a cumulative translation loss of approximately $90 million as of December 31, 2022, which could be realized upon a transition out. The C</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ompany is closely monitoring developments in Ukraine and Russia. Changes in laws and regulations or other factors impacting the Company’s ability to fulfill contractual obligations could have an adverse effect on the results of operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Consolidated and Combined Financial Statements present the Company’s historical financial position, results of operations, changes in equity and cash flows in accordance with generally accepted accounting principles in the United States of America (“GAAP”). The combined financial statements for periods prior to the Separation were derived from Enovis’s consolidated financial statements and accounting records and prepared in accordance with GAAP for the preparation of carved-out combined financial statements. Through the date of the Separation, all revenues and costs as well as assets and liabilities directly associated with ESAB have been included in the combined financial statements. Prior to the Separation, the combined financial statements also included allocations of certain general, administrative, sales and marketing expenses from Enovis’s corporate office and from other Enovis businesses to the Company and allocations of related assets, liabilities, and the Former Parent’s investment, as applicable. The allocations were determined on a reasonable basis, however, the amounts are not necessarily representative of the amounts that would have been reflected in the financial statements had the Company been an entity that operated independently of Enovis during the applicable periods. Re</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lated party a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">llocations prior to the Separation, including the method for such allocation, are discussed further in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 21, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">“Related Party Transactions.” </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Separation, the consolidated financial statements include ESAB and its wholly-owned subsidiaries and no longer include any allocations of expenses from Enovis. Accordingly:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Consolidated Balance Sheet </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as of December 31, 2022 con</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sists of the consolidated balances of ESAB, while the Combined Balance Sheet as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of December 31, 2021 consists of t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he combined balances of the former Fabrication Technology business of Enovis. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Consolidated and Combined Statement of Operations and Statement of Comprehensive (Loss) Income for the year ended December 31, 2022 consists of the consolidated results of ESAB for the nine months ended December 31, 2022 and the combined results of the former Fabrication Technology business of Enovis and the certain entities discussed in the “Separation from Enovis” section above for the three months ended April 1, 2022. The Combined Statement of Operations and Statement of Comprehensive (Loss) Income for the years ended December 31, 2021 and 2020 consist of the combined results of the former Fabrication Technology business of Enovis. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Consolidated and Combined Statement of Changes in Equity for the year December 31, 2022 consists of the consolidated activities of ESAB for the nine months ended December 31, 2022 and the combined activity of the former Fabrication Technology business of Enovis and the certain entities discussed in the “Separation from Enovis” section above for the three months ended April 1, 2022. The Combined Statements of Changes in Equity for the year ended December 31, 2021 and 2020 consist of the combined activity of the former Fabrication Technology business of Enovis.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Consolidated and Combined Statement of Cash Flows for the year ended December 31, 2022 consists of the consolidated activities of ESAB for the nine months ended December 31, 2022 and the combined activity of ESAB and the former Fabrication Technology business of Enovis and the certain entities discussed in the “Separation from Enovis” section above for the three months ended April 1, 2022. The Combined Statement of Cash Flows for the years ended December 31, 2021 and 2020 consist of the combined activity of the former Fabrication Technology business of Enovis. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated and Combined Financial Statements of ESAB for the years en</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ded December 31, 2020 and 2021 an</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d the three months ended April 1, 2022 may not be indicative of the Company's results had it been a separate stand-alone entity throughout the periods presented, nor are the results stated herein indicative of what the Company's financial position, results of operations and cash flows may be in the future.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Prior to the Separation, the Company was dependent on the Former Parent for all of its working capital and financing requirements under Enovis’s centralized approach to cash management and financing of its operations. With the exception of cash, cash equivalents and borrowings clearly associated with ESAB and related to the Separation, financing transactions relating to the Company during the period prior to the Separation were accounted for through the Former Parent’s investment account of the Company. Accordingly, none of Enovis’s cash, cash equivalents or debt at the corporate level has been assigned to the Company in these financial statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Former Parent’s Investment, which included retained earnings, represented Enovis’s interest in the recorded net assets of the Company. All significant transactions between the Company and the Former Parent prior to the Separation have been included in the accompanying Financial Statements. Transactions with the Former Parent are reflected in the accompanying Consolidated and Combined Statements of Equity as “Transfers to Former Parent, net” and in the accompanying Consolidated and Combined Balance Sheets within “Former Parent’s investment”. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated and Combined Financial Statements reflect, in the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly the Company’s financial position and results of operations as of and for the periods indicated. Intercompany transactions and accounts are eliminated in consolidation.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes certain estimates and assumptions in preparing its Consolidated and Combined Financial Statements in accordance with U.S. generally accepted accounting principles, or “GAAP”. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the Consolidated and Combined Financial Statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from those estimates.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These Consolidated and Combined Financial Statements included in this annual report have been prepared by the Company in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) in conformity with GAAP, for the preparation of the Consolidated and Combined Financial Statements.</span></div> 2 The Company’s fiscal year ends December 31. The Company’s first three quarters end on the last business day of the 13th week after the end of the prior quarter. <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Separation from Enovis</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2022, all remaining legal entities which were part of the Fabrication Technology segment of the Former Parent along with certain entities that were part of the Corporate segment of the Former Parent became subsidiaries of ESAB through a legal entity restructuring. This reorganization resulted in the inclusion of the following entities and pension plans in ESAB for the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> three months ending April 1, 2022:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain operating entities that form the historical Fabrication Technology business.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain entities which historically have been a part of the Former Parent’s Corporate reportable segment, including components of the Former Parent’s legal human resources, tax and other finance functions that served the entirety of the Former Parent. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain entities relating to the Former Parent’s previously divested Fluid Handling businesses which hold certain asbestos assets, liabilities, costs and insurance recoveries related to the asbestos obligations of these legacy industrial businesses. Refer to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 4, “Discontinued Operations” and Note 19,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> “Commitments and Contingencies” for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain pension plan assets and liabilities due to transfer of sponsorship of two U.S. defined benefit plans and a U.S. other post-retirement benefit plan from the Former Parent to ESAB as of March 21, 2022. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to Note 14, “Benefit Plans” for additional information on the benefit plans transferred to ESAB. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the exception of the operatin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g entities that form the historical Fabrication Technology business, the other contributions from the Former Parent wer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e not previously included in the Company’s 2019 to 2021 historical carve-out financial statements. These historical carve-out financial statements in ESAB’s Registration Statement on Form 10-12B/A filed with the SEC on March 17, 2022 (the “Form 10”), were presented on a combined basis. Such basis of accounting differences before and after the legal entity contributions may impact the comparability between periods in these Consolidated and Combined Financial Statements.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ESAB Corporation, which was incorporated on May 19, 2021, became the new ultimate parent company for the Former Parent’s Fabrication Technology business and certain other corporate entities during the three months ended April 1, 2022.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 4, 2022 (the “Distribution Date”), Colfax Corporation (“Colfax” or the “Former Parent”) completed the spin-off of Colfax’s Fabrication Technology business and certain other corporate entities as described above, through a tax-free, pro rata distribution (the “Distribution”) of 90% of the outstanding common stock of ESAB to Colfax stockholders (the “Separation”). To effect the Separation, each Colfax stockholder of record as of close of business on March 23, 2022 received one share of ESAB common stock for every three shares of Colfax common stock held on the record date. Upon completion of the Distribution, Colfax changed its name to Enovis Corporation and continued to hold 10% of the outstanding common stock of ESAB. In November 2022, Enovis sold a total of 6.0 million shares of the Company’s common stock as part of a secondary offering. After the secondary offering, Enovis no longer owned any of the Company’s outstanding common stock. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Separation, on April 4, 2022, ESAB and Enovis entered into a separation and distribution agreement as well as various other related agreements (collectively the “Agreements”) that govern the Separation and the relationships between the parties going forward, including a transition services agreement, an employee matters agreement, a tax matters agreement, an intellectual property matters agreement, and license agreement for the ESAB Business Excellence System ("EBX").</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the Separation on April 4, 2022, the Company entered into a credit agreement (the “Credit Agreement”). The Company drew down $1.2 billion under the Credit Agreement and used these proceeds to make payments to Enovis of $1.2 billion, which was used as part of the consideration for the contribution of certain assets and liabilities to the Company by Enovis in connection with the Separation. To manage pre-existing currency rate exposures and interest risks arising from these credit facilities, during the third quarter, the Company entered into interest rate swap agreements and cross currency swap agreements, ref</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">er </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to Note 15, “De</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">bt” and Note 16, “Derivatives” for additional information.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principles of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s Consolidated and Combined Financial Statements are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include all majority-owned subsidiaries over which the Company exercises control and, when applicable, entities or joint ventures for which the Company has a controlling financial interest or is the primary beneficiary. When protective rights, substantive rights or other factors exist, further analysis is performed in order to determine whether or not there is a controlling financial interest. The Consolidated and Combined Financial Statements reflect the assets, liabilities, revenues and expenses of consolidated subsidiaries and the noncontrolling parties’ ownership share is presented as a noncontrolling interest. </span></div>All significant intercompany accounts and transactions have been eliminated. 2 0.90 0.10 6000000 1200000000 1200000000 0.06 20000000 0.05 -90000000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Consolidated and Combined Financial Statements present the Company’s historical financial position, results of operations, changes in equity and cash flows in accordance with generally accepted accounting principles in the United States of America (“GAAP”). The combined financial statements for periods prior to the Separation were derived from Enovis’s consolidated financial statements and accounting records and prepared in accordance with GAAP for the preparation of carved-out combined financial statements. Through the date of the Separation, all revenues and costs as well as assets and liabilities directly associated with ESAB have been included in the combined financial statements. Prior to the Separation, the combined financial statements also included allocations of certain general, administrative, sales and marketing expenses from Enovis’s corporate office and from other Enovis businesses to the Company and allocations of related assets, liabilities, and the Former Parent’s investment, as applicable. The allocations were determined on a reasonable basis, however, the amounts are not necessarily representative of the amounts that would have been reflected in the financial statements had the Company been an entity that operated independently of Enovis during the applicable periods. Re</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lated party a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">llocations prior to the Separation, including the method for such allocation, are discussed further in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 21, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">“Related Party Transactions.” </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Separation, the consolidated financial statements include ESAB and its wholly-owned subsidiaries and no longer include any allocations of expenses from Enovis. Accordingly:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Consolidated Balance Sheet </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as of December 31, 2022 con</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sists of the consolidated balances of ESAB, while the Combined Balance Sheet as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of December 31, 2021 consists of t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he combined balances of the former Fabrication Technology business of Enovis. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Consolidated and Combined Statement of Operations and Statement of Comprehensive (Loss) Income for the year ended December 31, 2022 consists of the consolidated results of ESAB for the nine months ended December 31, 2022 and the combined results of the former Fabrication Technology business of Enovis and the certain entities discussed in the “Separation from Enovis” section above for the three months ended April 1, 2022. The Combined Statement of Operations and Statement of Comprehensive (Loss) Income for the years ended December 31, 2021 and 2020 consist of the combined results of the former Fabrication Technology business of Enovis. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Consolidated and Combined Statement of Changes in Equity for the year December 31, 2022 consists of the consolidated activities of ESAB for the nine months ended December 31, 2022 and the combined activity of the former Fabrication Technology business of Enovis and the certain entities discussed in the “Separation from Enovis” section above for the three months ended April 1, 2022. The Combined Statements of Changes in Equity for the year ended December 31, 2021 and 2020 consist of the combined activity of the former Fabrication Technology business of Enovis.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Consolidated and Combined Statement of Cash Flows for the year ended December 31, 2022 consists of the consolidated activities of ESAB for the nine months ended December 31, 2022 and the combined activity of ESAB and the former Fabrication Technology business of Enovis and the certain entities discussed in the “Separation from Enovis” section above for the three months ended April 1, 2022. The Combined Statement of Cash Flows for the years ended December 31, 2021 and 2020 consist of the combined activity of the former Fabrication Technology business of Enovis. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated and Combined Financial Statements of ESAB for the years en</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ded December 31, 2020 and 2021 an</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d the three months ended April 1, 2022 may not be indicative of the Company's results had it been a separate stand-alone entity throughout the periods presented, nor are the results stated herein indicative of what the Company's financial position, results of operations and cash flows may be in the future.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Prior to the Separation, the Company was dependent on the Former Parent for all of its working capital and financing requirements under Enovis’s centralized approach to cash management and financing of its operations. With the exception of cash, cash equivalents and borrowings clearly associated with ESAB and related to the Separation, financing transactions relating to the Company during the period prior to the Separation were accounted for through the Former Parent’s investment account of the Company. Accordingly, none of Enovis’s cash, cash equivalents or debt at the corporate level has been assigned to the Company in these financial statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Former Parent’s Investment, which included retained earnings, represented Enovis’s interest in the recorded net assets of the Company. All significant transactions between the Company and the Former Parent prior to the Separation have been included in the accompanying Financial Statements. Transactions with the Former Parent are reflected in the accompanying Consolidated and Combined Statements of Equity as “Transfers to Former Parent, net” and in the accompanying Consolidated and Combined Balance Sheets within “Former Parent’s investment”. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated and Combined Financial Statements reflect, in the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly the Company’s financial position and results of operations as of and for the periods indicated. Intercompany transactions and accounts are eliminated in consolidation.</span></div> The Company makes certain estimates and assumptions in preparing its Consolidated and Combined Financial Statements in accordance with U.S. generally accepted accounting principles, or “GAAP”. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the Consolidated and Combined Financial Statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from those estimates.<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes certain estimates and assumptions in preparing its Consolidated and Combined Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the Consolidated and Combined Financial Statements and the reported amounts of revenues and expenses for the period presented. Actual results may differ from those estimates.</span></div> Summary of Significant Accounting Policies<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principles of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s Consolidated and Combined Financial Statements are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include all majority-owned subsidiaries over which the Company exercises control and, when applicable, entities or joint ventures for which the Company has a controlling financial interest or is the primary beneficiary. When protective rights, substantive rights or other factors exist, further analysis is performed in order to determine whether or not there is a controlling financial interest. The Consolidated and Combined Financial Statements reflect the assets, liabilities, revenues and expenses of consolidated subsidiaries and the noncontrolling parties’ ownership share is presented as a noncontrolling interest. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All significant intercompany accounts and transactions have been eliminated.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Method Investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments accounted for under the equity method are initially recorded at the amount of the Company’s initial investment and adjusted each period for the Company’s share of the investee’s income or loss and dividends paid. All equity investments are reviewed periodically for indications of other-than-temporary impairment, including, but not limited to, significant and sustained decreases in quoted market prices or a series of historic and projected operating losses by investees. If the decline in fair value is considered to be other-than-temporary, an impairment loss is recorded and the investment is written down to a new carrying value. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recognizes revenue when control of promised goods or services is transferred to the customer. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled in exchange for transferring the goods or services. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides a variety of products and services to its customers. Most of the Company’s contracts consist of a single, distinct performance obligation or promise to transfer goods or services to a customer. For contracts that include multiple performance obligations, we allocate the total transaction price to each performance obligation using our best estimate of the stand-alone selling price of each identified performance obligation. A significant majority of our revenue relates to the shipment of off-the-shelf products that is recognized when control is transferred to the customer. On a limited basis, we have agreements with customers that have multiple performance obligations. In determining whether there are multiple performance obligations, we first assess the goods or services promised in the customer arrangement and then consider the guidance in ASC 606, Revenue from Contracts with Customers, to evaluate whether goods and services are capable of being distinct and are considered distinct within the customer arrangement. To determine whether promised goods or services are separately identifiable (i.e., whether a promise to transfer a good or service is distinct in the context of the contract), we evaluate whether the contract is to deliver (1) multiple promised goods or services or (2) a combined item that comprises the individual goods or services promised in the contract. Substantially all revenue involving development and application engineering projects consists of a single performance obligation and is recognized at a point in time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As mentioned above, a majority of revenue recognized by the Company relates to contracts with customers for standard or off-the-shelf products. As control typically transfers to the customer upon shipment of the product in these circumstances, revenue is generally recognized at that point in time. Revenue recognition and billing typically occur simultaneously for contracts recognized at a point in time. Therefore, we do not have material revenues in excess of customer billings or billings to customers in excess of recognized revenues. Refer to Note 13, “Accrued and Other Liabilities” for additional information on the Company’s contract liability balances. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For service contracts, the Company recognizes revenue ratably over the period of performance as the customer simultaneously receives and consumes the benefits of the services provided. The Company applies the available practical expedient involving the existence of a significant financing component. As the Company generally does not receive payments greater than one year in advance or arrears of revenue recognition, the Company does not consider any arrangements to include financing components. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The period of benefit for the Company’s incremental costs of obtaining a contract generally have less than a one-year duration; therefore, the Company applies the practical expedient available and expenses costs to obtain a contract when incurred. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Taxes Collected from Customers and Remitted to Governmental Authorities</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company collects various taxes and fees as an agent in connection with the sale of products and remits these amounts to the respective taxing authorities. These taxes and fees have been presented on a net basis within Net sales in the Consolidated and Combined Statements of Operations and are recorded as a component of Accrued liabilities in the Consolidated and Combined Balance Sheets until remitted to the respective taxing authority.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expense</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs of $36.0 million, $39.7 million and $34.8 million for the years ended December 31, 2022, 2021 and 2020, respectively, are expensed as incurred and are included in Selling, general and administrative expense in the Consolidated and Combined Statements of Operations. These amounts do not include development and application engineering costs incurred in conjunction with fulfilling customer orders and executing customer projects. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents include all financial instruments purchased with an initial maturity of three months or less. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade Receivables</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade receivables are presented net of an allowance for credit losses. The estimate of current expected credit losses on trade receivables considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. Estimated credit losses are reviewed periodically. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are valued at the lower of cost or net realizable value. Fixed manufacturing overhead costs are allocated to inventory based on normal production capacity and abnormal manufacturing activities are recognized as period costs. Cost for a substantial portion of U.S. inventories is determined using the last-in, first-out method (“LIFO”). The value of inventory stated on a LIFO basis as of December 31, 2022 and 2021 was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$131.1 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $142.4 million, respecti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vely. The valuation of LIFO inventories is made at the end of each year based on inventory levels and costs at that time. Cost of other inventories is determined by costing methods that approximate a first-in, first-out basis. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves are maintained for estimated obsolescence or excess inventory equal to the difference between the cost of inventory and the net realizable value based upon assumptions about future demand and market conditions. The reserve for excess and obsolete inventory was $40.1 million and $37.9 million as of December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021, respectively.</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net is stated at historical cost, which includes the fair values of such assets acquired through acquisitions. Repair and maintenance expenditures are expensed as incurred unless the repair extends the useful life of the asset. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Goodwill and Indefinite-Lived Intangible Assets</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the costs in excess of the fair value of net assets acquired through acquisitions by the Company. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the recoverability of Goodwill and indefinite-lived intangible assets annually or more frequently if an event occurs or circumstances change in the interim that would more likely than not reduce the fair value of the asset below its carrying amount. The annual impairment test date elected by the Company is the first day of its fourth quarter. Goodwill and indefinite-lived intangible assets are considered to be impaired when the carrying value of a reporting unit or asset exceeds its fair value. As of the annual impairment test date, the Company had three reporting units: Americas, EMEA &amp; APAC and Gas Control Equipment (“GCE”).</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the evaluation of goodwill for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting entity is less than its carrying value. If the Company determines that it is more likely than not for a reporting unit’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not for a reporting unit’s fair value to be less than its carrying value, a calculation of the reporting unit’s fair value is performed and compared to the carrying value of that reporting unit. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying value of a reporting unit exceeds its fair value, goodwill of that reporting unit is impaired and an impairment loss is recorded equal to the excess of the reporting unit’s carrying value over its fair value. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When a quantitative impairment test is needed, the Company measures fair value of reporting units based on a present value of future discounted cash flows. The discounted cash flow models indicate the fair value of the reporting units based on the present value of the cash flows that the reporting units are expected to generate in the future. Significant estimates in the discounted cash flow models include the weighted-average cost of capital, net sales and profitability of our business. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2022 a qualitative Goodwill impairment assessment was performed for the three reporting units. For the year ended December 31, 2021 a quantitative annual impairment test of Goodwill was performed for the GCE reporting unit while qualitative assessments were performed for the remaining two reporting units. A quantitative annual impairment test of Goodwill for each of the Company’s three reporting units was performed for the year ended December 31, 2020. All of the above tests indicated no impairment existed. Therefore, no impairment charges were recorded for the three years ended December 31, 2022. No material events that would represent impairment indicators have occurred subsequent to the performance of the 2022 annual impairment test.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the evaluation of indefinite-lived intangible assets for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying value. If the Company determines that it is more likely than not for the indefinite-lived intangible asset’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not that the indefinite-lived intangible asset’s fair value is less than its carrying value, a fair value calculation is performed and compared to the carrying value of the asset. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying amount of the indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The Company measures the fair value of its indefinite-lived intangible assets using the “relief from royalty” method. Significant estimates in this approach include projected revenues and royalty and discount rates for each trade name evaluated. At the impairment testing date, the first day of the fourth quarter, quantitative impairment tests were performed for all the indefinite-lived trade name brands for the years ended December 31, 2022, 2021 and 2020, all of which indicated no impairment existed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Long-Lived Assets Other than Goodwill and Indefinite-Lived Intangible Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Definite-lived intangible assets primarily represent acquired trade names, customer relationships, acquired technology and software license agreements. The Company uses accelerated and straight-line methods of amortization with lives ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkwZGMwN2NjMWFjNjQyMzI5ZDU5NmRjMDlmZWMxYWVmL3NlYzo5MGRjMDdjYzFhYzY0MjMyOWQ1OTZkYzA5ZmVjMWFlZl8xMjEvZnJhZzpiY2I3NWYwMTQ5Yzk0M2FiYTFlYzgwOTIxNzhkYjQ4Yi90ZXh0cmVnaW9uOmJjYjc1ZjAxNDljOTQzYWJhMWVjODA5MjE3OGRiNDhiXzEwNDQ1MzYwNTcwNDg5_b2ebfb86-b834-4e66-81d8-b071aed4e48d">ten</span> to thirty years. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses its long-lived assets and definite-lived intangible assets for impairment whenever facts and circumstances indicate that the carrying amounts may not be fully recoverable. To analyze recoverability, the Company projects undiscounted net future cash flows over the remaining lives of such assets. If these projected cash flows are less than the carrying amounts, an impairment loss equal to the difference between the carrying amount of the asset and its fair value would be recognized, resulting in a write-down of the assets with a corresponding charge to earnings. Assets held for sale are reported at the lower of the carrying amounts or fair value less cost to sell. The Company determines fair value using the discounted cash flow method or other accepted valuation techniques. The Company determined that no impairment indicators were evident during the years ended December 31, 2022, 2021 and 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative instruments to manage exposures to interest rates and net investment exposures. The Company does not enter into derivatives for trading or speculative purposes.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivatives are recognized at fair value on the Company’s Consolidated and Combined Balance Sheets. The accounting for gains and losses resulting from changes in fair value depends on the use of the derivative and whether it is designated and qualifies for hedge accounting. The Company formally documents the relationship of the hedge with the hedged item as well as the risk-management strategy for all designated hedges. Both at inception and on an ongoing basis, the hedging instrument is assessed as to its effectiveness, when applicable. If and when a derivative is determined not to be highly effective as a hedge, the underlying hedged transaction is no longer likely to occur, or the derivative is terminated, hedge accounting is discontinued.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to the credit risk of the counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. The Company manages individual counterparty exposure by monitoring the credit rating of the counterparty and the size of financial commitments and exposures between the Company and the counterparty.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain interest rate swap agreements are qualified and designated as cash flow hedges. The effective portion of the fair value unrealized gain or loss on cash flow hedges are reported as a component of Accumulated other comprehensive income ("AOCI") with offsetting amounts recorded in the Company’s Consolidated and Combined Balance Sheet depending on the position and the duration of the contract. The gain or loss on the derivative instrument due to the change in fair value is reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. If a derivative is deemed to be ineffective, the change in fair value of the derivative is recognized directly in earnings. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain cross-currency swap agreements are designated and qualify as a net investment hedge, the changes in the fair value of these instruments are recorded in AOCI in equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCI. Offsetting amounts are recorded in the Company’s Consolidated and Combined Balance Sheet depending on the position and the duration of the contract.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain foreign currency contracts which are not designated as hedges. These derivatives are held as offsets to certain balance sheet exposures. The gains or losses on these contracts are recognized in Interest expense (income) and other, net, in the Company’s Consolidated and Combined Statement of Operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warranty Costs</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated expenses related to product warranties are accrued as the revenue is recognized on products sold to customers and included in Cost of sales in the Consolidated and Combined Statements of Operations. Estimates are established using historical information as to the nature, frequency, and average costs of warranty claims.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Separ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ation, the Company’s domestic and foreign operating results were included in the income tax returns of Enovis. The Company accounted for income taxes under the separate return method. Under this approach, the Company determined its deferred tax assets and liabilities and related tax expense as if it were filing separate tax returns. The accompanying Combined Balance Sheets for the year ended December 31, 2021 did not contain current income tax payable or other long-term income tax payable liabilities, with the exception of certain unrecognized tax benefits for which ESAB could have reasonably be considered to be the primary obligor. The amounts are deemed settled with Enovis when they were due and therefore were included in Parent’s equity.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under ASC 740</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Income Taxes (“ASC 740”)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which requires recognition of deferred income tax assets and liabilities reflecting the tax consequences attributable to differences between the carrying amounts of existing assets and liabilities in the Consolidated and Combined Financial S</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tatements and their respective tax basis. Deferred income tax assets and liabilities are measured using enacted tax rates expected to be applied to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred income tax assets and liabilities are reported in Other assets and Other liabilities in the Consolidated and Combined Balance Sheets, respectively. The effect on deferred income tax assets and liabilities of a change in tax rates is generally recognized in Income tax expense in the period that includes the enactment date. Global Intangible Low-Taxed Income (“GILTI”) is accounted for as a current tax expense in the year the tax is incurred.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowances are recorded if it is more likely than not that some portion of the deferred income tax assets will not be realized. In evaluating the need for a valuation allowance, the Company considers various factors, including the expected level of future taxable income and available tax planning strategies. Any changes in judgment about the valuation allowance are recorded through Income tax expense and are based on changes in facts and circumstances regarding realizability of deferred tax assets.</span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company must presume that an income tax position taken in a tax return will be examined by the relevant tax authority and determine whether it is more likely than not that the tax position will be sustained upon examination based upon the technical merits of the position. An income tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The Company establishes a liability for unrecognized income tax benefits for income tax positions for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority to the extent such tax positions reduce the Company’s income tax liability. The Company recognizes interest and penalties related to unrecognized income tax benefits in Income tax expense in the Consolidated and Combined Statements of Operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense (income) and Other, Net</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense (income) and other, net is comprised of interest-bearing deposits of certain foreign subsidiaries, interest costs for the Company’s debt, amortization of debt issuance costs and interest income or expense of derivatives designated in hedging relationships. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, it is comprised of other non-operating income items, including certain pension-related activities, foreign exchange exposure on cash and intercompany positions and interest income or expense on foreign currency contracts not designated in hedging relationships. See “Foreign Currency Exchange Gains and Losses” policy below for additional information. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Gains and Losses</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company’s financial statements are presented in U.S. dollars. The functional currencies of the Company’s operating subsidiaries are generally the local currencies of the countries in which each subsidiary is located. Assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the balance sheet date. The amounts recorded in each year in Foreign currency translation are net of income taxes to the extent the unrealized foreign exchange is taxed currently or the underlying equity balances in the entities are not deemed to be permanently reinvested. Revenues and expenses are translated at average rates of exchange in effect during the year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transactions in foreign currencies are translated at the exchange rate in effect at the date of each transaction. Differences in exchange rates during the period between the date a transaction denominated in a foreign currency is consummated and the date on which it is either settled or translated for inclusion in the Consolidated and Combined Balance Sheets are recognized in Selling, general and administrative expense or Interest expense (income) and other, net in the Consolidated and Combined Statements of Operations for that period.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s net foreign transaction gains and losses included within the Consolidated and Combined Statements of Operations: </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,597 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,195 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">788 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest (income) expense and other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency transaction loss (gain), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,706 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,386 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,101 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">This table excludes the impact of the foreign exchange loss due to the remeasurement of the Company’s Argentinian operations, as described in the “Argentina Currency” paragraph below.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Argentina Currency</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Argentina is deemed to have a highly inflationary economy, resulting in the remeasurement of the company’s Argentinian operations into Brazilian real, the functional currency of the Argentinian entity’s direct parent. Gains and losses from the remeasurement are recorded in the Company’s Consolidated and Combined Statements of Operations each year. For the year ended December 31, 2022 the remeasurement of the financial statements of the Company’s subsidiary operating in a highly inflationary economy has resulted in a transaction foreign exchange loss to Cost of sales of $6.6 million, Selling, general and administrative expense of $3.3 million and Interest (income) expense and other, net of $2.4 million. The impact to the Company’s Combined Statements of Operations for the years ended December 31, 2021 and 2020 were not material. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Issuance Costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Costs directly related to the placement of debt are capitalized and amortized to Interest expense primarily using the straight-line method over the term of the related obligation.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See Note 15, “Debt”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional discussion regarding the Company’s borrowing arrangements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes certain estimates and assumptions in preparing its Consolidated and Combined Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the Consolidated and Combined Financial Statements and the reported amounts of revenues and expenses for the period presented. Actual results may differ from those estimates.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassification</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform to current year presentations, including certain items within the Consolidated and Combined Statements of Comprehensive Income.</span></div> Equity Method InvestmentsInvestments accounted for under the equity method are initially recorded at the amount of the Company’s initial investment and adjusted each period for the Company’s share of the investee’s income or loss and dividends paid. All equity investments are reviewed periodically for indications of other-than-temporary impairment, including, but not limited to, significant and sustained decreases in quoted market prices or a series of historic and projected operating losses by investees. If the decline in fair value is considered to be other-than-temporary, an impairment loss is recorded and the investment is written down to a new carrying value. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recognizes revenue when control of promised goods or services is transferred to the customer. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled in exchange for transferring the goods or services. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides a variety of products and services to its customers. Most of the Company’s contracts consist of a single, distinct performance obligation or promise to transfer goods or services to a customer. For contracts that include multiple performance obligations, we allocate the total transaction price to each performance obligation using our best estimate of the stand-alone selling price of each identified performance obligation. A significant majority of our revenue relates to the shipment of off-the-shelf products that is recognized when control is transferred to the customer. On a limited basis, we have agreements with customers that have multiple performance obligations. In determining whether there are multiple performance obligations, we first assess the goods or services promised in the customer arrangement and then consider the guidance in ASC 606, Revenue from Contracts with Customers, to evaluate whether goods and services are capable of being distinct and are considered distinct within the customer arrangement. To determine whether promised goods or services are separately identifiable (i.e., whether a promise to transfer a good or service is distinct in the context of the contract), we evaluate whether the contract is to deliver (1) multiple promised goods or services or (2) a combined item that comprises the individual goods or services promised in the contract. Substantially all revenue involving development and application engineering projects consists of a single performance obligation and is recognized at a point in time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As mentioned above, a majority of revenue recognized by the Company relates to contracts with customers for standard or off-the-shelf products. As control typically transfers to the customer upon shipment of the product in these circumstances, revenue is generally recognized at that point in time. Revenue recognition and billing typically occur simultaneously for contracts recognized at a point in time. Therefore, we do not have material revenues in excess of customer billings or billings to customers in excess of recognized revenues. Refer to Note 13, “Accrued and Other Liabilities” for additional information on the Company’s contract liability balances. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For service contracts, the Company recognizes revenue ratably over the period of performance as the customer simultaneously receives and consumes the benefits of the services provided. The Company applies the available practical expedient involving the existence of a significant financing component. As the Company generally does not receive payments greater than one year in advance or arrears of revenue recognition, the Company does not consider any arrangements to include financing components. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The period of benefit for the Company’s incremental costs of obtaining a contract generally have less than a one-year duration; therefore, the Company applies the practical expedient available and expenses costs to obtain a contract when incurred. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Taxes Collected from Customers and Remitted to Governmental Authorities</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company collects various taxes and fees as an agent in connection with the sale of products and remits these amounts to the respective taxing authorities. These taxes and fees have been presented on a net basis within Net sales in the Consolidated and Combined Statements of Operations and are recorded as a component of Accrued liabilities in the Consolidated and Combined Balance Sheets until remitted to the respective taxing authority.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expense</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>Research and development costs of $36.0 million, $39.7 million and $34.8 million for the years ended December 31, 2022, 2021 and 2020, respectively, are expensed as incurred and are included in Selling, general and administrative expense in the Consolidated and Combined Statements of Operations. These amounts do not include development and application engineering costs incurred in conjunction with fulfilling customer orders and executing customer projects. 36000000 39700000 34800000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>Cash and cash equivalents include all financial instruments purchased with an initial maturity of three months or less. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade Receivables</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div>Trade receivables are presented net of an allowance for credit losses. The estimate of current expected credit losses on trade receivables considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. Estimated credit losses are reviewed periodically. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are valued at the lower of cost or net realizable value. Fixed manufacturing overhead costs are allocated to inventory based on normal production capacity and abnormal manufacturing activities are recognized as period costs. Cost for a substantial portion of U.S. inventories is determined using the last-in, first-out method (“LIFO”). The value of inventory stated on a LIFO basis as of December 31, 2022 and 2021 was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$131.1 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $142.4 million, respecti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vely. The valuation of LIFO inventories is made at the end of each year based on inventory levels and costs at that time. Cost of other inventories is determined by costing methods that approximate a first-in, first-out basis. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves are maintained for estimated obsolescence or excess inventory equal to the difference between the cost of inventory and the net realizable value based upon assumptions about future demand and market conditions. The reserve for excess and obsolete inventory was $40.1 million and $37.9 million as of December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021, respectively.</span></div> 131100000 142400000 40100000 37900000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>Property, plant and equipment, net is stated at historical cost, which includes the fair values of such assets acquired through acquisitions. Repair and maintenance expenditures are expensed as incurred unless the repair extends the useful life of the asset. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Goodwill and Indefinite-Lived Intangible Assets</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the costs in excess of the fair value of net assets acquired through acquisitions by the Company. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the recoverability of Goodwill and indefinite-lived intangible assets annually or more frequently if an event occurs or circumstances change in the interim that would more likely than not reduce the fair value of the asset below its carrying amount. The annual impairment test date elected by the Company is the first day of its fourth quarter. Goodwill and indefinite-lived intangible assets are considered to be impaired when the carrying value of a reporting unit or asset exceeds its fair value. As of the annual impairment test date, the Company had three reporting units: Americas, EMEA &amp; APAC and Gas Control Equipment (“GCE”).</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the evaluation of goodwill for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting entity is less than its carrying value. If the Company determines that it is more likely than not for a reporting unit’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not for a reporting unit’s fair value to be less than its carrying value, a calculation of the reporting unit’s fair value is performed and compared to the carrying value of that reporting unit. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying value of a reporting unit exceeds its fair value, goodwill of that reporting unit is impaired and an impairment loss is recorded equal to the excess of the reporting unit’s carrying value over its fair value. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When a quantitative impairment test is needed, the Company measures fair value of reporting units based on a present value of future discounted cash flows. The discounted cash flow models indicate the fair value of the reporting units based on the present value of the cash flows that the reporting units are expected to generate in the future. Significant estimates in the discounted cash flow models include the weighted-average cost of capital, net sales and profitability of our business. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2022 a qualitative Goodwill impairment assessment was performed for the three reporting units. For the year ended December 31, 2021 a quantitative annual impairment test of Goodwill was performed for the GCE reporting unit while qualitative assessments were performed for the remaining two reporting units. A quantitative annual impairment test of Goodwill for each of the Company’s three reporting units was performed for the year ended December 31, 2020. All of the above tests indicated no impairment existed. Therefore, no impairment charges were recorded for the three years ended December 31, 2022. No material events that would represent impairment indicators have occurred subsequent to the performance of the 2022 annual impairment test.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the evaluation of indefinite-lived intangible assets for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying value. If the Company determines that it is more likely than not for the indefinite-lived intangible asset’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not that the indefinite-lived intangible asset’s fair value is less than its carrying value, a fair value calculation is performed and compared to the carrying value of the asset. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying amount of the indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The Company measures the fair value of its indefinite-lived intangible assets using the “relief from royalty” method. Significant estimates in this approach include projected revenues and royalty and discount rates for each trade name evaluated. At the impairment testing date, the first day of the fourth quarter, quantitative impairment tests were performed for all the indefinite-lived trade name brands for the years ended December 31, 2022, 2021 and 2020, all of which indicated no impairment existed.</span></div> 3 3 2 3 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Long-Lived Assets Other than Goodwill and Indefinite-Lived Intangible Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Definite-lived intangible assets primarily represent acquired trade names, customer relationships, acquired technology and software license agreements. The Company uses accelerated and straight-line methods of amortization with lives ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkwZGMwN2NjMWFjNjQyMzI5ZDU5NmRjMDlmZWMxYWVmL3NlYzo5MGRjMDdjYzFhYzY0MjMyOWQ1OTZkYzA5ZmVjMWFlZl8xMjEvZnJhZzpiY2I3NWYwMTQ5Yzk0M2FiYTFlYzgwOTIxNzhkYjQ4Yi90ZXh0cmVnaW9uOmJjYjc1ZjAxNDljOTQzYWJhMWVjODA5MjE3OGRiNDhiXzEwNDQ1MzYwNTcwNDg5_b2ebfb86-b834-4e66-81d8-b071aed4e48d">ten</span> to thirty years. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses its long-lived assets and definite-lived intangible assets for impairment whenever facts and circumstances indicate that the carrying amounts may not be fully recoverable. To analyze recoverability, the Company projects undiscounted net future cash flows over the remaining lives of such assets. If these projected cash flows are less than the carrying amounts, an impairment loss equal to the difference between the carrying amount of the asset and its fair value would be recognized, resulting in a write-down of the assets with a corresponding charge to earnings. Assets held for sale are reported at the lower of the carrying amounts or fair value less cost to sell. The Company determines fair value using the discounted cash flow method or other accepted valuation techniques. The Company determined that no impairment indicators were evident during the years ended December 31, 2022, 2021 and 2020.</span></div> P30Y <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative instruments to manage exposures to interest rates and net investment exposures. The Company does not enter into derivatives for trading or speculative purposes.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivatives are recognized at fair value on the Company’s Consolidated and Combined Balance Sheets. The accounting for gains and losses resulting from changes in fair value depends on the use of the derivative and whether it is designated and qualifies for hedge accounting. The Company formally documents the relationship of the hedge with the hedged item as well as the risk-management strategy for all designated hedges. Both at inception and on an ongoing basis, the hedging instrument is assessed as to its effectiveness, when applicable. If and when a derivative is determined not to be highly effective as a hedge, the underlying hedged transaction is no longer likely to occur, or the derivative is terminated, hedge accounting is discontinued.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to the credit risk of the counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. The Company manages individual counterparty exposure by monitoring the credit rating of the counterparty and the size of financial commitments and exposures between the Company and the counterparty.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain interest rate swap agreements are qualified and designated as cash flow hedges. The effective portion of the fair value unrealized gain or loss on cash flow hedges are reported as a component of Accumulated other comprehensive income ("AOCI") with offsetting amounts recorded in the Company’s Consolidated and Combined Balance Sheet depending on the position and the duration of the contract. The gain or loss on the derivative instrument due to the change in fair value is reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. If a derivative is deemed to be ineffective, the change in fair value of the derivative is recognized directly in earnings. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain cross-currency swap agreements are designated and qualify as a net investment hedge, the changes in the fair value of these instruments are recorded in AOCI in equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCI. Offsetting amounts are recorded in the Company’s Consolidated and Combined Balance Sheet depending on the position and the duration of the contract.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain foreign currency contracts which are not designated as hedges. These derivatives are held as offsets to certain balance sheet exposures. The gains or losses on these contracts are recognized in Interest expense (income) and other, net, in the Company’s Consolidated and Combined Statement of Operations.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warranty Costs</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated expenses related to product warranties are accrued as the revenue is recognized on products sold to customers and included in Cost of sales in the Consolidated and Combined Statements of Operations. Estimates are established using historical information as to the nature, frequency, and average costs of warranty claims.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Separ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ation, the Company’s domestic and foreign operating results were included in the income tax returns of Enovis. The Company accounted for income taxes under the separate return method. Under this approach, the Company determined its deferred tax assets and liabilities and related tax expense as if it were filing separate tax returns. The accompanying Combined Balance Sheets for the year ended December 31, 2021 did not contain current income tax payable or other long-term income tax payable liabilities, with the exception of certain unrecognized tax benefits for which ESAB could have reasonably be considered to be the primary obligor. The amounts are deemed settled with Enovis when they were due and therefore were included in Parent’s equity.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under ASC 740</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Income Taxes (“ASC 740”)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which requires recognition of deferred income tax assets and liabilities reflecting the tax consequences attributable to differences between the carrying amounts of existing assets and liabilities in the Consolidated and Combined Financial S</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tatements and their respective tax basis. Deferred income tax assets and liabilities are measured using enacted tax rates expected to be applied to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred income tax assets and liabilities are reported in Other assets and Other liabilities in the Consolidated and Combined Balance Sheets, respectively. The effect on deferred income tax assets and liabilities of a change in tax rates is generally recognized in Income tax expense in the period that includes the enactment date. Global Intangible Low-Taxed Income (“GILTI”) is accounted for as a current tax expense in the year the tax is incurred.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowances are recorded if it is more likely than not that some portion of the deferred income tax assets will not be realized. In evaluating the need for a valuation allowance, the Company considers various factors, including the expected level of future taxable income and available tax planning strategies. Any changes in judgment about the valuation allowance are recorded through Income tax expense and are based on changes in facts and circumstances regarding realizability of deferred tax assets.</span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company must presume that an income tax position taken in a tax return will be examined by the relevant tax authority and determine whether it is more likely than not that the tax position will be sustained upon examination based upon the technical merits of the position. An income tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The Company establishes a liability for unrecognized income tax benefits for income tax positions for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority to the extent such tax positions reduce the Company’s income tax liability. The Company recognizes interest and penalties related to unrecognized income tax benefits in Income tax expense in the Consolidated and Combined Statements of Operations.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense (income) and Other, Net</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense (income) and other, net is comprised of interest-bearing deposits of certain foreign subsidiaries, interest costs for the Company’s debt, amortization of debt issuance costs and interest income or expense of derivatives designated in hedging relationships. </span></div>In addition, it is comprised of other non-operating income items, including certain pension-related activities, foreign exchange exposure on cash and intercompany positions and interest income or expense on foreign currency contracts not designated in hedging relationships. See “Foreign Currency Exchange Gains and Losses” policy below for additional information. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Gains and Losses</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company’s financial statements are presented in U.S. dollars. The functional currencies of the Company’s operating subsidiaries are generally the local currencies of the countries in which each subsidiary is located. Assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the balance sheet date. The amounts recorded in each year in Foreign currency translation are net of income taxes to the extent the unrealized foreign exchange is taxed currently or the underlying equity balances in the entities are not deemed to be permanently reinvested. Revenues and expenses are translated at average rates of exchange in effect during the year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transactions in foreign currencies are translated at the exchange rate in effect at the date of each transaction. Differences in exchange rates during the period between the date a transaction denominated in a foreign currency is consummated and the date on which it is either settled or translated for inclusion in the Consolidated and Combined Balance Sheets are recognized in Selling, general and administrative expense or Interest expense (income) and other, net in the Consolidated and Combined Statements of Operations for that period.</span></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s net foreign transaction gains and losses included within the Consolidated and Combined Statements of Operations: </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,597 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,195 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">788 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest (income) expense and other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency transaction loss (gain), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,706 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,386 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,101 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">This table excludes the impact of the foreign exchange loss due to the remeasurement of the Company’s Argentinian operations, as described in the “Argentina Currency” paragraph below.</span></div> 2597000 2195000 788000 109000 191000 313000 2706000 2386000 1101000 6600000 3300000 2400000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Issuance Costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Costs directly related to the placement of debt are capitalized and amortized to Interest expense primarily using the straight-line method over the term of the related obligation.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See Note 15, “Debt”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional discussion regarding the Company’s borrowing arrangements.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassification</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform to current year presentations, including certain items within the Consolidated and Combined Statements of Comprehensive Income.</span></div> Recently Issued Accounting PronouncementsThe Company assesses the adoption impacts of recently issued accounting pronouncements on the Company’s Consolidated and Combined financial statements as well as material updates to previous assessments. There were no new material accounting standards issued or adopted in the year of 2022 that impacted the Company. Recently Issued Accounting PronouncementsThe Company assesses the adoption impacts of recently issued accounting pronouncements on the Company’s Consolidated and Combined financial statements as well as material updates to previous assessments. There were no new material accounting standards issued or adopted in the year of 2022 that impacted the Company. Discontinued Operations<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds certain asbestos-related contingencies and insurance coverages from divested businesses for which it does not have an interest in the ongoing operations. The entities that hold these assets and liabilities became subsidiaries of the Company during the year ended December 31, 2022 in connection with the Separation. These assets and liabilities were not included in the Company’s historical Combined Financial Statements for 2021 or 2020 as the Company did not have legal title to these assets, nor was the Company the legal obligor of these liabilities. The 2022 amounts reflect income, expenses, assets and liabilities historically recorded within the Former Parent’s divested businesses that were not part of Former Parent’s Fabrication Technology segment. Refer to “Note 1, Organization and Basis of Presentation” for additional information.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company has classified asbestos-related activity included in its Consolidated and Combined Statements of Operations, as part of Loss from discontinued operations, net of taxes. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Loss from discontinued operations, net of taxes consists of Selling, general and administrative expenses o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">f $7.5 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">net of a tax benefit of $4.4 million. See Note 19, “Commitments and Contingencies” for further information.</span></div><div style="text-align:center;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in operating activities related to discontinued operations for the year ended December 31, 2022 was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$23.1 million.</span></div> 7500000 -4400000 -23100000 Acquisitions<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 14, 2022, the Company completed the acquisition of Ohio Medical, LLC, a U.S. based global leader in oxygen regulators and central gas systems, for $127 million, net of cash received. In connection with the acquisition, the Company expects to realize an additional cash tax benefit with a net present value of approximately $15 million. This acquisition expands the Company’s presence in industrial specialty gas applications and products and broadens the Company’s U.S. presence.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2022, the Company completed the acquisition of Swift Cut Automation Limited, for $22 million, net of cash received. Swift-Cut is a provider of light industrial cutting systems and combined with ESAB provides a market-leading automated cutting portfolio. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisitions consummated during the year ended December 31, 2022 are accounted for under the acquisition method of accounting. The assets acquired and liabilities assumed reported on the Consolidated Balance Sheets represent the Company’s best estimate. These amounts are based upon certain valuations and studies that have yet to be finalized and are subject to adjustment once the detailed analyses are completed within twelve months from the respective acquisition dates.</span></div> 127000000 15000000 22000000 Revenue<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops, manufactures and supplies consumable welding and cutting products and equipment, as well as gas control equipment. The Company provides a wide range of products with innovative technologies to solve challenges in a range of industries, including cutting, joining and automated welding. Substantially all revenue is recognized at a point in time. The Company disaggregates its revenue into the following product groups:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">740,824 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">758,267 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">607,504 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,852,656 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,669,848 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,342,565 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,593,480 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,428,115 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,950,069 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sales mix in the above table is relatively consistent across both reportable segments. The consumables product grouping generally has less production complexity and shorter production cycles than equipment products.</span></div><div style="padding-left:63pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the nature of the business, the total amount of unsatisfied performance obligations with an original contract duration of greater than one year as of December 31, 2022 is immaterial. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, customers are billed in advance of revenue recognition, resulting in contract liabilities. As of December 31, 2022, 2021 and 2020, total contract liabilities were $25.9 million, $22.3 million and $21.6 million, respectively, and are included in Accrued liabilities on the Consolidated and Combined Balance Sheets. During the years ended December 31, 2022 and 2021, substantially all amounts included in the contract liability balance at the beginning of the respective year were recognized as revenue in the following year.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for Credit Losses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the activity in the Company’s allowance for credit losses included within Trade receivables in the Consolidated and Combined Balance Sheets is as follows:</span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.764%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.552%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Charged to Expense, net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Write-Offs and Deductions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Foreign<br/>Currency<br/>Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,912 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,526 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,978)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,471 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> The Company disaggregates its revenue into the following product groups:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">740,824 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">758,267 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">607,504 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,852,656 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,669,848 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,342,565 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,593,480 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,428,115 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,950,069 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 740824000 758267000 607504000 1852656000 1669848000 1342565000 2593480000 2428115000 1950069000 25900000 22300000 21600000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the activity in the Company’s allowance for credit losses included within Trade receivables in the Consolidated and Combined Balance Sheets is as follows:</span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.764%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.552%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Charged to Expense, net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Write-Offs and Deductions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Foreign<br/>Currency<br/>Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,912 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,526 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,978)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,471 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 23912000 4526000 4978000 11000 23471000 Earnings per Share from Continuing Operations<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has unvested share-based payment awards with a right to receive non-forfeitable dividends which are considered participating securities. The Company allocates earnings to participating securities and computed earnings per share using the two-class method as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:58.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.868%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Computation of earnings per share from continuing operations - basic:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations attributable to ESAB Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226,815 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,110 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,414 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Less: distributed and undistributed earnings allocated to nonvested shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Income from continuing operations attributable to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225,215 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,110 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,414 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average shares of Common stock outstanding – basic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,054,930 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,034,311 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,034,311 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Income per share from continuing operations – basic </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.75 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.62 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Computation of earnings (loss) per share from continuing operations - diluted:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Income from continuing operations attributable to common stockholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225,215 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,110 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,414 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average shares of Common stock outstanding – basic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,054,930 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,034,311 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,034,311 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Net effect of potentially dilutive securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98,129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average shares of Common stock outstanding – dilution</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,153,059 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,034,311 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,034,311 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Net income per share from continuing operations – diluted</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.74 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.92 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.62 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income from continuing operations attributable to ESAB Corporation for the respective periods is calculated using Net income from continuing operations, less Income attributable to noncontrolling interest, net of taxes, o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">f $4.3 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$3.6 million and $2.5 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for the years ended December 31, 2022, 2021 and 2020 respectively.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The total number of shares outstanding on April 4, 2022 was 60,034,311 which is being utilized for the calculation of both basic and diluted earnings per share for the years ended December 31, 2021 and December 31, 2020 as no ESAB common stock equivalents were outstanding prior to the Separation.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Potentially dilutive securities include stock options, performance-based restricted stock units and non performance-based restricted stock units.</span></div> The Company allocates earnings to participating securities and computed earnings per share using the two-class method as follows:<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:58.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.868%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Computation of earnings per share from continuing operations - basic:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations attributable to ESAB Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226,815 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,110 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,414 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Less: distributed and undistributed earnings allocated to nonvested shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Income from continuing operations attributable to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225,215 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,110 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,414 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average shares of Common stock outstanding – basic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,054,930 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,034,311 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,034,311 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Income per share from continuing operations – basic </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.75 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.62 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Computation of earnings (loss) per share from continuing operations - diluted:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Income from continuing operations attributable to common stockholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225,215 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,110 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,414 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average shares of Common stock outstanding – basic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,054,930 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,034,311 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,034,311 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Net effect of potentially dilutive securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98,129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average shares of Common stock outstanding – dilution</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,153,059 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,034,311 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,034,311 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Net income per share from continuing operations – diluted</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.74 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.92 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.62 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income from continuing operations attributable to ESAB Corporation for the respective periods is calculated using Net income from continuing operations, less Income attributable to noncontrolling interest, net of taxes, o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">f $4.3 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$3.6 million and $2.5 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for the years ended December 31, 2022, 2021 and 2020 respectively.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The total number of shares outstanding on April 4, 2022 was 60,034,311 which is being utilized for the calculation of both basic and diluted earnings per share for the years ended December 31, 2021 and December 31, 2020 as no ESAB common stock equivalents were outstanding prior to the Separation.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Potentially dilutive securities include stock options, performance-based restricted stock units and non performance-based restricted stock units.</span></div> 226815000 235110000 157414000 1600000 0 0 225215000 235110000 157414000 60054930000 60034311 60034311 3.75 3.92 2.62 225215000 235110000 157414000 60054930000 60034311 60034311 98129000 0 0 60153059000 60034311 60034311 3.74 3.92 2.62 4300000 3600000 2500000 60034311 Income Taxes<div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Separation from Enovis</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Separation, our operating results were included in the Former Parent’s various consolidated U.S. federal and certain state income tax returns, as well as certain non-U.S. returns. For periods prior to the Separation, our combined financial statements reflect Income tax expense and deferred tax balances as if we had filed tax returns on a standalone basis separate from the Former Parent. The separate return method applies the accounting guidance for income taxes to the standalone financial statements as if we were a separate taxpayer and a standalone enterprise for the periods prior to the Separation. For periods prior to the Separation, our pretax operating results include any transactions with the Former Parent as if it were an unrelated party.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Separation, we entered into agreements with the Former Parent, including a Tax Matters Agreement. The Tax Matters Agreement distinguishes between the treatment of tax matters for “joint” filings compared to “s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eparate” and “unitary state” filings prior to the Separation. “Joint” filings are returns, such as the U.S. federal return, that include operations from both Former Parent leg</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">al entities and the Company. By contrast, “separate” filings are tax returns (primarily U.S. state returns and non-U.S. returns) that </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exclusively include either the Former Parent’s or the Company’s </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> “Unitary state” filings are state tax returns which may include legal entities of both the Company and the Former Parent. In accordance with the Tax Matters Agreement, the Company is liable for and has indemnified the Former Parent against all income tax liabilities involving “separate” and “unitary state” filings for periods prior to the Separation, except to the extent a unitary state filing includes a legal entity of the Former Parent and the adjustment relates to that legal entity. The Company is also liable for fifty percent of all cash taxes paid as a result of any adjustment or redetermination or otherwise in connection with any tax contest relating to any joint return. </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Separation, the Company was required to enter into a transfer agreement under Section 965(h) and to become the primary obligor of the remaining installment payments associated with the Section 965 liability. The Former Parent is obligated under the Tax Matters Agreement for fifty percent of the installment obligation. Under the Separation Agreement, the Company is responsible for any tax indemnity related to the discontinued operations by the Former Parent. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Income from continuing operations before income taxes and Income tax expense consisted of the following:</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:53.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Domestic operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,140 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,505 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319,485 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308,948 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191,334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,251 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319,088 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205,839 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,928 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,477 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,262 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,451 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,797 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">921 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,728 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,779 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,819 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89,107 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89,053 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,002 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,501)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,698)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">358 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(677)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,794)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,895 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,656)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,937)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,644)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,031)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,170 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,409 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,971 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s Income tax expense differs from the amount that would be computed by applying the U.S. federal statutory rate as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:53.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes calculated at the U.S. federal statutory rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,008 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,809 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,933 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of tax rates on international operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,010)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,879)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(572)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in tax reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,734 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,346 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-taxable dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,675)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(542)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,351)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of U.S. taxation on international operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">310 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(313)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,634)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Permanent differences, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,209 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">483 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,284 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision to return</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,055)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Withholding taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,133 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,567 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,108 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,655)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,371 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation Allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,503 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,737 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,170 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,409 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,971 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company’s effective tax rate for each of 2022, 2021, and 2020 differs from the U.S. Federal statutory rate of 21% due to withholding taxes and permanent differences relating to foreign subsidiaries, partially offset by the favorable impact from the Company’s earnings outside the U.S. taxed at different rates than the U.S. federal statutory rate. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Separation, a portion of the Company’s income tax payable or receivable computed under the separate return method is adjusted to equity as it does not represent a liability or asset with the relevant taxing authorities since the Company activity for this period will be included as part of the Former Parent’s tax return, primarily the U.S. Federal Income Tax return, filed with taxing authorities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. All deferred tax assets and liabilities have been classified as noncurrent and are included in Other assets and Other liabilities in the accompanying Consolidated and Combined Balance Sheets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The temporary differences that gave rise to the significant components of deferred tax assets and liabilities are presented below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:62.764%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Post-retirement benefit obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,761 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,430 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenses currently not deductible</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,320 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,245 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating loss carryforward</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111,497 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax credit carryforward</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,320 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,124 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,450 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,685 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,873 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,648 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(88,202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,378 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,820 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121,858)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(135,726)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outside basis differences and other </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(102,336)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(108,542)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax liabilities </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(224,194)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(244,268)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax liabilities, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(96,816)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(162,448)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Deferred tax assets and liabilities have been classified as noncurrent and are included in Other assets and Other liabilities in the accompanying Consolidated and Combined Balance Sheets on a net jurisdictional basis as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:62.764%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,860 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,357 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(139,676)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(171,805)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liability, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(96,816)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(162,448)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he Company evaluates the recoverability of its deferred tax assets on a jurisdictional basis by considering whether deferred tax assets will be realized on a more likely than not basis. To the extent a portion or all of the applicable deferred tax assets do not meet the more likely tha</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n not threshold, a valuation allowance is recorded. During the year ended December 31, 2022, the valuation allowance increased from $15.5 million to $88.2 million with a net increase of $4.5 million recognized as an increase to Income tax expense, and a $0.6 million decrease related to changes in foreign currency rates. The increase in net operating loss carryforward, tax credit carryforward and valuation allowances was primary due to transfer from the Former Parent. In dete</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rmining how much of the relevant deferred tax asset could be realized on a more likely than not basis, consideration was given to tax planning strategies and, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">when applicable, future taxable income.</span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has U.S. Federal net operating loss carryforwa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rds of $18.1 million as of December 31, 2022 expiring in years 2028 through 2036. The Comp</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any’s ability to use these various carryforwards to offset any taxable income generated in future tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">able periods may be limited under Section 382 and other federal tax provisions. At December 31, 2022 the Company also has $424.3 million foreign net operating loss carryforwards primarily in the United Kingdom, Germany, the Netherlands and Sweden that may be subject to local tax restrictive limitations including as a result of changes in ownership. The foreign net operating losses can be carried forward indefinitely, except in applicable jurisdictions that make up less than five percent of the available net operating losses.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2022, the Company has changed its indefinite reinvestment assertion on $57.5 million of the undistributed earnings of the Company’s foreign subsidiaries. The remaining earnings continue to be indefinitely reinvested outside the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> United States. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has assessed a total deferred tax liability of $4.5 million as of December 31, 2022 on such earnings that have not been indefinitely reinvested. This is an increase of $4.5 million as compared to the deferred tax liability as of December 31, 2021. The Company has made no provision for U.S. income taxes or additional non-U.S. taxes on certain undistributed earnings of non-U.S. subsidiaries. These earnings could become subject to additional tax if the Company were to dividend those earnings or sell the Company's interest in the non-U.S. subsidiary. The Company cannot practically determine the amount of additional taxes that might be payable on those earnings. During the first quarter of 2023, the Company began to evaluate opportunities for repatriation of certain foreign earnings and will record a withholding tax charge accordingly during 2023 of approximately $11 million. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a liability for certain unrecognized income tax benefits for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority (“uncertain tax positions”). This liability for such uncertain tax positions includes the amount of benefit included in (i) its previously filed income tax returns and (ii) its financial results expected to be included in income tax returns to be filed for periods through the date of its Consolidated and Combined Financial Statements. The Company’s total unrecognized tax benefits were $20.2 million, $37.7 million and $35.2 million as of December 31, 2022, 2021 and 2020, respectively, inclusive of $5.6 million, $6.2 million and $5.2 million, respectively, of interest and penalties. The Company records interest and penalties on uncertain tax positions as a component of Income tax expense,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which was a benefit of $0.7 million, expense of $0.9 million and $0.7 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the years ended December 31, 2022, 2021 and 2020, respectively. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows (inclusive of associated interest and penalties):</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, January 1, 2020</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,014 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Addition for tax positions taken in prior periods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,785 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Addition for tax positions taken in the current period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">569 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reductions resulting from a lapse of applicable statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,827)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, including the impact of foreign currency translation and U.S. tax rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,201 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Addition for tax positions taken in prior periods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">738 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Addition for tax positions taken in the current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,987 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reductions related to settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(425)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reductions resulting from a lapse of applicable statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(565)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, including the impact of foreign currency translation and U.S. tax rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,681 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Addition for tax positions taken in prior periods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,971 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Addition for tax positions taken in the current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,171 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reductions related to settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(922)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfer from Former Parent, impact of foreign currency translation and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,801)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, including the impact of foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,897)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,203 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company files numerous group and separate tax returns in U.S. federal and state jurisdictions, as well as international jurisdictions. The Company is routinely examined by various U.S. and non-U.S. taxing authorities. The Company is subject to audit by the U.S., various states and foreign jurisdictions. In accordance with the Tax Matters Agreement with Former Parent, the Company is the primary obligor for (i) ESAB separate company state returns for all periods; (ii) unitary state returns that include only ESAB legal entities for all period</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s, and (iii) ESAB separate foreign returns for all periods. The Company also has an obligation with respect to certain liabilities associated wi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">th unitary state tax returns that include both ESAB legal entities and Former Parent legal entities for all periods, certain liabilities associated with pre-separation joint returns, fifty percent of the remaining Section 965 installment payments, and any tax indemnity associated with discontinued operations. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to U.S. tax law, the Company will file its initial U.S. federal income tax return for the post-</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separation per</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iod by October 2023. The IRS has not yet begun examination of the Company. The Company reviews its global tax provisions on a quarterly basis. Based on these reviews, the results of discussions and resolutions of matters with certain tax authorities, tax rulings and court decisions and the expiration of the statutes of limitations for continent tax liabilities are accrued or adjusted.</span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>Due to the difficulty in predicting with reasonable certainty when tax audits will be fully resolved and closed, the range of reasonably possible significant increases or decreases in the liability for unrecognized tax benefits that may occur within the next 12 months is difficult to ascertain. The Company does not believe the total amount of unrecognized benefits will change by a material amount within the next 12 months due to the settlement of audits and expirations of statutes of limitations. <div style="text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Income from continuing operations before income taxes and Income tax expense consisted of the following:</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:53.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Domestic operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,140 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,505 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319,485 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308,948 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191,334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,251 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319,088 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205,839 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,928 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,477 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,262 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,451 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,797 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">921 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,728 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,779 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,819 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89,107 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89,053 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,002 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,501)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,698)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">358 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(677)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,794)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,895 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,656)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,937)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,644)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,031)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,170 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,409 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,971 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Income from continuing operations before income taxes and Income tax expense consisted of the following:</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:53.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Domestic operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,140 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,505 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319,485 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308,948 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191,334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,251 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319,088 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205,839 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,928 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,477 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,262 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,451 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,797 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">921 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,728 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,779 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,819 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89,107 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89,053 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,002 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,501)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,698)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">358 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(677)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,794)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,895 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,656)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,937)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,644)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,031)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,170 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,409 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,971 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> -19234000 10140000 14505000 319485000 308948000 191334000 300251000 319088000 205839000 8928000 18477000 9262000 2451000 1797000 921000 77728000 68779000 49819000 89107000 89053000 60002000 -7501000 -12700000 -8698000 358000 161000 -677000 -12794000 3895000 -4656000 -19937000 -8644000 -14031000 69170000 80409000 45971000 <div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s Income tax expense differs from the amount that would be computed by applying the U.S. federal statutory rate as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:53.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes calculated at the U.S. federal statutory rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,008 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,809 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,933 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of tax rates on international operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,010)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,879)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(572)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in tax reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,734 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,346 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-taxable dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,675)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(542)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,351)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of U.S. taxation on international operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">310 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(313)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,634)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Permanent differences, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,209 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">483 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,284 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision to return</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,055)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Withholding taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,133 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,567 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,108 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,655)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,371 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation Allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,503 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,737 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,170 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,409 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,971 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 63053000 67008000 42820000 2809000 1933000 245000 -9010000 -8879000 -572000 -350000 2734000 1346000 0 46000 2675000 542000 587000 1351000 310000 -313000 -1634000 7209000 483000 1284000 -7055000 -7415000 1053000 12133000 9567000 6108000 -3655000 12371000 0 4503000 3737000 -235000 -184000 -653000 69170000 80409000 45971000 The temporary differences that gave rise to the significant components of deferred tax assets and liabilities are presented below:<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:62.764%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Post-retirement benefit obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,761 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,430 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenses currently not deductible</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,320 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,245 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating loss carryforward</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111,497 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax credit carryforward</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,320 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,124 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,450 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,685 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,873 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,648 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(88,202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,378 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,820 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121,858)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(135,726)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outside basis differences and other </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(102,336)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(108,542)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax liabilities </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(224,194)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(244,268)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax liabilities, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(96,816)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(162,448)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Deferred tax assets and liabilities have been classified as noncurrent and are included in Other assets and Other liabilities in the accompanying Consolidated and Combined Balance Sheets on a net jurisdictional basis as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:62.764%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,860 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,357 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(139,676)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(171,805)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liability, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(96,816)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(162,448)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 5761000 4430000 36320000 29245000 111497000 22374000 10320000 0 9124000 16450000 5685000 138000 36873000 24648000 88202000 15465000 127378000 81820000 121858000 135726000 102336000 108542000 224194000 244268000 96816000 162448000 42860000 9357000 139676000 171805000 96816000 162448000 15500000 88200000 4500000 -600000 18100000 424300000 57500000 4500000 4500000 11000000 20200000 37700000 35200000 5600000 6200000 5200000 -700000 900000 700000 A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows (inclusive of associated interest and penalties):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, January 1, 2020</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,014 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Addition for tax positions taken in prior periods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,785 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Addition for tax positions taken in the current period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">569 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reductions resulting from a lapse of applicable statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,827)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, including the impact of foreign currency translation and U.S. tax rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,201 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Addition for tax positions taken in prior periods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">738 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Addition for tax positions taken in the current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,987 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reductions related to settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(425)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reductions resulting from a lapse of applicable statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(565)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, including the impact of foreign currency translation and U.S. tax rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,681 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Addition for tax positions taken in prior periods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,971 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Addition for tax positions taken in the current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,171 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reductions related to settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(922)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfer from Former Parent, impact of foreign currency translation and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,801)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, including the impact of foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,897)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,203 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 34014000 2785000 569000 1827000 340000 35201000 738000 2987000 425000 565000 255000 37681000 1971000 1171000 922000 2801000 16897000 20203000 Goodwill and Intangible Assets<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes Goodwill activity by segment for the years ended December 31, 2022 and 2021: </span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.542%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Americas</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EMEA &amp; APAC</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, January 1, 2021</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">522,777 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,030,454 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,553,231 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill attributable to acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,159 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,159 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,782)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,615)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,397)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">519,154 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,013,839 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,532,993 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill attributable to acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,183 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,047 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,508 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82,964)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(79,456)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">585,845 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">943,922 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,529,767 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s Intangible assets, excluding Goodwill: </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.193%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.780%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Indefinite-Lived Intangible Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,691 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199,484 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Definite-Lived Intangible Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">482,499 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(203,041)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">448,839 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(185,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,192 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,005)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,503 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(49,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,464 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,754)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,904 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(74,799)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,547 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67,888)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">874,550 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(357,383)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">850,723 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(329,289)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to intangible assets of $35.6 million, $42.1 million and $41.8 million for the years ended December 31, 2022, 2021 and 2020, respectively, are included in the Selling, general and administrative expense in the Consolidated and Combined Statements of Operations. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expected Amortization Expense</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s expected annual amortization expense for intangible assets for the next five years is as follows: </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:81.278%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,812 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,249 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,116 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,651 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes Goodwill activity by segment for the years ended December 31, 2022 and 2021: </span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.542%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Americas</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EMEA &amp; APAC</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, January 1, 2021</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">522,777 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,030,454 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,553,231 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill attributable to acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,159 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,159 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,782)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,615)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,397)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">519,154 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,013,839 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,532,993 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill attributable to acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,183 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,047 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,508 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82,964)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(79,456)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">585,845 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">943,922 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,529,767 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 522777000 1030454000 1553231000 4159000 0 4159000 -7782000 -16615000 -24397000 519154000 1013839000 1532993000 63183000 13047000 76230000 3508000 -82964000 -79456000 585845000 943922000 1529767000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s Intangible assets, excluding Goodwill: </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.193%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.780%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Indefinite-Lived Intangible Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,691 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199,484 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Definite-Lived Intangible Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">482,499 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(203,041)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">448,839 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(185,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,192 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,005)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,503 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(49,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,464 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,754)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,904 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(74,799)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,547 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67,888)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">874,550 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(357,383)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">850,723 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(329,289)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s Intangible assets, excluding Goodwill: </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.193%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.780%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Indefinite-Lived Intangible Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,691 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199,484 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Definite-Lived Intangible Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">482,499 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(203,041)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">448,839 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(185,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,192 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,005)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,503 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(49,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,464 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,754)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,904 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(74,799)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,547 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67,888)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">874,550 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(357,383)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">850,723 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(329,289)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 180691000 199484000 482499000 203041000 448839000 185071000 71192000 50005000 71503000 49276000 22464000 9412000 16550000 8754000 94904000 74799000 91547000 67888000 22800000 20126000 22800000 18300000 874550000 357383000 850723000 329289000 35600000 42100000 41800000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s expected annual amortization expense for intangible assets for the next five years is as follows: </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:81.278%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,812 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,249 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,116 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,651 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 33812000 28249000 27204000 26116000 21651000 Property, Plant and Equipment, Net<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Depreciable Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,839 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5-40</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164,472 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172,835 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3-15</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382,830 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,074 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,141 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">550,937 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(278,915)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(264,659)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">284,226 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">286,278 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for the years ended December 31, 2022, 2021 and 2020 was</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$29.5 million, $32.5 million and $32.9 million, respectively.</span></div> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Depreciable Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,839 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5-40</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164,472 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172,835 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3-15</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382,830 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,074 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,141 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">550,937 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(278,915)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(264,659)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">284,226 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">286,278 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 15839000 16028000 P5Y P40Y 164472000 172835000 P3Y P15Y 382830000 362074000 563141000 550937000 278915000 264659000 284226000 286278000 29500000 32500000 32900000 Inventories, Net<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net consisted of the following:</span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,099 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148,376 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,086 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,595 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261,902 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">268,831 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">459,087 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">456,802 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIFO reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,168)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: allowance for excess, slow-moving and obsolete inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40,090)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(37,869)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416,829 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420,062 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>At December 31, 2022 and 2021, approximately 31.5% and 33.9% of total inventories, respectively, were valued using the LIFO method. <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net consisted of the following:</span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,099 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148,376 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,086 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,595 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261,902 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">268,831 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">459,087 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">456,802 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIFO reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,168)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: allowance for excess, slow-moving and obsolete inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40,090)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(37,869)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416,829 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420,062 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 153099000 148376000 44086000 39595000 261902000 268831000 459087000 456802000 2168000 -1129000 40090000 37869000 416829000 420062000 0.315 0.339 Leases<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain office spaces, warehouses, production facilities, vehicles, and equipment. Leases with an initial term of twelve months or less are not recorded on the balance sheet. Most leases include renewal options, which can extend the lease term into the future. The Company determines the lease term by assuming options that are reasonably certain of being renewed will be exercised. Certain of the Company’s leases include rental payments adjusted for inflation. The right-of-use lease asset is recorded on the Consolidated and Combined Balance Sheets, with the current lease liability being included in Accrued liabilities and noncurrent lease liability being included in Other liabilities. Operating lease expense was</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$21.3 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, $23.0 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $21.6 million for the years ended December 31, 2022, 2021 and 2020, respectively. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.854%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Future lease payments by year:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,603 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,876 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,127 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,502 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,196 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: present value discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,369)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,827 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">  Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.55</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">  Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 21300000 23000000 21600000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.854%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Future lease payments by year:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,603 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,876 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,127 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,502 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,196 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: present value discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,369)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,827 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">  Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.55</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">  Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table> 21603000 16876000 13127000 10502000 8221000 37867000 108196000 13369000 94827000 P7Y6M18D 0.035 Accrued and Other Liabilities<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued and Other liabilities in the Consolidated and Combined Balance Sheets consisted of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.674%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Noncurrent</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Noncurrent</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued taxes and deferred tax liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,615 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">203,760 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation and related benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,794 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,438 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,587 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,215 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asbestos liability </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230,581 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,899 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkwZGMwN2NjMWFjNjQyMzI5ZDU5NmRjMDlmZWMxYWVmL3NlYzo5MGRjMDdjYzFhYzY0MjMyOWQ1OTZkYzA5ZmVjMWFlZl8xNTEvZnJhZzoxMGM0ZTY3ODA4ZTU0N2Y4OGFmNDA1YzYxMmMxYmViOC90YWJsZToxNGQ0YWIyYWI5N2I0MGI4YmUyMTEwZThlMGRhYmJjYy90YWJsZXJhbmdlOjE0ZDRhYjJhYjk3YjQwYjhiZTIxMTBlOGUwZGFiYmNjXzctMC0xLTEtMTE0Njc2_5e47a541-8abf-4701-b3c5-c2adafbf5d96"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkwZGMwN2NjMWFjNjQyMzI5ZDU5NmRjMDlmZWMxYWVmL3NlYzo5MGRjMDdjYzFhYzY0MjMyOWQ1OTZkYzA5ZmVjMWFlZl8xNTEvZnJhZzoxMGM0ZTY3ODA4ZTU0N2Y4OGFmNDA1YzYxMmMxYmViOC90YWJsZToxNGQ0YWIyYWI5N2I0MGI4YmUyMTEwZThlMGRhYmJjYy90YWJsZXJhbmdlOjE0ZDRhYjJhYjk3YjQwYjhiZTIxMTBlOGUwZGFiYmNjXzctMC0xLTEtMTE0Njc2_772dbb20-1f05-45ae-86ba-2b4148b1174a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkwZGMwN2NjMWFjNjQyMzI5ZDU5NmRjMDlmZWMxYWVmL3NlYzo5MGRjMDdjYzFhYzY0MjMyOWQ1OTZkYzA5ZmVjMWFlZl8xNTEvZnJhZzoxMGM0ZTY3ODA4ZTU0N2Y4OGFmNDA1YzYxMmMxYmViOC90YWJsZToxNGQ0YWIyYWI5N2I0MGI4YmUyMTEwZThlMGRhYmJjYy90YWJsZXJhbmdlOjE0ZDRhYjJhYjk3YjQwYjhiZTIxMTBlOGUwZGFiYmNjXzctMC0xLTEtMTE0Njc2_86fa1289-967b-4a7a-8837-2fefbbe534d3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkwZGMwN2NjMWFjNjQyMzI5ZDU5NmRjMDlmZWMxYWVmL3NlYzo5MGRjMDdjYzFhYzY0MjMyOWQ1OTZkYzA5ZmVjMWFlZl8xNTEvZnJhZzoxMGM0ZTY3ODA4ZTU0N2Y4OGFmNDA1YzYxMmMxYmViOC90YWJsZToxNGQ0YWIyYWI5N2I0MGI4YmUyMTEwZThlMGRhYmJjYy90YWJsZXJhbmdlOjE0ZDRhYjJhYjk3YjQwYjhiZTIxMTBlOGUwZGFiYmNjXzctMC0xLTEtMTE0Njc2_a5cfa6a2-f0a7-4fb2-833e-3d72df8b6cce">Lease liability</span></span></span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,664 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,467 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,777 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warranty liability </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,946 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,954 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third-party commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,315 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,130 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,533 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,834 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,436 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,372 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,918 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285,310 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">545,339 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,109 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,945 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued Warranty Liability </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the activity in the Company’s warranty liability included in Accrued liabilities in the Company’s Consolidated and Combined Balance Sheets is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warranty liability, beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,954 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,022 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued warranty expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,322 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,707 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in estimates related to pre-existing warranties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,821 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,416 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of warranty service work performed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,680)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,909)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange translation effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(471)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(282)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warranty liability, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,946 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,954 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued Restructuring Liability</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s restructuring programs include a series of actions to reduce the structural costs of the Company. A summary of the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Consolidated and Combined Balance Sheets is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.535%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at Beginning of Period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Charges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at End of Period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="30" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Restructuring and other related charges:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Americas</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Termination benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,970 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,235)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility closure costs and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,451 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,094 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,421 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,617)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,384 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">EMEA &amp; APAC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Termination benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,774 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,672 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,391)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,145 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility closure costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,686)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,789 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,015 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,877 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,077)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,934 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">835 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,712 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,109 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,298 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,694)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,818 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Total Provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,096 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes severance and other termination benefits, including outplacement services. </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes the cost of relocating associates, relocating equipment, lease termination expense, and other costs in connection with the closure and optimization of facilities and product lines. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at Beginning of Period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Charges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at End of Period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="30" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Restructuring and other related charges:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Americas</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Termination benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,089 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,414 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility closure costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">469 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,978 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,397)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,558 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,392 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,852)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,094 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,612 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">EMEA &amp; APAC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Termination benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,247 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,219 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,641)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,774 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility closure costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,090 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,954)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,369 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,309 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,595)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,015 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,033 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,342 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,927 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,701 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,447)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,109 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,253 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Total Provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,954 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes severance and other termination benefits, including outplacement services.</span></div>(2) Includes the cost of relocating associates, relocating equipment, lease termination expense, and other costs in connection with the closure and optimization of facilities and product lines. <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued and Other liabilities in the Consolidated and Combined Balance Sheets consisted of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.674%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Noncurrent</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Noncurrent</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued taxes and deferred tax liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,615 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">203,760 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation and related benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,794 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,438 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,587 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,215 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asbestos liability </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230,581 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,899 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkwZGMwN2NjMWFjNjQyMzI5ZDU5NmRjMDlmZWMxYWVmL3NlYzo5MGRjMDdjYzFhYzY0MjMyOWQ1OTZkYzA5ZmVjMWFlZl8xNTEvZnJhZzoxMGM0ZTY3ODA4ZTU0N2Y4OGFmNDA1YzYxMmMxYmViOC90YWJsZToxNGQ0YWIyYWI5N2I0MGI4YmUyMTEwZThlMGRhYmJjYy90YWJsZXJhbmdlOjE0ZDRhYjJhYjk3YjQwYjhiZTIxMTBlOGUwZGFiYmNjXzctMC0xLTEtMTE0Njc2_5e47a541-8abf-4701-b3c5-c2adafbf5d96"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkwZGMwN2NjMWFjNjQyMzI5ZDU5NmRjMDlmZWMxYWVmL3NlYzo5MGRjMDdjYzFhYzY0MjMyOWQ1OTZkYzA5ZmVjMWFlZl8xNTEvZnJhZzoxMGM0ZTY3ODA4ZTU0N2Y4OGFmNDA1YzYxMmMxYmViOC90YWJsZToxNGQ0YWIyYWI5N2I0MGI4YmUyMTEwZThlMGRhYmJjYy90YWJsZXJhbmdlOjE0ZDRhYjJhYjk3YjQwYjhiZTIxMTBlOGUwZGFiYmNjXzctMC0xLTEtMTE0Njc2_772dbb20-1f05-45ae-86ba-2b4148b1174a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkwZGMwN2NjMWFjNjQyMzI5ZDU5NmRjMDlmZWMxYWVmL3NlYzo5MGRjMDdjYzFhYzY0MjMyOWQ1OTZkYzA5ZmVjMWFlZl8xNTEvZnJhZzoxMGM0ZTY3ODA4ZTU0N2Y4OGFmNDA1YzYxMmMxYmViOC90YWJsZToxNGQ0YWIyYWI5N2I0MGI4YmUyMTEwZThlMGRhYmJjYy90YWJsZXJhbmdlOjE0ZDRhYjJhYjk3YjQwYjhiZTIxMTBlOGUwZGFiYmNjXzctMC0xLTEtMTE0Njc2_86fa1289-967b-4a7a-8837-2fefbbe534d3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkwZGMwN2NjMWFjNjQyMzI5ZDU5NmRjMDlmZWMxYWVmL3NlYzo5MGRjMDdjYzFhYzY0MjMyOWQ1OTZkYzA5ZmVjMWFlZl8xNTEvZnJhZzoxMGM0ZTY3ODA4ZTU0N2Y4OGFmNDA1YzYxMmMxYmViOC90YWJsZToxNGQ0YWIyYWI5N2I0MGI4YmUyMTEwZThlMGRhYmJjYy90YWJsZXJhbmdlOjE0ZDRhYjJhYjk3YjQwYjhiZTIxMTBlOGUwZGFiYmNjXzctMC0xLTEtMTE0Njc2_a5cfa6a2-f0a7-4fb2-833e-3d72df8b6cce">Lease liability</span></span></span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,664 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,467 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,777 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warranty liability </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,946 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,954 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third-party commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,315 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,130 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,533 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,834 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,436 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,372 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,918 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285,310 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">545,339 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,109 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,945 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 49615000 161500000 58920000 203760000 74794000 57438000 74587000 62215000 30108000 230581000 0 0 25899000 0 22265000 0 18664000 76163000 20467000 88777000 12946000 0 14954000 0 18315000 0 16130000 0 7533000 285000 7834000 275000 47436000 19372000 35952000 7918000 285310000 545339000 251109000 362945000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the activity in the Company’s warranty liability included in Accrued liabilities in the Company’s Consolidated and Combined Balance Sheets is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warranty liability, beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,954 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,022 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued warranty expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,322 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,707 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in estimates related to pre-existing warranties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,821 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,416 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of warranty service work performed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,680)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,909)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange translation effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(471)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(282)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warranty liability, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,946 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,954 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 14954000 14022000 5322000 6707000 2821000 2416000 9680000 7909000 471000 282000 12946000 14954000 A summary of the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Consolidated and Combined Balance Sheets is as follows:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.535%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at Beginning of Period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Charges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at End of Period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="30" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Restructuring and other related charges:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Americas</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Termination benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,970 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,235)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility closure costs and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,451 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,094 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,421 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,617)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,384 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">EMEA &amp; APAC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Termination benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,774 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,672 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,391)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,145 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility closure costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,686)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,789 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,015 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,877 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,077)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,934 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">835 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,712 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,109 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,298 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,694)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,818 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Total Provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,096 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes severance and other termination benefits, including outplacement services. </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes the cost of relocating associates, relocating equipment, lease termination expense, and other costs in connection with the closure and optimization of facilities and product lines. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at Beginning of Period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Charges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at End of Period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="30" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Restructuring and other related charges:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Americas</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Termination benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,089 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,414 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility closure costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">469 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,978 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,397)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,558 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,392 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,852)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,094 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,612 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">EMEA &amp; APAC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Termination benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,247 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,219 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,641)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,774 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility closure costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,090 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,954)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,369 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,309 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,595)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,015 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,033 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,342 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,927 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,701 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,447)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,109 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,253 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Total Provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,954 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes severance and other termination benefits, including outplacement services.</span></div>(2) Includes the cost of relocating associates, relocating equipment, lease termination expense, and other costs in connection with the closure and optimization of facilities and product lines. 2044000 1970000 4235000 -14000 -235000 50000 9451000 9382000 0 119000 2094000 11421000 13617000 -14000 -116000 -37000 11384000 5774000 2672000 3391000 90000 5145000 241000 8205000 5686000 29000 2789000 6015000 10877000 9077000 119000 7934000 835000 11712000 8109000 22298000 22694000 105000 7818000 798000 23096000 1089000 5414000 4455000 -4000 2044000 469000 5978000 6397000 0 50000 1558000 11392000 10852000 -4000 2094000 220000 11612000 4247000 4219000 2641000 -51000 5774000 122000 2090000 1954000 -17000 241000 4369000 6309000 4595000 -68000 6015000 1033000 7342000 5927000 17701000 15447000 -72000 8109000 1253000 18954000 Benefit Plans<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors various defined benefit plans and other post-retirement benefits plans, including health and life insurance, for certain eligible employees or former employees. The Company uses December 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as the measurement date for all of its employee benefit plans. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Separation, the Former Parent offered both funded and unfunded noncontributory defined benefit pension plans in t</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he United States that were share</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d amongst its businesses, including the Company prior to becoming plan sponsor. The participation of the Company’s employees and retirees in this plan was as though it participated in a multiemployer plan with the Former Parent. As a result, prior to the Separation, a proportionate share of the cost associated with this defined benefit plan was allocated to the Company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">based on the Company’s share of total Former Parent headcount. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This allocation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is reflected within Interest expense (income) and other, net, in the Consolidated and Combined Statements of Operations.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, while any assets and liabilities associated with this defined benefit plan were retained by the Former Parent and were not recorded on the Company’s historical Combined Financial Statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Separation, certain U.S. defined benefit and other post-retirement plans, formerly sponsored by the Former Parent were transferred to the Company as of March 21, 2022. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transferred plans include a defined benefit pension plan with assets of $201.3 million and projected benefit liabilities of $200.7 million, one unfunded defined benefit plan with liabilities of less than $0.1 million and one other post-retirement benefit plan with liabilities of $11.7 million, all of which were recorded in the financial statements of the Former Parent at December 31, 2021. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, the Company recognized a Pension settlement gain of $9.1 million related to a completed buy-out of a foreign defined benefit plan by a third party plus the merger of two Company pension plans resulting in one plan benefiting from the surplus assets in the other plan. During the year ended December 31, 2021, the Company recognized a Pension settlement gain of $11.2 million when the trustees of a Company pension plan agreed to merge the plan with another Company pension plan and contribute the plan’s surplus assets.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These amounts are reflected in Pension settlement gain in the Consolidated and Combined Statements of Operations.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total changes in the Company’s pension and accrued post-retirement benefits and plan assets and includes a statement of the plans’ funded status: </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.059%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.349%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.059%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.353%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Post-Retirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142,914 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155,914 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">388 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfer from Former Parent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,690 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,697 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,684 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,785 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,668 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan amendments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">911 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,148)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,866)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,807)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,653)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,385)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,168)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(636)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(283)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(847)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation, end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256,022 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142,914 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,850 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated benefit obligation, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253,123 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139,513 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,850 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,503 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,114 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfer from Former Parent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">201,259 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51,266)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,706 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,315 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,210 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">636 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,583)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,594)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,385)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(636)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,947 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,272 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219,050 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,503 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Funded status, end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,972)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,411)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,850)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Amounts recognized on the Consolidated and Combined Balance Sheets as of December 31:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,701 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,025)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,393)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(824)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(49,648)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62,137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,026)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,972)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,411)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,850)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline">     </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Settlements includes gains </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of $9.1 million a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">nd $11.2 million classified as Pension settlement gain on the Company’s Consolidated Statement of Operations for the years ended December 31, 2022 and December 31, 2021, respectively.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For pension plans with accumulated benefit obligations in excess of plan assets, the accumulated benefit obligation and fair value of plan assets were $201.1 million and $149.8 million, respectively, as of December 31, 2022 and $68.5 million and $5.2 million, respectively, as of December 31, 2021.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For pensions plans with projected benefit obligations in excess of plan assets, the projected benefit obligation and fair value of plan assets were $206.8 million and $154.1 million, respectively, as of December 31, 2022 and $76.2 million and $10.7 million, respectively, as of December 31, 2021. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the Company’s foreign pension benefit obligations and plan assets, included in the table above, and includes a statement of the plans’ funded status:</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.293%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Pension Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,278 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,075 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,684 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,785 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,161 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,646 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan amendments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">911 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,131)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,787)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,452)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,984)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,022)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(283)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(847)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,401 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,278 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated benefit obligation, end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,500 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137,876 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,503 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,114 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,706 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,064 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,581)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,594)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,984)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,022)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,947 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,272 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,821 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,503 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Funded status, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28,580)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56,775)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected contributions to the Company’s pension and other post-employment benefit plans for the year ending December 31, 2023 are $5.2 million. The following benefit payments are expected to be paid during each respective fiscal year:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.381%"/><td style="width:0.1%"/></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Post-Retirement Benefits</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Plans</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,709 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,551 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">824 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,125 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">783 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,625 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,271 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">779 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,564 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,651 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">774 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,830 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,388 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">766 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028 - 2032</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,928 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,424 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,326 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s primary investment objective for its pension plan assets is to provide a source of retirement income for the plans’ participants and beneficiaries. The assets are invested with the goal of preserving principal while providing a reasonable rate of return over the long term. Diversification of assets is achieved through strategic allocations to various asset classes. Actual allocations to each asset class vary due to periodic investment strategy changes, market value fluctuations, the length of time it takes to fully implement investment allocation positions, and the timing of benefit payments and contributions. The asset allocation is monitored and rebalanced as required, as frequently as on a quarterly basis in some instances. The target allocation for plan assets varies by plan and jurisdiction. The actual allocation percentages as of December 31, 2022 and 2021 are consistent with the target allocation ranges of the plans.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the actual allocation percentages for the Company’s pension plan assets:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.858%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Actual Asset Allocation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">U.S. Plans: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Foreign Plans:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed income securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents various fixed income and equity securities.</span></div><div style="padding-left:9pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s pension plan assets for each fair value hierarchy level for the periods presented follows (see </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 17, “Fai</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r Value Measurements” for further description of the levels within the fair value hierarchy):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.755%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.382%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measured at Net Asset Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level<br/>One</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level<br/>Two</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level<br/>Three</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> <br/>Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">U.S. Plans:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,591 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,591 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity securities: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. large cap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,018 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,018 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. small/mid cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,789 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,289 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,078 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,928 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,928 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed income mutual funds:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. government and corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,497 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,497 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,118 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,118 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Foreign Plans:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,348 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,348 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,475 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,475 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-U.S. government and corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,289 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,289 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,236 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,236 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,232 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,143 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,675 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219,050 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:6.7pt">Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient (the “NAV”) have not been classified in the fair value hierarchy. These investments, consisting of common/collective trusts, are valued using the NAV provided by the Trustee. The NAV is based on the underlying investments held by the fund, that are traded in an active market, less its liabilities. These investments are able to be redeemed in the near-term. </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted-average interest crediting rates received in Cash and cash equivalents of foreign plans are immaterial relative to total plan assets.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.755%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.382%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measured at Net Asset Value </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level<br/>One</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level<br/>Two</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level<br/>Three</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> <br/>Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Foreign Plans:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">442 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">442 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-U.S. government and corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,310 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,310 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,570 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,570 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,836 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,836 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,057 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,446 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,503 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:6.7pt">The weighted-average interest crediting rates received in Cash and cash equivalents of foreign plans are immaterial relative to total plan assets.</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of net periodic benefit cost and Other comprehensive income of the Company’s defined benefit pension plans and other post-retirement employee benefit plans:</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.615%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Post-Retirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Components of Net Periodic Benefit (Income) Cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,684 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,785 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,577 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,668 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,260 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,313 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,220 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">785 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,195)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,519)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,397)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit (income) cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,670)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,778)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,379 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfer from Former Parent</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,134 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,629)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year net actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">949 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,788)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,533 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,807)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less amounts included in net periodic benefit cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,340)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(785)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement/divestiture/other gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,067)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total recognized in Other comprehensive (gain) loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,471 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,021)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,754 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,255)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each component of net periodic benefit (income) cost is included in the Company’s Consolidated and Combined Statements of Operations for the years ended December 31, 2022, 2021 and 2020. Service cost is included within Selling, general and administrative expense with the non-service costs included within Interest expense (income) and other, net. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Settlement gains of $9.1 million and $11.2 million are recorded within Pension settlement gain on the Company’s Consolidated Statement of Operations for the years ended December 31, 2022 and 2021, respectively.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of net periodic benefit cost and Other comprehensive income of the foreign defined benefit pension plans, included in the table above: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.247%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.247%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Pension Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Components of Net Periodic Benefit (Income) Cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,684 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,785 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,577 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,161 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,646 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,218 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,118 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">692 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,195)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,063)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,397)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit (income) cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,553)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,902)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,244 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year net actuarial loss (gain)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,262)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,710)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,389 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year prior service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less amounts included in net periodic benefit (income) cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(714)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(692)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement/divestiture/other gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of prior service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,067)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total recognized in Other comprehensive (gain) loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,248)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,841)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,709 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net unrecognized pension and other post-retirement benefit cost included in Accumulated other comprehensive loss in the Consolidated and Combined Balance Sheets that have not been recognized as a component of net periodic benefit cost are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Post-Retirement<br/>Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,066 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,388 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior service (income) cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,954 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,483 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,199)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key economic assumptions used in the measurement of the Company’s pension and other post-retirement benefit obligations are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Post-Retirement<br/>Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average rate of increase in compensation levels for active foreign plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline"> </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:6.7pt">Weighted-average rate of increase is only applicable to plans with compensation increase assumptions. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key economic assumptions used in the computation of net periodic benefit cost are as follows: </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.615%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Post-Retirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average expected return on plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average rate of increase in compensation levels for active foreign plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline"> </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:6.7pt">Weighted-average rate of increase is only applicable to plans with compensation increase assumptions. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In determining discount rates, the Company utilizes the single discount rate equivalent to discounting the expected future cash flows from each plan using the yields at each duration from a published yield curve as of the measurement date.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For measurement purposes, a weighted-average annual rate of increase in the per capita cost of covered health care benefits of 7.5% was assumed. The rate was assumed to decrease gradually to 4.1% by 2075 and remain at that level thereafter for benefits covered under the plans. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected long-term rate of return on plan assets was based on the Company’s investment policy target allocation of the asset portfolio between various asset classes and the expected real returns of each asset class over various periods of time that are consistent with the long-term nature of the underlying obligations of these plans.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains defined contribution plans covering certain union and non-union employees. The Company’s expense for the years ended December 31, 2022, 2021 and 2020 was $8.7 million, $7.9 million and $9.8 million, respectively.</span></div> 201300000 200700000 1 100000 1 11700000 9100000 11200000 <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total changes in the Company’s pension and accrued post-retirement benefits and plan assets and includes a statement of the plans’ funded status: </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.059%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.349%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.059%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.353%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Post-Retirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142,914 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155,914 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">388 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfer from Former Parent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,690 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,697 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,684 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,785 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,668 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan amendments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">911 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,148)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,866)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,807)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,653)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,385)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,168)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(636)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(283)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(847)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation, end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256,022 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142,914 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,850 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated benefit obligation, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253,123 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139,513 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,850 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,503 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,114 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfer from Former Parent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">201,259 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51,266)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,706 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,315 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,210 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">636 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,583)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,594)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,385)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(636)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,947 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,272 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219,050 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,503 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Funded status, end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,972)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,411)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,850)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Amounts recognized on the Consolidated and Combined Balance Sheets as of December 31:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,701 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,025)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,393)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(824)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(49,648)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62,137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,026)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,972)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,411)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,850)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline">     </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Settlements includes gains </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of $9.1 million a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">nd $11.2 million classified as Pension settlement gain on the Company’s Consolidated Statement of Operations for the years ended December 31, 2022 and December 31, 2021, respectively.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the Company’s foreign pension benefit obligations and plan assets, included in the table above, and includes a statement of the plans’ funded status:</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.293%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Pension Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,278 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,075 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,684 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,785 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,161 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,646 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan amendments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">911 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,131)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,787)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,452)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,984)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,022)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(283)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(847)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,401 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,278 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated benefit obligation, end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,500 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137,876 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,503 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,114 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,706 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,064 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,581)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,594)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,984)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,022)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,947 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,272 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,821 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,503 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Funded status, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28,580)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56,775)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 142914000 155914000 382000 388000 200690000 0 11697000 0 1684000 1785000 15000 14000 5874000 1668000 234000 22000 862000 911000 0 0 60148000 1866000 2807000 25000 12452000 6653000 35000 7000 23385000 8168000 636000 10000 283000 847000 0 0 266000 170000 0 0 256022000 142914000 8850000 382000 253123000 139513000 8850000 382000 84503000 73114000 0 0 201259000 0 0 0 -51266000 4706000 0 0 5315000 5210000 636000 10000 -7583000 -1594000 0 0 23385000 8168000 636000 10000 9947000 11272000 0 0 260000 -37000 0 0 219050000 84503000 0 0 -36972000 -58411000 -8850000 -382000 15701000 7119000 0 0 3025000 3393000 824000 23000 49648000 62137000 8026000 359000 -36972000 -58411000 -8850000 -382000 9100000 11200000 201100000 149800000 68500000 5200000 206800000 154100000 76200000 10700000 141278000 154075000 1684000 1785000 2161000 1646000 862000 911000 25131000 1787000 12452000 6653000 8984000 8022000 283000 847000 266000 170000 99401000 141278000 96500000 137876000 84503000 73114000 -12494000 4706000 5170000 5064000 -7581000 -1594000 8984000 8022000 9947000 11272000 260000 -37000 70821000 84503000 -28580000 -56775000 5200000 The following benefit payments are expected to be paid during each respective fiscal year:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.381%"/><td style="width:0.1%"/></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Post-Retirement Benefits</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Plans</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,709 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,551 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">824 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,125 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">783 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,625 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,271 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">779 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,564 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,651 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">774 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,830 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,388 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">766 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028 - 2032</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,928 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,424 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,326 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 22709000 7551000 824000 21890000 7125000 783000 21625000 7271000 779000 21564000 7651000 774000 20830000 7388000 766000 96928000 37424000 3326000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the actual allocation percentages for the Company’s pension plan assets:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.858%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Actual Asset Allocation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">U.S. Plans: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Foreign Plans:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed income securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents various fixed income and equity securities.</span></div><div style="padding-left:9pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s pension plan assets for each fair value hierarchy level for the periods presented follows (see </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 17, “Fai</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r Value Measurements” for further description of the levels within the fair value hierarchy):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.755%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.382%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measured at Net Asset Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level<br/>One</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level<br/>Two</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level<br/>Three</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> <br/>Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">U.S. Plans:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,591 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,591 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity securities: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. large cap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,018 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,018 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. small/mid cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,789 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,289 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,078 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,928 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,928 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed income mutual funds:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. government and corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,497 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,497 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,118 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,118 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Foreign Plans:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,348 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,348 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,475 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,475 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-U.S. government and corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,289 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,289 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,236 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,236 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,232 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,143 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,675 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219,050 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:6.7pt">Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient (the “NAV”) have not been classified in the fair value hierarchy. These investments, consisting of common/collective trusts, are valued using the NAV provided by the Trustee. The NAV is based on the underlying investments held by the fund, that are traded in an active market, less its liabilities. These investments are able to be redeemed in the near-term. </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted-average interest crediting rates received in Cash and cash equivalents of foreign plans are immaterial relative to total plan assets.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.755%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.382%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measured at Net Asset Value </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level<br/>One</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level<br/>Two</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level<br/>Three</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> <br/>Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Foreign Plans:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">442 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">442 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-U.S. government and corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,310 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,310 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,570 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,570 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,836 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,836 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,057 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,446 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,503 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:6.7pt">The weighted-average interest crediting rates received in Cash and cash equivalents of foreign plans are immaterial relative to total plan assets.</span></div> 0.36 0 0.13 0 0.50 0 0.01 0 0.04 0.23 0.34 0.25 0.16 0.01 0.34 0.38 0.12 0.13 0 1591000 0 0 1591000 31018000 0 0 0 31018000 10789000 11289000 0 0 22078000 18928000 0 0 0 18928000 73497000 0 0 0 73497000 0 1118000 0 0 1118000 0 11348000 0 0 11348000 0 2475000 0 0 2475000 0 24289000 0 0 24289000 0 0 24236000 0 24236000 0 0 8400000 0 8400000 0 33000 39000 0 72000 134232000 52143000 32675000 0 219050000 0 442000 0 0 442000 0 19305000 0 0 19305000 0 21310000 0 0 21310000 0 0 32570000 0 32570000 0 0 10836000 0 10836000 0 0 40000 0 40000 0 41057000 43446000 0 84503000 <div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of net periodic benefit cost and Other comprehensive income of the Company’s defined benefit pension plans and other post-retirement employee benefit plans:</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.615%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Post-Retirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Components of Net Periodic Benefit (Income) Cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,684 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,785 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,577 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,668 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,260 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,313 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,220 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">785 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,195)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,519)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,397)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit (income) cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,670)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,778)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,379 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfer from Former Parent</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,134 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,629)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year net actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">949 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,788)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,533 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,807)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less amounts included in net periodic benefit cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,340)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(785)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement/divestiture/other gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,067)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total recognized in Other comprehensive (gain) loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,471 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,021)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,754 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,255)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The following table sets forth the components of net periodic benefit cost and Other comprehensive income of the foreign defined benefit pension plans, included in the table above: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.247%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.247%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Pension Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Components of Net Periodic Benefit (Income) Cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,684 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,785 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,577 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,161 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,646 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,218 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,118 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">692 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,195)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,063)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,397)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit (income) cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,553)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,902)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,244 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year net actuarial loss (gain)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,262)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,710)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,389 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year prior service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less amounts included in net periodic benefit (income) cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(714)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(692)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement/divestiture/other gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of prior service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,067)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total recognized in Other comprehensive (gain) loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,248)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,841)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,709 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> <div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of net periodic benefit cost and Other comprehensive income of the Company’s defined benefit pension plans and other post-retirement employee benefit plans:</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.615%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Post-Retirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Components of Net Periodic Benefit (Income) Cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,684 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,785 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,577 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,668 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,260 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,313 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,220 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">785 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,195)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,519)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,397)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit (income) cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,670)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,778)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,379 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfer from Former Parent</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,134 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,629)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year net actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">949 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,788)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,533 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,807)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less amounts included in net periodic benefit cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,340)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(785)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement/divestiture/other gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,067)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total recognized in Other comprehensive (gain) loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,471 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,021)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,754 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,255)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The following table sets forth the components of net periodic benefit cost and Other comprehensive income of the foreign defined benefit pension plans, included in the table above: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.247%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.247%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Pension Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Components of Net Periodic Benefit (Income) Cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,684 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,785 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,577 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,161 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,646 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,218 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,118 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">692 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,195)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,063)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,397)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit (income) cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,553)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,902)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,244 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year net actuarial loss (gain)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,262)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,710)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,389 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year prior service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less amounts included in net periodic benefit (income) cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(714)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(692)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement/divestiture/other gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of prior service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,067)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total recognized in Other comprehensive (gain) loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,248)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,841)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,709 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 1684000 1785000 1577000 15000 14000 8000 5874000 1668000 2260000 234000 22000 16000 -4313000 -1220000 -785000 181000 0 8000 9114000 11195000 0 0 -8000 0 92000 2000 154000 0 0 0 11519000 2258000 2397000 0 0 0 -8670000 -8778000 2379000 68000 44000 16000 53134000 0 0 -2629000 0 0 -949000 5788000 -6533000 2807000 27000 -157000 862000 0 95000 0 0 0 -4340000 -1228000 -785000 181000 -8000 8000 67000 0 89000 0 0 0 1067000 5000 0 0 0 0 49471000 -7021000 5754000 -5255000 -35000 165000 9100000 11200000 1684000 1785000 1577000 2161000 1646000 2218000 -687000 -1118000 -692000 9114000 11195000 0 92000 2000 154000 2063000 2258000 2397000 -6553000 -8902000 2244000 12262000 5710000 -6389000 862000 0 101000 -714000 -1126000 -692000 67000 0 89000 1067000 5000 0 -13248000 -6841000 5709000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net unrecognized pension and other post-retirement benefit cost included in Accumulated other comprehensive loss in the Consolidated and Combined Balance Sheets that have not been recognized as a component of net periodic benefit cost are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Post-Retirement<br/>Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,066 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,388 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior service (income) cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,954 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,483 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,199)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> -71066000 -21388000 5199000 -56000 -112000 95000 0 0 70954000 21483000 -5199000 56000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key economic assumptions used in the measurement of the Company’s pension and other post-retirement benefit obligations are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Post-Retirement<br/>Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average rate of increase in compensation levels for active foreign plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline"> </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:6.7pt">Weighted-average rate of increase is only applicable to plans with compensation increase assumptions. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key economic assumptions used in the computation of net periodic benefit cost are as follows: </span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.615%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Post-Retirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average expected return on plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average rate of increase in compensation levels for active foreign plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline"> </span>(1)Weighted-average rate of increase is only applicable to plans with compensation increase assumptions. 0.046 0.019 0.050 0.066 0.043 0.019 0 0 0.032 0.006 0 0 0.022 0.013 0.020 0.026 0.060 0.076 0.019 0.013 0.019 0 0 0 0.048 0.036 0.041 0 0 0 0.032 0.036 0.041 0 0 0 0.032 0.034 0.037 0 0 0 0.075 0.041 8700000 7900000 9800000 Debt<div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.006%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revolving credit facilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">221,000 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,221,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized deferred financing fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,357)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,218,643 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline"> </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:6.7pt">In the Company’s Consolidated Balance sheet, $1.2 million of deferred financing fees related to the Revolving Facility are included in Other assets and $2.4 million of deferred financing fees related to the Term Facilities are recorded as a contra-liability within Long-term debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Term Loans and Revolving Credit Facility</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 4, 2022, the Company entered into a credit agreement (as amended and restated from time-to-time, the “Credit Agreement”) in connection with the Separation. The Credit Agreement initially consisted of the following facilities;</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.15pt"> A $750 million revolving credit facility (the “Revolving Facility”) with a maturity date of April 4, 2027</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A Term A-1 loan with an initial aggregate principal amount of $400 million (the “Term Loan A-1 Facility”), with a maturity date of April 4, 2027; and,</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.15pt">A $600 million 364-day senior term loan facility (the “Term Loan A-2 Facility”) with a maturity date of April 3, 2023.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Revolving Facility contains a $300 million letter of credit foreign currency sublimit and a $50 million swing line loan sub-facility.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 4, 2022, the Company drew down $1.2 billion available under the credit facilities made up of (i) $200 million under the Revolving Facility, (ii) $400 million under the Term Loan A-1 Facility and (iii) $600 million under the Term Loan A-2 Facility. The Company used these proceeds to make payments to Enovis of $1.2 billion, which was used as part of the consideration for the contribution of certain assets and liabilities to the Company by Enovis in connection with the Separation.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 28, 2022, the Company amended and restated the Credit Agreement by entering into Amendment No. 2 to Credit Agreement (“Credit Agreement Amendment”). The Credit Agreement Amendment provides for a $600 million term loan facility (the “Term Loan A-3 Facility” and, together with the Term Loan A-1 Facility, the “Term Facilities”, and together with the Revolving Facility, the “Facilities”) with a maturity date of April 3, 2025 to refinance the Company’s existing Term Loan A-2 Facility. Also on June 28, 2022, the Company borrowed the entire $600 million under Term Loan A-3 Facility to fund the repayment of the Term Loan A-2 Facility. The Company’s total borrowing capacity under the Credit Agreement remained unchanged. The draw-down and repayment related to these term facilities are presented net within the Consolidated and Combined Statements of Cash Flows. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary covenants limiting the ability of the Company and its subsidiaries to, among other things, incur debt or liens, merge or consolidate with others, dispose of assets, make investments or pay dividends. In addition, the Credit Agreement contains financial covenants requiring the Company to maintain (i) a maximum total leverage ratio of not more than 4.00:1.00, with step-downs to, commencing with the fiscal quarter ending June 30, 2023, 3.75:1.00, and commencing with the fiscal quarter ending June 30, 2024, 3.50:1.00, and (ii) a minimum interest coverage ratio of 3.00:1:00. The Credit Agreement contains various events of default (including failure to comply with the covenants under the Credit Agreement and related agreements) and upon an event of default the lenders may, subject to various customary cure rights, require the immediate payment of all amounts outstanding under the Term Facilities and the Revolving Facility. Certain U.S. subsidiaries of the Company have agreed to guarantee the obligations of the Company under the Credit Agreement. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans made under the Term Facilities will bear interest, at the election of the Company, at either the base rate (as defined in the Credit Agreement) or at the term Secured Overnight Financing Rate (“SOFR”) rate plus an adjustment (as defined in the Credit Agreement), in each case, plus the applicable interest rate margin. Loans made under the Revolving Facility will bear interest, at the election of the Company, at either the base rate or, (i) in the case of loans denominated in dollars, the term SOFR rate plus an adjustment or the daily simple SOFR plus an adjustment, (ii) in the case of loans denominated in euros, the adjusted Euro Interbank Offered Rate (“EURIBOR”) rate and, (iii) in the case of loans denominated in sterling, Sterling Overnight Index Average (“SONIA”) plus an adjustment (as all such rates are defined in the Credit Agreement Amendment), in each case, plus the applicable interest rate margin. The applicable interest rate margin changes based upon the Company’s total leverage ratio (ranging from 1.125% to 1.750% or in the case of the base rate margin, 0.125% to 0.750%). Each swing line loan denominated in dollars will bear interest at the base rate plus the applicable interest rate margin.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To manage exposures to currency exchange rates and interest rates arising in Long term debt, the Company entered into interest rate and cross currency swap agreements during the year ended December 31, 2022. Refer to Note 16, “Derivatives” for additional information. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December 31, 2022, the weighted-average interest rate of borrowings under the Credit Agreement was</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> 4.54%, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">including the net impact from the interest rate and cross currency swaps and excluding accretion of deferred financing fees, and there wa</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$529 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of borrowing capacity available on the Revolving Facility. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Indebtedness </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the debt agreements discussed above, the Company also has the ability to inc</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ur approximately $77 million of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">indebtedness pursuant to certain uncommitted credit lines, consisting of an uncommitted credit line that the Company currently has in place that the Company has used from time to time in the past for short-term working capital needs. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is party to letter of credit facilities with an aggregate capacity o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f $102.9 million.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Total letters of credit of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$31.5 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were outstanding as of December 31, 2022. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Financing Fees </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In total, the Company had deferred financing fees of $3.6 million included in its Consolidated and Combined Balance Sheet as of December 31, 2022, which will be charged to Interest expense (income) and other, net, using the straight-line method. The costs associated with the Term Facilities will be amortized over the contractual term of the Term Facilities and the costs associated with the Revolving Facility will be amortized over the life of the Credit Agreement. Of the $3.6 million, $1.2 million of deferred financing fees relating to the Revolving Facility are included in Other assets and $2.4 million of deferred financing fees relating to the Term Facilities are recorded as a contra-liability within Long-term debt. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contractual Maturities</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of the Company’s debt is as follows: </span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:75.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.012%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">621,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,221,000 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline"> </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:6.7pt">Total debt excludes $3.6 million of related unamortized deferred financing fees.</span></div> <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.006%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revolving credit facilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">221,000 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,221,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized deferred financing fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,357)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,218,643 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline"> </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:6.7pt">In the Company’s Consolidated Balance sheet, $1.2 million of deferred financing fees related to the Revolving Facility are included in Other assets and $2.4 million of deferred financing fees related to the Term Facilities are recorded as a contra-liability within Long-term debt.</span></div> 1000000000 221000000 1221000000 2357000 1218643000 1200000 2400000 750000000 400000000 600000000 P364D 300000000 50000000 1200000000 200000000 400000000 600000000 1200000000 600000000 600000000 4.00 3.75 3.50 3.00 0.01125 0.01750 0.00125 0.00750 0.0454 529000000 77000000 102900000 31500000 3600000 3600000 1200000 2400000 <div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of the Company’s debt is as follows: </span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:75.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.012%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">621,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,221,000 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline"> </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:6.7pt">Total debt excludes $3.6 million of related unamortized deferred financing fees.</span></div> 0 0 600000000 0 621000000 1221000000 3600000 Derivatives<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative instruments to manage exposures to currency exchange rates and interest rates arising in connection with Long-term debt and the normal course of business. The Company has established policies and procedures that govern the risk management of these exposures. Both at inception and on an ongoing basis, the derivative instruments that qualify for hedge accounting are assessed as to their effectiveness, when applicable. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to the credit risk of counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. None of the concentrations of risk with an individual counterparty was considered significant as of December 31, 2022. The Company does not expect any counterparties to fail to meet their obligations. The Company records derivatives in the Consolidated and Combined Balance Sheets at fair value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 14, 2022, the Company entered into two interest rate swap agreements to manage interest rate risk exposure. The aggregate notional amount of these contracts is $600 million and they mature in April 2025. These interest rate swap agreements utilized by the Company effectively modify the Company’s exposure to interest rate risk by converting a portion of the Company’s floating-rate debt to a fixed rate of 3.293%, plus a spread, thus reducing the impact of interest-rate changes on future interest expense. The applicable spread may vary between 1.125% to 1.750%, depending on the total leverage ratio of the Company. The spread is 1.250% as of December 31, 2022. These agreements involve the receipt of floating-rate amounts in exchange for fixed-rate interest payments over the life of the agreement without an exchange of the underlying principal amount.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above interest rate swap agreements are designated and qualify as a cash flow hedge, and as such the gain or loss on the derivative instrument due to the change in fair value is reported as a component of accumulated other comprehensive income (“AOCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. If a derivative is deemed to be ineffective, the change in fair value of the derivative is recognized directly in earnings. The Company did not have any ineffectiveness related to cash flow hedges during the year ended December 31, 2022. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash inflows and outflows associated with the Company’s interest rate swap agreements designated as cash flow hedges are classified in cash flows from operating activities in the accompanying Consolidated and Combined Statements of Cash Flows.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects a gain of $7.3 million, net of tax, related to interest rate swap agreements to be reclassified from AOCI to earnings over the next 12 months as the hedged transactions are realized. The expected gain to be reclassified is based on current forward rates in active markets as of December 31, 2022.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of designated cash flow hedges on the Company’s Consolidated and Combined Statements of Operations consisted of the following:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:28.781%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.692%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.045%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-13.5pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative type</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss recognized in the Consolidated and Combined Statements of Operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"/><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense (income) and other, net</span></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"/><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccecff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">413 </span></td><td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Hedges </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 22, 2022 the Company entered into two cross-currency swap agreements to partially hedge its net investment in its Euro denominated subsidiaries against adverse movements in exchange rates between the U.S. Dollar and the Euro. In addition, the cross-currency swap agreements include provisions to exchange fixed-rate payments in U.S. Dollar for fixed-rate payments in Euro and are designated and qualify as a net investment hedge. These contracts have a Euro aggregate notional amount of approximately €270 million and a U.S. Dollar aggregate notional amount of $275 million at December 31, 2022, and they mature in April 2025. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the spot rate of these instruments are recorded in AOCI in equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCI. The Company uses the spot method of assessing hedge effectiveness and as such, the initial value of the hedge components excluded from the assessment of effectiveness is recognized in the Interest expense (income) and other, net line item in the Consolidated and Combined Statement of Operations under a systematic and rational method over the life of the cross-currency swap agreements. Any ineffective portions of net investment hedges are reclassified from AOCI into earnings during the period of change. The Company did not have any ineffectiveness related to net investment hedges during the year ended December 31, 2022.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash inflows and outflows associated with the excluded components of the Company’s cross-currency swap agreements designated as net investment hedges are classified in operating activities in the accompanying Consolidated and Combined Statements of Cash Flows.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of the excluded components of designated net investment hedges on the Company’s Consolidated and Combined Statements of Operations consisted of the following:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:28.781%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.692%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.045%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-13.5pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative type</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain recognized in the Consolidated and Combined Statements of Operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap agreements</span></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"/><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense (income) and other, net</span></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"/><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccecff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,181)</span></td><td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows the fair value of the derivatives recognized in the Consolidated Balance Sheet: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:59.282%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.340%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Designated as hedging instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Assets</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:justify;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap agreements </span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,769 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:justify;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,342 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,769 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,342 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedging Instruments </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain foreign currency contracts that are not designated as hedges. As of December 31, 2022 and December 31, 2021, the Company had foreign currency contracts related to purchases and sales with notional values of $260.0 million and $180.8 million, respectively. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized the following in its Consolidated and Combined Financial Statements related to its derivative instruments not designated in a hedging relationship: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:57.551%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.099%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,338 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,426 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,601)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,631)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(469)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The year ended December 31, 2022 includes realized losses relating to certain corporate entities contributed to ESAB Corporation which are reflected within Interest expense (income) and other, net, in the Consolidated and Combined Statements of Operations. See Note 1, “Organization and Basis of Presentation” for additional details. These realized losses are offset by unrealized gains which are also reflected within Interest expense (income) and other, net, in the Consolidated and Combined Statements of Operations.</span></div> 2 600000000 0.03293 0.01125 0.01750 0.01250 7300000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of designated cash flow hedges on the Company’s Consolidated and Combined Statements of Operations consisted of the following:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:28.781%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.692%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.045%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-13.5pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative type</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss recognized in the Consolidated and Combined Statements of Operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"/><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense (income) and other, net</span></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"/><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccecff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">413 </span></td><td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 413000 2 270000000 275000000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of the excluded components of designated net investment hedges on the Company’s Consolidated and Combined Statements of Operations consisted of the following:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:28.781%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.692%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.045%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-13.5pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative type</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain recognized in the Consolidated and Combined Statements of Operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap agreements</span></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"/><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense (income) and other, net</span></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"/><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccecff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,181)</span></td><td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> -2181000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows the fair value of the derivatives recognized in the Consolidated Balance Sheet: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:59.282%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.340%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Designated as hedging instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Assets</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:justify;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap agreements </span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,769 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:justify;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,342 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,769 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,342 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 10769000 0 0 14342000 10769000 14342000 260000000 180800000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized the following in its Consolidated and Combined Financial Statements related to its derivative instruments not designated in a hedging relationship: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:57.551%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.099%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,338 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,426 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,601)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,631)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(469)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1) The year ended December 31, 2022 includes realized losses relating to certain corporate entities contributed to ESAB Corporation which are reflected within Interest expense (income) and other, net, in the Consolidated and Combined Statements of Operations. See Note 1, “Organization and Basis of Presentation” for additional details. These realized losses are offset by unrealized gains which are also reflected within Interest expense (income) and other, net, in the Consolidated and Combined Statements of Operations 1338000 177000 1426000 -17601000 -5631000 -469000 Fair Value Measurements<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes fair value measurement guidance prescribed by accounting standards to value its financial instruments. The guidance establishes a fair value hierarchy based on the inputs used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level One: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets. </span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level Two: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. </span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level Three: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inputs to the valuation methodology are unobservable and significant to the fair value measurement. </span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of financial instruments, including Trade receivables and Accounts payable, approximate their fair values due to their short-term maturities. The estimated fair values may not represent actual values of the financial instruments that could be realized as of the balance sheet date or that will be realized in the future. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is as follows (see </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 14, “Benefit Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s” for classification of the assets of the Company’s benefit plans within the fair value hierarchy):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>One</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>Two</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>Three</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,195 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,195 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts - not designated as hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,682 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,682 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,342 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,342 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,195 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,525 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,720 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts - not designated as hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,769 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,769 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,436 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,436 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Included within Other Current Assets in the Consolidated Balance Sheet.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Included within Accrued Liabilities in the Consolidated Balance Sheet.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>One</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>Two</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>Three</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,133 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,133 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts - not designated as hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,133 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,487 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,620 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts - not designated as hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,309 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,309 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Included within Other Current Assets in the Consolidated Balance Sheet.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Included within Accrued Liabilities in the Consolidated Balance Sheet.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s cash equivalents consist of investments in interest-bearing deposit accounts and money market mutual funds which are valued based on quoted market prices. The fair value of these investments approximate cost due to their short-term maturities and the high credit quality of the issuers of the underlying securities.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the fair value of foreign currency contracts, cross currency swap agreements and interest rate swap agreements using Level Two inputs based on observable spot and forward rates in active markets. Additionally, the fair value of derivatives designated in hedging relationships includes a credit valuation adjustment to appropriately incorporate nonperformance risk for the Company and the respective counterparty. For the year ended December 31, 2022, the impact of the credit valuation adjustment on the Company’s derivatives is immaterial. Refer to Note 16, “Derivatives” for additional information. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers in or out of Level One, Two or Three during the years ended December 31, 2022 and 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risk</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially subject the Company to concentrations of credit risk consist primarily of trade accounts receivable. Concentrations of credit risk are considered to exist when there are amounts collectible from multiple counterparties with similar characteristics, which could cause their ability to meet contractual obligations to be similarly impacted by economic or other conditions. The Company performs credit evaluations of its customers prior to delivery or commencement of services and normally does not require collateral. Letters of credit are occasionally required when the Company deems n</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ecessary. There are no customers which represent more than 10% of the Company’s Accounts receivable, net as of December 31, 2022 and 2021.</span></div> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is as follows (see </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 14, “Benefit Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s” for classification of the assets of the Company’s benefit plans within the fair value hierarchy):</span><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>One</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>Two</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>Three</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,195 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,195 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts - not designated as hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,682 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,682 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,342 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,342 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,195 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,525 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,720 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts - not designated as hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,769 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,769 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,436 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,436 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Included within Other Current Assets in the Consolidated Balance Sheet.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Included within Accrued Liabilities in the Consolidated Balance Sheet.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>One</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>Two</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>Three</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,133 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,133 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts - not designated as hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,133 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,487 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,620 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts - not designated as hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,309 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,309 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Included within Other Current Assets in the Consolidated Balance Sheet.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Included within Accrued Liabilities in the Consolidated Balance Sheet.</span></div> 8195000 0 0 8195000 0 3682000 0 3682000 0 14342000 0 14342000 0 2501000 0 2501000 8195000 20525000 0 28720000 0 2166000 0 2166000 0 10769000 0 10769000 0 2501000 0 2501000 0 15436000 0 15436000 8133000 0 0 8133000 0 2487000 0 2487000 8133000 2487000 0 10620000 0 2309000 0 2309000 Equity<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the balances of each component of Accumulated other comprehensive loss including reclassifications out of Accumulated other comprehensive loss for the years ended December 31, 2022, 2021 and 2020. All amounts are net of tax and noncontrolling interest, if any.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.160%"><tr><td style="width:1.0%"/><td style="width:41.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.351%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.351%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.928%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss Components</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Unrecognized Pension and Other Post-Retirement Benefit Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> Gain on Cash Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at January 1, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,887)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(399,641)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(423,528)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,328)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,328)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,791)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,816 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,025 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,119)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,816 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,697 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">628 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">628 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current period Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,491)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,816 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,325 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29,378)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(366,825)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(396,203)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,479 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,479 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,534 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72,867)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71,333)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,013 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72,867)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(63,854)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(831)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(831)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current period Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,182 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72,867)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,685)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,196)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(439,692)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(460,888)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts contributed by Former Parent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,504)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,759)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,263)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net actuarial gain </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82,351)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,336)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(88,975)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on long-term intra-entity foreign currency transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83,105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83,105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain on cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,782 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,782 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48,679)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(174,215)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,336)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,782 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(220,448)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,348 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current period Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42,651)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(174,215)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,336)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,102 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(214,100)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(63,847)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(613,907)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,336)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,102 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(674,988)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost. See Note 14,</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">“Benefit Plans” for additional details.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes unrecognized pension and other post-retirement costs and accumulated currency translation adjustments of certain entities which were part of the Corporate segment of the Former</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Parent and were transferred to ESAB Corporation in anticipation of the Separation. Please see Note 1, “Organization and Basis of Presentation” for more information on the entities</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">contributed from the Former Parent.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> During the year ended December 31, 2022, the amount on this line within the Gain on Cash Flow Hedges column is a component of Interest expense (income) and other, net. See Note 16, “Derivatives”, for additional details.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2022, 2021 and 2020, Noncontrolling interest decreased by $3.6 million, $1.1 million and $0.1 million, respectively, as a result of Other comprehensive loss, primarily due to foreign currency translation adjustments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Payments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Separation, the Company had no stock-based compensation plans; however, certain employees of the Company participated in the Former Parent’s stock-based compensation plans which provided for the grants of stock options and restricted stock units (“RSUs”). Prior to the Separation, the Former Parent allocated stock-based compensation expense to the Company based on ESAB employees participating in Former Parent plans. This is reflected in the accompanying Consolidated and Combined Statements of Operations and Comprehensive Income for the period prior to the Separation. Prior to the Separation, in addition to stock compensation expense related to direct employees of the Company, stock compensation expense related to certain corporate employees of the Former Parent was allocated to the Company based on the Company’s proportional share of total Former Parent revenues. For the three months ended April 1, 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.7 million of stock-based compensation expense was allocated to the Company. For the years ended December 31, 2021 and 2020, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2.6 million and $3.0 million, respectively, was allocated to the Company. Following the Separation, the company independently incurs stock compensation expenses as a stand-alone company.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Separation, the Company adopted the 2022 Omnibus Incentive Plan (the “Stock Plan”) that became effective upon the Separation. Outstanding equity awards of the Former Parent held by ESAB employees at the Separation date were converted into or replaced with awards of ESAB common stock under the Stock Plan, with the intent to maintain the economic value of the equity awards immediately before and after the Distribution. The terms of the equity awards period, exercisability and vesting schedule, as applicable, generally continued unchanged. Other than converted or replacement equity awards of ESAB issued in replacement of the Former Parent’s restricted stock units (“RSUs”) and stock options, the terms of the converted or replacement equity awards of ESAB (e.g. vesting date and expiration date) continued unchanged. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and recognizes compensation expense related to share-based payments based on the fair value of the instruments issued. Stock-based compensation expense is generally recognized as a component of Selling, general and administrative expense in the Consolidated and Combined Statements of Operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, the Company had $19.0 million of unrecognized compensation expense related to stock-based awards that will be recognized over a weighted-average period of 2.30 years. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Stock Plan, the Company may grant options to purchase common stock, with a maximum term of 10 years at a purchase price equal to the market value of the Company’s common stock on the date of grant. Stock-based compensation expense for stock option awards is based upon the grant-date fair value using the Black-Scholes option pricing model. The Company recognizes compensation expense for stock option awards on a straight-line basis over the requisite service period of the entire award. For the year ended December 31, 2022 the Stock-based compensation expense for the stock option awards was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.8 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, the Company granted certain employees performance-based restricted stock units (“PRSUs”), the vesting of which is fully based on company specific profit performance metrics over a three-year performance period. The awards also have a service requirement that equals the respective performance periods.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These PRSUs are valued at the market value of a share of Common stock on the date of grant taking into consideration the probability of achieving the specified performance goal. The ultimate payout of PRSUs with a profit performance metric adjusts the cumulative expense based on its estimate and the percent of the requisite service period that has elapsed.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Stock Plan, the Compensation Committee may also award non-performance-based restricted stock units (“RSUs”) to select executives, employees and outside directors, which typically vest over three years after the date of grant.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With limited exceptions, the employee must remain in service until the vesting date. The Compensation Committee determines the terms and conditions of each award, including any restriction period and other criteria applicable to the awards.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity of the Company’s PRSUs and RSUs is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.653%"><tr><td style="width:1.0%"/><td style="width:49.579%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.479%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.479%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.479%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.724%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PRSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSUs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number<br/>of Units</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant-Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number<br/>of Units</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant-Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Awards converted from Former Parent plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,636 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.03 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333,223 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.89 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187,556 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,354)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited and expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29,147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,288 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.99 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">464,278 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The fair value of shares vested during the year ended December 31, 2022 was $1.3 million. <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the balances of each component of Accumulated other comprehensive loss including reclassifications out of Accumulated other comprehensive loss for the years ended December 31, 2022, 2021 and 2020. All amounts are net of tax and noncontrolling interest, if any.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.160%"><tr><td style="width:1.0%"/><td style="width:41.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.351%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.351%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.928%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss Components</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Unrecognized Pension and Other Post-Retirement Benefit Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> Gain on Cash Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at January 1, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,887)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(399,641)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(423,528)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,328)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,328)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,791)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,816 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,025 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,119)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,816 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,697 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">628 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">628 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current period Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,491)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,816 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,325 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29,378)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(366,825)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(396,203)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,479 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,479 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,534 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72,867)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71,333)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,013 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72,867)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(63,854)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(831)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(831)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current period Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,182 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72,867)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,685)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,196)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(439,692)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(460,888)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts contributed by Former Parent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,504)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,759)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,263)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net actuarial gain </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82,351)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,336)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(88,975)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on long-term intra-entity foreign currency transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83,105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83,105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain on cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,782 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,782 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48,679)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(174,215)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,336)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,782 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(220,448)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,348 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current period Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42,651)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(174,215)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,336)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,102 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(214,100)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(63,847)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(613,907)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,336)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,102 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(674,988)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost. See Note 14,</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">“Benefit Plans” for additional details.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes unrecognized pension and other post-retirement costs and accumulated currency translation adjustments of certain entities which were part of the Corporate segment of the Former</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Parent and were transferred to ESAB Corporation in anticipation of the Separation. Please see Note 1, “Organization and Basis of Presentation” for more information on the entities</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">contributed from the Former Parent.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> During the year ended December 31, 2022, the amount on this line within the Gain on Cash Flow Hedges column is a component of Interest expense (income) and other, net. See Note 16, “Derivatives”, for additional details.</span></div> -23887000 -399641000 0 0 -423528000 -4328000 0 0 -4328000 -1791000 32816000 0 0 31025000 -6119000 32816000 0 0 26697000 -628000 0 0 0 -628000 -5491000 32816000 0 0 27325000 -29378000 -366825000 0 0 -396203000 7479000 0 0 7479000 1534000 -72867000 0 0 -71333000 9013000 -72867000 0 0 -63854000 831000 0 0 0 831000 8182000 -72867000 0 0 -64685000 -21196000 -439692000 0 0 -460888000 -50504000 -8759000 0 0 -59263000 -113000 0 0 0 -113000 1712000 -82351000 -8336000 0 -88975000 0 -83105000 0 0 -83105000 0 0 0 10782000 10782000 -48679000 -174215000 -8336000 10782000 -220448000 -6028000 0 0 -320000 -6348000 -42651000 -174215000 -8336000 11102000 -214100000 -63847000 -613907000 -8336000 11102000 -674988000 -3600000 -1100000 -100000 700000 2600000 3000000 19000000 P2Y3M18D P10Y 1800000 P3Y P3Y <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity of the Company’s PRSUs and RSUs is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.653%"><tr><td style="width:1.0%"/><td style="width:49.579%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.479%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.479%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.479%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.724%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PRSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSUs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number<br/>of Units</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant-Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number<br/>of Units</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant-Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Awards converted from Former Parent plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,636 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.03 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333,223 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.89 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187,556 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,354)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited and expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29,147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,288 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.99 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">464,278 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 0 0 0 58636 58.03 333223 52.89 51652 49.40 187556 47.28 0 0 27354 48.11 0 0 29147 52.40 110288 53.99 464278 50.80 1300000 Commitments and Contingencies<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asbestos Contingencies </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain entities that became subsidiaries of ESAB Corporation in connection with the Separation are the legal obligor for certain asbestos obligations including long-term asbestos insurance assets, long-term asbestos insurance receivables, accrued asbestos liabilities, long-term asbestos liabilities, asbestos indemnity expenses, asbestos-related defense costs and asbestos insurance recoveries related to the asbestos obligations from the Former Parent’s other legacy industrial businesses. As a result, the Company holds certain asbestos-related contingencies and insurance coverages.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These subsidiaries are each one of many defendants in a large number of lawsuits that claim personal injury as a result of exposure to asbestos from products manufactured or used with components that are alleged to have contained asbestos. Such components were acquired from third-party suppliers, and were not manufactured by any of the Company’s, or Former Parent’s, subsidiaries nor were the subsidiaries producers or direct suppliers of asbestos. The manufactured products that are alleged to have contained or used asbestos generally were provided to meet the specifications of the subsidiaries’ customers, including the U.S. Navy. The subs</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">idiaries settle asbestos claims for amounts the Company considers reasonable given the facts and circumstances of each claim. The annual average settlement payment per asbestos claimant has fluctuated during the past several years while the number of cases has steadily declined. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects such fluctuations to continue in the future based upon, among other things, the number and type of claims settled in a particular period and the jurisdictions in which such claims arise. To date, the majority of settled claims have been dismissed for no payment.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified asbestos-related activity in Loss from discontinued operations in the Consolidated and Combined Statements of Operations. This is consistent with the Former Parent’s classification on the basis that, pursuant to the purchase agreement from the Former Parent’s Fluid Handling business divestiture, the Former Parent retained its asbestos-related contingencies and insurance coverages. However, as the Former Parent did not retain an interest in the ongoing operations of the business subject to the contingencies, asbestos-related activity was classified as part of Loss from discontinued operations, net of taxes in the Consolidated Statements of Operations of the Former Parent. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has projected each subsidiary’s future asbestos-related liability costs with regard to pending and future unasserted claims based upon the Nicholson methodology. The Nicholson methodology is a standard approach used by experts and has been accepted by numerous courts. Consistent with the Former Parent, it is ESAB’s policy to record a liability for asbestos-related liability costs for the longest period of time that ESAB management can reasonably estimate. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that it can reasonably estimate the asbestos-related liability for pending and future claims that will be resolved in the next 15 years and has recorded that liability as its best estimate. While it is reasonably possible that the subsidiaries will incur costs after this period, the Company does not believe the reasonably possible loss or a range of reasonably possible losses is estimable at the current time. Accordingly, no accrual has been recorded for any costs which may be paid after the next 15 years. Defense costs associated with asbestos-related liabilities as well as costs incurred related to efforts to recover insurance from the subsidiaries’ insurers are expensed as incurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each subsidiary has separate insurance coverage acquired prior to Company ownership. The Company estimates the insurance assets for each subsidiary based upon the applicable policy language, expected recoveries and allocation methodologies, and law pertaining to the affected subsidiary’s insurance policies.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asbestos-related claims activity since December 31, 2021 is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"/><td style="width:75.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.030%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Number of claims)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Claims unresolved, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,559 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Claims filed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,338 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Claims resolved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,791)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Claims unresolved, end of period</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,106 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In dollars)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average cost of resolved claims</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,017 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Claims filed include all asbestos claims for which notification has been received or a file has been opened.</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> upon agreements or understandings in place with counsel for the claimants.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3) </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Excludes claims settled in Mississippi for which the majority of claims have historically been resolved for no payment and insurance recoveries.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s Consolidated and Combined Balance Sheet included the following amounts related to asbestos-related litigation:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.233%"><tr><td style="width:1.0%"/><td style="width:76.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.370%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term asbestos insurance asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215,112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term asbestos insurance receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,231 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued asbestos liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term asbestos liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230,581 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in Other assets in the Consolidated and Combined Balance Sheet.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay, and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Consolidated and Combined Balance Sheet.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in Other liabilities in the Consolidated and Combined Balance Sheet.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management’s analyses are based on currently known facts and assumptions. Projecting future events, such as new claims to be filed each year, the average cost of resolving each claim, coverage issues among layers of insurers, the method in which losses will be allocated to the various insurance policies, interpretation of the effect on coverage of various policy terms and limits and their interrelationships, the continuing solvency of various insurance companies, the amount of remaining insurance available, as well as the numerous uncertainties inherent in asbestos litigation could cause the actual liabilities and insurance recoveries to be higher or lower than those projected or recorded which could materially affect the Company’s financial condition, results of operations or cash flow. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various pending legal proceedings arising out of the ordinary course of the Company’s business. None of these legal proceedings is expected to have a material adverse effect on the financial condition, results of operations or cash flow of the Company. With respect to these proceedings, and the litigation and claims described in the proceeding paragraphs, management of the Company believes that it will either prevail, has adequate insurance coverage or has established appropriate accruals to cover potential liabilities. Legal costs related to proceedings or claims are recorded when incurred. Other costs that management estimates may be paid related to the claims are accrued when the liability is considered probable and the amount can be reasonably estimated. There can be no assurance, however, as to the ultimate outcome of any of these matters, and if all or substantially all of these legal proceedings were to be determined adverse to the Company, there could be a material adverse effect on the financial condition, results of operations or cash flow of the Company.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company had</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$104.8 million of unconditional purchase obligations with suppliers, the majority of which is expected to be paid by December 31, 2023.</span></div> P15Y P15Y <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asbestos-related claims activity since December 31, 2021 is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"/><td style="width:75.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.030%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Number of claims)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Claims unresolved, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,559 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Claims filed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,338 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Claims resolved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,791)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Claims unresolved, end of period</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,106 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In dollars)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average cost of resolved claims</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,017 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Claims filed include all asbestos claims for which notification has been received or a file has been opened.</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> upon agreements or understandings in place with counsel for the claimants.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3) </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Excludes claims settled in Mississippi for which the majority of claims have historically been resolved for no payment and insurance recoveries.</span> 14559 4338 4791 14106 10017 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s Consolidated and Combined Balance Sheet included the following amounts related to asbestos-related litigation:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.233%"><tr><td style="width:1.0%"/><td style="width:76.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.370%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term asbestos insurance asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215,112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term asbestos insurance receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,231 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued asbestos liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term asbestos liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230,581 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in Other assets in the Consolidated and Combined Balance Sheet.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay, and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Consolidated and Combined Balance Sheet.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in Other liabilities in the Consolidated and Combined Balance Sheet.</span></div> 215112000 17231000 30108000 230581000 104800000 Segment Information <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ESAB is a world leader in fabrication and gas control technology, providing our partners with advanced equipment, consumables, gas control equipment, robotics, and digital solutions, which enable the everyday and extraordinary work that shapes our world. The Company’s products are utilized to solve challenges in a wide range of industries, including cutting, joining and automated welding.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America, and “EMEA &amp; APAC,” which includes Europe, Middle East, India, Africa and Asia Pacific.</span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company’s management evaluates the operating results of each of its reportable segments based upon Net sales and segment Adjusted EBITDA, which represents Operating income excluding the impact of Restructuring and other related charges, separation costs, transaction and integration costs, acquisition-related amortization and other non-cash charges, and depreciation and other amortization.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s segment results were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)<br/></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Net sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">     Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,128,306 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,004,208 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">767,414 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EMEA &amp; APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,465,174 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,423,907 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,182,655 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,593,480 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,428,115 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,950,069 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Adjusted EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">     Americas</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188,577 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,623 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111,588 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EMEA &amp; APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248,177 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244,458 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,558 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">436,754 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">404,081 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">301,146 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Depreciation, amortization and other impairment charges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">     Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,281 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,380 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EMEA &amp; APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,697 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,009 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,264 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,978 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,899 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,644 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">     Americas</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,005 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,095 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,244 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EMEA &amp; APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,489 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,894 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,243 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,584 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,138 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the years ended December 31, 2022, 2021 and 2020, the total Net sales originating from the United States were $583.0 million, $533.5 million and $443.7 million, respectively. The remainder of the sales were derived from foreign countries. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following is a reconciliation of Net income from continuing operations to Adjusted EBITDA:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)<br/></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231,081 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238,679 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,868 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,409</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,971</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense (income) and other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,950 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,023)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pension settlement gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring and other related charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,096 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,954 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,633 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Separation costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,545 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,865 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition - amortization and other related charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,196 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,949 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,331 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and other amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,852 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,462 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,366 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">436,754 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">404,081 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">301,146 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="margin-top:5pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to removal of interest expense, net included within the Interest expense (income) and other, net line within the Consolidated and Combined Statements of Operations</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ncludes non-recurrin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">g charges and employee costs related to the planning and execution of t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">he separation from Enovis within the Selling, general and administrative expense line within the Consolidated and Combined Statements of Operations.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Investments in Equity Method Investees:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">     Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 24.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">     EMEA &amp; APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,527 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,180 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,527 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,180 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Total Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">     Americas</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,666,799 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,304,797 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">     EMEA &amp; APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,087,216 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,156,465 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,754,015 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,461,262 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Property, Plant and Equipment, Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,380 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,136 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Czech Republic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,278 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,273 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">India</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,892 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,312 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Russia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,111 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,797 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,666 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,720 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other foreign countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,899 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,040 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">284,226 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">286,278 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As the Company does not allocate all long-lived assets, specifically intangible assets, to each individual country, evaluation of long-lived assets in total is impracticable.</span></div> 2 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s segment results were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)<br/></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Net sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">     Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,128,306 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,004,208 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">767,414 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EMEA &amp; APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,465,174 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,423,907 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,182,655 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,593,480 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,428,115 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,950,069 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Adjusted EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">     Americas</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188,577 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,623 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111,588 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EMEA &amp; APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248,177 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244,458 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,558 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">436,754 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">404,081 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">301,146 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Depreciation, amortization and other impairment charges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">     Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,281 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,380 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EMEA &amp; APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,697 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,009 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,264 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,978 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,899 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,644 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">     Americas</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,005 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,095 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,244 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EMEA &amp; APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,489 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,894 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,243 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,584 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,138 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the years ended December 31, 2022, 2021 and 2020, the total Net sales originating from the United States were $583.0 million, $533.5 million and $443.7 million, respectively. The remainder of the sales were derived from foreign countries. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following is a reconciliation of Net income from continuing operations to Adjusted EBITDA:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)<br/></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231,081 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238,679 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,868 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,409</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,971</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense (income) and other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,950 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,023)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pension settlement gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring and other related charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,096 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,954 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,633 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Separation costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,545 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,865 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition - amortization and other related charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,196 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,949 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,331 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and other amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,852 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,462 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,366 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">436,754 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">404,081 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">301,146 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="margin-top:5pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to removal of interest expense, net included within the Interest expense (income) and other, net line within the Consolidated and Combined Statements of Operations</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ncludes non-recurrin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">g charges and employee costs related to the planning and execution of t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">he separation from Enovis within the Selling, general and administrative expense line within the Consolidated and Combined Statements of Operations.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Investments in Equity Method Investees:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">     Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 24.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">     EMEA &amp; APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,527 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,180 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,527 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,180 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Total Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">     Americas</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,666,799 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,304,797 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">     EMEA &amp; APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,087,216 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,156,465 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,754,015 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,461,262 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1128306000 1004208000 767414000 1465174000 1423907000 1182655000 2593480000 2428115000 1950069000 188577000 159623000 111588000 248177000 244458000 189558000 436754000 404081000 301146000 29281000 33890000 36380000 36697000 42009000 40264000 65978000 75899000 76644000 18005000 14095000 15244000 22238000 21489000 24894000 40243000 35584000 40138000 583000000 533500000 443700000 231081000 238679000 159868000 69170000 80409000 45971000 37950000 29000 1023000 9136000 11208000 0 23096000 18954000 21633000 15545000 2865000 0 34196000 35949000 36331000 34852000 38462000 38366000 436754000 404081000 301146000 0 0 28527000 28180000 28527000 28180000 1666799000 1304797000 2087216000 2156465000 3754015000 3461262000 <div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Property, Plant and Equipment, Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,380 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,136 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Czech Republic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,278 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,273 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">India</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,892 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,312 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Russia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,111 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,797 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,666 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,720 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other foreign countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,899 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,040 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">284,226 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">286,278 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As the Company does not allocate all long-lived assets, specifically intangible assets, to each individual country, evaluation of long-lived assets in total is impracticable.</span></div> 68380000 64136000 60278000 63273000 34892000 37312000 19111000 18797000 17666000 14720000 83899000 88040000 284226000 286278000 Related Party Transactions <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Agreements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 4, 2022, in connection with the Separation, the Company entered into several agreements with Enovis that govern the Separation and provide a framework for the relationship between the parties going forward including a separation and distribution agreement, a transition services agreement, tax matters agreement, employee matters agreements, a stockholder’s and registration rights agreement, an intellectual property matters agreement and a license agreement for Enovis Growth Excellence Business System (“EGX”). </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Separation and Distribution Agreement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into a separation and distribution agreement (the “Separation Agreement”) with Enovis immediately prior to the distribution of the Company’s common stock to Enovis stockholders. The Separation Agreement sets forth the Company’s agreements with Enovis regarding the principal actions to be taken in connection with the Separation. The Separation Agreement contains provisions that, among other things, relate to (i) assets, liabilities and contracts to be transferred, assumed and assigned to each of ESAB and Enovis as part of the Separation, (ii) cash distribution made to Enovis in partial consideration of the transfer of ESAB Assets to the Company in connection with the Separation, and (iii) cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of ESAB’s business with ESAB and financial responsibility for the obligations and liabilities of Enovis’s remaining business with Enovis. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transition Services Agreement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transition services agreement ("TSA") sets forth the terms and conditions pursuant to which the Company and its subsidiaries and Enovis and its subsidiaries will provide to each other various services. The services to be provided include human resources, payroll, certain information technology services, treasury services and financial reporting services. The charges for the transition services generally are expected to allow the providing company to fully recover all internal and external costs and expenses it actually incurs in connection with providing the service (including a reasonable allocation of overhead) provided in the manner and at a level substantially consistent with that provided by the respective providing company immediately preceding the Distribution Date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Matters Agreement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax matters agreement governs the Company’s and Enovis’s respective rights, responsibilities and obligations after the Separation with respect to tax liabilities and benefits, tax attributes, the preparation and filing of tax returns, the control of audits and other tax proceedings and certain other matters regarding taxes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Matters Agreement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The employee matters agreement sets forth, among other things, the allocation of assets, liabilities and responsibilities relating to employee compensation and benefit plans and programs and other related matters in connection with the Separation, including the treatment of outstanding equity and other incentive awards and certain retirement and welfare benefit obligations. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholders and Registration Rights Agreement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stockholders and registration rights agreement sets forth the right of the stockholders when requiring the Company to facilitate the resale of shares. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property Matters Agreement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intellectual property matters agreement sets forth the terms and conditions pursuant to which Enovis and the Company have mutually granted certain personal, generally irrevocable, non-exclusive, worldwide, and royalty-free rights to use certain intellectual property. The Company and Enovis are able to sublicense their rights in connection with activities relating to their businesses, but not for independent use by third parties.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">EGX License Agreement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The EGX license agreement sets forth the terms and conditions pursuant to which Enovis has granted a royalty-free, non-exclusive, worldwide, and nontransferable license to the Company to use EGX, solely in support of its businesses. The Company will be able to sublicense such license solely to direct and indirect wholly-owned subsidiaries. In addition, under the EGX license agreement, Enovis and the Company each license to each other improvements made by such party to EGX during the first two years of the term of the EGX license agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allocated Expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Separation, the Company operated as part of the Former Parent and not as a stand-alone company. Accordingly, the Former Parent allocated certain shared costs to the Company that are reflected as expenses in these financial statements. These amounts included, but were not limited to, items such as general management and executive oversight, compliance, human resources, procurement, and legal functions and financial management, including public company reporting, consolidated tax filings and tax planning. Management considered the allocation methodologies used by the Former Parent to be reasonable and to appropriately reflect the related expenses attributable to the Company for purposes of the three months ended April 1, 2022 and the years ended December 31, 2021, and 2020 combined financial statements; however, the expenses reflected in these financial statements may not be indicative of the actual expenses that would have been incurred during the periods presented if the Company had operated as a separate stand-alone entity. In addition, the expenses reflected in the financial statements may not be indicative of expenses the Company will incur in the future. Allocation methodologies utilized include the Company’s relative share of total Former Parent revenues and headcount.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company’s transactions with the Former Parent were considered to be financing transactions, which are presented as Transfers from (to) Former Parent, net in the accompanying Consolidated and Combined Statements of Cash Flows.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no stock-based compensation plans prior to the Separation; however, certain employees of the Company participated in the Former Parent’s stock-based compensation plans, which provided for the grants of stock options and RSUs among other types of awards. The expense associated with the Company's employees who participated in the plans of the Former Parent was allocated to the Company in the accompanying Consolidated and Combined Statements of Operations through the date of Separation.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s allocated expenses from the Former Parent were $6.0 million for the three months ended April 1, 2022, and $29.5 million and $24.2 million for the years ended December 31, 2021 and 2020, respectively, and are included in the Selling, general and administrative expense in the Consolidated and Combined Statements of Operations. Following the Separation, the company independently incurs expenses as a stand-alone company.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 14, “Benefit Plans,” for allocations of net periodic benefit associated with a Former Parent sponsored benefit plan.</span></div> 6000000 29500000 24200000 Subsequent Events<div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dividend of $3.0 million included in Accrued liabilities in the Consolidated Balance Sheet at December 31, 2022 was paid on January 13, 2023, to stockholders of record as of Decembers 30, 2022. In addition, on March 2, 2023, the Board of Directors declared a quarterly cash dividend of $0.05 per share of ESAB’s common stock payable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on April 14, 2023, t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o stockholders of record as of March 31, 2023. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 11, 2023, the Company completed the acquisition of Therapy Equipment Limited, a regional leader in oxygen regulators, for approximately $16 million.</span></div> 3000000 3000000 0.05 16000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.337%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Charged to Cost and<br/>Expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Write-Offs Write-Downs </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Deductions and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Foreign<br/>Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,912 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,526 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,978)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,471 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,465 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,503 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,876 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(642)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,202 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,931)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(974)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,912 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,647 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,738 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(920)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,465 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2020:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,008 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,936 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,448)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,311 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,855 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,738)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(470)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,647 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amounts charged to expense are net of recoveries for the respective period. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:106%;position:relative;top:-3.15pt;vertical-align:baseline">(2)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:106%">As of December 31, 2022, valuation allowance for deferred tax assets “Other” of $68.9 million is primarily due to valuation allowance transferred from Former Parent. </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Allowance for credit losses as of January 1, 2020 includes the cumulative-effect adjustment of the adoption of ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.</span></div> 23912000 4526000 4978000 11000 23471000 15465000 4503000 -68876000 -642000 88202000 32311000 -494000 6931000 -974000 23912000 12647000 3738000 0 -920000 15465000 32008000 4936000 3448000 -1185000 32311000 17855000 0 4738000 -470000 12647000 68900000 EXCEL 124 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( %TU9U8'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " !=-6=6T:'<)N\ K @ $0 &1O8U!R;W!S+V-O&ULS9)- M:L,P$$:O4K2WQ[+[ \+1)J&K%@H-M'0GI$DB8EE"FF+G]I7=Q*&T!RAHHYE/ M;]Z 6AV$]A%?H@\8R6*Z&5W7)Z'#BAV(@@!(^H!.I3(G^MS<^>@4Y6O<0U#Z MJ/8(=57=@T-21I&""5B$A,8;O>##9^QFF-& '3KL*0$O.3 Y M30RGL6OA"IA@A-&E[P*:A3A7_\3.'6#GY)CLDAJ&H1R:.9=WX/#^_/0ZKUO8 M/I'J->97R0HZ!5RQR^2W9KW9/C)95W535/D\;#D7M[5H[CXFUQ]^5V'GC=W9 M?VQ\$90M_/H7\@M02P,$% @ 735G5IE&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" !=-6=6!YZ'/DD( !Z, & 'AL+W=O$(D'/+GCEAQ2H(\*(D[V''..PF)TM;-57YNRF^N6";C**53 MCD26)(2_W]*8O5ZWW-;FQ"QZ#J4ZT;FY6I%G.J?R^VK*X:BS50FBA*8B8BGB M='G=ZKM?A]Z%"LBO^!'15['S&:FN+!C[I0[&P77+42VB,?6EDB#PYX4.:!PK M)6C'_]:BK>T]5>#NYXWZ7=YYZ,R""#I@\<\HD.%UJ]=" 5V2+)8S]OHONN[0 MF=+S62SR?]%K<6VWVT)^)B1+UL'0@B1*B[_D;0UB)Z#GU 3@=0#^$.#6W<%; M!WB'!G37 =V<3-&5G,.02')SQ=DKXNIJ4%,?*$?_Z2^$Y##N_ZLC7"AT]0IJ,?@J M5L2GURV8[8+R%]JZ^?TW]]SYIJ-C4VQH2:Q"KKLEUS6IWPR9G\&B(]'C^XKJ ML)G#7:?]IXZ/,:HI'TMB%3YG6SYGA_'IIVE&8C2C*\:E#I191_),AW=@C&H* MRI)8!=3Y%M3Y8:"FE$*VY^J(&0.;$K,D5B'6VQ+K';A><0*I4I[I MU,])L]:2Q$([*8UA36E9$JO0NMS2NC3V<)3*2+[#\(HIFF3)@G(=);.&X[CM MKHLO+W2DC*%-25D2JY!RG3)M MIYVVYN#&]"RI5>F5N;]K3) W]/I! .KB9/,!_077H8=4/^;,DI?.)9HQ05'_ MA:8913T9HKN8,=TO,3!K-89Y##?@EG; -2?T'V$.U!%,XD?VFFI!FN4F\& . MT2V5(14!T=*S:A5LJ57IE6;!-6?Y'^EMU\ I9R]1ZNO'HEGS?JC%9M4XV%*K M8BNM@VO.^#]BFS(A(1W^.UK5/S3,BMCIG6FM@SFN,;=CF >W= _N'ON04^.4 MU&,R"WB.UBV8HQI#.H9?<$O#X)JS_+^8LE;3D*6F''B/B(>]-CP4+K6TK-H% M6VI56J5A<,W9_F,DP2NP)7+QY\47-*=^QF&4:9&9E08L22"#F4OF_SI!*W"V M+R2&9^DGYQ0L!5I1CD1(N-: F:4;(SV&L<"ELC'#MALP>I1I85JV +;4JK-(*X(.LP.8=9?&6+5_((*O-]-#, MBD]4%S4P1S6F=@P+@$L+@ ^R .-44EYLP:JWN62#44O-K%A'S:H#L*56I58Z M 'R0 \BG(QJ :7IF7)MT[-&9L+1-?)^"#(@$A:"6GE4?8$NM2J_T =BL2RN3?.VA781Y"IF8:8GMD:F&9XQI7(AS# WBE!_ .VDB8 M9HLX\M4+5Z)]7II5&I=R6/4%:[6S7$V5B+WZ=.^YE]UR]2'JI@#A&IN_M% 29\_/- M/K'8V9:"?&"A-OB6%#(Q_;O8?:H/@^_WH\GC'(TGFQV^T1#=/J'9Z&XT&TT& M(S0E7*+Q>(RB\L8"^91+$J5PLJ@L5 LG-(9O&H.6G"5(AG1G _+WWWK8O?@F M5-5=E$9Y+KGB[.T=J:67YMO@H(8BZ*6JPT*DJ%%)*,WS=+:$"V&DA"P.P.6@ MSTI>B6+G6W[]-!>;;\3RK]QO7Y!D: $M@MPI0*N,BTSMAL)):%H6%VUWNWWT M&LD0NN1B!P7D72"RA)PW[P-- W7WFNXLBVJ'=U7MX*O*K>*' 3$!0)3+.$4_ M0;N0>O/I*K_E6E 4]8UB[:''\OOM#!"B$VT55]B?U.M"BE$GX M > PJ' A0KW3DD4KX#)5,XE4.=2I=M[8+1@[AC'T2F/H'68, 1"'WW&UEF:/W-V3EIA5]V=+K4JL='^>V;5]))97 MD=7S,HO5E=R9PQH3L^H .SO%VLK4Y47O\,A5=2=%W?;V[+:POI^7DW?*RXNJ M_'NB/*% ,5U"J'-Z 9.!%X7NQ8%DJ[ST>\&D9$G^,:0$'J_J OA^R9C<'*@; M;/^[P-M$D$I2B(0%%M-TT M37MADB.QZH?,-DWW[6<[D#$I1'U#?/;=S_\S=Q=50KZJ D"C=T:YBKU"ZW+B M^RHM@&'5$R5P5B:1.&I*.&PE M4D?&L/PS RJJV.M[YXT=R0MM-_PD*G$.3Z!?RJTTEM]0,L* *R(XDG"(O6E_ M,AM;?^?PC4"E+M;(9K(7XM4:RRSV BL(**3:$K#YO,$]4&I!1L;O$]-KKK2! ME^LS?>%R-[GLL8)[0;^33!>Q]\5#&1SPD>J=J+["*9^1Y:6"*O>+JMIW8&Y, MCTH+=@HV-B.\_N+WTSMTW"P>=^OI\_)Q$_G:8.VAGYX0LQH17D'T0[06 M7!<*/? ,LO\!OM'3B K/HF9A)W$.:0\-^K,:"'1 MDM=5;,OAYW2OM#1%\:LMXYHW;.?91IFH$J<0>Z83%,@W\)*;3_UQ<->A=MBH M'7;1&[4;S*!-6W?T@^1*HQO,RCOT0QQYCE:K;8>J4:-J]"%5*Y&Z!VQ3UDV8 M8:H)$Q)NT=KT/\6\JU;&C:[QAW0MB&1H.6^3U0T8ME:8?]%2#&3N!H="J7E1 M77=7L]O,IFG=DO_ E"^0F;P^]N-C'[^9.7_A MXJ=<,J;0ZRHOY$5OJ=3ZK-^7TR5;I?*4KUD!W\RY6*4*+L6B+]>"I;.JT2KO M4XS#_BK-BM[@O+KW( ;G?*/RK& / LG-:I6*_ZY8SE\N>J3W=N,Q6RQ5>:,_ M.%^G"S9FZL?Z0(,'F%[U+Y\QF5*!/. M?Y87-[.+'BY'Q'(V566(%/X]LR'+\S(2C./?)FAOVV?9;7#WRES]8 Q24\:8\E]5?]%)KH["'IANI^*II#"-8 M947]/WUM)F*G >EJ0)L&5&_@=S3PF@;>1QOX30._FID:I9J'4:K2P;G@+TB4 M:HA6?J@FLVH-^%E1YGVL!'R;03LU&-[?C>^_WXPNGZY'Z/)NA(;WMU$HEM>J*5$U\6,S?8#](%DBT/?<*ZH,^*(34^11XX1Q91: M!C3\>'-B:3[Z>'/LH/&VR?&J>%Y'O)MBRE<,C56J&.PUA?Z^G$@E8*_\8YOL M.IAO#U86D#.Y3J?LH@<50C+QS'J#7W\A(?[--E&'##8Z4+"]2?2WD^B[H@_N MH'C*-&?6]5DW#:JF98E\'M @\?P8LO>\.QL6G4]C0H)]W!IU-89%Z4Q)X&8(M@R1DV$,9U16+([1 M@A5,I#F"VH?2&=3FK-R;Y3&&V"N3L+I$:TR @L.'V]F3(_ MB",P=]K?-SU*Z_8U0P:]EH0N]EPE+\++(3$H:A3F>1 M>1'I6'>$MH3T'<+J-)\+OD)3L#U9L2F7(:\7)"\DFC P\JQ9F$BEK_8]UO2S MO_ P#8C.:]&1!,=&.DT=Q4'L=1Q:I+4OQ'FPOQ$#B*LB-D'VZG0"QY=.8\IB M[.-$AS%E?I!$I(.E=1'D?1N1O9=!*YYO*8D$QT:V;+HXC Q 4P=G>!S&'82M MQR!ND_&]/)LKMEDF&SPH]BU=M?]*&]*],DW?< (U,=9131G6*5V2?<#6?!"W M^VA3:!V[:1RM52F23C4HG.6PT MC@I>E*D3O#(I@%M7U0^DSF(EJ%X;AQ:5%^CF961143_H\(ZD=27$;4MVMJ". M?3V^O$)#+M:\7JM6PM@T\=2+_$AGM.B\@!!CB9HZ$D0^Z>)L'0I)G#_[KE-1 M0/(D^IK#ECQ"L &1!,O%X*?W))79U$KGM#V?_?5WT&BC0T7;?R30&B7J-DKO M'[S@-= ,MDPJ9#O;1[9I;KJ*=C? ::0[0ZLJT7]D653T-*3VY4-;)T7=3JJJ MX^ +.ZKX9V#KCN+=-_8.27[G*VQHQ\U=K8]\AG, MT%*WC6+KZ@7!A"O%5]7')4MG3)0" M^'[.N7J[*#O8OI0:_ ]02P,$% @ 735G5ENY!&Z8! W@X !@ !X M;"]W;W)K>W'/LZX_.@8N?]=NR\6&)J&\Y5O*X,V*BR14T!3KMMP*&B[3H"1N$\-PVDD8 ML4:OD_8]BEZ'[U0<,?HHD-PE22C>!C3FAVX#-]X[GJ+U1NF.=J^S#==T1M7+ M]E% JUVP+*.$,AEQA@1==1M]?!=@H@-2Q(^('N31,])2YIS_U(WQLMLP=$8T MI@NE*4+XV],AC6/-!'G\RDD;Q3=UX/'S._NW5#R(F8>2#GG\9[14FV[#:Z E M786[6#WQPW>:"[(UWX+',OU%AQQK--!B)Q5/\F#(((E8]A^^YD8QW!#TAH-+#IA]3,-!KD1TR/^TP) M>!M!G.H-IY/9]'X<])]' >I/ C289OID)%H>H4XBLTY F4^D;7X)ZB,5OPA**_^G.I!%33 MWW7N9^Q6/;M>8N[D-ES0;@.()15[VNC]_AMVC#_JG/M*LN"+R$YX_JGL* *P[;O.5X!.U%@ M%PKLB_-BJC94H,7)A+B.N93-7-A=G3+[*V?#5Y(%7T1VXJ53>.E,KB+51/05MF%)]8NK:]+R3:/9 M0E>N92!8!J$+MV",FW5#D*7B'$V'&^S:+BY-FV$-SB6F[Y5F5Q5F&KYAUD\N MMS#$O6C("X,#11S]0Y=H#0<)!+OUDHIH'^H=6\*S!+M@75JF:G_M +MZB]@: MA1(M0KE!*SA.;03N.59 M1DO_8Y]D$\ATW#IKO(HD!T)*SM2 '-LMF5,%W9@NL>L-\@N#_(L&_>>B5*?) MKRD(V[..! EH5+PJHPXF+WS&J+C8]#DW%1VNG6>UY-3G/BOF][I;(= MUL"P2WRS7-YU.,\U+.>,GJ-#(+ZHYYY*>5<:JDP5"I42T7RGPGE,D>*(<>AG M2O XUC4>,45A#5:UZG%5O5O17@41N[R[!G4HTW#/Z"8?NLG_'L>*XM&L/X## MEMARD6X"M5))95]W/!\;9;%5&(;Q*\_NH [G6:[IEP2WCP[^"17K] (%JR[? M,96=D8O>XI+63Z\FI?Z!OKRE%XH/FNSF]Q"*=<0DBND**(U;%Y(2V64J:RB^ M3:\7J M=\=I P 4 D !@ !X;"]W;W)KR*)8Q3Y"H6'"0N>]; N?$ZQCXW^!KC5NV,P42R M$.*'F4S"GM4P#F&"@38,C%X;'&&2&")RXV?):55;&N#N^(7]-H^=8EDPA2.1 M_!^'.NI95Q:$N&3K1-^+[6N6]XY[AP)XA9P9B'&.X3V!1J%:_[$N_0/<,W(;KUC@T>C_,^=KOL'G:Z:1#J$&L8212.GD M1^9(;A F/! IPK?!0FE)I^M[G?H%>ZN>W52<&Y6Q 'L6$2N4&[3Z__[C=!K_ MU2GWD63>!Y'MJ=JJ5&T=8^]30:%RP>GX2H MPAZE!B?]RB2!K.R61D]!Y5)")I0^EU0W97&*LX25K3#6SWNBEAQUHG9>98=S M]4K4&B/GVCW(L]=&S<[E09;9.[TF1;G*>S9EA%AS793A:K6Z%@SR;GBP/J3K M0M'=_] 4=XT[)E#E3'KX^&P7*QD+LH/:BT+^'*O="X,/.J'8;G64BPKI3P;4HS#82[2 M8C ZJ=Y=Z]&)VI@L+>2U1N4FSX5^/I.9>CH=D,'+BYOT867LB^'H9"T>Y%R: M+^MK#4_#G95EFLNB3%6!M+P_'8S)\815"I7$WZE\*E_=(^O*G5)?[<-L>3K M%I',Y,)8$P)^'N5$9IFU!#B^;8T.=F-:Q=?W+];_K)P'9^Y$*2D+:2H,U>U/%IM(&;]+"3N/<:/B: M@IX93:XNYU<7L_/Q[?03J\]GL$A[.QA?CR\D4S3]-I[=S=(2^S,_1 M[P=_H .4%NAVI3:E*);ER= #&MLN-@.>58/23N&/)>+#XB10T0QI1[UR?O5 MR5OU(3B_BP#=18!6]EA7!+[5"@C%R4[J#L9@%2>AWC>],9N]J1]@ MN ,8]@*\UG(MTB62WX$J(+ ^@*$S,@]#%K7P>:1($G0LC6@'+^J%=V56$J9^ MHS6$$0F8>O_JC9S!PSCFI 71(Q4Q'ODAQCN(P2 DM"NIDX9V"']7F7,Q&Y_-+F:WLZF_UB&] M]/6CQ<[/LO;6Z8;*2#^7C1<+M8'R!JW%LZTCO Z[-,5(2$-G:CQR 0_BKL73 M$!KI9S0 J3=RB;)4W*59:E(_YQ*7JVC,&6G3A4^.$])5DI&&UJKAQ/0AYWH6WHC?3SVX4J'HZ,U#DT=7?^'.RR%*$D#@,GK;F"'9-. M&R:C_4Q69[0]0:0N4_& ,]8N!#UR+*1)P#M0-H1&^PFMGO)]*%V.HBSDG+?) MS".8\(1WD1E]U<'UMW!3J%O,L[]U^[F]V__1O-&&!NF>]DWEN2I0:=3B*[#V M ?Z ,8'XE]()R'&A[C^^P@/AS@)#B/*JT*/8(S*E="V M;=J8$JJ695H\ ('9&@ :;)G?25T#?VG4*SWO)[B"H;6L#F2R9^\LN+P;MO.6 M1Z9KES6\3/MY>;R$!C%5!2QBV],P"VK# MS[2_+[R11L K*,*%+F R_%O-;?D(3RAKMS4>N2Z #9?2?BZUIV:0LJZ%3?^_ ME2B%1K8TMEOP(G79TIEP5X0F%*BWHPZG#:/2O8RZR3>9,!!.5?>+*H<=N;+' MCX^R.C'P@G:I\RB, NC*VM ]@D&(X[BCPZ$-R=+WD.QT/CY#$Z772HOJM%-6 M&NR?M:MH]L=3.9I#5D0^:^$,$)G1].EX_&+6N M#ICOE#$JKVY74BREM@+P_5XI\_)@SZQW_Z,8_0=02P,$% @ 735G5J?V ME0_2 @ 8P< !@ !X;"]W;W)K6&G.,IA*HE9I2N6?(7"QZ5NN]?3@FBT3 M;1[802^G2YB!OLVG$F=V[1*S%#+%1$8D+/K6P#T)?1-?!/QDL%%;8V(RF0OQ M8";G<=]R#!!PB+1QH/BSAA X-T:(\;ORM.J_-,+M\9/[:9$[YC*G"D+!?[%8 M)WWKNT5B6- 5U]=B!\5M"M!NTBT)"O2&E%-@YX4&R)--+J905&;0HW9L,RLXDQ+?,M0 MIX/P:C*[NC@?#6[&(S*8C$AX=3D\G^!D.+@83,(QF9V-QSE$C*=@&81 MY??D&[F=C=X M7H,\_+CZ;4BV].\W>YDB>J)Q&T+?PS"F0:[""KU]"<2D5RP,Z5X X^:((O_8^W ML)R6XSR'?R]J![Y;PW<_ 4]7.A&2_86XH"^(52-RZ>IOP?A.]7F&_9'('72_ M1O<_@5ZR$KPHE,8^P++E>RGX36#'G2.O^RR#EX'N"W9[JP6:Z^>2RB7+%.&P M0)73.L(RR+*EEQ,M\J(KSH7&'EL,$[P%09H ?+\00C]-3*.M[]7@'U!+ P04 M " !=-6=6[+5.(L@* !S:0 & 'AL+W=O7% MYK./Y>5%\5"OLCS]6&K5PWJ=E'^\2U?%TYL!&7S[X%-V>ULLC6:5YE1:Z5Z?+-X"UY'1M&4V%3XA]9^E0=O-::KGPIBJ_- MFW#Q9J W+4I7Z;QN$ G[\YA.TM6J(;%V_+:##O8QFXJ'K[_1O4WG66>^)%4Z M*5;_S!;UW9N!,] 6Z3)Y6-6?BJ<@W77(:GCS8E5M_M>>=F7U@39_J.IBO:O, M6K#.\NW?Y/?=0!Q4(,:1"G17@7(5K&,1C%T%X]0(YJZ"R56@XR,5K%T%BX_@ M'*E@[RK8IT88[RJ,N0KC8Q6<706'JV 7%V7QI)5-><9K7FSR=%.?95:6-Y*ZKDOV;<;JU9>3#U?7 M'WX-IV]O9E/M[=54FWQX_RZ\8F^N;]AG[V=7-]?:!T^;_?US>/,O;:A]OIYJ M+U^<:2^T+-=N[HJ'*LD7U<6H9HUID*/Y+O"[;6!Z)/!-427//Q%;_T6F;B1LNH79&UAS[/!X MJ5^,'@^UB@SG(6$^$A8@82$2%B%A,0C6T9&QUY'14T>G:&?+M XRE-H.H;K1 MS=.)6&YHC VS6VHJEN+S_=D2WK,E?+&$H5N.;=O=)A$V1L!D2YB%A/A(6 M(&$A$A8A83$(UI&?M9>?I=RO7J4UD]N\6*@B)W4MO>I;2M3>YI5=9E]>6B. MZBNM+K2\NRXHGG(VN$^4A8@(2%2%AT M4@+%H) =<8SWXA@KQ;%=ML\[R_:7*[9N/U-,!V-1\F,RYF<#9>"^ND#"9DB8 MAX3Y2%B A(6R;6Y0;F$0B:6&Q.3S'=2N3KX[^WQWE/G>.6VF[\(?;1-@UMO392MZ)O\2-@,"?.0,/^4@0V0$4,D+$+" M8A"LHQ%WKQ%7J9'WZ?K+P7+[7+LID[Q:LH^:HZ>7R[)8G^T4=*ZQA8-,)*ZX M(S H<1S^X$G9DKXZ0<)F2)B'A/FRL26N:[N<5)!!0R0LDO2 N(0[@(A!(3L: M('KKR.E*%A!:3Z4%D!I(90606DQ MBM85U('%3?H(ZB01$?&HTS+-L5":+QU?BQ"=GTV044,H+9+TP;#XI4V,BME-\]:K)DHO[@^R%XAH*0[MQA3E M10+UFZ&T&93F06D^E!9 ::%TVYNVPQL-LG)$MVP^_?\,XYFTSC-16\\ MX&( M'J)-Q?4OU(2&TF90F@>E^2>-;@"-&4)I$906HVA=O;1F-%&[T0CG81>B+>)+BE"7$IL:_"X: MZA%+P@Y-6W<<_BX#24%3=UUA\?IG.,"T=8"I_A?Z"A1J"$-I4RAM!J5Y4)H/ MI0506@BE15!:C*)UI=AZQU3M':M]!2JQ4:FC"V=5U4%ZBP9)FT%IGF1$B.T8 MO!/@2\I9EFGP"V!HXT(H+9)TP:3\77(Q*F8W?UN+FJIO__U^PX"*=]<.#9/R M!_+J^+U3&^HS0VD>E.9#:0&4%D)IT6F)%*."=H72&LA4;2!_EV% 1<]P2"S' MY"]/GZB#]U8)U%B&TCPHS8?2 B@ME&]\T^$GL4A6T+#XM4F,:EU7 *VU3-76 M,L RH*(U*%G:JMO16PM0BQE*\Z T_Z31#: Q0R@M@M)B%*VKE]9AIFJ'&6$9 M4)F92/7F'R\:J.4,IX0 :-X32(B@M1M&ZPFF]:?K<;=&/V2+- M%Y6V2.MC8:<6R68WO%R&- 3(O\GSW*-:G MK+[3V)+],/63?*&5S9125=DRFV\_9)A&20?/)Q2E=&AQ2T6#="TG4-J42FY> MUG7#- @1CG%FT- >E.9#:0&4%D)I$906HVA=O;8F.%6;X/\/O4HU^JPY/5'W MI+?P1$_=%O0F-HHXIFN,"3];0>_3EH0=-G%-X?8^:-P02HN@M!A%ZSX\LK7T M#?5-W<^>3WMN#E+S^\Y!4-K4$&_KMG63F.($!(WK06D^E!9 :2&4%D%I,8K6 M55;KT!MJA_Z[SE0;XHW6A!+A(2'JT+UE O7M#8G3+G;!@P;UH;0 2@NAM A* MBU&TKD;:JP ,]54 IU_12Z5J$1U(WB?E;997VBI=,KS^:LR:4VY_X6?[IB[N-S_,\J6HZV*]>7F7)HNT M; JP[Y=%47][T_S6R_YWEB[_!U!+ P04 " !=-6=6_5O#*^<" #S!P M& 'AL+W=OLVEII(R^\ M=.L@$A"J(8V7%;IIJOK!) >)FL34-M#^^YV3D$$'J)/Z)?;9]SR^YV+?-3=< M/,@04<%3$J>R981*+:],4_HA)DQ6^!)3VIESD3!%IEB8:0&[LZW[->9=M(R8Q*[//X5!2IL&9\-"'#.5K&Z MX9MO6.C) O1Y++,O; I?RP!_)15/"C!%D$1I/K*G(@\[ +MQ!. 4 .!^VA!]W1H-,?DC&9TMJ@-YQ.8'0-O1^W_>EON!LS@:D*444^ MB^_A$]Q./#@_NX SB%*8AGPE61K(IJDH.'V$Z1>!=/) G".!V X,.#%+Z*4! M!OL$)JDJI3E;:1WG)*.'?@6J]D=P+,0QP$*^0%ZCZM(/<-=>R:5H(=T?RC[.7OM,+LN+E=R MR7QL&50])(HU&N[[=W;#^GHHN7:_2/U[OINA?IUK=V??Q#A!]:=1+ISU% M]5)1_:0B+UI' =(3!*JJ)"2A0>KK N?T0 ,>QTQ(6))J&=);/B@P/^%R)RZK M8M=?"#P9QO_>@3JFP@ &(H 9 >&PO=V]R:W-H M965T"I8NZT;H8$\\+Q^LT M+T?3R_JS!S&]Y-NJR$OV()#I>+UA!7^Y&N'1VP??\^=5I3\83R\WZ3.; ML^J/S8-0[\;[*(M\S4J9\Q()MKP:7>.+Q/=T@UKQWYR]R(/72%MYXOR'?G.[ MN!IY^HI8P;)*ATC5GQV;L:+0D=1U_-4&'>U_4S<\?/T6_4MM7IEY2B6;\>+/ M?%&MKD;Q""W8,MT6U7?^\CMK#04Z7L8+6?^/7EJM-T+95E9\W3965[#.R^9O M^K/MB(,&.!QH0-H&Q&S@#S2@;0/ZT09^V\"O>Z:Q4O=#DE;I]%+P%R2T6D73 M+^K.K%LK^WFIQWU>"?5MKMI5T]G]W?S^ZVUR_?@Y0==W"9K=?[NYO5-OYH_J MLV^?[Q[GZ/X+FEW/?T=?OM[_.4?GZ(]Y@DY^.T6_H;Q$CRN^E6FYD)?C2EV0 M#CO.VA^_:7Z<#/PX)N@;+ZN51)_+!5OT XR5D[T=\F;GAC@C)BS[A"@^0\0C M!+B@V<>;8Z!Y\O'FGL,-W0\.K>/1H<%)Y0HMU=*4:"GX&JG5+M(J+Y^;Y9)7 M.9,74+^[ MTW=%G]ZI-)J7&5\SJ,^:MD'=5F?+W920V,/TET?[KL^=$Z>A*F@69[JW>H,I6LNJOSOM-F[R@7B MU8H)E*\W:2[T^*!LE8IG!B;%YH?"@[D1!I,H-B::K8J">&+.,T 5AKX/3[-H M[S5R>OW*I40GSXH:3I'R)U,UP_A2SR8UAZK7,[0I4F51^V9_;?.--@P9C:R+ M(]0P,+,UY[X?&2X!$:61![N,]RYCI\N'EEXDJZJ"U8.F+4-&8OOW)YB&AA5 MA3'QC(%-;-F DR,1I9%[Q[,>YII\%4BE (:%L)B;[J5^#V6YB700FD] W M'-FJD(3FX B_Z!O>I:PUW&)]\YZ6S(AE*.WM);^! '#LSN=>-A<)S-(%Q\N ME,8+),.^1_& G0/,PNZ]AY?G=4K.RXJI[%2Y!J>-U1N=241,2[;*,^VX)'TG MI'-"W%"R2DN5V#3Z'6PI4JTB66>$(D^?\F)X>VG#'VE_.6JTY%C1^EW;X1YV MXL_T4:0+IG=UEN_2IX+),[V5@YU(@>F,?6N* +(PB@-KGM@Z$D5T8!O!'7!A M-W'=ECN55KG(759\8,FI4ZN974$=CJAMQA92/S[8>/IF.O;"3KZ87F<9WVKR MVJ2O>G1 ,P&0CN)H8B960(>Q'WC$]&+K(B\82JX=RV WS-S7M/+>\@4-VL!Q MCF,_PJ9!6Z=VPMC$%T"FTJT7#!CL :[">;NHP0,>@2X!?LT, D-T@5>1,T- M$M!1;X+CH4VE Q@<_]+Y,%?+37X$\;&3C'XY!Q\S6G*L:/T^[5@*NV'J82L4 MNDNUP?T3XL4V#)W['O'-4R2DHT$06SP"QL-TX!Q).KPB;KQZ$#QC;-%.G'], M^,3F)3_V3?@"5 'Q3*^0*@@'4@'IR(NXR>LZ4P9DKH&XV82TT3HW-!NM67=J MC=GDI$!PXA'+&R#TXS@PS7V8Q$A'8L2)(UV2V\J:D\'U#YHC8!+WB3E-(2$- M2&BY@W1^$-$!BQT1D5^K@"WS,BVS#V0X*UN_3#LJ(&\KZ2_^) M"Q5!]:C41WUU-EFC3!V[\@HMTTR#P"O8O39C*6;3_\P99 M-7G-*^AX[5B-N M5G-Y%&S'BYV>0X;1KI #6K91+/:".#;)!]"%$34]VZ(ASQW4$3?4?6<*3)O: MH,IPQ_$,T%X0!_[$,FT+K6&&R'$RY+HC/>(FO8?&L[:\>"L9=%EBR9A\QR)4 M@(H\\_0!R"R#+DG?74=XY)T:%> N4QN90EI1UWA 2U A*K"7IJL0U5H"(OD# M!RG2(19Y![$.3.6:S@=N'A$ ?D(O,,]2@,SRX9+T;\UT!$7?*5#ELA+YT[8& MB[KJSDLU-)7@1:&GWK[0L^*%&BW0(07*3=0GYDB!LLB\-9% ,I],H@&G'4%1 M-T'-#B><=JKON*KSXT,J]# J\%"^R_9&[DM>K9!:;&BNTM'P'*407Q%H!P&4 MYO Z)7W3'5Q1-UP]BK24:L6U6\A)Q4_[O@<+&M2&(1*;)>T9H#HG. XH-LU! M;*64\="X'MQ==)>;P$/R20N3IR!K@7[MXE$4!)9?H!1%" [,RD$""2D)#^&T M[[<#'^H&G\_+I9JD.NTLN6#YLRZ09W4U$ZF)RNJ-L@9.O6'4':///CMU-E)[ M*N@<*$F%8619ARI7$\\R#LAHC(=F&3CKT0Z!J!N!!CV=H2?VG)>EGLWZG,M$SL%S M'[4IQ5=YR3SU0;*))4L &?;\>*BP2COJH6[J<1AEFG:<%FU.B8A'S&T5D $] MD4"R7D_T'7;D0]VUK?EVLVGNRJ6%P@29%5QNQ=#S#D>M9QTU6G*L:/U^[&"+ MNF'K]@U#W@X'P_N6#4G4#ZW[TH#,6M\?QBV_PRW?C5NW^]N [SMI0QT^?1$' M86 N8D!F.G%*&B?C@X>O%!T\UP^Q253?*V@>7-I_NG]0[KI^/,SX_ 9?),WC M;EV8YNF[;ZE0R4NB@BU52.]3I*Y'- ^T-6\JOJD?\7KB5<77]&ULW5MMG)R;/CM=3MT>N7_-V5??W2=+[1K;JRPG7KM;2[<]68[:NCV5'Z MXKU>KCQ]'XE>91K'_XIM7'MR)*K. M>;..+X.#M6[#__)SU,-#7CB-+YPRWV$CYO*-]/+U2VNVPM)J4*,/+"J_#>9T M2T:Y]A9/-=[SKW^S2]GJ?\J@HK86Y])I)\Q"7%GE5.OYR,JTCT/ M=$\/T)V=BG>F]2LG+MM:U4,"QV RG)[>0>]) MEOP)TWOR ,DGXL*TSC2Z[A51RD_Z>*M;V59:-N(:7RHXIG?B?\[FSENXUO^. MJ2@P\'2< 0JWG]U&5NK5T8;VLC?JZ/7W?YD].WEQAWA/LWA/[Z+^)PS[+>B* MMZ8CNPO=BMGSDZ<3<7E]=@XMVXVQ8<4/W__E;Z>G)R_H 7^5.+!OE'6:)>F;9%A&.KA9Q;707B7E6KUC1FN6,>E]+1 M0F\17S!S1VO<-/"TL>9&U\H)#7MNI/6ML@Y1Z%="UCBV71'B<\9X[JP0X(K(U;0$& MP7RU @.J79*&6S(@E"VLQ!=!RAI)SFK2IFZKIJMI]ZKS'O]/Q.]&M_0%22@[ M)$-)EMZJAI8-V"$[!#9((A2MX&8DMS7=F%1KK\ MA=T)SYIF-R%Q(&AR$M!L;*+ /F%KNDL%G3V"HK5*?A%S@)?Z.WPN/-U9#S$AQ M*JX5E!8$6UBS3JK[K17_(5LLVN62-:% A,"$E,BE&[6$1)!8>])$,/=6(8:2 M&6B[4 /F>P2D&[<,B\C5])?WN79&EU-^&YJN0::[JYTW \ MBEIV%TJC*BF+")8 @@5:@7MR2[O8M6E+Q:&,ACI M+(M!KKZ)T'#3R!!US,ZV1WZL*H)2D?%.,PD$-*--IV#MFJ41$?^\K;I="U^ 9,-O5\DMJAC@_*5 M(D"Z.=XRURY4-NNTYFXKW:D%)Q:!&P(( 1C%COD&&@[/JML,^O^5JDE(K ML<9OS)Y/"GRTUCY4+7I^P>\O%5"JRB]2/,BZUD0-K.@V-'+XZ[9-RHB*>F+" MA:I$W2E6 W3D2!*([38$GJU;Z0UK 87VX_1Z2LT1Q*[AV2T^^1BH7,K#@N!: M@![^,3P'WK,.6:9?'I+J[4P$#CC:)>O]G;0P]VD,['T=SWHEGT?25\3)_1I* MM6(H0!+=!H<@/J;B[Y1M.0P^5VKCB^R5LHKX!FEE$BBRVAAWZGF$@ ?TA$PO ME&B-+P,H8HJ<R\ M[WNUU-1-L?2YR1+<34!5LY/'L]/SXS,0:P@$)HU?7U[0FN $LY^"$X@?"O 6 M7T]P9!(+8.A7%$,"2>ER'MR5&AI4]@[DYJFYD56%CH;S5*T7L#ZB#(:<*UA1 M!9_.:&%0 (=F6@-G:&B[\KR24C3@ P<7K*S\EHH '$:;VD7S.%4TIX33.-(C MKV--Z?16KS5)Z$(2T2K5CSJH;<>&O55J N:X+<5)7(%%7$VJG( MCN?J>YR8)4AI.?ER*FDY1&I&#*.E'(P/*OF4X%;XYNF(]=^04T4+B#?8I/># M"],L4.;&VM+P:+PQ'0._CU@YC?*Q'#JT48_-8D'.T]/Z=OJ!*=$65!",?&*. M2C4I,!B*]^,%M#:A[@S=EI=PVT(-A_23A0'7ST_^FG-8YQ&W;8(5, 7BV%2? M>O1GDB[Y>ZJ\A+?+;7JDG#9!QC!"(9AB-/0K)D))^.MMDK0AU65;Q]1?-;%Q MS=K+J>#T270&O*#T#;L[[+*B-C7Q/1"&O%JAXN^BQ_%2UQMPN'J%)C05B,@2 M!>A4?$0Y3,Y0U(%2S=GST!RC8(?NO>7(,R/=5_"(C ZPAJ'-[.$&FJ)51#6\ M"3U3:$?B/HY(P6,,S2BP_-GT1*QUT]"^O0;&ZL1@HZ)]E("%U(U+'F0@5S+T M/\OY\?;3S$QK!#4O9.AMR\EN=VCW0R*SJ'$J1#+T=:)P+[.7,.)\BO0<.:'* M8+E&0MTD4>[SPDRG"":YA+=PJ8(2M@I='OZ_07N$DZ.1\<*2T&B[)PIS$URP"8@1*,SE4L(=*\Q"&6-I2%5P\JVT==DH MR !I& QHM=4VC*K-*T0"NYL=I2&I>=6NGS,O<+8@Y;4IUC,#MZUH1&&1:4; M74LXLP("585"4Z%AZYRG$+\$QJ*9$D#Z=9QT'5V>_^/H4;+][[%+&3/^B.W+ MT=B>W2M\!O+K.2I3VD5XF U6)+:"8FU126OXL_AN-CT5\QA;-!\-PNV385UT M+A02Q^._2BD G"TEI_(HKO@0WVV0)"4U,N*SY2*\ S _:N59I<1"V76(63 M:^Z=1EN!V TE.>>[Q(R^+P Y\Z/?E$N&88_59\13&/Q90E8[$8K=9_0&G56I M,R/+."^L=I]HVJ@=.W1$OE!4--9"5KFQ&\ (C1P=)S=W&+W?AP_RT$SXVSW=LV*!U6'J^Z .[GWG:.!'E#Y^LK 5 M@\4% LFS#^KV1J912EH .Q6O<4*6J:D'-C4N= 90 ?5U*DPGD"VLDM$G@7"1 MM(@F97*SUE48R!C2.@%_A%]P';]#:[32C4KE-M0P]ATNW4A]R-S:1P]$$NKZ MO*9N9-.1$0QW5-3^B,)J\+2U4H7?^.#!,F2;LCG?,@_0(J1BKY&;#93$HY-& M;H-9K5IV,8E."=HR1VGD",F+F6/*'%&15O7-!"A;\YEA,X1[]M=#]2L47'1E M"@H)^2^]*L*[WYWVE9B&RLHCO:'4J0D;)]6.W@L:!V2 2!^R\.,]++3*IPA' M\YIJ O2[-*;>:BIG36,B7@VHZY8F0N*5 8K15BB0\"1= J#(9=_+2D'CJ[B" M-Q.TV]9T0"0M:@U#G;E*^\?F)Y!6=3@^*(H?W'0AM17D-7C)AUS&-HZIJF1! M\)@N?L-:@Q>MNTB(*V)P!B 2%WK @5J_>]Y;YX!64A:N6**Y2HH)LT$8:;B@E$E/QYS;NIFXE0/H6*LBRUI M2I3[;I+Z4RAQT34+LM&A. N2SL M:H@V\OAB=-1"-22-%<()1HR( A?Q4*2F^D-4^L., N\7JA_=AI-8+UAHB^*T MWM).H;3LJX>DR2 D+,S'[CQ#JGF(=*>(I(5XT$?IAZO&XA;N#TVG4$0!MPA^NP/&3R,(-&W Z?PN+PRI)$*_8@B_ M!P_9-X9PH].Z7E$'$D/9*M*3M?(K4W.\.IJ1]KJ>L+Y0GRL4(O+;SK)O\(DX/(KN<9@N# XR M:44_?D@OL^<.O78L3*;BC',:N&UV_)Q'=1M<)*>,A&\W278>PCRA33KE).(/E*+QO=)G]<'I8!X.B M78SY%\6Q5[@S43ZCH+!J12=4B*H?_A.8[%&$P[ETW(75A[+NZ[2H]8-3Y):@ MU6#R?)MP2E19=P6QKU%=3W#_J+2/K)A&;HU6]U,WQ9%+%R!I2'SP?/SV4/U# MZ4_?W$Z']#ECDOAPLG\3YUOI]ZM8("O=J8_J[JO\R;J%MYRM_#G<]?_IS/EVOFOYU5WV.%/Y*8_[TYWN]%H MD[MO]B2#&!/B) E!THCZ03KDG!WO]_*D]@L#A[&"_0U,TDPGS)1Y5T1$JS5E)GC!LSZ<+/=VX>3F) M&;_+0F0F@1BQ]T@MOMKV^\NP[W0T9GRN,B_1KT30/KA>362A#TU5W:>EZ*I]B M]$/M/:'R$8DNS[]5764Y,+@=-(=L?'@$,Q@? MCE^8*?O/_KQJ[U:M5;?[^ >.)O=R=1P;NE3V/L0;93PS&>PZ(8V6YT5?MN^@ M"PR2@<"A6RQ[;A^W_:J*%!4U2?R:C6YC'NDS41C'R?KW+FSH^GEY**[8487A M1DM'7C2ZHX,>/I\HWTK3&1Y1IXDO'07$@_7;=\/WZT%,3:,E(NSDPE6L2-&Y M;KW)OS<(,U/2"^7R+[35R$"6;V<^=&@]*>[]%W/I=!_P,..RO_H3;C+3#G&, M1BH?G<1.TO$2G8UTX2I/E2Z^^D/C6YGS43D9_D)%]5#XZ5TKP=0=I?T[_\'$Y,!%]7=JZ\9'=]>='_NHN#@? R)<=\+C Y=##P MY0:&ULU3W[;]M&D_\*X:\H$D!6+#O-HTD#.&Z2"Y V0=Q^Q>%P/ZS( ME;0)1:J[I&WUK[]Y[8NB9#N]QW= &\L4=W=F=MXSNWYYW=JO;J5U5]RLZ\;] M=+3JNLV/CQZYO62GGVRKUZV?5>;1G^RA>O7:V6WKW7=7O]T-#OR#SZ;Y:K#!X]>O=RHI;[4 MW>^;3Q9^>Q1FJC\]F/KQ_C^_3"/XV^=LGG C&9M^U7_.5] M]=/1"0*D:UUV.(."'U?Z0MJGHV='1:47JJ^[S^WUOVG!YP>3.*=E%[EHP[6PU&/2IG[ M-<]]NF?NV6GQ2]MT*U>\:2I=Y1,\ D #M*<>VM>G!V?\69?3XFPV*4Y/3D\/ MS'<6L#^C^<[VS#>"9O$?YW/76>"6_QS#F.=[/#X?2M"/;J-*_=,1B(C3]DH? MO?K^'[,G)R\.0/LX0/OXT.Q_]I$(UN1;\+2)L(R5(WVJJZWN+W>M/QV [ ^;TQ^!NM0!"? MK[4%[(H'".'IR8O?IY?3XMWY^2?Z??;B(0$),]=]I0N8$^3M2VM-MSUNKQ%L MU\^=J8RR2(WV2MOB>F7*%:TFR!?Z1MO2.'BA!!&P(-U(#19@.D5/-: M3PI V70TCRV^M 9(?@6/>F"> C3NR,0K!23RD]9(A46@(@S7,++#R8RC84 B MVM3HL_$(J-;3M-.K&PJ+K.E@,_MMHBU:"20][!E]W+:A( HTET;D:0S,V;0=@@=;;6Y' M9RIL=2\V N6.FI^(H)S3B%]MU-S41.\)O "4[H'..)>^ 2OGF#_*=*%LK_%- MG*]IFQ1B8%6<4AB^0":Q;F4VA5LIQI"404. ([J#\1'/(7('I;%>^;*UB":9-^EED! M-.2WOJ%= QPUCU[S:,(#!,F0B%F-(HG8"'W7. 72KAN1?QD'/_VJA(&JOH!Y M@TFT A8'WC$MPS V!U-2%N")M$Y6 !IIY*NZ=4R?RER92C<5T%Z9BBDK*)D4 M>Y@5& %L/0#", #E$4>$Q#3X&],8UB9!..Y6JCD&+MNT%@7+ *#&XFP3T1FP MI9-BWG?$Y+@?B&373K*=11@=X*^(@RM=@D>%_ >2\V??X@@0VZ_@E($ EZP> M5 $&Q3"/KD (0265- ](\A=@=1@#OII5I!J1$/#J?!NHY:;%>Z8?K(;J']=: M .S%E:I[8E/D?*":)7B!H48QGL":"=9, \44@+'[X ^S:@ *")WHRJY0LW4;07QJB]%/P2< M86D#SSR2,-,OK=LKJT1'A9,0=OPB,!X AM:J@B? Y)U7]625VWEMEDP$@%C( M3\05M$9V@A@@$AX<[&1IX+N[4#;) J2 M90C7]*IF#/8>D2S:'KQ\-*'P/UC.+B@=-(S5L:I;$!P(*FKQ/TIZ@>9%?=.! M?+,F&5D"M%"F [Q;0;H%UHT,5Y.O(OR)IH2D"%];+$ <]3$X_'6RXTPQE[)J M)A:W,?Y'<$J"JH(@QS!9R:ZHI=5B4\G_"IS$J]([MVT2J)XF. )(.>\*L ^ M6OA.^[PP%K8&S;ESXX(2Q5_)4&W2Q'\P>)CRR'RWX_.#T(?F4XAX" M4Z^95]&3LN24LWTB)Z$'97$'-A*HIL6E=Y(YV@"_PLLM&+RVOJ(=A2=UNXF^ M#GO\I&=TLP2PM&4%0I8[:%N7JMM]BHJBDTS6 378(HH>$%RS!DMZ[@I<'@;@ M"W,(4\!P9RIGQ+Z!N]!EUC8HHC+G_*@$T'Z1;E26>&%<0Q$\7AMUVXTX69Z7 MW% E%?T&,$TU'PBV=^(I1O+'P(3= M!%1U&)5XR@A4Q*[A,^Y0V))L7.:]\,2(\8*#LU_!U2QF9Y-"8F&(]VTO/MQ' M$LD/,6:2^)@05E5%A"*_GG.#Y T!]V*$(%!0*IJVC4V_EZ#!#I.!HRXX_:! MV@)5M>7XFYB#(PATA!*Y42[GJ\'>P<0:U MK:13"?BW:@0-FEDBRPHEF0.>K MRETRDG 9JJZ4J4F/;A 7Y!WR!"M#OG#0$A1F83BM&W8C5.8>2" ,+Z+> CE& M+7_N,L)$-J]:6!V925""N&?+5AOL-[(6LCYND"ZV6EG*K%17K%O(DL!#-Z(6 M<%OSS0@K!>-)!(BVB)U.\=]&L!!O-FZ8T'IO] =S69H9"%FVHB;;.09/.+&* M_!7I03)5LY^@T+V!I8\)\ZIGE_T%>Q\LC-V>O1S;P;B_6>J (0/4&;(4+'+& M (L>W2_ 7MUHS(O5-8=M[%L$^<59/^LUQDODJ[U#'F\$__,> G++.:.4 4N> MS5%$ ,Q==+0(SK70^ $_@S/'+(B@-9(8)X5.+*[8*\D""8N .-&W'!P%;6VU MVT@*"5:CK8C0T28[/80CYBIB4@3U+82#';N>WM7Y%1X@2,[;X/T9H"3O _!_ MW$A0YH)'%8-33C<))U(Z4%1>DARZ?<'7K+V*2TR\NP+SD363JHO^]7[R;%$% M.V!&"!MPWI\3?^$-\U/^0NI0! GX[NS)]*18HPU &?WN[/GTJ?^51GUW]GCZ M+#SQTK4E2=>8DH>%2[V>@PC[I#K].Z/1\.%DDB!18^AOM6=XHJ7GZ4!H$7OR MFRXY3)IXJ92T#X8 F&$GPLADW[[%GLT\:XI)]>KGKIX8$S6@PQ+RI6\2$5GT M]4(\@F!.*,OI4XBZ[+OL6^_>38L+Y7@CZ0-FYL#U)63"-R5^T,DW:08Z38H" M[7HFQ*8'_E"X%9P9;T*N#/86=A M;UE<2'2AYH_C,I_#![\AH4A R:HP$SLJ7ILI!TZ+U]VNWVQ:V]'O: =@#W"W MW@CX0UCW9@NGE%)M$%+MLL\XA');(5D*I$/&61#+42YT],BG9@I54EW(IS^\Q'Q3:7%]Y2H9+T:H-DJKU*1W)A^%DB:Y X MS.6%?"&JE;(J]-K3^[3.VVV" 3@;L5AP>C)&1@62E1S"14'U%9/0!,-$'ZE6 MDG(55&D M.'84GE=UL^(:WOAN=C:;SG(E.GM\.GT$/*B/R1L%<1A1JUEG=*::LE%R9V4_:^9:&(WV9D)*S 25HVQN6 M4"74SNE.)&,C9:^$"[#$+_EJW&\=A*2=@\[6KM3B3$KP$=$!K889.;:*E5E M\$'OSG5WC9X !]B,4QP5JBTC\B%$HRA1.?#:-R+C.*G1,CX,-;[-"'4Z 8:8X_')D#?.GDZ?QR>W<%AN3*?%)XOY^@[,ZJ?: MUP30-+"UBM]NPK?:?SLAJL!N"[-C(B[1E"V6Z#@=+5:$O=F8[B=078_N!17' M0.1A;DH.KFS;+U?\P'EJ?=:8\!=:8EFJ(?U/YAM(2@7+O MI4$..6>,PONP)ALQ%SAM$"3GM,$G2-Z[4&:0,LF#0I_?\JB7J,!] #S$R$2, M:L+(1(P\)$W3DID)PIT6C#E/L MZ.456F*@0>I)RM><\*T4D0OG7[18>"Y H=@.,]?W)F&>7N7"# /FD^;$(UE= MBF-S8",T:O"PAR4H:B;DD8TT\#*!%PA$H;HGTG[\\\ASI2IQU_+%W(^^:\%- MBC>_O#DOOE?KS8OB_-/Y!6'^3CE.3K=UHD*\V7QW\29:S?>,H M24DSA2[-O@,WH5(W';OQOCM@M-YO2%.-\A8;M1W.2HE-53-BB!C-9YPFY'Z? M5;0B&+XZLA\(]EYRBH?<0P(8,TN63MD%!+.LH(/+O@[$'>!G.'L2NB7^]T _ M1, ]<-\^==;XP1[+FIMW?$YW1Y8(JWQFXLL2[!UF3C#&D91N2I &&1)RSL:] "BKTC*4S8Y]5V@L(I_0&H/!F^\6C M3AK.XOV;4L(M3FMTP: R2M.L@CQ-N#Y %*GG"[DW<^L/9'L$2QJ!%SX+RQN386FG+8]?7J\6L6,J8 M2_ UMBU[W* [.)#_&@Z2U*\/ _L_[3/="8C_)XY4H/,W(70+H1&5Y.T4JV_R MGF* _"_K,^4MH;>SZCY/:K]G) E)++0U?KG$45*=>$IY2!X\EUV9,JP@;U, M,5\IT975M=$++N+9=JOJ;NLKY9QU.^@18&82TW$JYFJ2ALZL25DFE_Y6=B.P M#BZ]XF19.)?>J'7LKL'N5^'M?->H4R7$H%FH30^R4'MRD %&;2@6+D9W/P%R M;A7F@;ZM-J78ROE$URVV+<\F?6B;I:2.)%_$_0XDPO=--?U\&]-P&[ZAC@-O MYV)>*9 #A#<4CZCY!E-,*[.!Y_%M7:Z:MFZ7S BN7737BC1:296TV*^7RKY21T5=R_D RXEE.*XD$1(,/=) C'8@Z?HXNNF\) MHDQ$,T?1FR0Q-7_VP][MI#Q#')LK MJ\3A)86JZ11#ASTK'J#[J,@IO&'-%:ELMZL-JO!E5E;NT%%O,.:$:+<5<]G& MTT5LC_H5^E7U8A Z(!E-'&?3UFIJ"=IOX-O=P&.Y\ 3-, #5^W*/;4BJ$WH:F2 M?L"_RQ8I)[WF?G76)9X3J:C/)H7J27*408-&HQH:9C9VCM214A6"HE9*>3PK MCI+73X'("BP@T"O,RTU"A :#1J>B:M(Q0J/T= &%(63N8/M\7-%RK#HIQ+') MP6 @D%J3G=V4+FKL'3/@^@WZ#+'DU\^_B$-/ZH];%'"'8I+*6E%,UR?UU!AU(*>XM,4Z@6D;% 56 M?=8M^ -M4&\>'3[&M(M0K L[$'S*) : ('9:&W^RBUOS1'VEMB]X*S)/.CE0 M),13B;8KW+7:I"/'^Z"$K@G:Q M "/(RI!T4:[Q+5!I;2CB_0Z MEB";P!R3_7#OFHX\& XQ.U:WP]J>I4L+A#OFSJAR.\K3HW9G*Z=6 5 06BN612N/TK/2XP MY%,^SK#CM83^L=JU.W!-BX^[ C%$X/]2*-)SX3X7M$.GY/0&L2TB@/8O5UJ) MJG)ZQ]DBKYQ:7!;DI>.1 UE/>OD+OD9DX 6RWR1BJ[W@NJ37?^C+P8SOO?;U M_:$/6%GQV7Q29E0 F=R?_*&1=-A'^@>UL(.!N: &D=@$&#J\/0,!ZOXHRC4/ M\IURRI^?\$Y7.)"2X$4#1 K?[/4W6Z%C5Z,4LARV/1K8 M,M^"ES00I>V5*K1[-]A4"B(O72_\$ M:M3Z*2_Q %JA=@X9A'VL8"# S0>=/5_'8\[L@TNPE%*-\TZT;*=NX#T G4]Q MOVG:*S/P5_)#\'&<=LF)>']83B8+R;W?Y8TDDS&.I&#H EF,80AF# U_8UK]^AHC0#RU+Y,Q]L M2Z2_-J'Q1FWY7*./BBD#A*B/O97=Q1!"$$S9;KRR\^H%7:(@/#A'.)L3K\AX MV"4CFGM H MM.6-0']#U#67SW89\I-">@6^9ELWRH5N'Q/BF=2GCT^*22Y0OLM'O@ZWF#!A M4%:-U4$!>>(&+DSV9@\SRJEW;X7Q320H*P%DUJZS9MYS&S4&&R'GY XEG4@: M*3M+S\;7OE7?)9=_%,DE,KP9Q@X.8?C&UI_OCCVUOG+5P&M*W:C22R8G0]*V M & O/D'$-1QU0W21A00?3N+ +]Z-;/&D3+A4(J7@L.M@'O*46@[?$GO>&Z<0 M. 4G/I.7N8'?^-(S+#7-88_:/[NP7S4=I,T+@:2[SOD2=Y#F'5POD3<^?2& M ;;4M*4<.\#LT^)=W8)7DZ;Z/[37QRAPE9\^=->]__#;^R!U9GBE"L=EHBY' M0"*UZ^7*Q*[9:?'/D$P,!RZ&ON?BUIJF0U 'X>8!\E/50Y+E/A"E.J,OE(L2 MP*X@Z3Z[V@4SMW_Q-(<_FR;5\.3&%-'^PN;4_YYT"0V$B+T.?PB/K KP'N79 M)3%%Y\_.<>T8FGSIJR57.:E)'!<< 3TGL&_Y'>$H?^(I]!9E"<#Q8H752V4K M=ERXH3VTZXQX!8.<"GB(U+O4KZ780>=]HF'U<4.GOM)I0]B:Z!#PQN(E)#4NW: MJ&Y"R!NLD M&:- +'OQM1W=M^*WG6Y2N',>D?'SG8ZW$*%,G)EIS\#ADYZE( A5V+=Q*"LEOI M>- V?$M,=3A._SLC99%G^5P$1X.$.?(XFF;8YCT.==*=B3S(1X:FSXSM!CSQGQ--LD4"K< MOQ12T3[!&I#T]ZY%3KX-_X.9ET&^93])+G5H+7DKTUWXZ=YXL-^%:M0'2JOX MCI,-WM*XE0,9^R]JH([,.TX]>JGCF,(;G!<%#.GH7]76M;*B#A=RI!:S];RR M.'ECG!FW/+^&#Y:)KA_7@\O1"(I^+Y&*D];=-!D;#!"<[P&(H\ZP9NYUI")IF&.-I0?CE[<$TJ-7^ MI&X60N9JFJM:H=*P(Q6&[P^HO./*9XX&M3"Y3\_?Y.'U:+C2,F89DT0W;.E: M-3PE+,J7TU7A$I;!=8R[A/79ID,$'E3+Z;!SO"WQKELH^0B>W/=YYUM8R1EG MWWKE%X%@+(G@TNO>&.P$0(E(TCBYXG.9:4%AP()J5]'(]7UXC:NW7Q'")G,2 MM"&EZO,:_@(Z1EQQ'";B;W/I< P-)WMY/??"<$VT'5">E%+[48 M -"F4%#!EU23WS&FF:CO1[8@W:>=)H&0 DKN[[H_S#\6_XZR_V9/WSYEZ+#? MHWA ;SD M>3%[/@/ SO8H*2$35? >(+$>\DA<\.G)$_IY]@Q_SB:SDQDA\-N*M!'N"HA1 M#-FQ;:8,Q9X=%49K)(5 O$&&G/Q#):)SBQ>D &E4R#+3W7.*W)G2FGE,+_NT MFPQ1P90&6ZQ 4UFU6;$YGA:[KR:/LHH@W[SG.Q/ <+-V1X,%T@6Z8#MHO]J+ M87DG#+D"^MJJO\#HJ8;"4VD+W3'8H4$TG8I/Z46?D@J12 &ZM>C=4"RX?7 ' MYK]76-LK\<%ZWO$U@I\3%2U_7PKE(9CS?6:_I4;L:9''8N+Q+A MW3!/ID_BG07W4L)XL!S-J#%M/L9!DWMA..-=S&?E$JEH0S;-*YD=P?BJ$!7]GV0[BR#7';W!O+66K5]ZC=>T^)WY(58.LX24^JICS3FVM1-ADCL93"/WN9, =/>^ M$'[D#GB\K=W7J?9 B\P,Z474\7"7)Q%/N?N:+@]6Z;T@U];]\+(SC8GO$G/"FC>F.Y&[!3*?XN+=)$U-'%N M9SKVIQ8>)7\B8ZW!<.$? G$<(/)?RPA/"_^W1L[Y3VS$U_D/E?RB[!+-6:T7 M,/1D^O2'([XMW__2M1OZ@QOSMNO:-7W$6WNTQ1?@^T4+(BR_X +A+["\^B]0 M2P,$% @ 735G5AW&$'B@ @ *@8 !D !X;"]W;W)K&ULK57;;MI $/V5D2/EJ<)@R$4)($'2JGF(A))>'JH^+/: 5[%W MW9UQ'/Z^LVOC$"GAI960O9\0:+PA.)C#\=9]2G],##\9[] M2_ N7M:*\,86/W7&^2RZC"##C:H+?K#-5^S\G'F^U!84GM"TL9,D@K0FMF4' M%@6E-NU;O73?X0!P.?P D'2 ).AN$P65MXK5?.IL \Y'"YL?!*L!+>*T\8?R MR$YVM>!X_H I&BYV<$=48P:+-+6U86VVL'+6R#A%.0.F:MM3) M!]2C!.ZMX9S@L\DP>TL0B\Y>;+(7NTR.,MYB.H#QZ!,DPR0YPC?NS8\#W_@# MOD.SMM"I1H)?BS6QD\OR^SW'+=_D?3Y?0%=4J11GD50(H7O&:'YZ,CH?7A]1 M.^G53HZQ_]M1_2?J;SG"C2TK97:@B-#_@&519;8*9:9E,V4"NY&:[5AURZI> M6:LWK" X?F4^/;E,1A?7)'-#EG*_VC?"15O_ MK^%M%[U7;JL-08$;@0X'%V<1N+8SM1.V5>@&:\O26\(PEV:.S@?(_L9:WD]\ M@O[O8?X74$L#!!0 ( %TU9U;JJW(H900 &P* 9 >&PO=V]R:W-H M965T]^=S68NKZF5;FHZTC@IC6VEQZ>M9JZS)(N@U#:S=#[_,&NETLEZ&?9N['II M>M\H33=6N+YMI=U>4F,VJV21[#9N555[WIBMEYVLZ([\+]V-Q==LM%*HEK13 M1@M+Y2JY6)Q='K%\$/A5T<;MK05'DAGSE3]^+%;)G %10[EG"Q)_]W1%3<.& M .//P68RNF3%_?7.^L<0.V+)I*,KT_RF"E^ODM-$%%3*OO&W9O,##?$._?!AXV%,XG;^@D X*:< ='064U]++]=*: MC; L#6N\"*$&;8!3FI-RYRU.%?3\^EJYW&BO=$^%^-R1E4R66\X\C+/(+!\, M749#Z0N&%JGX!$.U$]_I@HJG!F9 -4)+=] NTU+B4CG:?J*O<,Q MU,-@[_!MH0JI"X&SSCC9B.^MZ3LG?K_(G+8R+Z.7K>#[?1F>MD3JL$ M?>+(WE.R?O]N\6%^_DH41V,41Z]9?TO"_IFA%_8ITKBCRJ+3KK=0YX>P>)BOLE]:THD#O.=;)>@<@SO&! ML6)3J[P6RHO"8$<;+VIY3[ %4YY G\=">& RNC)P)LP(=1JP$C!X]N]KZ0-B M%G>P 2<^PFJ4S%03Q3+*94N80IE3A9*6]TP97.S"+GK+GGAK2]+"!2I:H!ZI MS!LQ&^3KHW%$G(\2 \&4H&P088E8Z;WKV,<0Z 'G_[C1=G)P[ M42OP;E6. L51!@(+\5%I$*VP=>>1#0Q*'RD%M(6(_W-X?AJ9*AY);JB"-MAK M2'CSA+4)I)"PQRG:6DBZ &7 M"DI@\A(SCP$W6VCGQC([S/# $(]DI.)&6L0]\O1NP_TYPT84J5"3/]JOW"C*;]]4CX* M;%ZA.4RCBB@%.&/1[)4*P#UV/2=BY.8GX\:NW9L19D]:4Y#T\H'S_48%;AK0 M$S'+-O/5-E;%)Q]FJ8KZ6K1NTCY M$"/$@/IXLQG."P!U785W#A.-]HN/ M@7%W?$I=Q!?$HWA\AWV2ML(81Z.74)U/3_!RL?%M$S^\Z<)[(C,>KY.PK/$< M),L"."\-J!X^V,'XP%S_#5!+ P04 " !=-6=6I7::GT,$ "-"0 &0 M 'AL+W=OB3:]F*TP2I M;Z"DD\66(E62BNW]^MV1LJL42;H]V)*HN^^^^^Z.U'QG M[%=7(WK8-TJ[15)[WUZEJ2MJ;(0;FQ8UO:F,;82G1[M-76M1E,&I46DVF;Q- M&R%ULIR'M7N[G)O.*ZGQWH+KFD;8PQJ5V2V2:7)<^"2WM>>%=#EOQ18WZ#^W M]Y:>TA-**1O43AH-%JM%LII>K6=L'PS^D+AS@WO@3')COO+#QW*13)@0*BP\ M(PBZ/. U*L5 1.-;CYF<0K+C\/Z(_FO(G7+)A<-KH_Z4I:\7R64")5:B4_Z3 MV?V&?3[GC%<8Y<(_[*+M^2R!HG/>-+TS,6BDCE>Q[W48.%Q.GG'(>H7J^);)YUDA=P\]83(ZVG1 M>Z^C=_:,]S2#6Z-][>"#+K%\#) 2E1.?[,AGG;V(^!Z+,9Q-1Y!-LNP%O+-3 M?FY&AA.HLJ MC\#7R/JT0A^@H*M"CV58%0-]3 5WM31PBZ4LA!K!SO'.]< %LDA2ES3H5A(71USIZ@]!&PJF2.I8.1:.8I<= M)\,/N34DLWX:/Q3E&&0\+/MQN/Y'V3<[67FX[FA>.MJ0XA#=R$:2?5^X+/M9 MW0+(&P9AF3B5!\E=0I:*M\ZA#$7GO=3;8W/$I@D#3 1#>3YL5NLC!L/1B?(5 M_1ON/'84D2=9'Z%:8WUEB. 8'@T$]5(XD-BV["R;L@('%!:0-S6@+0F;H7(@ M+$M4F$ZS%^??:4[E1^D:]+4I0]M$:T+G/B$KWGWZ;K&$P0DJ*7*IR),3>CZ0?6"7/:NJL M1X*S+F[\U(Z;#H[(!NTV? AP]2G_>%J>5D_?&JMXQ'XWCQ\JM\)N)4FBL"+7 MR?CB/ $;#__XX$T;#MS<>.K"<%N''9$-Z'UEC#\^<(#3%]CR7U!+ P04 M" !=-6=63H4?CH,% !:# &0 'AL+W=OQ[E7UY=;8[^X2@C/[FNEW56O\KZY& Q<7HF:N[YI MA,:;M;$U]]C:]46]W\%&6E:>#P>*RX:6X$_ZWYH/%;K!'*60MM)-&,RO65[WEZ.(Z M(_D@\+L46W>T9N3)RI@OM'E77/6&9)!0(O>$P/'8B!NA% '!C*\=9F]_)2D> MKW?H/P;?X'(X7Y\!F%M%-(@]WQHF#E+?=\<6G-EEF2!AHM@JM! M&\9)34FY\Q9O)?3\XJ/8"-V*RX$'&!T-\D[Q.BJFSRB.4O;>:%\Y]E87HG@, M,( 5>U/2G2G7Z4G$6Y'WV7B4L'28IB?PQGO7Q@%O?-HUMK:F9C>PU8(""*^O MV$T(K+#LS^7*A?._GHI Q,^>QJ=RN7 -S\55#_7@A-V(WN+EB]%T^.:$]=G> M^NP4^JG$G%1\VJQ=+#Y5 J&H&ZX?P-T-:K)Q"?BDVS6"T$*><5V@1)M&26QR MHU&N?*4$VPI52%V&]WGK/:T;:XHV]U%)?&UE@WKU">..Q!4]2QY0O 6U]Q+] M1X8 92,+NIK(+YCENA3,K _P(6E2:[/A5,3,B[S21IF2;/2&.:-PFE=<*0%= M!UF [7&D+I!P"^$$ZURUP9'.B83];:3>><9;$(-[4>S\[;.[%ASAVDN@/S#\ MH!G%:$J'96Y*+?^! O>XLP&6I^L]6M=C-POI>%E:40(>%GIWP-'PP4-T;12Z MY%%D66E-V[@+]H?@-E8:0YV(>@7R[FJ%?D;T,V2OWN'FRK0.OKC7[.TNX.R, MS;)A,D\S6DWF23J=834=SI+),*/JZ-+LV"B93])D.IEB-9V>)_-LCM4X2Y/) M=,(^&<\5-+$['R?9?!C663I/1J,)UJ/D?#),AM/SX+KCA%C+^Q 1'/"5H?0% M0H7HJ9!0Q)68)ITG6WENC7-L99!T*QICH[P3);GB8E3S(Y,?!8NB5PHM;$A7 M!?I!9"]#7X(<"5'B7OJ'2/8*-R"'ZBNL#:?=T[+.?8'-T2'.J&B(9 M[5:M0S4ZT(QV/L2*UZ:%,B1:[>"M6TLDL1$V?%%U#N65DB %+NZ8CEN-E:74 M4,]WC:MH;9 A)+"(D\G!0*,%>R!ZP%6\^YX>"+2LB=06%.XS4,2A^;%]424(1Q:2912$>JHV$0KUWN^=J0G:Q)L'+Z %'6I#]8JR0$!$8%P M+9\V+(G$I1P0>9,N8$]AH!IAU%DZZ9^#3DJ%F\_2M#_>;0/,63KJ3P\",*T1 M>218$LO;BJX#1.>6>6Y;+(^O,C&S5!-&R2(T ])%':^0W8)=>/H_& *23>CX832"? E-# .A8> MW(Z\"+$[;E3'G>>;OD,*2!AMPQT@*;NQHI">_8*B1'B6NP%N=UT8K,@NN0M< MZ'R-(^^.P/((IB+8WEOB/?0_65X$6X7K+#F?S5]3$QW%]]ELQ)X:)09'\QXJM@Q3+7UF MP: X^NU/]X/S,LZ+!_$X=;^'VU)3CUQ#==B?37K,QDDV;KQIPO2(;HSV$)85 MAG]A20#OU\;XW88NV/^=6/P+4$L#!!0 ( %TU9U9'+GVL_00 ,,- 9 M >&PO=V]R:W-H965T]F)3%,]WOG.G M3M9*WY@"T<)=*:0Y#0IKJZ/QV&0%ELR,5(62WBR5+IFE1[T:FTHCR[U0*<9) M%,W&)>,RF)_XO2L]/U&U%5SBE093ER73FW,4:GT:Q$&W\9FO"NLVQO.3BJWP M&NVOU96FIW&/DO,2I>%*@L;E:7 6'YU/W'E_X#>.:S-8@[-DH=2->[C,3X/( M$4*!F74(C/YN\0*%<$!$XVN+&?0JG>!PW:%_]+:3+0MF\$*)+SRWQ6EP$$". M2U8+^UFM?\#6GJG#RY0P_A?6S=G)+("L-E:5K3 Q*+EL_ME=ZX>!P$'TA$#2 M"B2>=Z/(LWS/+)N?:+4&[4X3FEMX4[TTD>/2!>7::GK+2<[./S MN5P9J%## M=<$TPE*K$BZ4M%S6] I^IE?,N="LQ&D<0A)E"3/X*6] U*/EW[+ 5>] _XX6QBK*5_^ MW&9P S?9#N=JZ,A4+,/3@(K$H+[%8/[V33R+CI\A.^G)3IY#?WVT_D-X^*5 M>E-63&Z@8 9J>8O&8@[&2>Z[6LFA8ALJ80MLS71N*+EM 0RTJQ6PBLHZ0ZI* MD$KN4X=9(K=L(1!R?LMSE$ZBX!F)$)6,E-*F]JC:\HQ7Q(0X&ULP*$KO$%0&R=@28%=J_U,,&.@1%NH',CZ MI2)M:W,$OY-HD^U N8KE@@"Z?'4_L?N)8/=2$I:J#:DU(>!=AI5M-3DF]WIS MJNL];U1MO>M!+;?Q\Z'*[D.E[D.U[SH7SX[@4I*%SQYEUFJ^J)LPD+L^7)^= MDW)=J>8$[,9[L -),@L/XJE;I=,PCB-:Q=-WX22>P(]HR \Y-PT2.<(95,OA M3L^_"U+NE%$:#'/(D+)P%D5[\/;-01(GQ_W_O[>#SI?$GAIJ=E,H07EDO!G3 M,'G"C"^^HV.^SVX)=84=)_+^Q0 ,:-092Q8Z IY??-RX&W:3/9A%832=A(=I MY)?I)$SC>+AL37E1'!_"[T Z>C?U?X>),V$T2Y[,DUVAC-E[:;KD7+@P?4_" M_&\=_1-=<7"YI.N 0ZZ4I;[$*?TVC;6N#0VZP6ZZ!X<'89P<_B/Y7L.W445' MB%@\38GRX3-T^7?D1ANZ)CLFC[+#%>\ ^#5]@-JU;X9D>87^;N5XNZZ9LOTAJ"H-[1)=UC"M0=G)2F3NO$N+0T#(P-0:(/J65W2! *EK S M&:5T7:*#Q#2$G70TZQ]=,]I)1M-^H[-D0\5"LV)[ZPZ;WNV$??^^-UML1CX! MW>BQRC(!LO:B1*G+C$$FD,*S2G,!DW8FK&EZ#.+>##QRX0+=<ZS72X/6L1[ZVKKY1?Y0KHLZQ*Z6JS0\RQW^)R*R[8;@4T#SS0\.? MK26WS32GA'FQP&C;]6P\N%B7J%?^\X&26]72-G?L?K?_0CEK+N;WQYO/FT], MKSC5E< EB4;4N(/F&M0]6%7Y:SH%E"[]?EG05Q9J=X#>+Q5YK'UP"OKOMOG? M4$L#!!0 ( %TU9U:Y&PO=V]R:W-H965T=4*I6' M(3D488, C0'$E7]]ONX9 ,2U*[W) ]YD7C!]/2]O^X9OCQ6]6]ZIU0C/NV+ M4K^ZVC7-X>[V5J]W:B_UO#JH$M]LJWHO&[RM'V[UH59RPXOVQ6WH^XO;ON75=L4>:D^UD*W^[VLG]ZJHCJ^N@JNN@]^RA]V#7UP^_KE03ZH M>]7\=5O20O=UQWU[UAVR+*26KVKBG_D MFV;WZBJ[$ANUE6W1_%0=_UU9>1*BMZX*S7_%T3P;15=BW>JFVMO%X&"?E^:_ M_&3UX"S(_ L+0KL@9+[-1LSE>]G(UR_KZBAJ>AK4Z 6+RJO!7%Z24>Z;&M_F M6->\_E"NJ[T2/\M/2K^\;4"1/K]=V]5OS>KPPNH@%-]79;/3XMMRHS9C K=@ MI>"+TP_ 9>E$O7\3THL_*)][G>EU4NJV5^*\W*]W4 M\(C_GI+94(RG*5*4W.F#7*M75P@#K>I'=?7ZKW\)%OZ+9_B->W[CYZA_UA[/ MKI[FS24I[M5!UI(#8EM7>]BM>LRU^%CG52V:2C0[Y3SCB:JM!3( O2T?$(4: MWJ[%44&)>;DN6E@=+W@918FJQ4=9J[+YZU^R,$A?:/$H0;K58EV5NBKRC6RP MXI?Y_5QLU09T"R'+C5BKND$&$;K!]T29.&Y@M%HU;5UJ3TC:M2CH?_=P697? M,"7[T)Q8$& VKS9:')X3"?17T-U&;/-2ENL<;/#62#<0#XF!LH;X,/"A/B$- M:L7,(NA576,Q?;&2!0A LV LWX)'L9-$MK#?6]X$92#:H]S(HBH5I1+H71N^ ME#'&F1;GXF=\U#]D:(F]:G;51LC#H9K#X.2GI:T8/1F7HZ.5 MEOT>',N'6EG%36_K63Z)<\F)Z'O9@( 6;[JEQLR37XE-KDGH-D>.UV*EFJ-2 M)MX:%.&&GZFV[&I[NYA,0/$7^B]^K7(3BV'P@IP2E"@4]Y"'_+/JGM/"&KE[ MEDQLOVO+O$&]-BYR2NNB>>WBOTTQ@,V'P-;M>D>F(0*CO&">\/"%;'I;6R\@ M*W/(K"KH?&SF0D'1!5DI;R@^2!0B_H[$+F'EMT]D97B,AG$Z!9S([[+JAO$, M @.]Y,638=8DK.Y;VNHT*]T8 =0G"*"!0+"R$T;!853]3/*TL60Y'S[NE=#K M^9?GC$1"&$9=48Z[')K?RX$?:,Y5'-R*U>NPT"OS)$U]*#D%U2;S]($PZ=+> MB""28)'+56$R!Y'?49P"3NS+?)NKB>T0EX]5\4@Q M=\' 7^K@VR])4S"N.C3=-^I3PUR*$6%+L5,VK.+J^XF#^%Q2JVZY^158D(/= MI"R;S64S(F(2B:-:6>C*U>\VWV(KR+.V>8-4N)9Z9TO$0>8;"D9IDRP_0F8? M]@<5Y X%FP*.&B2!CRKRY",5@/P\AW*"AH$HZI2V(I N*'_B.\Y2UB^_* F[ M#G245+!_;W.;T3@[V]QLRL*62E:?4%NX5@UJAOQRD6E&G8^P(LQ8%TT19[&JGKE!/J:0XC/=;]2YJ+34V-NS%N_%R MP^;%()JV)CWN\F7)<4+^I2?H8,#+00G['Y!@\B$RC0UM9&+?KG9:KT>A(OOF M98O/G#2]>II.&*QISN%V&2G57:>PK1HC&#+3!"@C;(DR2?L:'6RK MTF"-Z) M_U2R-MV)0&^A]BLPT?47]">@/[Z8?:"B"J"*+9"ROXJ]._$>KU&NU^Z#UV(6 M++TPBF_P,O"](/;I1>PE?D):0=]8NL]'>#K.$A'YF;>,,Q$L R^*8JR)?-\+ MDX!>X1D_R_ J]!,OBY836KD3[]J:E'TGOK,5]5J 9$C+@LR+TQ0OP-DB%/>< MH$(O!O7 2Y>I6$(Q'7-IZJ58M.EEP5)D2R_P4_KG)Y%8^)[OA]"P M0<;#EK,4<@8WT$'HI;Z/%YFW6&8W=LLH@8"+0,P6:7K3;\@/+Z&PR,N6B9C% MWB)9W+ >EU%J:,0Q?1![?A208A=@)R7%9KX7^TN\B!-OF09N0NSKYX0+;?+M MEK%3A\/EG@"U2;''JBTVL#@CIY;\#$Y-\/N)D]@I<*%TWS85D@?#9JFM/^JO M]4;3NJUEL6Y-R,GFL[M")1&;!B]2&(>L'H=>!NKW'10 47P";070:R3".!'? M0@WK'E'67&F0)W)*JB;;8RO'6V>P?V#,FJ5+_$_2\$:\V\GR@:NP11SP/)D]]!9IPS7"R5A*:B')>M3WH?TM"'YM-4QIJ]56/E8U.V4.:>$\/:=GXLNZ9*!8 MM0T(JT$6'EHZT.EG0ZX(]5JFGR-QD/] MPW-*(.,1UX5M=Q(QOR)^UP4>,6S.!$_) MERX(!\9>'/GB6Y.X@1",VN'7%);0=XL8HH"/%EZ$M!L"[:'&_P!_'*9I1:6U M\39XQ%'6&Q$$@1<# X948F*.!5->3Q[SF6A7@=Y3%J#>AP];R/![\L,_S >H M*"%J_@(0TT>0/8)-2G6)MP#4#:+,>@$8S5)"(@!XF5/49%_49EF&:DLU/DB\ M>)%,JM&49<#<,(4(!'VR@*'/Z%G'C'>?89] /"I8EF0W_#J"!4)@DQ]MTC?3 M7-?7B$1EBF[@0Y$1 UA@>@8H/U=4T#<7N*$M0N@@6'+3, OC&# ]^]RR3NK9 M$EH,%H;3!5!]G$UJZ?])1)O1.8GV:XNXW>1K"]>,TEUX_65Q-^+7H.*%S[U0 ME*03S,/<2T!0-F *)_!/G:XO>L]:X&?A5#<40O)M.[Z'YU6/",BN=-*46D^F M'];%I!Y63Z8/1ATC[1YWB@69(M)5T%K)(O^#VF:BNJ=^MLA_4UP79/I%8&RP_L>VF8I)[.FNFQT\V%&;'9H=L2@B/D,[C1 ;@ MX03-&M4&U;>MNQ[LB7HK-=U;F?'&)+42N4UR022(=QTD\T3LH2 +WZ^S;![V M'YAQ%ENY6TC"7\?.(F(.%>4/$SNR')X$N7.\[=GCE&M_ONAI;)1=X@Q9UD-3 MU8%9$Y5K QEMZ>MWHQ.RYS.]Y[1.X]Q.+$UH2_.TK1N-643>S]@NG6%]('D( M6N[-Y&Q7'<6^->W!"!>>.PU7^JK7A\%AG=B^ '="1N3@0YR"[-!)\"- M>K!'!!Y%3.FX,(!?V[1F_&\Z 3;=>,1*L^H1?GQ6XZ+>,*ZX#K)YT-M:\F?G MJ0O^D==FTLB^K>GCC.*C:A]V>!,M!F:$VP!T>002MYI1M5;#0:QC9YXBV\[' M#O@<4<4#L$?-[D<^UVM#\#/=4)P.$%9DC'T^M!3=S#/*0J<2=JT.FZ'KD0EQ M-A/BCWH!&F.3KJ_C,)Y'O>JZ./B,GVL'\=M*1.Y0=CT\N2\22HY&D41,P-DN>@I=$L^@ (5CSU9Q*YZ].CRJ$[@7Y3 MHCV(0FG;FFZ)_Y.ILGR4><$DIC@RI[E?EH3=T#'R;[C:#=Q#03D0HCUOH#Q0 M=_.:ZR1U,JWE#2Z7D^)7W-,.#?ET=SPU"# Z'V;[/8UNHFT.!T8:[KFDG.3V M_L:S>,BFS[,%B:.IW$C0O(CFGLZJRJ4L497F!+5GF8W*2(YS(J&Y"VP3CG$='332ABPUJDX$Y_<&J_;+L M+X)<=H!^S9FU(:EC95-D>&LGLIW-^>ACY%#F%@&>ZL:6!#%=JN!>TXT59\V_ M:C-QI$,PFXC..3PYQ4.PDR$/=%T)44RSJN[T3;F3:IH/C/CM&MX]74PC[^V' M0>4)JR,8M=B@6"8$0(9UW=@.)6ATD3"*[ M055GJR[\>C51@F5 :D =XN)DQ$=9HGY0]H 9'Y(&#+_$&@M^@"M]0HIG#[\. M^N(Z5J7908_&5,3KX$<.=G-F([8'-X*98_.RPG)XH+ M"X=SZ;%/=?,'M^&;Y3>[P$ A>6X"[ M&K>5$\3,0V8O]V"^PT2.(Z2N?ID$&Q\764.&W$A61N\F4_)O<<1Z"*SLJA*R2X_(SID'*Z+&2&Y\@837Y:K;IHF7Z6LL@E5V*4TX_2:+^IML<$TI$?[J=< M6^J#TH'S[E#"?+$<' ML7ACZX!1RL@T#= >A9:]R](%4.BE6?)%ZW@V;8=!=B"?+);B)S-LI$=-:).* MN"%$LI4'8T$'B)K3#O[415%[0KLR)B.Y8-_SA"S8.%ER_09C8=\?P0>'XWR/I57+WN(7)U>NIJZ=D2\3 MW/KV_LW;P0!VBGYR^W1KI[$V+%X8W#6^A-@CJ=&EVA+JY1U.;H".*0KM=7#N MC*-.11=X&=N@'^< ,3OG6JPB6Y%YX&G!Q>BXS;U@!RE.Q!N!15=$OL@Z)2() M='9_^+(.:+[X.;:P$Y#Q-WJX9N=><-3>]+V]8?K@7ABA9&#',SG=E!@'^QE$'Z[_TS&F>]/P0)']=-16F(NC?C&!]^NF=_H [IB6YAJ(=VW!F-ASFG0/61?JS%;#X4U>IL MPFAFQK:EA:O;0XVW//;G;ECQJ)W)>%T+QOT)G0)#C:TVA$CQ^*HJ6E,K\'5W MZYY5[N)A)P6907O=%GW'NZ[:F@;>ZWP@;$Y8#GD]$ME6:GU:JKEQ9?-V=Z!. MCZ61G&HV?=U?XIB+J=\HW3J_'T,@//"OY'@L4C;FIV3]I_T/\=Z8WY\-CYM? M\7V/5AT^BR#:8BD >G(E:O/+./.FJ0[\:S0$9%/M^>5.2;@3/8#OMU75=&]H M@_[GB:__!U!+ P04 " !=-6=6Y6DHK!(% !]"P &0 'AL+W=OVD;9 MR\'2N=79>&RKI6BY'>F54/C+7)N6.[R:Q=BNC.!U4&J;,8NB;-QRJ0:3BR"[ M-Y,+W;E&*G%OP'9MR\WF2C1Z?3F@@YW@O5PLG1>,)Q L=_ M'\6U:!IO"&%\V-H<[%UZQY5N;/@+Z_YM&@^@ZJS3[589$;12]?_YTS8/!PI%] T%ME5@ 7?O M**"\X8Y/+HQ>@_&OT9H_A%"#-H*3RA?EP1G\5:*>F[S1NE[+I@&N:KA3CJN% MG#4"IM8*9R_&#GWXE^-J:^^JM\>^88\R>*N56UJX5;6HOS0P1G![A&R'\(J] M:/%&5".(*0$6,?:"O7@?<1SLQ3\5,=Q(6S7:=D; /].9=09Y\^^Q//1>DN-> M?"^=V16OQ.4 F\4*\U$,)J]?T2PZ?R&&9!]#\I+UGZC:B_:.H_U.HAZ7 N:Z MP:Z6:@&.^Y_ZUI:?A(7/VK[OI-O ; -6++"A'>H9<*B_$=Q8$)XI@'46[4R8 M?:V#7SS0,YBVPLB*(ZG>WD[A-6]7YS"]GU[#HW:\@>&=0G.ZLZAA3^&*-UQ5 M@L#O7'4X:: W2.$$4L9(GN=XHB2*(Y*D23BG:4Q83 ]0.V?DK.O#^]AP%"AL7F.$JC: %%*VX4%UF).\8*

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�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�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

Q1B[W'A&CV=^^P6'P#RA\/HTEGHSU0LN. MH64NZS.9T9I*^+#%E MP5'1!.!Y[VR71WKW31$.0STGF")"0DM:F!Z[/W5V_\.FK)KL MC[2E*JCW4^.:C&*J]=X484("K?>FZ'2 >IW'@<*1X/]-RP<+83\O8WT$(!G& M>*K?0X#.,@3X!*JPTXN?FK6HP+YCXV)3HG??_=U M*VE<+"3/-[NJ0!++MQ(+45K7 EY:#@:U&',\U5T"=(1P?3Z ,CJU3&BL* H[ M26+69O?M6W9_?LONV2&[V^;YP6BO-W$8!;IOD"R*#-],&:'1U.*:HAC,W,O8 M.BU6HL7PEN#1AVZHD*3QXRKVTW.>K;IT4*-/8EZNBNP/.<:R17>7HG8AK,2Z MI8D7@6[^*6?=._1#6=?@BH>=5'7IDN?56N++6G\H%(]A-Y!]J>0CU%)&=%F5 M&]0^E8N ?H5FBF-&0C!%8Q[%QJ0Q92&GU.* M+ M_0POH,0WM]$L=H+1Q7/;I[7$E[5^A!54X?.IJGU>: ,[- ],/AHSRHSE Y!) MV#)F B"SXA91N$7.Q:W)0J;_NLGDRB\F9;Q,U>^E"=-[^)251C')A> 3(=* &-)1T3A6;$C69?RD9FW@I8ON?]Y=M] M3Q(3L-B415CW$N"PJ"N(]1TU93RR82A1M$;;66^++6#ZLB13) BCX*'L0K_GFUEOBRUH^OPC_BQK^AJ@(!&J;/.E,36Z:E"1.27]+13$/=3//Y64..L@RC\.2Q"GI^Z)@A[IAY[K*!C4)1:]-/@(: MIJ2U 75#'H,%,-2Q*GI.^.8BIZ6;'IS D]#%S#DL0IZ1^T M4,#%W,#EJ7C!@'(1)UQ_AH)D5*_1 "(<6JII3-$8<].87"%%MCJ RW_1V2K26^K/5#JFB0#="@CZH%\XIX7JTEOJSUXZL0C[D1;ZAJP4P2 PYK M0"KSM :DLA[78"<'N=Q@-UB\8"9S$1SJBQ>@PB$+=1\ 6P1;5C"F (ZY 6ZH M@L%,S@IC'4 !$<;8.(@&F#HY@]!W0$$;0SCE.!^SY >_ (GUW 93^,/<^'-Y08.9U#(F0:@? P)EYK$- M4&8]ML$4!S$W!UU7W&# 3EG(N>$;((NG@3%BIHP09ADRKI"(!W^I(@=W$MK% MAT!]6DM\6>L/A8(V[H:VZ^L"'-HS),0X%@#I>(1U] 9D(;7MAW)%4-R]=7A% M;8";&WOF80= 9'AD2G" +0XI9.'N0_&>Z@/GD(XY^V@&0 M\2C01W!R\BK61E2K[I6V6G9<9JO]6TS'7X^OS7WH7A;3?G_ M\G^Y3=E9O\N MWH]IM1B*4T&[R/9I6K_>MO^2U-NNQ>^GLNF*3?=Q[5(%Z)J!?+OR[)L MWKZT%SB^9#C['U!+ P04 " !=-6=6LJ\0@1L# !2"P &0 'AL+W=O M MJ(_MP[0/;K@0:T[,; >Z?[]K)\U"";2;V!?PXYZ3=N9 9U3B5"U*A@+_I7-=#IT>@Z9P9P67%^+]7NH$HH, M7R*XLK]D7<5Z#DD*I456@5%!QO+RGSY41C0 ?F<'(*@ P4L!804(;:*E,IO6 MA&HZ&DBQ)M)$(YL96&\L&K-AN7F--UKB+D.<'EU"#G.FR9337)%37K M[.";EF?U]2L_]MY6-K5FM9?&E.&Y6M($A@[:J$"NP!F5I&TY'HAL(^.PSCBT M[.%.!^>X,B/-,T$F3"5V:^K6FKI[-=FKK3PO4W3K]!HTDX"? M)_U\O>]E_MMC?B"R#1-ZM0F]_UKOO4,:<2"R#2/ZM1']P]5[?[N*(K_??W)J MMZ.BN/W(^MZ?3[5WR'*OV)H:O"&ULQ5E=;]LV%/TKA 8,&]!$(NW83F8;2,(.*]:B1HJM M#\,>%.G:%BJ)&DG;*; ?/U*2)4N1:,M1LI=$'^<>\AZ2ET?F=,?X-[$&D.@I M"F,QL]92)C>V+;PU1*ZX9 G$ZLV2\'B]9_\U35XE\^@*N&?AU\"7ZYDUL9 /2W<3 MR@>V^PWRA*XTG\="D?Y%NQSK6,C;",FB/%CU( KB[+_[E MQ$(!'+0$D#R#U M@&%+P" /&)P:,,P#AJDR62JI#M25[GS*V0YQC59L^B(5,XU6Z0>Q'O,CT$\4I!N$XN>I+56[ M.MKV\C;NLC9(2QN8H$\LEFN!WL<^^%4"6W6XZ#79]_J.&!DI>)=H@-\AXA#2 MT*'[T\-Q0S@]/=PQ9#,HQF"0\@U;^!;9,OKQ!SQR?LD'1#3);*31%>)&)*X' M,TN5 %\"]8\(VV2J$\RVA-91;YA(=\P91^T#L=2/?'1X51&-!!>R,2& _KK MHWJ-/DB(Q-]-J@[[5+5/,MH36475JT+5*^.D_)I63/ OW"UPM0,@7RG*-K%$ MW)7P#CWF:K/',%BYND8T:9NU@;.ATWO0=NY<.L/1U-X>JM8,P]=5V^$P] M1H4>HQ?I$:L].@$>,%\5SKTX'A.R29918[ZZE%5D:8;A04V6'.;4V I4)=]Q MD>^X6[[PE*B]6JTS#G+#8Z0V[42O-%<(D**C ./F>3&I"= ,&]2F#VUAP\T* M3 H%)D8%/LLU\&S^+%0:%P\@ P[*\\CCE=K(W+6F]$E&>R*K*'I=*'K]JI7Z MND]5^R2C/9%55,5.Z>&<-ZC5>2/U.G)56Y-[6&VUC>J+TMSGIU MWM:S@EW?Q_:XFH3/I&FF&X^:"Q8F9=+D?RS:>>/5[.H*',=0,Z::>NFAL=E$ MJZ] E7RVDS;M:CTRD;[8JM*6OIJ_+K&&O?JK'MEHWVQ5:4MS35^ M"W>-6^SUH+XH3_37YDZ?*TKIL'%'BZVU0&R)@MCCX I0%ZHX18E:VZDF*(0M MA (M&<]_0-*7:1G05:YYO3>;ZD'=>[?@GM=R8T[G:E:Z=-S1IK]HFVLVTO5Y MK9ETZ&)TS \3B:7$N?9N>QM:> MW^$;FITNES398?/9^7%V(UF2GJ@^,BE9E%ZNP?6! M:X!ZOV1,[F]T \4I_OP_4$L#!!0 ( %TU9U;U[@,/4 , %P. 9 M>&PO=V]R:W-H965TS<90X M1L A-PZ"VL<:;H!SAV1Y?*U!H\:G,]QN/Z/_Y3=O-S.E&FXD_\1F9C&.AA&: M04%7W-S+S3NH-S1P>+GDVO^C3;4VM8OSE3:RK(TM@Y*)ZDF_U0>Q94#(#@-2 M&Q#/NW+D64ZHH=E(R0U2;K5%;+1G M*PY(%L@/O9Z H8SK-^@$,8$^+N1*4S'3H]A8K\XVSFL/UY4'LM-#?H9Z^"TB M"2'H\6&"7I^\^3],;$DWS$G#G'C<7HCYK=!&K6R6&/3YO5V ;@V4^M\NEA5: MOQO-)?^E7M(O91&LIMLDQ-%[/*=N!M MW5NTSC A.$F24;SN<-IOG/:#3A\%+:4R[ ?,7)Z"4K91,$%%SL0<%0"=T:Q MTRTVIZ0W.._F,FBX#()I_&T6H-"5UF Z?0:M]TS08<-M>-"7:7@$KA<-UXMCA/2B(\%V MA10G[?69_&)B3W8D=AA@S[/"6_<[/FAD:[@#TVTO=1R\A_<-;HVZ'5W2WQG= M]MK&/[FW76"YI$*C)ZN!@&XL'6;0U5P!^.-\0OX\K6Q64YWD@D[V/=)6!G#_ ML!D0E)5]Z;9*@<-2$=9*W*$3B?_MB'4K%/@H2H%?2D4@\UJMP&&QN(>UY&OG M.*]2KJ YX\PP^+U4/(;(X%9E\&%E!A]#9W K-#BL-#])Q9>*$OIL(ZVFD+"F M[)F)->H@K'#Q5JW@ZJX/5,V9O=\X%-8L.3NW]JHJ9:J.D4M?/DREL<6(;RYL M^0?*+;#SA93FN>,JDJ:@S/X#4$L#!!0 ( %TU9U:$>A8HX@L ,^C 9 M >&PO=V]R:W-H965T=OL#2VF9. A>P?=?I'U^0L59KH;64?//F8LO: M#_C\# L\ D[O\^*W\MJ8*OA]M6K_,9D]4\N\V*5 M5/6WQ56_O"E,LE@/6BW[X6 PZ:^2-.O-3M>O?2IFI_EMM4PS\ZD(RMO5*BG^ M>&>6^?U9;]A[?.%S>G5=-2_T9Z*L-VC6R"S-O&J(I/[GSIR; MY;*1ZO7X3XOV-LML!FY__:C+]2]?_S(726G.\^6OZ:*Z/NM->\'"7":WR^IS M?J]-^PM%C3?/E^7ZO\']PWLGKWO!_+:L\E4[N%Z#59H]_)O\WOZ/V!H0AGL& MA.V \- !HW; Z- !XW; ^- !43L@>C)@.-XS8-(.F!PZX*0=<'+H*DW; =/U M7_?AS['^6\9)E!4,QC\%X2 ,@Z]?XN#%GSM7S,_$9OXJ& V?9>+# MF:&'$8;/([6[LB7 MQ_=9616W]1:R"O[UH7Y#\+XRJ_+?'6OY[D$;=VO-AO]->9/,S5FOWK*7IK@S MO=E?_C2<#/[6E2(2BTE,D)@D,45B&L*+/UCV:B"MZ6I:DZ0^0= M?6R(2"PF,4%BDL04B6D(@DACMGK,)QU[R*+E:@FD0UA6J:TMR0V5/_0^_YW9G( M\KNT#,[SXB9OVJ@\Z\P4>LH?U6)4$Z@F44VAFJ8T-WCVS/]PS$ZPZ(E]5(M1 M3:":1#6%:IK2W C:3F'H+Q7.D_(ZF.=9F2Z,9]L7[P14DZBF4$U3FALK6R8,_6W"+]%<8TF[?.8*'] :K%J"903:*: M0C5-:6[T;-

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end XML 125 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 126 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 127 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 417 512 1 false 104 0 false 10 false false R1.htm 0000001 - Document - COVER PAGE Sheet http://www.colfaxcorp.com/role/COVERPAGE COVER PAGE Cover 1 false false R2.htm 0000002 - Document - AUDIT INFORMATION Sheet http://www.colfaxcorp.com/role/AUDITINFORMATION AUDIT INFORMATION Cover 2 false false R3.htm 0000003 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS Sheet http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS Statements 3 false false R4.htm 0000004 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME Sheet http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME Statements 4 false false R5.htm 0000005 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME [Parenthetical] Sheet http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME [Parenthetical] Statements 5 false false R6.htm 0000006 - Statement - CONSOLIDATED AND COMBINED BALANCE SHEETS Sheet http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS CONSOLIDATED AND COMBINED BALANCE SHEETS Statements 6 false false R7.htm 0000007 - Statement - CONSOLIDATED AND COMBINED BALANCE SHEETS [Parenthetical] Sheet http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETSParenthetical CONSOLIDATED AND COMBINED BALANCE SHEETS [Parenthetical] Statements 7 false false R8.htm 0000008 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF EQUITY Sheet http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY CONSOLIDATED AND COMBINED STATEMENTS OF EQUITY Statements 8 false false R9.htm 0000009 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF EQUITY [Parenthetical] Sheet http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITYParenthetical CONSOLIDATED AND COMBINED STATEMENTS OF EQUITY [Parenthetical] Statements 9 false false R10.htm 0000010 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS Sheet http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS Statements 10 false false R11.htm 0000011 - Disclosure - Organization and Basis of Presentation Sheet http://www.colfaxcorp.com/role/OrganizationandBasisofPresentation Organization and Basis of Presentation Notes 11 false false R12.htm 0000012 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 12 false false R13.htm 0000013 - Disclosure - Recently Issued Accounting Pronouncements Sheet http://www.colfaxcorp.com/role/RecentlyIssuedAccountingPronouncements Recently Issued Accounting Pronouncements Notes 13 false false R14.htm 0000014 - Disclosure - Discontinued Operations Sheet http://www.colfaxcorp.com/role/DiscontinuedOperations Discontinued Operations Notes 14 false false R15.htm 0000015 - Disclosure - Acquisitions Sheet http://www.colfaxcorp.com/role/Acquisitions Acquisitions Notes 15 false false R16.htm 0000016 - Disclosure - Revenue Sheet http://www.colfaxcorp.com/role/Revenue Revenue Notes 16 false false R17.htm 0000017 - Disclosure - Earnings per Share from Continuing Operations Sheet http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperations Earnings per Share from Continuing Operations Notes 17 false false R18.htm 0000018 - Disclosure - Income Taxes Sheet http://www.colfaxcorp.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 0000019 - Disclosure - Goodwill and Intangible Assets Sheet http://www.colfaxcorp.com/role/GoodwillandIntangibleAssets Goodwill and Intangible Assets Notes 19 false false R20.htm 0000020 - Disclosure - Property, Plant and Equipment, Net Sheet http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNet Property, Plant and Equipment, Net Notes 20 false false R21.htm 0000021 - Disclosure - Inventories, Net Sheet http://www.colfaxcorp.com/role/InventoriesNet Inventories, Net Notes 21 false false R22.htm 0000022 - Disclosure - Leases Sheet http://www.colfaxcorp.com/role/Leases Leases Notes 22 false false R23.htm 0000023 - Disclosure - Accrued and Other Liabilities Sheet http://www.colfaxcorp.com/role/AccruedandOtherLiabilities Accrued and Other Liabilities Notes 23 false false R24.htm 0000024 - Disclosure - Benefit Plans Sheet http://www.colfaxcorp.com/role/BenefitPlans Benefit Plans Notes 24 false false R25.htm 0000025 - Disclosure - Debt Sheet http://www.colfaxcorp.com/role/Debt Debt Notes 25 false false R26.htm 0000026 - Disclosure - Derivatives Sheet http://www.colfaxcorp.com/role/Derivatives Derivatives Notes 26 false false R27.htm 0000027 - Disclosure - Fair Value Measurements Sheet http://www.colfaxcorp.com/role/FairValueMeasurements Fair Value Measurements Notes 27 false false R28.htm 0000028 - Disclosure - Equity Sheet http://www.colfaxcorp.com/role/Equity Equity Notes 28 false false R29.htm 0000029 - Disclosure - Commitments and Contingencies Sheet http://www.colfaxcorp.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 29 false false R30.htm 0000030 - Disclosure - Segment Information Sheet http://www.colfaxcorp.com/role/SegmentInformation Segment Information Notes 30 false false R31.htm 0000031 - Disclosure - Related Party Transactions Sheet http://www.colfaxcorp.com/role/RelatedPartyTransactions Related Party Transactions Notes 31 false false R32.htm 0000032 - Disclosure - Subsequent Events Sheet http://www.colfaxcorp.com/role/SubsequentEvents Subsequent Events Notes 32 false false R33.htm 0000033 - Disclosure - Schedule II - Valuation and Qualifying Accounts Sheet http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccounts Schedule II - Valuation and Qualifying Accounts Notes 33 false false R34.htm 0000034 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPolicies 34 false false R35.htm 0000035 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPolicies 35 false false R36.htm 0000036 - Disclosure - Revenue (Tables) Sheet http://www.colfaxcorp.com/role/RevenueTables Revenue (Tables) Tables http://www.colfaxcorp.com/role/Revenue 36 false false R37.htm 0000037 - Disclosure - Earnings per Share from Continuing Operations (Tables) Sheet http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsTables Earnings per Share from Continuing Operations (Tables) Tables http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperations 37 false false R38.htm 0000038 - Disclosure - Income Taxes (Tables) Sheet http://www.colfaxcorp.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.colfaxcorp.com/role/IncomeTaxes 38 false false R39.htm 0000039 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://www.colfaxcorp.com/role/GoodwillandIntangibleAssets 39 false false R40.htm 0000040 - Disclosure - Property, Plant and Equipment, Net (Tables) Sheet http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetTables Property, Plant and Equipment, Net (Tables) Tables http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNet 40 false false R41.htm 0000041 - Disclosure - Inventories, Net (Tables) Sheet http://www.colfaxcorp.com/role/InventoriesNetTables Inventories, Net (Tables) Tables http://www.colfaxcorp.com/role/InventoriesNet 41 false false R42.htm 0000042 - Disclosure - Leases (Tables) Sheet http://www.colfaxcorp.com/role/LeasesTables Leases (Tables) Tables http://www.colfaxcorp.com/role/Leases 42 false false R43.htm 0000043 - Disclosure - Accrued and Other Liabilities (Tables) Sheet http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesTables Accrued and Other Liabilities (Tables) Tables http://www.colfaxcorp.com/role/AccruedandOtherLiabilities 43 false false R44.htm 0000044 - Disclosure - Benefit Plans (Tables) Sheet http://www.colfaxcorp.com/role/BenefitPlansTables Benefit Plans (Tables) Tables http://www.colfaxcorp.com/role/BenefitPlans 44 false false R45.htm 0000045 - Disclosure - Debt (Tables) Sheet http://www.colfaxcorp.com/role/DebtTables Debt (Tables) Tables http://www.colfaxcorp.com/role/Debt 45 false false R46.htm 0000046 - Disclosure - Derivatives (Tables) Sheet http://www.colfaxcorp.com/role/DerivativesTables Derivatives (Tables) Tables http://www.colfaxcorp.com/role/Derivatives 46 false false R47.htm 0000047 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.colfaxcorp.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.colfaxcorp.com/role/FairValueMeasurements 47 false false R48.htm 0000048 - Disclosure - Equity (Tables) Sheet http://www.colfaxcorp.com/role/EquityTables Equity (Tables) Tables http://www.colfaxcorp.com/role/Equity 48 false false R49.htm 0000049 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.colfaxcorp.com/role/CommitmentsandContingenciesTables Commitments and Contingencies (Tables) Tables http://www.colfaxcorp.com/role/CommitmentsandContingencies 49 false false R50.htm 0000050 - Disclosure - Segment Information (Tables) Sheet http://www.colfaxcorp.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.colfaxcorp.com/role/SegmentInformation 50 false false R51.htm 0000051 - Disclosure - Organization and Basis of Presentation (Details) Sheet http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails Organization and Basis of Presentation (Details) Details http://www.colfaxcorp.com/role/OrganizationandBasisofPresentation 51 false false R52.htm 0000052 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) Sheet http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails Summary of Significant Accounting Policies - Narrative (Details) Details 52 false false R53.htm 0000053 - Disclosure - Summary of Significant Accounting Policies - Net Foreign Transaction Gains and Losses (Details) Sheet http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNetForeignTransactionGainsandLossesDetails Summary of Significant Accounting Policies - Net Foreign Transaction Gains and Losses (Details) Details 53 false false R54.htm 0000054 - Disclosure - Discontinued Operations - Narrative (Details) Sheet http://www.colfaxcorp.com/role/DiscontinuedOperationsNarrativeDetails Discontinued Operations - Narrative (Details) Details 54 false false R55.htm 0000055 - Disclosure - Acquisitions - Narrative (Details) Sheet http://www.colfaxcorp.com/role/AcquisitionsNarrativeDetails Acquisitions - Narrative (Details) Details 55 false false R56.htm 0000056 - Disclosure - Revenue - Disaggregation of Revenue (Details) Sheet http://www.colfaxcorp.com/role/RevenueDisaggregationofRevenueDetails Revenue - Disaggregation of Revenue (Details) Details 56 false false R57.htm 0000057 - Disclosure - Revenue - Narrative (Details) Sheet http://www.colfaxcorp.com/role/RevenueNarrativeDetails Revenue - Narrative (Details) Details 57 false false R58.htm 0000058 - Disclosure - Revenue - Allowance for Credit Loss Rollforward (Details) Sheet http://www.colfaxcorp.com/role/RevenueAllowanceforCreditLossRollforwardDetails Revenue - Allowance for Credit Loss Rollforward (Details) Details 58 false false R59.htm 0000059 - Disclosure - Earnings per Share from Continuing Operations (Details) Sheet http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsDetails Earnings per Share from Continuing Operations (Details) Details http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsTables 59 false false R60.htm 0000060 - Disclosure - Income Taxes - Components of Income Before Taxes and Income Tax Expense (Details) Sheet http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails Income Taxes - Components of Income Before Taxes and Income Tax Expense (Details) Details 60 false false R61.htm 0000061 - Disclosure - Income Taxes - Effective Income Tax Rate Reconciliation (Details) Sheet http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails Income Taxes - Effective Income Tax Rate Reconciliation (Details) Details 61 false false R62.htm 0000062 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details) Sheet http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails Income Taxes - Deferred Tax Assets and Liabilities (Details) Details 62 false false R63.htm 0000063 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities Balance Sheet Items (Details) Sheet http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesBalanceSheetItemsDetails Income Taxes - Deferred Tax Assets and Liabilities Balance Sheet Items (Details) Details 63 false false R64.htm 0000064 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 64 false false R65.htm 0000065 - Disclosure - Income Taxes - Gross Unrecognized Tax Benefits (Details) Sheet http://www.colfaxcorp.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails Income Taxes - Gross Unrecognized Tax Benefits (Details) Details 65 false false R66.htm 0000066 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details) Sheet http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsGoodwillDetails Goodwill and Intangible Assets - Goodwill (Details) Details 66 false false R67.htm 0000067 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details) Sheet http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails Goodwill and Intangible Assets - Intangible Assets (Details) Details 67 false false R68.htm 0000068 - Disclosure - Goodwill and Intangible Assets - Narrative (Details) Sheet http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsNarrativeDetails Goodwill and Intangible Assets - Narrative (Details) Details 68 false false R69.htm 0000069 - Disclosure - Goodwill and Intangible Assets - Expected Amortization Expense (Details ) Sheet http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsExpectedAmortizationExpenseDetails Goodwill and Intangible Assets - Expected Amortization Expense (Details ) Details 69 false false R70.htm 0000070 - Disclosure - Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details) Sheet http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details) Details 70 false false R71.htm 0000071 - Disclosure - Property, Plant and Equipment, Net - Narrative (Details) Sheet http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetNarrativeDetails Property, Plant and Equipment, Net - Narrative (Details) Details 71 false false R72.htm 0000072 - Disclosure - Inventories, Net (Details) Sheet http://www.colfaxcorp.com/role/InventoriesNetDetails Inventories, Net (Details) Details http://www.colfaxcorp.com/role/InventoriesNetTables 72 false false R73.htm 0000073 - Disclosure - Leases (Details) Sheet http://www.colfaxcorp.com/role/LeasesDetails Leases (Details) Details http://www.colfaxcorp.com/role/LeasesTables 73 false false R74.htm 0000074 - Disclosure - Accrued and Other Liabilities - Current and Noncurrent (Details) Sheet http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails Accrued and Other Liabilities - Current and Noncurrent (Details) Details 74 false false R75.htm 0000075 - Disclosure - Accrued and Other Liabilities - Warranty Liability Rollforward (Details) Sheet http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesWarrantyLiabilityRollforwardDetails Accrued and Other Liabilities - Warranty Liability Rollforward (Details) Details 75 false false R76.htm 0000076 - Disclosure - Accrued and Other Liabilities - Restructuring Rollforward (Details) Sheet http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails Accrued and Other Liabilities - Restructuring Rollforward (Details) Details 76 false false R77.htm 0000077 - Disclosure - Benefit Plans - Narrative (Details) Sheet http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails Benefit Plans - Narrative (Details) Details 77 false false R78.htm 0000078 - Disclosure - Benefit Plans - Obligation and Asset Rollforward (Details) Sheet http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails Benefit Plans - Obligation and Asset Rollforward (Details) Details 78 false false R79.htm 0000079 - Disclosure - Benefit Plans - Expected Benefit Payments (Details) Sheet http://www.colfaxcorp.com/role/BenefitPlansExpectedBenefitPaymentsDetails Benefit Plans - Expected Benefit Payments (Details) Details 79 false false R80.htm 0000080 - Disclosure - Benefit Plans - Plan Asset Allocation (Details) Sheet http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationDetails Benefit Plans - Plan Asset Allocation (Details) Details 80 false false R81.htm 0000081 - Disclosure - Benefit Plans - Plan Asset Allocation, Fair Value Hierarchy (Details) Sheet http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails Benefit Plans - Plan Asset Allocation, Fair Value Hierarchy (Details) Details 81 false false R82.htm 0000082 - Disclosure - Benefit Plans - Net Periodic Benefit Cost (Details) Sheet http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails Benefit Plans - Net Periodic Benefit Cost (Details) Details 82 false false R83.htm 0000083 - Disclosure - Benefit Plans - Accumulated Other Comprehensive Income (Details) Sheet http://www.colfaxcorp.com/role/BenefitPlansAccumulatedOtherComprehensiveIncomeDetails Benefit Plans - Accumulated Other Comprehensive Income (Details) Details 83 false false R84.htm 0000084 - Disclosure - Benefit Plans - Key Economic Assumptions (Details) Sheet http://www.colfaxcorp.com/role/BenefitPlansKeyEconomicAssumptionsDetails Benefit Plans - Key Economic Assumptions (Details) Details 84 false false R85.htm 0000085 - Disclosure - Debt - Schedule of Debt (Details) Sheet http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails Debt - Schedule of Debt (Details) Details 85 false false R86.htm 0000086 - Disclosure - Debt - Narrative (Details) Sheet http://www.colfaxcorp.com/role/DebtNarrativeDetails Debt - Narrative (Details) Details 86 false false R87.htm 0000087 - Disclosure - Debt - Schedule of Debt Maturities (Details) Sheet http://www.colfaxcorp.com/role/DebtScheduleofDebtMaturitiesDetails Debt - Schedule of Debt Maturities (Details) Details 87 false false R88.htm 0000088 - Disclosure - Derivatives - Narratives (Details) Sheet http://www.colfaxcorp.com/role/DerivativesNarrativesDetails Derivatives - Narratives (Details) Details 88 false false R89.htm 0000089 - Disclosure - Derivatives - Summary of the Effects of Designated Cash Flow Hedges on the Company???s Consolidated and Combined Statements of Operations (Details) Sheet http://www.colfaxcorp.com/role/DerivativesSummaryoftheEffectsofDesignatedCashFlowHedgesontheCompanysConsolidatedandCombinedStatementsofOperationsDetails Derivatives - Summary of the Effects of Designated Cash Flow Hedges on the Company???s Consolidated and Combined Statements of Operations (Details) Details 89 false false R90.htm 0000090 - Disclosure - Derivatives - Schedule of Fair Values of Derivative Instruments in the Financial Statements (Details) Sheet http://www.colfaxcorp.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails Derivatives - Schedule of Fair Values of Derivative Instruments in the Financial Statements (Details) Details 90 false false R91.htm 0000091 - Disclosure - Derivatives - Not Designated as Hedging Instruments (Details) Sheet http://www.colfaxcorp.com/role/DerivativesNotDesignatedasHedgingInstrumentsDetails Derivatives - Not Designated as Hedging Instruments (Details) Details 91 false false R92.htm 0000092 - Disclosure - Fair Value Measurements - Fair Value Hierarchy (Details) Sheet http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails Fair Value Measurements - Fair Value Hierarchy (Details) Details 92 false false R93.htm 0000093 - Disclosure - Equity - Accumulated Other Comprehensive Loss (Details) Sheet http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails Equity - Accumulated Other Comprehensive Loss (Details) Details 93 false false R94.htm 0000094 - Disclosure - Equity - Narratives (Details) Sheet http://www.colfaxcorp.com/role/EquityNarrativesDetails Equity - Narratives (Details) Details 94 false false R95.htm 0000095 - Disclosure - Equity - PRSU and RSU Activity (Details) Sheet http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails Equity - PRSU and RSU Activity (Details) Details 95 false false R96.htm 0000096 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.colfaxcorp.com/role/CommitmentsandContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 96 false false R97.htm 0000097 - Disclosure - Commitments and Contingencies - Claims Rollforward (Details) Sheet http://www.colfaxcorp.com/role/CommitmentsandContingenciesClaimsRollforwardDetails Commitments and Contingencies - Claims Rollforward (Details) Details 97 false false R98.htm 0000098 - Disclosure - Commitments and Contingencies - Asbestos Litigation (Details) Sheet http://www.colfaxcorp.com/role/CommitmentsandContingenciesAsbestosLitigationDetails Commitments and Contingencies - Asbestos Litigation (Details) Details 98 false false R99.htm 0000099 - Disclosure - Segment Information - Narratives (Details) Sheet http://www.colfaxcorp.com/role/SegmentInformationNarrativesDetails Segment Information - Narratives (Details) Details 99 false false R100.htm 0000100 - Disclosure - Segment Information - Segment Reporting Information, by Segment (Details) Sheet http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails Segment Information - Segment Reporting Information, by Segment (Details) Details 100 false false R101.htm 0000101 - Disclosure - Segment Information - Net Sales and PPE by Geography (Details) Sheet http://www.colfaxcorp.com/role/SegmentInformationNetSalesandPPEbyGeographyDetails Segment Information - Net Sales and PPE by Geography (Details) Details 101 false false R102.htm 0000102 - Disclosure - Related Party Transactions (Details) Sheet http://www.colfaxcorp.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.colfaxcorp.com/role/RelatedPartyTransactions 102 false false R103.htm 0000103 - Disclosure - Subsequent Events (Details) Sheet http://www.colfaxcorp.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.colfaxcorp.com/role/SubsequentEvents 103 false false R104.htm 0000104 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details) Sheet http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccountsDetails Schedule II - Valuation and Qualifying Accounts (Details) Details http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccounts 104 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:ConversionOfStockSharesConverted1, us-gaap:FiniteLivedIntangibleAssetUsefulLife - cfx-20221231.htm 4 cfx-20221231.htm cfx-20221231.xsd cfx-20221231_cal.xml cfx-20221231_def.xml cfx-20221231_lab.xml cfx-20221231_pre.xml exhibit1021letteragreement.htm exhibit1035amendedandresta.htm exhibit211listofsubsidiari.htm exhibit231consentofindepen.htm exhibit3101ceocertificatio.htm exhibit3102cfocertificatio.htm exhibit3201ceocertificatio.htm exhibit3202cfocertificatio.htm exhibit41-descriptionofsec.htm cfx-20221231_g1.jpg http://fasb.org/srt/2022 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 130 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "cfx-20221231.htm": { "axisCustom": 0, "axisStandard": 41, "baseTaxonomies": { "http://fasb.org/srt/2022": 1, "http://fasb.org/us-gaap/2022": 1669, "http://xbrl.sec.gov/dei/2022": 37 }, "contextCount": 417, "dts": { "calculationLink": { "local": [ "cfx-20221231_cal.xml" ] }, "definitionLink": { "local": [ "cfx-20221231_def.xml" ] }, "inline": { "local": [ "cfx-20221231.htm" ] }, "labelLink": { "local": [ "cfx-20221231_lab.xml" ] }, "presentationLink": { "local": [ "cfx-20221231_pre.xml" ] }, "schema": { "local": [ "cfx-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 813, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 6, "http://xbrl.sec.gov/dei/2022": 4, "total": 10 }, "keyCustom": 44, "keyStandard": 468, "memberCustom": 30, "memberStandard": 70, "nsprefix": "cfx", "nsuri": "http://www.colfaxcorp.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - COVER PAGE", "menuCat": "Cover", "order": "1", "role": "http://www.colfaxcorp.com/role/COVERPAGE", "shortName": "COVER PAGE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000010 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS", "menuCat": "Statements", "order": "10", "role": "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS", "shortName": "CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000100 - Disclosure - Segment Information - Segment Reporting Information, by Segment (Details)", "menuCat": "Details", "order": "100", "role": "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails", "shortName": "Segment Information - Segment Reporting Information, by Segment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000101 - Disclosure - Segment Information - Net Sales and PPE by Geography (Details)", "menuCat": "Details", "order": "101", "role": "http://www.colfaxcorp.com/role/SegmentInformationNetSalesandPPEbyGeographyDetails", "shortName": "Segment Information - Net Sales and PPE by Geography (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "if13204fa486e46d9aadebbe0a690947d_I20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i97e055540d744224b3824628839cff4f_D20220101-20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CostsAndExpensesRelatedParty", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000102 - Disclosure - Related Party Transactions (Details)", "menuCat": "Details", "order": "102", "role": "http://www.colfaxcorp.com/role/RelatedPartyTransactionsDetails", "shortName": "Related Party Transactions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i97e055540d744224b3824628839cff4f_D20220101-20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CostsAndExpensesRelatedParty", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DividendsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000103 - Disclosure - Subsequent Events (Details)", "menuCat": "Details", "order": "103", "role": "http://www.colfaxcorp.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DividendsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R104": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000104 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details)", "menuCat": "Details", "order": "104", "role": "http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccountsDetails", "shortName": "Schedule II - Valuation and Qualifying Accounts (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i9b8c654ffa1244759125f252bcff3fef_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - Organization and Basis of Presentation", "menuCat": "Notes", "order": "11", "role": "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentation", "shortName": "Organization and Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "12", "role": "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - Recently Issued Accounting Pronouncements", "menuCat": "Notes", "order": "13", "role": "http://www.colfaxcorp.com/role/RecentlyIssuedAccountingPronouncements", "shortName": "Recently Issued Accounting Pronouncements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - Discontinued Operations", "menuCat": "Notes", "order": "14", "role": "http://www.colfaxcorp.com/role/DiscontinuedOperations", "shortName": "Discontinued Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - Acquisitions", "menuCat": "Notes", "order": "15", "role": "http://www.colfaxcorp.com/role/Acquisitions", "shortName": "Acquisitions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - Revenue", "menuCat": "Notes", "order": "16", "role": "http://www.colfaxcorp.com/role/Revenue", "shortName": "Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - Earnings per Share from Continuing Operations", "menuCat": "Notes", "order": "17", "role": "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperations", "shortName": "Earnings per Share from Continuing Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "18", "role": "http://www.colfaxcorp.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - Goodwill and Intangible Assets", "menuCat": "Notes", "order": "19", "role": "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssets", "shortName": "Goodwill and Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "false", "longName": "0000002 - Document - AUDIT INFORMATION", "menuCat": "Cover", "order": "2", "role": "http://www.colfaxcorp.com/role/AUDITINFORMATION", "shortName": "AUDIT INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000020 - Disclosure - Property, Plant and Equipment, Net", "menuCat": "Notes", "order": "20", "role": "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNet", "shortName": "Property, Plant and Equipment, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000021 - Disclosure - Inventories, Net", "menuCat": "Notes", "order": "21", "role": "http://www.colfaxcorp.com/role/InventoriesNet", "shortName": "Inventories, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000022 - Disclosure - Leases", "menuCat": "Notes", "order": "22", "role": "http://www.colfaxcorp.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "cfx:AccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000023 - Disclosure - Accrued and Other Liabilities", "menuCat": "Notes", "order": "23", "role": "http://www.colfaxcorp.com/role/AccruedandOtherLiabilities", "shortName": "Accrued and Other Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "cfx:AccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000024 - Disclosure - Benefit Plans", "menuCat": "Notes", "order": "24", "role": "http://www.colfaxcorp.com/role/BenefitPlans", "shortName": "Benefit Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000025 - Disclosure - Debt", "menuCat": "Notes", "order": "25", "role": "http://www.colfaxcorp.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000026 - Disclosure - Derivatives", "menuCat": "Notes", "order": "26", "role": "http://www.colfaxcorp.com/role/Derivatives", "shortName": "Derivatives", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000027 - Disclosure - Fair Value Measurements", "menuCat": "Notes", "order": "27", "role": "http://www.colfaxcorp.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000028 - Disclosure - Equity", "menuCat": "Notes", "order": "28", "role": "http://www.colfaxcorp.com/role/Equity", "shortName": "Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000029 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "29", "role": "http://www.colfaxcorp.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS", "menuCat": "Statements", "order": "3", "role": "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS", "shortName": "CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000030 - Disclosure - Segment Information", "menuCat": "Notes", "order": "30", "role": "http://www.colfaxcorp.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000031 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "31", "role": "http://www.colfaxcorp.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000032 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "32", "role": "http://www.colfaxcorp.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000033 - Disclosure - Schedule II - Valuation and Qualifying Accounts", "menuCat": "Notes", "order": "33", "role": "http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccounts", "shortName": "Schedule II - Valuation and Qualifying Accounts", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiscalPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000034 - Disclosure - Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "34", "role": "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiscalPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000035 - Disclosure - Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "35", "role": "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000036 - Disclosure - Revenue (Tables)", "menuCat": "Tables", "order": "36", "role": "http://www.colfaxcorp.com/role/RevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000037 - Disclosure - Earnings per Share from Continuing Operations (Tables)", "menuCat": "Tables", "order": "37", "role": "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsTables", "shortName": "Earnings per Share from Continuing Operations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000038 - Disclosure - Income Taxes (Tables)", "menuCat": "Tables", "order": "38", "role": "http://www.colfaxcorp.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000039 - Disclosure - Goodwill and Intangible Assets (Tables)", "menuCat": "Tables", "order": "39", "role": "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsTables", "shortName": "Goodwill and Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME", "menuCat": "Statements", "order": "4", "role": "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME", "shortName": "CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000040 - Disclosure - Property, Plant and Equipment, Net (Tables)", "menuCat": "Tables", "order": "40", "role": "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetTables", "shortName": "Property, Plant and Equipment, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000041 - Disclosure - Inventories, Net (Tables)", "menuCat": "Tables", "order": "41", "role": "http://www.colfaxcorp.com/role/InventoriesNetTables", "shortName": "Inventories, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000042 - Disclosure - Leases (Tables)", "menuCat": "Tables", "order": "42", "role": "http://www.colfaxcorp.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000043 - Disclosure - Accrued and Other Liabilities (Tables)", "menuCat": "Tables", "order": "43", "role": "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesTables", "shortName": "Accrued and Other Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000044 - Disclosure - Benefit Plans (Tables)", "menuCat": "Tables", "order": "44", "role": "http://www.colfaxcorp.com/role/BenefitPlansTables", "shortName": "Benefit Plans (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000045 - Disclosure - Debt (Tables)", "menuCat": "Tables", "order": "45", "role": "http://www.colfaxcorp.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000046 - Disclosure - Derivatives (Tables)", "menuCat": "Tables", "order": "46", "role": "http://www.colfaxcorp.com/role/DerivativesTables", "shortName": "Derivatives (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000047 - Disclosure - Fair Value Measurements (Tables)", "menuCat": "Tables", "order": "47", "role": "http://www.colfaxcorp.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000048 - Disclosure - Equity (Tables)", "menuCat": "Tables", "order": "48", "role": "http://www.colfaxcorp.com/role/EquityTables", "shortName": "Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "cfx:ScheduleOfLossContingenciesByClaimsQuantitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000049 - Disclosure - Commitments and Contingencies (Tables)", "menuCat": "Tables", "order": "49", "role": "http://www.colfaxcorp.com/role/CommitmentsandContingenciesTables", "shortName": "Commitments and Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "cfx:ScheduleOfLossContingenciesByClaimsQuantitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME [Parenthetical]", "menuCat": "Statements", "order": "5", "role": "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical", "shortName": "CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME [Parenthetical]", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000050 - Disclosure - Segment Information (Tables)", "menuCat": "Tables", "order": "50", "role": "http://www.colfaxcorp.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000051 - Disclosure - Organization and Basis of Presentation (Details)", "menuCat": "Details", "order": "51", "role": "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails", "shortName": "Organization and Basis of Presentation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i5a43f6db8eb541ad9a0870f1e1356e01_I20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000052 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)", "menuCat": "Details", "order": "52", "role": "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails", "shortName": "Summary of Significant Accounting Policies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000053 - Disclosure - Summary of Significant Accounting Policies - Net Foreign Transaction Gains and Losses (Details)", "menuCat": "Details", "order": "53", "role": "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNetForeignTransactionGainsandLossesDetails", "shortName": "Summary of Significant Accounting Policies - Net Foreign Transaction Gains and Losses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000054 - Disclosure - Discontinued Operations - Narrative (Details)", "menuCat": "Details", "order": "54", "role": "http://www.colfaxcorp.com/role/DiscontinuedOperationsNarrativeDetails", "shortName": "Discontinued Operations - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000055 - Disclosure - Acquisitions - Narrative (Details)", "menuCat": "Details", "order": "55", "role": "http://www.colfaxcorp.com/role/AcquisitionsNarrativeDetails", "shortName": "Acquisitions - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "iafc28880885346d2b78942217dd2d8f0_D20221031-20221031", "decimals": "-5", "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000056 - Disclosure - Revenue - Disaggregation of Revenue (Details)", "menuCat": "Details", "order": "56", "role": "http://www.colfaxcorp.com/role/RevenueDisaggregationofRevenueDetails", "shortName": "Revenue - Disaggregation of Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6d4f3214f8b046588d6a643dae6df93c_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000057 - Disclosure - Revenue - Narrative (Details)", "menuCat": "Details", "order": "57", "role": "http://www.colfaxcorp.com/role/RevenueNarrativeDetails", "shortName": "Revenue - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i10ca7d1223c44c0db3ae08ac641c291c_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000058 - Disclosure - Revenue - Allowance for Credit Loss Rollforward (Details)", "menuCat": "Details", "order": "58", "role": "http://www.colfaxcorp.com/role/RevenueAllowanceforCreditLossRollforwardDetails", "shortName": "Revenue - Allowance for Credit Loss Rollforward (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "cfx:NetIncomeLossFromContinuingOperationsAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000059 - Disclosure - Earnings per Share from Continuing Operations (Details)", "menuCat": "Details", "order": "59", "role": "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsDetails", "shortName": "Earnings per Share from Continuing Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "cfx:NetIncomeLossFromContinuingOperationsAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - CONSOLIDATED AND COMBINED BALANCE SHEETS", "menuCat": "Statements", "order": "6", "role": "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS", "shortName": "CONSOLIDATED AND COMBINED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000060 - Disclosure - Income Taxes - Components of Income Before Taxes and Income Tax Expense (Details)", "menuCat": "Details", "order": "60", "role": "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails", "shortName": "Income Taxes - Components of Income Before Taxes and Income Tax Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000061 - Disclosure - Income Taxes - Effective Income Tax Rate Reconciliation (Details)", "menuCat": "Details", "order": "61", "role": "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails", "shortName": "Income Taxes - Effective Income Tax Rate Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000062 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)", "menuCat": "Details", "order": "62", "role": "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails", "shortName": "Income Taxes - Deferred Tax Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredIncomeTaxLiabilitiesNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000063 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities Balance Sheet Items (Details)", "menuCat": "Details", "order": "63", "role": "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesBalanceSheetItemsDetails", "shortName": "Income Taxes - Deferred Tax Assets and Liabilities Balance Sheet Items (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "icd1e1382cae040d384fd249c0c941e36_I20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DeferredIncomeTaxAssetsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000064 - Disclosure - Income Taxes - Narrative (Details)", "menuCat": "Details", "order": "64", "role": "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails", "shortName": "Income Taxes - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "cfx:ValuationAllowanceDeferredTaxAssetIncreaseAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i10ca7d1223c44c0db3ae08ac641c291c_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000065 - Disclosure - Income Taxes - Gross Unrecognized Tax Benefits (Details)", "menuCat": "Details", "order": "65", "role": "http://www.colfaxcorp.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails", "shortName": "Income Taxes - Gross Unrecognized Tax Benefits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i10ca7d1223c44c0db3ae08ac641c291c_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000066 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)", "menuCat": "Details", "order": "66", "role": "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsGoodwillDetails", "shortName": "Goodwill and Intangible Assets - Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "icb6b370021084edc95bee89f173afae4_I20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000067 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details)", "menuCat": "Details", "order": "67", "role": "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails", "shortName": "Goodwill and Intangible Assets - Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000068 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)", "menuCat": "Details", "order": "68", "role": "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsNarrativeDetails", "shortName": "Goodwill and Intangible Assets - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000069 - Disclosure - Goodwill and Intangible Assets - Expected Amortization Expense (Details )", "menuCat": "Details", "order": "69", "role": "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsExpectedAmortizationExpenseDetails", "shortName": "Goodwill and Intangible Assets - Expected Amortization Expense (Details )", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000007 - Statement - CONSOLIDATED AND COMBINED BALANCE SHEETS [Parenthetical]", "menuCat": "Statements", "order": "7", "role": "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETSParenthetical", "shortName": "CONSOLIDATED AND COMBINED BALANCE SHEETS [Parenthetical]", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000070 - Disclosure - Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details)", "menuCat": "Details", "order": "70", "role": "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails", "shortName": "Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8d291f69c2084d18a3b8a210e8688101_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000071 - Disclosure - Property, Plant and Equipment, Net - Narrative (Details)", "menuCat": "Details", "order": "71", "role": "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetNarrativeDetails", "shortName": "Property, Plant and Equipment, Net - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8d291f69c2084d18a3b8a210e8688101_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000072 - Disclosure - Inventories, Net (Details)", "menuCat": "Details", "order": "72", "role": "http://www.colfaxcorp.com/role/InventoriesNetDetails", "shortName": "Inventories, Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000073 - Disclosure - Leases (Details)", "menuCat": "Details", "order": "73", "role": "http://www.colfaxcorp.com/role/LeasesDetails", "shortName": "Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:TaxesPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000074 - Disclosure - Accrued and Other Liabilities - Current and Noncurrent (Details)", "menuCat": "Details", "order": "74", "role": "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails", "shortName": "Accrued and Other Liabilities - Current and Noncurrent (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:TaxesPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i10ca7d1223c44c0db3ae08ac641c291c_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000075 - Disclosure - Accrued and Other Liabilities - Warranty Liability Rollforward (Details)", "menuCat": "Details", "order": "75", "role": "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesWarrantyLiabilityRollforwardDetails", "shortName": "Accrued and Other Liabilities - Warranty Liability Rollforward (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "icb6b370021084edc95bee89f173afae4_I20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i10ca7d1223c44c0db3ae08ac641c291c_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000076 - Disclosure - Accrued and Other Liabilities - Restructuring Rollforward (Details)", "menuCat": "Details", "order": "76", "role": "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails", "shortName": "Accrued and Other Liabilities - Restructuring Rollforward (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "cfx:RestructuringSettlementAndImpairmentProvisionsBeforeNonCashCharges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000077 - Disclosure - Benefit Plans - Narrative (Details)", "menuCat": "Details", "order": "77", "role": "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails", "shortName": "Benefit Plans - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000078 - Disclosure - Benefit Plans - Obligation and Asset Rollforward (Details)", "menuCat": "Details", "order": "78", "role": "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails", "shortName": "Benefit Plans - Obligation and Asset Rollforward (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "id50d6c3deb6c4d7caea772587fa81a0e_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "cfx:DefinedBenefitPlanBenefitObligationTransferFromFormerParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i921605be5115440dbd7c3fc6b7a0c2b3_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000079 - Disclosure - Benefit Plans - Expected Benefit Payments (Details)", "menuCat": "Details", "order": "79", "role": "http://www.colfaxcorp.com/role/BenefitPlansExpectedBenefitPaymentsDetails", "shortName": "Benefit Plans - Expected Benefit Payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i921605be5115440dbd7c3fc6b7a0c2b3_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "ib888b28f54d54ea88905ead73af2cda0_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000008 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF EQUITY", "menuCat": "Statements", "order": "8", "role": "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY", "shortName": "CONSOLIDATED AND COMBINED STATEMENTS OF EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "ib888b28f54d54ea88905ead73af2cda0_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i0b3318a973b24cf185708a5144f84eb4_I20221231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000080 - Disclosure - Benefit Plans - Plan Asset Allocation (Details)", "menuCat": "Details", "order": "80", "role": "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationDetails", "shortName": "Benefit Plans - Plan Asset Allocation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i0b3318a973b24cf185708a5144f84eb4_I20221231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i14206f7dd9b24e6c85d179fd3fbd1d98_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000081 - Disclosure - Benefit Plans - Plan Asset Allocation, Fair Value Hierarchy (Details)", "menuCat": "Details", "order": "81", "role": "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails", "shortName": "Benefit Plans - Plan Asset Allocation, Fair Value Hierarchy (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i14206f7dd9b24e6c85d179fd3fbd1d98_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000082 - Disclosure - Benefit Plans - Net Periodic Benefit Cost (Details)", "menuCat": "Details", "order": "82", "role": "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails", "shortName": "Benefit Plans - Net Periodic Benefit Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "id50d6c3deb6c4d7caea772587fa81a0e_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i921605be5115440dbd7c3fc6b7a0c2b3_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000083 - Disclosure - Benefit Plans - Accumulated Other Comprehensive Income (Details)", "menuCat": "Details", "order": "83", "role": "http://www.colfaxcorp.com/role/BenefitPlansAccumulatedOtherComprehensiveIncomeDetails", "shortName": "Benefit Plans - Accumulated Other Comprehensive Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i921605be5115440dbd7c3fc6b7a0c2b3_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i921605be5115440dbd7c3fc6b7a0c2b3_I20221231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000084 - Disclosure - Benefit Plans - Key Economic Assumptions (Details)", "menuCat": "Details", "order": "84", "role": "http://www.colfaxcorp.com/role/BenefitPlansKeyEconomicAssumptionsDetails", "shortName": "Benefit Plans - Key Economic Assumptions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i921605be5115440dbd7c3fc6b7a0c2b3_I20221231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000085 - Disclosure - Debt - Schedule of Debt (Details)", "menuCat": "Details", "order": "85", "role": "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails", "shortName": "Debt - Schedule of Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProceedsFromLongTermLinesOfCredit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000086 - Disclosure - Debt - Narrative (Details)", "menuCat": "Details", "order": "86", "role": "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "shortName": "Debt - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:LettersOfCreditOutstandingAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000087 - Disclosure - Debt - Schedule of Debt Maturities (Details)", "menuCat": "Details", "order": "87", "role": "http://www.colfaxcorp.com/role/DebtScheduleofDebtMaturitiesDetails", "shortName": "Debt - Schedule of Debt Maturities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6e29ee9a0fe146d39cc9124eb9c8a179_I20220714", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNumberOfInstrumentsHeld", "reportCount": 1, "unique": true, "unitRef": "agreement", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000088 - Disclosure - Derivatives - Narratives (Details)", "menuCat": "Details", "order": "88", "role": "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails", "shortName": "Derivatives - Narratives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6e29ee9a0fe146d39cc9124eb9c8a179_I20220714", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNumberOfInstrumentsHeld", "reportCount": 1, "unique": true, "unitRef": "agreement", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i0f96f64c25774dd49c283a11e10b4a84_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000089 - Disclosure - Derivatives - Summary of the Effects of Designated Cash Flow Hedges on the Company\u2019s Consolidated and Combined Statements of Operations (Details)", "menuCat": "Details", "order": "89", "role": "http://www.colfaxcorp.com/role/DerivativesSummaryoftheEffectsofDesignatedCashFlowHedgesontheCompanysConsolidatedandCombinedStatementsofOperationsDetails", "shortName": "Derivatives - Summary of the Effects of Designated Cash Flow Hedges on the Company\u2019s Consolidated and Combined Statements of Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i0f96f64c25774dd49c283a11e10b4a84_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000009 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF EQUITY [Parenthetical]", "menuCat": "Statements", "order": "9", "role": "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITYParenthetical", "shortName": "CONSOLIDATED AND COMBINED STATEMENTS OF EQUITY [Parenthetical]", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000090 - Disclosure - Derivatives - Schedule of Fair Values of Derivative Instruments in the Financial Statements (Details)", "menuCat": "Details", "order": "90", "role": "http://www.colfaxcorp.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails", "shortName": "Derivatives - Schedule of Fair Values of Derivative Instruments in the Financial Statements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i5840e64293874064ac81c2b806f5cd7e_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:UnrealizedGainLossOnDerivatives", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000091 - Disclosure - Derivatives - Not Designated as Hedging Instruments (Details)", "menuCat": "Details", "order": "91", "role": "http://www.colfaxcorp.com/role/DerivativesNotDesignatedasHedgingInstrumentsDetails", "shortName": "Derivatives - Not Designated as Hedging Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i5840e64293874064ac81c2b806f5cd7e_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:UnrealizedGainLossOnDerivatives", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000092 - Disclosure - Fair Value Measurements - Fair Value Hierarchy (Details)", "menuCat": "Details", "order": "92", "role": "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails", "shortName": "Fair Value Measurements - Fair Value Hierarchy (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i10ca7d1223c44c0db3ae08ac641c291c_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000093 - Disclosure - Equity - Accumulated Other Comprehensive Loss (Details)", "menuCat": "Details", "order": "93", "role": "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails", "shortName": "Equity - Accumulated Other Comprehensive Loss (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000094 - Disclosure - Equity - Narratives (Details)", "menuCat": "Details", "order": "94", "role": "http://www.colfaxcorp.com/role/EquityNarrativesDetails", "shortName": "Equity - Narratives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "id2a683f2583c4c4188a9258facc5525f_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000095 - Disclosure - Equity - PRSU and RSU Activity (Details)", "menuCat": "Details", "order": "95", "role": "http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails", "shortName": "Equity - PRSU and RSU Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "id2a683f2583c4c4188a9258facc5525f_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "cfx:FutureClaimsPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000096 - Disclosure - Commitments and Contingencies - Narrative (Details)", "menuCat": "Details", "order": "96", "role": "http://www.colfaxcorp.com/role/CommitmentsandContingenciesNarrativeDetails", "shortName": "Commitments and Contingencies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "cfx:FutureClaimsPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cfx:ScheduleOfLossContingenciesByClaimsQuantitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i10ca7d1223c44c0db3ae08ac641c291c_I20211231", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyPendingClaimsNumber", "reportCount": 1, "unique": true, "unitRef": "claim", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000097 - Disclosure - Commitments and Contingencies - Claims Rollforward (Details)", "menuCat": "Details", "order": "97", "role": "http://www.colfaxcorp.com/role/CommitmentsandContingenciesClaimsRollforwardDetails", "shortName": "Commitments and Contingencies - Claims Rollforward (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cfx:ScheduleOfLossContingenciesByClaimsQuantitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i10ca7d1223c44c0db3ae08ac641c291c_I20211231", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyPendingClaimsNumber", "reportCount": 1, "unique": true, "unitRef": "claim", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cfx:ScheduleOfAsbestosRelatedLitigationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000098 - Disclosure - Commitments and Contingencies - Asbestos Litigation (Details)", "menuCat": "Details", "order": "98", "role": "http://www.colfaxcorp.com/role/CommitmentsandContingenciesAsbestosLitigationDetails", "shortName": "Commitments and Contingencies - Asbestos Litigation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cfx:ScheduleOfAsbestosRelatedLitigationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i8259cd571f3b4b07af1718f9a5f778ca_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cfx-20221231.htm", "contextRef": "i6be5bca577914653a63fe9f0dd533483_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000099 - Disclosure - Segment Information - Narratives (Details)", "menuCat": "Details", "order": "99", "role": "http://www.colfaxcorp.com/role/SegmentInformationNarrativesDetails", "shortName": "Segment Information - Narratives (Details)", "subGroupType": "details", "uniqueAnchor": null } }, "segmentCount": 104, "tag": { "cfx_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accounts Receivable, Allowance For Credit Loss, Foreign Currency Translation", "label": "Accounts Receivable, Allowance For Credit Loss, Foreign Currency Translation", "terseLabel": "Foreign Currency Translation" } } }, "localname": "AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslation", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/RevenueAllowanceforCreditLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "cfx_AccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the accrued liabilities during the reporting period.", "label": "Accrued Liabilities Disclosure [Text Block]", "terseLabel": "Accrued and Other Liabilities" } } }, "localname": "AccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilities" ], "xbrltype": "textBlockItemType" }, "cfx_AccruedThirdPartyCommisionsNoncurrent": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": 6.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Third-Party Commisions, Noncurrent", "label": "Accrued Third-Party Commisions, Noncurrent", "terseLabel": "Third-party commissions" } } }, "localname": "AccruedThirdPartyCommisionsNoncurrent", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "xbrltype": "monetaryItemType" }, "cfx_AccumulatedGainLossNetInvestmentHedgesParentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accumulated Gain (Loss), Net Investment Hedges, Parent", "label": "Accumulated Gain (Loss), Net Investment Hedges, Parent [Member]", "terseLabel": "Loss on Net Investment Hedges" } } }, "localname": "AccumulatedGainLossNetInvestmentHedgesParentMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "cfx_AcquiredTradeNamesCustomerRelationshipsAcquiredTechnologyAndSoftwareLicenseAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquired Trade names, Customer Relationships, Acquired Technology and Software License Agreements", "label": "Acquired Trade names, Customer Relationships, Acquired Technology and Software License Agreements [Member]", "terseLabel": "Acquired Trade names, Customer Relationships, Acquired Technology and Software License Agreements" } } }, "localname": "AcquiredTradeNamesCustomerRelationshipsAcquiredTechnologyAndSoftwareLicenseAgreementsMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "cfx_AdjustedEarningsBeforeInterestTaxesAndAmortization": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjusted Earnings Before Interest, Taxes And Amortization", "label": "Adjusted Earnings Before Interest, Taxes And Amortization", "terseLabel": "Adjusted EBITDA" } } }, "localname": "AdjustedEarningsBeforeInterestTaxesAndAmortization", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "cfx_AmericasBusinessSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Americas Business Segment", "label": "Americas Business Segment [Member]", "terseLabel": "Americas" } } }, "localname": "AmericasBusinessSegmentMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails", "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsGoodwillDetails" ], "xbrltype": "domainItemType" }, "cfx_AmericasSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Americas Segment", "label": "Americas Segment [Member]", "terseLabel": "Americas" } } }, "localname": "AmericasSegmentMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "cfx_AmortizationOfAcquiredIntangibleAssetsAndAcquisitionCosts": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization of Acquired Intangible Assets and Acquisition Costs", "label": "Amortization of Acquired Intangible Assets and Acquisition Costs", "verboseLabel": "Acquisition - amortization and other related charges" } } }, "localname": "AmortizationOfAcquiredIntangibleAssetsAndAcquisitionCosts", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "cfx_AsbestosRelatedActivityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asbestos Related Activity", "label": "Asbestos Related Activity [Member]", "terseLabel": "Asbestos Related Activity" } } }, "localname": "AsbestosRelatedActivityMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/DiscontinuedOperationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cfx_AuditorInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Auditor Information", "label": "Auditor Information [Abstract]" } } }, "localname": "AuditorInformationAbstract", "nsuri": "http://www.colfaxcorp.com/20221231", "xbrltype": "stringItemType" }, "cfx_ConsumableProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consumable Products [Member]", "label": "Consumable Products [Member]", "terseLabel": "Consumables" } } }, "localname": "ConsumableProductsMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/RevenueDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "cfx_DebtInstrumentCovenantInterestCoverageRatioMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenant, Interest Coverage Ratio, Minimum", "label": "Debt Instrument, Covenant, Interest Coverage Ratio, Minimum", "terseLabel": "Minimum interest coverage ratio" } } }, "localname": "DebtInstrumentCovenantInterestCoverageRatioMinimum", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "pureItemType" }, "cfx_DebtInstrumentCovenantLeverageRatioMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum", "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum", "terseLabel": "Maximum total leverage ratio" } } }, "localname": "DebtInstrumentCovenantLeverageRatioMaximum", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "pureItemType" }, "cfx_DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-government bonds", "label": "Debt Security, Government, Non-US And Debt Security, Corporate, Non-US [Member]", "terseLabel": "Non-U.S. government and corporate bonds" } } }, "localname": "DebtSecurityGovernmentNonUSAndDebtSecurityCorporateNonUSMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "cfx_DeferredTaxAssetPropertyPlantAndEquipmentAndGoodwillAndIntangibleAssets": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from depreciation and amortization.", "label": "Deferred Tax Asset, Property Plant and Equipment and Goodwill and Intangible Assets", "terseLabel": "Depreciation and amortization" } } }, "localname": "DeferredTaxAssetPropertyPlantAndEquipmentAndGoodwillAndIntangibleAssets", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "cfx_DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndGoodwillAndIntangibleAssets": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from depreciation and amortization.", "label": "Deferred Tax Liabilities, Property Plant and Equipment and Goodwill and Intangible Assets", "negatedLabel": "Depreciation and amortization" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndGoodwillAndIntangibleAssets", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "cfx_DeferredTaxLiabilitiesUndistributedForeignEarningsIncreaseDecreaseInLiabilityFromPriorYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Liabilities, Undistributed Foreign Earnings, Increase (Decrease) In Liability From Prior Year", "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings, Increase (Decrease) In Liability From Prior Year", "terseLabel": "Deferred tax liability, increase (decrease)" } } }, "localname": "DeferredTaxLiabilitiesUndistributedForeignEarningsIncreaseDecreaseInLiabilityFromPriorYear", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cfx_DefinedBenefitPlanBenefitObligationTransferFromFormerParent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Benefit Obligation, Transfer From Former Parent", "label": "Defined Benefit Plan, Benefit Obligation, Transfer From Former Parent", "verboseLabel": "Transfer from Former Parent" } } }, "localname": "DefinedBenefitPlanBenefitObligationTransferFromFormerParent", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "cfx_DefinedBenefitPlanEquitySecuritiesUSMidSmallCapMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "US small to mid-cap securities.", "label": "Defined Benefit Plan, Equity Securities, US, Mid/Small Cap [Member]", "terseLabel": "U.S. small/mid cap" } } }, "localname": "DefinedBenefitPlanEquitySecuritiesUSMidSmallCapMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "cfx_DefinedBenefitPlanInsuranceContractsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Insurance Contracts", "label": "Defined Benefit Plan, Insurance Contracts [Member]", "terseLabel": "Insurance contracts" } } }, "localname": "DefinedBenefitPlanInsuranceContractsMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationDetails", "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "cfx_DefinedBenefitPlanInvestmentFundsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Investment Funds", "label": "Defined Benefit Plan, Investment Funds [Member]", "terseLabel": "Investment funds" } } }, "localname": "DefinedBenefitPlanInvestmentFundsMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationDetails", "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "cfx_DefinedBenefitPlanOtherAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "", "label": "Defined Benefit Plan, Other Assets [Member]", "terseLabel": "Other" } } }, "localname": "DefinedBenefitPlanOtherAssetsMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "cfx_DefinedBenefitPlanOtherFixedIncomeMutualFundsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Other Fixed Income Mutual Funds", "label": "Defined Benefit Plan, Other Fixed Income Mutual Funds [Member]", "terseLabel": "Other" } } }, "localname": "DefinedBenefitPlanOtherFixedIncomeMutualFundsMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "cfx_DepreciationAndOtherAmortization": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails": { "order": 8.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Depreciation and Other Amortization", "label": "Depreciation and Other Amortization", "terseLabel": "Depreciation and other amortization" } } }, "localname": "DepreciationAndOtherAmortization", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "cfx_EMEAAPACBusinessSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EMEA & APAC Business Segment", "label": "EMEA & APAC Business Segment [Member]", "terseLabel": "EMEA & APAC" } } }, "localname": "EMEAAPACBusinessSegmentMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsGoodwillDetails" ], "xbrltype": "domainItemType" }, "cfx_EMEAAndAPACSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EMEA and APAC Segment", "label": "EMEA and APAC Segment [Member]", "terseLabel": "EMEA & APAC", "verboseLabel": "EMEA & APAC" } } }, "localname": "EMEAAndAPACSegmentMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails", "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "cfx_ESABCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ESAB Corporation", "label": "ESAB Corporation [Member]", "terseLabel": "ESAB Corporation" } } }, "localname": "ESABCorporationMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "cfx_EffectiveIncomeTaxRateReconciliationBusinessCombinationExpectedTaxDeductibleAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Business Combination, Expected Tax Deductible Amount", "label": "Effective Income Tax Rate Reconciliation, Business Combination, Expected Tax Deductible Amount", "terseLabel": "Cash tax benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationBusinessCombinationExpectedTaxDeductibleAmount", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cfx_EffectiveIncomeTaxRateReconciliationGILTIFDIIAndSubPartFOfForeignTaxCreditsAmount": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": { "order": 12.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, GILTI, FDII And SubPart F of Foreign Tax Credits, Amount", "label": "Effective Income Tax Rate Reconciliation, GILTI, FDII And SubPart F of Foreign Tax Credits, Amount", "terseLabel": "Effect of U.S. taxation on international operations" } } }, "localname": "EffectiveIncomeTaxRateReconciliationGILTIFDIIAndSubPartFOfForeignTaxCreditsAmount", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "cfx_EffectiveIncomeTaxRateReconciliationWithholdingTaxesAmount": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": { "order": 6.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Withholding Taxes, Amount", "label": "Effective Income Tax Rate Reconciliation, Withholding Taxes, Amount", "terseLabel": "Withholding taxes" } } }, "localname": "EffectiveIncomeTaxRateReconciliationWithholdingTaxesAmount", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "cfx_EmployeeRelatedLiabilitiesNoncurrent": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Employee-Related Liabilities, Noncurrent", "label": "Employee-Related Liabilities, Noncurrent", "terseLabel": "Compensation and related benefits" } } }, "localname": "EmployeeRelatedLiabilitiesNoncurrent", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "xbrltype": "monetaryItemType" }, "cfx_EnovisCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Enovis Corporation", "label": "Enovis Corporation [Member]", "terseLabel": "Enovis Corporation" } } }, "localname": "EnovisCorporationMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "cfx_EquipmentProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment Products [Member]", "label": "Equipment Products [Member]", "terseLabel": "Equipment" } } }, "localname": "EquipmentProductsMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/RevenueDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "cfx_FormerParentInvestment": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Former Parent Investment", "label": "Former Parent Investment", "terseLabel": "Former Parent's investment" } } }, "localname": "FormerParentInvestment", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "cfx_FormerParentInvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Former Parent Investment", "label": "Former Parent Investment [Member]", "terseLabel": "Former Parent\u2019s Investment" } } }, "localname": "FormerParentInvestmentMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY" ], "xbrltype": "domainItemType" }, "cfx_FormerParentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Former Parent", "label": "Former Parent [Member]", "terseLabel": "Former Parent" } } }, "localname": "FormerParentMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "cfx_FutureClaimsPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period for which the Company believes it can reasonably estimate the asbestos-related liability for pending and future claims that will be resolved.", "label": "Future Claims Period", "terseLabel": "Future claims period (in years)" } } }, "localname": "FutureClaimsPeriod", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "cfx_IncomeTaxReconciliationIncomeTaxExpenseProvisionToReturn": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": { "order": 11.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income Tax Reconciliation, Income Tax Expense Provision To Return", "label": "Income Tax Reconciliation, Income Tax Expense Provision To Return", "terseLabel": "Provision to return" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseProvisionToReturn", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "cfx_IntangibleAssetsScheduleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Line Items] for Intangible Assets Schedule [Table]", "label": "Intangible Assets Schedule [Line Items]", "terseLabel": "Intangible Assets Schedule [Line Items]" } } }, "localname": "IntangibleAssetsScheduleLineItems", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "cfx_InterestExpenseIncomeAndOtherNet": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest Expense (Income) and Other, Net", "label": "Interest Expense (Income) and Other, Net", "terseLabel": "Interest expense (income) and other, net" } } }, "localname": "InterestExpenseIncomeAndOtherNet", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "cfx_InterestExpenseIncomeAndOtherNetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Expense (Income) And Other, Net", "label": "Interest Expense (Income) And Other, Net [Member]", "terseLabel": "Interest expense (income) and other, net" } } }, "localname": "InterestExpenseIncomeAndOtherNetMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesSummaryoftheEffectsofDesignatedCashFlowHedgesontheCompanysConsolidatedandCombinedStatementsofOperationsDetails" ], "xbrltype": "domainItemType" }, "cfx_InternationalEquitySecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "International member", "label": "International Equity Securities [Member]", "terseLabel": "International" } } }, "localname": "InternationalEquitySecuritiesMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationDetails" ], "xbrltype": "domainItemType" }, "cfx_IssuanceOfCommonStockSharesSeparationAndReclassificationOfNetInvestmentFromFormerParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of Common Stock, Shares, Separation and Reclassification of Net Investment from Former Parent", "label": "Issuance of Common Stock, Shares, Separation and Reclassification of Net Investment from Former Parent", "terseLabel": "Issuance of common stock in connection with the Separation and reclassification of Net Investment from Former Parent (in shares)" } } }, "localname": "IssuanceOfCommonStockSharesSeparationAndReclassificationOfNetInvestmentFromFormerParent", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY" ], "xbrltype": "sharesItemType" }, "cfx_IssuanceOfCommonStockValueSeparationAndReclassificationOfNetInvestmentFromFormerParent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance Of Common Stock, Value, Separation And Reclassification Of Net Investment From Former Parent", "label": "Issuance Of Common Stock, Value, Separation And Reclassification Of Net Investment From Former Parent", "terseLabel": "Issuance of common stock in connection with the Separation and reclassification of Net Investment from Former Parent" } } }, "localname": "IssuanceOfCommonStockValueSeparationAndReclassificationOfNetInvestmentFromFormerParent", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY" ], "xbrltype": "monetaryItemType" }, "cfx_LeasesWeightedAverageDiscountRateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Leases, Weighted Average Discount Rate [Abstract]", "label": "Leases, Weighted Average Discount Rate [Abstract]", "terseLabel": "Weighted-average discount rate:" } } }, "localname": "LeasesWeightedAverageDiscountRateAbstract", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/LeasesDetails" ], "xbrltype": "stringItemType" }, "cfx_LossContingencyAverageCostResolvedClaims": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Average cost of asbestos claims resolved excluding claims settled in Mississippi for which the majority of claims have historically been resolved for no payment.", "label": "Loss Contingency Average Cost Resolved Claims", "terseLabel": "Average cost of resolved claims" } } }, "localname": "LossContingencyAverageCostResolvedClaims", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/CommitmentsandContingenciesClaimsRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "cfx_MembersEquityTransfersToFromParentNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Members' Equity, Transfers To (From) Parent, Net", "label": "Members' Equity, Transfers To (From) Parent, Net", "negatedTerseLabel": "Members' Equity, Transfers to (from) Parent, Net" } } }, "localname": "MembersEquityTransfersToFromParentNet", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY" ], "xbrltype": "monetaryItemType" }, "cfx_NetIncomeLossFromContinuingOperationsAttributableToParent": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net Income (Loss) from Continuing Operations Attributable to Parent", "label": "Net Income (Loss) from Continuing Operations Attributable to Parent", "terseLabel": "Income from continuing operations attributable to ESAB Corporation" } } }, "localname": "NetIncomeLossFromContinuingOperationsAttributableToParent", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "cfx_NetTransfersFromToFormerParentIncludingSeparationAdjustments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net Transfers From (To) Former Parent, Including Separation Adjustments", "label": "Net Transfers From (To) Former Parent, Including Separation Adjustments", "negatedTerseLabel": "Net Transfers from Former Parent, including Separation Adjustments" } } }, "localname": "NetTransfersFromToFormerParentIncludingSeparationAdjustments", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY" ], "xbrltype": "monetaryItemType" }, "cfx_NonCashImpairmentRestructuringProvisions": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails": { "order": 2.0, "parentTag": "us-gaap_RestructuringCharges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of impairment charges recognized during the period as a result of restructuring activities.", "label": "Non Cash Impairment Restructuring Provisions", "terseLabel": "Non cash charges" } } }, "localname": "NonCashImpairmentRestructuringProvisions", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "cfx_NonCashInterestExpense": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non-Cash Interest Expense", "label": "Non-Cash Interest Expense", "terseLabel": "Non-cash interest expense" } } }, "localname": "NonCashInterestExpense", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "cfx_NumberOfDefinedBenefitPlans": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Defined Benefit Plans", "label": "Number Of Defined Benefit Plans", "terseLabel": "Number of defined benefit plans" } } }, "localname": "NumberOfDefinedBenefitPlans", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails", "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "integerItemType" }, "cfx_OCIBeforeReclassificationsNetOfTaxAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "OCI, Before Reclassifications, Net Of Tax, Attributable To Parent", "label": "OCI, Before Reclassifications, Net Of Tax, Attributable To Parent [Abstract]", "terseLabel": "Other comprehensive income (loss) before reclassifications:" } } }, "localname": "OCIBeforeReclassificationsNetOfTaxAttributableToParentAbstract", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "cfx_OhioMedicalLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ohio Medical, LLC,", "label": "Ohio Medical, LLC, [Member]", "terseLabel": "Ohio Medical, LLC," } } }, "localname": "OhioMedicalLLCMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cfx_OtherComprehensiveIncomeLossNetOfTaxContributionsFromParent": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails": { "order": 1.0, "parentTag": "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Comprehensive Income (Loss), Net of Tax, Contributions from Parent", "label": "Other Comprehensive Income (Loss), Net of Tax, Contributions from Parent", "terseLabel": "Amounts contributed by Former Parent" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxContributionsFromParent", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "cfx_OtherComprehensiveIncomeLossTransferFromFormerParentBeforeTax": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails": { "order": 6.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other Comprehensive (Income) Loss, Transfer from Former Parent, before Tax", "label": "Other Comprehensive (Income) Loss, Transfer from Former Parent, before Tax", "terseLabel": "Transfer from Former Parent" } } }, "localname": "OtherComprehensiveIncomeLossTransferFromFormerParentBeforeTax", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "cfx_OtherForeignCountriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Foreign Countries", "label": "Other Foreign Countries [Member]", "terseLabel": "Other foreign countries" } } }, "localname": "OtherForeignCountriesMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformationNetSalesandPPEbyGeographyDetails" ], "xbrltype": "domainItemType" }, "cfx_PaymentsToFormerParentConsiderationTransferred": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments To Former Parent, Consideration Transferred", "label": "Payments To Former Parent, Consideration Transferred", "negatedTerseLabel": "Consideration to Former Parent in connection with the Separation" } } }, "localname": "PaymentsToFormerParentConsiderationTransferred", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "cfx_RestructuringSettlementAndImpairmentProvisionsBeforeNonCashCharges": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails": { "order": 1.0, "parentTag": "us-gaap_RestructuringCharges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount provided for estimated restructuring charges, remediation costs, before non-cash asset impairment charges during an accounting period. Generally, these items are either unusual or infrequent, but not both (in which case they would be extraordinary items).", "label": "Restructuring, Settlement And Impairment Provisions Before Non-Cash Charges", "terseLabel": "Charges" } } }, "localname": "RestructuringSettlementAndImpairmentProvisionsBeforeNonCashCharges", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "cfx_SaleOfStockByNonControllingInterestNumberOfSharesSold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Of Stock By Non-Controlling Interest, Number Of Shares Sold", "label": "Sale Of Stock By Non-Controlling Interest, Number Of Shares Sold", "terseLabel": "Number of shares sold (in shares)" } } }, "localname": "SaleOfStockByNonControllingInterestNumberOfSharesSold", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "sharesItemType" }, "cfx_ScheduleOfAsbestosRelatedLitigationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the presentation of asbestos litigation on the statement of financial position, including the amounts and location of such amounts.", "label": "Schedule Of Asbestos Related Litigation [Table Text Block]", "verboseLabel": "Schedule Of Asbestos Related Litigation" } } }, "localname": "ScheduleOfAsbestosRelatedLitigationTableTextBlock", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/CommitmentsandContingenciesTables" ], "xbrltype": "textBlockItemType" }, "cfx_ScheduleOfLossContingenciesByClaimsQuantitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the rollforward of asbestos claims activity during the year, including claims filed and resolved.", "label": "Schedule Of Loss Contingencies By Claims Quantities [Table Text Block]", "verboseLabel": "Schedule Of Loss Contingencies By Claims Quantities" } } }, "localname": "ScheduleOfLossContingenciesByClaimsQuantitiesTableTextBlock", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/CommitmentsandContingenciesTables" ], "xbrltype": "textBlockItemType" }, "cfx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period", "terseLabel": "Award performance period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/EquityNarrativesDetails" ], "xbrltype": "durationItemType" }, "cfx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAwardsConvertedFromFormerParentPlan": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Awards Converted From Former Parent Plan", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Awards Converted From Former Parent Plan", "terseLabel": "Awards converted from Former Parent plan (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAwardsConvertedFromFormerParentPlan", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails" ], "xbrltype": "sharesItemType" }, "cfx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAwardsConvertedFromFormerParentWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Awards Converted From Former Parent, Weighted Average Grant Date Fair Value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Awards Converted From Former Parent, Weighted Average Grant Date Fair Value", "terseLabel": "Awards converted from Former Parent plan (in usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAwardsConvertedFromFormerParentWeightedAverageGrantDateFairValue", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails" ], "xbrltype": "perShareItemType" }, "cfx_SharesIssuedValueShareBasedPaymentArrangementWithFormerParentCompany": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares Issued, Value, Share-Based Payment Arrangement with Former Parent Company", "label": "Shares Issued, Value, Share-Based Payment Arrangement with Former Parent Company", "terseLabel": "Former Parent Common stock-based award activity" } } }, "localname": "SharesIssuedValueShareBasedPaymentArrangementWithFormerParentCompany", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY" ], "xbrltype": "monetaryItemType" }, "cfx_SwiftCutAutomationLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swift Cut Automation Limited", "label": "Swift Cut Automation Limited [Member]", "terseLabel": "Swift Cut Automation Limited" } } }, "localname": "SwiftCutAutomationLimitedMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cfx_TheCreditAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Credit Agreement", "label": "The Credit Agreement [Member]", "terseLabel": "The Credit Agreement" } } }, "localname": "TheCreditAgreementMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails", "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "cfx_TherapyEquipmentLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Therapy Equipment Limited", "label": "Therapy Equipment Limited [Member]", "terseLabel": "Therapy Equipment Limited" } } }, "localname": "TherapyEquipmentLimitedMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "cfx_TransferredFromFormerParentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transferred From Former Parent", "label": "Transferred From Former Parent [Member]", "terseLabel": "Transferred From Former Parent" } } }, "localname": "TransferredFromFormerParentMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "cfx_TransfersToFromParentNet": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Transfers To (From) Parent, Net", "label": "Transfers To (From) Parent, Net", "negatedTerseLabel": "Transfers from (to) Former Parent, net" } } }, "localname": "TransfersToFromParentNet", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "cfx_U.S.EquitySecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "U.S. Equity Securities [Member]", "label": "U.S. Equity Securities [Member]", "terseLabel": "U.S." } } }, "localname": "U.S.EquitySecuritiesMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationDetails" ], "xbrltype": "domainItemType" }, "cfx_USGovernmentAgenciesDebtSecuritiesAndCorporateDebtSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "US Government Agencies Debt Securities and Corporate Debt Securities", "label": "US Government Agencies Debt Securities and Corporate Debt Securities [Member]", "terseLabel": "U.S. government and corporate" } } }, "localname": "USGovernmentAgenciesDebtSecuritiesAndCorporateDebtSecuritiesMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "cfx_UncommittedCreditLineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Uncommitted Credit Line", "label": "Uncommitted Credit Line [Member]", "terseLabel": "Uncommitted Credit Line" } } }, "localname": "UncommittedCreditLineMember", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "cfx_UnrecognizedTaxBenefitsDecreaseResultingFromTransferFromFormerParentImpactOfForeignCurrencyTranslationAndOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unrecognized Tax Benefits, Decrease Resulting From Transfer from Former Parent, Impact Of Foreign Currency Translation And Other", "label": "Unrecognized Tax Benefits, Decrease Resulting From Transfer from Former Parent, Impact Of Foreign Currency Translation And Other", "negatedTerseLabel": "Transfer from Former Parent, impact of foreign currency translation and other" } } }, "localname": "UnrecognizedTaxBenefitsDecreaseResultingFromTransferFromFormerParentImpactOfForeignCurrencyTranslationAndOther", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "cfx_ValuationAllowanceDeferredTaxAssetDecreaseAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "", "label": "Valuation Allowance, Deferred Tax Asset, Decrease, Amount", "negatedTerseLabel": "Decrease in valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetDecreaseAmount", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cfx_ValuationAllowanceDeferredTaxAssetIncreaseAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "", "label": "Valuation Allowance, Deferred Tax Asset, Increase, Amount", "terseLabel": "Increase in valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetIncreaseAmount", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cfx_WeightedAverageRemainingLeaseTermAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Lease Term [Abstract]", "label": "Weighted Average Remaining Lease Term [Abstract]", "terseLabel": "Weighted-average remaining lease term (in years):" } } }, "localname": "WeightedAverageRemainingLeaseTermAbstract", "nsuri": "http://www.colfaxcorp.com/20221231", "presentation": [ "http://www.colfaxcorp.com/role/LeasesDetails" ], "xbrltype": "stringItemType" }, "country_CZ": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CZECHIA", "terseLabel": "Czech Republic" } } }, "localname": "CZ", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformationNetSalesandPPEbyGeographyDetails" ], "xbrltype": "domainItemType" }, "country_IN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INDIA", "terseLabel": "India" } } }, "localname": "IN", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformationNetSalesandPPEbyGeographyDetails" ], "xbrltype": "domainItemType" }, "country_MX": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MEXICO", "terseLabel": "Mexico" } } }, "localname": "MX", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformationNetSalesandPPEbyGeographyDetails" ], "xbrltype": "domainItemType" }, "country_RU": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RUSSIAN FEDERATION", "terseLabel": "Russia" } } }, "localname": "RU", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails", "http://www.colfaxcorp.com/role/SegmentInformationNetSalesandPPEbyGeographyDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationDetails", "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails", "http://www.colfaxcorp.com/role/SegmentInformationNetSalesandPPEbyGeographyDetails", "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "currency_ARS": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Argentina, Pesos", "terseLabel": "Argentina, Pesos" } } }, "localname": "ARS", "nsuri": "http://xbrl.sec.gov/currency/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNetForeignTransactionGainsandLossesDetails" ], "xbrltype": "domainItemType" }, "currency_AllCurrenciesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "All Currencies [Domain]", "terseLabel": "All Currencies [Domain]" } } }, "localname": "AllCurrenciesDomain", "nsuri": "http://xbrl.sec.gov/currency/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNetForeignTransactionGainsandLossesDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r950", "r951", "r952" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/AUDITINFORMATION" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r950", "r951", "r952" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/AUDITINFORMATION" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r950", "r951", "r952" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/AUDITINFORMATION" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r950", "r951", "r952" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r953" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r948" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r947" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/AcquisitionsNarrativeDetails", "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r947" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r947" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r954" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r947" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r947" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r947" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r947" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r955" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r950", "r951", "r952" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/AcquisitionsNarrativeDetails", "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r946" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r949" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.colfaxcorp.com/role/COVERPAGE" ], "xbrltype": "tradingSymbolItemType" }, "srt_AffiliatedEntityMember": { "auth_ref": [ "r874", "r879", "r1073", "r1111", "r1112", "r1113" ], "lang": { "en-us": { "role": { "documentation": "An affiliate is a party that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with the entity.", "label": "Affiliated Entity [Member]", "terseLabel": "Former Partner" } } }, "localname": "AffiliatedEntityMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r352", "r353", "r505", "r534", "r890", "r896", "r898" ], "lang": { "en-us": { "role": { "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r290", "r366", "r375", "r381", "r447", "r668", "r669", "r670", "r697", "r698", "r731", "r732", "r734", "r735", "r782" ], "lang": { "en-us": { "role": { "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]", "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r290", "r366", "r375", "r381", "r447", "r668", "r669", "r670", "r697", "r698", "r731", "r732", "r734", "r735", "r782" ], "lang": { "en-us": { "role": { "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r290", "r366", "r375", "r381", "r447", "r668", "r669", "r670", "r697", "r698", "r731", "r732", "r734", "r735", "r782" ], "lang": { "en-us": { "role": { "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY" ], "xbrltype": "domainItemType" }, "srt_CurrencyAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by currency.", "label": "Currency [Axis]", "terseLabel": "Currency [Axis]" } } }, "localname": "CurrencyAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNetForeignTransactionGainsandLossesDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r489", "r490", "r491", "r492", "r635", "r798", "r834", "r875", "r876", "r912", "r930", "r942", "r1023", "r1116", "r1117", "r1118", "r1119", "r1120", "r1121" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails", "http://www.colfaxcorp.com/role/EquityNarrativesDetails", "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails", "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r489", "r490", "r491", "r492", "r635", "r798", "r834", "r875", "r876", "r912", "r930", "r942", "r1023", "r1116", "r1117", "r1118", "r1119", "r1120", "r1121" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails", "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails", "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Axis]", "terseLabel": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Domain]", "terseLabel": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r435", "r801", "r913", "r940", "r1018", "r1019", "r1025", "r1123" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/RevenueDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r435", "r801", "r913", "r940", "r1018", "r1019", "r1025", "r1123" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/RevenueDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r489", "r490", "r491", "r492", "r587", "r635", "r662", "r663", "r664", "r797", "r798", "r834", "r875", "r876", "r912", "r930", "r942", "r1012", "r1023", "r1117", "r1118", "r1119", "r1120", "r1121" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]", "terseLabel": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails", "http://www.colfaxcorp.com/role/EquityNarrativesDetails", "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails", "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r489", "r490", "r491", "r492", "r587", "r635", "r662", "r663", "r664", "r797", "r798", "r834", "r875", "r876", "r912", "r930", "r942", "r1012", "r1023", "r1117", "r1118", "r1119", "r1120", "r1121" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]", "terseLabel": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails", "http://www.colfaxcorp.com/role/EquityNarrativesDetails", "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails", "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r352", "r353", "r505", "r534", "r897", "r898" ], "lang": { "en-us": { "role": { "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r636", "r988", "r1125" ], "lang": { "en-us": { "role": { "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.", "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r381", "r636", "r958", "r988" ], "lang": { "en-us": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": { "auth_ref": [ "r362", "r889" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]", "terseLabel": "Schedule II - Valuation and Qualifying Accounts" } } }, "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccounts" ], "xbrltype": "textBlockItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r436", "r437", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r878", "r881", "r882", "r883", "r884", "r885", "r886", "r887", "r888", "r914", "r941", "r1025" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails", "http://www.colfaxcorp.com/role/SegmentInformationNetSalesandPPEbyGeographyDetails", "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r436", "r437", "r859", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r878", "r880", "r914", "r941", "r1025" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails", "http://www.colfaxcorp.com/role/SegmentInformationNetSalesandPPEbyGeographyDetails", "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r381", "r636", "r958", "r959", "r988" ], "lang": { "en-us": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]" } } }, "localname": "ValuationAndQualifyingAccountsAbstract", "nsuri": "http://fasb.org/srt/2022", "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureLineItems", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureTable": { "auth_ref": [ "r356", "r357", "r358", "r360", "r361", "r889" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureTable", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]" } } }, "localname": "AOCIAttributableToParentNetOfTaxRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r38", "r939" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "auth_ref": [ "r998" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]", "terseLabel": "Schedule of Accounts Receivable, Allowance for Credit Loss" } } }, "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r441", "r442" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Trade receivables, less allowance for credit losses of $23,471 and $23,912" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued liabilities", "totalLabel": "Accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails", "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accrued Liabilities [Abstract]", "terseLabel": "Accrued Liabilities [Abstract]" } } }, "localname": "AccruedLiabilitiesCurrentAndNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccruedSalesCommissionCurrent": { "auth_ref": [ "r43", "r894" ], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": 9.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Sales Commission, Current", "terseLabel": "Third-party commissions" } } }, "localname": "AccruedSalesCommissionCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r54", "r61", "r214", "r970", "r971", "r972" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Net Unrecognized Pension and Other Post-Retirement Benefit Cost" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r133", "r300" ], "calculation": { "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedTerseLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "auth_ref": [ "r322", "r332", "r333", "r725", "r899", "r970" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "terseLabel": "Gain on Cash Flow Hedges" } } }, "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r58", "r60", "r61", "r309", "r827", "r839", "r842" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r331", "r332", "r760", "r761", "r762", "r763", "r764", "r767" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r57", "r61", "r214", "r783", "r835", "r836", "r970", "r971", "r972", "r985", "r986", "r987" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY", "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r51", "r61", "r214", "r332", "r333", "r761", "r762", "r763", "r764", "r767", "r970" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Translation Adjustment" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails", "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r30", "r939" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r668", "r669", "r670", "r985", "r986", "r987", "r1106" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r666" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-Based Payment Arrangement, Expense", "terseLabel": "Stock-based compensation expenses" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityNarrativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForCreditLossMember": { "auth_ref": [ "r979", "r980", "r981", "r982", "r983" ], "lang": { "en-us": { "role": { "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]", "terseLabel": "Allowance for credit losses" } } }, "localname": "AllowanceForCreditLossMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r310", "r443", "r450" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "periodEndLabel": "Balance at End of Period", "periodStartLabel": "Balance at Beginning of Period", "terseLabel": "Allowance for credit losses" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETSParenthetical", "http://www.colfaxcorp.com/role/RevenueAllowanceforCreditLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]", "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableRollforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/RevenueAllowanceforCreditLossRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "auth_ref": [ "r451" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.", "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "negatedTerseLabel": "Write-Offs and Deductions" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/RevenueAllowanceforCreditLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r89", "r119", "r125" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r258", "r276", "r304", "r348", "r419", "r425", "r431", "r446", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r721", "r726", "r747", "r939", "r1021", "r1022", "r1114" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Total Assets:", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS", "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r295", "r315", "r348", "r446", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r721", "r726", "r747", "r939", "r1021", "r1022", "r1114" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "CURRENT ASSETS:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r242" ], "calculation": { "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "totalLabel": "Total assets at fair value" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets:" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsTotalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total assets, when it serves as a benchmark in a concentration of risk calculation, representing the sum of all reported assets as of the balance sheet date.", "label": "Assets, Total [Member]", "terseLabel": "Assets, Total" } } }, "localname": "AssetsTotalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityNarrativesDetails", "http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails", "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesBalanceSheetItemsDetails", "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r226", "r231" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails", "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesBalanceSheetItemsDetails", "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Base Rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BridgeLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financing which is expected to be replaced by a medium to long-term loan. The loan \"bridges\" the gap in time when otherwise no financing would be in place.", "label": "Bridge Loan [Member]", "terseLabel": "Swing Line Loan Sub-Facility" } } }, "localname": "BridgeLoanMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingAndBuildingImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.", "label": "Building and Building Improvements [Member]", "terseLabel": "Buildings and improvements" } } }, "localname": "BuildingAndBuildingImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r717", "r924", "r927" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AcquisitionsNarrativeDetails", "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails", "http://www.colfaxcorp.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r195", "r196", "r717", "r924", "r927" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AcquisitionsNarrativeDetails", "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails", "http://www.colfaxcorp.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r200", "r201", "r202" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Purchase price" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AcquisitionsNarrativeDetails", "http://www.colfaxcorp.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r203", "r718" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "verboseLabel": "Acquisitions" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/Acquisitions" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r91", "r298", "r891" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails": { "order": 2.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Member]", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationDetails", "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r86", "r91", "r97" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents, end of period", "periodStartLabel": "Cash and cash equivalents, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r86", "r247" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Increase (decrease) in Cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedging" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": { "auth_ref": [ "r13", "r86" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations", "negatedTerseLabel": "Cash used in operating activities, discontinued operations" } } }, "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DiscontinuedOperationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ChangeInAccountingEstimateLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Change in Accounting Estimate [Line Items]", "terseLabel": "Change in Accounting Estimate [Line Items]" } } }, "localname": "ChangeInAccountingEstimateLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNetForeignTransactionGainsandLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r306", "r307", "r308", "r348", "r387", "r388", "r391", "r393", "r401", "r402", "r446", "r493", "r495", "r496", "r497", "r500", "r501", "r532", "r533", "r535", "r536", "r537", "r747", "r877", "r957", "r974", "r989" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r141", "r486", "r487", "r861", "r1020" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r161" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Dividends on common stock (in dollars per share)" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITYParenthetical", "http://www.colfaxcorp.com/role/SubsequentEventsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r985", "r986", "r1106" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY", "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r29", "r156" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETSParenthetical", "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r29", "r939" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock - $0.001 par value - Authorized 600,000,000; 60,094,725 and 100 shares outstanding as of December\u00a031, 2022 and December\u00a031, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]", "terseLabel": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r63", "r327", "r329", "r338", "r823", "r831" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income attributable to ESAB Corporation" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r209", "r210", "r217", "r327", "r329", "r337", "r822", "r830" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "terseLabel": "Less: comprehensive income attributable to noncontrolling interest" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r208", "r217", "r327", "r329", "r336", "r821", "r829" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerSoftwareIntangibleAssetMember": { "auth_ref": [ "r933", "r1010", "r1011" ], "lang": { "en-us": { "role": { "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.", "label": "Computer Software, Intangible Asset [Member]", "terseLabel": "Software" } } }, "localname": "ComputerSoftwareIntangibleAssetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r102", "r103", "r243", "r244", "r439", "r860" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r102", "r103", "r243", "r244", "r439", "r843", "r860" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r102", "r103", "r243", "r244", "r439", "r860", "r1124" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]", "terseLabel": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r102", "r103", "r243", "r244", "r439" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk (as a percent)" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r100", "r102", "r103", "r104", "r243", "r245", "r860" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]", "terseLabel": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r102", "r103", "r243", "r244", "r439", "r860" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r211", "r900" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Separation from Enovis and Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r539", "r540", "r559" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Contract liability" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r539", "r540", "r559" ], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": 8.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Contract liability" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r539", "r540", "r559" ], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": 8.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract with Customer, Liability, Noncurrent", "terseLabel": "Contract liability" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r94", "r95", "r96" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Shares Converted", "terseLabel": "Number of shares recapitalized (in shares)" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r71", "r801" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesRelatedParty": { "auth_ref": [ "r72" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Costs of sales and operating expenses for the period incurred from transactions with related parties.", "label": "Costs and Expenses, Related Party", "terseLabel": "Allocated expenses" } } }, "localname": "CostsAndExpensesRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r977", "r1097", "r1099" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r977", "r1097" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "terseLabel": "Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r194", "r694", "r705", "r977" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "totalLabel": "Current income tax" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Current:" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r977", "r1097", "r1099" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "State" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r199" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails", "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r155", "r347", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r518", "r525", "r526", "r528" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r22", "r23", "r24", "r259", "r261", "r273", "r355", "r502", "r503", "r504", "r505", "r506", "r508", "r514", "r515", "r516", "r517", "r519", "r520", "r521", "r522", "r523", "r524", "r770", "r907", "r908", "r909", "r910", "r911", "r975" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails", "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Basis spread on variable rate (as a percent)" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r24", "r261", "r273", "r529" ], "calculation": { "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 }, "http://www.colfaxcorp.com/role/DebtScheduleofDebtMaturitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-Term Debt, Gross", "terseLabel": "Total debt", "totalLabel": "Long-term debt" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails", "http://www.colfaxcorp.com/role/DebtScheduleofDebtMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r250", "r252", "r502", "r770", "r908", "r909" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r45", "r355", "r502", "r503", "r504", "r505", "r506", "r508", "r514", "r515", "r516", "r517", "r519", "r520", "r521", "r522", "r523", "r524", "r770", "r907", "r908", "r909", "r910", "r911", "r975" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails", "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r45", "r157", "r158", "r159", "r160", "r249", "r250", "r252", "r270", "r355", "r502", "r503", "r504", "r505", "r506", "r508", "r514", "r515", "r516", "r517", "r519", "r520", "r521", "r522", "r523", "r524", "r527", "r770", "r907", "r908", "r909", "r910", "r911", "r975" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt term (in days)" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "auth_ref": [ "r251", "r514", "r530", "r908", "r909" ], "calculation": { "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "negatedLabel": "Unamortized deferred financing fees" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtPolicyTextBlock": { "auth_ref": [ "r153" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.", "label": "Debt, Policy [Policy Text Block]", "terseLabel": "Debt Issuance Costs" } } }, "localname": "DebtPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.", "label": "Deferred Compensation Liability, Current and Noncurrent", "terseLabel": "Deferred compensation plans" } } }, "localname": "DeferredCompensationLiabilityCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationPlanAssets": { "auth_ref": [ "r962" ], "calculation": { "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails": { "order": 3.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.", "label": "Deferred Compensation Plan Assets", "terseLabel": "Deferred Compensation Plan Assets" } } }, "localname": "DeferredCompensationPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r977", "r1098", "r1099" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Federal Income Tax Expense (Benefit)", "terseLabel": "Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r1092" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Federal, State and Local, Tax Expense (Benefit)", "terseLabel": "State" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r251", "r1024" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "terseLabel": "Unamortized deferred financing fees" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails", "http://www.colfaxcorp.com/role/DebtScheduleofDebtMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r194", "r977", "r1098" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "terseLabel": "Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r676", "r677" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesBalanceSheetItemsDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Other assets" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r89", "r194", "r695", "r704", "r705", "r977" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "totalLabel": "Deferred Income Tax" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Deferred:" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r26", "r27", "r260", "r272", "r689" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r676", "r677" ], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": 5.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 }, "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesBalanceSheetItemsDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "negatedTerseLabel": "Other liabilities", "terseLabel": "Accrued taxes and deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails", "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "auth_ref": [ "r90" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.", "label": "Deferred Income Taxes and Tax Credits", "terseLabel": "Deferred income tax" } } }, "localname": "DeferredIncomeTaxesAndTaxCredits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetDomain": { "auth_ref": [ "r189" ], "lang": { "en-us": { "role": { "documentation": "Identification of the deferred tax asset for which a valuation reserve exists.", "label": "Deferred Tax Asset [Domain]", "terseLabel": "Deferred Tax Asset [Domain]" } } }, "localname": "DeferredTaxAssetDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredTaxAssetsInventory": { "auth_ref": [ "r192", "r1096" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.", "label": "Deferred Tax Assets, Inventory", "terseLabel": "Inventory" } } }, "localname": "DeferredTaxAssetsInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r1095" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Deferred tax assets, net" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net [Abstract]", "terseLabel": "Deferred tax assets:" } } }, "localname": "DeferredTaxAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r192", "r1096" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforward" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration", "terseLabel": "Net operating loss carryforward, subject to expiration" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r192", "r1096" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets, Other", "verboseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "auth_ref": [ "r191", "r192", "r1096" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards", "terseLabel": "Tax credit carryforward" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits": { "auth_ref": [ "r1096" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from postretirement benefits.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits", "terseLabel": "Post-retirement benefit obligation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": { "auth_ref": [ "r192", "r1096" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.", "label": "Deferred Tax Assets, Tax Deferred Expense, Other", "terseLabel": "Expenses currently not deductible" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r690" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance", "verboseLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails", "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r182", "r1095" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesBalanceSheetItemsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "negatedTerseLabel": "Total deferred tax liabilities, net", "negatedTotalLabel": "Total deferred tax liabilities, net" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesBalanceSheetItemsDetails", "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Net [Abstract]", "terseLabel": "Deferred tax liabilities:" } } }, "localname": "DeferredTaxLiabilitiesNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r192", "r1096" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities, Other", "negatedLabel": "Outside basis differences and other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": { "auth_ref": [ "r1096" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.", "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings", "terseLabel": "Undistributed foreign earnings" } } }, "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": { "auth_ref": [ "r595" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.", "label": "Defined Benefit Plan, Accumulated Benefit Obligation", "terseLabel": "Accumulated benefit obligation, end of year" } } }, "localname": "DefinedBenefitPlanAccumulatedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": { "auth_ref": [ "r55", "r61", "r1068" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansAccumulatedOtherComprehensiveIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax", "terseLabel": "Pretax net unrecognized pension and other post-retirement benefit cost included in accumulated other comprehensive loss", "totalLabel": "Total" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansAccumulatedOtherComprehensiveIncomeDetails", "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": { "auth_ref": [ "r61", "r607" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansAccumulatedOtherComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax", "negatedTerseLabel": "Net actuarial loss (gain)" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": { "auth_ref": [ "r61", "r607" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansAccumulatedOtherComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax", "terseLabel": "Prior service (income) cost" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": { "auth_ref": [ "r578", "r922" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.", "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)", "terseLabel": "Actual return on plan assets" } } }, "localname": "DefinedBenefitPlanActualReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActuarialGainLoss": { "auth_ref": [ "r571" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.", "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)", "negatedTerseLabel": "Actuarial gain" } } }, "localname": "DefinedBenefitPlanActuarialGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "auth_ref": [ "r564", "r602", "r624", "r922", "r923" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "negatedTerseLabel": "Amortization" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": { "auth_ref": [ "r165", "r167" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.", "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position", "totalLabel": "Total" } } }, "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]", "terseLabel": "Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:" } } }, "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": { "auth_ref": [ "r257", "r275", "r562", "r563", "r586", "r922" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.", "label": "Assets for Plan Benefits, Defined Benefit Plan", "terseLabel": "Non-current assets" } } }, "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from assets transferred into (from) plan.", "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan", "terseLabel": "Transfer from Former Parent" } } }, "localname": "DefinedBenefitPlanAssetsTransferredToFromPlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": { "auth_ref": [ "r609" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate", "terseLabel": "Weighted-average discount rate, benefit obligation" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansKeyEconomicAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": { "auth_ref": [ "r610" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase", "terseLabel": "Weighted-average rate of increase in compensation levels for active foreign plans" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansKeyEconomicAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": { "auth_ref": [ "r609" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate", "terseLabel": "Weighted-average discount rate, net periodic benefit cost" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansKeyEconomicAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": { "auth_ref": [ "r611", "r629" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets", "terseLabel": "Weighted-average expected return on plan assets, net periodic benefit cost" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansKeyEconomicAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": { "auth_ref": [ "r610" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase", "terseLabel": "Weighted-average rate of increase in compensation levels for active foreign plans, net periodic benefit cost" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansKeyEconomicAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligation": { "auth_ref": [ "r566" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Benefit Obligation", "periodEndLabel": "Projected benefit obligation, end of year", "periodStartLabel": "Projected benefit obligation, beginning of year", "terseLabel": "Change in benefit obligation:" } } }, "localname": "DefinedBenefitPlanBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails", "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": { "auth_ref": [ "r573", "r631" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.", "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid", "negatedLabel": "Benefits paid" } } }, "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]", "terseLabel": "Change in benefit obligation:" } } }, "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]", "terseLabel": "Change in plan assets:" } } }, "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r580", "r589", "r628", "r920", "r921", "r922", "r923" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "terseLabel": "Employer contributions" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]", "terseLabel": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansAccumulatedOtherComprehensiveIncomeDetails", "http://www.colfaxcorp.com/role/BenefitPlansExpectedBenefitPaymentsDetails", "http://www.colfaxcorp.com/role/BenefitPlansKeyEconomicAssumptionsDetails", "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails", "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails", "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails", "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationDetails", "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": { "auth_ref": [ "r920", "r922" ], "lang": { "en-us": { "role": { "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.", "label": "Defined Benefit Plan, Equity Securities [Member]", "terseLabel": "Equity securities:" } } }, "localname": "DefinedBenefitPlanEquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember": { "auth_ref": [ "r920", "r921", "r922" ], "lang": { "en-us": { "role": { "documentation": "Security representing ownership in corporation or other legal entity, not domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.", "label": "Defined Benefit Plan, Equity Securities, Non-US [Member]", "terseLabel": "International" } } }, "localname": "DefinedBenefitPlanEquitySecuritiesNonUsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember": { "auth_ref": [ "r922", "r1049" ], "lang": { "en-us": { "role": { "documentation": "Security representing ownership in corporation or other legal entity, domiciled in United States of America (US), classified as having large market capitalization, for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.", "label": "Defined Benefit Plan, Equity Securities, US, Large Cap [Member]", "terseLabel": "U.S. large cap" } } }, "localname": "DefinedBenefitPlanEquitySecuritiesUsLargeCapMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": { "auth_ref": [ "r596" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years", "terseLabel": "2028 - 2032" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": { "auth_ref": [ "r596" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One", "terseLabel": "2023" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": { "auth_ref": [ "r596" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five", "terseLabel": "2027" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": { "auth_ref": [ "r596" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four", "terseLabel": "2026" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": { "auth_ref": [ "r596" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three", "terseLabel": "2025" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": { "auth_ref": [ "r596" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two", "terseLabel": "2024" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": { "auth_ref": [ "r597", "r923" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year", "terseLabel": "Expected employer contributions in the next fiscal year" } } }, "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r564", "r601", "r623", "r922", "r923" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails": { "order": 6.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "negatedTerseLabel": "Expected return on plan assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": { "auth_ref": [ "r577", "r588", "r589", "r590", "r920", "r921", "r922" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.", "label": "Defined Benefit Plan, Plan Assets, Amount", "periodEndLabel": "Fair value of plan assets, end of year", "periodStartLabel": "Fair value of plan assets, beginning of year", "terseLabel": "Transfer from Former Parent" } } }, "localname": "DefinedBenefitPlanFairValueOfPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails", "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails", "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Plan Assets, Period Increase (Decrease)", "terseLabel": "Other" } } }, "localname": "DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": { "auth_ref": [ "r572" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)", "negatedTerseLabel": "Foreign exchange effect" } } }, "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": { "auth_ref": [ "r562", "r586", "r922" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.", "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan", "totalLabel": "Funded status, end of year" } } }, "localname": "DefinedBenefitPlanFundedStatusOfPlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear": { "auth_ref": [ "r613" ], "lang": { "en-us": { "role": { "documentation": "Assumed rate, for next fiscal year, based on annual change in cost of health care cost benefits used to measure expected cost of benefits covered by defined benefit postretirement plan. Factors include, but are not limited to, estimate of health care inflation, change in health care utilization or delivery pattern, technological advances, and change in health status of participant. Excludes factors for change in composition of plan population by age and dependency status.", "label": "Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year", "terseLabel": "Weighted-average annual rate of increase (as a percent)" } } }, "localname": "DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r564", "r569", "r600", "r622", "r922", "r923" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails", "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r598", "r620", "r922", "r923" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "totalLabel": "Net periodic benefit (income) cost" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]", "terseLabel": "Components of Net Periodic Benefit (Income) Cost:" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanOtherChanges": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change, classified as other.", "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change", "terseLabel": "Other" } } }, "localname": "DefinedBenefitPlanOtherChanges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanOtherCosts": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails": { "order": 5.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of defined benefit plan cost (credit), classified as other.", "label": "Defined Benefit Plan, Other Cost (Credit)", "terseLabel": "Other" } } }, "localname": "DefinedBenefitPlanOtherCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsAccumulatedBenefitObligation": { "auth_ref": [ "r1076" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated benefit obligation for defined benefit pension plan with projected benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation", "terseLabel": "Plans with projected benefit obligations in excess of plan assets, projected benefit obligation" } } }, "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsAccumulatedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets": { "auth_ref": [ "r617", "r922" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of plan asset for defined benefit pension plan with projected benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets", "terseLabel": "Plans with projected benefit obligations in excess of plan assets, fair value of plan assets" } } }, "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation": { "auth_ref": [ "r617", "r618", "r922" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation", "terseLabel": "Plans with accumulated benefit obligations in excess of plan assets, accumulated benefit obligation" } } }, "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets": { "auth_ref": [ "r617", "r618", "r922" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets", "terseLabel": "Plans with accumulated benefit obligations in excess of plan assets, fair value of plan assets" } } }, "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAmendments": { "auth_ref": [ "r574" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.", "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment", "terseLabel": "Plan amendments" } } }, "localname": "DefinedBenefitPlanPlanAmendments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": { "auth_ref": [ "r582", "r1088" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.", "label": "Defined Benefit Plan, Plan Assets, Benefits Paid", "negatedLabel": "Benefits paid" } } }, "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r579" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign exchange effect" } } }, "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": { "auth_ref": [ "r565", "r605", "r627" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails": { "order": 4.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 }, "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 }, "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails": { "order": 7.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement", "negatedLabel": "Settlement gain", "negatedNetLabel": "Pension settlement gain", "negatedTerseLabel": "Pension settlement gain", "terseLabel": "Pension settlement gain", "verboseLabel": "Pension settlement gain" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails", "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails", "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails", "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS", "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS", "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r567", "r599", "r621", "r922", "r923" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "terseLabel": "Service cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails", "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": { "auth_ref": [ "r568" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.", "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement", "negatedTerseLabel": "Settlements" } } }, "localname": "DefinedBenefitPlanSettlementsBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": { "auth_ref": [ "r585" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.", "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement", "terseLabel": "Settlements" } } }, "localname": "DefinedBenefitPlanSettlementsPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanTextBlock": { "auth_ref": [ "r630", "r800", "r922" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for defined benefit plan.", "label": "Defined Benefit Plan [Text Block]", "terseLabel": "Benefit Plans" } } }, "localname": "DefinedBenefitPlanTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1": { "auth_ref": [ "r613" ], "lang": { "en-us": { "role": { "documentation": "Ultimate trend rate for health care cost for defined benefit postretirement plan.", "label": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate", "terseLabel": "Health care cost trend rate (as a percent)" } } }, "localname": "DefinedBenefitPlanUltimateHealthCareCostTrendRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": { "auth_ref": [ "r1048" ], "lang": { "en-us": { "role": { "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.", "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage", "terseLabel": "Actual asset allocation" } } }, "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanCostRecognized": { "auth_ref": [ "r632" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for defined contribution plan.", "label": "Defined Contribution Plan, Cost", "terseLabel": "Defined contribution plan, cost" } } }, "localname": "DefinedContributionPlanCostRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r89", "r131" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation and other amortization" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r89", "r131" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation, amortization and other impairment charges" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r89", "r414" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation, amortization and other impairment charges:" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r317", "r318", "r746", "r898" ], "calculation": { "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative Asset" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeBasisSpreadOnVariableRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.", "label": "Derivative, Basis Spread on Variable Rate", "terseLabel": "Basis spread on variable rate (as a percent)" } } }, "localname": "DerivativeBasisSpreadOnVariableRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails", "http://www.colfaxcorp.com/role/DerivativesNotDesignatedasHedgingInstrumentsDetails", "http://www.colfaxcorp.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails", "http://www.colfaxcorp.com/role/DerivativesSummaryoftheEffectsofDesignatedCashFlowHedgesontheCompanysConsolidatedandCombinedStatementsofOperationsDetails", "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "auth_ref": [ "r49", "r229", "r255", "r316", "r898" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset", "terseLabel": "Other Assets" } } }, "localname": "DerivativeFairValueOfDerivativeAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r49", "r229", "r255", "r316", "r898" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset", "terseLabel": "Other Liabilities" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed interest rate related to the interest rate derivative.", "label": "Derivative, Fixed Interest Rate", "terseLabel": "Fixed interest rate" } } }, "localname": "DerivativeFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r1105" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "terseLabel": "Realized loss" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNotDesignatedasHedgingInstrumentsDetails", "http://www.colfaxcorp.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r227", "r230", "r234", "r235", "r898" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails", "http://www.colfaxcorp.com/role/DerivativesNotDesignatedasHedgingInstrumentsDetails", "http://www.colfaxcorp.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails", "http://www.colfaxcorp.com/role/DerivativesSummaryoftheEffectsofDesignatedCashFlowHedgesontheCompanysConsolidatedandCombinedStatementsofOperationsDetails", "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r241", "r730" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "Derivatives" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/Derivatives" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails", "http://www.colfaxcorp.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails", "http://www.colfaxcorp.com/role/DerivativesSummaryoftheEffectsofDesignatedCashFlowHedgesontheCompanysConsolidatedandCombinedStatementsofOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about derivatives and hedging activities.", "label": "Derivative Instruments and Hedging Activities Disclosures [Table]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails", "http://www.colfaxcorp.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails", "http://www.colfaxcorp.com/role/DerivativesSummaryoftheEffectsofDesignatedCashFlowHedgesontheCompanysConsolidatedandCombinedStatementsofOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r224", "r227", "r234" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r224", "r227", "r234", "r235", "r239", "r240", "r729" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNotDesignatedasHedgingInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNotDesignatedasHedgingInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r317", "r318", "r746", "r898" ], "calculation": { "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivative liabilities" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r1103", "r1104" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Notional amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeNumberOfInstrumentsHeld": { "auth_ref": [ "r220", "r222" ], "lang": { "en-us": { "role": { "documentation": "The number of derivative instruments of a particular group held by the entity.", "label": "Derivative, Number of Instruments Held", "terseLabel": "Number of derivative instruments held" } } }, "localname": "DerivativeNumberOfInstrumentsHeld", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r219", "r221", "r224", "r225", "r237", "r354" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivatives" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails", "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/RevenueDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r558", "r913", "r914", "r915", "r916", "r917", "r918", "r919" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/RevenueDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r1025" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share", "verboseLabel": "Loss on discontinued operations (in dollars per share)" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "perShareItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": { "auth_ref": [], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share", "terseLabel": "Loss on discontinued operations (in dollars per share)" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "perShareItemType" }, "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": { "auth_ref": [ "r2", "r3", "r4", "r5", "r12", "r15", "r678", "r703", "r710" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.", "label": "Discontinued Operation, Tax Effect of Discontinued Operation", "negatedNetLabel": "Income tax benefit" } } }, "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DiscontinuedOperationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discontinued Operations and Disposal Groups [Abstract]" } } }, "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "auth_ref": [ "r19", "r138" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "terseLabel": "Discontinued Operations" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DiscontinuedOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r924", "r927" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]", "terseLabel": "Disposal Group Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DiscontinuedOperationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DividendsCommonStock": { "auth_ref": [ "r161", "r269" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Common Stock", "negatedTerseLabel": "Dividends declared ($0.15 per share)" } } }, "localname": "DividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableCurrent": { "auth_ref": [ "r43" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Dividends Payable, Current", "terseLabel": "Dividends payable" } } }, "localname": "DividendsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DomesticPlanMember": { "auth_ref": [ "r1089", "r1090", "r1091" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Domestic Plan [Member]", "terseLabel": "Domestic Plan" } } }, "localname": "DomesticPlanMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationDetails", "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r339", "r373", "r374", "r375", "r376", "r377", "r384", "r387", "r391", "r392", "r393", "r397", "r735", "r736", "r824", "r832", "r903" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "totalLabel": "Net income per share (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Earnings (loss) per share - basic" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r339", "r373", "r374", "r375", "r376", "r377", "r387", "r391", "r392", "r393", "r397", "r735", "r736", "r824", "r832", "r903" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "totalLabel": "Net income per share - diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Computation of earnings (loss) per share from continuing operations - diluted:", "verboseLabel": "Earnings (loss) per share - diluted" } } }, "localname": "EarningsPerShareDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS", "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r394", "r395", "r396", "r398" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings per Share from Continuing Operations" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r758" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Effect of foreign exchange rates on Cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "verboseLabel": "Compensation and related benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r667" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized stock-based compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityNarrativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r667" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Unrecognized compensation cost, period for recognition (in years)" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityNarrativesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]", "terseLabel": "Termination Benefits" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]", "terseLabel": "Option" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityNarrativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r156", "r290", "r331", "r332", "r333", "r363", "r364", "r365", "r370", "r378", "r380", "r400", "r447", "r538", "r668", "r669", "r670", "r697", "r698", "r734", "r760", "r761", "r762", "r763", "r764", "r767", "r783", "r835", "r836", "r837" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY", "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails", "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r114", "r420", "r961" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Investments in Equity Method Investees:" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsPolicy": { "auth_ref": [ "r85", "r115", "r246" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.", "label": "Equity Method Investments [Policy Text Block]", "terseLabel": "Equity Method Investments" } } }, "localname": "EquityMethodInvestmentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquitySecuritiesMember": { "auth_ref": [ "r113", "r274", "r943", "r944", "r945" ], "lang": { "en-us": { "role": { "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.", "label": "Equity Securities [Member]", "terseLabel": "Equity securities" } } }, "localname": "EquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationDetails", "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FacilityClosingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Facility Closing [Member]", "terseLabel": "Facility Closure Costs" } } }, "localname": "FacilityClosingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r741", "r742", "r744" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r516", "r589", "r590", "r591", "r592", "r593", "r594", "r742", "r794", "r795", "r796", "r908", "r909", "r920", "r921", "r922" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails", "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r743" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "verboseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r516", "r589", "r594", "r742", "r794", "r920", "r921", "r922" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level One" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails", "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r516", "r589", "r594", "r742", "r795", "r908", "r909", "r920", "r921", "r922" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level Two" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails", "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r516", "r589", "r590", "r591", "r592", "r593", "r594", "r742", "r796", "r908", "r909", "r920", "r921", "r922" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level Three" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails", "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": { "auth_ref": [ "r589", "r740", "r745" ], "lang": { "en-us": { "role": { "documentation": "Fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Measured at Net Asset Value Per Share [Member]", "terseLabel": "Measured at Net Asset Value" } } }, "localname": "FairValueMeasuredAtNetAssetValuePerShareMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r516", "r589", "r590", "r591", "r592", "r593", "r594", "r794", "r795", "r796", "r908", "r909", "r920", "r921", "r922" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails", "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Intangible asset, useful life (in years)" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r302", "r472" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedTerseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r126" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsExpectedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r126" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsExpectedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r126" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsExpectedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r126" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsExpectedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r126" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsExpectedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r469", "r471", "r472", "r474", "r802", "r806" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails", "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r124", "r806" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r120", "r123" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails", "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiscalPeriod": { "auth_ref": [ "r204" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.", "label": "Fiscal Period, Policy [Policy Text Block]", "terseLabel": "Fiscal Period" } } }, "localname": "FiscalPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FixedIncomeFundsMember": { "auth_ref": [ "r1049" ], "lang": { "en-us": { "role": { "documentation": "Investment that pools funds from investors to invest in a combination of underlying investments, primarily fixed income investments.", "label": "Fixed Income Funds [Member]", "terseLabel": "Fixed income mutual funds:" } } }, "localname": "FixedIncomeFundsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FixedIncomeSecuritiesMember": { "auth_ref": [ "r922", "r1049" ], "lang": { "en-us": { "role": { "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity.", "label": "Fixed Income Securities [Member]", "terseLabel": "Fixed income" } } }, "localname": "FixedIncomeSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]", "terseLabel": "Foreign Tax Authority" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r751", "r753", "r755", "r757" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "terseLabel": "Foreign currency transaction loss (gain), net" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNetForeignTransactionGainsandLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r769" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency Exchange Gains and Losses" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r898", "r920", "r937" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Cross currency swap agreements" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails", "http://www.colfaxcorp.com/role/DerivativesNotDesignatedasHedgingInstrumentsDetails", "http://www.colfaxcorp.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails", "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignPlanMember": { "auth_ref": [ "r1089", "r1090", "r1091" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Foreign Plan [Member]", "terseLabel": "Foreign Plan" } } }, "localname": "ForeignPlanMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansExpectedBenefitPaymentsDetails", "http://www.colfaxcorp.com/role/BenefitPlansKeyEconomicAssumptionsDetails", "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails", "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails", "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails", "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationDetails", "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r89" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedTerseLabel": "Loss (gain) on sale of property, plant and equipment" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeographicConcentrationRiskMember": { "auth_ref": [ "r101", "r860" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).", "label": "Geographic Concentration Risk [Member]", "terseLabel": "Geographic Concentration Risk" } } }, "localname": "GeographicConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r301", "r457", "r819", "r906", "r939", "r999", "r1006" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Balance end of period", "periodStartLabel": "Balance beginning of period", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS", "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r459", "r906" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Goodwill attributable to acquisition" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Goodwill and Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r463" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "verboseLabel": "Impact of foreign currency translation" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r69", "r348", "r419", "r424", "r430", "r433", "r446", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r747", "r905", "r1021" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r224", "r729" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails", "http://www.colfaxcorp.com/role/DerivativesNotDesignatedasHedgingInstrumentsDetails", "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails", "http://www.colfaxcorp.com/role/DerivativesNotDesignatedasHedgingInstrumentsDetails", "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of Goodwill and Indefinite-Lived Intangible Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r130", "r137" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of Long-Lived Assets Other than Goodwill and Indefinite-Lived Intangible Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r70", "r90", "r207", "r373", "r374", "r375", "r376", "r389", "r393" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 }, "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "totalLabel": "Net income from continuing operations" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS", "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r349", "r706" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "terseLabel": "Domestic operations" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r66", "r256", "r266", "r286", "r419", "r424", "r430", "r433", "r825", "r905" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0 }, "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income from continuing operations before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS", "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r349", "r706" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "terseLabel": "Foreign operations" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]", "terseLabel": "Income from continuing operations before income taxes:" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "auth_ref": [ "r65", "r265", "r267", "r282", "r339", "r369", "r373", "r374", "r375", "r376", "r387", "r391", "r392", "r736", "r824" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Basic Share", "terseLabel": "Income from continuing operations (in dollars per share)", "verboseLabel": "Income per share from continuing operations \u2013 basic (in dollars per share)" } } }, "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS", "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "auth_ref": [ "r65", "r282", "r285", "r339", "r369", "r373", "r374", "r375", "r376", "r387", "r391", "r392", "r393", "r736", "r824", "r832" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "terseLabel": "Income from continuing operations (in dollars per share)", "verboseLabel": "Income per share from continuing operations \u2013 assuming dilution (in dollars per share)" } } }, "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS", "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "auth_ref": [ "r1", "r2", "r3", "r4", "r5", "r15", "r283", "r294", "r712" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Loss from discontinued operations, net of taxes" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS", "http://www.colfaxcorp.com/role/DiscontinuedOperationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r924", "r927" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]", "terseLabel": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DiscontinuedOperationsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DiscontinuedOperationsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r0", "r6", "r7", "r8", "r9", "r10", "r11", "r14", "r16", "r17", "r18", "r135", "r136" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]", "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DiscontinuedOperationsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r475", "r479" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesSummaryoftheEffectsofDesignatedCashFlowHedgesontheCompanysConsolidatedandCombinedStatementsofOperationsDetails", "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNetForeignTransactionGainsandLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesSummaryoftheEffectsofDesignatedCashFlowHedgesontheCompanysConsolidatedandCombinedStatementsofOperationsDetails", "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNetForeignTransactionGainsandLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r185" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r350", "r680", "r687", "r693", "r702", "r707", "r713", "r714", "r716" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Tax Examination [Line Items]", "terseLabel": "Income Tax Examination [Line Items]" } } }, "localname": "IncomeTaxExaminationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesBalanceSheetItemsDetails", "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationTable": { "auth_ref": [ "r186" ], "lang": { "en-us": { "role": { "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.", "label": "Income Tax Examination [Table]", "terseLabel": "Income Tax Examination [Table]" } } }, "localname": "IncomeTaxExaminationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesBalanceSheetItemsDetails", "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r351", "r379", "r380", "r417", "r678", "r703", "r709", "r833" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0 }, "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax expense", "totalLabel": "Income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS", "http://www.colfaxcorp.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesandIncomeTaxExpenseDetails", "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails", "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r330", "r674", "r675", "r687", "r688", "r692", "r696" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r1093" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": { "order": 7.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "terseLabel": "Valuation Allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r673", "r679" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": { "order": 8.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount", "terseLabel": "Changes in tax reserves" } } }, "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationDeductionsDividends": { "auth_ref": [ "r1093" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": { "order": 13.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for dividend.", "label": "Effective Income Tax Rate Reconciliation, Deduction, Dividends, Amount", "negatedTerseLabel": "Non-taxable dividends" } } }, "localname": "IncomeTaxReconciliationDeductionsDividends", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationDispositionOfAssets": { "auth_ref": [ "r1093" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": { "order": 5.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to disposition of asset. Includes, but is not limited to, intra-entity transfer of asset other than inventory.", "label": "Effective Income Tax Rate Reconciliation, Disposition of Asset, Amount", "terseLabel": "Capital gain" } } }, "localname": "IncomeTaxReconciliationDispositionOfAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r1093" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": { "order": 9.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount", "terseLabel": "Effect of tax rates on international operations" } } }, "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r679" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "terseLabel": "Taxes calculated at the U.S. federal statutory rate" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpense": { "auth_ref": [ "r1093" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": { "order": 10.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount", "terseLabel": "Permanent differences, net" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "auth_ref": [ "r1093" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount", "terseLabel": "Other" } } }, "localname": "IncomeTaxReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings": { "auth_ref": [ "r1093" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to repatriation of foreign earnings.", "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount", "terseLabel": "Repatriation of foreign earnings" } } }, "localname": "IncomeTaxReconciliationRepatriationOfForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r1093" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount", "terseLabel": "State taxes" } } }, "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": { "auth_ref": [ "r1093" ], "calculation": { "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": { "order": 4.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount", "negatedTerseLabel": "Research and development tax credits" } } }, "localname": "IncomeTaxReconciliationTaxCreditsResearch", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r93" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Income tax payments, net" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r88" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r88" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedTerseLabel": "Trade receivables, net" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r88" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedTerseLabel": "Inventories, net" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "auth_ref": [ "r88" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "negatedTerseLabel": "Other operating assets and liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r470", "r473" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r121", "r127" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IndefinitelivedIntangibleAssetsAcquired": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.", "label": "Indefinite-Lived Intangible Assets Acquired", "terseLabel": "Indefinite-Lived Intangible Assets" } } }, "localname": "IndefinitelivedIntangibleAssetsAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [ "r301" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "terseLabel": "Total intangible assets" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r118", "r122" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpensePolicyTextBlock": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing interest expense, including the method of amortizing debt issuance costs.", "label": "Interest Expense, Policy [Policy Text Block]", "terseLabel": "Interest expense (income) and Other, Net" } } }, "localname": "InterestExpensePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r341", "r344", "r345" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest payments, net" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r936" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest rate swap agreements" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails", "http://www.colfaxcorp.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails", "http://www.colfaxcorp.com/role/DerivativesSummaryoftheEffectsofDesignatedCashFlowHedgesontheCompanysConsolidatedandCombinedStatementsofOperationsDetails", "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]", "terseLabel": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r454" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "verboseLabel": "Inventories, Net" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/InventoriesNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r964" ], "calculation": { "http://www.colfaxcorp.com/role/InventoriesNetDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory, Finished Goods, Gross", "verboseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/InventoriesNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryGross": { "auth_ref": [ "r968" ], "calculation": { "http://www.colfaxcorp.com/role/InventoriesNetDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Inventory, Gross", "totalLabel": "Inventories, gross" } } }, "localname": "InventoryGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/InventoriesNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryLIFOReserve": { "auth_ref": [ "r967" ], "calculation": { "http://www.colfaxcorp.com/role/InventoriesNetDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.", "label": "Inventory, LIFO Reserve", "negatedTerseLabel": "LIFO reserve" } } }, "localname": "InventoryLIFOReserve", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/InventoriesNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r312", "r892", "r939" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.colfaxcorp.com/role/InventoriesNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories, net", "totalLabel": "Inventories, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS", "http://www.colfaxcorp.com/role/InventoriesNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r297", "r311", "r399", "r452", "r453", "r454", "r799", "r901" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r966" ], "calculation": { "http://www.colfaxcorp.com/role/InventoriesNetDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Raw Materials, Gross", "verboseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/InventoriesNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r116", "r968" ], "calculation": { "http://www.colfaxcorp.com/role/InventoriesNetDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves", "negatedLabel": "Less: allowance for excess, slow-moving and obsolete inventory", "negatedTerseLabel": "Reserve for excess and obsolete inventory" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/InventoriesNetDetails", "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r965" ], "calculation": { "http://www.colfaxcorp.com/role/InventoriesNetDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Inventory, Work in Process, Gross", "verboseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/InventoriesNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInvestmentExpense": { "auth_ref": [ "r75", "r287" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses related to the generation of investment income.", "label": "Investment Income, Investment Expense", "terseLabel": "Interest expense and other, net" } } }, "localname": "InvestmentIncomeInvestmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeNonoperating": { "auth_ref": [ "r74" ], "calculation": { "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails": { "order": 6.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.", "label": "Investment Income, Nonoperating", "negatedLabel": "Interest income and other, net" } } }, "localname": "InvestmentIncomeNonoperating", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationDetails", "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]", "terseLabel": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationDetails", "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LIFOInventoryAmount": { "auth_ref": [ "r895" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of LIFO (last in first out) inventory present at the reporting date when inventory is also valued using different valuation methods.", "label": "LIFO Inventory Amount", "terseLabel": "LIFO inventory amount" } } }, "localname": "LIFOInventoryAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r1026" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]", "terseLabel": "Land" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r1110" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of Future Minimum Lease Payments" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r779" ], "calculation": { "http://www.colfaxcorp.com/role/LeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.colfaxcorp.com/role/LeasesDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r779" ], "calculation": { "http://www.colfaxcorp.com/role/LeasesDetails_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r779" ], "calculation": { "http://www.colfaxcorp.com/role/LeasesDetails_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r779" ], "calculation": { "http://www.colfaxcorp.com/role/LeasesDetails_1": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r779" ], "calculation": { "http://www.colfaxcorp.com/role/LeasesDetails_1": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r779" ], "calculation": { "http://www.colfaxcorp.com/role/LeasesDetails_1": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r779" ], "calculation": { "http://www.colfaxcorp.com/role/LeasesDetails_1": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r779" ], "calculation": { "http://www.colfaxcorp.com/role/LeasesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: present value discount" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r780" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]", "terseLabel": "Letter of Credit" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Letters of credit outstanding amount" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r42", "r348", "r446", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r722", "r726", "r727", "r747", "r904", "r1021", "r1114", "r1115" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r34", "r263", "r280", "r939", "r976", "r997", "r1107" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "verboseLabel": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r44", "r296", "r348", "r446", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r722", "r726", "r727", "r747", "r939", "r1021", "r1114", "r1115" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "CURRENT LIABILITIES:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails", "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r242" ], "calculation": { "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Liabilities, Fair Value Disclosure", "totalLabel": "Total liabilities at fair value" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "terseLabel": "Liabilities, Noncurrent [Abstract]" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r39" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Line of credit facility, maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r39" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Line of credit facility, remaining borrowing capacity" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r24", "r261", "r277", "r515", "r531", "r908", "r909" ], "calculation": { "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "totalLabel": "Long-term debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r153", "r355", "r520" ], "calculation": { "http://www.colfaxcorp.com/role/DebtScheduleofDebtMaturitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtScheduleofDebtMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "auth_ref": [ "r153", "r355", "r520" ], "calculation": { "http://www.colfaxcorp.com/role/DebtScheduleofDebtMaturitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Five", "terseLabel": "2027" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtScheduleofDebtMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r153", "r355", "r520" ], "calculation": { "http://www.colfaxcorp.com/role/DebtScheduleofDebtMaturitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Four", "terseLabel": "2026" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtScheduleofDebtMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r153", "r355", "r520" ], "calculation": { "http://www.colfaxcorp.com/role/DebtScheduleofDebtMaturitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Three", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtScheduleofDebtMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r153", "r355", "r520" ], "calculation": { "http://www.colfaxcorp.com/role/DebtScheduleofDebtMaturitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtScheduleofDebtMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.", "label": "Long-Term Debt [Member]", "terseLabel": "Long-term Debt" } } }, "localname": "LongTermDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails", "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r305" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r45", "r154" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.", "label": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time", "terseLabel": "Weighted-average interest rate (as a percent)" } } }, "localname": "LongtermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LossContingencyAccrualCarryingValueCurrent": { "auth_ref": [ "r488" ], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.", "label": "Loss Contingency, Accrual, Current", "terseLabel": "Asbestos liability", "verboseLabel": "Accrued asbestos liability" } } }, "localname": "LossContingencyAccrualCarryingValueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails", "http://www.colfaxcorp.com/role/CommitmentsandContingenciesAsbestosLitigationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualCarryingValueNoncurrent": { "auth_ref": [ "r488" ], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": 7.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.", "label": "Loss Contingency, Accrual, Noncurrent", "terseLabel": "Asbestos liability" } } }, "localname": "LossContingencyAccrualCarryingValueNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails", "http://www.colfaxcorp.com/role/CommitmentsandContingenciesAsbestosLitigationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Loss Contingency Accrual [Roll Forward]", "terseLabel": "Loss Contingency Accrual [Roll Forward]" } } }, "localname": "LossContingencyAccrualRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CommitmentsandContingenciesClaimsRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyClaimsSettledAndDismissedNumber": { "auth_ref": [ "r1016", "r1017" ], "lang": { "en-us": { "role": { "documentation": "The number of claims settled and dismissed during the period.", "label": "Loss Contingency, Claims Settled and Dismissed, Number", "negatedTerseLabel": "Claims resolved" } } }, "localname": "LossContingencyClaimsSettledAndDismissedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CommitmentsandContingenciesClaimsRollforwardDetails" ], "xbrltype": "integerItemType" }, "us-gaap_LossContingencyNewClaimsFiledNumber": { "auth_ref": [ "r1016", "r1017" ], "lang": { "en-us": { "role": { "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.", "label": "Loss Contingency, New Claims Filed, Number", "terseLabel": "Claims filed" } } }, "localname": "LossContingencyNewClaimsFiledNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CommitmentsandContingenciesClaimsRollforwardDetails" ], "xbrltype": "integerItemType" }, "us-gaap_LossContingencyPendingClaimsNumber": { "auth_ref": [ "r1016", "r1017" ], "lang": { "en-us": { "role": { "documentation": "Number of pending claims pertaining to a loss contingency.", "label": "Loss Contingency, Pending Claims, Number", "periodEndLabel": "Claims unresolved, end of period", "periodStartLabel": "Claims unresolved, beginning of period" } } }, "localname": "LossContingencyPendingClaimsNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CommitmentsandContingenciesClaimsRollforwardDetails" ], "xbrltype": "integerItemType" }, "us-gaap_LossContingencyReceivableCurrent": { "auth_ref": [ "r143" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of receivable related to a loss contingency accrual that is expected to be collected within one year or the normal operating cycle, if longer. For example, an insurance recovery receivable.", "label": "Loss Contingency, Receivable, Current", "terseLabel": "Long-term asbestos insurance asset" } } }, "localname": "LossContingencyReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CommitmentsandContingenciesAsbestosLitigationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyReceivableNoncurrent": { "auth_ref": [ "r143" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of receivable related to a loss contingency accrual that is expected to be collected after one year or beyond the normal operating cycle, if longer. For example, an insurance recovery receivable.", "label": "Loss Contingency, Receivable, Noncurrent", "terseLabel": "Long-term asbestos insurance receivable" } } }, "localname": "LossContingencyReceivableNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CommitmentsandContingenciesAsbestosLitigationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and equipment" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r48", "r262", "r279", "r348", "r446", "r493", "r495", "r496", "r497", "r500", "r501", "r747" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "auth_ref": [ "r161" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "negatedTerseLabel": "Distributions to noncontrolling owners" } } }, "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.", "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners", "terseLabel": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners" } } }, "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Movement in Standard Product Warranty Accrual [Roll Forward]", "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]" } } }, "localname": "MovementInStandardProductWarrantyAccrualRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesWarrantyLiabilityRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MovementInValuationAllowancesAndReservesRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]", "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]" } } }, "localname": "MovementInValuationAllowancesAndReservesRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r343" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r343" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "verboseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r86", "r87", "r90" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r67", "r90", "r268", "r284", "r294", "r325", "r328", "r333", "r348", "r369", "r373", "r374", "r375", "r376", "r379", "r380", "r389", "r419", "r424", "r430", "r433", "r446", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r736", "r747", "r905", "r1021" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net income attributable to ESAB Corporation", "verboseLabel": "Net income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS", "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r212", "r216", "r325", "r328", "r379", "r380", "r972" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Less: Income attributable to noncontrolling interest, net of taxes", "verboseLabel": "Income attributable to noncontrolling interest, net of taxes" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS", "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r373", "r374", "r375", "r376", "r384", "r385", "r390", "r393", "r419", "r424", "r430", "r433", "r905" ], "calculation": { "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net Income (Loss) Available to Common Stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]", "terseLabel": "Computation of earnings per share from continuing operations - basic:" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r292", "r367", "r368", "r371", "r372", "r381", "r382", "r383", "r444", "r445", "r448", "r449", "r699", "r700", "r701", "r733", "r737", "r738", "r739", "r748", "r749", "r750", "r771", "r772", "r781", "r784", "r803", "r804", "r805", "r838", "r839", "r840", "r841", "r842" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.", "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]", "terseLabel": "Recently Issued Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/RecentlyIssuedAccountingPronouncements" ], "xbrltype": "textBlockItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Issued Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r205", "r538", "r985", "r986", "r987" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interest" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Not Designated as Hedging Instrument" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails", "http://www.colfaxcorp.com/role/DerivativesNotDesignatedasHedgingInstrumentsDetails", "http://www.colfaxcorp.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r992" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails", "http://www.colfaxcorp.com/role/SegmentInformationNarrativesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportingUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.", "label": "Number of Reporting Units", "terseLabel": "Number of reporting units" } } }, "localname": "NumberOfReportingUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": { "auth_ref": [ "r61", "r64" ], "calculation": { "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.", "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent", "totalLabel": "Other comprehensive (loss) income before reclassifications" } } }, "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r419", "r424", "r430", "r433", "r905" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating income" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r776", "r938" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease expense" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]", "terseLabel": "Future lease payments by year:" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/LeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r774" ], "calculation": { "http://www.colfaxcorp.com/role/LeasesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "verboseLabel": "Present value of lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r774" ], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Lease liability" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r775" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.", "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r774" ], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Lease liability" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r775" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.", "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r773" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Lease asset - right of use" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r778", "r938" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Operating leases" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/LeasesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r777", "r938" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Operating leases" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/LeasesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r191" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Operating loss carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r20", "r218" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "verboseLabel": "Organization and Basis of Presentation" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "verboseLabel": "Other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAccruedLiabilitiesNoncurrent": { "auth_ref": [ "r46" ], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Noncurrent", "terseLabel": "Other" } } }, "localname": "OtherAccruedLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r314", "r939" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r226", "r239" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Other Assets" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails", "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesBalanceSheetItemsDetails", "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r303" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax": { "auth_ref": [ "r56", "r58", "r606" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax", "terseLabel": "Current year prior service cost" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r55", "r58", "r208", "r213" ], "calculation": { "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails": { "order": 2.0, "parentTag": "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent", "negatedTerseLabel": "Net actuarial gain (loss)" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r208", "r209", "r213" ], "calculation": { "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails": { "order": 5.0, "parentTag": "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "terseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r52", "r58", "r752", "r754", "r759" ], "calculation": { "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails": { "order": 3.0, "parentTag": "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "terseLabel": "Net actuarial gain (loss)" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": { "auth_ref": [ "r58", "r62", "r324", "r606" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax", "negatedTerseLabel": "Amortization of prior service cost" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r319", "r320" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "terseLabel": "Unrealized gain on derivatives designated and qualifying as cash flow hedges, net of tax expense of $3,240" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": { "auth_ref": [ "r320" ], "calculation": { "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails": { "order": 4.0, "parentTag": "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent", "terseLabel": "Unrealized gain on cash flow hedges" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax": { "auth_ref": [ "r319", "r320" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax", "terseLabel": "Loss related to interest rate swap agreements" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNarrativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": { "auth_ref": [ "r321" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax", "terseLabel": "Unrealized gain on derivatives designated and qualifying as cash flow hedges, net of tax expense" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "auth_ref": [ "r320", "r323", "r728" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "terseLabel": "Loss recognized in the Consolidated and Combined Statements of Operations:" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesSummaryoftheEffectsofDesignatedCashFlowHedgesontheCompanysConsolidatedandCombinedStatementsofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax": { "auth_ref": [ "r58", "r62", "r171" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails": { "order": 5.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax", "negatedTerseLabel": "Settlement/divestiture/other gain" } } }, "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r50" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "verboseLabel": "Foreign currency translation, net of tax (benefit) expense of $(2,930), $740 and $(1,598)" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "auth_ref": [ "r50", "r59", "r756", "r766" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax", "terseLabel": "Foreign currency translation, tax expense (benefit)" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r64", "r156", "r326", "r329", "r335", "r760", "r765", "r767", "r820", "r828", "r970", "r971" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Other comprehensive (loss) income", "totalLabel": "Other comprehensive (loss) income" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME", "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive (loss) income:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r208", "r209", "r213", "r326", "r329" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest", "negatedTerseLabel": "Decrease in noncontrolling interest" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityNarrativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r208", "r209", "r213", "r326", "r329" ], "calculation": { "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "totalLabel": "Net current period Other comprehensive (loss) income" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": { "auth_ref": [ "r55", "r58", "r922", "r1067" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax", "totalLabel": "Total recognized in Other comprehensive (gain) loss" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r55", "r58" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedTerseLabel": "Defined benefit pension and other post-retirement plan activity, net of tax benefit of $1,840, $1,192 and $367" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": { "auth_ref": [ "r53", "r58", "r171" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax", "negatedTerseLabel": "Current year net actuarial (gain) loss" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": { "auth_ref": [ "r55", "r59", "r208" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax", "terseLabel": "Defined benefit pension and other post-retirement plan activity, net of tax benefit" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": { "auth_ref": [ "r58", "r62", "r324", "r606" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax", "terseLabel": "Amortization of net (gain) loss" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax [Abstract]", "terseLabel": "Less amounts included in net periodic benefit cost:" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossTax": { "auth_ref": [ "r59", "r331", "r335", "r678", "r708", "r711", "r760", "r763", "r767", "r820", "r828" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Tax", "negatedTerseLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITYParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]", "terseLabel": "Other intangible assets" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesMember": { "auth_ref": [ "r226", "r239" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other liabilities.", "label": "Other Liabilities [Member]", "terseLabel": "Other Liabilities" } } }, "localname": "OtherLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesBalanceSheetItemsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r46" ], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities", "totalLabel": "Total accrued and other liabilities, Noncurrent" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails", "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).", "label": "Other Nonoperating Income (Expense) [Member]", "terseLabel": "Interest (income) expense and other, net" } } }, "localname": "OtherNonoperatingIncomeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNetForeignTransactionGainsandLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "auth_ref": [ "r164", "r562", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r609", "r611", "r612", "r614", "r615", "r616", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r632", "r633", "r634", "r922", "r923", "r924", "r925", "r926" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.", "label": "Other Postretirement Benefits Plan [Member]", "terseLabel": "Other\u00a0Post-Retirement\u00a0Benefits" } } }, "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansAccumulatedOtherComprehensiveIncomeDetails", "http://www.colfaxcorp.com/role/BenefitPlansExpectedBenefitPaymentsDetails", "http://www.colfaxcorp.com/role/BenefitPlansKeyEconomicAssumptionsDetails", "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails", "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails", "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic": { "auth_ref": [ "r390", "r956" ], "calculation": { "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.", "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Basic", "negatedTerseLabel": "Less: distributed and undistributed earnings allocated to nonvested shares" } } }, "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": { "auth_ref": [ "r83" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.", "label": "Payment for Contingent Consideration Liability, Financing Activities", "negatedTerseLabel": "Payment of deferred consideration" } } }, "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r478", "r973" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments for Restructuring", "negatedLabel": "Payments" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r82" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedTerseLabel": "Payment of deferred financing fees and other" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividends": { "auth_ref": [ "r80" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.", "label": "Payments of Dividends", "negatedTerseLabel": "Payment of dividends", "terseLabel": "Dividends paid" } } }, "localname": "PaymentsOfDividends", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS", "http://www.colfaxcorp.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r77", "r719" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Cash consideration" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r77" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedTerseLabel": "Acquisitions, net of cash received", "terseLabel": "Cash consideration, net" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AcquisitionsNarrativeDetails", "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireProductiveAssets": { "auth_ref": [ "r340", "r1100", "r1101", "r1102" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Payments to Acquire Productive Assets", "verboseLabel": "Capital expenditures:" } } }, "localname": "PaymentsToAcquireProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r78" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedTerseLabel": "Purchases of property, plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToMinorityShareholders": { "auth_ref": [ "r84" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.", "label": "Payments to Noncontrolling Interests", "negatedTerseLabel": "Distributions to noncontrolling interest holders" } } }, "localname": "PaymentsToMinorityShareholders", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": { "auth_ref": [ "r23", "r562", "r563", "r586", "r922" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.", "label": "Liability, Defined Benefit Plan, Current", "negatedTerseLabel": "Current liabilities" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r25", "r562", "r563", "r586", "r922" ], "calculation": { "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.", "label": "Liability, Defined Benefit Plan, Noncurrent", "negatedTerseLabel": "Non-current liabilities" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r163", "r562", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r609", "r611", "r612", "r614", "r615", "r616", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r632", "r633", "r637", "r922", "r923", "r927", "r928", "r929" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Pension\u00a0Benefits" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansAccumulatedOtherComprehensiveIncomeDetails", "http://www.colfaxcorp.com/role/BenefitPlansExpectedBenefitPaymentsDetails", "http://www.colfaxcorp.com/role/BenefitPlansKeyEconomicAssumptionsDetails", "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails", "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails", "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PercentageOfLIFOInventory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of LIFO (last in first out) inventory to total inventory as of the balance sheet date if other than 100 percent.", "label": "Percentage of LIFO Inventory", "terseLabel": "Percentage of inventory valued at LIFO" } } }, "localname": "PercentageOfLIFOInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/InventoriesNetDetails" ], "xbrltype": "percentItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "PRSUs" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityNarrativesDetails", "http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r313", "r455", "r456", "r893" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r960" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "terseLabel": "Reclassification" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r79" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-Term Debt", "terseLabel": "Indebtedness incurred" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": { "auth_ref": [ "r79" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from issuance of long-term debt classified as other.", "label": "Proceeds from Issuance of Other Long-Term Debt", "terseLabel": "Proceeds from borrowings on term credit facility" } } }, "localname": "ProceedsFromIssuanceOfOtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLongTermLinesOfCredit": { "auth_ref": [ "r79" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Proceeds from Long-Term Lines of Credit", "terseLabel": "Proceeds from borrowings on revolving credit facility and other" } } }, "localname": "ProceedsFromLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS", "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r76" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from Sale of Property, Plant, and Equipment", "terseLabel": "Proceeds from sale of property, plant and equipment" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrual": { "auth_ref": [ "r150", "r151", "r264" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.", "label": "Standard and Extended Product Warranty Accrual", "periodEndLabel": "Warranty liability, end of period", "periodStartLabel": "Warranty liability, beginning of period" } } }, "localname": "ProductWarrantyAccrual", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesWarrantyLiabilityRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "auth_ref": [ "r43", "r142", "r144" ], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Product Warranty Accrual, Current", "terseLabel": "Warranty liability" } } }, "localname": "ProductWarrantyAccrualClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualNoncurrent": { "auth_ref": [ "r46" ], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer) for estimated claims under standard and extended warranty protection rights granted to customers.", "label": "Product Warranty Accrual, Noncurrent", "terseLabel": "Warranty liability" } } }, "localname": "ProductWarrantyAccrualNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualPayments": { "auth_ref": [ "r145" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.", "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments", "negatedTerseLabel": "Cost of warranty service work performed" } } }, "localname": "ProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesWarrantyLiabilityRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease": { "auth_ref": [ "r147" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the standard and extended product warranty accrual from changes in estimates attributable to preexisting product warranties.", "label": "Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties", "terseLabel": "Changes in estimates related to pre-existing warranties" } } }, "localname": "ProductWarrantyAccrualPreexistingIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesWarrantyLiabilityRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r146" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.", "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued", "terseLabel": "Accrued warranty expense" } } }, "localname": "ProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesWarrantyLiabilityRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r294", "r325", "r328", "r342", "r348", "r369", "r379", "r380", "r419", "r424", "r430", "r433", "r446", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r720", "r723", "r724", "r736", "r747", "r825", "r905", "r934", "r935", "r972", "r1021" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income", "totalLabel": "Net income", "verboseLabel": "Net income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS", "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME", "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY", "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetNarrativeDetails", "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r138", "r862", "r863", "r864" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property, Plant and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r132", "r299" ], "calculation": { "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property, plant and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetNarrativeDetails", "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment [Member]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r134", "r281", "r826", "r939" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant and equipment, net", "totalLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS", "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails", "http://www.colfaxcorp.com/role/SegmentInformationNetSalesandPPEbyGeographyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r134", "r862", "r863" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r132" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetNarrativeDetails", "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Depreciable Life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "durationItemType" }, "us-gaap_PurchaseObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.", "label": "Purchase Obligation", "terseLabel": "Unconditional purchase obligation" } } }, "localname": "PurchaseObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r993", "r994", "r995", "r996" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Receivable [Policy Text Block]", "terseLabel": "Trade Receivables" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": { "auth_ref": [ "r61", "r64" ], "calculation": { "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.", "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent", "negatedTerseLabel": "Amounts reclassified from Accumulated other comprehensive loss" } } }, "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]" } } }, "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r614", "r787", "r788" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r614", "r787", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r1113" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r785", "r786", "r788", "r789", "r790" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLongTermLinesOfCredit": { "auth_ref": [ "r81" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Repayments of Long-Term Lines of Credit", "negatedTerseLabel": "Repayments of borrowings on revolving credit facility and other" } } }, "localname": "RepaymentsOfLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r181", "r289", "r1122" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development costs" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r181" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expense, Policy [Policy Text Block]", "terseLabel": "Research and Development Expense" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "RSUs" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityNarrativesDetails", "http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r89", "r481", "r483", "r1013" ], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 }, "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Charges", "totalLabel": "Total Provision", "verboseLabel": "Restructuring and other related charges" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails", "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS", "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [ "r477", "r478", "r483", "r484" ], "lang": { "en-us": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Cost and Reserve [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r478", "r482" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "periodEndLabel": "Balance at End of Period", "periodStartLabel": "Balance at Beginning of Period" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveCurrent": { "auth_ref": [ "r963", "r1014", "r1015" ], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Current", "verboseLabel": "Restructuring liability" } } }, "localname": "RestructuringReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveNoncurrent": { "auth_ref": [ "r969", "r1014", "r1015" ], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": 9.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Noncurrent", "terseLabel": "Restructuring liability" } } }, "localname": "RestructuringReserveNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]", "terseLabel": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserveTranslationAdjustment": { "auth_ref": [ "r1014", "r1015" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.", "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign Currency Translation" } } }, "localname": "RestructuringReserveTranslationAdjustment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r31", "r161", "r278", "r838", "r842", "r939" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r290", "r363", "r364", "r365", "r370", "r378", "r380", "r447", "r668", "r669", "r670", "r697", "r698", "r734", "r835", "r837" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanFundingStatusAxis": { "auth_ref": [ "r1027", "r1028", "r1029", "r1030", "r1031", "r1032", "r1033", "r1034", "r1035", "r1036", "r1037", "r1038", "r1039", "r1040", "r1041", "r1042", "r1043", "r1044", "r1045", "r1046", "r1047", "r1048", "r1049", "r1050", "r1051", "r1052", "r1053", "r1054", "r1055", "r1056", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087" ], "lang": { "en-us": { "role": { "documentation": "Information by status of funding for defined benefit plan designed to provide retirement benefits.", "label": "Defined Benefit Plan, Funding Status [Axis]", "terseLabel": "Defined Benefit Plan, Funding Status [Axis]" } } }, "localname": "RetirementPlanFundingStatusAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails", "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanFundingStatusDomain": { "auth_ref": [ "r1027", "r1028", "r1029", "r1030", "r1031", "r1032", "r1033", "r1034", "r1035", "r1036", "r1037", "r1038", "r1039", "r1040", "r1041", "r1042", "r1043", "r1044", "r1045", "r1046", "r1047", "r1048", "r1049", "r1050", "r1051", "r1052", "r1053", "r1054", "r1055", "r1056", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087" ], "lang": { "en-us": { "role": { "documentation": "Status of funding for defined benefit plan designed to provide retirement benefits.", "label": "Defined Benefit Plan, Funding Status [Domain]", "terseLabel": "Defined Benefit Plan, Funding Status [Domain]" } } }, "localname": "RetirementPlanFundingStatusDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails", "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanSponsorLocationAxis": { "auth_ref": [ "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r609", "r610", "r611", "r612", "r614", "r615", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r1089", "r1090", "r1091" ], "lang": { "en-us": { "role": { "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Axis]", "terseLabel": "Retirement Plan Sponsor Location [Axis]" } } }, "localname": "RetirementPlanSponsorLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansExpectedBenefitPaymentsDetails", "http://www.colfaxcorp.com/role/BenefitPlansKeyEconomicAssumptionsDetails", "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails", "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails", "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails", "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationDetails", "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanSponsorLocationDomain": { "auth_ref": [ "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r609", "r610", "r611", "r612", "r614", "r615", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r1089", "r1090", "r1091" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Domain]", "terseLabel": "Retirement Plan Sponsor Location [Domain]" } } }, "localname": "RetirementPlanSponsorLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansExpectedBenefitPaymentsDetails", "http://www.colfaxcorp.com/role/BenefitPlansKeyEconomicAssumptionsDetails", "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails", "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails", "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails", "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationDetails", "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r163", "r164", "r562", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r609", "r611", "r612", "r614", "r615", "r616", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r632", "r633", "r634", "r637", "r922", "r923", "r924", "r925", "r926", "r927", "r928", "r929" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansAccumulatedOtherComprehensiveIncomeDetails", "http://www.colfaxcorp.com/role/BenefitPlansExpectedBenefitPaymentsDetails", "http://www.colfaxcorp.com/role/BenefitPlansKeyEconomicAssumptionsDetails", "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails", "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails", "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r163", "r164", "r562", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r609", "r611", "r612", "r614", "r615", "r616", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r632", "r633", "r634", "r637", "r922", "r923", "r924", "r925", "r926", "r927", "r928", "r929" ], "lang": { "en-us": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansAccumulatedOtherComprehensiveIncomeDetails", "http://www.colfaxcorp.com/role/BenefitPlansExpectedBenefitPaymentsDetails", "http://www.colfaxcorp.com/role/BenefitPlansKeyEconomicAssumptionsDetails", "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails", "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails", "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]", "terseLabel": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r410", "r411", "r423", "r428", "r429", "r435", "r436", "r439", "r557", "r558", "r801" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "verboseLabel": "Net sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS", "http://www.colfaxcorp.com/role/RevenueDisaggregationofRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerMember": { "auth_ref": [ "r439", "r991" ], "lang": { "en-us": { "role": { "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue from Contract with Customer Benchmark [Member]", "terseLabel": "Revenue from Contract with Customer Benchmark" } } }, "localname": "RevenueFromContractWithCustomerMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r561", "r902" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r560", "r561" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/Revenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r334", "r348", "r410", "r411", "r423", "r428", "r429", "r435", "r436", "r439", "r446", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r747", "r825", "r1021" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Net sales" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving credit facilities" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.", "label": "Sale of Stock, Percentage of Ownership after Transaction", "terseLabel": "Percentage of outstanding stock after spin-off (as a percent)" } } }, "localname": "SaleOfStockPercentageOfOwnershipAfterTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of Accrued and Other Liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r61", "r1108", "r1109" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "verboseLabel": "Schedule of Accumulated Other Comprehensive Loss" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": { "auth_ref": [ "r168" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.", "label": "Schedule of Allocation of Plan Assets [Table Text Block]", "terseLabel": "Schedule of Allocation of Plan Assets" } } }, "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r171" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.", "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": { "auth_ref": [ "r608" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.", "label": "Defined Benefit Plan, Assumptions [Table Text Block]", "terseLabel": "Schedule of Assumptions Used" } } }, "localname": "ScheduleOfAssumptionsUsedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r195", "r196", "r717" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.", "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfChangeInAccountingEstimateTable": { "auth_ref": [ "r99", "r376" ], "lang": { "en-us": { "role": { "documentation": "A summarization of the nature of changes in accounting estimates, including changes that occur in interim periods. Changes in accounting estimate have the effect of adjusting the carrying amounts of existing assets or liabilities or altering the subsequent accounting for existing or future assets or liabilities. Changes in accounting estimates are a necessary consequence of assessments, in conjunction with the periodic presentation of financial statements, of the present status and expected future benefits and obligations associated with assets and liabilities. Changes in accounting estimates result from new or better information. Examples of items for which estimates are necessary are uncollectible receivables, inventory obsolescence, service lives and salvage values of depreciable assets, warranty obligations, and regulatory reviews.", "label": "Schedule of Change in Accounting Estimate [Table]", "terseLabel": "Schedule of Change in Accounting Estimate [Table]" } } }, "localname": "ScheduleOfChangeInAccountingEstimateTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNetForeignTransactionGainsandLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.", "label": "Schedule of Changes in Projected Benefit Obligations [Table Text Block]", "terseLabel": "Schedule of Changes in Projected Benefit Obligations" } } }, "localname": "ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r193" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r45", "r157", "r158", "r159", "r160", "r249", "r250", "r252", "r270", "r908", "r910", "r978" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Long-Term Debt" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of Deferred Tax Assets and Liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r173", "r174", "r175", "r176", "r177" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansAccumulatedOtherComprehensiveIncomeDetails", "http://www.colfaxcorp.com/role/BenefitPlansExpectedBenefitPaymentsDetails", "http://www.colfaxcorp.com/role/BenefitPlansKeyEconomicAssumptionsDetails", "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails", "http://www.colfaxcorp.com/role/BenefitPlansNetPeriodicBenefitCostDetails", "http://www.colfaxcorp.com/role/BenefitPlansObligationandAssetRollforwardDetails", "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationDetails", "http://www.colfaxcorp.com/role/BenefitPlansPlanAssetAllocationFairValueHierarchyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r227", "r234", "r729" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Schedule of Net Foreign Transaction Gains and Losses" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r232" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": { "auth_ref": [ "r219", "r221", "r222", "r224", "r225", "r232", "r234", "r236", "r238" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Schedule of Derivative Instruments [Table Text Block]", "terseLabel": "Schedule of Derivative Instruments" } } }, "localname": "ScheduleOfDerivativeInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r228" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.", "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]", "terseLabel": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location" } } }, "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesTables", "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r990" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share from Continuing Operations" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": { "auth_ref": [ "r169" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.", "label": "Schedule of Expected Benefit Payments [Table Text Block]", "terseLabel": "Schedule of Expected Benefit Payments" } } }, "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r741", "r742" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "verboseLabel": "Schedule of Assets and Liabilities Measured at Fair Value" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r120", "r123" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r906" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r906", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r977" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "terseLabel": "Schedule of Income before Income Tax, Domestic and Foreign" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r127", "r128" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table]", "terseLabel": "Intangible Assets Schedule [Table]" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r127", "r128" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r21", "r35", "r36", "r37" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "verboseLabel": "Schedule of Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/InventoriesNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r153" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "terseLabel": "Schedule of the Contractual Maturities of the Company's Debt" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r170" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule of Net Benefit Costs [Table Text Block]", "terseLabel": "Schedule of Net Benefit Costs" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock": { "auth_ref": [ "r172" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts related to pension plans and/or other employee benefit plans in accumulated other comprehensive income or loss that have not yet been recognized as components of net periodic benefit cost, such as the net gain (loss), net prior service cost or credit, and net transition asset or obligation.", "label": "Schedule of Net Periodic Benefit Cost Not yet Recognized [Table Text Block]", "terseLabel": "Schedule of Net Periodic Benefit Cost Not yet Recognized" } } }, "localname": "ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": { "auth_ref": [ "r178" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.", "label": "Schedule of Nonvested Share Activity [Table Text Block]", "terseLabel": "Schedule of Nonvested Share Activity" } } }, "localname": "ScheduleOfNonvestedShareActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r152" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Schedule of Product Warranty Liability" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Schedule of Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetNarrativeDetails", "http://www.colfaxcorp.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r253", "r254" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r477", "r478", "r479", "r480", "r483", "r484", "r485" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "auth_ref": [ "r139", "r140" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "terseLabel": "Schedule of Restructuring Reserve by Type of Cost" } } }, "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "auth_ref": [ "r68", "r111" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]", "terseLabel": "Schedule of Long-Lived Assets, by Geographical Areas" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r108", "r109", "r110", "r117" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "verboseLabel": "Schedule of Segment Reporting Information [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformationNetSalesandPPEbyGeographyDetails", "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r108", "r109", "r110", "r117" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "verboseLabel": "Schedule of Segment Reporting Information, by Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityNarrativesDetails", "http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.", "label": "Secured Debt [Member]", "terseLabel": "Term loans" } } }, "localname": "SecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails", "http://www.colfaxcorp.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r407", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r433", "r439", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r480", "r485", "r906", "r1123" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails", "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsGoodwillDetails", "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r407", "r408", "r409", "r419", "r422", "r427", "r431", "r432", "r433", "r434", "r435", "r438", "r439", "r440" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "verboseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformationNetSalesandPPEbyGeographyDetails", "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r73" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative expense" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general and administrative expense" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNetForeignTransactionGainsandLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.", "label": "Senior Notes [Member]", "terseLabel": "Senior Notes" } } }, "localname": "SeniorNotesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeveranceCosts1": { "auth_ref": [ "r89" ], "calculation": { "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.", "label": "Severance Costs", "terseLabel": "Separation costs" } } }, "localname": "SeveranceCosts1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r88" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r931" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Performance vesting period (in years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityNarrativesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r656" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Forfeited and expired (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r656" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited and expired (in usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r654" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r654" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value, Amount Per Share [Abstract]", "terseLabel": "Weighted- Average Grant-Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValueRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r651", "r652" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Number of units, nonvested, ending balance (in shares)", "periodStartLabel": "Number of units, nonvested, beginning balance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of Units" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r651", "r652" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted-average grant date fair value, nonvested, ending balance (in usd per share)", "periodStartLabel": "Weighted-average grant date fair value, nonvested, beginning balance (in usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r655" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r658" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "terseLabel": "Fair value of vested shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityNarrativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r655" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityNarrativesDetails", "http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Equity Award [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityNarrativesDetails", "http://www.colfaxcorp.com/role/EquityPRSUandRSUActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r932" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "terseLabel": "Maximum term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EquityNarrativesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "auth_ref": [ "r162", "r180" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).", "label": "Shareholders' Equity and Share-Based Payments [Text Block]", "verboseLabel": "Equity" } } }, "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/Equity" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r40" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]", "terseLabel": "Short-Term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r38" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-Term Debt, Type [Domain]", "terseLabel": "Short-Term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r98", "r346" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r149" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the standard and extended product warranty accrual.", "label": "Standard and Extended Product Warranty Accrual, Foreign Currency Translation Gain (Loss)", "negatedTerseLabel": "Foreign exchange translation effect" } } }, "localname": "StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesWarrantyLiabilityRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyPolicy": { "auth_ref": [ "r148" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.", "label": "Standard Product Warranty, Policy [Policy Text Block]", "terseLabel": "Warranty Costs" } } }, "localname": "StandardProductWarrantyPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r293", "r407", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r433", "r439", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r476", "r480", "r485", "r906", "r1123" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Business Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails", "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsGoodwillDetails", "http://www.colfaxcorp.com/role/SegmentInformationSegmentReportingInformationbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r306", "r307", "r308", "r348", "r387", "r388", "r391", "r393", "r401", "r402", "r446", "r493", "r495", "r496", "r497", "r500", "r501", "r532", "r533", "r535", "r536", "r537", "r747", "r877", "r957", "r974", "r989" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r47", "r156", "r290", "r331", "r332", "r333", "r363", "r364", "r365", "r370", "r378", "r380", "r400", "r447", "r538", "r668", "r669", "r670", "r697", "r698", "r734", "r760", "r761", "r762", "r763", "r764", "r767", "r783", "r835", "r836", "r837" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY", "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails", "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY", "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r363", "r364", "r365", "r400", "r801" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY", "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r28", "r29", "r156", "r161" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Common stock-based award activity (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r28", "r29", "r161", "r179" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Common stock-based award activity" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r29", "r32", "r33", "r112", "r939", "r976", "r997", "r1107" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "negatedLabel": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total ESAB Corporation equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS", "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r205", "r206", "r215", "r290", "r291", "r332", "r363", "r364", "r365", "r370", "r378", "r447", "r538", "r668", "r669", "r670", "r697", "r698", "r734", "r760", "r761", "r767", "r783", "r836", "r837", "r976", "r997", "r1107" ], "calculation": { "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS", "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFEQUITY", "http://www.colfaxcorp.com/role/EquityAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Equity:" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r768", "r792" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails", "http://www.colfaxcorp.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r768", "r792" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r768", "r792" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails", "http://www.colfaxcorp.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r768", "r792" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails", "http://www.colfaxcorp.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]", "terseLabel": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r791", "r793" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": { "auth_ref": [ "r184", "r187", "r188" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.", "label": "Summary of Income Tax Contingencies [Table Text Block]", "terseLabel": "Schedule of Income Tax Contingencies" } } }, "localname": "SummaryOfIncomeTaxContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosures:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r41" ], "calculation": { "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable, Current", "terseLabel": "Accrued taxes and deferred tax liabilities" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "auth_ref": [ "r197" ], "lang": { "en-us": { "role": { "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.", "label": "Technology-Based Intangible Assets [Member]", "terseLabel": "Technology" } } }, "localname": "TechnologyBasedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r198" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Trade names" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [ "r477", "r478", "r483", "r484" ], "lang": { "en-us": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UndistributedEarningsOfForeignSubsidiaries": { "auth_ref": [ "r271", "r288", "r671", "r715" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.", "label": "Undistributed Earnings of Foreign Subsidiaries", "terseLabel": "Undistributed earnings of foreign subsidiaries" } } }, "localname": "UndistributedEarningsOfForeignSubsidiaries", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnfundedPlanMember": { "auth_ref": [ "r1027", "r1028", "r1029", "r1030", "r1031", "r1032", "r1033", "r1034", "r1035", "r1036", "r1037", "r1038", "r1039", "r1040", "r1041", "r1042", "r1043", "r1044", "r1045", "r1046", "r1047", "r1048", "r1049", "r1050", "r1051", "r1052", "r1053", "r1054", "r1055", "r1056", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087" ], "lang": { "en-us": { "role": { "documentation": "Defined benefit plan in which retirement benefits are payable directly from general assets of employer sponsoring plan.", "label": "Defined Benefit Plan, Unfunded Plan [Member]", "terseLabel": "Defined Benefit Plan, Unfunded Plan" } } }, "localname": "UnfundedPlanMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/BenefitPlansNarrativeDetails", "http://www.colfaxcorp.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrealizedGainLossOnDerivatives": { "auth_ref": [ "r89" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.", "label": "Unrealized Gain (Loss) on Derivatives", "terseLabel": "Change in unrealized gains" } } }, "localname": "UnrealizedGainLossOnDerivatives", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DerivativesNotDesignatedasHedgingInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r672", "r682" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails", "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation": { "auth_ref": [ "r1094" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from foreign currency translation.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation", "negatedTerseLabel": "Other, including the impact of foreign currency translation and U.S. tax rate changes" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "auth_ref": [ "r685" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities", "negatedTerseLabel": "Reductions related to settlements with taxing authorities" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r681" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Unrecognized tax benefits, income tax penalties and interest accrued" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": { "auth_ref": [ "r681" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense", "terseLabel": "Unrecognized tax (benefits), income tax penalties and interest expense" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r684" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "terseLabel": "Addition for tax positions taken in the current period" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r683" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions", "terseLabel": "Addition for tax positions taken in prior periods" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r686" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations", "negatedTerseLabel": "Reductions resulting from a lapse of applicable statute of limitations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r105", "r106", "r107", "r403", "r404", "r405", "r406" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceByDeferredTaxAssetAxis": { "auth_ref": [ "r189" ], "lang": { "en-us": { "role": { "documentation": "Information by type of deferred tax consequences attributable to deductible temporary differences.", "label": "Valuation Allowance by Deferred Tax Asset [Axis]", "terseLabel": "Valuation Allowance by Deferred Tax Asset [Axis]" } } }, "localname": "ValuationAllowanceByDeferredTaxAssetAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r691" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "terseLabel": "Valuation allowance on deferred taxes" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": { "auth_ref": [ "r979", "r980", "r981", "r982", "r983" ], "lang": { "en-us": { "role": { "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.", "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]", "terseLabel": "Valuation allowance for deferred tax assets" } } }, "localname": "ValuationAllowanceOfDeferredTaxAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesAdjustments": { "auth_ref": [ "r984" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment", "terseLabel": "Foreign Currency Translation" } } }, "localname": "ValuationAllowancesAndReservesAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesBalance": { "auth_ref": [ "r356", "r361" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount", "periodEndLabel": "Balance at End of Period", "periodStartLabel": "Balance at Beginning of Period" } } }, "localname": "ValuationAllowancesAndReservesBalance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "auth_ref": [ "r359" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense", "terseLabel": "Charged to Expense, net" } } }, "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/RevenueAllowanceforCreditLossRollforwardDetails", "http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDeductions": { "auth_ref": [ "r360" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction", "negatedTerseLabel": "Write-Offs Write-Downs Deductions and Other" } } }, "localname": "ValuationAllowancesAndReservesDeductions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDomain": { "auth_ref": [ "r356", "r357", "r358", "r360", "r361" ], "lang": { "en-us": { "role": { "documentation": "Valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]" } } }, "localname": "ValuationAllowancesAndReservesDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "auth_ref": [ "r356", "r357", "r358", "r360", "r361" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]" } } }, "localname": "ValuationAllowancesAndReservesTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r990" ], "calculation": { "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment", "terseLabel": "Net effect of potentially dilutive securities (in shares)" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r386", "r393" ], "calculation": { "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "totalLabel": "Weighted-average shares of common stock outstanding - assuming dilution (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r384", "r393" ], "calculation": { "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "verboseLabel": "Weighted-average shares of common stock outstanding - basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.colfaxcorp.com/role/EarningsperSharefromContinuingOperationsDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 10 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1000": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1001": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1002": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1003": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1004": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1005": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1006": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1007": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1008": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1009": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1010": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1011": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1012": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1013": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1014": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1015": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1016": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1017": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1018": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1019": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1020": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1021": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1022": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1023": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1024": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1025": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1026": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1027": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1028": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1029": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1030": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1031": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1032": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1033": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1034": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1035": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1036": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1037": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1038": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1039": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1040": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1041": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1042": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1043": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1044": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1045": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1046": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1047": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1048": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1049": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1050": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1051": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1052": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1053": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1054": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1055": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1056": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1057": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1058": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1059": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1060": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1061": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1062": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1063": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1064": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1065": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1066": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1067": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1068": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1069": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1070": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1071": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1072": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1073": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1074": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1075": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1076": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1077": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1078": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1079": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1080": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1081": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1082": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1083": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1084": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1085": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1086": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1087": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1088": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1089": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1090": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1091": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1092": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1093": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1094": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1095": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1096": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1097": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1098": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1099": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1103": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1104": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1105": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1107": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1108": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1110": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1113": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1114": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1115": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1116": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1117": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1118": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1119": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1120": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1121": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1123": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1124": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1125": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "11", "Subsection": "03", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r113": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "https://asc.fasb.org/topic&trid=2144416", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907644&loc=d3e11281-110244", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12524-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(4))", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(5)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=2122178", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r203": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=d3e5291-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r218": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r241": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org/topic&trid=2229140", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=28365394&loc=d3e23770-108382", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(20))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(b))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "3B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column B))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column D))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column E))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org/topic&trid=2122394", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(1)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(2)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a-c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/subtopic&trid=2235042", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(13))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126928070&loc=d3e28200-109314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r716": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "54B", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL7495116-110257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r769": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r793": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "715", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472162&loc=d3e58407-109430", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(1)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(2)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(3)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "21D", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r868": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r869": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r870": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r871": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r872": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r873": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r874": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r875": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r876": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r877": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r878": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r879": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r880": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r881": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r882": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column C", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r883": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r884": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r885": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r886": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column G", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r887": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column H", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r888": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column I", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r889": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "09", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r890": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(m)", "Publisher": "SEC", "Section": "4", "Subparagraph": "(1)(iii)", "Subsection": "08", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r891": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r892": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r893": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r894": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r895": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r896": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r897": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r898": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r899": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r900": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r901": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r902": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r903": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r904": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r905": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r906": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r907": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r908": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r909": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r910": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r911": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r912": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r913": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r914": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r915": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r916": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r917": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r918": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r919": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r920": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r921": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r922": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r923": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r924": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r925": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r926": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r927": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r928": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r929": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r930": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r931": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r932": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r933": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r934": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r935": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r936": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r937": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r938": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r939": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r940": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r941": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r942": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r943": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r944": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r945": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r946": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r947": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r948": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r949": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r950": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r951": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r952": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r953": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r954": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r955": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r956": { "Name": "Accounting Standards Codification", "Paragraph": "60", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2740-109256", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r957": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r958": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r959": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r960": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r961": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r962": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r963": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r964": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r965": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r966": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r967": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r968": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r969": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "210-10-S99-1(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r970": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r971": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r972": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r973": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r974": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r975": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r976": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r977": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r978": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r979": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column B))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r98": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r980": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r981": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r982": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column D))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r983": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column E))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r984": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r985": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r986": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r987": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r988": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r989": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e777-108305", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r990": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r991": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r992": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r993": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r994": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r995": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r996": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r997": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r998": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r999": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" } }, "version": "2.2" } ZIP 131 0001877322-23-000007-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001877322-23-000007-xbrl.zip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�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�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�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
=>!E(BP1KP?KMA)"2BLBFSX3 M.O6:.(.E+#]F!>A_PWU]]-HF1[(KGB 68Y0?"3G_8''Y),7?]9==ZCB^6U55 M3S!W%Z^M)1?\ M]'?8M+PUUI,K,VC">KWR1KJE%@=LX(,&9T1BYI7&]^I@!YIUV%MEC<6=BPY[ MA*ANL^W4]*+9RLW,[?OKUR,%AB6'ET7B^XBL="DURR!GOOQDK3);TD\6/!2 M;^Q!K([97H>B+3R^4NQWAM+/F*4E(;L"HM@@JP'2&( MK74"SU)ZM(K7%2UZ(]_58K;%G*X^Z[9ZP8D13EE.3"# T?>*;,M#E1988!LZ[Y7/S!<;YG@B^Y/NNLB=>8=H^ID"42*"FC7 MA=J+,^)+L(RO6VF=7G:DF4W'[BR.[=A8NE:F=09.?)?]W706VS%(HP][!#C6 M[:#T&E4G&(Q+6#4@TOW4E*_0:/#F1IT-$94S(H2CQ1F.]EN<>X[5L@>?[KG^ MKA7*2Y0\Q6'R7/T>S2]G-)!P [SM01.!M(/SD$X3QKUD4G.Q;MI-AW59=@[[ M0V/*H^73HW=[+BM%\^C'8- MDJF8''AX<2.5"N 7@C:X154 0EL[I>4N%W0WE_%["MEXNT32O+_'HZ;8*HO3 M([&*+OZ.PH9VXF&CH4PH)R3=+9+3 F>F>;AIO(Q24 08*E/.J1S@$MUR[Z." MR>/2U.Y Y#:,Z#1+^08\MT\%))S\T#';EJ_9>Q6^7ZVWA;8RUPS=3I',_G;^Q+: MFQUW78MH'-%+S*>R4%=">21B>SNGN>QZ/\!'1EI@SS7]AZ)-]8T"C"AJ2U'Q:)8]"VX(KZT5>A+[@85O$I\/[ M6/.65-SHY2Q;:FZ"5*>4_%*]V=N-D]3>,GW/M56^(G1F.^$"X8_ZB)?%BYJQ MP/B:>#CHGSF)?O. MOISOF&9[/[=CW'93[G**RMTXAG26;11"CW1U$Q](S@M66)*( P)KXRU7B8^Q M@SN+ SO; 9\0V,'+S!'YX%3UE*=?KOM?J#FUOU(P7YCKS'(0,>'5 M+FVUF,%&ER3,09?_\AYWF*C B>-0A+ E1%4L;3,[K\C%TVU\(7^IE(()^I*L MLY8*@D^6PUE5[$B/*(@@Z'W9?\"\L88R,>5SL?FJS+*E5=7X#)_FC 'N _'^ MST>E_L_1X9$GJ2>)!4JY.(\M0I^/QZYA!+=:*0*0F% ^0M3YK#0I_S#,;Z)Y M8XI VG;YV!UAQ>%$V[P?R-8^RU, 8.F^L2LKCRY*O08Q]7LL:*(VWFTMWK<\ M*>+4#X:VK"SCC'_YZB5*?\*;?*-?1]L8&3FU(#!8_?,1T^7 5/G37\LI L&* M$VY+7\9)T,]ZRL-7V*TFK>Q]!4_=I4_2VA)U>=561A<^P4E"G,0!A5_'%C 2 M,QP?:4Y_[MUC4 ;]HN/5I-M18=I&=((+P[T2< M[/B2BQFT7>7^M &!R]5#[JU8X=0+X1"\7X/IU,73/J?'#)M>T3T*1_#'YO"> M7"'5W[T;\B7B<'OQ,XE_(E-C_%;!.^*]S"?QM]YHO12???B\@/VWK9*NZK.] M]Z< QYXQ!*3^"5>OO]=]+*I3(GI!B)Q.>E) X,/HX*IK<2H+1,EO3/US M)9):G&L"(VGUHEL, /'?,$ZDLPKM(JP'?H$R2&$\B1O\H2!>2(FU]K7]S[@$^.SS\T(_!-R:3,/T9CPX.F4-P_OFN8D MZ0Z&*YNVV^S<5LSN^C16=OKN9E=B3MFUGL6<4V<9#GMY@1/!IFBR7LO5_;X< 9H#KJV/(H_85X6^(]@:=A9YZ_]P@[Q0H[B>0+%9BRA-/KEBJC M;CX#MW46XMU+.PY?GIIHOHZ 8T1-\/@!G>HT@PDW# (1)IL4L/;^AOHKF^H[ M:( "__0*='OF9/51 00_HA1E$@FP);]=G-R'X')]X!+8SF*F&0AVL.=Z[JCE1&L[KO\Z/X[[0)3Y? M6X-_6[<+#90-RN[6.]O5L'X7Z$'0[EF@P^&3R4BT'NMZQF1T8AY;HP[)[_8. M#SC81?WDQPG(%JQ."$*?<5'V6VKA>DATR;& X5M+6! Y5,"\WIW(I6]H^XI@ MF2*2_D3K"2)N#ZP,928X4@9R26I8(Z9-3N\S+EC;[_5^9)T;H)]V MB5.:UJ$"SLF?V#V$,@*Y''J>9$ N"A5SYFQ!Q4LC&>8W.!D:9.$B#XH$FA]/ M-0;+MI,2KWXQ>F'4U%RY^*$.0#/[:_W&1;[G_9TB;A70E1@8B82F7: M O]#M89IL7:Y0)G6,MKY-AI#;.0"\BT\ZP3'?6P]0^@..E'M #8J7/4&H;.W/OC M_9G9L]=ZUGJ>Y\V[UQ9?V6Q'3%N1')]B+)Q%7*4?GA(>9'-O^9WX7TU%-+)J M\C]F-9C>)#K%4\Y)&\H1Y1(*Y2>R@NIXU32$/R]_\Q$1&:HHNU=XGI"1[!V) M.@DOMYF130ZWS'&:'+$+&>:X>@(>1!'P&!PY!M'8MXDV:K4R+RWPJ]KG%5FP MVYK>SC[%S%Z2L[@BPA6UIX*P)AT*SR[2H.X)IJ7XR]Y?-ZKKYSE\P(\/:4$2 M(GT"4@4W5)D\I8(+0:[$8^PP5F>";@V[3;GZ:E1T@M9 M9LMLM?A0K!ZR)'U*[$&=.\!*M'4%)@D_P$EYF)A\HW325FA]2[:=6_;%SH>: M?@]$',R'M7.OMJ5EIG,&@"34DCN=\*@3]Z: U$$/V?JI$.#\QNI6>'(05P0N M,%S*8NV^#=CC"\6VI*<.[N?2/.,?>#VJ93>M=YR_>EKQI^7M7]P1\KOZ9$Z* M +5!R\\7>D^F>NO(/+],8!"I/-QS"O7H/'GY ^A'2UO8TI#\EP%BIY]ZG MK;)HP^UYFA3 U-L^GI&(L%\O@-C,:%DLE2W MH)-M99\A),E8BT?#8UP^SM] MVZ [14EK\C4*&[7-\ +%)#E4;.FCP3'(:S2L&#LXM:*_&7 KJ>A#PTY2]/D1 ME@L&\[-0@NUX$(S:!L6]DA3Z8G@&6'5*\7OY8Q)A7>F\W.@!P[HN:]Y5@^H_ M'V<<$L\"OT[(9M9@ 4'LX+ UVSZ,V*J';R$GD91:_75SKY&V:CU[^T/DW<_G MI0?[BR<\4UK7@@0 6(^K9IR*-\SB>= M([3NM-%+_17@CJM;&-"2D+%I(^#G.MU+N4W\7M;X,WTUTXV0NXM2M!<]^T_< M*C![FU!;R%=IO?0?H?QM7+&V6+:MHZ[,LLU!%3&3EMGRIM;&]H3B/%/,2?Y]^Z#_G[\WZ33K6YBXO]1_Z!FU.YNMF^LC*_I_#_ZV M8 C^.'DYX9;>,\XW\FC\EN)ER@"U]ACDOYH"98;BRE:YCT&^!:$KJW@Y["K\ M^M4"64/WY=?A)MQ7O^?.!B+:GL4FRZ!C$EFZ%JAHJ-]''9(J<-90;XO&\H$H MF"U9?*)V1B_JR$PQ8HCG4\=,]7NXP1-UM@E=$$E1B0Y_#.$ZE(NB32SO4>.\ MO\KV5^$-L!Y0.OH&YK85C'HC-H0V:2JVI]7MGG]=*940G+*)\",_W&Q SL$( M QA60PB$'YB;N!3@!(MT=7^@\* PY-]3\ M=%V6YZ907P:@Y!2//$,;1_&@?"6$<,A:[KH^&Q.Q*#_+MED\W]7W#R;X%%_( M64$4!LTM+X!.@>O.UKTR,*,GVP"XC5]=M, ?@W;U(_$BN\<@O+>?O:^'Y&2H MQ%6ED 2?/,NQ7*=+_$^8>30Z\]U &<_W,]P!+6+B (RG994'?GT0P_F#,%>, M_]$\RFVOIM(B_%[&QSK5-]-I+&[7FVNDMLU9X*8=:Y090H;@0UJAEAJJTMG* M'A%$*$&&< VLB<''WW[@RFIE_"#T M__CF\@XP0:^0NL13QJ%$\!!6-59@)EZE9*[%.<#QKH3#E9J.C/I:":C+E):7 MBV:M(_:[Q\J%R=H-)VZ^#:]8UAA'Z3#F9 ]7C@/!=S\"V MXFU(&#Q$\&>.-O+D_.U6%YCU]'H:9ZI9-MNGN[[,Q 1'5:;]9Y#MHH4B*VHN MQ;0"P)!BJ%D&#B4K<,\A\U[K<1TK4U[G^Z?8*3O=)OEWMI6OW%$L#SL8VM,P MDCPP@ZOU%RWE])D!'6M[3V"L-'&K=8E']'C'NWD0B_7:%]T6S>KU7 =_7.": M#TQ\\#3.2->7_]O)\AYHBT5LEPIRI)KLA)">]I[]4QDB\E=74T\>3T&XT9^;[+1I+OS!#7B^FQO3.1BKH[NH?MZ(4VRJ?L(23>^$D/ M#0CMU2[V^\?<>VY@>74[BVOX ZBJ(U?M .WS+QLH7'&7 D%^1PV_EPIMTLKO M>D4TUVQL(L9^K7GHZVO :VDOS0K_L"A>W1'#I_ -?8[A0$M@OP^)/9I/H#C@ M8(O[]H"&(L*&6,([7@J_@^(UN15[]0GO;H6[>W]6Q/G67,6JFL"=R4QTA^VB M$ZF:D+A[':_BY_ EQ*] QI70FA38K"8 1QXY1&B2 3&_-R%KEA,.SQ@RZ1H0 M!+[^MLOH"PI7[9KQ%.%#-,4GQM!;+YTE_21E <=YU%+87/MNE:L>=E3YT3 I M.6SW9G^8ZER631][]/>'@5!<8[O@.[*2_*XO+F@Q=D"O+C%D&]A!W%;&EK;4 MN%[L&VE0MMS+Z;CCE=PD>H+1Z^O(T@LCP_XYRFT\A&OD&3QC0"^L\'?EO:FC M(]W4##OAIRF3S#S/_/:OTSA'U_I<89\E%N$+(U-FC11I>Q=Z6CP*1?' ME76;0KN:"]C@UH<;562GJ294SZ4W!/#N>3QTL75]HCO-KT=FZ$$Y16O;^\1S-Z;2DJN>S\;#?H:S?;+LQI=>?Z:/BB]J3HPSU$=^ MUD8U9_0L.L;H/+/C*23#9#V!#( M-$[]$HH'< /#0^-%?H*=ZK0.!J=,6\YJUHHR0$F(JYF:X>K6HO74=GTTQ00"<5'<09<<&EFFAFB"&L"+3-<.B%]_L;'6_9;F/_92^<6@E$QPVZ#R?@!R""2&, MR6=0/>X&0630/;VX<<)>OVC:^%#B'P4YE9/)#T@RUXP#3R(^D(22WN!H.X5. MS\!3(TK?]E*@!(<,5D"C=T43:,+!XO0R4CI/$/8'T#0)HFURS5]G?%A'F,,S MK-&GWC7=Q77'\*S3X]([7\M#'Q41G*!+J6MJW:L+ZQ;$W.XT2>==FJRLH^.* M2DXP?YZ_CO:$WN&#[!\1>QQ=XM$RVUD+(*;=R_Z- \PV!K\5I15\POU/,%7* MU]?EMP0M]5TCZ*30(+0)U]8>7WJC]@&VH0LK@MG]SS3/+5CPW,6TMR=[_7YG M>'/!(>WKH=K0%1*LB74W U>'M>WOT@#N:HH5, VBP*&YTP@G_%+;W&TQUA 7 MW*L'\C$IVF+WZX?&JE]\8JWXB50FM":/O>OSD)O^"Y8)*B")]>>/?@[NN*W[ M^:3&3S\3C!)=HKZ&\7=&TNU.+/6]UFK\*D-=IZ]<1BKVA[MAGP.Z(65EA7/9 M^<6J@FP'TV_SI"6T]F6J[Y=DI/NNRVUJO 7 M>RIUS]^F:CD$-%K^<$:?,E)2S%':#P =2:80;!..0:T271W$HEX8$U(9<2Z_ M5Q33#V$_!O4:X]"T>;=/O_ <$W(UWRP@F2&9[W_'CF6 8J1.,Q608?3*HTB1 M11&>!+4^<%(16.W]#B(\I'YQ&RU4-7J7F6BF-'IR_)O\Z]JXK\Y>)^%OP._. MUIVFYAR#[D/Y:9/M>VF:&3RTSY+G"8SPZS<2YC[#!+&'-E6R*3L2+."HD49%/:W6^!2/T.M*175=X-DOX++9[_=C#9W>,GSS)CB MY]&E07=?]+Z] MX/EO=[ECG["Q+NA]_E@,A'V! ;$NS0W1'XPO?N_MCT]_H-[/18"32J>T/HKU M"WK:?PF-=%MZ.'")E,LIS:N7-F(YCGQ ZT:UFI<2+7#0#.@M")8T_):X%X]0 MJG)>L*@S-QAWQ')&".R6@@_>G^:GM^MBR^2[V1J5-[,G_J97WAO]\%+5X,/+3T7:W^#SO\Y?Z^:[ MN4'/+:XX[*A\=Q2Z([<&C75J5\7PJW\UKE[Q.]]2N]O8LU'S#)1?HB)Y=8I% M6U>67Y/A3[S 6I<,M1FA09C&%_5#GZZ*(!2/P D&3+76I67% 14J2]O7!T>> MHH<;H-^K:V2"(9TN#-@*YPV$#O7#[M_5IS1>0(SHB8];.35+.PW8TGC!)UI) M[2L6X6R.$2H^TKJ4U)*T\.>27G!F=G:Z5HI\VQ5"?4_GR,?R._'$\NXB-H0] M(=%E'H6_Y5[:E1E9["XSTBBR%O^E>T3DID8"MO=5=L M+6A1J1_2F)C2O)?D:I;E?@_++#K^8FKK[.30V7U5@7[!-V:*EBX%,Z 1D9)% ML>@HV\K[>7=3/<^4U]P_Y^IVB2%G[8=W&I\L0\X=T+<88%HS*OP24:"^ZCVME#%(O[C] QP+:87&80)1B_GKS$SX@8V$EB(V7]>< M5VM0\):3_;*R_UQ3O)(TZ'W)D'1F\ZWB+3;Y[T7 &?!N^-K>(KVUME90;&"+ M2RY$B_CF(/&OPVLV@:,N+:UDV8>ISCTI0F>L1G+^+&W:#9XZ4>KMD M4#W&AFR !B[HB:$6W-\#'D>Y\K&YGG RUDM0O_;:;_R3&IO.W3@9B48-+RGA MPY<5^A"F8Y"?A-):QF"1*'(@G35G^"BC_ MO>[+QRM=?V_RQ4LN\2^L[R=AJA3K?X$%_/!.NT%19"D_#'.G:<5V@V_"OE5N MWW[ITOWX-QJFS'9X9TL &WXJ.>%N0(K'1Q^2/7"P!L;:XOZV#D#X$"+SG:SA M6M3Q)@#5']SX]72*2:'/6-)EM'[%-Y[/ZD87SZ27&F0 M3X"@P5)J98[N]'_/P_#I*!NO(:(U_GFCLCW"_(O+R^BJ]D[9K$AP7JO\$[&7 M'M@? ED7^&LRVY_4_+N)S1[V'$4PWHM;Y>PZ V#6-Q(,I2EZ7_XN7U35_.#9 M-/OGPWN9=.W<:UQ5$E>_F-1=B9K\>9;I;ZB+BZD"77!8/':EC%*CD:KP:9+] MOT/\P 2-?:3P#&8&P109A4#(E<&6#587=G(&:0+)K[,J25$_1W3OJ/+,D?FU92#1^8:*(%Q'D\U>I'@/ M(C[>2JSPVD]^7A9G7J-A21?".HV#OYUN):1PQZ#%ZC54ST737FQ=/X2U/(DB M%2%8U3II'3@YKO!DP]^7%#%[^EEC9:8Q*$@_YC3$@1%[XT$T A7><[[QW]3W:D63O?S*GH2V=[M"+O\I(G3HI:G:!J06X3K:" MFZX/[>!]R%8(B>;LZ],M$I)N2TJ> ,V M>]L%F83BFAV[SE%?_=W#9M,-?B,TI:[S(MX]6-G *CBX%FLL\!;SC&?VLZN/ MRH,W@TEA7!J-"3?W*$;TX'<"&MUZ=!>2W+K:=)#BA)_OMWY9NX/PC@P/8NI3 M.J&6>G%-W:)MQ,=\R7?C%6A>6'F9^02 M;C#+AUG*B#_*FZK[K 8H2OQI9Z4(6)/\B"RO\-5IUWXKW#Z_L,#6?^#?NN%U M>4K]M&P60YB#B.PS=;]-5 RL]=OC-0N^AL#Z7 M #&RUA:DF991C.JU*=X\\A?-3!GY8W(@^/#YDO*5$5-QR[385J7"AZ#3D@5F MB%J"&XT#7B1),29@Y_&K.RWK'1_!0W6:3BM*;NY89*IFY,&EWU4OGE<8N<MY3C+]!T:6W2R>0^[A/=YBE3Q0S6SIH:(V2;S>:!ZK^.=E35#W:&V M;"0T*5N%5*1)R/01U7B"1PS+98)6K Z#:.Q:ZT7\R!&,$%*1-MBE:V..8MO2 M::VCPYM?*^YM[P\2[Y= *_3.P)BT]O77?!P5WP=1-Y0T!G/R?A3C)6QM"6/: M6?>%!-4'[K9.-S\X?%K"O9,R)O3ZM8(FP^$),A,BD "C^QE<%E2L2\A/$/LZ M;R-%*^KJ4!\Z#*O5/UKQ]>8F.FR;_VJ2?8FYU*)&VXUJ3Y8.%)8))]]?%XLB MF$).4'B(/@DM?&M4TW[BEGQ?/=:@U7%3979@L(_WR<@UG:==1@M[S;B_1]LT M]D=D/H0]-1;)OXUA-XA8"V!R0\\:F!Q]["HML=%KU^]A/G,FW;)[\#1WI_;# MA:65KJ(WX'$Z*L69!C $JZ!8#S:"Y*O@ROM*VC%-5M/**RYKU@&*\+O+O(R? M9#)SM#^).A4;4!@^A-#41??VEJQ"X*S06+F7J"!P],@,]P#1G#$6QD@( _1J$VWSS10L'VN=805?#[/O[ M-[>$5/H?F%>PG\BOYHFW&X.S=+%0,S"X-S3-CP!:V6+'=^T0*8NX031[*GF6 MN-+!E>SCS70YLR9XZ'M@^M0M\ &27E\HGA6F?.J^[%V/3LP K%ZRRWK-B=]ME0-E'I31NZ<^[83? M$6873UPG?6V;]HGM,Y2>"=3,8-D2XM'TJW;+3_I6N'6Z6S!6^TO<,T1=&SJ[ M>?XK?;$?B?]N(SNA-&5@379$(P"K7(2M+MJ$W\9]U,:Z MU(D/:S[Y/"VF$Y%V*JGC!0=&_];9[H/'9YGV-4B&]/84"TP=K"TT0!K*4[\# MF<3K X+GX.^&'N^HRQ4\YU8T;QB"O&C7MW;F],] .E?ZW!FS0;Z:_(\3K6N8 MYHT!""-<9XV^ZW&=?MZ%J&"PJ$+Q8#O^&6.?1<"*;9LJ>2H-JVI)?MSCA#( MC/2L['QNB,DBMK1-AA52]=R.=2UH* "U#MZ%DCG\NA1F:8SP4=NY'4/YH8?M MX$2*U)D"_$?.*_>\;AHSWW:,3,RS7;FR+?L.)&@65/37$9Q0R$[5^0#\*K,HZU%!LU[.LEO[%].*Z1X>'-?D&19[Z MEB8'8=E:;2H?$D9(1> Q_*856R0=].^+96WW/RS[09^;[LA S^);)8TYNIDV M; 'IB3YHNH<($%QSKTA2ZGQYW\5(!T)BW*U0_7>.;59[J_+4.R)9_&D=BKKB MHF0_C[D_&*Z?N84R<[\Z4Y4X750#?RR,-\I>&UNPL^IFC6:_6*V!+XI9!T)Q M';:;^]9G.,(4G+OFQ M/K01U>."\H$^1;6L4OCV^@R5)@TDYR6U"9L-1)92/%5=WB=8[IW<6"2_,0Y7.$CC9]@?VC$F>ZS0OA1Q(*R( M&C"==-7%JPU8P0U&>4LDGEX3AJ@OWU3I,16T;%\ MK9!,>CUC"(57DZ2 U#5?3=DB&\"7&9WEUE/BHLOH5J12_%#UEZ78-QI;[Z6/ M$D5_!5- O0"L%E[47\1M<'%-30K*<<<+>[/ J-G M)PP>N37_CZE6D O(651SQBX#08E4 ,#>^19"OM0:\FXG?#=XM$:]*Z+M^[NJ M0]%@9"F@L:K+)1AM<:=-6/=PB<:V2$@<:D+.T$.(\B6O B9#5PG?QX=(3WG1)=NZ(::B9M^7+:3"O86_LC@'Z*VR[&I) MZ-#8A-;5$ET3,J+ 2:*T'[.:%_R]W(9RW$T4/!WBWI.6A7V8N0(<+_*O_]5. M 5&"J!6:XT&N]/3Z(<<,3TYV7JARWSHZ4Q=ZIJ%TR?>15?"=2B46#?,J5VCG M^0_GW&6KQ#;]KR;^^#-=GY?5@PERO>@(6I:9T*Y(N^1X(=ZQ.+K?_D36(SE ]F M$:I:5X5=<;.MN\(DV/X["(7D4S7*['TE%@&J<$)=!>+7,6#$.8)Y)9%UX.'G M]K!,KP,=F#6]6'.V%I%2E*7U&X>DQ3 M1K]MTHH 8$\V OQ,\EVZ />UBO<4"Y\2U\XLK:=U_@="//T=!7,Z:),;WD\Z M=,S.="V_C3;D!7P)Z1NDY'__O&]!T>!8ASH$.P[#;N;KN>;\C)IM-U/:>(_K MU(6U@,ROE]USI41,7O.>>'0,(MBCED;-.X%U7S+4@_;94)LX']VI]C@7J=0\ MN2.7LN0Q@W_P!6NYR\<>(!7\<8;+6K$JNU%=ELK]-MI C.1#;=CK4J:-/Z9W M!KIE\7B'2Q.ZBFD3#4O4:FZ"1:6LG,T--DJ9LMR/Z.$1RFPPOVH%5/=""#>" M^,V(K?U0B%;=@ND0]AB4]M>YR(H0EQMLH)TG^5+\4#"S[MF JX6TU??/[NF3 M+3QFR')[HU.;H\@\!&?5*-\RVXV;G6P.HE>X!XQE8U[C>.&5%?]#OT'U,?Y0 M;.3Z,2C)4 0YC6K:V 7CH^3-DA&ID#B]@+3GQZ @(G?GO#*O9<3M,(.6Y*]O M6'1\KH&$/1)Q13L?B;D]&()I;1 .V8++_]EYNQ(P=>ZT/?G2%ONBK-!E+7IH M?OP>";DG%JL]IYP!R"5+GS3@ L$TQ[4R4XWU'O >C!\J#]9 M*/Y]O[;JU'VPN+GY4^7T8?4NF=5F\.MB1;%-#*"84QFP#L;NDUR(/G%K'V;^ MC'/V:Q\5MD258ZTT';4S4.6?&D<^E9ASF,D@%G1-_/X\IM?+ ;4#ZI.1NL). M3W0Z0I5:"KW+F>T;3+QZ 2&_9F.R&&[!G'9O*TA,_+S@[3*/=V&ON:,.\!/@ M>RL\A+^)\0;ZMW+:D:^\!4K3FE%APIY&2;$+BC& 4PIR%-J$V@43L/L3U#+4 M/>$N*71J%>PK_!IQIU _3LCMQNB%NS*(X,/,P23MMS>OJ'=7V,+?@)]A<)7T M^BNK)NCTDE!,2 @@-M ^5[WVDKBFM,J^8#GM^]B:M_'PNK]7^H];HIJZ9\ZY MFJC+<$?2V"O)#D7II'D4IR$$.:*7V[O'#.;RV.Y1%WWSC82,'FH020] D3UHX\ASDW59!T."KP!W+L%KEU?D M$KX'2:?H&T4?3I47< R+?G^69=D]'J5//N>;A>I1I[/#JSP1H!I?:T*^.16R M61?TAUN:Y4-[VTS@CRRO)F/AH%?A)?Y]BEUNYW5%ZFK.O@&/8199:1Q\ZVZK MJ2AO>JO1)"(PO$A%>.'@:G^7WKQ4IG+-+=]KLBFZE-I)K&NWFU=DSYW2@M3S M,LO_F.B_$)B_N_P,OQ,I?-=)U5")W?L]KCN%!D!D<+EQ]::3WLW1\/!RU\^I$M_N MC;8[.+LP/U4WO;2SP,QW5&L&0IHA?(D[,/Y./S(/D-MKR$TTR-.)N?T%1]1N M?82OKE )\&XMNB*DU&4Y^#=Q.&#J[/EC4.A"=3P)AM58F]^9(.O1:=A1"Y(R M!Q6I13"L56/\L^UUN;)SN5"'*7'W8)2&XU4,;4"SY MQ'O74Z;:M"/,$!%L)((A7"[B0'Y:80$LWO^$-4&&.H*27.-_H$/51+8C#9)7 M?MG'GUF,]H/7I]6+?TL\?+D!846(P/@H,M1GQZ#[&8N/!F#"O<06\TCV?3QMI(EX<,;S*R/H)UVK!ORT880"@=0 M3.](;P!]@CXIE_"Y->AV9+6[[_3VX]#G&#]"SMNBP$+]RG<\3;*1+$.J'8Q7 M:Q:N=SYFI?!D]$$E:!+W8+Q(7OC$T".@#K^:8&!Z(K^0[&M.)_N47#;99VGL(-C+^GF%,+ M48'@1/07(-R"Z$^ !_5+JD_F<4/L6WYG-IP@5PU(C*G^ENJK>8F]D8T)>H7J M4<1X:P,"9'N*-[&NIR/M!D)L!CGLC=M.L[-\Y_ J6#FKKY-)\YR&#<=591278#F :<8&!#A7<3;X%^E'W;=YQR_5N_^':?<)JPF=7H3RON1)PFY"PFE MU3];M;4S*L:(/6(V8A8?1V30_.?]&3Z?SWP=#1Y&+7JNJ\7]"0*D-_IMGUA< MG7W?>7T-Q;.,A3^R:IY4O:OW.EM,J_]DDOVB=I/ZKZ]O5"T^YW>@EMQ(UL!W M' J0QO1"XJ?@0M=GM"8X@)R+U_OS0E]4VV@7"(QLJ6=*E]G^PFZ=S1?AB$KP MVT$!9YQV4$0U$@00B218#]%.?VEY'H6,NCI]8_+'2[X?0[S"A1=DA(=>/.M) M#_>\-V@[.<-PZ$V&W>>#!Y'6Z3H%OHWAZO2MILC.&"BQI%9[+/K.DYRT2RP, M I=.#1E8SB"IFISSCBPT@I9YE^'X-(.I@,8VHEQC^#?SNLU3$O M*/GTW'O$Q:A'/M)FE4.DCE[N#O48;;RLMXE7_2TCK1\PSC^U@7TTMNM$&;S* M7F*H;J=].%%TMA8!/9-_KO.%Z,;5YWJ]3A$F.?L%W9X'MI^-ZQ:P](7*21M M!)%I;8C":TL*(4< SZAT.D0N*'20/KXH%* M Q8K$2_G O^KAR:_\@0SN+IW],/06^0F?%!"%S]%FOHBZ T02AB!,<)=+VK3 M?@V9=5G)Y)TMBF2733'QD,^6HI0=SL,='1!O_FZ=9<)E #I#YIV$Q)V&M54. M>+E9V]3?)B)C9&O]3( D9T*SGYALNOM[!H6/HN>\>6!PY!IN3>MC3.O;MIWW.N9N!6]M%G0'(@/X&8@H M"E\0*9.>;2I9T1?5-+3K:5 $-O#$";77MT\;V'.ZB9%1>E:W\R:3ED)*Q>5_ MI69YRG*I9_?2^H]!34+]J'\?<-NOBM+;^V6D%*!V@[":8+/<[P%JGMM9P>[; M7_=7]FP_]XEI2+CE&O*6^M3[K_%G,"9T@3^* <[D]H_;TMCWUV%)F ;672=" MZX"&A&V_^3&H+_QQ4-RO4-V6\K-2 :G\@5XNUW0EQ$Z8BU\P.>]1?0PZL0I$ M$>7IQ**/3X/UK)[4\DM-TQC4=DUO*'5=2OZE^5-T9$M;G[C+Q@-07H/AKOJ=0;O9]R"J' MQ[+1I&ISD1^O6(4IR.-4_7O9P;E]RVMA:,-?=.!H8&ZA!-UH8R@QU/T,,8K_ M9(L*TU6B3U)=( +RJ'(SVT*R,R"HQ5A9^ZF3$.^OPM,R5YH"<>+B#R3YZ#P? MAIQR#:?PI/;G,7=QSF0//!Y*PQ']/7C(^IR#]0FRL:/GJ'NZ%1&4SD I^V#, M][IYCK-,>,P"&$9]#KWGW"4)-%D!3&O)=&ZRN)HN\? 8Y)'J\!MQ0?,!?YY9 M6YLG@\O-4\\&729>[4LKZJO)T-^_<&F#_(,6P66=CP%7F?59ILT?6+YQ!4C M=NMA1\.0?9$?G6!.T/<]2$>3[E_;5*PILT#A3YS+^!UBB"S:LN'HI<<\=\2Q'WBNO]^6=NINT;KID2V-]VJ0??,W_D MX"J^OSSU)HNAEQK]E[Z8*2D^%;^7JED4;7@V=PT5%_(3/Z_V]V<+3+XOVX+! MJL0M/^>=B[OUX=%ZM+O&JG#=-D63H^DZ[6M ](^]55HE+Y-9WLS82AE M=Z_3+-371[9A@-*_:Z9]/E&!;'7#TK^5""4(@2**$+3 U >U;4\-; U MWOZVY$>YCM0S;3;:LQY2%R0]<)/MF1U["AZ=3C];Z S]SU1U-,W\V09C?TBX MF6,:HZ("@_YQ",]T8RV2U[P1K*Z_K[@M=-'L(;?H[5T?8H[%M$YE( MGD2?V- .NI$^,^>.T,=%%HB&S/S5K3,';Y.U#ODA*$.,%V#\)IJV3TI$>:N M%R7@0QC8'T8T6"-N7LKL'=MAGJ2\"=3_P,H*J::[V8W5'26R-,4;**77[ EB M'84_=MVG;]>ZY\A[>1E'T(Y_;_SMOGI-0]0+^3R^?1/!&0%%'.]O+T1U]AJJ M'O.$QH_\W'X,ZH;LW^.'U+X AO!D+$T)W/7/ MOUJBYQH. [QYF _'Q0->,,F-G5:U FW1=WD1%0!CIWU9Y>H4PE4B!8"W4'$X MRBSU"E%_!7['N;89G< CGBW6QF\NZ)@6UE_C+1>M$.<#J_K'$T&G?DI*TAL: MKK*(]Z\M=K5;4K&=3OPVDE%"_>WBKMD]/RP_;8O5)J^>O3G.:9%P*TQ[N;:] M:QNXCJ^+.P:Q'8.\(W\BQ1'G<[L+!6T,Z$FBKRL\=_^1F [V3=GT>_XNF8-@>6"1@7PH]ROS4;TZ&YW[Y'_$?^U>$/ MLR3.5EOPN']F0W^X ,*9?"-PNU ;E4.#>%$]YXY!=XN8X9%]1P6DIG?+N;/- MU1?5?57]X^P;H06BE?=H=T&!3!<^?:I;N'R6:7^>QJ'@67/_'X'6+6ZLVR92 M+E;>+^0G++>@J]>X(ZVG2]O0TSMN=K _KPJUI&088@6AO>P_N7TI6@"LEC:) M(;C47B>A"5R/K'%@9L#;7YIXQ=*LL#9*+M;M94#)H#P[*9E3S_M&KSK2>V+E MCQWK-]2. NY?4)JZFHBL) EJ)XT5/F&/:2.*M!-V7)$%U>ZN\.A3F3O. 6*C MV1$)"KQ.[IT%G_-/1/W#&1>!FD@/"RZ7I@!$X%?9M)\[]M1C91%^F 6:6',3-%0I_&?D XZ*N[/]?:[OUB1K0@ M;E+X1\OKY7$9Y:1N]?,G(<_4Q27C1(],_G\PU.J_\#!*F-"&+M<7W9CYM=Z* M1L>7?BCTX%U M2^*/%E^YNJ5;S$RAW"7/8F6=O9&RJPTQBUF"7>MM:/1'=-;GW\MG$KP4E*^] M\0Z5.6%I<,I"N"X#A2LM8O.BMAN>AC.1Y EY@1E7B,P>BD!\[6";J.3+3!OF M8,'=B\,Y,%7#\N$5(^/VZ(L'I-?42J0@;03%& JFJS8>M9)\R^9TM8:>\MV( M%O;2->';S-'6/A?D&4S/Z[*TJ27"T,VN&;L\9(@0D]MK#4_O. M8?U06,%YTOB/B&S4$MO-XXHU M;Q#?5LO*GT^P%IGC*?)67_]YOVAW0KLV@ ZI8FK>,0@/496G]4Z_H'1N?-)I MK5:[NF*?;;CX!OP6$X "SHZO[I1&190 8-)=(JH_(D3_4CLQL/AMGZQ>8"S? M^[]NJ<5<58TO/STKFVP1<7G)(K"*_ 1#PWKKEH1PO @DP2K_2D-KGE_ P]$; MH4[3JE)F$=30GM03X%]Q(?/E[O*\_[TQY W==2@N'];P%=70NO/N-L%I0 .[ MLMW^?&IK136-+4NMY:;TNTL,G[R^[-F?-[]8S,K0G3%D:9RFK8WB#%KIWACEAP:[NV"W! M3-C"5]DO$Z+#7 UHAYFG"71U)3X_M$JX-A&GCER&G#)@(/,!-CH69? G:@(( MD[GUFVG@*Y9E3W13PPJ_C:KE0JY_VSM]>AD&\PW#1N7D!WF7E/CY<2E)-%YZ M6)4"LKL8S1@M_Y] FNG;Q)(^C2-;?J>V[KZ@QREJ#L)SO1;2MV_!FD)QOY/E MNBGJM==\"/'][64EY[XEC*BJV2IM]0('4(N@]]7B48[7VU=34[.=<&B:OR48$RKZHKY*12Y+U&:.@R!]2X>M]5I^^CY;;3W&+_O!#'[^5Z"9. +*.VGH7JPC\,Y9[T^#L3="BG M#<6IQ9W&A*EU&\!F#2,VC"^0&=2XW[U<,N+MT/&A\;=1RFP>>P)>P[)8W5-D MX#'=Z-F0;0;(.G"3>;LO- $@>ZA0=K8D4Q/"!K\ZL-'1^7M&LQ$]&Z3(UG?F MD$U7_72/\@FD&^4.&X80%-1;Y CD/SJD5CO37ARU$9R<8LVHKQ&0]:"DUF>N MMIXX)9&_!9>I3Z(*S%Y?N_IY]^ &O_*B[N'#QW:LZ;1N#.$ZAHFV1#M+!/>2 M]Q+TZF(H?OB*O"C3OKS:H==7.,^FF#LMBK&DFYN%A%PKG1=K&X3M%M!W:95- M /W\4.(%4;K%1"TM3#L8B,YD-UV:SW?[D,'1Q#KRTU MLM#MWRHIJF,695@M\?_S4=SBX]HP.YFN^MWT2=U#%?QS M*1&.TO1PXF81P0[#4Y9-5H%GT LGME.[O2ZE2V[1'>[3BY1$IR%&1T=G0G/\ M0VXD2[HER_DK)@W?81G.7J!G(N[.#RQEF.G 6)G/IO5#FSSRR=*TL2YAX(1OU4!4^#O7IFVA^@W_ M@R9]&PU0!.?'3S=Q.P[CCP?^K^.9/U$> $-T.Q #/:F&E/8[,JRLBN!ZMG"O M72#UYNI6^+5SSK6U> ^OS 7S]$OEWS= M1W^&-7&ECUD\!@''(!*,;DW:[L'$4+[7R0J4V]0"A#6A;R#<^!C4J*)U.)J? MX#S6=;-J\M(7?7-.>:[:IRS#[BO#=+TY+PKN*4I!L@$,^(F3=4D&$426K1M? MFEVTP(W&W)V6$RJS8VL71,_..C2@=7P4C3S8)>7P:D](J!8?"O^OH"5OJ70U M9H3JI$4"0J?2DWU-PEWTNT^>!N5!]_RUOA\AOM)VI4_0!A/KB*./0Q3Q"X3W MW#DBK&]5SOFQV M@B*02WJ+CD61'FVU)W<('U[I<[PM&>GCFP])B[2@"(AUYZXVMSY!G">S(%2: M8EJ.00+;@NT)[\[%"2/TB[&&WICGX ^<.PF:ZV-RL[8C]YB6$9%D2XHAP;8[ M%85EZ>6V[A=UK"S'+L/#^OI(X$>1M5I3U6ZF 6R'A59,E4Q/N9IN*G4*,:9O*M$)]8'E-S&?L!+_W==6 M]QPA1_"8(-7\^RAQG.Q?Y),<[\N^TH:S-7*MI#]0=&!QKZ\TGG]-5-YK^&:\_-HZ=<5MQ*OHS%RZ717>I$LOE[>ICWX?FCG4_\2F8\?: M19LN:E'K75VTQ5TM)AZ#UN3^9/L*9@Z0=#6I==K%FIVF7*>?L?MOR.+.WI4' MSK@$*D7CM=%>/FQVN^4 M-$"]'7N+G*11P(%\A\)HF['"KN&;H[UO$_#>Y7YZU9%W_]DZ14OG88:W8U,T2G-9LR,(2KZ3\?BE9=[B;3"F1Q>+R1-9=I'*T1]HSGW6G MOXG- \@T#A="@NW2NS76:.@=%'O9SS\3I\S6ZI)R,.UGJ0'?.?_P31\(G= M<++[,G*LW:PT]PF2!5ZWYI32PB;[H9F B?/WRK&L?7?ZXGA_LM@A3Z#4C=T[ M.P_>X%/V401;#'!VOJ]H:;L/NW3/ ]Q%F$CJU-*TK@4B[3ZX//4]0Q3/'!% M#,A)7'5P<;[U5$!^B1*Y#CV!4";DU!%-AT1?H//+-O4>W;R?][SZ2?TED6C9 MAPO*2S>\@2-^(L\ XVN1:8%@[JO%WI-_ MYC_DP6]EHA*NDYY\QO0RWW_0$PW:,I1&]1@W4V6&,+P4 4(&/I3$#Y0U*35NNN) MIU[]O=?;FF?7B7;STY#[F@X;$4SE^/9QN.B 44M>_;;Q!1:,WC'H-F>:ZZ]5 M$ODC4>%1A>&KRI:#5P4KOJ)XQ :U9OY+$<&8?T:-#H>BN2]^7R+07X!I.[T[ M8Z\^7VU M,3AGB>E3(!O[P/",6KJWNJ/\_M^YY>[_HT<@M'^N9#)(AK \4..:ZOI)6>YC MPFD.N0;3]W M-;/T)I8S-9'!>DVI=%# GO^D ,^-6V<%CMCI%1VT"R9S(J#4=RC/4;5%I0&] M,=*733V'IZ)G.OBEOC=U-,>9"0P.0@V='C9F<2JGZS":<@4Q( >@]]-8 M29UT >Y0OI141K_.KN6X,3Y7#D)([P.;?D9W8$.L&!,:+0NR#< M^HSV+]!MD/UL:GA1P\1. Q%#\@,BUD91R:AFAXG^(%'@R?YX$U$GZ5FV!\XQZA@T/S4#(J-%C$'/YO_GE:4$>1)9<.G68SFF. M%O%N-=[7&Y[2K,XW#GZ 4T"8A7SHK9*.Z7VK^/0$8]WISHME]QZ+_PPA,XZ,BV0&\G=\&JF3N16H^([!7B JE>1(?6Y@ M3 @G(>>Z3B(> Y7A1"5[HMGNMR[Y^=!'"E$F"CCK((7.80E2DHPE[A+N1C(F)_62EO;@5'N).EVQSFK*LNP=-4*/1=UI[3^&4 MUEA'F7';(,AR0FOK&-1:M]-![".]![P]":EXR)"U&L,FR^;=>3>RR*^[7<8&]]8QG*/?= ?J< ;<^^%V+$.TX6QSHX8^2I%&%AF'8!AY4E?YPW/+&QB M;?KUS!,K:D<&_,)59\B6O%>W/URZFR%EW%_^VDM<#1M$8]\GWZ>$4XM_T2X M&J2]H!,6 OF^*Y+3FA=/ANA%Q7C???JIEV#2 +J&VL0"C^3*Q'R MI%.N$NL.9K;P?72B9//^J%RGF^&4)UN6!1_H1DS]+:8\ M#,ZWC7)=>/H3[W.]?OC0Y671QXHW8':B_,X0$3U!4IS^-]0K'B(Y;T%4F%QO MF*-$1MU6&1_OT[W;^>%I1'&6;ZE/T/F"5XC!TWM]X%/ "7IEM5%KZ&;NH"<7 M^D_-O!&=3Z((X%6N3OV$2^M;OU21MW9T45E;)&4+7\K2?5]J(JM5GWM44R%QN:Q82.LF8V^]D_53Q[5EQ1>F*;CNE M/[STJ*YB(21! $4VIPWEP!J=4D)?[19/A50+:]J$G34=]0GW94M12GN*1+S_ M[BTKZ"(>R)P@O,)(33&PK4'.BOZW]KXKJLFPZS(("DA7$*0%!$1%>I,B4>DB M!I4B1(P*2"N[V#=9*^O-4\[>9^=]GG.$R.%TT[!*JQ\,4X+0H1[")K]WT\&2 M"G\1V=!\M,IE&YUJY2RS.P>3]9W.W=UA!^46A)Q)YV5-XNIQ?3(08DX7#F\6 MQG>5PBSN(!2H6X^U;3QHN)%]Q7\6U DJKCRV"7'#3+LMH4F3E.V> M[/\J&^)5B8F?UZ4>7,WW)"*$>QZL(40?',1BW<-SOWJK7%EQ^ '6>1:5$;&5 M"&+001"X:3 MF5DMQ]ZPL2PQUF@CBV-$Q_?+'ZGXNR,EA3^W6/IS_"DG MOCY5-%,Y\8Q5MZJ895N_#[I7,U5,BV5BVDZNXX[^NW^R#W(&B@,#WQ3H6T3= M$.?06'\3_?6)ZCW_^B=Q4.?3 MBF\R'E&VO=NT:R<>[=TWC!@L^=@?X;O2E'!\(OQE-]WR)1Z[M"P;1\!,^SH# MXG09/&MPH;8O]0UEG!F;,?$8D:AK(]1@K#6PLMJB62GGG5MH>3ND4F/Q'=ED MT!R$Y*0,LGB5Z7< OV7N_O.I],M<[EJK/B".*7(W,:&0R)[&5-P%DW1,\.Y6JTC%TKCCNTWWA;-_$F(-&Y=O-MR=:6]52O*]5 MNC#26Y.:)A,>007WX'CQ-FA!\R 3KQ>8S!R.,+?;!\5D+6+^"J"7ZS$,VX>8 MHXR+'M7,.-*#[X5.^,NN9FM,VS+UY.G;W!MUX4;-1O,)IEOQ4! M.694\7QFVI/5<"/DT%SMDD'?/.?P^/HV.E96KG:X;8[VQ1.M/X!?O@276)B4 M,9QTW@?Q<9OO@S V^R#& 1_64PJV+T"66,C5\?.5:4H7@9IUONS\.:R8K$M= MLO_Q@8=.T6ZJ[AMSXUD96Q^G/5PD*BZ]@"4V8/I1;U>0#O0[Z XH2P,U@&[( MB45[O 44"*T!"/&NNWII[]&=EH$'+')",V;D$T_!CC[-:\$0G$4BMSZ%1*R*U[Y!G@TC9^;K=>T.36)"%'Y M4KXBVLAQ)_F"8HS?'1:3M[=$M&BCL'RKT60>Z*)?1,W@N"S2B6!AU%#AP8EZ MOBHT],-$-<-@"?99[=&7@&HWK+@J_\2US0O?37X?G7WZ^L,TLQ3GN\821=ZG M*)-PE,&NQG]%!>(11FOION)D?[(=Y_2?A31T/;H3D]!V& BEP@@G8RK8 D8]L/8<&.J< M>3&(<%/./-OFVO/^RVV]NR(\OQ4JI5?O@O0_3ZY,DOZ]=;)GOD'),A##^R!W M,'!:O\LY97FFH:HQAWC^ALVQR0E]6SF;<,];/*OQ;<-JP@31:[=J'_'A3$\=V+LP?MA<;'$6I(F_1+##4FQMCN"Z)- M8?T&K+4CGQ.:YITZ-X4>\\U.52(_DV=)_F&G)?H)3N8%+?(R2>OR07YYF4V= M?> -Q-(1+"DZU&%OEK]U'[*P[ALT$,#F58^VG]=W@<0M$X@G8AXRM( ',(7 MX>"P&T.&L3&!%56DZ^^/\BA/:YCM+3TO=U<9>>9X1PK,OP_JD%:#>)6;Z"'] M(77WLQ;Q!5[3U6B"3EM3[)S0S.J4/?DY_F;^ M+Y9::LHAMU(R+_\(T!E,$PCK*6DL(*874:JZ3GLH'N&13C6<#.%3[?NI9L-G M.Y3S1&5F]9"1]N#6N'CBNS??&N9JW":K-\A^JNYM;9]3)>236\8N$Z[K#021OO&O+!TKDJYOO0"7W-;UPC<;%>K[2L2MPU%")YED6N.W6A/PB1 MG]RE+!$F2BETHDPUKMQEZK9BGHIWGCT69?;PD+K(]*ZHU@9H-Z3O\NX0$+ 0 MM;"C DSN@WA5TB@UL=\ Y?.#VH:?7!Z57M=\;*TJ.0?YO-YD5+RQ%6#P)>A* M;?:94J^Q%]D?$3>;IVMPGN/.A2-P$RC=%5@@UI#-B9AI3YKO,..\TL+3'4#- M^"X1*CK[]4YB>-M*56N+1/A+(9S\(WNY:M[>B%U;7)S]6-4?HT?!J3^YLG6S M#G]P!#V]^"M\#9Z'QO:1!.@P!H19VH# +[%XEY:DFIO)ESTCT);#&\_G+P;) M*GRR3ZC-2=?NR7D:>U=.P>V._]ZQ5ZZYM-,5*L5D< P$C-+PQ=0?>D,_CX0# M1MZOY[W;Q%E39'5XR.,GU1&JCWX; M!//]CDGD.>%],NN[F(B%S=$ID/:_2.G00"^6-\61W:A:\&?P>G17ONM1(BJI M=+8TNP)Q?YAORF%)7\,8NHW_RA_8+&<$&U#F_7!Z-VUF@=9-4>^ B@$P6E#] M<#%5/+5-:38%K WX>[CW%<=;$/O3A>[&KO#R><4 ^ZW = MU?<:LR!X 1]$$.]($UQ'\[7H$ZG%\\X^+C^HOOJ.+#_-B \'DWL.K2G'\^0_ M >$3R/"+J&%1"G>>GW"WQ MVETI359:68JQ$_5C>T3Z*&WH)"GNC(H%;+6!)%<-%*C*^RF MYX0]_6P5]B5!8H;DYBQBW&/$"ZV&^-6 V5Y=&"6$&FT",Q1O'T7$S M3?OP- MR0_R)DQGT_[NX,]FSB2T_7#K^1B@HV2C8-U'K\X#SEJRB#N\)EF M H:<3[G>MX3H) 0+E&SW^T:4+<@=G7+MBU(\XJ]DS9'UC/N@*_1X.V.=35IA M[ U487(>W:'2 J4;,K@IT-A[]52GQ,WWFPP845VD1<6;KQ3[*LE?K"659.8JVYSO,I/KAZ9@M$>-@":""">G7%J]GF\_V: 8W2<]F5'B->]R MY')1GZB5UL.08^?FGG)LB&V+D__=^Y6A3': 9_H(9:28Q:HS0RY4\22&M9L_ MT3'[_G2Q\RVK)WW9)/J(F(@H1& MA_"9M &VR.M3SJPN*2?O] <;+#?;R B985]:_(U9JM3J:XE:>6T?ZMG16=%^ M[U(AQ)2)1;I2=FGO*7VD=/I5P,9\3#=-.BQ0%\+O>UNF.8N,&K[R9FS8L0=V)U7&D-N4&_20%6KPNWM0Z:'/TO@',(RZC/57P MNC6/2?0(>\)BVL9U%H#3.-):Q.NZI%_5]6\;IG_@:%]F($?[EBZ /5A3F,;" M7+HV$->.X67H$J:"AZ09-E110VBL3G-^G4 ]QTJJ/!$G[/?N H.>: ML2(>,9V+ M&AN?LV$J7 8^P8YQLQI=6!J@N@\B[8/*YK.//8?]4K\?M['2 &LEG>^W$Z(7 M%5$%:)6>^VQ96%LKJ4.Q^D\TF?\: 0MH^M'Y#_TM?RTT]O=_^W>F1N8'SG\S M.L^Q./#MK3#?7E6E^DW1%/&8@.,VI^6>7U@.G&AI&3(<>.C5>W-]Y&WIDR"C MVWC\I@%5HD5/3-G%1W]F]:.#.F#%ED@K'.$(:SR*#B7!_>B"^Z#Y<"E:^$O6 MQH;V[]NF$/(JY=Z,^.?/E,WDXE1=5<4T@LW3=Z_=,ZP6#[/]OQ0$O@^*[68C MN:>/AIAA]3,+,/ETY8WPF]_U_9D_M=.T\QB[B<:W" &R80Z7ZWV?N*0G?W;= M.\VL: X9':QN31/7(-YJ/DC:=,982>N)1/ZVX6N=]X3?PN:#/N"#MA(#L3<5 %=D-LQWJGY M!L$OT0XQJUAL?IK!DJGL>*924^;F:*7:;;CB7Z%6"+G/:2*S9\RF;;[D$@?; M336>BWS\H,>T]SAN;NTW=%%G?(26UHE)PTGH#LUPVC$+V]09,O7#")T%M@[X MF=:L/6YVG?*AYD?'V'X.6PH;R&"Y/Q08N+Q8^YS\.P>;W13\JBGF3V R&PA3I8B1;VQ:1^T$$W45 V^(S19\?#95RQVEV,?_6-G8&&V#O,'Q$&Z): DV.86K5R:Z4(=HW MX+0;%4MXT!0[&K[_+LG"_@NII'=*&.T2Q3'+,^JL*0>EN+'1JJ*C;;? MR/MJ17MH\T3H7*L]1>2B@F##&KB1FZQ+P$T'$6ZASHPW5)WINS[QQZH>+6A; M/<=S]CK-(\0YP%W1+U+16@D5JM5[[2'I-IXKMO\Q:WA,T9UBP3[14UY*/@- M"]^F!CRA.X:YT:R894BEHK6\OE3CTX<)J9&:8\\H=O[O9*:4*==%5M5_\=2^[3BM'@ M2U[L*>M<\,E#,$07:(_:AIU[=IQ<;KB0UN%T=W]PPA+UM5 M.W*A>.@59B[# M=!$:S9*DD Q74U%*0**,DZ[?IV!G05M_1N=FF2JWNE#/(=_H&7R2Z1*"+ MZN1*_62<#^0XJ@)KMH MVP=%93S:&77&H=W374_L>*7%OFR,B.6,L+?C7F,B;] ]V&MCA])@]4,:]&/9 M9NTNQ:@K;Z=-%5N+L1RWC%_%VL/R/_M?\X#6-8[6B"A6W+G(%?3<9**F?Q\$ MG,4P2D,7T$A6[?""TT1 M+Y[)'1S7/R.FJ$5"=X!Q/O D$1@238'WIB4T[2;MI,7J0P)&-Y$7R\_/K5^* M!:[$>O/>YV\<>5Y"N$KB^#3,/8>61GH2,7$0'H8YE;MCQCR&28LIGO7A]:BX MU:)Y]4/WJ!;"_%Y)C)Q,B?OV;3:1<4TRL<%P_,+B_2IJE!,0CB!4/%HX!BU6 MC6DLFK0YT>?K"\EM3=>P_J22C!8,&@(KHOK:%(%Q>ACJ*T8&XJN>!*_G3B8% MPRY63 %!9B/!TW='=:84QEC#P_G2>T>+W_=+A2=^=] _)+0=A^Z0*_FABEM, MATL&GP?#?NC@\4+"OW>S)6.ST$H-/:W=ADK1'ZTR+ ;:X\S/?91B;Y&E?FSKI[<8BNP'&<7 M=X7N2NS7>.6Q9)0QKR"W(M;/Y2;'N1/[:2@9+6LBP^!/ZBKN@N=D9-P +8$%YU;=W*1V2O4@Y4K-H7+ABE>.Y$S?RGK@IA^K?H0G.((/F13 M@>YP8#,%\P1:"DBX._DG191#\'T_\R7,TV#?##Q+MC8-[:' M_OZFH>HIZFEJ51MSJD6?T]4$4O/U38GR4A:C6.JG(_ZJXY&1#[LS.)091SU9 MA\%$=7S;/HAX*)<(B=%#2>2T3V;K[8-^N33/58U=#8@"YRG.B.(#)XV:[[65 MUG1AIGV)EGT+,>!:#-EZ27UZGLB:=(SKD07;WK@Q^HSNB"G3^5N&,38/OV1B MKF9@'O+ *8"PF\,X"F'_-EOZE; -=1FD)-!/Q(?Y&8L'>A,Q,28ZU."?%;HQ M]-D9G<Y M38?/0_-_HJA.QZ?36BS?5$-98C4IN%_L3"]3+#9 :MO-0V,R@.>ENT'O'(Y&E/+V#31&N M]%=E74("OB@9>BBM)R=S-?PV?%.L+F6/7O(W[.HBSO0(LAP5A?R*/N MU:_AU95@Z5L+YZWM0P.3%:BVI5Y5JD]:X9C$[B%QU_$\IXB6K$C<>=SB:\@' M3_(3^E6VH/(SW[(D *D+49DTQAL]$Y&5!5:9CBQNECO8>"*4[>./$4!S>LN!Q8P$WRA"4PL(2 MJN#.OC8I%E9J&_-Z#1X)XTHQ2A):9(NCM(D5KG[D;$V4!8=KQV\^"GY8,7+'S' M(?[J0L@GU-W.TRQQQF%*1.QKEGRZJK%Y:+EOT1?3M]HU,T7)T?>U!H5RA8VY MYF$&(#"\Z*EQ'U&Y'1/;9@*<%.RK,PMK2,0VMD$V SZNBIW_UYU\>%I MUG]VX@PI7:_RU7+XM>>"/)"(:Q? !7#*5=Q4$FV5&=MV$M@DGOQ(R>E$*M2NTO^^>7^B&^"D MA6+4&%A *%JM@<.MPGF(5@"V._W)5(-+[('!J?;%I?2.U0"A;@R%#)FI8QT1 M(J$!\YVANO!\= .N\0W=!-**-0F D LC*G<*$^E799=FV<[PP\-.PBN/0_C+ MUFV.NS[?(KZO_\4[(BU% '07 YJU8(54Z9DLTU%]N:(H6H M:/5"Q1)R='YN+&#^U/ZJ-ZGC>-:Y\O+X6].@YH0)F;+$ W1?I0TLAP^FF@# MJ:@@SQ= !%T9W0$G0]PQ(J@>V=.C+0+@&/>QZK/UK5;KP@VDCU]6DB\Y*#D> MN^_IF:%@T&]G_R%L'W3EUVNA+/1B)KI.O0\Q]7M1:;-](04E,99QGRKPODIBB\/0]"*MY5U[T]-QF"KQNMR-M1KTK>UX$6*!L M0JEJ^9Z/U57]_BB>3?\N\MQ*P]+(M8_!,]F-KL_J.27CE-H\S]7HME(]>+(%_,,\AE]%U M71AG*:[,MRDU8??6C89X;MV*%590O*_@+V_G[/;HW"S'F2]Q7 >$E)_0P0P8 MLQSBOP\"L28@]4*1JDCE4J0>A:$Y]0L\,SP_Z_.X:?!L6YB7M15Y*=3R%D8S MV?34ZU<1$6R*Z:"'L[I9R@"!ZD1 D\TI,6=_4M,Z-T7PMTW2GP0NG\26E7X- M:OWP,E+AA:A_3.S"?!OQW(FR=O!47V]>&GEM"0J<4N^M.BQPA.XX1AA#RA/, M6U/7G_ X3DB%JP4HQ;]D3-Y\><;B^X&!Z7N!<(?_\Y2AK!$] $ OQ:6:" Q2 M?B^&1F.N-TVL"J^/5;]!()9=A')SM*URU1ZT>*XLO'+W)"* T!QRS#[(+&H? MI"; SLXS5'8V$ADUR2T*!-:Y;]EW7Q)5*DZ5EW?:74MT>JQ\%>J(#T4XS?0C M-[R[;IY=.$JN_![:D&'KK/[*>0GW43R.=2X,O#@+%VP[!UCOX*N.! EF&OD< MVY6->+.7%<2?%AFG\MW$]>5WP?.)B2H[_)EGRM)7=![^#5:ZKE-45*KW*L]% MI;ZH("M[T+QJOJPANJN/-S9&HK]!S'V>!KO=?_#_*1I_& KEH(Z@^E#*5'7R MZGO4 D;,&.Q&@&%(7*-( T*2S9>-@((6G)K-[[5[S,D\MY.ZJ7K/N? Y \E[ M:(88G,7;03=%#2](MBC0G5@#*.7ZM)XV\5IL ^M;2^NQ[U6((*6>UF\MJ7H( MIRRL2I:$@URA><2*.0CUA#6,^0 G9['MC#P07*Q./D^A$X:Z:HX!]T?-:ZDG M\\N_H4,K#$R30E,55F#X^IZUS!4/D9J=73,"H_@6*$QTZK=P-_VB9^*B& MTY+@K/,[257]NF&TZI.S#PW7X[\_M!<[*PL9,SS%N0('%!=( M@U0\S1#@?4+17X+'ZBSGMI@&5"T.$G$@^[-^N:(XS,61WL7^\Y+-*5N=XJ+RT?S]!^/ MQUO9'[LY)Z@/NEPKWP&*ZI__)U9L_^HCA$>W0QK2R)R+27#>-;A "X0_Q)"; M5J^/E2RLKAU4+Y0\K'[L!39T*'N?+#6^F?/ \^#H(_&KD +@37B9,NTD/9UI0# M:*"?"9/JO"U&!4>W>(O-%LI0JU;CS03NC[K4C,_*^_+3DW8/G-//XR2LF= MY7KQIH>#^]0>S(-(MXZCID-FWGFG+^:>[CT%/9\S@+Q@% GGX'-;0/^JC,]_3Y5J]W;:C_>RQ&&$[MW-9HA].\4)NL@=\ MG-6+HT!;30G N@K+0Y5(6AZM[A.:$^8S<^OPIZTT&,6CY6**$ MOOF6V?MP/Z+&F],8RK6:*<320N_"3"A!B.Q .3)I/E[-DO7)SEAG9Y]_M#UH M,=@VFT\#@Q][)>(LEE2VGDL]-QDJ>FHB!-#I$JPIW#'(L,(7:L M1:1LC?:W(2LG_G#]3Y7FR@0NV7L"'8[+%L<9=?+Q'V]&D5W!P"D$R8EN@QI% M-ZQVLAT 'U*EN"V)LKXQNKY-A[K>/-GJWI*Z,JK+@[_ BSUK<;-0@P."8 ^R M8/Y?>1(4NN,"CA"!?$S5:R;".6U*&:[#P:IG($> 2.]-]2J_:JXB*2^%^)K, M!ID3=V[V%KK4)EPZB+C+_N9UUE=L;LR'38:H$,U@'Q2]ZC""!!-4 M\.R0!2JM?YA\8;%YPBQOX%";N&,F-N-F>/I<2FHYW54TJ[W&FIF-6\08YG3M M@_"K+LR:>EQT(XX?J:\<)SLPV=&8UZ*O&EQ^Q1)S#O;P7N0"IXJ$@1JG_\6M MM'JO_^MYQO_@/_@/_H/_X+\WA/:G_P=02P,$% @ 735G5E31'YYY@ $ MW+@/ !0 !C9G@M,C R,C$R,S%?;&%B+GAM;.R]ZW+<.)8N^G^> J?.C^.* M$+IX 4&B8WIVR+<:1[@LC^V:WA..$QFXRNQ*9:I)IFSUTV^ E\Q47@$F2+'[ MG-BSJRV)!-;Z0'Q8 -;EW__7C[LY>)!%F2\7?_DI_%/P$Y +OA3YXO8O/_W^ MY2W,?OI?__%O__;O_Q>$__OEI_?@]9*O[N2B J\*22LIP/>\^@;^*F3Y!U#% M\@[\=5G\D3]0"/^C?NG5\OZQR&^_52 *HGCWK\6?&>&82A) %C,&4^^%5(= M;G9>%$]:-5(2(V6(C93_]['.?KE ?$_R5ONR>A"N5O>#+QE/8?K!F[A?-#_( MX07>ZN9BD9L/ZLU"C/7MKKNZ6/3A)?;U62PK.A_AL]ATLR7RW/SBO?Y7VXUI MZ 29UOVTU+TEJOQ1R860#5L^:1KDXB\_Z7_-5B6\I?1^]JMPPQ1I=QBL^3NV&RF<*G5JH%1M&2U9FUC&J4H^D7.J[+[#32_J>>Q?7^_['T8UT6G M%2WXF3%JG_B%F];O*_ADN(QQVE/]:MGSFVH&0HOU$U@60A;:P#Z@XMZW_W)5 MY@M9EM?\[ZN\S$W;US_RJ.)<;Z-2AJ7JN]1A^UH_"FF;;3KACU\*NB@I-_Q47B]$_>.\ MMF#*C\MYKA_0NZ*76JL_9H*R3$B]HXF%""$*XA0R%ND-#L]20AC&8H%$$?&W_UV@$:I4\&D47P^J)"_O+,2I+7@S7+G]>WF _9C537.\!JUS/ M?-WO1[DP%R>OYC2_*S^LZF.*-(ZP8"2%F?X'1!D-(<&!@"P@*I0T1!A'L_N= MX^^S\_A\QRX3=K?[ 2V16D*P6IA&YP]27 $F;_/%0DL/E@HTDKAQIL4@$"F# M- LIC##5@R"QWD-C/29!&$>9"-.4IFD["-TY[K,,P>'SZH$'0 L^(/1VZY)? M, =>@(RP8$O:*]#*"QJ!KT CLK_UQ1X>3PN)18>CKACV .PN#0YO]EL#/LEY M?0NDR?/IPL/*JM#_MIP!YYJ9T/??B@IJ69]:7U\[<3T:5[;(>/KTSW8WZH=O MJ_SN9V_]7K^/_K544MM:XMV"+^^DWK!>Z[U.57Z0U8P$7$H>4)BEB$.$X@32 M0#(8IP&6(L(2I4X'4L>[FMJF\*;Z)@M :_'CLL1YA7?YP>*-OLS JG<+33*UF]@K6A2/>KV] MOENN%M4L%BD-LB2",5,"(B$XI"2((>5"! &3@H?2C1N.=S8U=JC=&(#0$KMR MPPE <8R0X$$$B4JD!I2%&M"(P Q)@F00H"3CLVKM0#$>H$=<0_R:X8M;J$?N MSC>HMI3K!ZK!-RL:I2\&)2/P%?BUT :Q3ZH]CX(WLCW1UU[I?<*U>*"VVS:^D)O!V5>(5S8#ZY&$EGBK%&QQ// MG.]O5+*Q5G^7<>Q?]+0'?'IIV1RZK#3)W6@QZ-,SD22+TB@B!#(1&UEJE15:?*GR_<0CJ,1L\]YC 8/\,F=,\7X@ILM $; M=0:A-P^P#K6;=9#D>;>[[I"=W0_W:-+'AKEV2$299L14!)"%/-'LF*:0<$Y@ MF.!(_QH1E67]M\E3]/$T$H*-B+W<.P\ V6#*>:"#9]RL MG7+@//%DOZEMXO_$:BYOU+N%T#2RR"OY/G\P+%/I,<[97#;';E^H_N?&ER=( MPUB&40)I'$0090I#JN<\3 1+9$"DU']WF?\]Y9@:271JF-OJC2*PU@1L5&G/ ME-W(H^]0V3'," ,P, VY80^^UHH,XVQU(9B>:*VO%*-RWX50[1+DICG;JKN;&B=NCF/NU\/.WM _>%)UK.(#[G<9;WTW([6(8^QVHZF\8AUA/%K4^PGKYUD5=\Y[AM M=GAF-]?%\@8II8EQ>I>AWH(%-#47:RE,0\Z2,%01#L(>GN^'>YL:J;PR\ +> M^5>7W^D]H+>%E ;[?A[M1V"V8Q-OX U,)IUG^CH8H)-T@.!=*TS\NI4?Z>LY M7,=/JWW$/?S,2_UHY%J(.M2/SC_27!M"K^A]7M'Y+(@4R:32C)&@&")*8N/W M'4-,%14HY %Q"]8]TL_4J&,C)KC7T!-2$)9@4"\?#4R\;BCXGQ'X 'O?<^ HT8']>@]T)#HSD0YTG MGX=JD%/F$]T^X]GS>3!.GTA;O-^7N'2C/*^OM692D"@D@8(XR1A$$18PBXC^ MD=(@PRB*8IFXD=.F\:D1T+9L]=9_V;APWRV+*O]'_6M7WME"TI9;^N$S.']L MQ/+)#OO*>F. K:9'GN7[2NW/Y //C'&K-(M%$*O$!& @RO5\UI.:J(!"@5FD M4!QCYK81<>M^:C-^_ZIB?;/1W%DX7CH[#L80UT43(HU>MT3/=C7TK#="4[X( M\G/_-]?.QV2',!$\3I(B M7+ ,(H01S @-($FDXF$2JR!T,EQ&U"O[HK2]XG@C.N?M1*:XO.+LDU[N=2ZVY3_)! M+E:R?*M5>_-#,\2"SE^MRFIYI\GB>B%,)$_-M@W'OGSM-&)40I5L:-,(-9F"8PPT*IF 9*,V,_R\^WJ%.CSFT[I@Z@:BR8+EB5/8)M MA4"M45^[T?NPN]J8SSF8(]JCK9I-E8).3[!6M$W993?6(_DW#34RW@U>[X(^ MDW$\%.#'#>G!>KQT-7HMB_Q!KX,//HQ2X(51Z^>1%@W/V'I? M*WS)]TQ+A&=XCZ\,OCNZ*/UTW5N]'.EE9S]A,B:,9*E24&7FSBA)&&1!&L&( MZSU&FD61$DX[#:M>)T?AT[LML%B@-1W$ZO^Z(F M$YA0/7Z6?%7D52[+UKN=F6P688BA"DQ!,,81I GFD+,T#C,F J2G\Z\ M[^/J_'U.63ZO6V]7LO+U2FY2\7 4X0AILRDT.1F5_A<+*8**Q3)$61A3X91L MPJ7SJ1'5VU6U*F1S7P[N6WG-%<"CI(4C:3D-0I_+[Z5>=>45V+M M[S1XO +5$C#9A$(,D62G#W*#W)J?Z?H9;\SM0#E]6V[91L]B&_5G=+C#Q^WN ME*:*_]$3]FW^(&=Q&BDL*8<1SB1$H7%_#%$*51R0B)%,"#>OH%Y23(WGOGR3 MA:1&0L=Z#[V&P([]_^ORG8YO.1+! $@R)9"8?1B!@IKB$/$RD<0$761+8$-[I M;J;&:$92.RX[ ]]ILO('RL!L9(3LLS]T@4HL>7TKU<8-#0[9D_ZF!YTU4=LA MTC"Q?K9FUS"*PYIAS[P\"H7:*=!QI.73/>\G:?GM8[%\R(7>5C_^7AI?]#4- M7_,J?ZC[JOTVZQ2.4FPR.,XR'$I*TAB&F&CC4 J]]Z42P32+">-4DBS LX6\ M-:54OCA<7UXBE-6,(,V,V!-MP.LZK1-8:55,J/IR;>/0M3970&SITSVB%7*\ M$KUH0"VO2@:\V)%YUVYD_^F\Y7\H%5I'$AF'*M4 M[TL99&%B" &'D*DPA8*GE%& M\E!N*$"'/HS;*]':BGX%-O(.5I_5#J9A2K6>Z?LYJ[;:P7*F@*ME(SW#'U:L ME']?Z8;>/.C_?-&MM MM2A0G,5%0I'$(D4HQ)!F3D&5IC%"0I8'D3F$,QWJ: M&BMM! 6UI,"(VM.&.0ZO'1MY 6U@YNF)E[O#_SDL?#GN'^UG7 ?\<^KN.=*? M?:$G19CS*RE,9J;V&%0E(:.1I##-6 H18B;!"@EAD@4!UUN:)))NV?IW>Y@: M)=35!.=+ZGJTLP^=Y;2_!)"AIWLC6UU<<0#OJZ.J^YK=>^V/.ZN/J;/R!?HOH[XM"\N7M(O^'%%_HC]8?LGRWX$6=JN:3+%=S8_&;L.@VVN2C M+/*E>?KCLLR;T_XX$A0E1,"4<6V44X2@7H@S*$-$.5-QC#/JLO+Z$6MJ$[]+ M=EO'+U3T![CO)-4__2$7YD*G^B;;?.^5R;BJ-7);VCT-J)T],/XP#4Q,VPK5 M\6^=2E>@4PJLE6H26'31]4MKS?R9'WZ1]F2S>!)J5$/'+Y"[UI'GUON> MG=S=T>+1Y(9K2RAN3FUR66Z2!<1(2L72 ,8LTA:7T/_*"),0QW$4IY+'&7?* M?FW;\=1X^6FRQ'4QTB?"NYZO6 Z![7&+?V '/WVI13X%Z;!I&!PA\W9(8]GM MR&/< D'9$4_D<*"#46G@ MN(*[$_[$D^XNTIM,*D]OD#1SO'Q\-:?Y7?E?*ZI_:YQ@=@NP8H)%H!A4%*<0 ML4S!+*4<8IRH0(2/;,LS@M5RH\#.+:M97%\^@D8C ML%')WMGXDC$[334CCL/0)H[[ +B8/%['Q-Y#?*2Q&@7R!9^OA/E= M^ZC*YWI5,GESC.3S!RF.!T XN:9[&(H3ONN7M#Z:<[L'"+:]WWTTU\^V_4\I M;G5?KV69WR[JC[[S9T")$@&.H0Q$!%$2"$@5$U!@E42*1E&&G8Y.CW4T-3NW ME1-L"=K3VCT*K9W-ZP.P@5>:7E@YV[_G@/!D!1_M9E1;^)RRNQ;QV>=]9;!Y M2_.B]J6Z45M)GPC"-#9YM5)J:L=D(8.$\QB*( LX4X%DR*D*KF6_4R.-.O6J MDD5S]/YV6=SI?^M=RBD?PHMPI['>;>C_#YD,,X@$I9"F*88A$H$DA 1Q&,R: M>YK/E=XM/1OZNS(,-P9&5/!@9#5VDREVKHVG-D6WU'-D89A*_\582\,,"@M% M$(9) $F@$HA(C""1D5DR44JS.%88D790WBS$,P]))\&S#(AF_L20^9U.@C18>J?#O3YS=J>34)Q/[G3Z=9^YG1ZW4W+N9@5N M+_A,>OE%:8HTO<_+:D:%9"*F$9215!!%*8$T2Q3D/$.$$Q0A=4&YI/Z"36WQ M/Y7/HU7N"JS5,[RW5G!])0^^;G0$;Q:KNS;,SG'+X6WL[?CS.49T8()]GL'T ME*ZJ/_*#IK+J(=8$TESU!],N!=8%[??UO[B_;S*=FNB8\MO;^?+[NT6=#][T MM4XU1Z),!E'*(4E-$*[B(EK+#=:"FP0?G>BU6U,MO),WO_-PV-'6$" /S%O>\'6F+E>P M/'&7=;>CDIF'NYQVLA].=7UM;<35&G5=&=S9"BF>(J MAH+4&=[C##(>Z4TTS3C!@G.56"5//M?1U.BID16TPK9;)@TIZ 2VXZ.S^)[F M'Y^H#A#%OU.HJP?K[W M%5K',EM9CW]?Z*U$5>1L54G15NY[0PMS.5'." ZR),,AY%$J(,H$A2R,(A@D M"HF8$[TMG#[*Z42:^J+Z/[&*17LOF?]<'(P%*$A4D"<0\#2"BV#C=9QF4 M,7\PZE ,?7-0 MC\(3;;H0HZ:\ZU5=K7>I:J8=I(:%-SA]70=<+M"X%P'> -R[ O#7LGN@@RGF M0.\?33:_>W..]SZ_RS73MRE6HHB&<7R[_RY M.3GE6\%QPNW^]/NC.=9;J;'M.F_W0C_K]6.Q%"M>_946!5U476;!K1R9890H MBN,,IEC$$"E-H#2,!(Q3A E53(6QTV7$N0ZG1J&=H'TSDIX%V,Z.] G;P$S: MB@K6R V:=M06&$_VWMGN1K7F;)7?M=6LW^M'*M#J.(9H%(PQ[U82RZMOJ6QZ\"LY83W&I!+W7NWP?<^D3>"W[/ MZ=3?_73#YOEMO3+N#VTYP75]S2P38^P/@N3=5J MGKV^J^-(E=#U#B]$,OABM1; M2?'<->M=H+(H8>_4G->$L=TI^M,,AY]E534NK>5?\^J;?MX4O%I5WY9-X<%9 M&&(5A0F%2BAMUC$90"9HI&T[BD.6$HXYZF'6>15RH@;@)VDVSW7RV*)-C%4M M0;E1!GS7VI@TLW5UP(T^7O+)]AQO.WX>?_B>/;MLI]MN=MG/N^/9Z >N+<;3 M5Y+9RW ?-M=L3]FFD'+V,E@M,\]>V(G['>C^JM3^<[.]ZI(X&$F:% Y-!H=9 M0A/!N"(PB$(.4:!"2(@VG].,)G$B]6]399_L[0))7#ACG&1O%R>^N'1LSM^Q MCH3W9,X(UD/R]IF&Q/X*=Z2A&>F"=]@A F M MH1D*I>*2(XBCV*P> 8%,,@X#$G."%:'$K:CAZ>ZF=G50"]G7Z^D,LI8L[0VO MH;GV?$:=L?+B^*:[TYU-*(?-4>JQ>\N]A.(F['HA_FM%Y[DRM9BO.3>YZF]T0MTBH&-9N"KT0W4RCD44'+2O<_1RE+VAF.[=&7_1MQ/HOSG@]L?(0P(_TMFQGV/?OD"<..MU;G*T ]Z^ MRFZ?ZO9NH]^6^F61BUN]KZ>++O92B8@BE4$>!@PB(A"D. FAB%E"4H$88MQE M$[W;P=3H^_/W>A]H3"(C)/B\8O MY3WVT'M0VNV:+P%H8 YN1&MP.1M5Z;PQ M/J:XIZWP7O.C;GZ/*;>[W3WZG*,55V^/^>-,LT:S53:%>MKB+ID0)"&4PS1. M"$0Q#B%%II9MQ 2*HR#.B+2RUDYT,K5IK44$&QD=R^6<1/.,U>4)HX%GMBL\ M]FN^A?XGDGEUKS<3O/MI,[E/-C_..F^AX'H]MWFVW[K]?KFX_2*+N]>25=O1 MOS(0%,D81A@+/=5C!4F*.4P(%AGE*L4$NZS>A[N9VF0W4D+=T1T06DZW5?L( MD'9K]^7P##S/:V2,A,"(:/S>NXI\[8$J^(U6*]_>D:=A\;2^'^EDU%7^M**[ M:_V9IWL2P29IUBSB$0^Q2&'"N;;=8VVV4T8I1&D21SC#M$Y$;.\^L=7V-#T> MYAL!'6?]%FJ64[T?%D//;PL W*?OOJJ^YNQ6R^-.U'V5]F;G@4?4*?7"ND:[I\%Z3LS]G\(#;2B=H!Y/P_='LXZ'LY032D7&H+:[B4FEK2 5 ML5YPN9"FZKI(1-#?X^2\ %,SQ#>.%?,ZE.(2)Q0+^.U6[B%!'9AK]QQ5.NE! M*SY8R]\\ 8P&0_FNV$,WB#>+1??/Z-]B#\YICQ>'=GK67/I&"_E2-R:,@Y]< ME V#FLQ"MXT/W^/FD38DMLYA\G[M81%A%',:8"B#--5DETA(@BPSU9DXE53& M'#LE!;]L*T3V%+*U.[8?JY5##1Y>-R]93P.L!VQCCML U-M M,Q(O+4?L9=\1UZ:\7"($LS8=S&HD!;K#2&)$H#*!A6F2*A ME(K9!8[V%\)EUH\3,UH7@5/SY?>RB1K-.^$!74OOF+&\Q]C8L>ZP> _,LB;= M> UV)[ZAU!=& V "D]9*@(T6@^0E[P^B)Q;M(<"HK-D?H%V6O*"EG@9NZQU[ MH[HL+SOY7;Y0-M>F](_JI=;XCYF(LEABSJ!,4I./*A201LP4\N.41U0&DEE= MC_?L?W*F:RN^*0NP3I.TDQ_)<6/O.B*6YN=P. ]M:]I #+[6\@.C *@U\&E5 M]L/.EPGIV/NX]F(_:/:,PY[-7,IYK[X9Z[-\M]"$^[?M?C=1X;O3C80!Q2G) M8"2(@H@$ 60126' >)C%<4KCS"EN[A)AILR&K3;&T7NMSWK:;FG4EQQ[#)TK M4PX[("/2INU8C,2B_7'U3JD]1'DF?NT/VG&RO:!-GP49.I*?L33@B@L,8RD9 M1!D2D(@P@'J?'7),!<8L[I&V[W2O5G-V_#Q\KY9E76SJ>U=HH)3%0\XE^+XL M_@#WLC#W>;:U;BSQMR-(#W".1($570ASV&CB_-[\J.3"[*&/5W!8)\M3IFSK M.>/=4S&'7=P&+>6P[FP"A1QV%;71=YJ7?DKU>%_F]3^VN3J46J*!6W]VZK4J;2N9:M+OEXG.E3>WZ M-JR\656E,6-T7[.,8Y6FQG<*FX1OD9*0(8IAAFC,%8E#$5HM*G;=36U-:"0& MC9W3^, Q/S 02O7""TYE17ZX_F_' M\,A^HV%G4PZ&\+Y@\&6UN?8]J@O6"9=>@ZM=(/T)[M5P\Z,F? M+QT7F=Z?9%OFC_<+SJ6$_H[1C+*Z #L]1&5H/G4W-I M+; _EK*&QA,SG>]O5#:R5G^7@>Q?[,E.VG3EG#.LUB0 M&,8)#R$2F$*2<0EIR+E4-&!((1?&.=G;U-AF+2S@M;1 ->(Z1YB>QMB.6KPA M-S"M;$!K! 6=I -DC;'"Q!.?G.YK5"ZQ4GN71^Q>ZIN HC2$9#SX3(J+]B[C M%2T*DZ>P-I6Z[,$RX8IBAF&BA((H8R8O95RA*- LGBH.$4(84H$#2 *& X0D2Q/BYN@]#.SC.'C7PFIK MD8XW '84/PRH _.]$1IL27VUN7#VGC[;'2!O^46L.QXYYX@K(/MY2)Q;Z&UG MRL5*FNHSIC_CVVV*J+U:Z2EH:M$LYSE_W#BS!0BKA <2READ$(7&YLQB"9'> M\(58,BF0TU;7K?NIK16M]*:RAZGJSK1FT*1 MG?#@:R/^,,Z"_9#S9\FZ=#ZV:=L#F .V;I]6>A[;-?387+1^H3^,B_>B[.H( M-]RZTES:AG8O%UL!>$*P,".FW+DVSA#!#+(H,C>>3"&E!,Z$4[1)?U&F1GBM M)HYQ=A<,A>7YWB@ #WWPUWH?-5K4Z;-;/<"+5I.?K\!&&;#19I#XN\M!]75D MV%^0<<\2+P9L[Y#Q\A;=74)>MYF6ONA79ZG2PT'2$%*L0FWO90)29(K_I2P) M)9%QR%-;YX_MAJ=&;)ULP AG[\WQ!*O37'4) @,SCYWR3GX8AS3MY7'QI*'1 M?"L.B;_M17'P[[V#$_3LK1Z-]U=UO1!O_K[*[TW;OY=2K>;OA8&&219QB$5@O @"B..K&:A0Y^3FZ#ROI \KP.%C'S.$0AG0;8S-3Q# M-_#,[J2]JGU=JR8DH9/X"C0RG\:S3\"!+4+^H@[.]CAVZ($M! ?B#ZQ?[4&ST<=TO.XV-'7$.B/K1][?3CQ+KFCT;_[%-Y;;U' NTF2602=O-]&8( MJ5# 3%%ELI $+,VH8$GDPH%G>YP:Z34".U+9>5SMN,LK6@.352/K%=CR-MTN M[#@ (UFCXXF"SO?TSBW:+27UG.YK)I^3?ZMV7Q:D[+\H/^ M&-OP$1X$2:8)"\998%@LS&#&)8U_&"C .@L MA%H'4"L!C!9]0WP<1\F._ ;$?F &] ^[>^A//_!\!?\X]CYN^$\_:/8"@'HV MTS-UFS29WA=-/'89SDQ83RS#"!).D,G&QB$))(.28!4E+)2$.Y5PVVE_:D3V M6=[3YGZQSH/AFCQM!SP[_KD DH'Y92U9?=CD,5//$95]91_;:7WW[!^6=69<*78J0?QJ<@:] MUL;V>E,Y(THEC%,%619E$"6))@V98L@8$3'*XD12-+NO3[8^5[2H+ EC JJY M3,E=!8>;G9W8D+;55VZ-X$"8'9 R1S(/1O8KL.CT-#E>;O-%79^%T7D]L4W MXJH4)M]9$[CH&+&944$(2W $@XAQB"(379#*&"8"IQE+<413VGYY;Q;B M7_F[Z]2;U%TW2(V=Z MNYZ?=84&$W3^9?E)5JMB,>,ACB1F!"8IDA!E(8>9T M1+$W:":2$8%8)="X1 M8FK[U;6 H%J"HA;1ON9I[Y$XO?B-A>_ B]7VI<+.?<(!O_7-0'Q9@D]C#81] M:=HQ!F2DPK7##8Q3F=M+$3U1!+=WTZ.5R+U4^>T"NA>WY;X&F36L637G\^5W MLRMY+94L"BET?_79:I>JNKDDG!$6H(QD#,:IJ3$9,0Q)B!@,9"82J2*92.R0 M.+V/#%8S%L#"MG#^^3^-H=HWE$;6#:/@#8?FBK5P]M&V#\.62?[&UL_VL;U0^X M6UN]YBO@I/6\7!;FA_;WYIR%MWEYA @I2[(,ZO]HPU*F$E*548B(4&&6HI E M3EE&G"68VHF&E@RVH@%:BWYI3,FY(;#FH.& '9B5&DF;JCOZ#Z 3]G"=B"$# M2"PQ&RR"Y%S_SQQ"8@G/^1@2VX8N=/=^\X/>Y8O:7JO+F,T00T@S6@A3$@MH MTNE!1G ,L5 9BB,B2)KU\N[>[6EJM/5DO5^+VM;[9-OZ%M^__*QH*BQ3WGY1[-NBU#B*"0*AI)I^DMX!&DHS%:/"JH)D ;8,:_ 6*)/C5HW MPF[[ %T!HSQX8=3_N9_1->+78+OAG.(8#WY^=OGP]MBFCHVTM_WM:(*/O#$> M>T#V=]2C2] SGT-W3:*7Q]?+%:O4:G[-N;D:*3])+G7'NI._%GDE;Y0J9X03 M92ZK(2))J%# 'Q2,>/K91@(^;5YEJ[/I9L*W4TQ6MK'99*><0'5UEJ]%*K!+4MGE'H8DJ= \&;T'>QD9 /ME*+[QM3) MI_NXD.MYU9Q5TGGCU?Y9\E51%\9JSXFB#"54!D);-C2"B.$,TBA*3#1BBFFF M4$JL I,U^%7$EK1=@-%&WA['EC8HNKAN>T5S M-"_M;53O:C%].5Y;XW'2Q_I\*R.Z4UNK]-1SVOZU2VYZ]_:TUS_R2&: M")C@)(8HD@G,,AQ S%%"DCB+1>CDNG*BK^FQ:WU[N985=,)JLT*+V^N^]S#( M+C>^%T,WSIVO.VH];WU/XN'UWO=P3\]P\WM2Y<-WOZ=?\>4'5U?!R=FJ/DYY M^?CF[GZ^?-3+8""H$I@3R%' (,)!!+.8,$B3@&+.(Y&Y91NU[GEJE-+)!?BV MO)?ZOAV#W793-P"8@^_S#F50KMW>NK183Y0P\>:=&D-ZOIU!;C"/MV/]/K.G MVQDXSGNXG6N@YW%Z4YGS?5N/4YM1Z[*Q2!"1(E,D2V\J4:@$9!&/H$P9#DC( M$Q6[I44^UM/4B*DK5CK?2.IX''X4TRBF46RRB1%MF>L].I&0HC"!"8TC1A&/ M@S1TB:[P@^D(<14#8FIYF> #J>&O#6J0MH0E.2%@1C?'RAE]1]".OT88EX&)S13_:4_. M6@>XM1HFZ4^C"-C6Y K4N@QRQ7DAGIY(L:\4H[+EA5#MTNBES?7FUU>T_%8G M7Q%Z _[X>VF"9]_F"[K@>OY?FPH,M5DX$Y1(B22%+)42(H$PS!1#$%$6RH2J M2/'893=GW_74MG=FRG(M.KAO93>'3"]6)IUAOO@9J$X#0-8!O^@*H/8GV.J,Z X>^,ZEA'8Q]2G5'XP"G5N3?Z4<7[ M?"%O5..>W'KNH)BQ%#,!N:D1CX( 0Z94 DD8)T)Q*<+0*9AKOXNI48.1T&P' M&QG=J. @'84/.#R[*\49M,&]>WMT4= MI[+.D+S]UQD7482Q""'&Q'@Y9!1F)(WTUBAF22:BF(3D,B^'@368&B/5>H+O M6E&]AUIK"EA[Z;_>([LO7#D-XB(XW48%XG0\O_S-XK(PW/ M>2^8L01Q6VC+HIJ]:N3('V13I[4I:7ZCKL6R+C;0EFC,@I1IZUE!@H- KX<1 MA31A&<2)WH@CR2075N6 [;NAH%()T5[QCM!YONH>);9%A%[I?7Z*8 M&B?&X=E$\M M9SF36,/WZA1\'HX4#J$RV/[_26?/O%D_I/CYG?7!MRX**OE,Y[(TWCIY:?;L MG<-^&@HI991JXDA,A?40Z[UPR&"@XC 2F>!Z.]PCL.1P;U,CCR_?\D+ >UI4 MCYH_.F'[!4,LY(B1.JWTD M2N+,2WTC)6I3YZ.9)%\*NBAIG93,7(N]J^1=.4LT0_"8$)CP,(,(X1AF@A*8 MR2A4(44()8%;K,3I#J=&(JV\H!88;$D,OM;WM+70CAXL9T&WHQ6?4 [,+!>B MV".*P@X:;W$49[H;.9+"3OG]6 K+]_I1S6?^38K57-ZH@PDPWRW6R0)N5.N6 M1^99O:D36J6?.J0]GPC4WDYO\&?JQM9:@4_/*IJKY**-O1Y'/.*8#,ZKWX6Q3 M'P.C+*BU](C3+FIUXE![T/ MG2OI#SH@(Q*\_5B,Q.*]@?7.V.Z2/!,[]X;L.!/W;[(?Z[9Y<.1G63SD7'XV M,;LO:2F%$41W6M^F?5C6=R527'^GA2B_F)"X[;^;,\\/R^I_9&5*LM\N\G_H M+4=]._]V6;2_,L^%,Q:)(" \@RF77;A,DG$HTIB'(I8I=\N*,Z[X4^/VWQ?% M6F!S'+K6J+Y;N3)1V,:+Q21,+S9J@!?:BGR4M"@=:7[D;\5N99CN%S#T8F(T MA;6JX"-]K'<$UX7>X]_6)EN=RJ)1&M1:7]4W1OJWE1[\"FP477L[F>]D2UE_ MB\SSC)&G=6EDX4==RIYG8'97OV>2XM)MBMX2Y95\KS=-XMVBTO,NU^MRXP>[ M8^/&3,@ $PZSV*QZ88CT]L1D$&%I%@%&"5AK 39J MG'.;]S8\KEN004 ?<>MQ&N^1MAO.('K?9MA+\$S;"V>(CF\KW)OJQXZM(:+I M^9K_?95K'E^5^4+JCLI?BV59SE(4!A$)*414&N\%)2%A-((L#1$B&=>; 2)#=^.PNP'9GYA&U@YNI$-[&Y5[;)7?)1KK]RZMO%IG\:6\^J(;ZB*"LE":\BQ0!#&&2,D0$D$0 M# 1#+(L4B;B3/]2ISJ;&)ENW1)VPCI$_5A#;<8HOX ;FDUZ875 C]#@8WJMZ M'NCJF>IP'E?Z>.7,$^_THXV:>CX62Y57LRPF),D$A2S#"40L2?7N"PD84<2S M#"LE$'-)-K;5MA,IC)!-K!;-I!)3KKDWM@&SF_,]81AXBC<(?#R-@/.4/J"K MIQF\W?*H$_: 2KOS\] C;M-1R'SV9E'EU>,G>9N;+#N+ZH,>O5E(LSC*]%*= MA#&'"*<,TE2$,$Z$GJPBB;BTNK4]UL'45NM&1K 1$A@I[:;H41!/SU,?T P\ M61U1L9ZVYU0_,'=+R?]TNWSX1;_:3%O]C\UL/=K@*%/VG#K=O#W[G*^0)G,I MR2LIWJZJ5='=378;@?^1M'BK/Y$9YU&8Q$IO]:5D$$6"P(SK*8_C4 9*B#1+ MZ&6Q3E9R3(T*]$>%+XU]LAL 6]M]<%@'-^L/14MU6H!&CF0'&9$TV F&5(1TSQ(W-R9C_4T-7K;" H:21TO<8XB:GE5XP.GH2]D M=B$"7X>Y<3F'A:][E:/]C'M[[AGRM:5%,=K%T1AS0V;_.%*5X&&-5_X*ZQL'[&30H2 MIB8 FD0BTW,L#B%-%88\09@JA5,I63MN;Q:6^X#G&K5.P"&O#L1S#YCE@<3H M0S#TZ<660O\/:%0RN:E:I4"K%=A6RSAP/55LG7+H>VJ['Y/HM\4&,]!M:' M-$,@._P!32UU'0+<%0]82P[JS+I/9/=Z-.,*F+]C&>N>QSZ2<87DP'&,T\;%OJA"_62P?\A+0A0 ?BWS!\WN3$Z^.Q=]2RHV_3H)O1UB^ M(!V8H9Z(>=54L'L$7]O_'>3NR@893U1TLJM1N<=&Z5VRL7K'/2'^H2RGY:HP MFZW.6;=LLX"G)%!APA*(L=ZN(L8CR"3*(.:(IC0449Q:V4=NW4Z-<=9RUA7/ M:T'M 5W[C/;#H#Q2)GMKM/TDKW?'ZD32 M>H?&1DM6[Z[@=I+Z'F^[$_IVPA!MF';W@:\E+\Q=PR=9KN;&1'VK%:O316H; MUOS[[;*XDT63(?_=G?Z>3$:P92'SVS9G+6^R2\[K3_9Z(6ZJ;WHB183J4:,8 M9I(BB&),( FC%"HJB:()37 B.I^&+W9KP[@:]/")^#+",M,IUIBUC6IMH8DK MD-?:&;-6-?H!WBH(JHV&M16\-#K:4^C(7\_Y16Z"'\,X"^63Q#_FQ*!3_0IT MRH.U]L"H#$Y^,PT(X$:!%@;0X0"V@ :"7 SZ6_&?NF>[K[+4\M[B_2?N#5N)7+8U7WH]I>4 CR M:7NCU7L\J,9V6'H3T];3T"-O D M[HE5CW#4DTA<$)5ZN-V1@U-/*KIK*2$WN:;RKEZ<; 2UW[H=P?+\ MMOQRA :>ZP:<.A'7NIC>&T_@V.\_+P=II'VB.UA.&[C3.)S8:!UY<;0-T6G! MMS^M_=[=FMS4]2U&D1=D>&C+.HZLHH)@>V6,[GM"A-FFQ0 M&N$=\V';#(&M"X!78 ?W!*@Q_=Q@J@76'VY3ED:T=6>TT*"6VJ -03[#@+VK_;CH_K0Q!APA?RFZ:TN)6/*%QAOIT^2SVE9YBKGS1F+ M^-NJ*;ULSF>N;UZ]^VA>V1R^?%R652&KO*A3F6_=B9G"S3?*^%1UT5,LI%%& M<0Q9%@6FH@"%C"*B33N4R@3S)$F("\<]DQY3X\WWLBP!O5NNFJI3QC=7SVY- MF@M9M74%<@Y8>W5LR@W\V8T\G^M[L2/D?X*O8&"2KR4'3R +QH0?J[=4^:AVETIGUL< M]S./MI;P^YRR?)Y7N2Q?YR6?+\M5L97D/A(H"!DAD"FF]P(D,@DP,8=IHG^O MHE3*V"H1EW6/4UO1NDK8M+N !%ORVV_\[= ^?TCB'<.!UX,.OBV!P49BN^0U M/<&T/U3Q#NI(9RQ?ODF@>S&IS<4&4U./1W^H@+;0S[>@%ZO"G%*;/Q?RWH1, MZ9\:N^Q/?@YFG+ \<4YCU\YHQS9.:FV?XKB]V#,B3;>XU-_!0G?4QHLL%YOU MQZPR!Q_I5A.]EWN=SU=Z:]>><> &7I>VQ09KN:^ZBIHO MC'H_-QN/8X_6 8W*[$7J4FB@U=3W"=9 8^ K%L^S=./&ZPT#[5Y,WT#=N+L8 MF9.[SEWIOU9TGJM';0#H):H^L-E:F$SX]$S1@"(9(BAB12#*1 H)(Z9:,DY# M+#D3*;=U07+J>6H$__G-*] 51;H"800#<@76&M5;@XU.H%/JJ9UK]+(T<=U' MZC2;#XK_P#P]//1.WE6]8+S ^\JMO]&\LWK!L.V]U:^!?M;Q5CUD>I0Q J%)!5A0)PN D[V-C5B>U(_?"TN M^&H$!K7$CCGJ3F-M9W1Z0W!@:KH$/&ZN\_ MD==GMZ6FKE>US78K%_S)OGY]:T02B@(>*1BGL8"(8602JH?*I0BSBG43%:'Z6;:AI(8)B$.J9!9 MS%(\>Y %6]K2V\G^7";7=J_#S3$C;NNY])ND1MH[]Z(%IS&V(REON U,2EN M;4DZ4 4#*U \D<[IOD8E&2NU=TG%[B7WX)HO!36Y^3X_WK'E?(:3.**IY% @ M$TY#5 JS0&^U>"B2(.2""Q'9AM,\:7EJEDXK'&BDLP^8>0K7Z;E_$0@#SW-+ M_9V"8 [JVBOLY6E+HP6Z'%1@.[3E\ -](]K>YG/Y856'2.(HQ8QA"0,>UMF! M]4+-8P0S&B4D#&2FE&/!Q$WC4YMZ;3R6$1 T$KK&JVT!=WX&7@+'P)/0 8D> MT6C[*E\0@K;5V,AQ9_MJ[ >;'7CF E_G+4> -H(9D0P+*2(H2$@A4JG2=C0+ M]2HI:9;J>9M@IW)?A[N9VD3MZ4MU!DL[>_ERA :>NWO@> P2MP/!IROJ?B?C M>XH>5?2@(^?QI_O-_&O.5W>KN0F>..4HNCDIYZF,HX0FD#)D\J\J 9G"!#+. M5<0IQ5&4NG""JP!38XLM^<$A%_.G;AO][R^)-GK+I>"%/(I/UA'<$:*,;"+-2&82 @"J,(4HD9Q)'D)&61#)!3BGZW M[J?&@(?B3/K>(SL.A+4).!"\PQN ?9#M8^3U ,B?B>?2^=@&7@]@#IAW?5KI M6362SN6-:O(&2/T=:@Z]U;^X^;[05/ MO[\V4;QU]D3=EXG.4B1* \PD5!&- M-)D1"JF($0Q4@B5E7 6Q$YFY"C U.ML(;4(,EJNJU*M0?:=2IR1IPZ#+^WP! METJ!%[0$U,26F)<<(TNAZ M@N>K\)QK]^.6F.L)SEXQN;[M]/8>3/@#\YF\J;LRFZ4TUR\;2:9'ZNFN0@PVG' MHB,.TL"D>N+4\&DHW>BU/SUA[,]_\2)IQO9H] '= 1]'+\U>5M^S3?:]Y4U> M[_;;=!PS%,6$9U$"LS# $"5"01J$&21$6ZP(AW',K;R9W+J=&NVVTO:KWGD& M83N*](_;P$RXKMG9%3QX$DA2"PU>M&(?M^5[U^NTP\ESJ550$BQTK:[7BLN+"]\#'\WBO*)ZE@DM5U8V/Q[_8=6 M\"M?95GZ@C544>%CW3YO1>$S8)PM)WSN_;Y\5>0/M-+66KE;S):I+(AHB&&* MTA"B,""0"!Y!A<,L"S+&J'1DJ&-=38V3MB1U99^C:-KRC0^,!F>8M9#CE 4^ MCXHW*CG:TSM-.TWP?U'H+Z))>0C M?32_NC95SM_\?957C^\69574&=7*FJZ^?*.+F_LZN]*ONHFJ?+?X6"_$R\F#L7=B,W7_?BYZ%N4QJ_8,1HB:E#.<0X;B$.*(Q@'",4'PQP6)'2[>;D#.=#?R%8>= M\OMW&);O]3XAW*G[WCFEOEU5JT*^N;N?+Q^-%_>BN3 Q-/=!6_-O\Y+3N7%9 MG,4AS;A,,DADH&UE:DJ,+M/4J&KMZ2M;V0'?%MZ8 M/":7\L+L5U6M!7C4:CB?-EX\EM8'D6..T/!GE <*2:R'K%$)=#J!)TJ9.V<] M9HU>M>>VUQ-,7RC[.]R\6**QSSU]07C@2-1;T_VX^_=2WJ@W997?T4IJJSECL6*\_ M( ,3V"X6XYR#'H;#$]/L-#XJ:1Q6;'?^'WFJWU1^N2HUF92EWI"R-M/@H5(4 M2/* 8\HAYAF%**PSWP@,XRC65A=%4<2%6ZHLNXY=OO5Q.OQ3G9_H;.\VYG?H'4IU;ONCI+FL3*17.(A%CG"42 MJH1QB)04D*@H@IE4B0IX(%/A6"?^>&=3XY2G%S"%N8"Y) CS),X];Z]ZHC?Z MS=5VA.6 EU8'X!CJPFJ[J^>]K#J@]-F+JD/O^+JD^BRK:MZDR6Y_>\/F^6U3 MHC/#!(M Q##D00)1$IL(QT#_&(L$980)@L+90MZ:%$5?+KF6.B6%U50AS539 MDV5 9YZ-R)=>+IT<@[[W2!=#^IQ71MU/&Y&OZJ+EK>73+:YU9=6-HD->&-G M.=C=T,G.G_D:R :8\S<^5JU<6&WJT.&DHC2)PBB!*4]CB&(5PRQ),\C3+-+_ MCZ6(<=?3F./=3>]09A/IYGKQ>9B_M;GK B[74H!/;8[8!-YR\V1A6G8YL;;@ L6]W.+W=CY+>T&*A M6RL_RJ*+G\CY#*=1PA /81"8LA0L)3!#4L$LT*8)PED42C:KS 2U8Z"#O3@1 MSKJOX6:+24349HVZ-PGVC*!U#)Q8SN>T*#>_=3S@/8RQ'>=ISR#B_YY$^&?Q$F<+O*C1?S+\LZ3O-6&ZP]"NL,^P78L=Y$ M!G3,@C\G<^0=/KK>C'Y3YG=55#2?US__JL=^_3:KE3:G2IXK"(TR0CZK$0TK M\/B5C489@(-5DL;I>6H))_Y;4ZPI"]#$"M<[U'7YU%F:$&RRM,)09'K;3L,( M9AG-M U-XT!;S3CE3N5)GD>-J1T#U'6#'^JZP4L%'FK)VZP44TE*LO5CP$%KI\J7RT7#[(P 9IZY-XNBSM9?*0FR^-?97[[3?_^6O^9WLHZB\=K MO>_:,"\/%462QI!F80R1B%-(]%H,98+2$-$D(W;W:--6AA$0(!B5/24A4(N*$N!Q8>99O:I:MD1@4 MLBF'72W7M8- 84BS_$[O ;TM9!]'?=\C>_DMR\#C]?Q7*D9!8#0$M8I73Z], MFOINNZJ.?Y5RP3",<&_21[K)7))< *W+C<@EW?1;)MHEK?RR_"U?+ N]I-7+ MW;?E7+=1SI#BE!JW'D%3:HY%(L@BO0BD.%!2A2S@F>IQ!W^ZUXG>G[_.RZV$ M?L?+PX%6#3=6/S,0=B3M ==Q.+<3]$3=-H\I)NQ@\<2!9SH;E=+L%-]E*,NW MW,]_3U%?73]3R6+73M[8*8'D$4<\@)Q)#E&0*D@2DD""11@)1D*D0MLCVHLD MF9JMV0E\X/34_I#ILK$Y?Y Y&N+/8"V^:%3Y&1AEKL")\; R"CV/C?T9W6AC M--(QV@ACY72VY07?$\=/E[4_V@F1%QBV#W'\-'A9!;[MXZ/W.65U(-"KILA< MX]/45IR;I0+).$$8DCC!$&',($MY!I.89YD*,OU9LSZE^*PEF-KZM:X4Q[>/ MNLV]GWL* \>QL#.K!T5XX/5J#>Z3>X2U]%>@E;_V"MUHX+],GS-XGNOUV??_ M+(7[G.$Y5L'/O:&^\8G".!KGE7RO"5?L!B"]?/R-_FU9O#*G%G5IC5C2A(2* M0A*I$"*19I"B*(.9I)1&*$*".A41<.Q_:J2W$1_.C?Q@+_ZN5X43UU&Q(\ ! ML1Z8_K9@?M\/YAX1C;W \A;:Z-;[R#&.O:#9#W;LUTS/(])"WM.\JX+:,NF, M2*S2@#.8"1I %$0!)$$FH?ZMBH.4)MHV=Z&S@[U,C;1:(8%LJR@['G$>!-+R M9/-2>(8^T&R161<[?N7;CCJ)@*^SRX-]C'MD>4K-O9/*DP_[OSC?Q*C43ST- M3]E*&U5^D-7O^G-9%E7^#RG6-SE%7N:+V]>K0O^W\:W='-,020*1I@IR;0Y! ME(144TNL8,*$C(4F/$(2S^&. ZHST3N<;K-C:B^!A=2['EZMJ$FO#%Z8$,B? MP?Q4([YRP[!=GHIN!",H>G9'@=K*CVA\2EZTZ]M49O^ M:4-KAUH022"C)(8ZNVO'FN4)B&A;C<9-MU.;2)OI-[VMG]J/GPUTH-:?,<#/^H' !8O]6PNEM7^GCFX/ [NZWT)O+ MI;D -G^:!3S%28)C&#)DJJK' 6013:',F BC#*4DM;(Q>O4^-?*ZV'>HWQA8 MW[L.@^SP=ZX'MI/FO^O4BH<*YYBL\>V=Q):&QD7RA1F=G^L6ADPF;X'N8+GD M3_7]S*GD+6 YGTG>IA$W]A,RG[U95'44DJ8*R@W+OJ85[4[6(YFE@J5,;Z$2 M!%$2I)"E*H*QU'NI2(4H#:W*[ISK:&JP[/V1/8$VDK=Q7_"<7(@M(#GA M('SJ[='J(_%\EX6U:-IU3C)F>#N>_/)?*GK M=K*,(9R& @J1Z1UCQA.8A;&$-) $8YK&D=LYEVW'4^/23F[#IIWDS;ZF<1]= M2P^^UO(['G59CX?=[G$(E ?FW\M =<\[YXB0KTQQMMV.F]O-$8R];&RN[_LJ MXWRC.]-+V^+V%;W/*SJ_9F5EK,J9) I',M0\%6.N+3Z"($&:NY(4IXF4.$)V M^S_WKJ=&7*^^F70>IZ]B]=X-C\8;E86T"-+@.)R3K;Q(JW\0ZUK5C72[DRSL,]W(3/P6]G(_H&=6!& M;AQPM^5=^]^V(O]\GI;[N=%:@N33Y_5#(6 MP0S:4IF0@BO0*@6VM3+^(+Y,+\\ CQ Z8"/-9$( '*!S<>5W:;;GS4BUY'^\ M*\N5%-L>_W5>VL,9:CRF54O\?YL+IL-%=A*F9 MD5JV.SUW2Z,(9'6.;FIR H/ZQC^O'AUO1]S'Q/*>9%"D!R;46L 2-.)?-8G( MKP[G1=_D=.Y2MNHMEI)U%42/=RJ]T?1UN^(NP+CW++T!VKMQZ=]23W.5YTW0 MTVXVUC4E'S1R, [C*!,8QDQF$ D104HT4T92! E*8H(Y=[)2>XDQ->/TK"7: M!5<6NUHZFJC]!LW2,AU\*(8V2%^]6T>Q[NGPU!@=W B]"$M?MF<_(<8U.2\" M:L_2O*RUO@8FK>JEN$[2R5_.DXJK:6H >L!B8L-YAZF&]G(/!FI1WK9V1C M[(RZ^S;7N1=ZN[7H);_>U,YS_OA%_JA>:D'_F!$12!00 EG""$1Q%L",! *2 M3$49YH2$Q*E0[K&.ID8'[:F0%M0US=)1*.U(P = W/ !AMS1&:D!%_;_S7B M@EI>OQXF)R'QYT]RN)NQO4=.*GO 5^3T\SWRQ+]ZU\,D63M:18IC&?$(HB T MF902#%F<,)-)"4=QD"0TX]:)XB\296JDRB-_ M60?C)9+W L233/)^6NQG W]:YV,RGN.?[W6OR^+]LA&@WL9)&<V@&T$;L+I6Y%!)W.O;?-YW.TL9Z]H#KST M7 JDLPUM#8XG8_I\?Z-:U=;J[YK7]B_VS)V2EZ;Z5KY82=$Z>9OBI0NA_W"_ M+.G\UV*YNB\=HQ@<6YW0Q-B6'&Q$KUW_.N%!(_T@T0P]D?.5E\.Q]W$S<_2# M9B\W1\]F^LVO)N]'5W^AFT6AS$C"0@3C "<0B2" C*4(*A5D$<%"QBIV6<@/ M]C*UQ?O5[Y\^O?GP!5Q__OSFRV?'0*O#.-JQT<7H#,PY75*@+COQ$+QR$@-/ M['&XCU$YXJ2:NTQP^N%^\_WW12'Y\G9ADJ?J[4(;KEYN3LGD@LY-H*$FG,[1 MO'6IG:F$)BCD&A3#+M'G/E$AQQ#..8Z<2*1?(,C7NV%8%5/0'>-&F M\3 ND^T1EOGU?:=2O6"O2[*V#OQNE'/)4-H1TT@#-#!]/1D;+37H]+@"FY-Z M\/')R*QC+-Z<&1EGHO. J2I_54I..Z TM%KJ+\IKSU=UJ;NJ8F$1%/*],P3LF M5!)KGF':FLNB&!*:44BC-&1AJC!-G#SBSWSYSH<^VS6$H #A[.V;_K*;/UI;59] MD%672/OU2GY9?I95-:]/BLMP%G%%PI@@& BF($I4"ID0IJ14R!G"21B&<8]J M4GWEL9I?XY>#:HNB@'(M*C!5H"[-?&TY1A(A&JM(ZNV^X!#Q)( T$0@F8F<_/,B*6E[4C?/]# MW]H>K+A@'+*:F," &UOEJ#([MN1>V^\SE@NHO[_=%>2]YKG*](VAJM0F"<69\N&2<"H@0 M$Y"E 8&<)ECB-%!!;.6=?+*7J9D,G: ]:MT=1_(TNWG#9V#JLH?&J?S=6=4O M*(1WO.W12N*=56^[.-[YA]UC%#Y3D^JW#G]Z^?AAN3!GC5KX>9TGJ;G/Z#*7 M-SD*/B_G8I8F,:&!8E"E4: GO]);/IPB*%2H!!$H)1FR#4WH)<'4B&%3GJ%L M,CF46DB3>*W]^?@YEZ<1.4TBH^ \-,%H^8U?>A,P^?+19&*#6TJL[V*UP;0N M8=#FU3"J##T"]@$%@X_$2'$$@XV(4QC!16B>B![HU^YH00,7J;T=*W!90WVO MG>K#Y8^TJ![K?*$FE]!R41J?QOFR7!5R$^[).2=$* 1C;*I6")% RABM2[0& M*%.21T[WW Y]3VV5:44'M>Q@6WC7&RE[^&VOI@8!=? [JF-X@HW@X.L@P;@] M$/-V;V7?\\@76,Z0[-]DN3=Q2:2_V6^;+,?-%?U*<^;&%;N)P%J["LGRMWRQ M++IZ:9I6:Y^A[59,A8WJ\3=9?5OJOSSH1^H-_-I-.%$XS#@6>DQ-$H%4_A_J MOK:Y;1Q+]Z^P:J>VTE5"#PF"!+#[R7$G/:F;3G+;Z9W:Z@\JO-J:D26/*"?Q M_/H+\$6B+8D"*)#FO7NGD]@BSCD/A(<'P'D1@&>4@$2(-$X$0R+Q"JQ\!1NF M1JEU9%_9-E;L &C::U@FJ%.)]\&9?9IKC/Y5<:/MB7\!!J;_9Q5+JZ_ 'H)V MTDS]%:@LBRK3HI9M[0!193-H#=\=<8.':AOR6E,8M%[$N!:\0BF*5YFBXU4N M7D>5_JU5BKK)<)FE_$EMYSP5-#;+VS:"R@%*F=D.Q"@&B#.",9&::>81%M(E M:Z(A'SMU*]YZLUW_]+RAA4=I_TZHSQ\L783QS7OSDV)NIM.F '"0*%B6#J* 0\* RK@@+)64(:=.GQTRIN;(-VI&E9Z1 M530J-75OE'X*SFX.# 32T*$%_OAX=48_@T"OINBGQARM'_H9H]JMT,]]M-\I M@WFEJ\7MRM[UUZUUW#AD6+0')AD;<%B" MW:@?\:?HC;4@6JQ^:O7#W5LQR-E6?Q #T54/!4;EL_X O22\"T;JQXA&DE!* MEB=(MOF%3=O]K,O*GC:S]ZO:W/^B^';.19*8/4L,L$P50%1I0#1FP.Q@M$(T MRU/NE;W@*'=JW->H73$?7V\VZ^]E5MUZ%95)T**,!(XT$[8#N&=3'M?)<..^ M 2 >F/">H]OH;,.YJE*S9:ZYU3NRBH!2X=T7?6WZ^$6#^612(,#Z[,7T65^G&UDM=WMEU< M\6'5_LQB)18/2U7LP[P4431.\AS %!-@,WH!XP0!S"#46J@,,2\W*X124R,T M6WQCM5T^U6WZHKWRT7,+??>@ >;/=5J-FF@P+Z0& ?;Q@90:>2-;3@0#[>Z 8X@D$AE"5(QPU+Y=%KL%N=%LR-T5&S*A^XC[OSX M] RX;DP9#K*!.;!!JU6BL-8U>E-K&[#(CALL@6CKC+!1"^KQI:CY_UG:W^W'Q32 *VCVIW$F M%20IC(E7Q>8^2DS-K]O;8$]\RK.>4OFHTKX^ ]J:%T/TZWHMOR^6R[KXI[09 MV8NMJC__866\D-N%[952/>H9)]QG0MWH;.AI&ICDVC.TV=>O/S9;([52NP#/ M4&&S?508-^[U I . E6CO0=1E;BYS%@L M]B')1'F-Y@1OQH^9V7Z+,IQBO5%<0JKVM2R;$/O M>PM['FG'BX>0Z U]Y5#K:BNUU-I&>W7/O3_\;QITSV*1B[.2,0. .SQ"$NYX.^G %RCUD/ -1((>L>7R2O M*/4S"'0$J9]ZJY"I\:"1N](V+@K<<SV=E.FN$7L MWIZ-VPWX8@]Y_:V-6FU49 7_UCS\4%8PC%@1,?.)XG%9/KYY-DW[.,Z?P]"V M+^ =/.X\U&C$[FMX1W7O3J%.2VO\?,Z6AAZ9FVXP.QX17HS::%G[ MI7[1FT;3G^P-;TO9H,GUYS$)EP;?(6OLA/7S9A])+7=XJ.=]Z?K^?KTJ:U15 M-:@^/VX+>^-ON&HN89I1*CA 2)K_)(("0@D&>9IQ)#.8Z5K M5%AE9TWMP?5>7_\2A$Z0)QE!*A4)2!FA /'$<':6$H PP0DDC*E4SJL7_LV6 M;1QK_H<"_J7@X>!_JVX7*]LR(^)L688,#X,WXW$J>)H#316QFR,$",0V1(O2 M7*=*48QKO-^M'(N2AT6[$3ODSEX.#[3;JS(4= ._*6MRN*G(H=)T%K5T#1@7 MX(!(J*B +E'CQ@0X&'T0$>#R3%]?NWK=/OVZ61?%'.(XOIRB.4X MED3CA/.?6M#0,__YUFKHZT$_ \_59>X+R> ^ M'O$QDX.YP,\&']GG/6;8H9-[]%/]%FP33#+/DCQ-"64@IK$PK_=, ZJD!)I# MA-)$*26PCP?;##PU;[71RV]I[F#BFL7*" &0(&0;LV@;HPX!27&N!6,R)=S? MZ^P#UH@>9NWN\)VGN=;U45I/%+7(M4YC K1(,X"TQH!F20(4BP7&]G&AGH%; ;=E3R?VG,2]H_^'T_ MPO]M_:V,,_^P:M(5ZFB"O[/-AJVV3U=";![9\O?U%/0!1@&8JL^&HQ*;!= ])(#+QFJ=XD(\[;> M/MDJ/+;LJ"TT^F!5>/OTU8Q8)OOJ3,,TXQI@Q'+;B88#1BD&,=&002$5TU[T MZ"!S:G38J#PKBT)MR]#TG=JSR*K=*]W:!7XWL@L,ZL#DU@HI__HLG#]XEK4' M+N%*/YR5.';9!U<(CI1\<'XT5-OJ*[&U%*>VCYO5Y[(\6!V@G$"5Z"1C0"EL MMO#$NFD)3P$F.E$BAZGRJ];E+GIJ=%3I&6U*16UYF@=;JH[UR(?Q@-^-AX8! M=6 Z.MX3M*S_UV2\'+L2U^M-5$]%95Y=YW[(7J#GT!RL^^=)P:_<[_,<(.<[ M?)X=H4?+/WOO\-9\2>3U^M[F(Y:18U?6B;M5%7_N/U+'OU]9=Z[\SQ>U,5^M M>WND4O6DG2.(.&,) E I!I R+AC/( ,$:XS33$G,G$XO!]!M-W&^\I0,S*REVJ#4.VK;%K6,LY4/VY^K#8Q*XV;5'U'+R+I1\^M- MJ$<;PM>;V+$:%+["!/OU+AQF"KJZ&@:6.%Z_PV&@>M8)<2 1ES08.ZQ?@1/* M)4H9R-,D!HC9)F"Q1"!AC"AJ=AHT3_R;@%U6%62\1EU;]J/*-"U4GR9%[V1^ MU[(W [26O/G7?KEWCSW*8G6LI6R@CG2>N(0[T>Z4-O8QMHOI1\ZNG1Z[C-#- MN-4!N*VE7.W/E\OU=[OKGBT7^R^X?_CJRN'G6>3J&8PPSE"!.@I0V2D]C661 IR*@RTYI+ M\VJ,W<@Z%([CL'-X),]?EX9 9V#N+6&Q&Q&K9%1KV:>NV"F4/ J+!4!KK,IB MQU +5%SL# I=U<5./3I>>;$SRC^K+W;NLWTW!YO%-V9K,GY8V2HV9<7&7]EB M92.>WC[]3KV=[4LOR+%W>*ABAT6/,T(IP!3F@&48VCW"S%(&12YHI*B MA/L=3/118VJOGUK-J*UGK_CAGK/BZNT.C?7 )-P'YAX^[R4H!7.#>RDQLF=\ M"5"'SO)%H_F1H&T^_FZU76R?OCSRY4*\7Z[9=A[',A&<94!GMFTFM/'(J=) M9 )G--98**<[K:.C3XVR*@6C2L.H5-&-JHYCU\U %R,RM'?G 88SH70:?80G M"B5^OEU_^ZMYKJ((\Y<],QP?;90%WVE(LXZ[/]3/1ZG3D&_NE-I^M#B;E5_? MF K&:9)H6_I48( 0TH":C2^0/-<\XYG*N=<%R6E14UNX36YVJ6K4Z.IY'>V ML)M/$0:W@9=W7\B\?8?S: 3R#SH$C>H#G#?XY7O>X8F^]>Z*[6=ML\YM2[(; MM?FV$*JX62_EG&4X3VWIBQS&U+S8^!_[<+\% M?R7$X_WCT@8._*(>-DHL*C]#/2Q5>?^VDE?WZ\UV\>_RYR>SHN=)'K.40P1B M%4N S[MY:-LTBW965;$;Y&F>L13F,(- ,%L"C-H 6B(5$ F!*220F__7S[GK M%CPU?Z^*4_YXN:MW!F]?[R\Y1FQK^1LNH%QVO]T?#Y471R;I24,G[Y_M/T_ MFU_4O1,_J1_;K]_5\IOZ;;W:WA5S1..8:,0 A-+L5KDF-N&* H*RA"D6)P1? M6"S'2Y^I\9SYLJ:75LKQFQ!7QAL-YL&)\%A-G<::J#)G_]O*H%GTOXIMHL^K ML$&I(2 =K+".GS:O7&VG%W3G2_#T&[;G9K\)IGV_WORR?N1;_;@T[JIMME;\ MKH0R1,Z7RI98U'6Y4:[R.->8@11JF\F6(4"D3 #$4J029ASBV(=+O368&GLV MRD9[;6?[>/*R+M;U1LF%O3PKBHO*P_K/EN/V?<@Y&'Z?/@#\_AOROA"&VGE[ MRQ]WB]T7GH.]=.^!+NX$5KJW/_3I-99+_AY7-'?V7^:P:R M[TFSS5B>OF5PFU/7.]G^,S7X36R[\U*IW2SZ4!2/*N@M[''[P_=9JH9_K=Y* MSXSKZ*?T_'-]=[9\NX_9_&2FN(X@2M(XIIPA@%%N6Y7F$/"8YX9K(*4Q5S%G MT&_+>ES0U.C&ZAGM%9U%5M6> 5HGP77=?EX.V>#[REYH]=@V=D,1;#]X0LS( M&[UN8P]W<&<^W[<>FUEOJMC6!8F^K)<+\?35;/_>&F7_.:48-WY@?(Y&E M-/>*\SHK<6I$TR@18W.?2/'S^+N1C5!T1R8;2X%TC^>W!6<4&'E9^6- M&UWN:OY!D+GS@[V[[!SIXE/_]BJ/!Q!'VO+X/-V/M&[4:K'>?%IO55'7G" 8 MYBI/-1!*$H (4H!Q@8'B2* \3CB%PH>?#B1,C8HJ!:-20S_Z.03/C6DN@F1H M4FFA<;Z4B3QN%/R<:D^ZVM6W+U?KK_; MY'A#$BNQ?)2VF& K6+,\1K"E^3?JSKQTR_1Z>\A@+Q*_VFNF_=& P@KJF#.0 M<,G-[HA#6]4] TF<<\83PPRQ5Y'\@?2<'*?49MHK(&NH31__'E6F1HVMMNEG M.QJ["LM\9F]3H_-,RZE1OQ*.'/?Z$STT4PXRQ]&?I<'#G%$-/"FA.'P@+<=] M$PP+]<'[9&!Q/;?$=O0R#Z 4^65=;#=J:W;<]D+A,$"LN'[<;,QOVAF$5,DD MY9D$7* 8( $5X##'0"JJL88*)UKV2+:Z7#,G)AH_S:I6M'\B9X Y<]QOCS,% M(_6ZW:WA 9. MI%0!R9"2*6IV2Q1"DB2,B!213')9XG^\?/-S]'MSJCRVDPT!KA7ZPXP3]TOL?'1'_A5],=-M+ #"!FM6GPX M0-IUY0..VC,MB15W]G^V-L@WME1E]I/9/B]LXJC]A9'__ >M3\XE1%DJM0 J M%0J@3,6 ,9V#1# M$PTI0_'\H6PJ?;-EFZW;)O0BG7Q6]4O-!CPEM/<5Y?O/ M_D7MU;7E*6X7JY7-8++[Q^X>[0-,88:9%!AG(+.M#5'*&.!(0*#RA#*89/F5^^BH3Y[8Q'VTJ!G9IK&:SZMKO71O^O>Y1]1$[ M2R]^V'XB8!9;"&1#I;Q=I,NX^7$A8#M(I@LR:+\W:-?EWOOU1BUN5]5YLWCZ MNC%[82;J4EWEOZI."E?R'X_%MLSZ4=O/^BO[,<\TY@BG O 8*]OHEP/"! >< M0R6RA+!5=L2B=J8:+O7?Q:M5%EJV':P?5,?ROZT2_XQ MO_C+&SBC:?S3+/H+1G%))W]YD\PR2CS#00;Z7KC1_NO/]<#O@[-Q';.H^1XT MAD8M2\MY;=D:[8TMT[WL-\$8'.YM,>R$!'J-#*3DJ.^788%^^>(96%K?A,^= M"@:>Z_5JNU@]F@W&9^.D5L>M;\N2>+N&QZK1=9ZI+-48VA10R !29FO'E-9 M4!X+G2G*E5>1_OZJ3.TPLV&3]4YSWY30WI/B1OGC0#TPK3\/S;.K.]I;$NU- M:8HZ[ENJVT;JM3TABK>B0.E[DBIL= MA&'PN<*$*9CG(.$I!DB3#' D$4AC(6.=Z(S'7C4U3HN:&@M>__'[[^\^?8T^ M?KAZ^^'CAZ\?WMW\EQ\/=L#JQG-AP!HI/&UA::D)$?RS431@A/%Y- (Q4(>@ M41GFO,$O&<3AB4O\+$,YORNKO)%1$E+I$^Z=NF+.21++C*4 YAP!%',%&,3, M^%A,IXKD(N8]G*JS$A!<1N81MYI754F:SDZT>_VTN^Y M";,ZSZ%EQ\U%=PM^+@JF0Y&WQS;<8T M(C>[L.F:">CFE*"I M4SRJVUVK:L^;/26S=&"8$8@.S2C^PO(GD'!*!R..DF%$)XYRQ+TGB[.TXSU*5H4MSQFSCV]TSCWD1R6V MQ_V5&4W:$=\OV>T\I@F.5<8 S%0.$,,<,,$3D.&8I+E .1*I"VTC0S3X.PM0\-Y^IR6^4EN_LQ"< M[NAW_M%^7/1^L5ILU4)(IP3(&B. MC&^@&6!(IT I2C73DD'BU8+41>C4V&BO:)6:/HL>2UVCI5'6%CR/GA3;^):[ MV]AO61O%72^U3R $C7H\A+X!G\_-$+F1YGCJ>,#W;0>"!@Y-/% M4P8>'BF>_*3?TBXVV[GMO,;JB/S_^\B,/_QD2*-I [D+3.2YRLVKFP"(RZAX M% -JCQJI)+9*-T% =B8C7U*)TS-]@W-MBV&Q+4QT@SQ%)@]KG$? MN4T'B%,.4(S,5E=!'&OH5W6D0YK/"ABG=,@S9?NF W3AZT8;@3 ;F#6>@U6K M.4# OP,:P4)U3TL:.5KWK,F' ;OG'[FTU56545;8K*7;U>+?]B;-HX^13A*D M)$,@334Q6R0B .>)-@3#XTRG.47$ZRXLD%Y3X59&_K8[O()&ZD)51#$@S>=NDRK5VHR%03*TTVEP@Q_X19S]3)2HOAE M48CENGCAS.7P+-**?Q33>>O8J!#]Y/(1#RI/U QOA'ZZ?,/'J6?O+#?;-7 MC/,DJF(;YN]+55_9&F]KLUW\NVHZD0N4Y#!)S%(G.4#2;E-UJ@',4RA4BKCV M"]ET$3HU(FCK/(M82]/R7;LN5\3B_H$M-F70D[ACFUM5>)8"*@!)S(%N7%!=)S'6BKB&G=V3,#4:*>M8V25] HQ M/0EC-X6$ &=@NO#&Q2O>J\OX"Z*[C@X[6BQ7EU'MR*W.S_7S,GP:?\]QSI&4 M>0)4CC* $HP!,3\ .4]PQI5.%/>ZLO<1/K7EWVYTZ7IDZGE\XC4W;J['4(@/ MS"EAP?;V1_J@%L@O\1(]JG_2!Y27?DJO,?INI_CVP\I>.]I-P!^K>I^@I#VC ML;SZ9:/N%X_WQDLJ/UH4C\S@8--Q;#C4/$9)IDA" 92* R0T!SR)S=\433-. M%11:SE=E"U#'QE,7:N2T/&FU/-MZ#;=*6R9$4FFUL;$Y>K$R6MM+=ZTZ^OT- M,F>NV['AYV&LG1K?1GM39E%[1AIKHC>U/3^5.[CJF=JF,LFO* ,V0^[F@N ; M;*-WF38C[P�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�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